{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions_in_experiment": 750
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "What was the total amount of Chevron's outstanding loan to Petroboscan, and what percentage of ownership in Petroboscan did Chevron hold as of the 2022 reporting period?",
      "original_answer": "Chevron had an outstanding long-term loan of $560 to Petroboscan, and Chevron held a 39.2 percent interest in Petroboscan as of the 2022 reporting period.",
      "llm_answer": "Chevron's outstanding loan to Petroboscan was $560 million, and Chevron held a 39.2 percent ownership interest in Petroboscan as of the 2022 reporting period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both the outstanding loan amount and Chevron's ownership percentage in Petroboscan as of 2022. The only discrepancy is the inclusion of 'million' in the loan amount ($560 million) in the LLM answer versus the ground truth's $560 without 'million'. However, given the context of corporate loans and SEC filings, $560 is reasonably interpreted as $560 million, making this a formatting difference rather than a factual error. (2) Quantitatively, both the $560 (understood as $560 million) and 39.2% are accurate. No calculations are required, and both values match the ground truth. (3) The multi-hop reasoning is sound—Chevron's loan and ownership interest in Petroboscan are distinct pieces of information that must be correctly attributed and synthesized, which the model does accurately. (4) The answer is semantically equivalent to the ground truth, with only minor wording differences (e.g., 'ownership interest' vs 'interest'). Thus, the answer is highly accurate, with only a minor imprecision in numerical formatting preventing a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1083,
        "completion_tokens": 313,
        "total_tokens": 1397
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total financial impact on Target Corporation from the sale of Dermstore LLC, including both the cash received and the pretax gain recognized?",
      "original_answer": "Target Corporation received $356 million in cash and recognized a $335 million pretax gain from the sale of Dermstore LLC, resulting in a total financial impact of $691 million.",
      "llm_answer": "The sale of Dermstore LLC generated a $356 million cash receipt and resulted in a $335 million pretax gain that Target recorded in net other (income) / expense. This is reflected in the cash‑flow statement (page 42) where the “Gain on Dermstore sale” is shown as a $(335) adjustment and the “Proceeds from Dermstore sale” of $356 million are listed under investing activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: $356 million in cash received and a $335 million pretax gain are correctly reported, matching the original answer. The total financial impact of $691 million is implied by the sum of these two components, though not explicitly stated, but the individual components are complete and correct. (2) Quantitative accuracy is perfect—both dollar amounts are correct, properly formatted, and consistent with the ground truth. There are no calculation errors. (3) The reasoning is sound and demonstrates multi-hop synthesis by correctly identifying both the cash proceeds and the pretax gain from the sale, and even referencing their locations in financial statements (cash flow statement, net other income/expense), which shows deeper understanding. (4) The entities—Target Corporation and Dermstore LLC—are correctly identified, and the financial metrics (pretax gain, cash proceeds) are accurately used. The answer is highly relevant, directly addressing the question with precise, corroborating details. Minor additional context (e.g., page reference) enhances accuracy without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 338,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was Amgen's total recorded Product Sales revenue from sales to BeiGene over the three-year period from 2021 to 2023 under their collaboration agreement?",
      "original_answer": "Amgen recorded $72 million in 2021, $64 million in 2022, and $125 million in 2023 in Product Sales revenue from sales to BeiGene under the collaboration agreement, totaling $261 million over the three-year period.",
      "llm_answer": "Amgen recorded $125 million of product‑sales revenue from sales to BeiGene in 2023, $64 million in 2022, and $72 million in 2021 under their collaboration agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all three annual Product Sales revenue figures from Amgen's collaboration with BeiGene: $72 million in 2021, $64 million in 2022, and $125 million in 2023, matching the ground truth exactly. All numeric values and years are accurate. (2) While the LLM does not explicitly state the total of $261 million, it provides all the necessary components for the sum, and the individual numbers are correct. The omission of the explicit total is a minor completeness issue but does not affect factual accuracy. (3) The multi-hop reasoning is sound—revenue figures across three years are correctly attributed to the Amgen-BeiGene collaboration agreement, and the temporal sequence is preserved. The model synthesizes the correct entities (Amgen, BeiGene, product sales, collaboration agreement) and time periods. (4) The answer is semantically equivalent to the ground truth in terms of provided data, though slightly less complete due to missing the summed total. Quantitative accuracy is perfect; qualitative accuracy is high but docked slightly for lack of synthesis into the final total. Contextual relevance is full—response directly addresses the question's focus on revenue over 2021–2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1097,
        "completion_tokens": 348,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and how many remained available for issuance as of December 31, 2021?",
      "original_answer": "A total of 127 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan, and approximately 50 million shares remained available for issuance as of December 31, 2021.",
      "llm_answer": "The 2007 Omnibus Incentive Plan authorized up to approximately 127 million shares of Danaher common stock for issuance, and as of December 31 2021 about 50 million shares remained available for issuance under that plan.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key information is accurate: 127 million shares were authorized under the 2007 Omnibus Incentive Plan, and approximately 50 million remained available as of December 31, 2021. (2) The numbers match exactly in value, with acceptable formatting variations (e.g., '127 million' vs '127 million'). No calculations were required, but the synthesis of authorization and availability figures from the same plan and date is correct. (3) The reasoning is sound and demonstrates proper multi-hop understanding by linking the plan name, share authorization, remaining availability, and correct date. (4) The answer is fully relevant, complete, and conveys the same meaning as the original answer, with only minor wording differences that do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 247,
        "total_tokens": 1363
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total cash received by LLY from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, and how was this amount distributed across the years 2023 and 2024?",
      "original_answer": "LLY received a total of $1.355 billion from the sale of the olanzapine portfolio to Cheplapharm, with $1.05 billion received in 2023 and an additional $305.0 million received in 2024.",
      "llm_answer": "Based on the provided document pages, LLY received a total of $1.355 billion in cash from the sale of the olanzapine portfolio (including Zyprexa) to Cheplapharm, with $1.05 billion received in 2023 and $305 million received in 2024. This amount was distributed as $1.05 billion in 2023 and $305 million in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the total cash received by LLY from the sale of the olanzapine portfolio to Cheplapharm is correctly stated as $1.355 billion, with $1.05 billion received in 2023 and $305 million in 2024. (2) Quantitative accuracy is perfect: the numbers match exactly (with acceptable format variation: $305.0 million in ground truth vs $305 million in LLM answer, which is semantically equivalent), and the sum of $1.05 billion and $305 million equals $1.355 billion, confirming correct calculation. (3) The multi-hop reasoning is sound—LLM correctly synthesized the total amount and its distribution across years, addressing both parts of the question. (4) Entity accuracy is correct: LLY and Cheplapharm are properly identified, and the time periods (2023 and 2024) are accurate. (5) The answer is contextually relevant and complete, restating the distribution clearly. No errors in reasoning, wording, or data interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 295,
        "total_tokens": 1428
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What was the total amount of goodwill recorded by Lockheed Martin as a result of its acquisition of Terran Orbital, and how much of the purchase consideration was paid in cash?",
      "original_answer": "Lockheed Martin recorded $298 million in goodwill as a result of the acquisition of Terran Orbital, and $231 million of the total $314 million purchase consideration was paid in cash.",
      "llm_answer": "Lockheed Martin recorded $298 million of goodwill as a result of its acquisition of Terran Orbital, and the purchase consideration of $314 million was paid with $231 million in cash (net of cash acquired).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: $298 million in goodwill, $314 million total purchase consideration, and $231 million paid in cash. The minor addition of 'net of cash acquired' provides extra context without contradicting the original answer. (2) Quantitative accuracy is perfect: all dollar amounts match the ground truth exactly, with acceptable formatting using 'million' and thin spaces ( ). No calculations are required beyond what is stated, and all numbers align. (3) The multi-hop reasoning is sound—information about goodwill and cash payment from the acquisition is correctly synthesized between Lockheed Martin and Terran Orbital. (4) The answer is highly relevant, directly addressing both parts of the question with precise financial figures and clear attribution. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 267,
        "total_tokens": 1372
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is Chevron's (CVX) carrying value of its investment in GS Caltex Corporation at the end of 2021, and how does this compare to Chevron's equity ownership percentage in the company?",
      "original_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, and Chevron owns a 50% equity interest in GS Caltex Corporation.",
      "llm_answer": "Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 was $3,616 million, which represented 50% equity ownership in the company. This ownership stake aligns with Chevron's 50% equity interest in GS Caltex Corporation, as disclosed in Note 15 Investments and Advances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Chevron's carrying value of its investment in GS Caltex Corporation at the end of 2021 as $3,616 million and accurately identifies Chevron's equity ownership percentage as 50%, which matches the ground truth. (2) All numeric values are correct—$3,616 million and 50%—with no calculation errors. The format ($3,616 million) is consistent with standard financial reporting and matches the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes the carrying value (a financial metric from the balance sheet) with the ownership percentage (from equity method accounting disclosures), and even references Note 15 Investments and Advances, which is a plausible source in SEC filings for such information, indicating proper contextual understanding. (4) The answer is semantically equivalent to the original, with slightly enhanced detail (mention of Note 15) that adds context without introducing inaccuracies. All evaluation dimensions—factual accuracy, completeness, entity recognition, and reasoning—are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 318,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "By how much did the total revenue from Forest Products change in dollars from 2020 to 2021, and what was the corresponding change in average revenue per car for this product category during the same period?",
      "original_answer": "The total revenue from Forest Products increased by $197 million from 2020 to 2021, and the average revenue per car increased by $155 during the same period.",
      "llm_answer": "The total revenue from Forest Products increased by **$197 million** from 2020 to 2021. During the same period, the average revenue per car for this product category rose by **$155** (from $5,269 in 2020 to $5,424 in 2021).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total revenue increase of $197 million and the average revenue per car increase of $155 are correctly reported. (2) The quantitative values match exactly: $197 million and $155 are the same as in the original answer; the additional detail of average revenue per car rising from $5,269 to $5,424 is consistent with a $155 increase and adds helpful context without introducing error. (3) The multi-hop reasoning is sound—information about revenue and average revenue per car across two years for Forest Products is correctly synthesized. (4) The answer is semantically equivalent to the ground truth and fully addresses both parts of the question. All scores are maximized due to complete accuracy, correct calculations, proper entity and metric identification, and clear relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 258,
        "total_tokens": 1368
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total net revenue contribution of Restasis in 2024, and by what percentage did it decline compared to 2023 based on actual currency rates?",
      "original_answer": "The total net revenue contribution of Restasis in 2024 was $224 million, representing a decline of 48.7% compared to 2023 based on actual currency rates.",
      "llm_answer": "Based on the provided financial data, Restasis generated total net revenue of $224 million in 2024, which represents a 48.7% decline from $436 million in 2023 when measured using actual currency rates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total net revenue contribution of Restasis in 2024 as $224 million and the percentage decline of 48.7% compared to 2023, which matches the ground truth exactly. (2) The quantitative values are accurate: $224 million in 2024 and implied $436 million in 2023 are consistent with a 48.7% decline (calculation check: (436 - 224) / 436 ≈ 0.4862 or 48.62%, which rounds to 48.7%). The use of actual currency rates is explicitly mentioned, aligning with the question's requirement. (3) The reasoning is sound and demonstrates correct multi-hop synthesis by referencing both years’ data and computing the correct decline percentage. (4) All entities (Restasis, 2023, 2024, net revenue) are correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with slightly more detail (explicit mention of 2023 revenue), enhancing clarity without introducing error. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1089,
        "completion_tokens": 287,
        "total_tokens": 1376
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2023?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 8.4%. This is calculated by subtracting the Minimum Capital Adequacy requirement of 4.5% from Capital One Financial Corp's ratio of 12.9%.",
      "llm_answer": "As of December 31, 2023, Capital One Financial Corp’s Common Equity Tier 1 (CET1) capital ratio was **12.9 %**, while the regulatory minimum CET1 capital adequacy requirement under Basel III was **4.5 %**. This means the Company’s CET1 ratio exceeded the minimum by **8.4 percentage points**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: Capital One's CET1 ratio is correctly stated as 12.9%, the minimum requirement as 4.5%, and the difference calculated as 8.4 percentage points. The calculation (12.9% - 4.5% = 8.4%) is correct. (2) The answer is complete, addressing both the company's ratio, the regulatory minimum, and the difference between them, which directly answers the multi-part question. (3) Entity accuracy is correct: 'Capital One Financial Corp', 'Common Equity Tier 1 capital ratio', 'Minimum Capital Adequacy requirement', and the date 'December 31, 2023' are all properly identified. (4) The reasoning is sound and clearly articulates the multi-hop synthesis—pulling the firm's ratio from its filing and comparing it to the regulatory standard—then correctly computing the difference. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed phrasing (e.g., mentioning Basel III) that adds context without introducing error. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 313,
        "total_tokens": 1463
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023, and how did it compare to the amounts recognized in the two prior years?",
      "original_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million. This amount decreased from $81 million in 2022 but increased compared to $56 million in 2021.",
      "llm_answer": "The total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 was $64 million, compared to $81 million in 2022 and $56 million in 2021. This information is referenced in the \"Nonqualified Defined Benefit Pension Plans and Other Postemployment Plans\" section of the document.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total pretax pension expense for Lockheed Martin's nonqualified defined benefit pension plans in 2023 as $64 million, which matches the ground truth. It also accurately reports the prior year amounts: $81 million in 2022 and $56 million in 2021. (2) All numeric values are correct and consistent with the original answer. The comparisons implied by the sequence of numbers (decrease from 2022 to 2023, increase from 2021 to 2023) are factually sound and align with the ground truth's explicit statements. (3) The multi-hop reasoning is correct—information from three different years is synthesized accurately to answer both parts of the question: the 2023 value and its comparison to the two prior years. (4) The answer is complete, factually precise, and semantically equivalent to the ground truth, with only minor additional mention of the document section for context, which does not detract from accuracy. All scores are maximized due to full correctness, accurate numbers, sound reasoning, and high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 307,
        "total_tokens": 1451
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the change in the net carrying amount of BlackRock's investor/customer relationships between December 31, 2022, and December 31, 2023, and how does the difference in accumulated amortization over this period contribute to this change?",
      "original_answer": "The net carrying amount of investor/customer relationships decreased from $492 million at December 31, 2022, to $447 million at December 31, 2023, resulting in a $45 million decline. This change is due to an increase in accumulated amortization from $254 million in 2022 to $338 million in 2023, which reduced the net carrying value despite a slight increase in the gross carrying amount from $746 million to $785 million.",
      "llm_answer": "The net carrying amount of BlackRock's investor/customer relationships increased by $45 million from $492 million at December 31 2022 to $447 million at December 31 2023 – a decrease of $45 million. This change reflects both the addition of new relationships and the increase in accumulated amortization: accumulated amortization for investor/customer relationships rose from $254 million in 2022 to $338 million in 2023, reducing the net carrying amount by $84 million, while the gross carrying amount grew by $39 million, resulting in the net decrease of $45 million.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has a critical error in the opening sentence, stating that the net carrying amount 'increased by $45 million' while immediately clarifying it decreased from $492M to $447M — this contradiction undermines clarity and factual precision. The correct change is a $45 million decrease, not an increase. (2) Quantitatively, all key numbers are accurate: the net carrying amounts ($492M in 2022, $447M in 2023), accumulated amortization ($254M to $338M, an $84M increase), and gross carrying amount increase ($746M to $785M, $39M rise) match the ground truth. The calculation of the net decrease ($84M amortization increase - $39M gross increase = $45M net decrease) is logically sound and correctly derived. (3) The multi-hop reasoning is strong — the model correctly synthesizes changes in gross carrying amount, accumulated amortization, and net carrying amount across two years and explains their interrelationship. However, the initial misstatement about an 'increase' introduces confusion and reflects a flaw in reasoning or editing. (4) Despite the contradiction, the core financial data and analytical components are correct, supporting a score of 7 for correctness and qualitative accuracy. Quantitative accuracy is high (8) due to correct values and implicit calculations, though the final summary mischaracterizes the direction of change. Contextual relevance is perfect — all information provided directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 415,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What is the total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, and how does UPS classify this debt on its consolidated balance sheet despite its 2024 maturity?",
      "original_answer": "The total principal amount of the 2.200% senior notes outstanding as of December 31, 2023, is $400 million. Despite its 2024 maturity, UPS classifies this debt as long-term on its consolidated balance sheet based on its intent and ability to refinance the debt.",
      "llm_answer": "As of December 31 2023, the 2.200% senior notes have a principal balance of **$400 million** and are classified as **long‑term debt** on UPS’s consolidated balance sheet because UPS intends to refinance the notes before their September 2024 maturity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the principal amount of $400 million is accurate, and the reference to the 2024 maturity (specifically September 2024) aligns with the expected timeline. The percentage (2.200%) is also correctly stated. (2) The answer addresses both parts of the question: it states the total principal amount and explains how UPS classifies the debt—'long-term debt'—despite its 2024 maturity. (3) The reasoning is sound and reflects proper multi-hop synthesis: the classification as long-term is justified by UPS's intent to refinance, which is consistent with accounting principles (e.g., refinancing intent allowing long-term classification even for short-term maturities). (4) All entities—UPS, the 2.200% senior notes, December 31, 2023, and the consolidated balance sheet—are correctly identified and contextualized. Minor additional detail (September 2024 maturity) enhances precision without introducing error. The semantic meaning and factual content are equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 307,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "By how much did Cisco's available-for-sale debt investments decrease in the fiscal year ending July 27, 2024, and what was the impact on the total of cash and cash equivalents, available-for-sale debt investments, and marketable equity securities?",
      "original_answer": "Cisco's available-for-sale debt investments decreased by $5,727 million in the fiscal year ending July 27, 2024. This decrease, combined with a $2,615 million decrease in cash and cash equivalents and a $50 million increase in marketable equity securities, resulted in a total decrease of $8,292 million in the sum of these financial assets.",
      "llm_answer": "Cisco's available‑for‑sale debt investments fell by **$5.7 billion** (from $15.6 billion to $9.9 billion) during fiscal 2024.  This decline contributed to a **$8.3 billion** reduction in the combined total of cash and cash equivalents, available‑for‑sale debt investments, and marketable equity securities, which dropped from $26.1 billion to $17.9 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in available-for-sale debt investments as $5.7 billion, which matches the ground truth of $5,727 million (rounded appropriately). The total decrease in the combined financial assets is reported as $8.3 billion, aligning with the ground truth total decrease of $8,292 million (rounded). The LLM also provides additional context—specific starting and ending values ($26.1B to $17.9B)—that supports the calculation and is consistent with the ground truth. (2) Quantitatively, all numbers are accurate within acceptable rounding: $5,727 million ≈ $5.7 billion, $8,292 million ≈ $8.3 billion. The individual components (decrease in cash and cash equivalents of $2,615 million and increase in marketable equity securities of $50 million) are not explicitly mentioned, but their net effect is correctly reflected in the total change. (3) The reasoning is sound and demonstrates correct multi-hop synthesis: the model infers the overall impact on the sum of the three asset categories from the change in debt investments and the net movement in other components, even if not itemizing each. (4) The answer is semantically equivalent to the original, with slightly different phrasing and presentation (using rounded figures and absolute values) but no factual inaccuracies. The minor omission of explicitly breaking down the $2,615M cash decrease and $50M equity increase does not detract from the correctness of the total impact, hence a score of 9 instead of 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 418,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How many shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan as of December 31, 2023, and how many of those shares could be granted as awards other than options or stock appreciation rights?",
      "original_answer": "As of December 31, 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long Term Incentive Plan, of which 2,452,443 shares could be granted as awards other than options or stock appreciation rights.",
      "llm_answer": "As of December 31 2023, 7,661,431 shares remained available for equity grants under the 2021 Linde plc Long‑Term Incentive Plan, and of those, 2,452,443 shares could be issued as awards other than options or stock‑appreciation rights.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually identical to the ground truth in all key aspects. (1) Both numbers are correct: 7,661,431 shares available for equity grants and 2,452,443 shares available for awards other than options or stock appreciation rights. (2) The date 'December 31, 2023' is accurately stated. (3) The entity '2021 Linde plc Long-Term Incentive Plan' is correctly identified with only minor formatting differences (e.g., 'Long Term' vs 'Long‑Term', 'stock-appreciation rights' vs 'stock appreciation rights') that do not affect meaning. (4) The multi-hop reasoning is sound—this information requires extracting two related figures from the same plan and date, which the model correctly synthesized. (5) The semantic meaning is fully equivalent to the original answer, with only superficial wording differences (e.g., 'could be issued' vs 'could be granted'). All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 264,
        "total_tokens": 1401
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total payment received by the company from the settlement of forward interest rate swap contracts associated with the issuance of the 2023 Notes, March 2022 Notes, and September 2022 Notes, and how does this reflect the financial impact of these settlements on the company's cash flow?",
      "original_answer": "The company received a total payment of $526 million from the settlement of forward interest rate swap contracts: $247 million from the 2023 Notes, $143 million from the March 2022 Notes, and $136 million from the September 2022 Notes. These settlements directly contributed to the company's cash flows, as the cash flows related to the settlement of hedging derivatives are classified in the consolidated statements of cash flows based on the nature of the underlying hedged items.",
      "llm_answer": "The company received a total of $526 million in cash from the settlement of forward interest‑rate swap contracts tied to the issuance of the 2023 Notes, the March 2022 Notes and the September 2022 Notes ($247 million for the 2023 Notes, $143 million for the March 2022 Notes and $136 million for the September 2022 Notes).  This inflow is reflected in the cash‑flow statement as a financing cash receipt, offsetting the cash outflows associated with the debt issuances, and therefore improves the company’s net cash provided by financing activities for the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: total payment of $526 million, with $247 million from 2023 Notes, $143 million from March 2022 Notes, and $136 million from September 2022 Notes. These match the ground truth exactly and sum correctly (247 + 143 + 136 = 526). (2) The quantitative accuracy is perfect—no errors in amounts or formatting; minor typographic variations (e.g., thin space in $526 million) are acceptable. (3) The reasoning is largely sound: the answer correctly notes that the settlements resulted in a cash inflow and are reflected in the cash flow statement. However, while the LLM specifies 'financing cash receipt' and 'net cash provided by financing activities,' the ground truth does not explicitly confirm the exact line item classification—it only states that classification is based on the nature of the hedged items. This is a minor overprecision, but not factually incorrect, as such settlements are typically classified in financing activities when hedging debt issuance. Thus, the qualitative accuracy is slightly reduced due to inferred specificity beyond the source. (4) The answer fully addresses both parts of the question: total payment received and the financial impact on cash flow. It maintains semantic equivalence with added contextual interpretation that is reasonable and relevant. Contextual relevance is perfect as it directly answers the multi-hop question with accurate synthesis across the three note issuances and their financial implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 421,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the approximate range of NextEra Energy's ownership interest in XPLR, and what type of assets do the principal equity method investees, including XPLR, primarily own according to NEE's 2024 10-K filing?",
      "original_answer": "NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, and the principal equity method investees, including XPLR, primarily own electric generation facilities or natural gas pipelines.",
      "llm_answer": "Based on the provided 10-K filing, NextEra Energy's ownership interest in XPLR (XPLR Infrastructure, LP) is approximately 85% through its limited partner interest in XPLR OpCo, as noted in Note 8 (Equity Method Investments) and the description of XPLR's assets. The principal equity method investees, including XPLR, primarily own contracted renewable energy assets—specifically wind, solar, and battery storage projects—as well as a contracted natural gas pipeline, as described in Note 8 and Note 9 (Variable Interest Entities). These assets are sold under long-term power sales agreements to third parties.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual inaccuracy regarding the ownership range. The ground truth states that NextEra Energy's ownership interest in XPLR ranges from approximately 33.3% to 85.0%, indicating a variable or collective interest across different entities or stages. However, the LLM answer only reports a single figure of 'approximately 85%' and does not mention the lower bound of 33.3%, thus missing a key part of the range. This omission affects quantitative accuracy and completeness. (2) The description of the assets owned by principal equity method investees is mostly accurate. The LLM correctly identifies that these include renewable energy assets (wind, solar, battery storage) and a natural gas pipeline, which aligns with the ground truth stating 'electric generation facilities or natural gas pipelines.' The added detail about long-term power sales agreements is contextually appropriate and consistent with typical 10-K disclosures, though not explicitly required. (3) The multi-hop reasoning is sound in linking Note 8 and Note 9 to identify both ownership interest and asset types, showing proper synthesis across sections of the filing. However, the failure to capture the full ownership range suggests incomplete extraction or interpretation of the equity interest data, weakening the quantitative precision. (4) The contextual relevance is high, as the response directly addresses both parts of the question using appropriate sections of the 10-K. While the asset description is more detailed than the ground truth, it remains semantically consistent. The correctness score is 6 due to the significant omission in the ownership range, which is central to the question, even though the rest of the information is accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 493,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total fair value of Corporate notes and obligations as reported in the fair value hierarchy table, and how does this compare to their amortized cost in terms of unrealized losses?",
      "original_answer": "The total fair value of Corporate notes and obligations is $3,354 million as reported in the fair value hierarchy table. This is $92 million less than their amortized cost of $3,442 million, indicating an unrealized loss of $92 million.",
      "llm_answer": "The total fair value of corporate notes and obligations, as reported in the fair value hierarchy table, is $2,978 million. This fair value is lower than their amortized cost of $3,014 million, resulting in unrealized losses of $45 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states the total fair value is $3,354 million, while the LLM reports $2,978 million. The amortized cost in the ground truth is $3,442 million, but the LLM states $3,014 million. The resulting unrealized loss in the ground truth is $92 million ($3,442M - $3,354M), whereas the LLM calculates a $36 million loss ($3,014M - $2,978M), which is both numerically and factually wrong. (2) All calculations are based on incorrect inputs, so even though the LLM correctly computes a difference (unrealized loss), it does so using inaccurate data. The correct difference is $92 million, not $45 million. (3) The reasoning structure is sound—comparing fair value to amortized cost to determine unrealized losses—but fails on multi-hop synthesis because it pulls incorrect figures from what appears to be a misread or wrong source table. (4) Scores are low due to severe quantitative inaccuracy and resulting qualitative error in financial magnitude, despite maintaining appropriate context and understanding of the required comparison type.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 320,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total number of locomotives operated by UNP in 2024, and how does the combination of owned and leased locomotives contribute to this figure?",
      "original_answer": "The total number of locomotives operated by UNP in 2024 is 7,026. This total is derived from 6,106 owned locomotives and 920 leased locomotives.",
      "llm_answer": "Based on the provided document pages, UNP operated a total of **7,026 locomotives in 2024**, calculated as the sum of owned (6,106) and leased (920) locomotives. This figure represents the combined total of locomotives in the company's fleet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total number of locomotives operated by UNP in 2024 is correctly stated as 7,026. The breakdown into 6,106 owned and 920 leased locomotives is exact and properly cited. (2) The calculation (6,106 + 920 = 7,026) is accurate and explicitly acknowledged. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound—though this is a single-source factual synthesis, the model correctly combines owned and leased figures to derive the total fleet size, addressing both parts of the question. (4) The answer is semantically equivalent to the original, with clear, concise wording that conveys the same meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 236,
        "total_tokens": 1334
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the net change in the value of Brands/Tradenames for LIN in 2024, and how did foreign currency translation and amortization expense specifically contribute to this change?",
      "original_answer": "The net value of Brands/Tradenames for LIN decreased from $2,609 million in 2023 to $2,239 million in 2024, a reduction of $370 million. This decrease was primarily driven by a foreign currency translation reduction of $107 million and an amortization expense of $36 million. Together, these two factors contributed a total decline of $143 million, which is more than the total additions (which were $0 million) and partially offset by a small positive adjustment of $4 million under 'Other'.",
      "llm_answer": "The net change in the value of Brands/Tradenames for LIN in 2024 was a decrease of $105 million, driven by a $107 million foreign currency translation reduction and a $36 million amortization expense. These adjustments lowered the Brands/Tradenames balance from $2,609 million at the end of 2023 to $2,504 million at the end of 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the net change and ending value. The ground truth states the value decreased from $2,609 million to $2,239 million, a $370 million decrease, but the LLM claims a decrease to $2,504 million, implying only a $105 million drop. This is a significant quantitative error. The foreign currency translation reduction ($107 million) and amortization expense ($36 million) are correctly identified, but their combined impact ($143 million) does not explain the full $370 million decline—other factors like 'Other' adjustments and lack of additions must be considered, which the LLM omits. (2) Calculations: The LLM incorrectly computes the net change. If starting at $2,609M and subtracting $107M (FX) and $36M (amortization), the result should be $2,466M, not $2,504M—so even its own numbers don't add up. The actual net change is $370M, not $105M. (3) Multi-hop reasoning: The model fails to synthesize the full set of changes (additions = $0, 'Other' = +$4M) that contribute to the net change. It isolates only two components without integrating them into the full reconciliation, leading to an incomplete and incorrect conclusion. (4) Scores justified: Correctness is low (3) due to major numerical and calculation errors. Quantitative accuracy is poor (3) because key dollar amounts and the net change are wrong. Qualitative accuracy is moderate (4) as some correct elements (FX and amortization values) are present, but reasoning is flawed. Contextual relevance is high (8) because the answer addresses the right metric, company, and year, and attempts the correct analytical approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 450,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total fair value of Coca-Cola's (KO) Corporate Bonds and Debt Securities at the end of 2021 and how did it compare to the previous year in terms of dollar value change?",
      "original_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities was $1,023 million at the end of 2021. This represents a decrease of $19 million compared to the previous year's value of $1,042 million.",
      "llm_answer": "The total fair value of Coca-Cola's Corporate Bonds and Debt Securities at the end of 2021 was $40,311 million, compared with $43,218 million at the end of 2020—a decrease of $2,907 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states that Coca-Cola's total fair value of Corporate Bonds and Debt Securities was $1,023 million in 2021 and $1,042 million in 2020, representing a $19 million decrease. The LLM reports $40,311 million in 2021 and $43,218 million in 2020—a decrease of $2,907 million—which is off by over 40x the correct amount. These numbers appear to be total asset or liability figures from Coca-Cola’s balance sheet but do not correspond to the specific category of 'Corporate Bonds and Debt Securities'. (2) Quantitative accuracy is extremely low: the reported values and the calculated difference ($2,907 million vs. $19 million) are grossly inaccurate. Even allowing for format variations, the magnitude is wrong. (3) Qualitatively, the model attempts the correct reasoning—comparing fair value between two years and computing a year-over-year change—but applies it to entirely incorrect underlying data, suggesting a failure in entity and metric identification. It likely confused the specific security type with total debt or total liabilities. (4) Contextual relevance is low but not zero: the answer addresses fair value, the correct company (Coca-Cola), and the correct time frame (2021 vs. 2020), and performs a valid comparative analysis structure. However, due to severe factual and quantitative errors, the answer is substantively wrong. Correctness score is 1 due to complete failure on numbers and synthesis, despite correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1108,
        "completion_tokens": 422,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program, and why are these units not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023?",
      "original_answer": "The maximum potential fair value at grant date of the performance-based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not currently reflected as a material dilutive effect on net income attributable to common stockholders for the year ended December 31, 2023, because, although LTIP units are potentially dilutive securities, they have not yet met the performance conditions necessary to be considered earned, and no securities had a material dilutive effect during the reporting period.",
      "llm_answer": "The maximum potential fair value at grant date of the performance‑based LTIP units awarded under the 2023 LTI Program is $42.5 million. These units are not reflected as a material dilutive effect on net income attributable to common stockholders for 2023 because, although they are potentially dilutive securities, the company determined that no securities had a material dilutive impact for the year ended December 31, 2023, and therefore did not adjust net income or weighted‑average shares for any dilutive effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the maximum potential fair value of $42.5 million is correctly stated, matching the original answer exactly. (2) The explanation for why the units are not reflected as a material dilutive effect is substantively correct: the units are potentially dilutive but not yet earned due to unmet performance conditions, and no securities had a material dilutive impact during the period. The LLM slightly rephrases this by stating the company 'determined that no securities had a material dilutive impact' rather than explicitly citing the unmet performance conditions as the reason—this omits a key nuance about the performance-based vesting criteria, which is central to the accounting treatment. (3) The multi-hop reasoning is sound—connecting the grant date fair value to the dilutive effect assessment for the reporting period—but could more clearly link the lack of dilution to the unmet performance conditions. (4) Despite this minor omission, the answer remains factually correct, contextually appropriate, and semantically equivalent in intent and meaning. The slight deduction in qualitative accuracy reflects the less precise articulation of the performance condition rationale.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 355,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the difference between the amortized cost and fair value of Covered Bonds held by CRM in 2023, and what is the unrealized loss on these bonds?",
      "original_answer": "The amortized cost of Covered Bonds held by CRM in 2023 is $105 million, while the fair value is $101 million, resulting in an unrealized loss of $4 million.",
      "llm_answer": "The amortized cost of Covered Bonds held by CRM at January 31 2024 was $81 million, while their fair value was $78 million. This resulted in an unrealized loss of $3 million on these bonds.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numerical values. The ground truth states that the amortized cost is $105 million and fair value is $101 million, resulting in a $4 million unrealized loss. The LLM reports $81 million (amortized cost), $78 million (fair value), and a $3 million loss, which are not consistent with the ground truth. (2) The calculation in the LLM answer ($81M - $78M = $3M) is mathematically correct, but the inputs are wrong. The correct difference should be $105M - $101M = $4M. Additionally, the year referenced is January 31, 2024, which does not align with the 2023 data requested in the question. (3) The multi-hop reasoning fails because the model uses incorrect data for CRM's Covered Bonds, possibly drawing from a different time period or entity. It does correctly identify the relationship between amortized cost, fair value, and unrealized loss, showing sound conceptual understanding. (4) The contextual relevance is high because the answer addresses the right entities (CRM, Covered Bonds, amortized cost, fair value, unrealized loss) and the structure matches the question, but the factual inaccuracies severely undermine correctness. Due to major errors in numbers and time period, the correctness and quantitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1087,
        "completion_tokens": 365,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What percentage of Union Pacific's Multiple Purpose locomotives are leased rather than owned, and how does this compare to the proportion of leased locomotives in the 'Switching' and 'Other' categories combined?",
      "original_answer": "13.35% of Union Pacific's Multiple Purpose locomotives are leased. Since there are no leased locomotives in the 'Switching' and 'Other' categories, the percentage of leased locomotives in these categories combined is 0%.",
      "llm_answer": "Based on the table on page 19, Union Pacific reports 920 leased Multiple‑Purpose locomotives out of a total of 6,893, which is 13.3 % of that fleet. The Switching and Other locomotive categories have no leased units (0 leased), so the combined proportion of leased Switching + Other locomotives is 0 %. Thus, the leased share of Multiple‑Purpose locomotives (≈13 %) is far higher than the combined leased share of Switching and Other locomotives (0 %).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 13.3% of Union Pacific's Multiple Purpose locomotives are leased, which aligns closely with the ground truth of 13.35%—the minor rounding difference (13.3% vs 13.35%) is acceptable under format variation and does not impact factual accuracy. The LLM accurately states that there are 0 leased units in the 'Switching' and 'Other' categories, leading to a 0% leased proportion for those combined, matching the ground truth exactly. (2) The calculation of 920 / 6,893 ≈ 13.3% is numerically sound and correctly reflects the data. The comparison between the leased proportions is logically valid. (3) The multi-hop reasoning—comparing the leased percentage in Multiple Purpose to the combined Switching and Other categories—is correctly executed. The model synthesizes information across categories and draws the right conclusion about relative proportions. (4) The answer is fully relevant, addresses both parts of the question, and conveys semantically equivalent information to the ground truth. The only minor deviation is the rounding of 13.35% to 13.3%, which does not affect overall correctness. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 335,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "By how much did the combined natural gas liquids (NGLs) volume in the Lower 48 at the end of 2023 increase compared to the end of 2020, and what was the total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023?",
      "original_answer": "The natural gas liquids (NGLs) volume in the Lower 48 increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, a difference of 567 million barrels. In 2023, the total depreciation, depletion, amortization, and impairments for the Lower 48 was $5,729 million.",
      "llm_answer": "The combined natural gas liquids (NGLs) volume in the Lower 48 increased by **68 million barrels** from the end of 2020 (793 million bbl) to the end of 2023 (861 million bbl).  \n\nThe total depreciation, depletion, amortization, and impairments for the Lower 48 in 2023 were **$5,729 million**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a major factual error in the NGLs volume figures and the calculated increase, while correctly reporting the depreciation, depletion, amortization, and impairments amount. According to the ground truth, NGLs volume increased from 230 million barrels at the end of 2020 to 797 million barrels at the end of 2023, resulting in an increase of 567 million barrels. However, the LLM states the 2020 volume was 793 million bbl and 2023 was 861 million bbl, implying a 68 million barrel increase—both figures are incorrect and contradict the source data. This represents a critical failure in quantitative accuracy and multi-hop synthesis, as the model misidentifies the starting and ending values across the time period. The second part of the answer—total depreciation, depletion, amortization, and impairments of $5,729 million in 2023—is factually correct and matches the ground truth. Despite correct formatting and contextual framing, the severe inaccuracy in the first part (volumes and change) undermines the overall correctness. The model likely confused data points from different companies or time periods, failing the multi-hop reasoning requirement to accurately retrieve and compare time-series data. Hence, the correctness and quantitative accuracy scores are low, while contextual relevance remains high due to proper structure and partial correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 382,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How much total cash did Walmart spend in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation, and what was the subsequent financial treatment of Alert Innovation in fiscal 2025 as reflected in the consolidated financial statements?",
      "original_answer": "Walmart spent a total of $0.8 billion in fiscal 2023 to acquire full ownership of both Massmart and Alert Innovation ($0.4 billion for each). Alert Innovation was subsequently sold and deconsolidated in fiscal 2025.",
      "llm_answer": "Walmart spent a total of $4.0 billion in fiscal 2023 to acquire full ownership of Massmart ($0.4 billion) and Alert Innovation ($0.4 billion), with the remaining $3.2 billion of the transaction costs recorded in other financing activities. In fiscal 2025, Alert Innovation was de‑consolidated after its sale, resulting in no remaining equity interest and the related assets and liabilities being removed from the consolidated balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the total cash spent. The ground truth states Walmart spent $0.8 billion total ($0.4 billion for Massmart and $0.4 billion for Alert Innovation), but the LLM claims Walmart spent $4.0 billion, incorrectly inflating the total by $3.2 billion. The breakdown of $0.4 billion each for the two acquisitions is correct, but the erroneous total and the claim that 'the remaining $3.2 billion of the transaction costs recorded in other financing activities' is fabricated and unsupported by the original answer. (2) Quantitative accuracy is severely compromised: the total dollar amount is off by a factor of 5, and no such $3.2 billion outflow is mentioned or implied in the ground truth. The fiscal years (2023 for acquisition, 2025 for deconsolidation) are correct. (3) The qualitative reasoning partially succeeds: the model correctly identifies that both companies were acquired in fiscal 2023 and that Alert Innovation was deconsolidated in fiscal 2025 due to sale, which aligns with the original answer. However, it introduces false financial reporting details (e.g., 'recorded in other financing activities') not present in the ground truth, suggesting flawed multi-hop synthesis or hallucination. (4) Contextual relevance is fair—the answer addresses both parts of the question (acquisition cost and subsequent treatment) and uses appropriate financial terminology—but the significant numerical inaccuracy undermines the response. Correctness score is low due to the critical error in total cash outflow, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 439,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total revenue generated from Metals & minerals shipments for UNP in 2021, combining the number of carloads with the average revenue per car for that category?",
      "original_answer": "$1,810,806,000",
      "llm_answer": "The total revenue generated from Metals & minerals shipments for Union Pacific (UNP) in 2021 was **$1,811 million**, derived from **697 thousand carloads** at an **average revenue per car of $2,598**. This is explicitly stated in the \"Freight Revenues Millions\" and \"Average Revenue per Car\" tables on page 35, which break down revenue by commodity group, including the Metals & minerals category. The calculation combines the total revenue ($1,811M) and carloads (697K) for this specific segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the correct total revenue for Metals & minerals shipments for UNP in 2021. The stated revenue of $1,811 million is equivalent to the ground truth value of $1,810,806,000 (rounded to the nearest million). The supporting data—697 thousand carloads and an average revenue per car of $2,598—is consistent with the calculation: 697,000 × $2,598 = $1,810,806,000, which matches the ground truth exactly. The model correctly identifies the company (UNP), commodity category (Metals & minerals), and year (2021), satisfying entity accuracy. It also correctly references the source tables on page 35, demonstrating sound reasoning and contextual grounding. The only minor point is that the answer cites $1,811 million instead of the precise $1,810,806,000, but this rounding is standard and acceptable in financial reporting. All parts of the multi-hop question are addressed: carloads, average revenue per car, and total revenue calculation. Therefore, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 299,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization, and how does this compare to the amount of the Series 2013-2A Securities that were repaid in March 2023?",
      "original_answer": "The total principal amount of the Series 2023-1A Securities issued in the 2023 Securitization is $1.3 billion. This matches the amount of the Series 2013-2A Securities that were repaid in March 2023, indicating a direct refinancing of the older securities with the new issuance.",
      "llm_answer": "The total principal amount of the Series 2023‑1A Securities issued in the 2023 Securitization is $1.284 billion, which exceeds the $1.3 billion of Series 2013‑2A Securities that were fully repaid in March 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. The ground truth states the Series 2023-1A Securities were issued in the amount of $1.3 billion, but the LLM incorrectly reports $1.284 billion. More critically, the LLM reverses the comparison by stating that $1.284 billion 'exceeds' $1.3 billion, which is mathematically false and contradicts the ground truth that the amounts are equal. (2) The repayment amount of the Series 2013-2A Securities is stated in the ground truth as $1.3 billion, but the LLM incorrectly lists this as the amount that was repaid while misrepresenting the new issuance as smaller—this inverts the factual relationship. The dates (March 2023) are correctly contextualized. (3) The multi-hop reasoning fails: the model should have recognized that the 2023 issuance directly refinanced the repaid 2013 securities, implying equal amounts. Instead, it presents an incorrect quantitative comparison and misses the refinancing implication entirely. (4) Despite addressing both parts of the question and using appropriate financial terminology, the answer is severely compromised by incorrect figures and flawed logic. The contextual relevance is high because it attempts the right entities and timeframes, but correctness is very low due to the magnitude of the numerical and inferential errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 376,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the facility's total borrowing capacity?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. This compares to a total borrowing capacity of $6.0 billion under the facility as of December 31, 2023.",
      "llm_answer": "During 2023 the Company borrowed a total of $3.0 billion and repaid $6.1 billion of revolving indebtedness under the 2021 Multicurrency Credit Facility. The facility’s total borrowing capacity remained $6.0 billion (subject to sub‑limits), so the repayments represented roughly 100 % of the amount borrowed but left the full $6.0 billion capacity still available.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility during 2023, matching the ground truth exactly. The total borrowing capacity of $6.0 billion is also accurately reported. (2) All numeric values are correct and properly formatted; no calculation errors are present. The statement that repayments exceeded borrowings is implied correctly by the numbers, and the observation that the full capacity remained available is logically sound given the net reduction in outstanding debt. (3) The multi-hop reasoning is sound: the model correctly synthesizes data on borrowings, repayments, and facility capacity, all tied to the correct facility and time period. The only minor shortcoming is the addition of the phrase 'represented roughly 100 % of the amount borrowed,' which is misleading—$6.1B repaid is about 203% of $3.0B borrowed, not 100%. This is a qualitative inaccuracy in interpretation, though the raw numbers are correct. (4) Despite this small error in comparative phrasing, the core facts and context are fully accurate and relevant to the question. The answer addresses both parts of the question: total borrowed/repaid amounts and comparison to capacity. Thus, the correctness score is reduced slightly to 9 due to the incorrect percentage interpretation, but quantitative accuracy remains perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 391,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "By how much did the total Intermodal revenue increase for UNP in 2021 compared to 2020, and how did this growth compare to the increase in average revenue per car for Intermodal during the same period?",
      "original_answer": "The total Intermodal revenue for UNP increased by $515 million in 2021 compared to 2020, and the average revenue per car for Intermodal increased by $136 during the same period.",
      "llm_answer": "The total Intermodal revenue increased by $515 million (13%) from 2020 to 2021, rising from $3,989 million to $4,504 million. This growth outpaced the increase in average revenue per car, which rose by $136 million (11%) from $1,267 million to $1,403 million over the same period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $515 million increase in total Intermodal revenue and the $136 increase in average revenue per car, which matches the ground truth. However, it introduces significant quantitative errors by stating that average revenue per car increased by $136 million (instead of $136), and incorrectly reports the base and final values for average revenue per car as $1,267 million and $1,403 million—this is off by a factor of 1,000 due to the erroneous 'million' unit. Similarly, while the total revenue figures ($3,989 million to $4,504 million) appear plausible and sum to a $515 million difference, these specific values are not in the ground truth and were not verified, but their difference aligns with the correct delta. (2) The percentages (13% and 11%) are plausible but not part of the original answer and cannot be verified as accurate without source data; their inclusion adds detail but risks misleading precision. (3) The multi-hop reasoning is partially sound—the model connects total revenue change and average revenue per car change correctly in structure, but the unit error in average revenue per car severely undermines quantitative accuracy. (4) The contextual relevance is high as the answer addresses both parts of the question and provides additional context (percentages, absolute values), and the qualitative reasoning framework is logical despite factual inaccuracies in units and unverified supporting numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1128,
        "completion_tokens": 407,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021, and how does this compare to the net gain or loss reported from operations in the same region for the same year?",
      "original_answer": "The total capital expenditure in the EMENA region in 2021 was $534 million, while the net loss reported from operations in the same region was $24 million. This indicates that despite significant investment in the region, operations resulted in a net loss.",
      "llm_answer": "The total capital expenditure in the Europe, Middle East and North Africa (EMENA) region in 2021 was $534 million, which was lower than the net gain of $8,017 million reported from operations in the same region for that year.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total capital expenditure in the EMENA region in 2021 as $534 million, which matches the ground truth. However, it incorrectly stated that there was a net gain of $8,017 million from operations, while the ground truth reports a net loss of $24 million. This is a major factual error that completely misrepresents the financial performance of the region. (2) The number $8,017 million does not appear in the ground truth and is likely a hallucination or confusion with another figure (possibly a global or consolidated number from another context). The correct figure is a net loss of $24 million, so the comparison between capex and operational performance is entirely wrong. (3) The multi-hop reasoning failed because the model did not correctly retrieve or synthesize the net gain/loss figure for EMENA operations in 2021. Despite correctly identifying the region, metric, and year for capital expenditure, it failed on the second key data point. (4) The contextual relevance is high because the answer addresses both parts of the question and uses appropriate terminology, but the qualitative and quantitative accuracy scores are low due to the critical error in the operational result, which reverses the conclusion (gain vs. loss).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 359,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Microsoft position Copilot Pro within its AI-driven productivity strategy as described in its strategic ambitions, and in which specific revenue category is Copilot Pro classified in the financial reporting?",
      "original_answer": "Microsoft positions Copilot Pro as a consumer subscription service that offers faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with its ambition to reinvent productivity and business processes. In the financial reporting, Copilot Pro is classified under 'Office Consumer products and cloud services revenue,' which includes Microsoft 365 Consumer and Copilot Pro subscriptions, Office licensed on-premises, and other Office services.",
      "llm_answer": "Microsoft positions Copilot Pro as a consumer‑focused subscription that extends the AI capabilities of Microsoft 365, offering faster and more powerful AI assistance within Office apps and on the web to boost personal productivity. In the company’s financial reporting, Copilot Pro is included in the “Office Consumer products and cloud services” revenue line, which falls under the Productivity and Business Processes segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that Microsoft positions Copilot Pro as a consumer-focused subscription offering faster and more powerful AI assistance in Microsoft 365 apps and on the web, aligning with the company's ambition to reinvent productivity—this matches the strategic positioning in the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all descriptive financial categorizations are correct. (3) The LLM correctly identifies that Copilot Pro is classified under 'Office Consumer products and cloud services' revenue, which is accurate per the ground truth. It also correctly situates this within the broader 'Productivity and Business Processes' segment, which is consistent with Microsoft’s financial reporting structure, though this additional context was not in the original answer—this is accurate but slightly beyond the provided truth. (4) The answer is semantically equivalent, with only minor differences in phrasing (e.g., 'consumer-focused subscription' vs 'consumer subscription service'). The only reason for not scoring a 10 is that the original answer includes a more complete breakdown of what the revenue category encompasses (e.g., Microsoft 365 Consumer, on-premises Office, etc.), which the LLM omits. However, this does not detract from the core correctness. All entities, strategy alignment, and classification are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 426,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total increase in RSU shares available to be granted under the 2019 Incentive Plan as a result of the 2024 special dividend adjustment, and how was this increase determined based on the Nasdaq stock price movement?",
      "original_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan was 128,000. This increase was determined by proportionally adjusting the maximum number of shares issuable under the plan in response to the 2024 special dividend, which was calculated using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the Nasdaq opening price of $662.70 on December 27, 2023 (the ex-dividend date), resulting in an adjustment factor of 1.018.",
      "llm_answer": "The total increase in RSU shares available to be granted under the 2019 Incentive Plan due to the 2024 special dividend adjustment was **128,000 shares**, as explicitly stated in Note 7-Stock-Based Compensation. This increase was determined by proportionally adjusting the maximum shares issuable under the plan based on the Nasdaq stock price movement, specifically using the ratio of the Nasdaq closing price of $674.62 on December 26, 2023 (last trading day before the ex-dividend date) to the Nasdaq opening price of $662.70 on December 27, 2023 (ex-dividend date).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The total increase in RSU shares is accurately stated as 128,000, which matches the original answer. (2) The explanation of how the increase was determined is factually correct: the adjustment was based on the ratio of the Nasdaq closing price on December 26, 2023 ($674.62) to the opening price on December 27, 2023 ($662.70), resulting in an adjustment factor of approximately 1.018 (though the exact factor is not restated in the LLM answer, the method is correctly described). (3) The multi-hop reasoning is sound—linking the special dividend adjustment to the share increase under the 2019 Incentive Plan using stock price movement across the ex-dividend date boundary. (4) All entities (2019 Incentive Plan, 2024 special dividend, Nasdaq prices, correct dates) are accurately identified and synthesized. The mention of 'Note 7-Stock-Based Compensation' adds contextual support without contradicting the ground truth. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 317,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the headwinds from PFAS manufactured products quantitatively affect the 2024 sales performance of 3M's Transportation and Electronics segment when comparing reported sales to non-GAAP adjusted sales?",
      "original_answer": "The headwinds from PFAS manufactured products caused a 4.5 percentage point difference in the 2024 sales performance of 3M's Transportation and Electronics segment. Reported sales decreased by 1.4%, but when adjusted for PFAS-related special items, sales increased by 3.1%. This implies that the PFAS-related headwinds reduced sales growth by 4.5 percentage points (from +3.1% to -1.4%).",
      "llm_answer": "The Transportation and Electronics segment reported a 1.4% decline in reported sales for 2024, but when adjusted for the PFAS headwinds (a non‑GAAP measure), sales actually rose 3.1%. The segment’s operating income also improved, with the adjusted margin reflecting the positive impact of exiting PFAS‑manufactured products.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative facts: reported sales declined by 1.4% and adjusted sales increased by 3.1%, which aligns with the ground truth. However, it does not explicitly state the 4.5 percentage point difference caused by PFAS headwinds, which is the core quantitative impact asked in the question. While this difference can be inferred (3.1% - (-1.4%) = 4.5%), the failure to explicitly quantify the headwind's effect results in a partial deduction. (2) All numbers are accurate: 1.4% decline in reported sales and 3.1% growth in adjusted sales match the ground truth. The implied calculation of a 4.5 percentage point drag is mathematically correct, but the answer does not perform or state this calculation directly. (3) The reasoning is sound and reflects multi-hop understanding—linking PFAS headwinds to the adjustment between reported and non-GAAP sales in 3M’s Transportation and Electronics segment. The mention of operating income and margin, while contextually relevant, is extraneous and not required by the question, slightly diluting focus. (4) The answer is contextually fully relevant and semantically close to the original, with only the missing explicit synthesis of the 4.5 percentage point impact preventing a top score. Thus, correctness is high but not complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 371,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the total recognized gain on equity method investment contracts in 2021, and what was the fair value of these contracts as of December 31, 2021?",
      "original_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31, 2021, was $(3) million.",
      "llm_answer": "The total recognized gain on equity method investment contracts in 2021 was $2 million, and the fair value of these contracts as of December 31 2021 was $3 million.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total recognized gain on equity method investment contracts in 2021 as $2 million, which matches the ground truth. However, it incorrectly reported the fair value as $3 million instead of $(3) million. The parentheses around the 3 in the original answer indicate a negative value (i.e., -$3 million), which the LLM failed to capture. This is a critical error in financial reporting, as sign matters significantly in valuation contexts. (2) The first number ($2 million) is quantitatively accurate, but the second ($3 million vs. -$3 million) is incorrect due to the missing negative sign. While the magnitude is correct, the direction (positive vs. negative) is wrong, which affects interpretation. (3) The reasoning appears sound in identifying the relevant metric and year, and the model likely retrieved the correct figure from the source, but failed to preserve the negative sign during reporting—indicating a possible formatting or parsing issue. The multi-hop aspect (two distinct data points from the same context) was handled partially well. (4) The correctness score is 5 due to one correct and one incorrect key number. Quantitative accuracy is 5 because half the numerical content is wrong in sign. Qualitative accuracy is 7 because the model understood the entities and time frame but made a critical error in value representation. Contextual relevance is 10 as the answer directly addresses both parts of the question with appropriate financial terms and timing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1084,
        "completion_tokens": 419,
        "total_tokens": 1504
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does Abbott Laboratories' use of interest rate hedge contracts with a total notional value of $2.2 billion as of December 31, 2024, impact the fair value of its long-term debt, which stood at $13.7 billion on that date?",
      "original_answer": "Abbott Laboratories uses interest rate hedge contracts totaling $2.2 billion to convert fixed-rate debt into variable-rate debt, directly affecting the fair value of its long-term debt. This hedging strategy reduces the volatility in the fair value of the $13.7 billion long-term debt caused by changes in long-term benchmark interest rates. Without these hedges, the fair value of the debt would fluctuate more significantly with market interest rate changes, potentially impacting Abbott's financial position and earnings.",
      "llm_answer": "Abbott's interest rate hedge contracts with a $2.2 billion notional value are designated as fair‑value hedges of fixed‑rate debt, so changes in the fair value of the hedges offset changes in the fair value of the debt due to interest‑rate movements. Consequently, the fair value of the $13.7 billion long‑term debt is effectively stabilized; any increase in the debt’s fair value from rising rates is offset by a corresponding gain in the hedge, and vice‑versa, resulting in little net impact on the overall fair‑value position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the $2.2 billion notional value of interest rate hedges and the $13.7 billion long-term debt as of December 31, 2024, are accurately reported. Number formats match and are semantically equivalent. (2) The explanation correctly identifies that these are fair-value hedges used to convert fixed-rate debt to variable-rate exposure, and that the hedges offset changes in the fair value of debt due to interest rate movements—this matches the original answer’s claim about reducing volatility in fair value. (3) The multi-hop reasoning is sound: it connects the use of hedges to their impact on the fair value of debt, explaining the offsetting mechanism clearly. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the purpose is to reduce volatility caused by changes in long-term benchmark rates, nor does it mention potential impacts on financial position or earnings, which are included in the original for broader context. However, the core financial mechanism and quantitative impact are correctly conveyed. Thus, while extremely close, it omits a small amount of contextual depth, justifying a 9 instead of a 10 in correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 359,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the total oil-equivalent proved reserves (in million barrels) for equity companies in Asia, and how does this compare to the total proved reserves for consolidated subsidiaries in Asia, based on the data from ExxonMobil's 2024 10-K filing?",
      "original_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 2,286 million barrels. This means that the consolidated subsidiaries in Asia hold approximately 1.8 times more oil-equivalent reserves than the equity companies in the same region.",
      "llm_answer": "The total oil-equivalent proved reserves for equity companies in Asia are 1,276 million barrels, while the total proved reserves for consolidated subsidiaries in Asia are 1,315 million barrels. Thus, the consolidated subsidiary reserves in Asia are slightly higher than the equity‑company reserves.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the oil-equivalent proved reserves for equity companies in Asia as 1,276 million barrels, matching the ground truth. However, it incorrectly reported the total proved reserves for consolidated subsidiaries in Asia as 1,315 million barrels, whereas the correct value from the knowledge graph is 2,286 million barrels. This is a significant numerical error affecting the core comparison. (2) The calculation of the relative size between consolidated and equity reserves is therefore also incorrect: the LLM states that consolidated reserves are 'slightly higher,' but the actual data shows they are approximately 1.8 times larger (2,286 / 1,276 ≈ 1.79), which is a substantial difference, not a marginal one. The comparison reasoning fails due to the wrong input number. (3) The multi-hop reasoning appears structurally sound—comparing two reserve types in the same region from ExxonMobil’s 2024 10-K—but the failure to retrieve the correct value for consolidated subsidiaries undermines the synthesis. It seems the model accessed partial or incorrect data for the second entity. (4) Despite the factual inaccuracy in one key number, the answer is well-structured, addresses all parts of the question, uses correct terminology, and attempts the proper comparison, earning moderate scores in qualitative accuracy and high relevance. However, the quantitative inaccuracy severely limits correctness, warranting a mid-range score of 5/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 410,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did the Swiss Tax Reform impact Mondelēz International's effective tax rate in 2019, and what was the net financial benefit recorded in that year as a result of this reform?",
      "original_answer": "The Swiss Tax Reform reduced Mondelēz International's effective tax rate in 2019 by 22.3 percentage points, contributing to a net financial benefit of $767 million recorded during that year.",
      "llm_answer": "The Swiss tax reform enacted in September 2019 generated a $767 million benefit in 2019, which was recorded in the third quarter of that year. This benefit reduced Mondelēz International’s effective tax rate for 2019 from 22.4 % (excluding the reform) to an overall 0.1 % rate, reflecting the $769 million deferred‑tax reduction offset by a small indirect‑tax charge. The reform’s ongoing effects began on January 1 2020, but the net financial benefit of $767 million was recognized in 2019.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $767 million net financial benefit recorded in 2019 due to the Swiss Tax Reform, which matches the ground truth. However, the effective tax rate impact is inaccurately described. The ground truth states the reform reduced the effective tax rate by 22.3 percentage points, but the LLM claims the rate went from 22.4% to 0.1%, implying a 22.3-point reduction indirectly, though this framing is not equivalent and introduces confusion by specifying pre- and post-reform rates not in the original answer. Additionally, the LLM mentions a $769 million deferred-tax reduction offset by a small charge, which is not in the ground truth and introduces unverified detail. (2) The dollar amount ($767 million) is correct. The date (2019) is correct. The 22.3 percentage point reduction is implied but not stated directly; instead, the LLM constructs a narrative around specific rate values (22.4% to 0.1%) that, while arithmetically close (a 22.3-point drop), are not explicitly confirmed in the ground truth and may be speculative. The mention of $769 million in deferred taxes is unsupported. (3) The multi-hop reasoning is sound—the model connects the Swiss tax reform to its financial impact on Mondelēz in 2019, correctly isolating the benefit timing and recording period. It distinguishes between the one-time 2019 benefit and ongoing effects starting in 2020, showing good synthesis. (4) The correctness score is 8 because the core financial benefit is accurate and the directional impact on the tax rate is correct, but the precise mechanism and rate description introduce minor inaccuracies. Quantitative accuracy is 7 due to the unsupported $769 million figure and inferred rate values. Qualitative accuracy is 9 due to strong reasoning and entity identification. Contextual relevance is 10—fully on point with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 508,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What was the total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG?",
      "original_answer": "The total financial impact on PepsiCo in 2022 from both the pension obligation transfer to TBG and the gain recognized from the remeasurement of its 39% ownership stake in TBG was $665 million.",
      "llm_answer": "The total financial impact on PepsiCo in 2022 from the pension obligation transfer to TBG and the gain from remeasuring its 39% stake was a $520 million gain recognized from the remeasurement of the TBG investment, partially offset by a $108 million currency‑translation charge related to the divestiture that was recorded in other comprehensive loss. Consequently, the net effect on PepsiCo’s income was a $520 million pre‑tax gain, with the related tax impact reflected in the $433 million deferred tax expense noted in the income‑statement summary.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states the total financial impact was $665 million, but the LLM reports a $520 million gain from remeasurement and a $108 million currency-translation charge, resulting in a net gain of $412 million pre-tax (not $665 million). Neither the individual components nor the total match the ground truth. The $520 million gain and $108 million charge are not supported by the original answer and appear to be fabricated or misattributed. (2) Quantitative accuracy is severely lacking: the correct total impact is $665 million, but the LLM does not mention this number at all. It introduces numbers ($520M gain, $108M loss, $433M tax expense) that are not present in the ground truth and are not summed to the correct total. There is no indication that the $665 million figure was derived or referenced. (3) The multi-hop reasoning is flawed. The question requires summing the impact of two specific events: the pension obligation transfer and the remeasurement gain. The LLM fails to identify the correct values for either component or their sum. Instead, it introduces unrelated elements like a currency-translation charge and deferred tax expense, which were not part of the original answer, indicating a failure to synthesize the correct information from the knowledge graph. (4) Contextual relevance is moderate because the answer discusses PepsiCo, TBG, remeasurement of ownership stake, and pension obligations in 2022—so the general topic is correct—but the specific financial figures and conclusions are inaccurate, making the response misleading despite topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 454,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total amount of sales-based milestone payments made by Merck to Eisai for Lenvima in 2021, and how does this compare to the accrued but unpaid sales-based milestone payments as of December 31, 2021?",
      "original_answer": "Merck made $200 million in sales-based milestone payments to Eisai for Lenvima in 2021. As of December 31, 2021, $600 million in sales-based milestone payments were accrued but not yet paid. This indicates that the accrued but unpaid amount was three times the amount paid in 2021.",
      "llm_answer": "The sales‑based milestone payments made by Merck to Eisai in 2021 totaled **$200 million**. As of December 31 2021, **$600 million** of sales‑based milestone payments had been accrued but remained unpaid.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the $200 million in sales-based milestone payments made by Merck to Eisai for Lenvima in 2021 and the $600 million accrued but unpaid as of December 31, 2021, matching the ground truth exactly. All numeric values are accurate. (2) Quantitative accuracy is perfect: both dollar amounts are correct, and though the LLM did not explicitly state the 'three times' comparison, the numbers themselves are presented such that the comparison can be inferred. The absence of explicit comparative language does not introduce inaccuracy but slightly reduces completeness in reasoning articulation. (3) The multi-hop reasoning is implicitly sound—information about payments made in 2021 and accrued amounts as of year-end is correctly attributed to the right companies, drug (Lenvima), and time period. However, the LLM omits the interpretive synthesis that the unpaid amount was three times the paid amount, which was part of the original answer’s reasoning. This is a minor gap in qualitative reasoning, not a factual error. (4) Contextual relevance is excellent—the response directly answers both parts of the question with precise data and appropriate context. The slight deduction in correctness and qualitative accuracy reflects the missing comparative interpretation, but all factual and quantitative elements are fully correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 381,
        "total_tokens": 1518
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How much cash did PepsiCo receive from the sale of the Naked brand and other juice brands to PAI Partners, and what percentage ownership interest in TBG did PepsiCo retain as part of the transaction?",
      "original_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and retained a 39% noncontrolling ownership interest in TBG.",
      "llm_answer": "PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, and it retained a 39 % ownership interest in the resulting TBG joint venture.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly states that PepsiCo received approximately $3.5 billion in cash from the sale of the Naked brand and other juice brands to PAI Partners, matching the original answer exactly in value and context. (2) It accurately reports that PepsiCo retained a 39% ownership interest in TBG, with the minor but acceptable rephrasing of '39 %' (spacing is irrelevant) and specifying 'the resulting TBG joint venture,' which adds clarifying context without altering the meaning. (3) The multi-hop reasoning is sound—both parts of the question (cash received and ownership retained) are addressed with correct synthesis of financial transaction details. (4) All entities (PepsiCo, PAI Partners, TBG) and financial figures are accurate. The answer is fully relevant and complete, warranting top scores across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 263,
        "total_tokens": 1373
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does Southern Company's adoption of the fair value approach for liability-hedging securities, as opposed to the calculated value approach, affect the recognition of changes in the market value of plan assets in relation to the measurement of net periodic pension cost?",
      "original_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities results in the immediate recognition of changes in the market value of these plan assets, as opposed to amortizing these changes over five years under the calculated value approach. This change leads to a more current reflection of asset value changes in the measurement of net periodic pension cost, aligning it more closely with the changes in the related pension obligations.",
      "llm_answer": "Southern Company's adoption of the fair value approach for liability-hedging securities (instead of the prior calculated value approach) results in the immediate recognition of changes in the market value of those specific plan assets in the calculation of net periodic pension cost. This contrasts with the prior method, which smoothed asset returns by amortizing changes in the calculated value over five years, thereby deferring the impact of market fluctuations on the expected return component of net periodic pension cost. Consequently, the fair value approach leads to a more current reflection of asset value changes in the net periodic pension cost measurement.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes that Southern Company's adoption of the fair value approach leads to immediate recognition of changes in market value for liability-hedging securities, as opposed to the five-year amortization under the calculated value approach. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the reference to 'five years' is consistent and correct in both answers. (3) The multi-hop reasoning is sound: the model correctly contrasts the two accounting methods and explains the impact on net periodic pension cost, linking asset valuation changes to pension cost measurement. (4) All entities—Southern Company, liability-hedging securities, net periodic pension cost, fair value vs. calculated value approaches—are accurately identified and contextualized. The explanation includes additional clarity about the 'expected return component' and 'smoothing' effect, which enhances understanding without introducing error. The answer fully addresses the question with precise, relevant, and factually correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 326,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total increase in Netflix's content spending from 2019 to 2021, and how did the growth in produced content compare to the growth in licensed content over this period?",
      "original_answer": "Netflix's total content spending increased by $3,014,120,000 from 2019 to 2021. During this period, produced content spending grew by $2,201,108,000, which was a significantly faster rate of growth compared to the $813,012,000 increase in licensed content spending.",
      "llm_answer": "The total increase in Netflix's content spending from 2019 to 2021 was $3,014 million (from $9,216 million in 2019 to $12,230 million in 2021). Produced content grew by $2,201 million (from $1,973 million to $4,175 million), while licensed content increased by $813 million (from $7,243 million to $8,056 million) over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the total content spending increase is correctly stated as $3,014 million ($3.014 billion), which aligns with the ground truth of $3,014,120,000 (minor rounding difference of $120,000 is negligible and within acceptable formatting variation). Produced content spending increase is $2,201 million ($2.201 billion), matching the ground truth of $2,201,108,000 (difference of $108,000, again minor and acceptable). Licensed content increase is $813 million, matching the ground truth of $813,012,000 (difference of $12,000). These minor discrepancies are likely due to rounding in presentation and do not affect factual accuracy. (2) The answer is complete, addressing both the total spending increase and the comparative growth between produced and licensed content. (3) Entities are correct: Netflix, 2019–2021 time frame, and the distinction between produced and licensed content are all accurately identified. (4) The reasoning is sound: the LLM correctly synthesizes multi-hop data (spending figures across years and categories) and presents a clear comparison, concluding that produced content grew faster than licensed—consistent with the ground truth. (5) Semantic equivalence is maintained: though the LLM provides additional detail (specific year amounts), the core information and comparative insight match the original answer. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 412,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total pre-tax impairment charge recorded by PepsiCo in 2023 related to its 39% noncontrolling interest in TBG, and how does this compare to the gain recognized in 2022 from the remeasurement of the same investment?",
      "original_answer": "PepsiCo recorded a pre-tax impairment charge of $321 million in 2023 related to its 39% noncontrolling interest in TBG. In contrast, in 2022, the company recognized a gain of $520 million from the remeasurement of this investment at fair value. This results in a net pre-tax difference of -$199 million over the two-year period.",
      "llm_answer": "PepsiCo recorded a **$321 million pre‑tax impairment charge** in 2023 related to its 39 % noncontrolling interest in TBG (Note 13), which was reflected in selling, general and administrative expenses within the PBNA division. This impairment contrasts with the **$520 million pre‑tax gain** recognized in 2022 from the remeasurement of the same investment (Note 13), when the fair‑value adjustment of the 39 % stake was recorded.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $321 million pre-tax impairment charge in 2023 and the $520 million pre-tax gain in 2022 are accurately reported, with no calculation or numerical errors. The format variations (e.g., 'million' vs 'M') are acceptable and semantically equivalent. (2) The answer addresses both parts of the multi-part question: the 2023 impairment charge and the comparison to the 2022 remeasurement gain. (3) Entity accuracy is correct—PepsiCo, TBG, 39% noncontrolling interest, and the relevant years (2022 and 2023) are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly contrasts the 2023 impairment with the 2022 gain, demonstrating understanding of the temporal and financial relationship between the two events. Although the net difference of -$199 million is not explicitly stated in the LLM answer, the question did not require it—the comparison is adequately conveyed by stating both figures. The inclusion of 'Note 13' and accounting treatment adds contextual precision without introducing error. Overall, the answer is factually accurate, complete, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 350,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Netflix's increased investment in original programming in 2021 affect content amortization and cost of revenues as a percentage of revenue?",
      "original_answer": "Netflix's increased investment in original programming in 2021 led to a $1,423 million increase in content amortization. Despite this rise in amortization, the cost of revenues as a percentage of revenue decreased from 61% to 58%, primarily due to delays in content releases caused by the COVID-19 pandemic, which slowed the rate of amortization growth relative to revenue growth.",
      "llm_answer": "The increased investment in original programming in 2021 led to a higher amortization of content assets, but because content amortization grew more slowly than the 19% revenue increase (driven by membership growth and price changes), cost of revenues as a percentage of revenue declined from 61% in 2020 to 58% in 2021. This resulted in an improved operating margin despite the higher absolute content amortization expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key outcome—that despite increased investment in original programming in 2021, Netflix's cost of revenues as a percentage of revenue decreased from 61% to 58%. It accurately captures the core dynamic: higher content amortization but slower growth in amortization relative to revenue growth. However, it omits the specific $1,423 million increase in content amortization, which is a quantitatively important detail from the ground truth. (2) The percentages (61% to 58%) and the year (2021 vs. 2020) are correct. The 19% revenue increase is contextually accurate and aligns with Netflix's reported performance, though not explicitly mentioned in the original answer. The missing $1,423 million figure is a notable omission in quantitative terms. (3) The reasoning is sound: the LLM correctly infers that slower amortization growth relative to revenue led to a decline in cost of revenues as a percentage of revenue, and it links this to operating margin improvement. While the original answer attributes the slowed amortization to pandemic-related content delays, the LLM cites revenue growth as the primary driver—this shifts emphasis slightly but does not invalidate the logic. (4) The answer is highly relevant and conveys the essential conclusion. The omission of the exact dollar increase in amortization prevents a perfect score, but all other elements—percentages, direction of change, causal logic—are correct. Hence, correctness is rated 9/10, with high marks across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 425,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the combined total net revenue from Ozurdex in 2024, and how did its international revenue growth compare to the previous year in terms of percentage change at actual currency rates?",
      "original_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Its international revenue grew by 8.3% compared to the previous year at actual currency rates.",
      "llm_answer": "The combined total net revenue from Ozurdex in 2024 was $494 million. Internationally, Ozurdex revenue grew 8.3% at actual currency rates, compared with a 14.0% increase in the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the combined total net revenue from Ozurdex in 2024 as $494 million, matching the ground truth. It also accurately reports the international revenue growth at actual currency rates as 8.3% compared to the previous year, which is correct. (2) All numeric values are factually accurate: $494 million and 8.3% are both correct. However, the LLM adds that there was a '14.0% increase in the prior year,' which was not asked for and is not present in the ground truth. While this additional information is not incorrect per se, it introduces extraneous data not requested, slightly affecting qualitative accuracy. (3) The multi-hop reasoning is sound—revenue total and international growth rate are correctly synthesized from the relevant data points. The model correctly identifies Ozurdex, the year 2024, and the appropriate metric (international revenue growth at actual currency rates). (4) The answer is contextually relevant and semantically equivalent to the ground truth in addressing the two parts of the question. The correctness score is 9 instead of 10 due to the minor over-answering with an unrequested prior-year comparison, but all required information is accurate and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1099,
        "completion_tokens": 346,
        "total_tokens": 1445
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total pretax gain Target Corporation recognized from the sale of Dermstore LLC, and how was this gain treated in the financial statements according to the notes?",
      "original_answer": "Target Corporation recognized a total pretax gain of $335 million from the sale of Dermstore LLC, and this gain was included in Net Other Income in the financial statements.",
      "llm_answer": "Target Corporation recognized a $335 million pretax gain from the sale of Dermstore LLC in February 2021, which was recorded in “Net Other (Income) / Expense” on the consolidated income statement. This gain is disclosed in Note 2 (Dermstore Sale) of the financial statements.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the pretax gain of $335 million is accurately reported, and the date (February 2021) is consistent with the known sale timing. (2) The answer correctly identifies that the gain was recorded in 'Net Other Income' (referred to as 'Net Other (Income) / Expense' in the LLM answer, which is the full line item name), aligning with the financial statement treatment. (3) The reasoning is sound and complete: it addresses both parts of the question—amount of gain and its financial statement treatment—and correctly references Note 2 (Dermstore Sale) as the source, demonstrating proper multi-hop synthesis from the entity (Target Corporation), transaction (sale of Dermstore LLC), and financial reporting details. (4) Semantic equivalence is maintained: minor wording differences (e.g., 'Net Other (Income) / Expense' vs 'Net Other Income') do not affect factual accuracy. All entities—Target Corporation, Dermstore LLC, financial statement line item, and note reference—are correct. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1119,
        "completion_tokens": 311,
        "total_tokens": 1430
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What is the difference between the amortized cost and fair value of Salesforce's (CRM) mortgage-backed obligations as reported in their 2024 10-K, and what percentage of the total marketable securities at fair value does this difference represent?",
      "original_answer": "The difference between the amortized cost and fair value of Salesforce's mortgage-backed obligations is $8 million ($244 million amortized cost - $236 million fair value). This $8 million difference represents approximately 0.14% of the total marketable securities at fair value ($5,722 million).",
      "llm_answer": "Based on the provided pages, the document does not explicitly state the amortized cost or fair value of Salesforce's mortgage-backed obligations. However, in the \"Marketable Securities\" table on page 75, the fair value of mortgage-backed obligations is listed as $122 million (with an amortized cost of $128 million). The difference between amortized cost ($128 million) and fair value ($122 million) is $6 million. This difference represents 0.12% of the total marketable securities at fair value ($5,184 million), calculated as ($6 million / $5,184 million) * 100 ≈ 0.12%. \n\nNote: The question references \"mortgage-backed obligations,\" but the document only provides data for \"Mortgage-backed obligations\" within marketable securities (not specifically \"mortgage-backed obligations\" as a standalone category). The calculation uses the mortgage-backed obligations line item from the marketable securities table. The document does not provide a direct reference to \"mortgage-backed obligations\" in the context of the question's phrasing, but the data for this line item is present in the marketable securities tables on pages 75 and 76. The percentage is derived from the total marketable securities fair value ($5,184 million as of January 31, 2025). \n\nAnswer: The difference between amortized cost ($128 million) and fair value ($122 million) for mortgage-backed obligations is $6 million, representing 0.12% of the total marketable securities at fair value ($5,184 million).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that the amortized cost is $244 million and fair value is $236 million, resulting in an $8 million difference. The LLM incorrectly reports amortized cost as $128 million and fair value as $122 million, leading to a $6 million difference. Additionally, the total marketable securities at fair value is stated as $5,722 million in the ground truth, but the LLM uses $5,184 million, which is incorrect. These errors affect both the difference and the percentage calculation. The LLM calculates 0.12% ($6M / $5,184M), while the correct percentage is approximately 0.14% ($8M / $5,722M). (2) The numbers are not accurate: the amortized cost, fair value, difference, total marketable securities, and resulting percentage are all incorrect. Even allowing for format variations, the values do not match the ground truth. (3) The reasoning is partially sound in that the LLM identifies the relevant line item (mortgage-backed obligations) in the marketable securities table and attempts the correct calculation (difference and percentage of total). However, it fails in multi-hop synthesis because it uses incorrect underlying data, possibly from a different year or document version. (4) The answer is contextually relevant—addressing the right metric and company—and the structure and intent are correct, but the factual foundation is flawed, leading to a low correctness score despite appropriate methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 413,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of adopting the new LDTI accounting guidance, and what time periods do these adjustments cover according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statements of comprehensive income and its consolidated balance sheet as a result of adopting the new LDTI accounting guidance. The adjustments to the consolidated statements of comprehensive income reflect the effects of the guidance as of December 31, while the balance sheet adjustments were applied to the financials as of December 31, 2022.",
      "llm_answer": "The 2023 10-K filing discloses that MetLife retrospectively adjusted its previously reported consolidated financial statements to reflect the adoption of the new LDTI accounting guidance. Specifically, the adjustments impacted the Company's consolidated statements of comprehensive income, balance sheet, equity, and cash flows, covering the comparative periods of 2021 and 2022 as presented in the filing. These adjustments were made to reflect changes in accounting for market risk benefits, future policy benefits, deferred policy acquisition costs, and related balances under the new LDTI framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies compared to the ground truth. (1) Correct elements: The LLM correctly identifies that MetLife retrospectively adjusted its financial statements due to LDTI adoption and mentions the consolidated statements of comprehensive income and balance sheet, which aligns with the original answer. It also correctly references the 2023 10-K filing and the retrospective nature of the changes. (2) Quantitative accuracy: The original answer specifies that balance sheet adjustments were applied as of December 31, 2022, and income statement adjustments reflect effects as of December 31 (implied 2022 for comparative purposes). The LLM incorrectly states the adjustments cover '2021 and 2022' without specifying that the balance sheet adjustments are as of a point in time (Dec 31, 2022), and implies both years are fully adjusted, which is not confirmed in the ground truth. (3) Qualitative accuracy: The LLM overstates the scope by including 'equity' and 'cash flows' as adjusted statements, which are not mentioned in the original answer. The original answer only specifies the consolidated statements of comprehensive income and balance sheet. This reflects a failure in precise entity identification. Additionally, while the LLM provides detail on affected line items (e.g., deferred policy acquisition costs), this level of granularity is not in the ground truth and may reflect overinference. (4) Contextual relevance: The response stays on topic and addresses the question's intent, explaining what was adjusted and the time periods, even if with errors. Overall, the answer captures the general idea but fails in precision on key entities and time periods, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 475,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What is the total potential financing commitment Disney has through its two cruise ship credit facilities, and how does the interest rate structure differ between the Disney Treasure and the Disney Destiny borrowings?",
      "original_answer": "Disney has a total potential financing commitment of $2.2 billion through its two cruise ship credit facilities. The Disney Treasure borrowing carries a fixed interest rate of 3.80%, while the Disney Destiny borrowing, if utilized, will have a fixed interest rate of 3.74%.",
      "llm_answer": "Based on the provided financial disclosures, Disney has a total potential financing commitment of **$2.2 billion** through its two cruise ship credit facilities—$1.1 billion borrowed under one facility for the Disney Treasure and a second $1.1 billion facility available for the Disney Destiny. The interest rate structure differs in that the Disney Treasure borrowing carries a fixed interest rate of **3.80%**, while the potential Disney Destiny borrowing would carry a fixed rate of **3.74%**, both payable semi-annually over a 12-year term.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total financing commitment of $2.2 billion is accurate, with the breakdown of two $1.1 billion facilities aligning with the total. The interest rates—3.80% for Disney Treasure and 3.74% for Disney Destiny—are correctly reported with exact precision. Minor additional details (semi-annual payments, 12-year term) are consistent with typical financing structures and do not contradict the ground truth. (2) The answer addresses both parts of the multi-part question: total commitment and interest rate differences. (3) Entities—Disney, Disney Treasure, Disney Destiny—are correctly identified, and the financial terms are accurately attributed. (4) The reasoning is sound, demonstrating proper synthesis across the two credit facilities and correct interpretation of fixed-rate terms. The answer is semantically equivalent to the ground truth, with slightly more detail but no factual deviation. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 295,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How much did Chevron's equity in earnings from Angola LNG Limited contribute to its total upstream equity earnings in 2024, and what does this indicate about Chevron's production involvement in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings of $3,580 million in 2024. This indicates that Chevron has a significant production involvement in Angola, as Angola LNG is one of its equity method affiliates contributing directly to upstream earnings, and Chevron's production volumes include its share from Angola LNG operations.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings in 2024, reflecting the company's significant production involvement in Angola through this major equity affiliate. This contribution underscores Chevron's active role in Angola's liquefied natural gas sector and its broader upstream operations in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's equity in earnings from Angola LNG Limited contributed $405 million to its total upstream equity earnings in 2024, which matches the ground truth. The total upstream equity earnings of $3,580 million is not explicitly mentioned in the LLM answer, but the $405 million figure is accurate and contextually sufficient to address the first part of the question. (2) All numeric values are correct and properly formatted; $405 million is consistent with the ground truth. There are no calculation errors. (3) The reasoning is sound: the LLM correctly infers that this contribution indicates significant production involvement in Angola, particularly in the LNG sector, and identifies Angola LNG Limited as a key equity affiliate. While the ground truth additionally notes that Chevron's production volumes include its share from Angola LNG operations, this detail is omitted but does not undermine the overall validity of the conclusion. (4) The answer is semantically equivalent and highly relevant, with only minor omission of the total upstream earnings figure. The core facts, entities, and implications are accurately conveyed, warranting a high correctness score with a small deduction for incompleteness on the total earnings context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 363,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, and how much of this amount was converted into U.S. dollar denominated borrowings through cross-currency swaps?",
      "original_answer": "The total amount of Canadian dollar denominated notes Disney had outstanding as of September 28, 2024, was Canadian $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). Of this, Canadian $1.3 billion ($1.0 billion USD) remained outstanding and was converted into U.S. dollar denominated borrowings through cross-currency swaps, while the other Canadian $1.3 billion ($0.9 billion USD) was paid in October 2024.",
      "llm_answer": "Based on the provided document pages, the total amount of Canadian dollar‑denominated notes outstanding as of September 28 2024 is $1.3 billion (approximately $0.9 billion in one tranche and $1.0 billion in another). The Company has entered into pay‑floating interest‑rate and cross‑currency swaps that effectively convert these Canadian‑dollar borrowings into U.S.‑dollar‑denominated borrowings indexed to SOFR.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The total Canadian dollar-denominated notes outstanding are stated as $1.3 billion, but the ground truth specifies $2.6 billion (CAD $1.3 billion + CAD $1.3 billion). The LLM incorrectly splits this $1.3 billion into $0.9 billion and $1.0 billion tranches, which misrepresents both the total amount and the structure. The correct breakdown is two $1.3 billion CAD tranches, one of which ($1.3 billion CAD = $1.0 billion USD) was swapped into USD via cross-currency swaps, while the other was paid off. (2) Quantitative accuracy is low: the total outstanding amount is off by 50% ($1.3B vs $2.6B), and the tranche values are misrepresented. The LLM appears to confuse USD equivalents with CAD principal amounts. (3) Reasoning is partially sound in identifying the use of cross-currency swaps to convert CAD borrowings to USD, but fails the multi-hop synthesis: it does not correctly identify that only half of the total CAD notes were swapped, while the other half were repaid. This critical distinction is missing, undermining the answer's completeness. (4) Contextual relevance is high—the response addresses the right topic, instruments, and mechanisms (cross-currency swaps, SOFR conversion)—but due to major numerical and structural errors, the factual core is flawed. Semantic equivalence is not achieved due to incorrect totals and misallocated amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 400,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023?",
      "original_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,380 million. This is calculated by summing the $1,265 million in private funds from the U.S. Plans and the $115 million in private funds from the Non-U.S. Plans.",
      "llm_answer": "The total fair value of investments in private funds reported across both U.S. and Non-U.S. Plans by Honeywell as of December 31, 2023, is $1,265 million for the U.S. plans and $74 million for the Non-U.S. plans, for a combined total of $1,339 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the numerical values provided. The ground truth states that the U.S. Plans reported $1,265 million and Non-U.S. Plans reported $115 million, totaling $1,380 million. However, the LLM reports $1,265 million for U.S. plans (correct) but $74 million for Non-U.S. plans (incorrect), leading to a total of $1,339 million (incorrect). This represents a clear error in both the Non-U.S. value and the final sum. (2) The calculation in the LLM answer is mathematically consistent ($1,265M + $74M = $1,339M), but the inputs are factually wrong—especially the Non-U.S. amount, which is off by $41 million. The correct total should be $1,380 million. (3) The multi-hop reasoning appears structurally sound—the model attempts to sum U.S. and Non-U.S. components—but fails due to incorrect source data retrieval, suggesting a failure in synthesizing accurate figures from the underlying documents. (4) Contextual relevance is high as the answer addresses the right question, time period (December 31, 2023), entities (Honeywell, U.S. and Non-U.S. Plans), and metric (fair value of private fund investments). However, due to major quantitative errors, the correctness and accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 353,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, impact the structure of its revenue recognition for cloud versus license-based offerings?",
      "original_answer": "Oracle's strategy of offering flexible deployment models, including Oracle Cloud Services, leads to a distinct revenue recognition pattern where cloud services revenues are generally recognized ratably over the contractual period, while on-premise and cloud license revenues are recognized up front at the point of delivery. This difference results in more predictable and stable revenue streams from Oracle Cloud Services compared to the point-in-time recognition of license revenues, which can be significantly affected by the timing of large license transactions.",
      "llm_answer": "Oracle's flexible deployment models—including on-premise, cloud, and hybrid options—directly shape its revenue recognition by separating cloud services and license support (which are recognized ratably over contractual terms) from perpetual cloud and on-premise license sales (which are recognized up front at delivery). This structure allows Oracle to generate recurring, predictable revenue from subscription-based cloud services while maintaining point-in-time revenue recognition for traditional license purchases, creating a distinct contrast in revenue patterns between its cloud offerings and legacy license-based products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Oracle recognizes cloud services revenue ratably over the contractual period and license-based revenue (on-premise and perpetual cloud licenses) up front at delivery. This matches the original answer's core distinction in revenue recognition patterns. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in terms of calculations, but the absence of any incorrect numbers supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly links Oracle's deployment strategy to differing revenue recognition treatments between cloud and license models, synthesizing business strategy with accounting policy. (4) The only minor shortcoming is that the LLM answer introduces the term 'license support' as being recognized ratably, which, while accurate, slightly extends beyond the scope of the original answer's focus on cloud services vs. license revenues. However, this addition does not distort the meaning and may reflect deeper contextual knowledge. Overall, the answer is factually correct, complete, and contextually precise, warranting a high correctness score with only a slight deduction for minor expansion beyond the original scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 375,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total worldwide sales growth percentage of ERLEADA from 2021 to 2023, and how did this growth contribute to the overall performance of the Oncology segment in 2023 compared to 2022?",
      "original_answer": "ERLEADA's worldwide sales grew from $1,291 million in 2021 to $2,387 million in 2023, representing an 84.9% increase over the two-year period. In 2023, ERLEADA's sales increased by 26.9% compared to 2022, contributing significantly to the overall Oncology segment's 10.5% total sales growth in 2023. ERLEADA was the third-largest contributor to the Oncology segment's growth after DARZALEX (22.2% growth) and TREMFYA (17.9% growth), highlighting its strong performance within the portfolio.",
      "llm_answer": "The worldwide sales growth of ERLEADA from 2021 to 2023 was 26.9% (2021: $1,291 M, 2022: $1,881 M, 2023: $2,387 M), reflecting continued share gains and market growth in metastatic castration‑resistant prostate cancer. This growth contributed to the Oncology segment’s overall sales increase of 10.5% in 2023 versus 2022, helping drive the segment’s total revenue to $17.7 billion and supporting the broader Innovative Medicine segment’s 4.2% worldwide sales growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the key calculation. It states that ERLEADA's worldwide sales growth from 2021 to 2023 was 26.9%, but this is actually the year-over-year growth from 2022 to 2023, not the total two-year growth. The correct total growth from 2021 ($1,291M) to 2023 ($2,387M) is (2,387 - 1,291) / 1,291 = 84.9%, as stated in the ground truth. The LLM incorrectly applies the 26.9% figure to the entire period, which is a major quantitative error. (2) The individual sales figures for 2021 ($1,291M), 2022 ($1,881M), and 2023 ($2,387M) are accurate and consistent with the ground truth, and the 10.5% Oncology segment growth in 2023 vs 2022 is correctly reported. However, the LLM introduces an unsupported figure of $17.7 billion for the Oncology segment’s total revenue and mentions a 4.2% growth in the Innovative Medicine segment, which are not in the original answer and not requested by the question. (3) The multi-hop reasoning is partially sound—linking ERLEADA’s growth to the Oncology segment performance is valid—but fails on the primary calculation. The model does not correctly synthesize the full 2021–2023 growth, misrepresenting a one-year growth rate as a two-year rate. (4) Contextually, the answer addresses both parts of the question and provides relevant context about market dynamics, earning high marks for relevance. However, due to the critical error in the growth percentage calculation and the introduction of unverified data, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the reasoning structure is logical but based on incorrect numerical interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 461,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the total notional amount of net investment hedge derivative contracts and non-U.S. dollar denominated debt used as net investment hedges by MDLZ as of December 31, 2023, and how does this compare to the total fair value of derivative assets recorded in other current and other assets on the consolidated balance sheet for the same date?",
      "original_answer": "As of December 31, 2023, the notional amount of net investment hedge derivative contracts was $7,456 million, and the notional amount of non-U.S. dollar denominated debt used as net investment hedges totaled $4,355 million (comprising $3,516 million in Euro notes, $386 million in Swiss franc notes, and $453 million in Canadian dollar notes), for a combined total of $11,811 million. Meanwhile, the total fair value of derivative assets recorded in other current assets and other assets was $1,347 million and $250 million, respectively, for a total of $1,597 million. This indicates that the notional amount of the hedges significantly exceeds the fair value of the derivative assets.",
      "llm_answer": "As of December 31 2023, MDLZ reported a total notional amount of **$7.456 billion** for net‑investment‑hedge derivative contracts and **$4.752 billion** of non‑U.S.‑dollar debt designated as net‑investment hedges (combined $7.456 bn + $4.752 bn = $12.208 bn). The fair value of these derivative assets recorded in “Other current assets” and “Other assets” on the consolidated balance sheet was **$61 million** for currency exchange contracts and **$135 million** for commodity contracts, for a total derivative‑asset fair value of **$196 million** (as shown in the “Total derivatives” line for 2023). Thus, the notional amount of net‑investment hedges is far larger than the recorded fair‑value amount of $196 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The notional amount of net investment hedge derivative contracts is correctly stated as $7.456 billion (matching the ground truth $7,456 million), but the non-U.S. dollar denominated debt is incorrectly reported as $4.752 billion instead of the correct $4,355 million. The breakdown provided in the ground truth ($3,516M Euro, $386M Swiss franc, $453M CAD) totals $4,355M, not $4,752M, indicating a clear error in either sourcing or calculation. The LLM's combined total of $12.208 billion is therefore incorrect; the correct combined total is $11,811 million. (2) The fair value of derivative assets is severely misstated: the LLM reports $61M + $135M = $196M total, but the ground truth states $1,347M in other current assets and $250M in other assets, totaling $1,597M — nearly 8 times higher. This is a major quantitative error. Additionally, the LLM introduces 'currency exchange' and 'commodity contracts' not specified in the original answer, adding unsupported detail. (3) While the LLM attempts multi-hop reasoning by comparing notional amounts to fair values, the conclusion that 'notional amount is far larger' is based on incorrect inputs, undermining the validity of the synthesis. The correct comparison (notional: $11.8B vs. fair value: $1.6B) still supports the same qualitative conclusion, but the magnitude is misrepresented. (4) The contextual relevance is acceptable because the structure and intent align with the question, and the date (December 31, 2023) and company (MDLZ) are correct. However, due to major errors in core financial figures and calculations, the correctness score is low. Minor formatting variations like $7.456 billion vs. $7,456 million are acceptable, but the discrepancies here go beyond formatting and reflect factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 505,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023?",
      "original_answer": "The total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $686 million. This is calculated by adding $676 million from the U.S. Plans and $10 million from the Non-U.S. Plans.",
      "llm_answer": "Based on the provided data, the total value of Mortgage/Asset-backed securities investments held by Honeywell's U.S. and Non-U.S. plans combined as of December 31, 2023, is $676 million for U.S. plans and $10 million for Non-U.S. plans, resulting in a combined total of **$686 million**. This is derived from the \"Mortgage/Asset-backed securities\" line item in the fair value breakdown for both U.S. and Non-U.S. plans on page 109 and page 112.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the U.S. Plans' Mortgage/Asset-backed securities value is correctly stated as $676 million, and the Non-U.S. Plans' value is correctly stated as $10 million. The combined total of $686 million is accurate and properly calculated. (2) Quantitative accuracy is perfect: all dollar amounts are correct, and the sum ($676M + $10M = $686M) is mathematically sound. Format variations (e.g., $676 million vs $676M) are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound—information from both U.S. and Non-U.S. plans is correctly identified and synthesized to compute the total. The mention of specific pages (109 and 112) supports the sourcing, indicating proper cross-document synthesis. (4) The answer is semantically equivalent to the original, with clear, precise, and relevant information that directly addresses the question. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 291,
        "total_tokens": 1468
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How much total prepaid royalty revenue from Nestlé is remaining to be recognized by Starbucks as of September 29, 2024, and how does this relate to the Global Coffee Alliance's 40-year arrangement?",
      "original_answer": "As of September 29, 2024, Starbucks had $177.0 million (current) and $5.8 billion (long-term) of deferred revenue remaining to be recognized from the $7 billion up-front prepaid royalty received from Nestlé. This recognition schedule is based on the 40-year estimated economic life of the Global Coffee Alliance arrangement, over which the payment is being recognized on a straight-line basis as other revenue.",
      "llm_answer": "As of September 29 2024, Starbucks has $5.8 billion of long‑term deferred revenue remaining that was recorded as the upfront prepaid royalty from Nestlé under the Global Coffee Alliance. This amount will be recognized ratably over the 40‑year term of the alliance, meaning the company will continue to recognize a portion of this deferred revenue each year for the next several decades.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.8 billion long-term deferred revenue and the 40-year recognition period, which are key facts from the ground truth. However, it omits the $177.0 million in current deferred revenue, which is a significant quantitative and qualitative omission. The total deferred revenue from the $7 billion up-front payment is split into current and long-term portions, and excluding the current portion makes the answer incomplete. (2) The numbers mentioned ($5.8 billion and 40-year term) are accurate and correctly formatted. The missing $177.0 million is a factual gap, but no incorrect numbers are presented. (3) The reasoning about straight-line recognition over the 40-year economic life of the alliance is correct and reflects proper multi-hop synthesis between the prepaid royalty, deferred revenue, and revenue recognition policy. However, the failure to mention the current portion suggests incomplete synthesis of the full financial structure. (4) The answer is highly relevant and correctly frames the relationship between the deferred revenue and the 40-year arrangement. The omission of the current liability affects completeness but not the core logic. Thus, the answer is mostly correct but lacks full completeness on the quantitative breakdown.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 365,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What is the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by XOM in its 2023 10-K filing?",
      "original_answer": "The total fair value of long-term obligations to equity companies is $1,896 million, and the total guarantees related to equity company obligations amount to $1,862 million. Adding these together results in a total of $3,758 million.",
      "llm_answer": "Based on the provided document pages, the total fair value of long-term obligations to equity companies and guarantees related to equity company obligations as disclosed by ExxonMobil (XOM) in its 2023 10-K filing is $7,807 million. This figure is derived from the \"Guarantees\" table in the \"Other Information\" section on page 106, which lists \"Total\" as $7,807 million, representing the sum of Equity Company Obligations ($1,862 million) and Other Third-Party Obligations ($5,945 million).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative accuracy and reasoning. (1) The ground truth states that the total fair value of long-term obligations to equity companies is $1,896 million and guarantees related to equity company obligations are $1,862 million, totaling $3,758 million. The LLM incorrectly reports a total of $7,807 million, which includes $5,945 million in 'Other Third-Party Obligations'—a category unrelated to equity companies. (2) The calculation is flawed: the LLM adds equity company guarantees ($1,862 million) to other third-party obligations ($5,945 million), which are explicitly separate and not part of the question. The question specifically asks for 'long-term obligations to equity companies' and 'guarantees related to equity company obligations'—not third-party obligations. (3) The multi-hop reasoning fails: the model misidentifies the relevant components, conflating equity company obligations with broader guarantee categories. It does not isolate the correct figures for equity-related items. (4) While the LLM references the correct document section (page 106, 'Guarantees' table), it extracts and interprets the data incorrectly. The contextual relevance is low because the answer addresses a broader, incorrect scope. Minor credit is given for referencing the right document area, but factual and logical errors dominate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 380,
        "total_tokens": 1567
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the total value of Mortgage/Asset-backed securities investments made by Honeywell's U.S. and Non-U.S. plans as of December 31, 2023, and how does this allocation compare between the two plans?",
      "original_answer": "Honeywell's U.S. plans have $676 million invested in Mortgage/Asset-backed securities, while the Non-U.S. plans have $10 million invested in the same category. This results in a total investment of $686 million in Mortgage/Asset-backed securities across both U.S. and Non-U.S. plans. The U.S. plans account for 98.5% of this total, highlighting a significantly larger allocation to Mortgage/Asset-backed securities in U.S. plans compared to Non-U.S. plans.",
      "llm_answer": "As of December 31 2023, the U.S. pension plans held $676 million of mortgage/asset‑backed securities, while the non‑U.S. pension plans held $10 million of such securities. Thus, the U.S. plans’ allocation to mortgage/asset‑backed securities is substantially larger than that of the non‑U.S. plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: the U.S. plans' investment of $676 million and Non-U.S. plans' $10 million in Mortgage/Asset-backed securities as of December 31, 2023, are correctly reported. The total value of $686 million is implied through the sum of the two amounts, though not explicitly stated. The comparison correctly identifies that the U.S. allocation is substantially larger than the Non-U.S., which aligns with the ground truth observation of a 98.5% U.S. share. However, the LLM omits the explicit percentage (98.5%) and the total sum ($686 million), which were part of the original answer and directly responsive to the question asking for 'total value' and 'how this allocation compares'. While the qualitative reasoning is sound and the entities (Honeywell, U.S./Non-U.S. plans, security type, date) are accurate, the lack of explicit computation and percentage slightly reduces completeness. The answer remains semantically equivalent in intent and mostly in content, but the missing total and percentage prevent a perfect score. Contextual relevance is excellent as all information provided directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 337,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022?",
      "original_answer": "The total pre-tax financial impact of 'Medical device regulations' adjustments on Medtronic's Non-GAAP income before income taxes across fiscal years 2021 and 2022 was $185 million. This includes $83 million in fiscal year 2021 and $102 million in fiscal year 2022.",
      "llm_answer": "Based on the GAAP to Non-GAAP Reconciliations in the 2022 10‑K (page 33), the line item “Medical device regulations (4)” shows a pre‑tax impact of **$102 million** for fiscal year 2022 and **$83 million** for fiscal year 2021. Therefore, the total pre‑tax financial impact of “Medical device regulations” adjustments on Medtronic’s Non‑GAAP income before income taxes was **$102 million in fiscal 2022 and $83 million in fiscal 2021**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the pre-tax financial impacts of 'Medical device regulations' adjustments for both fiscal years 2021 ($83 million) and 2022 ($102 million), matching the ground truth exactly. The total impact of $185 million is implied by the sum of the two amounts, though the LLM did not explicitly state the combined total. (2) All numeric values are accurate and correctly attributed to the respective fiscal years. The calculation of the total ($83M + $102M = $185M) is mathematically correct, but the LLM omitted the explicit summation, which is a minor completeness issue. (3) The reasoning is sound: the model correctly referenced the GAAP to Non-GAAP reconciliation in Medtronic’s 2022 10-K and extracted the relevant line item. It properly synthesized data across two fiscal years, fulfilling the multi-hop requirement. (4) The answer is contextually fully relevant, directly addressing the question with precise data. The only reason for not scoring a 10 is the lack of explicit mention of the total $185 million, which was the primary quantity asked for in the question. However, since both components are provided and correct, the answer is substantially accurate and requires only minimal inference to derive the final total.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 355,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How much goodwill impairment was recognized for the OpenTable and KAYAK reporting unit in total during 2020, and what was the key factor that led to the continued impairment in the annual test as of September 30, 2020?",
      "original_answer": "A total goodwill impairment of $1.062 billion was recognized for the OpenTable and KAYAK reporting unit in 2020. This includes $489 million recognized during the interim test in March 2020 and an additional $573 million during the annual test in September 2020. The key factor that led to the continued impairment in the annual test was the lowered outlook for monetization opportunities in restaurant reservation services and slower recovery trends in airline travel, which is a key vertical for KAYAK.",
      "llm_answer": "The total goodwill impairment recognized for the OpenTable and KAYAK reporting unit in 2020 was $573 million, recorded during the September 30, 2020 annual impairment test. The key factor that drove the continued impairment was the prolonged impact of the COVID‑19 pandemic, which extended the assumed recovery period to 2019 profitability levels—particularly for KAYAK’s flight vertical and OpenTable’s restaurant‑reservation services—resulting in significantly reduced cash‑flow forecasts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a major factual error in the total goodwill impairment amount. The ground truth states a total of $1.062 billion, composed of $489 million in March 2020 and $573 million in September 2020. The LLM only reports the $573 million from the annual test, omitting the earlier $489 million impairment, resulting in a significant underreporting of the total. While the $573 million figure is accurate and correctly tied to the September 30, 2020 annual test, the failure to include the interim impairment makes the total quantitatively incorrect. (2) The key factor for continued impairment is reasonably well-captured: the LLM cites the prolonged impact of the pandemic affecting recovery in KAYAK’s flight vertical and OpenTable’s reservation services, which aligns with the ground truth’s mention of slower recovery in airline travel and lowered monetization outlook. However, the phrasing 'recovery period to 2019 profitability levels' introduces a detail not in the original and slightly misrepresents the reasoning, which was about reduced future cash flows due to slower recovery, not a specific return-to-2019 benchmark. (3) The multi-hop reasoning is partially sound—information is synthesized across the two reporting units and time points, but the model fails to combine both impairment events to arrive at the correct total, indicating a breakdown in full synthesis. (4) The contextual relevance is high as the answer addresses both parts of the question and focuses on the correct entities and time frame. However, the quantitative inaccuracy severely undermines the correctness score, warranting a 4. Qualitative accuracy is moderate due to correct identification of causal factors, and quantitative accuracy is low due to the missing $489 million component.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 495,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "By how much did Walmart's ownership stake in Flipkart increase between fiscal 2023 and fiscal 2024, and what financial transaction supported this change?",
      "original_answer": "Walmart's ownership stake in Flipkart increased by 10% (from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024). This increase was supported by a $3.5 billion transaction during fiscal 2024, where the company acquired shares from certain Flipkart noncontrolling interest holders.",
      "llm_answer": "Walmart's ownership stake in Flipkart increased by approximately 10 percentage points, rising from about 75% as of January 31, 2023 to roughly 85% as of January 31, 2024. This change was driven by a $3.5 billion transaction in fiscal 2024 in which the Company purchased shares from certain Flipkart non‑controlling interest holders, thereby increasing its ownership interest.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Walmart's ownership stake in Flipkart increased by approximately 10 percentage points, from 75% as of January 31, 2023, to 85% as of January 31, 2024, matching the ground truth exactly in both magnitude and timing. The $3.5 billion transaction amount is also accurately reported. (2) All numeric values—percentages (75% to 85%), the resulting 10 percentage point increase, the $3.5 billion figure, and the fiscal years (2023 to 2024)—are factually correct and consistent with the original answer. Minor wording differences (e.g., 'percentage points' vs. '%') do not affect meaning and are semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes ownership change over time and links it to a specific financial transaction involving noncontrolling interest holders, demonstrating accurate cross-temporal and cross-entity understanding. (4) The answer is fully complete, addressing both parts of the question—quantitative change and supporting transaction—with precise, relevant details. All scores are maximized due to perfect factual alignment, correct calculations, accurate entity identification, and clear, logical presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 346,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What percentage of Procter & Gamble's total net sales does the Baby, Feminine & Family Care segment represent, and within this segment, what is the North American market share of the Bounty brand in the paper towel category?",
      "original_answer": "The Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds over 40% North American market share in the paper towel category.",
      "llm_answer": "The Baby, Feminine & Family Care segment accounts for 24% of Procter & Gamble's total net sales. Within this segment, the Bounty brand holds approximately 40% market share in the North American paper towel category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that the Baby, Feminine & Family Care segment represents 24% of Procter & Gamble's total net sales, matching the ground truth exactly. It also correctly identifies that the Bounty brand holds approximately 40% market share in the North American paper towel category. The ground truth specifies 'over 40%', while the LLM says 'approximately 40%'. This is a minor semantic difference—'approximately' may slightly understate the 'over 40%' claim, but it is close enough to be considered factually aligned in most business contexts. (2) All numeric values are accurate: 24% and ~40% are correct percentages. No calculations were required, and the figures match the original answer within acceptable rounding or phrasing variation. (3) The multi-hop reasoning is sound: the model correctly links the segment-level sales contribution to the brand-level market share within a specific geography and product category. It synthesizes information across corporate segments and brand performance accurately. (4) Scores reflect near-perfect factual accuracy with only a slight deduction in qualitative accuracy due to the wording difference between 'over 40%' and 'approximately 40%'. Correctness score is 9 due to this minor imprecision; all other dimensions are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 365,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving Thales-Raytheon Systems and Related Matters, and how does this resolution connect to the SEC Administrative Order?",
      "original_answer": "RTX recorded a pre-tax charge of $364 million in 2024 related to Thales-Raytheon Systems and Related Matters. This resolution is directly connected to the SEC Administrative Order, which was issued as part of the settlement of investigations into improper payments made by Raytheon Company and its joint venture TRS in connection with certain Middle East contracts since 2012. The SEC Administrative Order requires RTX to retain an independent compliance monitor and fulfill cooperation and disclosure obligations for a period of three years from the monitor's engagement.",
      "llm_answer": "The total pre‑tax charge recorded by RTX in 2024 for resolving the Thales‑Raytheon Systems and related matters was $364 million, which is part of the $918 million combined pre‑tax charge disclosed for the DPAs, SEC Administrative Order and related settlements. This resolution is referenced in the SEC Administrative Order that required RTX (through Raytheon Company) to retain an independent compliance monitor and implement remedial compliance measures to address the criminal and civil investigations into payments made in connection with certain Middle East contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $364 million pre-tax charge for Thales-Raytheon Systems in 2024 is correctly stated, matching the original answer. The additional context about the $918 million combined charge, while not in the ground truth, does not contradict it and may reflect broader disclosure; it is plausible and does not detract from accuracy. (2) The connection to the SEC Administrative Order is correctly described: RTX (via Raytheon Company) is required to retain an independent compliance monitor and implement compliance measures, which matches the ground truth's mention of monitorship, cooperation, and disclosure obligations. (3) The multi-hop reasoning is sound—linking the 2024 charge to the resolution of investigations tied to Middle East contracts and the SEC order demonstrates proper synthesis across entities and time. (4) Minor deduction in qualitative accuracy because the LLM slightly expands on the compliance obligations by saying 'implement remedial compliance measures'—while reasonable, this phrasing is broader than the original, which specifies 'cooperation and disclosure obligations.' However, this does not make the answer factually incorrect. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 368,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "What is the total number of approved indications for Trodelvy as of April 2021, and in which specific countries was the drug approved for the treatment of metastatic triple-negative breast cancer by September 2021?",
      "original_answer": "As of April 2021, Trodelvy had two approved indications: one for locally advanced or metastatic urothelial cancer and another for unresectable locally advanced or metastatic triple-negative breast cancer (TNBC). By September 2021, Trodelvy was approved for TNBC in Australia, Great Britain, Switzerland, the United States, and Canada.",
      "llm_answer": "As of April 2021, the FDA granted accelerated approval of Trodelvy for metastatic urothelial cancer, and by September 2021 the drug had received full regulatory approval for metastatic triple‑negative breast cancer in the United States, Europe, Canada, Australia, Switzerland and other Orbis‑participating countries. Consequently, Trodelvy was approved for metastatic triple‑negative breast cancer in those specific countries by September 2021.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains key inaccuracies. It correctly identifies that Trodelvy had regulatory approvals related to metastatic triple-negative breast cancer (TNBC) and urothelial cancer, but fails to explicitly state the total number of approved indications as of April 2021, which is two according to the ground truth. Instead, it only implies this by mentioning two approvals without summarizing the count. (2) The list of countries where Trodelvy was approved for TNBC by September 2021 includes the United States, Canada, Australia, and Switzerland — matching the ground truth — but incorrectly adds 'Europe' and 'Orbis-participating countries' as if they are specific countries, which they are not. The ground truth specifies Great Britain, not Europe broadly, and does not mention the Orbis program. This introduces entity inaccuracies. Additionally, the claim of 'full regulatory approval' for TNBC by September 2021 contradicts the known timeline; the FDA granted accelerated approval for TNBC earlier, with full approval coming later. The April 2021 approval mentioned in the LLM answer was actually for urothelial cancer, not TNBC, which was first approved earlier (in April 2020). (3) The multi-hop reasoning is partially sound — the model connects approvals across time and geography — but fails in synthesizing the correct number of indications and misattributes approval types and dates. It conflates the sequence of approvals and misrepresents the nature (accelerated vs. full) and timing. (4) Despite these issues, the answer is contextually relevant and captures some correct geographic approvals. The core facts about key countries are mostly right, and the drug’s indication areas are correctly referenced, just not fully or accurately counted or dated. Hence, a moderate score is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 501,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, and how does this compare to the amount expected to be reclassified from AOCI into earnings within 12 months?",
      "original_answer": "The total net gain for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024, is $11.5 million, and $9.5 million of this amount is expected to be reclassified from AOCI into earnings within 12 months.",
      "llm_answer": "The total net gain/(loss) for 'Foreign currency - other' derivatives included in AOCI as of September 29, 2024 is $11.5 million, and the amount expected to be reclassified from AOCI into earnings within 12 months is $9.5 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The quantitative values are accurate: $11.5 million is correctly reported as the total net gain for 'Foreign currency - other' derivatives in AOCI as of September 29, 2024, and $9.5 million is correctly stated as the amount expected to be reclassified into earnings within 12 months. (2) The answer addresses both parts of the multi-part question completely: it reports the total net gain in AOCI and the portion expected to be reclassified, fulfilling the completeness requirement. (3) The entities are accurate — the derivative type ('Foreign currency - other'), the date (September 29, 2024), and the accounting treatment (AOCI) are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis, as it correctly links the AOCI balance to the expected reclassification impact on earnings, indicating understanding of both current position and forward-looking impact. (5) The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of thin spaces) that do not affect accuracy. All scores are maximized due to full factual correctness, precise numbers, logical coherence, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 348,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What is the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024, and how do these facilities differ in terms of maturity dates and interest rate margins?",
      "original_answer": "The total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of September 29, 2024, is $103.6 million (¥5.0 billion at $34.5 million and ¥10.0 billion at $69.1 million). The first facility matures on December 30, 2024, and carries an interest rate margin of 0.400% over TIBOR, while the second facility matures later, on March 27, 2025, and has a lower margin of 0.300% over TIBOR.",
      "llm_answer": "Based on the provided document pages, the total dollar value of the two Japanese yen-denominated credit facilities available to Starbucks as of the end of fiscal 2024 is **$103.6 million** ($34.5 million + $69.1 million). These facilities differ in maturity dates and interest rate margins as follows:  \n- The **¥5.0 billion facility** matures on **December 30, 2024**, with an interest rate of **TIBOR + 0.400%**.  \n- The **¥10.0 billion facility** matures on **March 27, 2025**, with an interest rate of **TIBOR + 0.300%**.  \n\nBoth facilities are currently unused (no borrowings outstanding as of September 29, 2024), but their terms specify the stated maturities and variable interest rate structures based on TIBOR with distinct applicable margins.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the two yen-denominated facilities are correctly converted to $34.5 million (¥5.0 billion) and $69.1 million (¥10.0 billion), summing to the correct total of $103.6 million. The maturity dates (December 30, 2024, and March 27, 2025) and interest rate margins (0.400% and 0.300% over TIBOR) are exactly as stated in the original answer. (2) The answer is complete, addressing both parts of the question: total dollar value and differences in maturity and interest rate terms. (3) Entity accuracy is perfect—Starbucks, fiscal 2024 (as of September 29, 2024), Japanese yen, TIBOR, and the two facilities are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly aggregated two separate credit facilities, converted yen amounts to dollar equivalents using implied exchange rates, and contrasted their terms. (5) The semantic meaning is equivalent to the ground truth, with clear, well-structured presentation. Minor additions (e.g., noting the facilities are unused) are contextually appropriate and do not detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 339,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 under both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans or programs, and what was the average price paid per share under the open-market program?",
      "original_answer": "The total number of Accenture plc Class A ordinary shares purchased in the fourth quarter of fiscal 2024 was 2,072,263 — consisting of 2,000,308 shares purchased under the publicly announced open-market share purchase program and 72,255 shares acquired through transactions unrelated to publicly announced share plans. The average price paid per share under the open-market program was approximately $302.45, calculated by dividing the aggregate purchase price of $605 million by the 2,000,308 shares acquired.",
      "llm_answer": "In the fourth quarter of fiscal 2024, Accenture purchased a total of **2,072,563** Class A ordinary shares—**2,000,308** of these were bought under the publicly announced open‑market share purchase program, and the remaining **72,255** were acquired in transactions unrelated to that program (e.g., employee‑share‑plan withholdings). The average price paid per share for the shares purchased under the open‑market program was **$303.05**.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the breakdown of shares purchased — 2,000,308 under the open-market program and 72,255 through unrelated transactions — which matches the ground truth. However, the total number of shares is reported as 2,072,563, which is incorrect; the correct total is 2,072,263 (2,000,308 + 72,255 = 2,072,563 is mathematically wrong — the actual sum is 2,072,563, but the ground truth states 2,072,263, suggesting a possible typo in the original or LLM answer; however, per ground truth, the total should be 2,072,263). This discrepancy suggests either a data error or miscalculation. More critically, the average price per share is reported as $303.05, whereas the ground truth calculates $302.45 using $605 million divided by 2,000,308 shares. Recalculation confirms: 605,000,000 / 2,000,308 ≈ $302.45, so the LLM's figure is inaccurate. (2) Quantitative accuracy suffers due to the incorrect total share count and wrong average price. The component numbers (2,000,308 and 72,255) are correct, but the total and derived average are not. (3) The reasoning is mostly sound — the model recognizes the need to separate the two types of purchases and compute or report the average price for the open-market program. It correctly identifies the context and entities. (4) Despite minor wording differences (e.g., mentioning employee-share-plan withholdings as an example), the answer is contextually relevant and addresses both parts of the multi-part question. The core facts are mostly right, but the incorrect total and average price — especially the latter, which involves a miscalculation — reduce the correctness score. Final scores reflect mostly correct entities and structure, but flawed quantitative output.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 476,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the total carrying value of the 6.375% 2037 Notes and how much principal amount of these notes was exchanged according to the information provided in the respective sections?",
      "original_answer": "The total carrying value of the 6.375% 2037 Notes is $478 million, and the principal amount of these notes that was exchanged is $74 million.",
      "llm_answer": "The 6.375% 2037 Notes had a total carrying value of $478 million as of December 31 2021. In 2020, $74 million of principal from these notes was exchanged in the debt‑exchange transaction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The total carrying value of the 6.375% 2037 Notes is accurately stated as $478 million, and the principal amount exchanged is correctly reported as $74 million. (2) All numeric values match the original answer exactly; format variations (e.g., 'million' vs 'M') are acceptable and do not affect accuracy. The dates (as of December 31, 2021, and the 2020 exchange) are consistent with the source data. (3) The multi-hop reasoning is sound: the model correctly identifies both the carrying value (a valuation metric from financial statements) and the exchanged principal (from a specific transaction), synthesizing information from different time points and contexts. (4) The answer is semantically equivalent to the ground truth, with added clarity on timing without introducing errors. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1091,
        "completion_tokens": 265,
        "total_tokens": 1356
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the expected average amortization period for Netflix's content assets, and how does the accelerated amortization policy impact the distribution of amortization expense over the life of a content asset, particularly within the first four years?",
      "original_answer": "Netflix expects over 90% of a licensed or produced content asset to be amortized within four years after its month of first availability. The accelerated amortization policy results in a higher proportion of the asset's cost being expensed earlier, particularly in the initial months following availability, reflecting the expectation of more upfront viewing, especially for films compared to TV series.",
      "llm_answer": "Netflix amortizes its content assets on an accelerated basis, expecting over 90 % of a title’s cost to be expensed within four years of its first availability. Consequently, while the content is capitalized for up to ten years (or the shorter of the contractual window and ten years), the bulk of the amortization expense is recognized in the first four years, front‑loading the cost of revenues. This accelerated amortization means that earnings are lower in the early years of a title’s life and higher in later years when the expense tapers off.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the key figure of 'over 90%' of a content asset being amortized within four years is correctly stated, matching the original answer exactly. There are no calculation errors or incorrect numbers. (2) The answer correctly identifies Netflix's accelerated amortization policy and its impact—front-loading expenses, particularly in the first four years—which reflects the intended economic behavior of content consumption. (3) The reasoning is sound: it explains that although content may be capitalized for up to ten years, the majority of amortization occurs earlier, which is consistent with the expectation of higher initial viewership, especially for films. While the original answer specifically mentions 'initial months' and contrasts films vs. TV series, the LLM captures the essence of upfront expense recognition without explicitly making that distinction. (4) The LLM adds contextual detail not in the original (e.g., impact on earnings over time), which is accurate and enriches the response without introducing error. The only minor shortcoming is the lack of explicit mention that the accelerated pattern reflects expected viewing patterns, particularly for films versus TV series, which slightly reduces qualitative completeness. However, the core multi-hop synthesis—linking amortization policy to expense timing and business rationale—is correct and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 404,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What is the total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 if all investments experience a -10% change in exchange rates, based on the disclosed exposure?",
      "original_answer": "The total potential financial impact on BLK's Foreign Exchange Rate Risk Investments in 2023 from a -10% change in exchange rates would be $112 million, as calculated from the disclosed exposure of $1,125 million.",
      "llm_answer": "Based on the Foreign Exchange Rate Risk table on page 63, BlackRock's total exposure to foreign exchange rate risk investments was $1,125 million as of December 31, 2023. A hypothetical 10% adverse change in foreign exchange rates would result in a $112 million impact, as shown in the \"Effect of -10% Change\" column. Therefore, the total potential financial impact if all investments experience a -10% change in exchange rates is $112 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: BLK's total foreign exchange rate risk exposure is $1,125 million as of December 31, 2023, and a -10% change results in a $112 million impact. These values match the ground truth exactly. (2) Quantitatively, the calculation is accurate: 10% of $1,125 million is $112.5 million, but the disclosed 'Effect of -10% Change' is stated as $112 million, which aligns with the reported figure (likely due to rounding or specific modeling assumptions in the source). The LLM correctly reports the disclosed value rather than recalculating, which is appropriate per SEC filing practices. (3) The reasoning is sound and reflects proper multi-hop synthesis: it connects the exposure amount to the hypothetical scenario using the documented impact, demonstrating understanding of risk disclosure structure. (4) All entities—BLK (BlackRock), the correct year (2023), the correct risk type (foreign exchange rate risk), and the financial metric (potential impact)—are accurately identified and contextualized. The answer is semantically equivalent to the ground truth and fully addresses the question with precise, relevant details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 335,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How many amendments to the Target Corporation Deferred Compensation Trust Agreement are listed in the 2022 10-K filing, and what are their effective dates?",
      "original_answer": "There are three amendments to the Target Corporation Deferred Compensation Trust Agreement listed in the 2022 10-K filing. Their effective dates are June 8, 2011; October 25, 2017; and December 18, 2020.",
      "llm_answer": "The 2022 10‑K filing lists **four amendments** to the Target Corporation Deferred Compensation Trust Agreement. Their effective dates are:\n\n1. **Amendment dated June 8, 2011** – effective January 1, 2009.  \n2. **Amendment dated October 25, 2017** – effective January 1, 2009.  \n3. **Amendment dated December 18, 2020** – effective January 1, 2009.  \n4. **Amendment dated June 8, 2011** (re‑listed as a separate entry) – effective January 1, 2009.  \n\nThese correspond to entries (22), (23), (24) and (21) in the exhibit list on page 68.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantity and factual details. (1) The original answer states there are three amendments, with effective dates of June 8, 2011; October 25, 2017; and December 18, 2020. The LLM incorrectly reports four amendments and misstates the effective dates as January 1, 2009 for all, which contradicts the ground truth. The June 8, 2011 date refers to the amendment date, not the effective date, but the ground truth treats it as the effective date—still, the LLM fabricates a uniform effective date not present in the original. (2) Quantitatively, the number of amendments (4 vs 3) is wrong, and all effective dates are incorrect. The LLM appears to confuse amendment dates with effective dates and invents a recurring January 1, 2009 effective date not supported by the truth. (3) The reasoning is flawed: it cites four entries (21)-(24), but the original answer and likely the document only recognize three distinct amendments. The duplication of the June 8, 2011 amendment as a 're-listed' entry is not substantiated and appears to be a misinterpretation of the exhibit list. (4) Contextually, the answer addresses the right document and topic, showing some relevance, but fails on core facts. The mention of specific exhibit numbers adds apparent detail but does not align with the verified truth, suggesting hallucination or misreading. Overall, major factual and quantitative errors result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 400,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total carrying value of the 6.90% 2038 Notes and how much principal amount of these notes was exchanged according to the debt exchange transactions disclosed?",
      "original_answer": "The total carrying value of the 6.90% 2038 Notes is $254 million, and the principal amount exchanged in the debt exchange transactions was $37 million.",
      "llm_answer": "The 6.90% 2038 Notes had a total carrying value of $254 million, and $37 million of their principal amount was exchanged in the 2020 debt‑exchange transaction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total carrying value of $254 million and the principal amount exchanged of $37 million are accurately reported, with acceptable formatting (using 'million' instead of numeric figures). (2) The answer addresses both parts of the question: the total carrying value and the exchanged principal amount. (3) The entity '6.90% 2038 Notes' is correctly identified, and the reference to the '2020 debt-exchange transaction' adds context without contradicting the ground truth—this detail is consistent with typical disclosures and does not introduce inaccuracy. (4) The reasoning is sound, demonstrating correct synthesis of financial data from the relevant SEC filings. The answer is semantically equivalent to the original, with no factual, numerical, or contextual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1083,
        "completion_tokens": 254,
        "total_tokens": 1337
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "By how much did the Fleet Ballistic Missile (FBM) program contribute to the increase in both product sales and product costs at Space in 2023, and what was the net financial impact on Lockheed Martin's operations from these changes?",
      "original_answer": "The Fleet Ballistic Missile (FBM) program contributed to a $940 million increase in product sales and an $815 million increase in product costs at the Space business segment in 2023. The net financial impact from these changes was an increase in gross profit of $125 million ($940M - $815M) for the Space segment related to the FBM program.",
      "llm_answer": "The Fleet Ballistic Missile (FBM) program contributed approximately $815 million of higher product costs at Space in 2023, and product sales rose by about $799 million (1 %) largely due to the FBM ramp‑up. The net financial impact was an increase in both sales and costs, but the additional revenue from the FBM program more than offset the higher expenses, resulting in a positive contribution to overall earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that the FBM program contributed a $940 million increase in product sales, but the LLM reports only $799 million (a substantial underreporting of $141 million). The LLM correctly identifies approximately $815 million in higher product costs, aligning with the ground truth. However, due to the incorrect sales figure, the net financial impact is misrepresented. The correct net impact is $125 million in increased gross profit ($940M - $815M), but the LLM fails to compute or state this figure, only vaguely noting a 'positive contribution to earnings' without quantification. (2) Number verification: $799M ≠ $940M (sales), $815M = $815M (costs), net impact missing or incorrect. The 1% sales increase mentioned is not in the original answer and introduces unverified context. (3) Multi-hop reasoning is partially sound—the model recognizes that increased sales and costs from FBM affect profitability and attempts to compare them—but fails in accurate synthesis due to wrong input numbers and missing calculation of net impact. (4) Scores reflect major factual errors in key financial figures (especially sales), leading to a low correctness and quantitative accuracy score. Qualitative reasoning is acceptable but incomplete. Contextual relevance is high as the answer addresses the right program, segment, year, and financial concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 399,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total carrying value of the 5.375% 2043 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged during the period?",
      "original_answer": "The total carrying value of the 5.375% 2043 Notes was $185 million, which represents approximately 0.555% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $76 million in principal of these notes was exchanged during the period.",
      "llm_answer": "The 5.375% 2043 Notes had a carrying value of $185 million, which represented roughly 0.55% of AMGN’s total debt carrying value of $33,309 million in 2022. Approximately $76 million principal of these notes was exchanged during the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the carrying value of the 5.375% 2043 Notes ($185 million), the total debt carrying value ($33,309 million), the percentage (0.55% vs. ground truth 0.555%), and the exchanged principal ($76 million). The only minor discrepancy is the rounding of 0.555% to 0.55%, which is acceptable for 'roughly' or 'approximately' in context. (2) All numeric values match the ground truth exactly except the percentage, which is rounded but still semantically equivalent. The calculation (185 / 33,309 ≈ 0.555%) is accurate, and the LLM reports it as 'roughly 0.55%', which is reasonable. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from AMGN’s 2022 debt disclosures, identifies the specific note tranche, retrieves its carrying value and exchange activity, and computes its proportion relative to total debt. (4) Scores reflect near-perfect factual accuracy, with full quantitative precision and only a negligible rounding difference in presentation. The answer is fully relevant and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 308,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total value of securities on loan subject to indemnification, and how much collateral was held against these securities as of December 31, 2023, and what is the potential financial impact if significant borrower defaults occur simultaneously with rapid declines in collateral value?",
      "original_answer": "As of December 31, 2023, the total value of securities on loan subject to indemnification was approximately $259 billion, and BlackRock held approximately $276 billion in cash and securities as collateral against these loans. If significant borrower defaults were to occur simultaneously with rapid declines in the value of pledged collateral, there could be collateral shortfalls, which may result in material liabilities under these indemnities and could cause BlackRock's revenue and earnings to decline.",
      "llm_answer": "The total value of securities on loan subject to indemnification was approximately $259 billion as of December 31, 2023, and BlackRock held about $276 billion of cash and securities as collateral against those loaned securities. If significant borrower defaults occurred simultaneously with rapid declines in the value of the pledged collateral, the shortfall could trigger material indemnity liabilities, leading to a decline in BlackRock’s revenue and earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the total value of securities on loan subject to indemnification is correctly stated as $259 billion, and the collateral held is accurately given as $276 billion, both as of December 31, 2023. (2) Quantitative accuracy is perfect—both figures match the original answer exactly, with only minor formatting differences (e.g., thin space in '$259 billion'), which are acceptable. (3) The qualitative reasoning is sound: the LLM correctly identifies the risk scenario—simultaneous borrower defaults and rapid collateral value declines—and accurately describes the potential consequences, including collateral shortfalls, material indemnity liabilities, and negative impacts on BlackRock’s revenue and earnings. (4) The answer addresses all parts of the multi-hop question: it provides the two financial figures, the time reference, and the forward-looking risk assessment, synthesizing information correctly across entities and implications. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 317,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "What is the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. as documented in the 2022 10-K filing?",
      "original_answer": "The total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. is two.",
      "llm_answer": "The 2022 10-K filing (Target Corporation) does not specify the total number of amendments made to the Pharmacy Operating Agreement between Target Corporation and CVS Pharmacy, Inc. The document lists the agreement and its amendments (e.g., \"Pharmacy Operating Agreement dated December 16, 2015,\" \"First Amendment dated November 30, 2016,\" \"Second Amendment dated January 9, 2018\"), but it does not explicitly state how many amendments were made in total. The question cannot be answered definitively from the provided pages.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. The ground truth states there are two amendments to the Pharmacy Operating Agreement, which is directly supported by the naming of the 'First Amendment dated November 30, 2016' and 'Second Amendment dated January 9, 2018' in the 10-K filing. Despite listing these two amendments explicitly, the LLM incorrectly concludes that the total number is unspecified. (2) The quantitative accuracy is very low because the correct number of amendments (two) is clearly inferable from the document references, yet the LLM fails to make this logical inference and instead claims the information is not available. (3) The reasoning is flawed: this is a straightforward multi-hop inference where naming a 'First' and 'Second' Amendment directly implies exactly two amendments. The LLM fails to perform this basic synthesis, indicating poor qualitative reasoning. (4) Contextual relevance is moderate because the LLM correctly identifies the relevant agreement and cites actual amendment dates from the document, showing it accessed the right context, but ultimately draws the wrong conclusion. The answer would have been correct if it had simply counted the numbered amendments.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 343,
        "total_tokens": 1512
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What is the change in the net carrying amount of Technology-related finite-lived intangible assets from December 31, 2022, to December 31, 2023, and how does this compare to the change in the accumulated amortization for the same category over the same period?",
      "original_answer": "The net carrying amount of Technology-related finite-lived intangible assets decreased by $38 million from $180 million in 2022 to $142 million in 2023. Over the same period, the accumulated amortization increased by $37 million from $81 million in 2022 to $118 million in 2023. This indicates that the decline in net carrying amount is primarily due to the increase in accumulated amortization.",
      "llm_answer": "The net carrying amount of technology-related finite-lived intangible assets decreased by $38 million from $142 million at December 31 2022 to $104 million at December 31 2023. Over the same period, accumulated amortization for this category increased by $37 million (from $81 million to $118 million), reflecting the $38 million reduction in net carrying amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the net carrying amount values and the resulting change. According to the ground truth, the net carrying amount decreased from $180 million in 2022 to $142 million in 2023, resulting in a $38 million decrease. However, the LLM incorrectly states the 2022 value as $142 million and the 2023 value as $104 million, which implies a $38 million drop but from wrong starting and ending points. This misrepresents the actual financial position. (2) The accumulated amortization figures are correct: $81 million in 2022 to $118 million in 2023, an increase of $37 million. However, the LLM incorrectly attributes the full $38 million reduction in net carrying amount solely to amortization without acknowledging the slight discrepancy ($38M vs $37M), though this part is mostly reasonable. (3) The multi-hop reasoning is partially sound — the model correctly identifies the relationship between amortization and carrying amount — but fails in data retrieval for the carrying amounts, undermining the synthesis. (4) Scores reflect that core concepts and one data stream (amortization) are correct, but critical financial figures (carrying amounts) are wrong, leading to a misleading narrative despite correct directional logic and partial numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 368,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and how does this compare to the change in the same category in the Americas region?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million, while in the Americas region, the increase was $7,048 million. This means the growth in the Americas was significantly higher compared to the Asia Pacific region.",
      "llm_answer": "Based on the provided financial tables, the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $1,546 million (from $657 million in fiscal 2023 to $2,203 million in fiscal 2024), while the change in the same category in the Americas region was a decrease of $3,152 million (from $5,678 million in fiscal 2023 to $12,726 million in fiscal 2024, representing a $7,054 million increase in absolute terms but a net change of -$3,152 million when comparing the two years' values). However, the question asks for the comparison of the change in the same category between regions, and the data shows the Asia Pacific growth was $1,546 million while the Americas revenue for Subscriptions and Services actually increased by $7,054 million year-over-year, meaning the comparison should reflect the absolute changes rather than directional increases. The correct interpretation is that the Asia Pacific region saw a $1,546 million increase, while the Americas region saw a $7,054 million increase in Subscriptions and Services revenue year-over-year.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the Asia Pacific year-over-year increase as $1,546 million, which matches the ground truth. However, it initially misstates the Americas change as a 'decrease of $3,152 million', which is factually incorrect—the ground truth states a $7,048 million increase. The LLM later corrects itself by noting a $7,054 million increase (close to the true $7,048M), likely due to a calculation or rounding difference. This inconsistency undermines quantitative accuracy. (2) The calculation for Asia Pacific is correct: $2,203M - $657M = $1,546M. For the Americas: $12,726M - $5,678M = $7,048M, but the LLM reports $7,054M, a minor discrepancy of $6 million, possibly due to data misreading. The erroneous claim of a '$3,152 million decrease' appears to stem from a confusion with another metric or region and is not explained. (3) The multi-hop reasoning is partially sound—comparing Subscriptions and Services revenue changes across regions—but the initial misinterpretation of the Americas change as negative introduces flawed logic. The model eventually arrives at the correct direction and approximate magnitude but with internal contradiction. (4) Despite the confusion, the final comparison acknowledges the Americas had a much larger absolute increase than Asia Pacific, aligning with the ground truth's conclusion. Thus, core facts are mostly present with significant but not critical errors, warranting a score of 7 for correctness. Quantitative accuracy is slightly penalized for the $6M error and the false decrease claim. Qualitative reasoning is weakened by the contradictory statements. Contextual relevance remains high as the answer directly addresses the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 469,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What is the total fair value of redeemable preferred securities held by CVS as of December 31, 2023, and how much of the unrealized loss on these securities has been recognized in fair value as of the same date?",
      "original_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million. Of the total unrealized loss of $1 million on these securities, $1 million has been recognized in fair value as there are no unrealized losses in the 'Less than 12 months' category and the entire unrealized loss of $1 million is in the 'Greater than 12 months' category.",
      "llm_answer": "The total fair value of redeemable preferred securities held by CVS as of December 31, 2023, is $20 million, and the unrealized loss on these securities recognized in fair value at that date is $1 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all quantitative aspects: the total fair value of $20 million and the recognized unrealized loss of $1 million match the ground truth exactly. The dates (December 31, 2023) and entities (CVS, redeemable preferred securities) are accurate. The answer addresses both parts of the question—total fair value and amount of unrealized loss recognized. While the LLM omits the explanatory detail about the 'Greater than 12 months' category and the absence of losses in the 'Less than 12 months' category, this contextual reasoning is not strictly necessary to answer the two-part factual question. The core facts and numbers are correct, and the semantic meaning fully aligns with the original answer. Thus, the response is complete for the question asked, though slightly less detailed in justification. No calculation errors; multi-hop synthesis (if required across tables or sections) is implicitly correct given accurate output.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 277,
        "total_tokens": 1439
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What was the total amount of borrowings under HD's commercial paper programs at January 30, 2022, and how does this compare to the combined capacity of their back-up credit facilities at that date?",
      "original_answer": "The total amount of borrowings under HD's commercial paper programs at January 30, 2022, was $1.0 billion. The combined capacity of their back-up credit facilities at that date was $3.0 billion, consisting of a five-year $2.0 billion credit facility and a 364-day $1.0 billion credit facility. Therefore, HD had $1.0 billion in outstanding borrowings, which was fully covered by the $3.0 billion in available back-up credit facilities.",
      "llm_answer": "The total amount of borrowings under HD's commercial paper programs at January 30 2022 was $1.0 billion, which represents the outstanding balance on the program. This figure is well below the combined capacity of the back‑up credit facilities, which provided up to $3.0 billion of available borrowing at that date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.0 billion in borrowings under HD's commercial paper program at January 30, 2022, and accurately states the $3.0 billion combined capacity of the back-up credit facilities. These figures match the ground truth exactly. (2) All numeric values are correct: $1.0 billion in borrowings and $3.0 billion in credit capacity. The comparison 'well below' is factually accurate and logically sound, as $1.0 billion is indeed less than $3.0 billion. (3) The multi-hop reasoning is sound—information about commercial paper borrowings and back-up credit facilities comes from different parts of the filing and must be synthesized. The LLM correctly links the two concepts and draws a valid conclusion about coverage, though it omits the specific breakdown of the $3.0 billion into the five-year $2.0 billion and 364-day $1.0 billion facilities. This detail is present in the ground truth and adds completeness, but its absence does not invalidate the core correctness. (4) The answer is semantically equivalent to the original in terms of key facts and implications. The omission of the facility breakdown slightly reduces completeness but does not affect the primary quantitative or comparative accuracy. Hence, a score of 9 is justified—excellent accuracy with minor room for enhanced detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 374,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What was Amgen's total revenue from sales to BeiGene in 2023, and how much did Amgen pay in profit and loss sharing expenses related to these products during the same year?",
      "original_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million, and Amgen paid $40 million in profit and loss sharing expenses related to these products during the same year.",
      "llm_answer": "Amgen's total revenue from sales to BeiGene in 2023 was $125 million. The company recorded $40 million in profit‑and‑loss sharing expenses related to these products during the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, both values—$125 million in revenue and $40 million in profit and loss sharing expenses—are accurately reported with correct units and year (2023). Minor formatting differences (e.g., thin space in '$125 million' or hyphenation in 'profit‑and‑loss') do not affect meaning and are typographically acceptable. (2) The answer is complete, addressing both parts of the question: revenue from sales and related sharing expenses. (3) Entity accuracy is correct—Amgen and BeiGene are properly identified, and the financial metrics are appropriately named. (4) The reasoning, while not explicitly shown, is sound in synthesis—linking Amgen's revenue and expense figures to the same transactional relationship with BeiGene in 2023, indicating correct multi-hop understanding. (5) The semantic meaning is equivalent to the original answer, with no omissions or distortions. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1098,
        "completion_tokens": 289,
        "total_tokens": 1387
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024, and how does this relate to the valuation method used for the corresponding Crypto Asset Safeguarding Asset as of December 31, 2023?",
      "original_answer": "The year-over-year increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million ($2,886 million in 2024 - $1,241 million in 2023). This increase corresponds to the valuation method used for the Crypto Asset Safeguarding Asset, which, as of December 31, 2023, was valued at $1,241 million and categorized under 'Significant Other Observable Inputs (Level 2)'—indicating that the liability tracks the asset's valuation, which is not based on active market quotes but on other observable market data.",
      "llm_answer": "The year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability from 2023 to 2024 was $1,645 million (calculated as $2,886 million in 2024 minus $1,241 million in 2023). This liability is measured at fair value using quoted prices on the active exchange for the underlying crypto assets (Level 2 valuation), and the corresponding safeguarding asset is recorded at the same fair value on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly calculated the year-over-year dollar increase in PYPL's Crypto Asset Safeguarding Liability as $1,645 million ($2,886M - $1,241M), matching the ground truth exactly. All numeric values (2023 liability: $1,241 million, 2024 liability: $2,886 million) are accurate and properly formatted. 2) The calculation is correct and clearly explained. 3) The LLM accurately identifies the relationship between the liability and the valuation method of the corresponding asset as of December 31, 2023, noting that both are measured at fair value using Level 2 inputs. However, there is a minor inaccuracy in describing Level 2 as 'quoted prices on the active exchange'—the ground truth specifies 'Significant Other Observable Inputs (Level 2)', which may include prices not from active markets but derived from observable data. This subtle distinction affects the precision of the qualitative explanation. 4) Despite this nuance, the core reasoning is sound: the liability tracks the asset’s fair value, and both are on the balance sheet at the same valuation. The answer addresses both parts of the multi-hop question (dollar increase and valuation method) and synthesizes information correctly across time and accounting concepts. Hence, full marks for quantitative accuracy and contextual relevance, minor deduction in qualitative accuracy for imprecise valuation description, leading to a 9/10 overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 394,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How many shares were available for future grants under UnitedHealth Group's 2020 Stock Incentive Plan as of December 31, 2024, and what types of share-based awards are explicitly referenced in the plan documentation?",
      "original_answer": "As of December 31, 2024, UnitedHealth Group had 48 million shares available for future grants under the 2020 Stock Incentive Plan. The plan documentation explicitly references several types of share-based awards, including Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards, as evidenced by the various form agreements listed in the filing.",
      "llm_answer": "As of December 31 2024, the 2020 Stock Incentive Plan had **48 million shares available for future grants**. The plan documentation explicitly references **stock options, restricted shares, and other share‑based awards** (including stock appreciation rights, performance awards, and similar instruments).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 48 million shares available for future grants as of December 31, 2024, which matches the ground truth exactly—this satisfies the quantitative requirement perfectly. (2) The number and date are accurate with no calculation involved, so quantitative accuracy is flawless. (3) However, the qualitative accuracy is slightly lower because while the LLM mentions 'stock options, restricted shares, and other share-based awards,' it generalizes the specific award types. The ground truth specifies 'Non-Qualified Stock Option Awards, Restricted Stock Unit Awards, and Performance-Based Restricted Stock Unit Awards'—more precise categories directly pulled from form agreements. The LLM's answer includes broader terms like 'performance awards' and 'stock appreciation rights' which, while potentially part of the plan, are not explicitly confirmed in the ground truth and may overgeneralize. It fails to name the exact award types referenced in the documentation, indicating a partial synthesis failure in multi-hop reasoning. (4) Contextual relevance is full—the response directly addresses both parts of the question and stays within scope. Overall, the core fact (48 million shares) is correct, but the characterization of award types lacks the specificity required for full factual alignment, warranting a 7/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 382,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How much remaining contracted revenue for Paxlovid is expected to be recognized from deliveries between 2025 and 2028, and how does this compare to the revenue recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner?",
      "original_answer": "Pfizer has approximately $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from deliveries between 2025 and 2028. This is significantly higher than the $129 million recognized in 2024 from a one-time sales true-up settlement agreement with a commercialization partner.",
      "llm_answer": "The 2024 Form 10‑K states that “Remaining Performance Obligations—Contracted revenue expected to be recognized from remaining performance obligations for firm orders in long‑term contracts to supply Paxlovid totaled approximately $1 billion as of December 31, 2024, with expected delivery of product with contracted revenue from 2025 through 2028.” This $1 billion represents the portion of the remaining contracted revenue that will be recognized between 2025 and 2028.  \n\nIn contrast, the document notes that “2024 includes a one‑time sales true‑up settlement agreement with our commercialization partner” that generated a $129 million benefit, and that “During 2024, we recognized revenue of approximately $2.9 billion that was included in the balance of Paxlovid and Comirnaty deferred revenues as of December 31, 2023.” Thus, the revenue recognized in 2024 from the one‑time true‑up settlement agreement is separate from, and much smaller than, the $1 billion of future Paxlovid revenue that will be recognized from 2025‑2028.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1 billion in remaining contracted revenue for Paxlovid expected to be recognized from 2025 to 2028 is accurately reported, as is the $129 million recognized in 2024 from the one-time sales true-up settlement agreement. These figures are cited directly from the 2024 Form 10-K and match the ground truth exactly. (2) The answer is complete, addressing both parts of the question: the future revenue expectation (2025–2028) and the comparison to the 2024 true-up revenue. (3) Entity accuracy is correct—Pfizer is the implied company (context from 10-K), Paxlovid is the product, and the time periods (2024, 2025–2028) are properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis: it distinguishes between future contracted revenue and a past one-time settlement, correctly noting that the $129 million is separate and smaller than the $1 billion. The semantic meaning fully aligns with the original answer, with no factual or interpretive errors. Minor additional context (e.g., mention of $2.9 billion in deferred revenue recognition) does not detract from accuracy and supports contextual clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 343,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How much of AIG's ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO were covered by the parental guarantee from Berkshire Hathaway Inc. as of December 31, 2023?",
      "original_answer": "As of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, which was secured by a parental guarantee from Berkshire Hathaway Inc.",
      "llm_answer": "Based on the provided document pages, the parental guarantee from Berkshire Hathaway Inc. was provided to secure NICO's obligations under the adverse development reinsurance agreement, but the document does not specify a monetary amount or percentage of the ceded loss reserves that were covered by this guarantee as of December 31, 2023. Consequently, the exact coverage amount cannot be determined from the given information.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect and contradicts the ground truth. The original answer clearly states that as of December 31, 2023, AIG had $12.4 billion in ceded loss reserves under the 2017 adverse development reinsurance agreement with NICO, and this amount was secured by a parental guarantee from Berkshire Hathaway Inc. The LLM incorrectly claims that the document 'does not specify a monetary amount' and that 'the exact coverage amount cannot be determined,' which is false given the provided ground truth. (2) The quantitative failure is severe: the correct figure ($12.4 billion) is entirely omitted, and no attempt is made to report it. This is a direct mismatch with the ground truth. (3) The multi-hop reasoning is flawed. The question requires recognizing that the ceded loss reserves under the NICO agreement are explicitly tied to the Berkshire Hathaway parental guarantee — a connection the LLM fails to make, despite the ground truth stating it directly. Instead, the model misattributes the purpose of the guarantee without supporting that interpretation from the data. (4) The contextual relevance is moderate because the LLM addresses the correct entities (AIG, NICO, Berkshire Hathaway, parental guarantee) and time frame, but fails completely on factual accuracy and synthesis. Due to the complete absence of the correct dollar amount and the erroneous claim of insufficient information, the correctness and quantitative accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 412,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What was the total amount of credit receivables purchased by PayPal for its merchant finance offerings in the years ended December 31, 2021 and 2020, and how does this relate to the outstanding balance of merchant loans, advances, and interest and fees receivable as of December 31, 2021?",
      "original_answer": "PayPal purchased approximately $1.8 billion in credit receivables for both the years ended December 31, 2021 and 2020. As of December 31, 2021, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.4 billion, net of the participation interest sold to WebBank of $63 million. This indicates that PayPal maintains a significant portion of the credit risk on the receivables it purchases, as only a small fraction is sold to third parties.",
      "llm_answer": "The company purchased approximately $1.8 billion of credit receivables for its merchant‑finance offerings in both 2021 and 2020. As of December 31 2021, the outstanding balance of merchant loans, advances and interest and fees receivable (net of participation interest sold) was about $1.4 billion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PayPal purchased approximately $1.8 billion in credit receivables in both 2021 and 2020, matching the ground truth exactly. It also accurately reports the outstanding balance as of December 31, 2021, at $1.4 billion, net of participation interest. (2) All numeric values—$1.8 billion (for both years) and $1.4 billion (outstanding balance)—are factually correct and properly attributed to the right time periods. The format variation (using 'billion' vs 'B' or 'M') is acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years for purchases and links it to the year-end outstanding balance. However, the LLM omits the specific detail about the $63 million participation interest sold to WebBank, which is part of the full context in the ground truth. While the phrase 'net of participation interest sold' acknowledges the reduction, the absence of the exact figure slightly reduces completeness and qualitative accuracy. (4) Despite this minor omission, the core facts, numbers, and relationships are correctly conveyed, and the answer remains contextually precise and highly relevant. The correctness score is 9 due to the missing $63 million detail, which is important for full transparency on risk retention, but not critical enough to downgrade further as the net effect ($1.4B) is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 394,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the total amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in November 2023, and how much of this debt was repaid by July 2024?",
      "original_answer": "The Japanese subsidiary of Costco issued $500 million in Guaranteed Senior Notes in November 2023, and by July 2024, $77 million of this debt had been repaid.",
      "llm_answer": "The Japanese subsidiary issued approximately $500 of Guaranteed Senior Notes in November 2023, and by July 2024 it had repaid $77 of that debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Costco's Japanese subsidiary issued $500 million in Guaranteed Senior Notes in November 2023 and repaid $77 million by July 2024. However, the LLM omits the word 'million' after both dollar amounts, stating '$500' and '$77' instead of '$500 million' and '$77 million'. This is a minor formatting issue but does not change the intended meaning, as the context clearly implies millions. (2) The numeric values are accurate and match the ground truth exactly when interpreted correctly. The dates (November 2023 and July 2024) are also correct. (3) The multi-hop reasoning is sound—correctly linking Costco, its Japanese subsidiary, the debt issuance, and subsequent repayment over time. The synthesis across entities and time periods is accurate. (4) Despite the missing 'million', the answer is semantically equivalent and conveys the correct information. Hence, a high score of 9 is justified for correctness and quantitative accuracy, with full marks for qualitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1078,
        "completion_tokens": 303,
        "total_tokens": 1382
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "By how much did the decrease in the value of available-for-sale debt investments from 2021 to 2022 exceed the net gains realized from these investments during the same period?",
      "original_answer": "The decrease in the value of available-for-sale debt investments from 2021 to 2022 was $3,259 million, while the net gains from these investments decreased by $44 million. Therefore, the decrease in investment value exceeded the change in net gains by $3,215 million.",
      "llm_answer": "The decrease in the value of available‑for‑sale debt investments from 2021 to 2022 was $3,259 million, while net gains realized on those investments fell by $44 million. Therefore, the decline in the investment value exceeded the realized gains by roughly $3,259 million.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in value of available-for-sale debt investments ($3,259 million) and the decrease in net gains ($44 million), which matches the ground truth. However, it fails to perform the correct calculation to answer the actual question: by how much the decrease in value exceeded the net gains. The correct calculation is $3,259M - $44M = $3,215M, but the LLM incorrectly states the difference as 'roughly $3,259 million', which is factually wrong. (2) Numeric values are accurate: $3,259 million and $44 million are correctly cited. The calculation error is in the final comparison. (3) The reasoning is partially sound—information is synthesized from the correct time period and metric—but fails at the final multi-hop step of computing the difference between the two figures. The model conflates the total decline in value with the excess over the net gains, indicating a logical error. (4) Scores reflect that core data is correct (high quantitative accuracy), but reasoning and final answer are flawed (moderate qualitative and overall correctness), though the response remains fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 329,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, combining both its unsecured revolving credit facility and unused letters of credit?",
      "original_answer": "The total amount of unused short-term credit capacity available to Amazon as of December 31, 2021, is $14.2 billion. This includes the full $7.0 billion unsecured revolving credit facility, as there were no borrowings outstanding under the Credit Agreement, and $7.2 billion of unused letters of credit.",
      "llm_answer": "As of December 31 2021, Amazon had $7.2 billion of unused letters of credit and a $1.0 billion secured revolving credit facility (with $338 million drawn in 2020 and $803 million drawn in 2021). The unused portion of that facility—i.e., the total unused short‑term credit capacity—is therefore $7.2 billion + ($1.0 billion – $803 million) ≈ $7.4 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. According to the ground truth, Amazon had a $7.0 billion unsecured revolving credit facility with no borrowings outstanding, meaning the full $7.0 billion was available. However, the LLM incorrectly states it was a $1.0 billion secured facility with $803 million drawn, leading to a miscalculated unused portion of $197 million. Additionally, the LLM claims $7.2 billion in unused letters of credit, which matches the ground truth, but combines it with the wrong credit facility value. The final calculated total of approximately $7.4 billion is less than half the correct total of $14.2 billion. (2) Number verification: $7.2 billion in unused letters of credit is correct; however, $1.0 billion facility and $803 million drawn are incorrect (should be $7.0 billion facility, $0 drawn). The calculation logic is sound but based on wrong inputs, so the result is invalid. (3) Multi-hop reasoning is partially present—LLM attempts to sum unused credit lines—but fails because it uses incorrect source data for the revolving credit facility. It does not correctly identify or synthesize the correct facility size or its unsecured nature as stated in the original answer. (4) Scores reflect major factual and quantitative errors that invalidate the core answer, though the mention of unused letters of credit and attempt at summation preserve minimal relevance and partial qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 404,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the total cash outflow for acquisitions made by TMO in 2023, including its acquisition of The Binding Site Group, and how much of this total was specifically allocated to The Binding Site Group?",
      "original_answer": "The total cash outflow for acquisitions made by TMO in 2023 was $3.61 billion, with $2.70 billion specifically allocated to the acquisition of The Binding Site Group.",
      "llm_answer": "Based on the provided document pages, the total cash outflow for acquisitions made by Thermo Fisher Scientific (TMO) in 2023, including its acquisition of The Binding Site Group, was **$3.61 billion**. Of this total, **$2.70 billion** was specifically allocated to The Binding Site Group acquisition (as stated on page 24: \"During 2023, acquisitions of The Binding Site Group and CorEvitas, LLC used cash of $2.70 billion and $0.91 billion, respectively\"). This confirms that The Binding Site Group accounted for the majority of the $3.61 billion total cash outflow for acquisitions in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total cash outflow for acquisitions by TMO in 2023 is correctly stated as $3.61 billion, with $2.70 billion allocated to The Binding Site Group. (2) Quantitative accuracy is perfect: the numbers match the ground truth exactly, and the breakdown from the cited document page (acquisition costs of $2.70 billion for The Binding Site Group and $0.91 billion for CorEvitas, LLC) sums to $3.61 billion, confirming the total. (3) Multi-hop reasoning is sound—the model correctly synthesized the total acquisition outflow by combining the two acquisitions mentioned in the document and attributed the correct portion to The Binding Site Group. (4) The answer is contextually relevant, directly addressing both parts of the question and citing a specific source page for verification. Wording differs slightly from the original answer but maintains full semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 280,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What percentage of Union Pacific's chassis units are leased rather than owned, and how does this compare to the much smaller leased proportion of containers in their highway revenue equipment fleet?",
      "original_answer": "Union Pacific owns 30,635 chassis units and leases 17,705, meaning 36.6% (17,705 / 48,340) of chassis are leased. In contrast, only 1.1% (545 / 47,984) of containers are leased. This shows a significantly higher reliance on leasing for chassis compared to containers.",
      "llm_answer": "Based on the provided document pages, **Union Pacific reports that 27% of its freight car fleet (59,189 total units) is leased**, with 26,137 leased units out of 59,189 total freight cars. This represents a leased proportion of approximately 44% for freight cars. However, the document does not explicitly state the percentage of leased chassis units in the highway revenue equipment fleet. It only states that Union Pacific owns 30,635 chassis units and leases 17,705 units (totaling 48,340), but it does not provide a percentage for chassis leasing relative to total chassis units. The document also does not provide a direct comparison percentage for chassis leasing versus freight car leasing. Therefore, the exact percentage of leased chassis units is not specified in the provided text, and no comparative percentage is given for how this compares to the leased proportion of containers in the highway revenue equipment fleet. The document only states that containers have 545 leased units out of 47,984 total (a small leased proportion), but does not quantify this as a percentage for comparison.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors. (1) It incorrectly shifts focus to freight cars (59,189 units, 27% leased), which are unrelated to the question about chassis and containers in the highway revenue equipment fleet. This misidentifies the relevant entity and metric. (2) Despite stating that the document does not provide a percentage for leased chassis, the LLM itself provides the raw numbers (17,705 leased, 30,635 owned, total 48,340), from which the percentage (36.6%) can and should be calculated. Failing to compute this basic percentage when all components are present is a major quantitative and reasoning failure. (3) Similarly, for containers, the LLM notes 545 leased out of 47,984 total but again fails to calculate the 1.1% rate, despite this being a straightforward computation. (4) The original answer correctly computes both percentages and draws the appropriate comparison—chassis leasing (36.6%) is much higher than container leasing (1.1%)—which the LLM completely misses due to incorrect focus and lack of calculation. (5) The LLM falsely claims the percentages are not provided in the document, when in fact they are easily derivable from the given numbers. This reflects a failure in multi-hop reasoning: synthesizing ownership data into proportions and comparing across equipment types. While the raw numbers cited for chassis and containers are accurate (hence partial credit on quantitative accuracy), the overall answer is misleading and factually inadequate. The contextual relevance is moderate because it discusses Union Pacific’s leasing but off-topic regarding equipment type.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 445,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How many different supplemental indentures related to Senior Notes that include the 2035 Note were identified across the referenced exhibits, and which trustee was involved in the most recent of these agreements?",
      "original_answer": "Two supplemental indentures related to Senior Notes that include the 2035 Note were identified: the Fifth Supplemental Indenture dated September 14, 2015, and the Tenth Supplemental Indenture dated November 20, 2024. The trustee involved in the most recent of these agreements was Computershare Trust Company, National Association, as successor to Wells Fargo Bank.",
      "llm_answer": "Based on the referenced exhibits in the 10-K filing, **four supplemental indentures** related to Senior Notes that include the 2035 Note were identified across the exhibits. The most recent of these agreements was the **tenth supplemental indenture**, dated **November 20, 2024**, involving **Computershare Trust Company, National Association** as the successor trustee to Wells Fargo Bank, National Association. This agreement includes the 2035 Note among other notes (e.g., 2029, 2054, and 2064 Notes). \n\n**Answer:**  \nFour supplemental indentures related to Senior Notes with the 2035 Note were identified, and the most recent agreement was executed with **Computershare Trust Company, National Association**.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that four supplemental indentures were identified, while the ground truth confirms only two: the Fifth Supplemental Indenture (September 14, 2015) and the Tenth Supplemental Indenture (November 20, 2024). The mention of 'four' is a significant factual error. (2) The date of the most recent agreement (November 20, 2024) and the trustee — Computershare Trust Company, National Association, as successor to Wells Fargo Bank — are correctly identified, which supports partial credit. However, the core quantitative claim (number of indentures) is wrong. (3) The multi-hop reasoning is partially sound in that the model correctly associates the 2035 Note with the Tenth Supplemental Indenture and identifies the correct trustee for that agreement, but it fails in accurately enumerating the total number of relevant supplemental indentures across exhibits, suggesting a failure in synthesis or data retrieval. (4) Despite the major error in quantity, the answer is contextually relevant and includes accurate details about the most recent agreement and the trustee, hence high contextual relevance and moderate qualitative accuracy. The correctness and quantitative accuracy scores are low due to the incorrect count, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 363,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the expensing methodology for non-employee director deferred stock units granted in 2023 differ from those granted prior to 2022, and what is the vesting timeline for the 2023 awards?",
      "original_answer": "Deferred stock units granted to non-employee directors in 2023 are expensed on a straight-line basis over the requisite service period, whereas awards granted prior to 2022 were expensed in full on the grant date because they vested immediately. The 2023 awards vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration in certain circumstances.",
      "llm_answer": "The expensing methodology for non-employee director deferred stock units granted in 2023 differs from those granted prior to 2022 in that prior awards vested immediately and were expensed on the grant date, whereas 2023 awards vest on the earlier of the first anniversary of the grant date or the day preceding the next Annual Meeting of Shareholders and are expensed on a straight-line basis over the requisite service period. The vesting timeline for the 2023 awards is over a three-year period, consistent with the general service period used for these awards.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the change in expensing methodology: 2023 awards are expensed on a straight-line basis over the service period, while pre-2022 awards were expensed in full on the grant date due to immediate vesting. It also correctly states the vesting condition for 2023 awards as the earlier of the first anniversary of the grant date or the day before the next Annual Meeting. However, it introduces a significant factual error by stating that the vesting timeline is over a 'three-year period,' which contradicts the ground truth specifying a one-year or event-based vesting (not three years). This incorrect duration undermines the quantitative and qualitative accuracy. The reasoning is mostly sound in comparing the two periods and linking vesting to expensing, but the erroneous vesting period suggests a failure in accurately retrieving or synthesizing the specific timeline. While the answer addresses both parts of the question and maintains contextual relevance, the incorrect vesting duration—a key quantitative element—reduces overall correctness. Semantic equivalence fails on this point, as 'three-year period' is not equivalent to the actual 'one-year or earlier of' timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 339,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, and what percentage of the total identifiable assets in that same region and business unit did this profit represent?",
      "original_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million. The identifiable assets in that same region and business unit were $698 million. Therefore, the operating profit represented approximately 36.4% of the identifiable assets.",
      "llm_answer": "The total operating profit from the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023 was $254 million, representing 6.5 % of the $3,913 million of identifiable assets for that region and business unit.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the operating profit of $254 million for the Oral, Personal and Home Care business in the Africa/Eurasia region in 2023, which matches the ground truth. However, it incorrectly stated the identifiable assets as $3,913 million, whereas the ground truth specifies $698 million for the same business unit and region. This leads to a significant error in the calculated percentage. The LLM reports 6.5%, but the correct percentage is approximately 36.4% ($254M / $698M). (2) The quantitative accuracy is low because while one number (profit) is correct, the asset figure is wrong, and the resulting percentage is therefore incorrect. The calculation using the LLM's numbers (254 / 3,913 ≈ 6.5%) is mathematically correct, but based on false inputs. (3) The multi-hop reasoning fails because the model did not correctly retrieve or synthesize the identifiable assets specific to the Oral, Personal and Home Care unit in Africa/Eurasia, instead possibly using total regional assets or assets from another segment. This breaks the logical chain required for accurate representation. (4) Contextual relevance is high because the answer addresses both parts of the question (profit and percentage of assets) and uses appropriate financial terminology, but the factual inaccuracies severely undermine correctness. Scores reflect partial credit for correct profit figure but major deductions for incorrect asset value and derived percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 407,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "What was the total amount of AMD's purchases from and resales to the ATMP JV in fiscal year 2024, and how does this compare to the amount of the loan AMD provided to the ATMP JV during the same year?",
      "original_answer": "In fiscal year 2024, AMD's purchases from the ATMP JV amounted to $1.7 billion, and its resales to the ATMP JV totaled $121 million, resulting in a combined total of $1.821 billion. This is significantly higher than the $100 million loan AMD provided to one of the ATMP JVs in October 2024.",
      "llm_answer": "Based on the provided document pages, AMD's total purchases from and resales to the ATMP JV in fiscal year 2024 were $1.7 billion in purchases and $121 million in resales. The loan AMD provided to the ATMP JV during the same year was $100 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all key numerical values: $1.7 billion in purchases, $121 million in resales, and a $100 million loan, all of which match the ground truth. The quantitative accuracy is perfect, with correct figures and no calculation errors. The answer addresses both parts of the question—AMD's transactions with the ATMP JV and the loan amount—though it does not explicitly compute the combined total of purchases and resales ($1.821 billion) as the original answer does. However, by stating both figures, it enables the reader to infer the sum, and the comparison to the $100 million loan remains clear. The entities (AMD, ATMP JV, fiscal year 2024) and time reference (October 2024 implied within fiscal year 2024) are accurate. The reasoning is sound and contextually appropriate, though slightly less explicit in synthesizing the total value. Semantic equivalence is maintained, and the response is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 275,
        "total_tokens": 1423
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021, and how does this growth compare to the increase in the Research and medical products segment over the same period?",
      "original_answer": "The revenue for the Analytical and physical instrumentation product line increased by $156 million from 2019 to 2021 ($2,620 million in 2021 vs. $2,464 million in 2019). The Research and medical products segment increased by $11,290 million over the same period ($24,802 million in 2021 vs. $13,512 million in 2019). The increase in Analytical and physical instrumentation revenue was relatively modest compared to the significant growth in Research and medical products.",
      "llm_answer": "The total increase in revenue for the Analytical and physical instrumentation product line from 2019 to 2021 was $356 million (from $2,464 million in 2019 to $2,620 million in 2021), while the Research and medical products segment increased by $11,290 million over the same period (from $13,512 million in 2019 to $24,802 million in 2021). This indicates that the Research and medical products segment experienced significantly larger growth compared to the Analytical and physical instrumentation product line.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the calculated revenue increase for the Analytical and physical instrumentation product line. It states the increase was $356 million, but the correct increase is $156 million ($2,620M - $2,464M). This is a significant miscalculation that affects the quantitative accuracy. All other numbers are correct: the 2019 and 2021 figures for both product lines match the ground truth, and the $11,290 million increase for Research and medical products is accurate. (2) The calculation error undermines the quantitative accuracy despite correct input values. The LLM incorrectly computes 2,620 - 2,464 as 356 instead of 156. This is a factual error in arithmetic, not just a typo, as the values cited before and after the calculation are correct. (3) The multi-hop reasoning is otherwise sound: the model correctly identifies both product lines, retrieves the correct revenue figures for both years across the two segments, and synthesizes the comparison appropriately. The conclusion that Research and medical products grew significantly more is logically valid and consistent with the data. (4) The contextual relevance is high because the structure and intent of the answer align perfectly with the question. The qualitative accuracy is moderately high because the reasoning framework is correct, but the major calculation error limits the score. The correctness score is 6 because while most elements are present and the direction of comparison is accurate, the core numerical claim is wrong, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 434,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Microsoft's SQL Server product line contribute to its Intelligent Cloud segment's financial performance, given the segment's reported structure and revenue drivers?",
      "original_answer": "Microsoft's SQL Server is a core component of the Intelligent Cloud segment, which includes server products and cloud services. SQL Server contributes to the segment's revenue through volume licensing programs, OEM licenses, and retail packaged products. As part of the server products category, SQL Server also drives revenue through Client Access Licenses (CALs), which provide access rights to the server product and are reported alongside the associated server product revenue. This aligns with the Intelligent Cloud segment's primary revenue drivers, which include server product licensing and cloud services like Azure.",
      "llm_answer": "Microsoft's SQL Server product line is a key component of the Intelligent Cloud segment, contributing to its revenue through server products and cloud services. As detailed on page 13, the Intelligent Cloud segment includes server products such as SQL Server, Windows Server, and related licensing (including CALs), as well as cloud services like Azure. Revenue from these offerings is driven by volume licensing, OEM sales, and cloud consumption, and is reported within the Intelligent Cloud segment's total revenue of $75,251 million for fiscal year 2022 (page 15). This segment's growth, fueled by cloud adoption and services like Azure and SQL Server, directly supports Microsoft's overall cloud strategy and financial performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies SQL Server as a core component of the Intelligent Cloud segment and accurately describes its contribution through server products and cloud services. The revenue streams—volume licensing, OEM sales, and cloud consumption—are consistent with the ground truth's mention of volume licensing, OEM licenses, retail, and CALs. The inclusion of CALs is implied in 'related licensing' on page 13, which supports the qualitative accuracy. (2) The quantitative figure of $75,251 million for Intelligent Cloud revenue in fiscal year 2022 is correct and matches Microsoft's reported financials for that period (FY2022), though this specific number is not in the original answer. However, since the original answer does not provide any numerical data, the inclusion of an accurate, real-world figure from the correct fiscal year enhances the response without introducing error. (3) The multi-hop reasoning is sound: the model connects SQL Server to the Intelligent Cloud segment, identifies its revenue mechanisms, and situates it within broader cloud strategy, synthesizing information about product lines, licensing models, and segment performance. (4) The answer is contextually excellent, directly addressing how SQL Server contributes financially to the segment. The only minor shortcoming is that it does not explicitly name Client Access Licenses (CALs) as a distinct revenue driver, instead grouping them under 'related licensing,' which slightly reduces precision compared to the original answer. However, this does not constitute a factual error. Overall, the response is factually correct, comprehensive, and semantically equivalent to the ground truth with strong contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 482,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What is the total change in value of Insurance Buy-in Contracts from December 31, 2022, to December 31, 2024, and how does this reflect in both the 2023 and 2024 year-end balances?",
      "original_answer": "The value of Insurance Buy-in Contracts increased from $950 million at December 31, 2022, to $1,605 million at December 31, 2023, and then decreased to $1,390 million at December 31, 2024. This results in a net increase of $440 million over the two-year period ($1,390 million - $950 million = $440 million).",
      "llm_answer": "The total change in the fair value of insurance buy‑in contracts is a decrease of $215 million from December 31 2023 to December 31 2024. This change is reflected in the year‑end balances as $1,605 million at the end of 2023 and $1,390 million at the end of 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly reports the 2023 and 2024 year-end balances ($1,605 million and $1,390 million) and accurately calculates the decrease of $215 million from 2023 to 2024. These numbers are factually correct and match the ground truth. However, the question asks for the total change from December 31, 2022, to December 31, 2024, which requires a multi-hop calculation: starting at $950 million in 2022, ending at $1,390 million in 2024, resulting in a net increase of $440 million. The LLM completely omits the 2022 value and fails to compute or mention the total two-year change, which is the primary focus of the question. While the reported values for 2023 and 2024 are accurate, the answer does not address the full time span or the net change over the entire period. This is a significant omission in completeness and reasoning, especially since the question explicitly asks about the change from 2022 to 2024 and how it reflects in both year-end balances. The model only partially answers the question, focusing narrowly on the 2023–2024 decrease. Thus, while quantitatively accurate for the subset it covers, it fails on multi-hop synthesis and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 331,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and how much in dividends was paid on those shares during 2024?",
      "original_answer": "$886 million was the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, and $26 million in dividends was paid on those shares during 2024.",
      "llm_answer": "As of December 31 2024, the total value of TI common stock held in both U.S. and non‑U.S. defined‑contribution plans was $34 million, and dividends paid on those shares during 2024 were not material.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both key numerical values. The ground truth states that the total value of TI common stock held in both U.S. and non-U.S. defined contribution plans as of December 31, 2024, was $886 million, but the LLM reports $34 million—a significant discrepancy. Additionally, the ground truth confirms $26 million in dividends was paid during 2024, whereas the LLM claims dividends were 'not material,' which contradicts the specific and material $26 million figure. (2) Quantitative accuracy is extremely low: both dollar amounts are wrong, and no correct calculation or reference to actual data is present. The LLM does not approximate or partially capture the correct values. (3) Qualitatively, the reasoning appears flawed—there is no indication of proper multi-hop synthesis across U.S. and non-U.S. plans, and the dismissal of dividends as 'not material' suggests either a failure to retrieve or interpret the relevant data. The entities (TI common stock, defined contribution plans, year 2024) are correctly identified, but the information tied to them is inaccurate. (4) Contextual relevance is high because the LLM addresses the correct question structure, refers to the right company (TI), time period (December 31, 2024), and financial instruments (common stock, dividends, defined contribution plans), but the core factual content is entirely incorrect. Thus, while the framing is appropriate, the answer fails on factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1111,
        "completion_tokens": 411,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What was the principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in their 2022 10-K, and how does this amount compare to the combined principal of their 3.900%, 4.450%, and 5.200% Senior Notes from the same filing?",
      "original_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 was $1,250 million. The combined principal of their 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes totals $2,250 million. Therefore, the 5.300% Senior Notes due 2050 represent approximately 55.6% of the combined principal of the other three notes.",
      "llm_answer": "The principal amount of UPS's 5.300% Senior Notes due 2050 disclosed in the 2022 10-K is $1,250 million. This amount is greater than the combined principal of the 3.900%, 4.450%, and 5.200% Senior Notes, which total $2,250 million ($1,000 million + $750 million + $500 million).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amount of the 5.300% Senior Notes due 2050 as $1,250 million, which matches the ground truth. It also correctly identifies the individual principal amounts of the 3.900% ($1,000 million), 4.450% ($750 million), and 5.200% ($500 million) Senior Notes and their sum ($2,250 million). However, it makes a critical logical error in the comparison: it states that $1,250 million is greater than $2,250 million, which is factually incorrect. This undermines the core reasoning required by the question. (2) All numeric values are accurate and formatting is consistent; the sum calculation ($1,000M + $750M + $500M = $2,250M) is correct. However, the comparison statement fails basic arithmetic logic, which is a severe quantitative reasoning flaw. (3) The multi-hop synthesis—pulling data from different notes and combining them—is structurally sound, but the final inference is invalid due to the incorrect comparison. The model should have calculated the percentage ($1,250 / $2,250 ≈ 55.6%) as in the ground truth, but instead made a false claim about relative size. (4) Contextual relevance is high because all relevant entities, years, and note types are correctly referenced. However, the qualitative and overall correctness scores are low due to the fundamental error in reasoning and conclusion, despite correct input data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 384,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What is the total weighted-average grant-date fair value of all Service-Based RSUs that were both outstanding at the beginning of the year and still outstanding at the end of 2024, after accounting for grants, vesting, and forfeitures?",
      "original_answer": "The total weighted-average grant-date fair value of Service-Based RSUs that remained outstanding throughout 2024 is $183.41 million.",
      "llm_answer": "Based on the information in the provided pages, the total weighted-average grant-date fair value of all Service-Based RSUs that were outstanding at the beginning of the year and still outstanding at the end of 2024 is $183.41 per share, as reflected in the \"Outstanding as of December 31, 2024\" row for Service-Based RSUs in Table 10.1 on page 135. This value represents the grant-date fair value after accounting for grants, vesting, and forfeitures during the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor error in unit specification. The ground truth states the total value is $183.41 million, which is a total dollar amount. However, the LLM incorrectly reports it as '$183.41 per share', introducing a per-share mischaracterization that is not present in the original answer. This is a significant but isolated error affecting quantitative interpretation. All other aspects are accurate: the figure $183.41 is correctly cited, the time frame (beginning to end of 2024), the treatment of grants, vesting, and forfeitures, and the source (Table 10.1, page 135) are properly referenced. The reasoning correctly reflects that the value represents Service-Based RSUs that remained outstanding throughout 2024 after adjustments. The multi-hop synthesis is sound, and the context is fully relevant. The error does not affect the core number or the logic but misrepresents the unit, which slightly undermines quantitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 280,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does UPS's estimation process for uncertain tax positions, as described in both the notes to the financial statements and the management discussion section, influence the potential recognition of tax benefits or additional charges to the tax provision, and what specific criteria determine the measurement of these benefits?",
      "original_answer": "UPS evaluates uncertain tax positions using a two-step process that directly affects the recognition of tax benefits or additional charges to the tax provision. First, it determines whether a tax position is more likely than not to be sustained on audit, based on available evidence. Second, it measures the largest amount of tax benefit that is more likely than not to be realized upon settlement. The difference between this recognizable benefit and the total benefit claimed or to be claimed is recorded as a liability. This process, detailed in both the financial statement notes and the management discussion, leads to quarterly reevaluations based on changes in facts, tax law, audit outcomes, or new activity, which can result in either recognizing a tax benefit or recording an additional charge to the tax provision.",
      "llm_answer": "UPS assesses uncertain tax positions using a two-step process: first, a tax position must be more likely than not to be sustained on audit; second, the largest amount of tax benefit that meets this threshold is measured and recognized. This process directly influences whether tax benefits are recognized or additional charges are recorded to the tax provision, as changes in recognition or measurement can result in either a benefit or an increased tax expense. The measurement of these benefits depends on the probability of various outcomes and is subject to quarterly reevaluation based on changes in facts, tax law, or audit activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the two-step process (more likely than not recognition and measurement of the largest benefit that meets the threshold) is accurately described. The influence on tax provision—either recognizing a benefit or recording an additional charge—is correctly explained. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the absence of any incorrect numbers supports a perfect score. (3) The multi-hop reasoning is sound: the answer synthesizes the recognition and measurement criteria and links them to financial statement impacts, as required by the question. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that the difference between the total position claimed and the recognizable benefit is recorded as a liability—a key detail in the original answer. While implied in the discussion of recognition, its omission slightly reduces completeness. Otherwise, the answer is semantically equivalent, contextually relevant, and correctly references quarterly reevaluations due to changes in facts, law, or audits.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 355,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What was the total capital expenditure in Africa/Eurasia in 2021, and by what percentage did organic sales in this region increase during the same year?",
      "original_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "llm_answer": "The total capital expenditure in Africa/Eurasia in 2021 was $33 million, and organic sales in this region increased by 7.0% during the same year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually identical to the ground truth. (1) Both parts of the question are correctly addressed: total capital expenditure in Africa/Eurasia in 2021 is accurately stated as $33 million, and the organic sales increase is correctly reported as 7.0%. (2) All numeric values match the original answer exactly—$33 million and 7.0%—with no calculation or formatting discrepancies. (3) The multi-hop reasoning is sound, as the answer correctly synthesizes two distinct financial metrics (capital expenditure and organic sales growth) for the specified region and year. (4) The response is semantically equivalent and fully contextually relevant, with precise entity alignment (Africa/Eurasia, 2021) and correct metric usage. No errors in reasoning, entities, or numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1074,
        "completion_tokens": 232,
        "total_tokens": 1306
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What was the increase in Johnson & Johnson's Contact Lenses/Other sales from 2020 to 2021, and how did this growth contribute to the overall increase in Vision segment sales during the same period?",
      "original_answer": "Johnson & Johnson's Contact Lenses/Other sales increased by $446 million (from $2,994 million in 2020 to $3,440 million in 2021). Vision segment sales grew by $769 million (from $3,919 million in 2020 to $4,688 million in 2021). Therefore, the increase in Contact Lenses/Other sales accounted for approximately 58% of the total growth in Vision segment sales from 2020 to 2021.",
      "llm_answer": "The Contact Lenses/Other sales increased by **14.9%** from $2,994 million in 2020 to $3,440 million in 2021. This growth contributed to the overall Vision segment sales rise of **19.6%**, as the Vision segment’s total sales grew from $3,919 million in 2020 to $4,688 million in 2021, with the Contact Lenses/Other operational growth being a key driver of that increase.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the Contact Lenses/Other sales increase from $2,994 million in 2020 to $3,440 million in 2021, which is a $446 million increase, and correctly reported Vision segment sales growth from $3,919 million to $4,688 million (a $769 million increase). However, the LLM did not explicitly calculate or state that the $446 million increase accounted for approximately 58% of the total $769 million Vision segment growth, which is a key part of the original answer. Instead, it reported percentage growth rates (14.9% and 19.6%), which are accurate but do not directly address the contribution of Contact Lenses/Other to the overall Vision segment growth. (2) The percentage calculations are correct: (3,440 - 2,994) / 2,994 ≈ 14.9%, and (4,688 - 3,919) / 3,919 ≈ 19.6%. The dollar amounts match the ground truth exactly. (3) The multi-hop reasoning is partially complete: the model correctly pulled data from two related segments and time periods but failed to synthesize the relative contribution (i.e., $446M / $769M ≈ 58%) which is essential to fully answering how the growth contributed to the overall increase. (4) The contextual relevance is perfect—the response stays on topic and discusses the correct companies, segments, years, and metrics. Quantitative accuracy is high because all numbers and derived percentages are correct, but qualitative accuracy is reduced due to missing synthesis. Correctness score is 7 because core facts are accurate but a key analytical component (proportional contribution) is omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 429,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What was the impact of AspenTech's consolidation into Emerson's financial statements on the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022?",
      "original_answer": "The consolidation of AspenTech into Emerson's financial statements significantly reduced the Control Systems & Software segment's earnings and margin performance in 2023 compared to 2022. In 2022, AspenTech contributed $12 million in earnings, but in 2023, it reported a loss of $107 million. This $119 million deterioration directly impacted the overall segment earnings, which remained flat at $529 million in 2023 despite revenue growth, compared to $437 million in 2022. Additionally, the segment margin declined from 14.7% in 2022 to 11.6% in 2023, a 3.1 percentage point decrease, largely driven by AspenTech's poor performance.",
      "llm_answer": "The consolidation of AspenTech into Emerson’s financial statements contributed to a decline in the Control Systems & Software segment’s earnings and margin in 2023 versus 2022.  In 2023, the segment’s earnings fell 6 % (from $449 million to $422 million) and its margin dropped 3.1 percentage points (from 14.7 % to 11.6 %), a reduction that the company attributed to $249 million of incremental intangibles amortization from the Heritage AspenTech acquisition and related acquisition‑related costs.  By 2024, after the full integration of AspenTech, the segment’s earnings fell further to $282 million (‑33 % versus 2023) and its margin collapsed to 5.2 % (‑6.4 percentage points), driven largely by $560 million of additional intangibles amortization from the Test & Measurement acquisition and the $231 million inventory step‑up amortization that negatively impacted margins by roughly 1.3 percentage points.  Thus, the consolidation initially pressured earnings and margins in 2023, and the subsequent acquisition‑related amortization deepened the margin erosion in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Control Systems & Software segment earnings increased from $437 million in 2022 to $529 million in 2023 (not decreased from $449M to $422M as claimed). The LLM incorrectly states that earnings fell 6%, when in fact they rose despite AspenTech's negative impact. The margin decline from 14.7% to 11.6% (3.1 percentage points) is correctly reported, but the explanation attributes it entirely to amortization without mentioning AspenTech's swing from $12M profit to $107M loss, which the ground truth identifies as the primary driver. (2) The LLM introduces incorrect financial figures: segment earnings are misstated as $449M (2022) and $422M (2023), whereas ground truth reports $437M (2022) and $529M (2023). It also fabricates $249M of intangibles amortization and invents a 'Test & Measurement acquisition' and $560M amortization in 2024—none of which are in the original answer or relevant to the 2023 vs 2022 comparison. The $231M inventory step-up is also not in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the impact of AspenTech's performance deterioration ($12M profit to $107M loss = $119M negative swing) on segment earnings, which the ground truth explicitly states as the reason earnings were flat despite revenue growth. Instead, it invents explanations not present in the source. (4) The contextual relevance is moderate because it addresses the consolidation impact on earnings and margins, but the severe quantitative and factual errors—especially the reversal of earnings direction—warrant a low correctness score. The inclusion of irrelevant 2024 data further detracts from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 478,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How much total monetary liability did Visa record in fiscal 2022 for U.S. covered litigation, and how is this liability recovered under the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa recorded a total monetary liability of $861 million in fiscal 2022 for U.S. covered litigation. Under the U.S. Retrospective Responsibility Plan, this liability is recovered through a downward adjustment to the conversion rate of class B common stock to class A common stock.",
      "llm_answer": "Visa recorded a total monetary liability of **$1,441 million** for U.S. covered litigation in fiscal 2022. Under the U.S. retrospective responsibility plan, this liability is recovered through a **downward adjustment to the conversion rate of its class B preferred stock into class A common stock**, effectively reducing the number of shares issuable when the preferred stock is converted.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The total monetary liability recorded by Visa in fiscal 2022 for U.S. covered litigation is stated as $1,441 million, which is incorrect. The ground truth from the knowledge graph is $861 million. This is a major quantitative discrepancy that undermines the accuracy of the answer. (2) The recovery mechanism under the U.S. Retrospective Responsibility Plan is partially correct but contains a key error: the LLM states that the adjustment applies to 'class B preferred stock', whereas the correct entity is 'class B common stock'. This mischaracterization of the stock class is a critical factual error affecting the qualitative accuracy. (3) The multi-hop reasoning is partially sound in that the model correctly identifies the mechanism of recovery via conversion rate adjustment, showing understanding of the plan’s structure. However, it fails in synthesizing the correct numerical value and the correct stock classification, indicating a failure to accurately retrieve or interpret the source data. (4) Despite the incorrect numbers and stock type, the answer is contextually relevant—addressing both parts of the question and referencing the correct company, fiscal year, and general recovery mechanism. Hence, contextual relevance is high, but correctness and accuracy scores are low due to fundamental factual errors in both quantitative and qualitative dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 399,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "What was the total financial impact on Pfizer from its historical ownership of Meridian in 2021, including both operational results and post-closing adjustments?",
      "original_answer": "The total financial impact on Pfizer from its historical ownership of Meridian in 2021 was a $512 million negative impact, which includes a $345 million pre-tax legal charge in the second quarter and an after-tax loss of $167 million related to the sale of Meridian in the fourth quarter.",
      "llm_answer": "Based on the provided pages, Pfizer's total financial impact from its historical ownership of Meridian in 2021 was an after-tax loss of $167 million related to the sale of Meridian (reflected in discontinued operations) and a pre‑tax charge of $345 million in the second quarter of 2021 to resolve a legal matter involving Meridian. These items are disclosed in the notes to the financial statements and the selected quarterly financial data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both components of the financial impact: the $345 million pre-tax legal charge in Q2 2021 and the $167 million after-tax loss from the sale in Q4 2021. These match the ground truth exactly in amount and timing. (2) All numeric values are accurate and correctly attributed—$345 million pre-tax charge and $167 million after-tax loss. While the LLM does not explicitly sum these into a total negative impact of $512 million (i.e., $345M + $167M), it provides both components, allowing for correct inference. The absence of the explicit sum is a minor omission but does not negate the factual accuracy of the components. (3) The reasoning is sound: the LLM correctly links both financial impacts to Pfizer’s historical ownership of Meridian in 2021 and cites appropriate disclosures (notes to financial statements, quarterly data), indicating proper synthesis across relevant sections. (4) The answer is contextually fully relevant, addressing both operational results (legal charge) and post-closing adjustments (sale-related loss). The only reason for not awarding a 10 is the lack of explicit summation into the total $512 million negative impact, which is implied but not stated. Thus, correctness is rated 9 for near-perfect accuracy with a minor completeness gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 368,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "What is the minimum supplementary leverage ratio (SLR) that Bank of America Corporation must maintain under Basel 3, including the leverage buffer, and how does this requirement differ from the SLR requirement for its insured depository institution subsidiaries?",
      "original_answer": "Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of 3.0 percent plus a leverage buffer of 2.0 percent, totaling 5.0 percent, to avoid restrictions on capital distributions and discretionary bonus payments. In contrast, its insured depository institution subsidiaries are required to maintain a higher minimum SLR of 6.0 percent to be considered well capitalized under the PCA framework.",
      "llm_answer": "Under Basel 3, Bank of America Corporation must maintain a minimum supplementary leverage ratio (SLR) of **6.0 %** (i.e., 6 % of supplementary leverage exposure). This is the SLR required of the parent holding company.  \n\nIn contrast, its insured depository‑institution subsidiaries (e.g., Bank of America, N.A.) are required to hold a higher SLR of **6.0 %** to be deemed “well capitalized” under the Prompt Corrective Action framework, and they must also meet the broader Basel 3 leverage‑ratio minimum of **3 %** plus a 2 % leverage buffer, which together amount to a minimum SLR of roughly **5 %** for those banks. Thus, the parent’s SLR requirement (6 %) is stricter than the minimum SLR threshold used to classify its bank subsidiaries as well‑capitalized.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in the quantitative values assigned to the SLR requirements. According to the ground truth, Bank of America Corporation (the parent holding company) must maintain a minimum SLR of 3.0% plus a 2.0% leverage buffer, totaling 5.0%, not 6.0% as stated. The LLM incorrectly states the parent company's requirement as 6.0%, which is factually wrong. Conversely, the insured depository subsidiaries are correctly required to maintain 6.0% to be well capitalized under the PCA framework — this part is accurate. However, the LLM confuses the direction of the comparison: it claims the parent’s requirement (6.0%) is stricter than the subsidiaries’ (5.0%), but in reality, the subsidiaries’ 6.0% requirement is higher than the parent’s 5.0%, making the subsidiary requirement more stringent. (2) The calculation of 3% + 2% = 5% for subsidiaries is correct, but this buffer framework applies to the parent under Basel III, not the subsidiaries under PCA. The PCA framework does not use a buffer system; it sets a fixed 6.0% threshold for 'well capitalized' status. Thus, applying the 3% + 2% = 5% logic to the subsidiaries is a misapplication of regulatory frameworks. (3) The multi-hop reasoning is partially sound — the model attempts to compare parent and subsidiary requirements — but it incorrectly maps which regulatory regime (Basel III with buffer vs. PCA) applies to which entity. It reverses the relative stringency of the requirements due to the numerical error. (4) Despite these critical errors, the answer is contextually relevant and structured appropriately, addressing both parts of the question and attempting correct terminology. Hence, moderate scores for qualitative accuracy and contextual relevance, but low quantitative and overall correctness due to key factual and logical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 498,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact MetLife's accounting treatment for mortgage loans, specifically in terms of the allowance for credit losses and the timing of credit loss recognition?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed MetLife's accounting treatment for mortgage loans by requiring the establishment of an allowance for credit losses (ACL) at the time of purchase based on expected lifetime credit losses, rather than recognizing credit loss only when it was probable that amounts due would not be collected. This shift moved the company from an incurred loss model to an expected loss model, resulting in earlier recognition of credit losses and presenting mortgage loans at the net amount expected to be collected.",
      "llm_answer": "The adoption of the credit‑loss guidance on January 1 2020 required MetLife to recognize an allowance for credit losses (ACL) on mortgage‑loan receivables at acquisition, recording the allowance in earnings within net investment gains (losses) rather than waiting for an incurred loss. This change shifted the timing of credit‑loss recognition from the incurred‑loss model (losses recorded only when collection became probable) to a lifetime‑expected‑loss model, causing the ACL to be established as each loan is originated and updated as conditions change. Consequently, the allowance is now reflected in the amortized cost basis of mortgage loans and recognized in earnings immediately, affecting the timing of credit‑loss expense and the presentation of mortgage‑loan balances net of ACL.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: the adoption date (January 1, 2020) is correct; the shift from an incurred loss model to an expected lifetime credit loss model is accurately described; the establishment of the allowance for credit losses (ACL) at acquisition or origination is correctly stated; and the impact on financial reporting—earlier recognition of credit losses and presentation of mortgage loans net of ACL—is fully aligned with the original answer. (2) There are no numerical values requiring calculation in this question, but the date (January 1, 2020) is correctly cited. (3) The multi-hop reasoning is sound: the answer synthesizes the change in accounting standard, its effect on timing (from probable to expected losses), the accounting treatment (ACL recorded in earnings via net investment gains/losses), and the balance sheet presentation (amortized cost basis net of ACL). (4) The LLM uses slightly more detailed terminology (e.g., mentioning net investment gains (losses)) than the original, but this adds precision without introducing error. Overall, the response demonstrates complete understanding, correct entity identification (MetLife, mortgage loans, ACL), and accurate qualitative synthesis across accounting concepts and timing implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 379,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, change the timing and methodology of recognizing credit losses on leveraged lease receivables and mortgage loans, and what specific models and inputs were used under the new guidance?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition of credit losses from an incurred loss model to an expected lifetime credit loss model for both leveraged lease receivables and mortgage loans. For leveraged lease receivables, the Company now uses a probability of default and loss given default model to estimate expected lifetime credit loss, incorporating third-party credit ratings and historical default data. For mortgage loans, the Company applies significant judgment to estimate expected lifetime credit loss over the contractual term adjusted for prepayments and extensions, considering past events and current and forecasted economic conditions. This represents a shift from recognizing credit losses only when incurred to proactively accounting for expected losses over the life of the asset.",
      "llm_answer": "The adoption of the credit loss guidance on January 1 2020 required the Company to shift from an incurred‑loss model to an expected‑lifetime credit loss model for both leveraged lease receivables and mortgage loans. Under the new guidance, an allowance for credit loss is recorded in earnings for the portion of the investment that is not expected to be collected, using a probability‑of‑default/loss‑given‑default approach for leveraged leases and a discounted cash‑flow model that incorporates expected prepayments, extensions, and forecasted economic conditions for mortgage loans. Significant judgment is applied to pool leases with similar risk characteristics, assess lessee credit ratings, and incorporate third‑party forecasts and market data when estimating expected lifetime credit loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the shift from incurred loss to expected lifetime credit loss model on January 1, 2020, is correctly dated and described. The use of a probability of default/loss given default (PD/LGD) model for leveraged lease receivables, incorporating third-party credit ratings and historical data, is accurately reflected. For mortgage loans, the answer correctly notes the use of a discounted cash flow model that considers prepayments, extensions, and forecasted economic conditions, along with the application of significant judgment. (2) There are no numeric inaccuracies—dates (January 1, 2020) are correct, and no erroneous figures are introduced. (3) The multi-hop reasoning is sound: the answer synthesizes changes in timing (from incurred to expected) and methodology across two asset types, correctly attributing distinct models to each. (4) The only minor deviation from the original answer is that the LLM specifies a 'discounted cash flow model' for mortgage loans, while the ground truth emphasizes judgment in estimating losses over the contractual term adjusted for prepayments/extensions. While these are semantically aligned, the original does not explicitly name 'discounted cash flow' as the model. This is a slight expansion but not factually incorrect, hence the 9/10 on qualitative accuracy. Overall, the answer is contextually complete, factually precise, and correctly structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 417,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does Texas Instruments' (TXN) structural cost advantage in manufacturing analog products using 300-millimeter wafers contribute to its ability to generate and return significant amounts of cash, as highlighted in its business model and competitive advantages?",
      "original_answer": "Texas Instruments achieves a 40% cost reduction per unpackaged chip by using 300-millimeter wafers instead of 200-millimeter wafers, which directly supports its competitive advantage in manufacturing and technology. This cost advantage enables greater control over the supply chain and lowers production costs, contributing to higher gross margins. As a result, TI is positioned to generate significant free cash flow, which aligns with its stated objective of maximizing long-term free cash flow per share growth and returning substantial amounts of cash to shareholders.",
      "llm_answer": "Texas Instruments' structural cost advantage from owning and operating its own 300-millimeter wafer fabrication facilities—evidenced by the 40% lower cost per unpackaged chip versus 200-millimeter wafers—enables significantly higher gross margins (67.5% in 2021 vs. 64.1% in 2020) and operating profit margins (48.8% of revenue), directly driving the $8.76 billion in cash flow from operations. This strong cash generation, which included $6.29 billion in free cash flow, underpins the company's ability to return $4.41 billion to shareholders through dividends and buybacks while maintaining a robust cash position of $9.74 billion.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 40% cost reduction per unpackaged chip using 300mm wafers, which aligns with the ground truth and is central to TI's structural cost advantage. It also correctly links this to higher gross margins and strong cash generation. However, the specific financial figures—such as gross margin of 67.5% in 2021 vs 64.1% in 2020, operating margin of 48.8%, $8.76B cash flow from operations, $6.29B free cash flow, $4.41B returned to shareholders, and $9.74B cash position—are not present in the original answer and cannot be verified against the provided ground truth. These numbers may be factually accurate but introduce unverified data not supported by the knowledge graph, reducing quantitative accuracy. (2) The original answer does not include any specific financial metrics beyond the 40% cost reduction, so the inclusion of detailed margins and cash flow figures represents an overreach in precision without grounding in the source truth. While such figures may exist in TI’s actual filings, they are not part of the validated knowledge graph response, making them potentially misleading in an evaluation context. (3) The reasoning is sound: the model correctly traces the causal chain from 300mm wafers → lower costs → higher margins → strong cash flow → shareholder returns. This demonstrates proper multi-hop synthesis between manufacturing advantage and financial outcomes. (4) Contextual relevance is perfect—the answer directly addresses how the cost advantage enables cash generation and return, which is the core of the question. The qualitative reasoning and entity identification (Texas Instruments, 300mm wafers, cost reduction, free cash flow, shareholder returns) are accurate and well-synthesized. However, the correctness score is reduced due to unsupported numerical claims, even though the conceptual flow is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 510,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What is the total value of the 1.5-Year Floating Rate (SOFR + 0.35%) Senior Notes issued by TMO as of December 31, 2021, and how does this compare to the value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of the same date?",
      "original_answer": "The total value of the Floating Rate (SOFR + 0.35%) 1.5-Year Senior Notes issued by TMO as of December 31, 2021, is $1,000 million. The value of the Floating Rate (SOFR + 0.39%) 2-Year Senior Notes due on October 18, 2023, as of December 31, 2021, is $500 million. Therefore, the 1.5-Year Senior Notes are valued at twice the amount of the 2-Year Senior Notes as of December 31, 2021.",
      "llm_answer": "As of December 31, 2021, Thermo Fisher’s 1.5‑Year Floating Rate Senior Notes (SOFR + 0.35%) totaled $1,000 million, while the 2‑Year Floating Rate Senior Notes (SOFR + 0.39%) due on October 18, 2023 amounted to $500 million. Consequently, the 1.5‑year notes were valued at $1,000 million and the 2‑year notes at $500 million, making the former twice the size of the latter.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $1,000 million for the 1.5-Year Floating Rate Senior Notes (SOFR + 0.35%) and $500 million for the 2-Year Floating Rate Senior Notes (SOFR + 0.39%) due October 18, 2023, are accurately reported as of December 31, 2021. The comparison stating that the 1.5-year notes are twice the size of the 2-year notes is mathematically correct (1,000 / 500 = 2). (2) The answer is complete, addressing both parts of the question: the total value of each note series and their comparative valuation. (3) Entity accuracy is correct—TMO (Thermo Fisher Scientific) is properly identified, and the financial instruments are accurately described with correct interest rate spreads, maturities, and time reference. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: the model correctly retrieves and compares two distinct debt instruments from the same issuer and reporting date, drawing a valid conclusion about their relative sizes. (5) The semantic meaning is equivalent to the original answer, with only minor rephrasing (e.g., 'twice the size' vs 'valued at twice the amount'). All formatting variations (e.g., $1,000 million) are acceptable and unambiguous.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 355,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How many shares of UnitedHealth Group common stock were available for future issuance under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan (ESPP) combined as of December 31, 2023, and which plan had more shares available?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan and 17 million shares were available under the ESPP, making a total of 70 million shares available for future issuance combined. The 2020 Stock Incentive Plan had more shares available than the ESPP.",
      "llm_answer": "As of December 31, 2023, the 2020 Stock Incentive Plan had 53 million shares remaining available for future issuance, and the 1993 Employee Stock Purchase Plan had 17 million shares available. Combined, these plans offered 70 million shares for future issuance, with the 2020 Stock Incentive Plan having more shares available than the ESPP.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: 53 million shares available under the 2020 Stock Incentive Plan, 17 million under the ESPP, and a combined total of 70 million shares—correctly calculated (53 + 17 = 70). (2) The dates (December 31, 2023) and plan names (2020 Stock Incentive Plan, 1993 Employee Stock Purchase Plan/ESPP) are correctly identified. (3) The multi-hop reasoning is sound: the model correctly synthesized data from two different plans, computed the total, and made the correct comparison—identifying that the 2020 Stock Incentive Plan had more shares available. (4) The semantic meaning is equivalent to the original answer, with only minor rephrasing (e.g., 'remaining available' vs 'available'). No errors in numbers, logic, or entities. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 261,
        "total_tokens": 1446
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "What was the total liability for postemployment benefits reported by CAT in 2023, and how did the pension benefits freeze impact the assumptions used in their financial reporting?",
      "original_answer": "The total liability for postemployment benefits reported by CAT in 2023 was $621 million, which includes $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation plans. The pension benefits freeze, which became effective December 31, 2019, resulted in the elimination of service cost and rendered certain actuarial assumptions no longer applicable to the pension reporting.",
      "llm_answer": "The total liability for postemployment benefits reported by Caterpillar in 2023 was $2,597 million for other postretirement benefits (reflected in Statement 3 as a liability of $2,597 million), with the overall postemployment benefit liability (including pension and OPEB) amounting to $701 million for non‑current postemployment benefit obligations. The freeze of U.S. pension benefits effective December 31 2019 eliminated service‑cost components and the compensation‑increase assumption, which altered the actuarial assumptions used—specifically removing the rate of compensation increase and affecting the discount‑rate and other actuarial calculations that determine benefit obligations and periodic cost measurements. This freeze is noted in the actuarial assumptions tables and impacts the reported net periodic benefit cost and mark‑to‑market gains/losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. The ground truth states that CAT's total postemployment benefit liability in 2023 was $621 million, broken into $56 million for other postemployment benefits and $565 million for non-qualified deferred compensation. However, the LLM incorrectly reports $2,597 million for other postretirement benefits and $701 million for overall postemployment liabilities, which do not match the ground truth. These numbers are not only wrong but appear to conflate different line items or reporting categories. (2) The date of the pension freeze is correctly identified as December 31, 2019, which matches the ground truth. However, the LLM incorrectly states that the compensation-increase assumption was removed and that discount-rate calculations were affected, while the ground truth specifies that the freeze led to the elimination of the service cost and rendered certain actuarial assumptions no longer applicable—without specifying which ones beyond service cost. While it is reasonable to infer that compensation growth assumptions may no longer apply, the LLM overreaches by asserting impacts on discount rates and mark-to-market gains/losses, which are not supported in the original answer. (3) The multi-hop reasoning is partially sound—the model connects the pension freeze to changes in actuarial assumptions, which is correct in principle—but fails in accurate synthesis of financial figures across the entities and years. The liability figures are entirely inconsistent with the ground truth, suggesting a failure to retrieve or interpret the correct data points. (4) The contextual relevance is moderate: the answer addresses both parts of the question (liability amount and impact of freeze), uses appropriate financial terminology, and references actuarial assumptions, but the severe numerical inaccuracies undermine the overall correctness. The qualitative reasoning about the freeze’s impact is plausible but goes beyond the information provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 557,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "What was the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans, and how does this compare to the prior year?",
      "original_answer": "The total fair value of Merck's investments in developed markets equities for U.S. Pension Plans in 2024 was $2,555 million for investment funds and $2,171 million for equity securities, totaling $4,726 million. In 2023, the fair value was $2,797 million for investment funds and $2,071 million for equity securities, totaling $4,868 million. This represents a decrease of $142 million from 2023 to 2024.",
      "llm_answer": "Based on the provided document pages, the total fair value of Merck's investments in developed markets equities in 2024 across both investment funds and equity securities for U.S. Pension Plans is $2,171 (Level 1) + $41 (Level 2) = $2,212. This compares to $2,071 (Level 1) + $223 (Level 2) = $2,294 in 2023, representing a decrease of $82 from the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. It reports a total fair value of $2,212 million for 2024 and $2,294 million for 2023, which significantly deviates from the ground truth totals of $4,726 million (2024) and $4,868 million (2023). The LLM incorrectly uses Level 1 and Level 2 values for equity securities only, failing to include investment funds. Specifically, it uses $2,171 (Level 1 equity securities) and adds $41 (Level 2 equity securities), but omits the $2,555 million in investment funds entirely. Similarly, for 2023, it uses $2,071 + $223 = $2,294, again missing the $2,797 million in investment funds. (2) Calculations within the LLM’s incorrect framework are arithmetically correct ($2,171 + $41 = $2,212; $2,071 + $223 = $2,294; difference of $82), but these numbers do not reflect the actual total fair value across both investment funds and equity securities as required. The correct calculation should be $2,555 + $2,171 = $4,726 in 2024 and $2,797 + $2,071 = $4,868 in 2023, with a decrease of $142 million. (3) The multi-hop reasoning failed: the model did not synthesize data across both investment funds and equity securities, instead focusing only on equity securities broken down by valuation levels. This indicates a misunderstanding of the structure of the financial disclosures. (4) Scores reflect major factual and quantitative errors (correctness: 2), poor quantitative accuracy due to wrong inputs despite correct arithmetic (2), limited qualitative accuracy as reasoning is flawed but internally consistent (3), and moderate contextual relevance since the answer addresses the right topic and pension plans but with wrong data (6).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 465,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How many shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and how many remain available for issuance as of December 31, 2024, considering the plan's role in issuing stock options, RSUs, and PSUs as stated in the plan documentation and stock-based compensation disclosures?",
      "original_answer": "A total of 135 million shares of Danaher common stock were authorized for issuance under the 2007 Omnibus Incentive Plan since its inception, and approximately 47 million shares remain available for issuance as of December 31, 2024, after accounting for shares issued through stock options, RSUs, and PSUs under the plan.",
      "llm_answer": "Based on the disclosed information in the 2007 Omnibus Incentive Plan documentation and stock-based compensation disclosures within the provided 10-K pages, **approximately 135 million shares of Danaher common stock have been authorized for issuance under the plan since its inception, and as of December 31, 2024, approximately 47 million shares remain available for issuance** (excluding shares underlying outstanding awards), consistent with the plan's role in issuing stock options, RSUs, and PSUs. This figure is derived from the stock-based compensation disclosures and plan description in the filing, which explicitly state the total authorized shares and remaining availability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers '135 million shares authorized' and 'approximately 47 million shares remaining' are accurate and match the original answer exactly; minor phrasing like 'approximately' is acceptable and reflects typical reporting language in SEC filings. (2) The answer addresses both parts of the multi-part question: total shares authorized since inception and shares remaining as of December 31, 2024. (3) Entity accuracy is correct—Danaher, the 2007 Omnibus Incentive Plan, and the relevant award types (stock options, RSUs, PSUs) are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the remaining shares are derived from total authorized minus those used for various equity awards, as disclosed in stock-based compensation footnotes and plan documentation. The mention of 'excluding shares underlying outstanding awards' adds technical precision consistent with how availability is typically reported. (5) Semantic equivalence is strong—the LLM conveys the same core facts and context as the ground truth, with slightly expanded wording but no deviation in meaning. All scoring categories warrant top marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 354,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the growth in Google Play's revenue contribution, as part of non-advertising revenues, potentially affect Google's overall profit margins, given the differing margin profiles between advertising and non-advertising revenue streams?",
      "original_answer": "Google Play generates revenues from app sales, in-app purchases, and digital content, and is a growing component of Google's non-advertising revenues. According to the 2022 10-K filing, non-advertising revenues—including those from Google Play, hardware, and Google Cloud—are increasing and may adversely affect overall profit margins because the margins on these revenues vary significantly and may be lower than those on advertising revenues. As Google Play's revenue contribution grows, if its margins remain lower than those of advertising, the overall profit margin of Google could decrease unless offset by efficiencies or higher-margin offerings.",
      "llm_answer": "The growth in Google Play's revenue contribution—part of non-advertising revenues—could pressure overall profit margins because non-advertising revenues (including Google Play) typically carry lower margins than advertising revenues. As noted in the 10-K, \"the margins on these revenues vary significantly and may be lower than the margins on our advertising revenues,\" and the document explicitly states that non-advertising revenues are \"increasing and may adversely affect margins.\" This is further supported by the fact that newer advertising formats (e.g., YouTube and Google Play ads) \"monetize at a lower rate than our traditional search ads,\" directly linking the shift toward non-advertising revenue streams to potential margin compression.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Google Play is part of non-advertising revenues and that these revenues typically carry lower margins than advertising revenues, which can pressure overall profit margins. The answer cites the 2022 10-K accurately by quoting that 'the margins on these revenues vary significantly and may be lower than the margins on our advertising revenues' and notes that increasing non-advertising revenues 'may adversely affect margins'—both of which are consistent with the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (Google Play, non-advertising revenues, advertising margins) are correctly identified. The reasoning is sound and reflects proper multi-hop synthesis between Google Play's growth, its margin profile relative to advertising, and the impact on overall profitability. The only minor shortcoming is the inclusion of 'YouTube and Google Play ads' as lower-monetizing advertising formats, which slightly conflates advertising within non-advertising streams—YouTube ads are advertising revenue, not non-advertising. While this does not invalidate the overall conclusion, it introduces a small conceptual blurring. However, the core logic and factual basis remain strong, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 379,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What specific financial instruments does CVS use to hedge against credit quality risk, and how does the company expect these instruments to impact its overall risk exposure?",
      "original_answer": "CVS uses derivative financial instruments such as interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps to hedge against credit quality risk. The company expects these instruments, when used for hedging, to reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.",
      "llm_answer": "CVS uses interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps to hedge interest rate and credit quality risks, and expects these instruments to reduce overall risk exposure. The company manages credit quality risk by maintaining high average credit quality ratings and diversified sector exposure within its debt securities portfolio, and it expects these hedging instruments to mitigate interest rate and credit-related volatility in its investment portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All financial instruments listed—interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options, and credit default swaps—are correctly identified as tools CVS uses to hedge against credit quality and interest rate risks. The statement that these instruments are expected to reduce overall risk exposure matches the original answer's claim that they 'reduce overall risk despite subjecting the company to varying degrees of interest rate, equity price, and credit risk when viewed separately.' (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative data points are factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes that CVS uses specific derivatives for hedging and links them to risk mitigation outcomes. The addition of context about maintaining high credit quality ratings and diversified sector exposure, while not in the original answer, is consistent with prudent risk management and does not contradict the ground truth; it adds minor supplementary detail without distorting the core response. (4) The only reason for not giving a perfect 10 is that the LLM slightly expands the scope by mentioning 'managing credit quality risk' through portfolio composition, which was not part of the original answer, but this does not detract from correctness. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 437,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What was the total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021?",
      "original_answer": "The total amount invested in Hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $691 million. This is calculated by summing $682 million from U.S. Pension Plans and $9 million from Other Postretirement Benefit Plans.",
      "llm_answer": "The total amount invested in hedge funds/limited partnerships across both U.S. Pension Plans and Other Postretirement Benefit Plans in 2021 was $682 million for U.S. Pension Plans and $38 million for Other Postretirement Benefit Plans, for a combined total of $720 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the numeric values. According to the ground truth, the amount invested in Other Postretirement Benefit Plans was $9 million, not $38 million as stated by the LLM. The U.S. Pension Plans amount ($682 million) is correct. However, due to the incorrect $38 million figure, the combined total is miscalculated as $720 million instead of the correct $691 million. (2) Quantitative accuracy is low because the key numbers—especially the $38 million vs. $9 million—are materially off, and the final sum is therefore incorrect. While $682 million is accurate, the error in the second component undermines the overall calculation. (3) The reasoning structure is sound in that the model attempts to sum two components across plans, indicating correct multi-hop logic (aggregating across U.S. Pension and Other Postretirement Benefit Plans). However, it fails in execution due to incorrect data retrieval for the Other Postretirement Benefit Plans. (4) Contextual relevance is high because the answer addresses the right entities, time period (2021), and asset class (hedge funds/limited partnerships), and attempts the correct synthesis. The core failure is data accuracy, not understanding of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 355,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "What is the total number of freight cars UNP both owns and leases as of 2024, and how much did they spend on acquiring freight cars in 2024 based on their capital plan and lease buyout figures?",
      "original_answer": "UNP owns or leases a total of 56,176 freight cars as of 2024. Based on the capital plan and lease buyout figures, they spent $143 million on acquiring freight cars in 2024.",
      "llm_answer": "As of December 31 2024, Union Pacific owned 33,704 freight cars and leased 22,472, for a total of 56,176 freight cars.  Based on its 2024 capital plan, the company expects to spend roughly $788 million on acquiring freight cars (including about $143 million of lease‑buyout purchases).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that UNP owns or leases a total of 56,176 freight cars as of 2024, matching the ground truth exactly. It breaks this down into 33,704 owned and 22,472 leased, which sum correctly to 56,176. The spending figure of $143 million on lease-buyout purchases is accurately reported as part of the capital plan, which aligns with the ground truth. However, the LLM adds that the total expected spending on freight car acquisition is $788 million, which includes the $143 million for lease buyouts. This additional detail is not in the original answer and may imply a broader scope than what was asked—specifically, the question only asks for how much was spent on acquiring freight cars based on the capital plan and lease buyout figures. While $143 million is the precise figure tied directly to acquisition via buyouts, the inclusion of $788 million could be misleading if interpreted as total spending, though it is presented as context. (2) All numeric values—33,704, 22,472, 56,176, $143 million, and $788 million—are factually accurate and correctly formatted. The sum of owned and leased cars is correct. The $143 million figure matches the ground truth exactly. (3) The multi-hop reasoning is sound: the model synthesizes ownership and leasing data to compute total freight cars and correctly identifies the $143 million lease-buyout amount as part of acquisition spending. The only nuance is that the full $788 million may not represent direct 'acquisition spending' in the way the question implies, but rather total planned expenditure, some of which funds acquisitions. (4) The answer is highly relevant and conveys the required information with high precision. The slight over-inclusion of $788 million does not contradict the ground truth but adds context, which may enhance understanding without introducing error. Thus, the answer is factually correct and complete, warranting a high score, though not perfect due to potential ambiguity in interpreting 'spending on acquiring freight cars.'",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 550,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "By how much did changes in non-marketable equity securities contribute to the overall increase in other income (expense), net, from 2020 to 2021, given the role of these investments in Google's equity portfolio?",
      "original_answer": "The changes in non-marketable equity securities contributed $6.9 billion to the overall increase in other income (expense), net, from 2020 to 2021. This was the primary driver behind the $5.2 billion net increase in other income, despite being partially offset by a $1.3 billion increase in accrued performance fees.",
      "llm_answer": "The increase in other income (expense), net, attributable to changes in non‑marketable equity securities was $9.8 billion. This reflects the $9.8 billion of unrealized gains recorded on non‑marketable equity securities held at the end of 2021 (up from $1.5 billion in 2020), which contributed to the overall rise in other income (expense), net, from $6.9 billion in 2020 to $12.0 billion in 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key numeric claim. The ground truth states that changes in non-marketable equity securities contributed $6.9 billion to the increase in other income (expense), net, whereas the LLM claims $9.8 billion, which is a significant overstatement. Additionally, the LLM incorrectly states that other income increased from $6.9 billion in 2020 to $12.0 billion in 2021 (implying a $5.1 billion increase), but this conflicts with the ground truth that the net increase was $5.2 billion — while that part is close, the component attribution is wrong. The $9.8 billion figure appears to conflate the absolute unrealized gains in 2021 with the year-over-year change, misrepresenting the contribution. (2) The calculation is flawed: the LLM suggests a rise in unrealized gains from $1.5 billion in 2020 to $9.8 billion in 2021 (a $8.3 billion increase), but even that internal logic does not support attributing the full $9.8 billion as the 'contribution' to the increase in other income. The ground truth identifies $6.9 billion as the actual incremental contribution, partially offset by other factors. (3) The multi-hop reasoning is unsound: the model fails to correctly isolate the incremental change in non-marketable equity securities' impact year-over-year and instead uses absolute values, leading to incorrect synthesis. It also omits the key detail about the $1.3 billion increase in accrued performance fees offsetting the gain, which is critical context in the original answer. (4) Despite the incorrect numbers and flawed reasoning, the answer is contextually relevant — it addresses the right metric (other income), the correct time period (2020 to 2021), and the correct driver (non-marketable equity securities), so it receives moderate scores for qualitative accuracy and contextual relevance. However, the quantitative inaccuracy is severe enough to warrant a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 527,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023, and how were these contracts classified in the company's financial statements upon final settlement?",
      "original_answer": "The total value of the forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 was $0.7 billion ($0.3 billion in 2022 and $0.4 billion in 2023). These forward contracts were initially classified as equity instruments and recorded within capital surplus. Upon final settlement, the forward contracts were reclassified from capital surplus to treasury stock.",
      "llm_answer": "The forward contracts associated with the ASR transactions executed by CVS in 2022 and 2023 had a total notional value of $1.5 billion (the 2022 ASR) and $2.0 billion (the 2023 ASR), respectively. Upon final settlement, these forward contracts—originally classified as equity instruments recorded within capital surplus—were reclassified from capital surplus to treasury stock when the remaining shares were received.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the quantitative values. The ground truth states the total value of forward contracts was $0.7 billion ($0.3B in 2022 and $0.4B in 2023), but the LLM incorrectly reports $1.5 billion for 2022 and $2.0 billion for 2023, which are not only wrong individually but also sum to $3.5 billion—over five times the correct total. These figures appear to confuse the ASR notional amounts with the forward contract values, indicating a failure in data retrieval or synthesis. (2) Despite the numerical inaccuracies, the LLM correctly describes the classification treatment: forward contracts were initially recorded as equity instruments in capital surplus and reclassified to treasury stock upon final settlement. This part of the qualitative reasoning is accurate and matches the original answer. (3) The multi-hop reasoning is partially sound in terms of tracing the accounting treatment across time (initial classification and reclassification upon settlement), but the core financial data is entirely incorrect, undermining the answer's validity. The model fails to correctly associate the specific forward contract values with the respective years, which is central to the question. (4) Due to severe quantitative inaccuracy, the correctness score is low (2/10). The qualitative accuracy is slightly higher (3/10) because the accounting treatment is correctly explained. Contextual relevance is moderate (6/10) as the response addresses the right concepts and structure but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 426,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the Lowe's Companies Benefit Restoration Plan, as amended and referenced in the 2024 10-K filing, relate to the defined contribution retirement plan in terms of addressing restrictions under the Internal Revenue Code of 1986 for eligible employees?",
      "original_answer": "The Benefit Restoration Plan supplements benefits provided under the defined contribution retirement plan (401(k) Plan) for participants whose benefits are restricted due to provisions in the Internal Revenue Code of 1986. The Company Match under the 401(k) Plan varies up to a maximum of 4.25% of eligible compensation, and this matching contribution is mirrored in the Benefit Restoration Plan for affected participants.",
      "llm_answer": "The Lowe's Companies Benefit Restoration Plan, as amended and restated effective January 1 2025 (Exhibit 10.3), is a non‑qualified supplemental retirement plan that provides eligible employees with benefits that would otherwise be limited by the Internal Revenue Code’s restrictions on the 401(k) Plan.  It therefore restores the ability of certain participants to receive additional employer matching contributions and salary deferrals under the 401(k) framework, ensuring they receive the full retirement benefits they would be entitled to absent the Code’s limitations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the purpose of the Benefit Restoration Plan as a non-qualified plan that restores benefits limited by the Internal Revenue Code's restrictions on the 401(k) Plan, which aligns with the ground truth. It accurately explains the plan's role in enabling eligible employees to receive full employer matching contributions they would otherwise miss due to IRS limits. However, the LLM answer omits the specific quantitative detail that the Company Match under the 401(k) Plan is up to 4.25% of eligible compensation and that this match is mirrored in the Benefit Restoration Plan—this is a key factual element from the original answer. While the LLM mentions 'additional employer matching contributions,' it does not specify the percentage or the mirroring mechanism, leading to a partial loss in quantitative accuracy. The date 'January 1, 2025' for the amendment is mentioned in the LLM answer but not in the ground truth; however, since the question references the 2024 10-K and plans 'as amended,' this may be contextually valid and not necessarily incorrect. The reasoning is sound, and the answer is contextually relevant, capturing the core relationship between the two plans. Thus, the answer is largely correct but lacks precise numerical support, warranting a score of 8 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 368,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, including both CS&Co and TDAC, and how does this compare to the total borrowing capacity under these facilities?",
      "original_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31, 2023, was $1.65 billion, which includes $950 million outstanding under CS&Co's secured uncommitted lines of credit and $700 million outstanding under TDAC's secured uncommitted lines of credit. This represents a utilization rate of approximately 91.7% of the total borrowing capacity of $1.8 billion.",
      "llm_answer": "The total amount outstanding under all secured uncommitted lines of credit at December 31 2023 was $950 million for CS&Co and $700 million for TDAC, for a combined outstanding balance of $1.65 billion. These lines provide a total borrowing capacity of $1.8 billion, meaning the unused portion of the facilities was approximately $150 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key figures: $950 million for CS&Co, $700 million for TDAC, and a total outstanding of $1.65 billion at December 31, 2023. It also correctly states the total borrowing capacity as $1.8 billion, which matches the ground truth. The unused portion is accurately implied as $150 million ($1.8B - $1.65B), though not explicitly labeled as a utilization rate. (2) All numeric values are factually correct and calculations are accurate. The sum of $950M + $700M = $1.65B is correct, and the difference from $1.8B capacity is correctly $150M. The only minor omission is the explicit mention of the 91.7% utilization rate, which is present in the original answer but not in the LLM response. However, this percentage can be derived from the provided numbers, so the information is semantically present in implied form. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from both CS&Co and TDAC, combines the amounts, and compares them to the total capacity. Entity identification (CS&Co, TDAC, secured uncommitted lines of credit, December 31, 2023) is accurate. (4) The answer is highly accurate, complete, and relevant. The omission of the explicit percentage slightly reduces qualitative accuracy, but since all data needed to compute it is provided, the core information is preserved. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 413,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What was the total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021, and how does this compare to the total value of hedge funds/limited partnerships and real estate investments combined in the same year?",
      "original_answer": "The total value of Coca-Cola's investments in mutual, pooled, and commingled funds at the end of 2021 was $87. This is greater than the combined total of hedge funds/limited partnerships ($9) and real estate investments ($5), which together amounted to $14. Thus, mutual, pooled, and commingled funds represented a significantly larger portion of the investment portfolio than the other two categories combined.",
      "llm_answer": "The total value of Coca-Cola's investments in mutual, pooled and commingled funds at the end of 2021 was $290 million for U.S. pension plans and $560 million for non‑U.S. pension plans, for a combined total of $850 million. This combined amount is larger than the sum of the hedge‑fund/limited‑partnership investments ($682 million + $38 million = $720 million) and the real‑estate holdings ($381 million + $8 million = $389 million), which together equal $1.109 billion. Thus, the mutual/pooled/commingled fund total ($850 million) is lower than the combined hedge‑fund and real‑estate total ($1.109 billion).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The ground truth states that Coca-Cola's investments in mutual, pooled, and commingled funds totaled $87 million at the end of 2021, while the LLM claims a combined total of $850 million ($290M + $560M), which is nearly 10 times higher. Similarly, the LLM reports hedge fund/limited partnership investments as $720 million and real estate as $389 million, summing to $1.109 billion—again, vastly exceeding the ground truth values of $9 million and $5 million respectively (combined $14 million). These numbers are not only wrong but misrepresent the scale and composition of the investment portfolio. (2) Calculations in the LLM answer are internally consistent (e.g., $290M + $560M = $850M), but they are based on fabricated or misattributed data. The comparison conclusion—that mutual/pooled/commingled funds ($850M) are *lower* than the combined other categories ($1.109B)—is factually incorrect per the ground truth, which shows the opposite: $87M > $14M. (3) The multi-hop reasoning fails because the model does not synthesize the correct data points from the actual 2021 Coca-Cola 10-K filing. Instead, it appears to pull unrelated or erroneous figures, possibly from pension plan disclosures of other companies or misread contexts. There is no evidence of accurate cross-referencing or correct entity alignment. (4) The contextual relevance is low because the answer discusses U.S. and non-U.S. pension plans, which are not mentioned in the original question or ground truth. The qualitative accuracy is poor due to incorrect entities, metrics, and flawed logic. Only the structure of the response and the attempt at comparison show minimal alignment with the task, warranting a minimal correctness score of 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 490,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the treatment of LTIP units as participating securities impact Simon Property Group's earnings per share calculation, based on the disclosure regarding distributions equal to 10% of the regular quarterly distributions on Operating Partnership units?",
      "original_answer": "LTIP units are treated as participating securities under the two-class method of computing earnings per share because they entitle participants to receive distributions equal to 10% of the regular quarterly distributions paid on a unit of the Operating Partnership. This impacts earnings per share because participating securities must be included in the computation of earnings per share using the two-class method, which allocates earnings to both common shares and participating securities. Although the LTIP units do not have full parity with common units in terms of distributions, their participation in a portion of the distributions affects the allocation of earnings and thus the resulting earnings per share figure.",
      "llm_answer": "LTIP units are treated as participating securities that receive distributions equal to 10 % of the regular quarterly distributions on Operating Partnership units. Because they are entitled to these distributions, they are included in the two‑class method calculation for earnings per share, which can increase the denominator (and potentially the numerator) used in the EPS computation. Consequently, the presence of LTIP units as participating securities can affect the diluted earnings‑per‑share calculation for Simon Property Group.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, the 10% distribution figure is accurately reported, and there are no numerical inaccuracies. (2) The answer correctly identifies that LTIP units are treated as participating securities due to receiving 10% of the regular quarterly distributions on Operating Partnership units, which triggers application of the two-class method for EPS computation—this is factually sound and matches the original answer. (3) The reasoning is mostly solid: it correctly links the distribution entitlement to classification as a participating security and explains the impact on EPS calculation. However, it slightly oversimplifies by suggesting the two-class method affects the 'denominator' (which is more characteristic of the treasury method for dilutive securities), whereas the two-class method allocates earnings between classes rather than adjusting shares outstanding. The original answer correctly emphasizes that earnings are allocated to both common shares and participating securities, which the LLM omits. This nuance is important for full qualitative accuracy. (4) Despite this, the LLM answer remains contextually relevant and captures the core mechanism and impact on EPS. Minor lack of precision in describing the two-class method prevents a perfect score, but all key facts and percentages are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 385,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the total amount of NEE's noncontrolling interest investment in XPLR OpCo as of December 31, 2024, and how is this entity classified in NEE's financial reporting structure based on its control and governance characteristics?",
      "original_answer": "NEE's noncontrolling interest investment in XPLR OpCo totaled $3,315 million as of December 31, 2024. XPLR OpCo is classified as a variable interest entity (VIE) in which NEE is not the primary beneficiary due to lack of control over significant activities and absence of a controlling financial interest, and therefore it is accounted for under the equity method.",
      "llm_answer": "Based on the provided document pages, NEE's noncontrolling interest investment in XPLR OpCo is reported as approximately $3,315 million at December 31 2024 (see Note 8 – Equity Method Investments and Note 9 – Variable Interest Entities). This entity is classified as a variable interest entity (VIE) in NEE's financial reporting structure; specifically, NEE consolidates certain VIEs within the NEER segment but does not consolidate XPLR OpCo because the limited partners or non‑managing members lack substantive rights over the significant activities, and NEE does not have a controlling financial interest. Consequently, XPLR OpCo is accounted for under the equity method, with NEE holding an approximate 52.6 % noncontrolling interest in XPLR and a corresponding investment recorded in equity‑method investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the noncontrolling interest investment amount as $3,315 million as of December 31, 2024, matching the ground truth exactly. It also accurately states that XPLR OpCo is classified as a variable interest entity (VIE) and is accounted for under the equity method due to NEE not being the primary beneficiary. The additional detail about NEE holding approximately a 52.6% noncontrolling interest is consistent with the equity method accounting and adds contextual clarity, though this specific percentage is not in the ground truth; however, it does not contradict it and may be inferred from the knowledge base. (2) All numeric values—$3,315 million and December 31, 2024—are correct and match the ground truth. Format is consistent and acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from VIE classification (Note 9) and equity method accounting (Note 8), linking control characteristics (lack of substantive rights, no controlling financial interest) to the conclusion of non-consolidation and equity method treatment. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., percentage interest), but no factual inaccuracies. The only minor deduction is for introducing the 52.6% figure not present in the original answer, which, while plausible, was not part of the verified truth. Otherwise, all key facts, logic, and classifications are correct and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 411,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the total number of distribution methods Linde uses to supply process gases, and how does the company's on-site delivery method differ from the other methods in terms of contract duration and customer volume requirements?",
      "original_answer": "Linde uses three distribution methods to supply process gases: on-site, merchant, and packaged. The on-site delivery method differs significantly from the others in that it serves customers with the largest volume requirements and typically involves contracts ranging from 10 to 20 years in duration, often containing minimum purchase requirements. In contrast, merchant and packaged gas contracts are generally shorter, ranging from three to seven years and one to three years respectively, and do not typically include minimum purchase requirements or volume commitments.",
      "llm_answer": "Linde uses four primary distribution methods to supply process gases: on-site (tonnage), merchant (bulk liquid), packaged (cylinder), and other (including engineering contracts). The on-site method differs from the others in that its contracts typically have much longer durations (ranging up to 20 years) and require significantly higher minimum purchase volume commitments from customers, whereas merchant and packaged gas contracts generally lack minimum purchase requirements and have shorter terms (typically 3-7 years).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states that Linde uses four distribution methods, but the ground truth specifies only three: on-site, merchant, and packaged. The inclusion of 'other (including engineering contracts)' as a fourth method is not supported by the original answer and introduces an inaccuracy. This affects both completeness and entity accuracy. (2) Quantitatively, the LLM correctly identifies contract durations for on-site (up to 20 years) and merchant (3-7 years), which aligns with the ground truth ranges of 10-20 years and 3-7 years respectively. However, it omits the specific mention of packaged gas contracts being shorter (1-3 years), instead grouping merchant and packaged together as having 3-7 year terms, which is inaccurate for packaged gas. The absence of this distinction reduces quantitative precision. (3) The reasoning around minimum purchase requirements is mostly correct—on-site includes them, while merchant and packaged typically do not—but the conflation of merchant and packaged contract lengths shows a failure in precise multi-hop synthesis across all methods. (4) Despite these errors, the core idea that on-site differs in long-term duration and high-volume commitments is conveyed, and the overall structure addresses both parts of the question, warranting moderate scores. Contextual relevance remains high as the response stays focused and informative.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 388,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relate to the Board of Directors' prior authorization in April 2021 for repurchasing up to $50.0 billion of Class C stock, and what condition was required for the stock split to proceed?",
      "original_answer": "The 20-for-one stock split of Alphabet's Class C Capital Stock, announced in February 2022, relates to the prior $50.0 billion Class C stock repurchase authorization from April 2021 because the stock split required an increase in the number of authorized shares of Class C stock to accommodate the split. This condition was necessary to ensure that the company had enough authorized shares post-split for both ongoing operations and the repurchase program. The stock split was subject to stockholder approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Class A, Class B, and Class C stock.",
      "llm_answer": "The February 2022 20‑for‑one stock split was approved by the Board of Directors in February 2022, but it could only proceed after the Board obtained stockholder approval to amend the company’s charter to increase the authorized share count for the split. This amendment was required as a condition for the split to be implemented.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct regarding the 20-for-one stock split announced in February 2022 and the requirement for stockholder approval to amend the charter to increase the authorized share count, which matches the ground truth. All dates and the nature of the stock split are accurate. However, the LLM answer omits a key part of the multi-hop reasoning: the connection between the stock split and the prior $50.0 billion share repurchase authorization from April 2021. The ground truth explains that increasing the authorized shares was necessary not only to accommodate the split but also to ensure sufficient authorized shares remained available for the ongoing repurchase program. This linkage is a critical component of the question and is missing in the LLM response, reducing completeness and qualitative accuracy. While the condition for stockholder approval is correctly identified, the broader strategic context involving the repurchase program is not addressed. Quantitative accuracy is perfect—dates and split ratio are correct. Contextual relevance is high as the answer addresses the core event and condition, but misses synthesis across both the repurchase authorization and split.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 337,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023, and how much in committed capital contributions did GM have outstanding to the same entity as of December 31, 2023?",
      "original_answer": "GM's equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million, and GM had $0.8 billion in committed capital contributions outstanding to the same entity as of December 31, 2023.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, GM's total equity earnings contribution from Ultium Cells Holdings LLC in 2023 was $293 million (as stated in Note 22, Equity income (loss), where it specifies \"Equity earnings related to Ultium Cells Holdings LLC were $293 million in the year ended December 31, 2023\"). As of December 31, 2023, GM had $0.8 billion in committed capital contributions outstanding to Ultium Cells Holdings LLC (as disclosed in Note 11, Variable Interest Entities, which states \"inclusive of $0.8 billion and $1.4 billion in committed capital contributions to Ultium Cells Holdings LLC at December 31, 2023 and 2022\").",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the equity earnings contribution of $293 million in 2023 and the $0.8 billion in committed capital contributions outstanding as of December 31, 2023, are accurately reported, with acceptable format variation ($0.8 billion = $800 million). (2) The answer is complete, addressing both parts of the multi-part question: the 2023 equity earnings and the year-end committed capital. (3) Entity accuracy is correct—Ultium Cells Holdings LLC, GM, and the correct time period (2023, specifically December 31, 2023) are all properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis by referencing two different notes from the 10-K (Note 22 for equity earnings and Note 11 for capital commitments), correctly interpreting the disclosures. The inclusion of supporting evidence from the filing enhances the qualitative accuracy. (5) The semantic meaning is equivalent to the original answer, with no factual discrepancies. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 305,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the total value of The Coca-Cola Company's investments in hedge funds and limited partnerships in 2021 as reported in both its consolidated financial statements and its other postretirement benefit plan assets, and how does this dual reporting reflect the company's overall exposure to such investment vehicles?",
      "original_answer": "The Coca-Cola Company reported $720 million in hedge funds and limited partnerships within its consolidated financial statements and $9 million in such investments within its other postretirement benefit plan assets for 2021. This totals $729 million in exposure to hedge funds and limited partnerships across both reporting categories.",
      "llm_answer": "The Coca‑Cola Company reported total investments in hedge funds and limited partnerships of **$682 million** for its U.S. pension plan and **$38 million** for its non‑U.S. pension plans in 2021. These amounts are disclosed in the pension‑plan asset breakdown on page 102 and are also reflected in the “Other postretirement benefit plan assets” table on page 103, where hedge‑fund/limited‑partnership holdings are listed as part of the other postretirement‑benefit‑plan assets. The dual reporting shows that the company’s exposure to these alternative‑investment vehicles is captured both within its core pension‑plan asset portfolio and in the separate postretirement‑benefit‑plan assets, underscoring the overall significance of hedge‑fund and limited‑partnership investments to its broader benefit‑plan strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numbers and misrepresents the source of the investments. The ground truth states $720 million in consolidated financial statements and $9 million in other postretirement benefit plan assets, totaling $729 million. The LLM instead reports $682 million and $38 million, which sum to $720 million—close to only one component but misallocated. These figures appear to refer to pension plans (U.S. and non-U.S.), which are not mentioned in the original answer and may be conflated by the model. (2) The quantitative inaccuracies are significant: the $682M and $38M values do not match the ground truth’s $720M and $9M. Additionally, the LLM incorrectly attributes the $38 million to non-U.S. pension plans and combines them under postretirement benefit plan assets, which contradicts the original data. The total exposure is miscalculated as $720M instead of $729M, and the breakdown is entirely wrong. (3) The multi-hop reasoning fails: the question asks for investments reported in *consolidated financial statements* and *other postretirement benefit plan assets*. The LLM incorrectly shifts focus to pension plans, which are not part of the original answer, indicating a failure to correctly identify and synthesize the required reporting categories. It also misinterprets where the data is located (e.g., citing page 102/103 details not in the prompt), introducing hallucinated context. (4) While the LLM attempts to address the dual reporting concept and its strategic implication—showing some contextual understanding—the fundamental errors in entities, numbers, and sourcing severely undermine the answer’s validity. The reasoning about significance and dual reporting is plausible but built on false premises, leading to a mostly incorrect response. Hence, low scores on correctness and quantitative accuracy, moderate on qualitative reasoning due to partial logic, and mid-range on relevance for addressing the general theme.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 537,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the increased use of e-commerce by retail tenants, as mentioned in the risk factors, contribute to the difficulty Simon Property Group (SPG) faces in leasing spaces and maintaining rental rates at its properties?",
      "original_answer": "The increased use of e-commerce by retail tenants has led to lower demand for physical retail space, which directly contributes to higher vacancy rates at SPG's properties. This oversupply of vacant space, combined with the increased bargaining power of creditworthy retail tenants, results in downward pressure on rental rates and occupancy levels. Additionally, SPG may need to increase spending on tenant improvements and offer more lease modifications to attract or retain tenants, all of which materially and adversely affect SPG's financial performance and leasing strategy.",
      "llm_answer": "The increased use of e‑commerce is identified as a key competitive risk that can erode foot traffic and sales at Simon Property Group’s malls. As retailers shift sales online, tenants may under‑report sales or close underperforming stores, which reduces occupancy and puts downward pressure on rental rates that SPG can charge. This makes it harder for the company to lease space and maintain its previous rental levels.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core impact of e-commerce on Simon Property Group (SPG), including reduced foot traffic, store closures, lower occupancy, and downward pressure on rental rates—aligning with the ground truth. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. However, the LLM answer omits key elements from the original answer: (1) it does not mention the increased bargaining power of creditworthy tenants, (2) it fails to note SPG's potential need to increase spending on tenant improvements or offer lease modifications, and (3) it does not explicitly link the oversupply of vacant space to leasing difficulties. These omissions reduce completeness and weaken the multi-hop synthesis, which is required to fully connect e-commerce trends to SPG's financial and operational challenges. While the reasoning is logically sound and contextually relevant, the answer is partially incomplete in conveying the full causal chain described in the ground truth. Semantic equivalence is mostly preserved but lacks depth in strategic and financial implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 320,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What was the cumulative impact on UNP's deferred tax expense in 2024 and 2023 from corporate income tax legislation enacted in Arkansas, and how does this compare to the 2022 impact from Arkansas legislation?",
      "original_answer": "The cumulative impact on UNP's deferred tax expense from Arkansas tax legislation was $34 million in 2024 and $114 million in 2023, totaling $148 million over the two years. In 2022, Arkansas legislation contributed to a $95 million reduction in deferred tax expense. Therefore, the reduction in 2024 and 2023 was greater than the 2022 impact by $53 million.",
      "llm_answer": "The cumulative impact of Arkansas corporate income tax legislation on UNP's deferred tax expense was a $34 million reduction in 2024 and a $114 million reduction in 2023, while the 2022 impact from Arkansas legislation was a $95 million reduction.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the deferred tax expense impacts for 2024 ($34 million), 2023 ($114 million), and 2022 ($95 million), all of which match the ground truth in terms of numeric values and years. These numbers are presented accurately with correct entity (UNP) and metric (deferred tax expense) identification. (2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and no calculation errors are present in the reported figures. (3) However, the LLM answer is incomplete in reasoning and synthesis. The original question asks for a comparison between the cumulative 2024–2023 impact and the 2022 impact. While the LLM provides the necessary numbers, it fails to compute or state the cumulative two-year total ($148 million) or the $53 million difference ($148M - $95M) that shows the greater reduction in 2023–2024 versus 2022. This missing comparative analysis represents a gap in multi-hop reasoning, as the synthesis across years to answer the comparative component is not completed. (4) Despite this omission, the answer is factually correct and contextually relevant, hence a correctness score of 7: core data is accurate, but a key inferential step required by the question is missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 348,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does NEE's limited partner interest in XPLR OpCo potentially impact its financial obligations and liquidity, particularly if XPLR is unable to access capital on commercially reasonable terms?",
      "original_answer": "NEE's limited partner interest in XPLR OpCo could negatively affect its liquidity and financial obligations if XPLR is unable to access capital on commercially reasonable terms. This is because XPLR's inability to secure capital would hinder its ability to complete acquisitions or meet growth opportunities, reducing its cash distributions to unitholders, including NEE. Additionally, if XPLR issues more common units or converts existing securities into common units, NEE's share of future distributions could be diluted. This directly impacts NEE’s cash flows, which are crucial for meeting its financial obligations and paying dividends.",
      "llm_answer": "NEE's limited partner interest in XPLR OpCo could become a significant liquidity risk if XPLR cannot obtain capital on commercially reasonable terms, as NEE may be required to provide additional funding or absorb losses that could impair its ability to meet debt obligations and maintain dividend payments. This risk is heightened by the possibility that XPLR's financing constraints could force it to delay or abandon growth initiatives, thereby reducing cash distributions to NEE and potentially triggering impairments on NEE's investment.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core financial mechanism and risks involved, but misses a key element of dilution risk from equity issuance, which is a critical part of the original answer. (1) There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are present or required. (2) The LLM correctly identifies the risk to NEE’s liquidity and dividends if XPLR cannot access capital, and links it to reduced distributions and growth delays—this aligns with the original answer. (3) However, the LLM fails to mention the dilution risk arising from potential future issuance of common units by XPLR, which directly impacts NEE’s share of future cash flows—a key multi-hop insight in the ground truth. This omission reduces qualitative accuracy. (4) The reasoning is sound where present, and the response is highly relevant to the question, addressing liquidity, financial obligations, and the impact of capital constraints. The absence of the dilution component prevents a higher score, but the core causal chain (capital access → growth/distributions → NEE cash flow → financial obligations/dividends) is correctly synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 346,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "What is the difference between the fair value of mortgage-backed obligations reported in the 'Marketable securities' section and the 'Fair Value' column of the marketable securities table?",
      "original_answer": "The difference between the fair value of mortgage-backed obligations reported in the two sections is $58. In the 'Marketable securities' section, the fair value is $178, while in the 'Fair Value' column of the marketable securities table, it is $236.",
      "llm_answer": "The fair value of mortgage-backed obligations reported in the \"Marketable securities\" section ($236 million) differs from the \"Fair Value\" column of the marketable securities table ($236 million) only in presentation: the table’s \"Fair Value\" column reflects the securities’ fair value, while the section’s figure is the same amount reported as part of the overall marketable‑securities total. In other words, the $236 million figure in the narrative is the fair‑value amount shown in the table’s \"Fair Value\" column.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) Quantitatively, it states that both values are $236 million, but the ground truth specifies that the 'Marketable securities' section reports $178 and the 'Fair Value' column reports $236, with a difference of $58. The LLM incorrectly claims there is no numerical difference, which contradicts the original answer. (2) The calculation of the difference ($236 - $178 = $58) is entirely missing, and the reported values are wrong. (3) Qualitatively, the reasoning is flawed: it asserts the values are the same and only differ in presentation, but the question hinges on a real $58 discrepancy between two reported figures, indicating either an error or different reporting scopes. The model fails to recognize or address this discrepancy. (4) Contextually, while the response is about the right topic and references the correct sections, it misrepresents the core facts. The answer should have identified the two different values and computed their difference. Due to complete failure in numerical accuracy and multi-hop comparison, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 313,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the revenue recognition method for Google Play impact the financial reporting of non-advertising revenues, given the increasing portion of these revenues and their effect on margins?",
      "original_answer": "Google Play's revenue is reported on a net basis because Google's performance obligation is to facilitate a transaction between app developers and end users, for which it earns a service fee. This method reduces the total revenue amount reported for Google Play sales. As non-advertising revenues, which include Google Play, are increasing and have varying margins that may be lower than advertising revenues, this trend could adversely affect overall margins.",
      "llm_answer": "The revenue recognition method for Google Play requires reporting of app sales and in-app purchases on a net basis as a service fee, rather than gross revenue. This results in lower reported revenue amounts and impacts margins, as non-advertising revenues (including Google Play) have lower margins than advertising revenues and are growing as a portion of total revenue. Consequently, the increasing share of non-advertising revenues, recognized net of fees, puts downward pressure on overall margins despite the absolute growth in these revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Google Play revenue is recognized on a net basis because it acts as a facilitator earning a service fee, which reduces reported revenue—this aligns with the original answer. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts), so quantitative accuracy is not compromised; all financial concepts are correctly described without error. (3) The multi-hop reasoning is sound: the model connects the net revenue recognition method to its impact on reported non-advertising revenues and correctly links the growing proportion of these lower-margin revenues to downward pressure on overall margins. (4) The only minor limitation is that the LLM does not explicitly state that Google's performance obligation is to 'facilitate a transaction between app developers and end users,' which provides slightly less context on *why* the net method is used, though the implication is present. Otherwise, all key elements—net reporting, lower margins, increasing share of non-ad revenue, and margin pressure—are accurately conveyed. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 348,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What is the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023, and how does this compare to the previous year's commitment?",
      "original_answer": "General Motors committed $0.8 billion to Ultium Cells Holdings LLC in 2023, which is a decrease from $1.4 billion in 2022. This indicates a reduction in GM's capital commitment to the joint venture by $0.6 billion year-over-year.",
      "llm_answer": "Based on the provided document pages, the total amount of committed capital contributions General Motors made to Ultium Cells Holdings LLC in 2023 was $0.8 billion (as disclosed in Note 11 under \"Nonconsolidated VIEs\" on page 79, which states \"inclusive of $0.8 billion and $1.4 billion in committed capital contributions to Ultium Cells Holdings LLC at December 31, 2023 and 2022\"). This represents an increase from $1.4 billion in 2022, but the question asks for the **committed capital contribution amount in 2023**, which is $0.8 billion. However, the question also asks how this compares to the previous year's commitment. The document indicates that the committed capital contribution at December 31, 2023, was $0.8 billion, while at December 31, 2022, it was $1.4 billion. Therefore, the commitment **decreased** from $1.4 billion in 2022 to $0.8 billion in 2023. \n\n**Answer:**  \nThe total committed capital contribution General Motors made to Ultium Cells Holdings LLC in 2023 was $0.8 billion, which is a decrease from $1.4 billion in the previous year (2022).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the committed capital contributions for both years: $0.8 billion in 2023 and $1.4 billion in 2022, matching the ground truth exactly. The comparison correctly notes a decrease from 2022 to 2023. (2) All numeric values are accurate and properly cited from the document (Note 11, page 79). The calculation of the year-over-year change (a $0.6 billion reduction) is implied correctly through the stated values, though not explicitly computed in the answer — this is a minor omission but does not detract from correctness. (3) The multi-hop reasoning is sound: the model synthesizes data from two time points (Dec 31, 2023 and Dec 31, 2022) to compare annual commitments. There is a brief moment of confusion in the explanation where it says 'this represents an increase from $1.4 billion in 2022' — this appears to be a typo or contradiction, but it is immediately corrected with the accurate statement that the commitment decreased. This transient error does not invalidate the final correct conclusion. (4) The answer is contextually complete and directly addresses both parts of the question: the 2023 amount and the comparison to the prior year. The final boxed answer is fully correct. The qualitative score is slightly reduced due to the brief contradictory statement, but quantitative and contextual accuracy are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 381,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total cash consideration paid by Mastercard in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc., and how much of this amount was attributed to goodwill?",
      "original_answer": "Mastercard paid a total cash consideration of $2.8 billion in 2024 for all acquisitions, including the acquisition of RF UlEmate Parent, Inc. Out of this, $1.7 billion was attributed to goodwill.",
      "llm_answer": "Mastercard paid a total cash consideration of $2.8 billion for all acquisitions in 2024, of which $1.7 billion was attributed to goodwill (primarily from the $2.7 billion purchase of RF UlEmate Parent, Inc.).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the total cash consideration of $2.8 billion and the $1.7 billion attributed to goodwill, matching the ground truth exactly. These figures are accurate and properly formatted. (2) All numeric values are correct: $2.8 billion total cash consideration and $1.7 billion goodwill. The mention of a $2.7 billion purchase price for RF UlEmate Parent, Inc. is not part of the original answer but may reflect additional context from the source; however, it does not contradict the total acquisition spend of $2.8 billion across all deals, so it doesn't introduce a factual error. (3) The multi-hop reasoning is sound—LLM correctly links Mastercard’s 2024 acquisitions, includes RF UlEmate Parent, Inc., and allocates the correct goodwill amount. The slight addition of a $2.7 billion figure for RF UlEmate is plausible (as it would be part of the $2.8 billion total) and does not undermine the correctness. (4) The answer is semantically equivalent to the ground truth, with only minor elaboration. Scores reflect high accuracy: full marks for quantitative and contextual accuracy; a minor deduction in qualitative accuracy due to the unverified but reasonable $2.7 billion detail, which slightly extends beyond the provided truth without error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1113,
        "completion_tokens": 360,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was the total amount spent by UNP on freight car lease buyouts over the three-year period from 2022 to 2024, and how does this relate to the company's capital plan for acquiring freight cars in 2025?",
      "original_answer": "UNP spent a total of $270 million on freight car lease buyouts from 2022 to 2024 ($70 million in 2022, $57 million in 2023, and $143 million in 2024). This spending trend aligns with the company's 2025 capital plan, which includes acquiring freight cars to support asset replacement and growth opportunities, as part of a broader $3.4 billion investment strategy.",
      "llm_answer": "UNP spent $143 million on freight‑car lease buyouts in 2024 (the amount recorded as “lease buyouts of $143 million” in the cash‑capital‑investment table). This buyout activity is part of the company’s 2025 capital plan, which calls for roughly $3.4 billion of capital spending to replace older assets and acquire additional freight cars to support growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but misses key parts of the question. It correctly identifies the $143 million spent on lease buyouts in 2024, which matches the ground truth. However, it fails to report the total amount spent from 2022 to 2024 ($270 million), and omits the individual amounts for 2022 ($70 million) and 2023 ($57 million). This is a critical omission since the question explicitly asks for the three-year total. (2) Quantitatively, the only number provided—$143 million in 2024—is accurate, but the absence of the other two years and the sum ($70M + $57M + $143M = $270M) results in significant quantitative incompleteness. The $3.4 billion capital plan figure for 2025 is correctly cited. (3) The reasoning partially connects lease buyouts to the 2025 capital plan, correctly framing it as part of asset replacement and growth, which aligns with the original answer. However, it does not demonstrate full multi-hop synthesis by aggregating data across the three years as required. (4) The contextual relevance is high because the answer addresses the relationship between past spending and future plans, but correctness and quantitative accuracy are reduced due to missing data. The answer focuses only on 2024, failing the multi-year scope of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 362,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program based on the disclosed forward contract amounts and initial treasury stock transactions in 2022 and 2023?",
      "original_answer": "The total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation under the 2021 Repurchase Program was $3.5 billion. This is calculated by summing the $2.0 billion notional amount from the ASR disclosed in the 2023 transaction and the $1.5 billion notional amount from the ASR disclosed in the 2022 transaction.",
      "llm_answer": "Based on the disclosed forward contract amounts and initial treasury stock transactions in the 2021 Repurchase Program, the total notional amount of accelerated share repurchase agreements entered into by CVS Health Corporation was $3.0 billion (the $3.0 billion fixed‑dollar ASR entered into in January 2024). This $3.0 billion figure represents the notional amount of the ASR disclosed for 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the total notional amount and the timing of the ASR agreements. The ground truth states the total is $3.5 billion, composed of a $1.5 billion ASR in 2022 and a $2.0 billion ASR in 2023. The LLM incorrectly claims a single $3.0 billion ASR entered in January 2024, which is outside the 2022–2023 timeframe specified in the question. (2) Quantitative accuracy is poor: the total amount is wrong ($3.0B vs $3.5B), the individual components are missing or misstated, and the date of the transaction (2024) contradicts the question’s focus on 2022 and 2023. Even if the $3.0B were correct, it does not match the sum of the disclosed forward contracts. (3) The multi-hop reasoning failed: the model did not correctly synthesize the two separate ASR transactions from 2022 and 2023, and instead invented a single transaction not supported by the ground truth. It also mischaracterized the disclosed amounts by aggregating them incorrectly. (4) Contextual relevance is moderate because the answer addresses ASR agreements under the 2021 Repurchase Program, but the incorrect timing and amounts severely undermine accuracy. The mention of a January 2024 transaction introduces irrelevant data not present in the ground truth. Overall, major factual and calculation errors lead to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 377,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Given GM's dependency on full-size ICE pickup trucks for near-term profitability and the risks outlined in the forward-looking statements, how does the company's reliance on these vehicles interact with its strategic shift toward electric vehicles (EVs) to impact long-term financial stability?",
      "original_answer": "GM's near-term profitability is heavily dependent on the success of its full-size ICE pickup trucks, which currently generate the highest profit margins and fund the company's strategic shift toward EVs. However, the forward-looking statements highlight that any shift in consumer preferences toward smaller, more fuel-efficient vehicles could weaken demand for these high-margin ICE vehicles. This would reduce the cash flow available to invest in EV development, which is critical to GM's long-term strategy. Therefore, a decline in ICE truck sales could jeopardize both short-term financial performance and the funding necessary to transition to an all-electric future, creating a dual risk that threatens both immediate and long-term financial stability.",
      "llm_answer": "GM’s near‑term profitability relies heavily on high‑margin full‑size ICE trucks and SUVs, which fund its EV transition. However, accelerating EV adoption, stricter emissions rules, and the need to fund EV development expose the company to margin pressure and cash‑flow volatility. Consequently, while ICE sales provide current cash flow, the long‑term financial stability hinges on successfully shifting that cash to support EV profitability and managing the associated transition risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and captures the core dynamic between GM's reliance on ICE vehicles for current profitability and the funding of its EV transition. It correctly identifies that high-margin ICE trucks and SUVs fund the EV shift, which aligns with the ground truth. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM omits a key risk mentioned in the original answer: the potential decline in demand for full-size ICE trucks due to shifts in consumer preferences toward smaller, more fuel-efficient vehicles. Instead, the LLM cites 'accelerating EV adoption' and 'stricter emissions rules' as risks, which, while relevant, reframes the demand risk rather than emphasizing the vulnerability of the very cash cows funding the transition. This misses a critical nuance in the multi-hop reasoning: that weakening ICE truck sales directly threaten the internal funding mechanism for EV development. However, the LLM does correctly convey the dual dependency and transition risk to long-term financial stability. The answer is contextually relevant and well-articulated, hence a perfect score for contextual relevance. Overall, the answer is semantically close to the ground truth but lacks full completeness in outlining the specific demand-side risk to ICE vehicles as a threat to both short- and long-term stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 399,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the uncertainty around the pace of the energy transition, as influenced by changing commodity prices and regulatory developments, affect Chevron's asset impairment assessments and upstream investment decisions?",
      "original_answer": "Chevron evaluates the pace of the energy transition as a key factor in its commodity price forecasting and asset impairment assessments. Due to the uncertainty around the energy transition, Chevron may face reduced demand for traditional oil and gas products, which directly affects upstream earnings, cash flows, and capital expenditure programs. This uncertainty complicates impairment evaluations, as future cash flows from upstream assets depend on long-term assumptions about commodity prices, carbon costs, production profiles, and regulatory changes. If the energy transition accelerates or commodity prices remain low, Chevron may be forced to impair upstream assets, particularly those tied to crude oil, which could negatively impact its financial condition and reduce its ability to invest in new business lines such as lower-carbon energy solutions.",
      "llm_answer": "The pace of the energy transition and volatile commodity prices and regulatory changes are key drivers of uncertainty that Chevron incorporates into its impairment testing and reserve‑based depreciation calculations.  When reserve estimates are revised downward or commodity‑price outlooks deteriorate, the company may trigger impairment reviews and adjust the amortization of proved‑property costs, potentially increasing DD&A expense; similarly, lower reserve valuations can lead to write‑downs of upstream assets and affect capital‑budget decisions for new upstream projects.  Consequently, these uncertainties can cause Chevron to reduce or defer upstream investment spending and to reassess the economic viability of existing reserves and related infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the answer correctly identifies that uncertainty around the energy transition, commodity prices, and regulatory changes affect Chevron's impairment assessments and upstream investment decisions. It accurately describes the mechanism—downward reserve revisions or deteriorating price outlooks triggering impairment reviews, affecting DD&A, and influencing capital budgeting. These points are semantically equivalent to the original answer’s focus on impaired cash flows, reduced capital expenditures, and financial impacts. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no discrepancies. (3) The multi-hop reasoning is sound: the LLM connects energy transition uncertainty to commodity price forecasting, then to impairment testing and depreciation practices, and finally to capital allocation decisions—mirroring the causal chain in the ground truth. (4) The only minor gap is that the LLM does not explicitly mention 'carbon costs' or 'accelerated energy transition' as a specific risk leading to crude oil asset impairments, which is a nuanced but important detail in the original. However, this does not undermine the overall correctness. The response is contextually precise, directly addressing how uncertainty impacts both impairment and investment. Thus, high scores across all dimensions with a 9 on correctness due to slight omission of emphasis on low-carbon transition pressures on crude-specific assets.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 429,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Mastercard's provision of Consumer Engagement Services, as part of its broader payment solutions, support its global payments network operations and financial performance?",
      "original_answer": "Mastercard's provision of Consumer Engagement Services enhances its global payments network by drawing on the company's principled and responsible use of secure data, which helps attract and retain consumers and merchants. This, in turn, strengthens the network's utility and drives additional payment flows, contributing to the company's financial performance. These services are part of a suite of offerings that are fundamentally interdependent and support the overall efficiency and attractiveness of Mastercard's global payments network.",
      "llm_answer": "Mastercard’s Consumer Engagement Services—part of its broader payment solutions—strengthen the global payments network by deepening relationships with consumers and financial institution partners, driving higher transaction volumes and cross‑border activity. This expanded engagement fuels revenue growth, supports diversified customer acquisition, and enhances the company’s financial performance through increased net revenue and adjusted net income.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of core concepts and correctly identifies that Consumer Engagement Services support Mastercard's global payments network and financial performance. It accurately captures the multi-hop logic: these services enhance engagement, which drives transaction volumes and revenue growth, thereby improving financial performance. While the original answer emphasizes the principled use of secure data and the interdependence of service offerings, the LLM response focuses more on outcomes (e.g., revenue growth, net income) and relationship-building without explicitly mentioning data responsibility or the suite-like nature of the offerings. However, the omission does not distort the overall meaning. There are no numerical values in either answer, so quantitative accuracy is not applicable—scored as 10 by default. The LLM answer is contextually relevant and semantically aligned with the original, though slightly less precise in reflecting the specific mechanisms (data use, network utility) emphasized in the ground truth. Thus, the correctness and qualitative accuracy scores are high but not perfect due to minor gaps in completeness and nuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 340,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What was the total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025, considering the initial acquisition cost and the deconsolidation in the final year?",
      "original_answer": "The total net cash outflow impact from Walmart's acquisition and deconsolidation of Alert Innovation was $0.4 billion, as the company initially spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no net cash inflow from its deconsolidation in fiscal 2025.",
      "llm_answer": "The total net cash outflow impact from Walmart's acquisition and subsequent sale of Alert Innovation across fiscal years 2023 and 2025 was $0.4 billion for the acquisition in fiscal 2023 and $0.7 billion for the deconsolidation in fiscal 2025, resulting in a net cash outflow of $1.1 billion.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both magnitude and direction of cash flows. The ground truth states that Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023 and realized no cash inflow from deconsolidation in fiscal 2025, resulting in a total net cash outflow of $0.4 billion. The LLM incorrectly claims a $0.7 billion cash outflow from deconsolidation in fiscal 2025, which contradicts the ground truth that there was no net cash inflow (i.e., no additional outflow) during deconsolidation. (2) The quantitative inaccuracies are severe: the LLM invents a $0.7 billion outflow not present in the original data and miscalculates the net impact as $1.1 billion instead of $0.4 billion. The acquisition cost of $0.4 billion is correct, but the deconsolidation amount is entirely wrong. (3) The multi-hop reasoning fails: while the model recognizes the need to combine acquisition and deconsolidation impacts, it incorrectly assumes a cash outflow during deconsolidation, showing flawed understanding of financial implications of deconsolidation. (4) Scores are low because the core financial facts and calculations are incorrect. The contextual relevance is slightly higher because the model attempts the right entities (Walmart, Alert Innovation), time periods (fiscal 2023 and 2025), and concept (net cash impact), but the substance is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 388,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "Considering the information provided about LTIP Units in both disclosures, what is the combined total of potentially dilutive securities for the year ended December 31, 2023, and why was no adjustment made to net income attributable to common stockholders?",
      "original_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023, includes units exchangeable for common stock and LTIP Units. No adjustment was made to net income attributable to common stockholders because these securities had no material dilutive effect during the reporting period.",
      "llm_answer": "The combined total of potentially dilutive securities for the year ended December 31, 2023 is not quantified in the provided excerpts, but the disclosures state that “potentially dilutive securities include units that are exchangeable for common stock and long‑term incentive performance units (LTIP units) granted under our long‑term incentive performance programs.” The company also notes that “no securities had a material dilutive effect for the years ended December 31, 2023, 2022, and 2021,” and that it “have not adjusted net income attributable to common stockholders and weighted average shares outstanding for income allocable to limited partners or units… as doing so would have no dilutive impact.” Consequently, no adjustment was made to net income attributable to common stockholders because the potentially dilutive securities (including LTIP units) would not have altered earnings per share or diluted earnings per share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that the combined total of potentially dilutive securities for the year ended December 31, 2023 includes units exchangeable for common stock and LTIP Units, aligning with the ground truth. While the exact numerical total is not provided in either the LLM or original answer, both acknowledge that such securities exist without quantifying them—this is consistent because the source disclosures may not have specified a numerical total. The reasoning for why no adjustment was made to net income attributable to common stockholders is accurately explained: these securities had no material dilutive effect during the reporting period, as confirmed by the statement that no securities had a material dilutive effect for 2023, 2022, and 2021. The LLM correctly synthesizes this across time periods and explains the accounting treatment (no adjustment due to lack of dilutive impact), demonstrating sound multi-hop reasoning. The only minor shortcoming is a slight lack of emphasis on the term 'material dilutive effect' as the precise reason, though the meaning is preserved. All entities (LTIP Units, common stock, net income attribution) and dates (December 31, 2023) are correct. Number formats and calculations are not applicable here, but qualitative and contextual accuracy are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 367,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total value of Investments measured at NAV across both disclosed asset categories in the 2023 10-K filing for VZ, and how does this compare to the total investments at fair value in each category?",
      "original_answer": "The total value of Investments measured at NAV across both asset categories in the 2023 10-K filing for VZ is $14 million ($9 million from the first category and $5 million from the second). This represents 3.1% of the total investments at fair value, which sum to $902 million ($441 million in the first category and $461 million in the second).",
      "llm_answer": "The total value of Investments measured at NAV across both disclosed asset categories in VZ’s 2023 10‑K is $4,432 million for the pension plan and $5 million for the other postretirement benefit plans, for a combined total of $4,437 million. This NAV‑measured amount is considerably smaller than the total investments recorded at fair value, which amount to $13,536 million for the pension plan and $466 million for the other postretirement plans.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively, it reports a total NAV-measured investment of $4,437 million ($4,432M + $5M), which is vastly different from the ground truth total of $14 million ($9M + $5M). The fair value totals are also wrong: LLM reports $13,536M and $466M, while the correct values are $441M and $461M, summing to $902M. These numbers are off by orders of magnitude. (2) The calculation of the percentage of NAV to fair value is missing, and the stated comparison is inaccurate. The correct ratio is $14M / $902M = 3.1%, but the LLM does not compute or mention this. (3) The multi-hop reasoning fails: the model incorrectly identifies the asset categories as 'pension plan' and 'other postretirement benefit plans', which are not the disclosed categories in the context of this question. There is no evidence of correct synthesis across the required data points. (4) The entities (VZ, 2023 10-K) and metric (investments at NAV vs fair value) are relevant, but the execution is fundamentally flawed. The answer fabricates large-scale figures likely from unrelated sections of the filing. Due to massive numerical inaccuracies and failure to correctly synthesize the required information, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 350,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much in equity earnings did GM report from Ultium Cells Holdings LLC in 2023, and in what financial statement category were these earnings disclosed?",
      "original_answer": "General Motors reported $293 million in equity earnings from Ultium Cells Holdings LLC in the year ended December 31, 2023, and these earnings were disclosed under 'Automotive and other cost of sales' in the financial statements.",
      "llm_answer": "In 2023, GM reported $293 million of equity earnings from its investment in Ultium Cells Holdings LLC. These earnings were disclosed in the “Equity income (loss)” line of the segment‑reporting table under the “Total Equity income (loss)” row, which is part of the consolidated financial statements.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the equity earnings amount of $293 million from Ultium Cells Holdings LLC in 2023, matching the ground truth. This satisfies the quantitative accuracy requirement. However, the financial statement category is incorrect. The ground truth states that these earnings were disclosed under 'Automotive and other cost of sales', whereas the LLM claims they were reported under 'Equity income (loss)' in the segment-reporting table. These are distinct line items with different meanings—'Equity income (loss)' typically reflects equity-method investment earnings, but the specific disclosure location per the filing is 'Automotive and other cost of sales', which suggests a presentation choice where equity earnings are netted or reclassified into cost of sales. (2) The number $293 million is accurate and correctly attributed to GM, Ultium Cells Holdings LLC, and the year 2023. No calculation errors are present. (3) The multi-hop reasoning is partially sound—the model correctly links GM to its equity earnings from Ultium Cells LLC—but fails in the second hop by misidentifying the financial statement category. This indicates a failure to accurately extract or interpret the specific disclosure location from the source document. (4) The correctness score is 6 due to the accurate dollar amount but significant error in the disclosure category. Quantitative accuracy is 10 because all numbers are correct. Qualitative accuracy is 5 due to the critical misrepresentation of the financial statement line item. Contextual relevance is 8 because the answer addresses the core question and provides relevant context, albeit with a key factual error in classification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 465,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the change in equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) from 2023 to 2024, and how does this shift reflect in the overall ownership structure of MA?",
      "original_answer": "The equity ownership of Principal or Affiliate Customers (Class B stockholders) decreased from 0.8% in 2023 to 0.7% in 2024, a reduction of 0.1 percentage points. This shift indicates a minor decline in the relative ownership stake of this group within MA's overall ownership structure.",
      "llm_answer": "The equity ownership percentage of Principal or Affiliate Customers (Class B stockholders) fell from **0.8 % in 2023 to 0.7 % in 2024**. This modest decline reflects a slight reduction in their share of total equity, while the overall ownership structure remains dominated by public investors (≈ 89.9 % equity ownership) and the Mastercard Foundation (≈ 9.3 % equity ownership).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the change in equity ownership of Principal or Affiliate Customers (Class B stockholders) from 0.8% in 2023 to 0.7% in 2024, matching the ground truth exactly. The reduction of 0.1 percentage points is implied and accurate. (2) All numeric values—0.8%, 0.7%, and the implied 0.1 percentage point decrease—are factually correct. The additional context about public investors (~89.9%) and the Mastercard Foundation (~9.3%) is consistent with known ownership structures of MA and does not contradict the ground truth; it enhances the answer without introducing errors. (3) The multi-hop reasoning is sound: the model correctly tracks the change over time (2023 to 2024) for the specified shareholder class and contextualizes it within the broader ownership structure. While the original answer does not include the public and Foundation percentages, their inclusion in the LLM response is accurate and adds relevant context. (4) The answer is semantically equivalent and slightly more informative. The only reason for not scoring a 10 is that the original answer emphasizes the 'minor decline' in relative stake, which the LLM captures as a 'modest decline'—this is equivalent, but the LLM could have more directly mirrored the 'relative ownership stake' phrasing to fully reflect the structural implication. However, this is a minor wording difference, not a factual one.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 392,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total financial impact on Walmart (WMT) in terms of cash outflows related to Alert Innovation during fiscal 2023, and what happened to this entity in the following fiscal year?",
      "original_answer": "Walmart spent $0.4 billion to acquire Alert Innovation in fiscal 2023, and then subsequently sold and deconsolidated the entity in fiscal 2025.",
      "llm_answer": "The total cash outflows related to Alert Innovation during fiscal 2023 were recorded as part of the company’s investing activities, amounting to approximately $0.4 billion for the acquisition of the business. In the following fiscal year (fiscal 2024), this entity was subsequently sold and de‑consolidated, effectively ending its involvement with Walmart.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.4 billion cash outflow for Walmart's acquisition of Alert Innovation in fiscal 2023, which matches the ground truth. However, it incorrectly states that the sale and deconsolidation occurred in fiscal 2024, while the original answer specifies fiscal 2025. This is a factual error in timing, affecting the qualitative accuracy. (2) Quantitatively, the $0.4 billion figure is accurate and properly contextualized as an acquisition-related cash outflow under investing activities. No calculation errors are present. (3) The multi-hop reasoning is mostly sound—linking the acquisition in fiscal 2023 to the subsequent divestiture—but fails on the correct sequencing of fiscal years for the sale. The entity identification (Alert Innovation, Walmart) and financial event types (acquisition, deconsolidation) are correct. (4) The answer is highly relevant and complete in structure, addressing both parts of the question, but the fiscal year error prevents a perfect score. The core financial fact is correct, and only the follow-up event timing is off by one year.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 316,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How much total principal was repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024, and what was the impact on the facility's remaining borrowing capacity as of December 31, 2023?",
      "original_answer": "The company repaid a total principal of $1.5 billion using borrowings from the 2021 Multicurrency Credit Facility in early 2024 ($500 million from the 0.600% Notes and $1.0 billion from the 5.00% Notes). As of December 31, 2023, the company still had the ability to borrow up to $6.0 billion under the facility, which includes a $3.5 billion sublimit for multicurrency borrowings, a $200.0 million sublimit for letters of credit, and a $50.0 million sublimit for swingline loans.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, the total principal repaid using borrowings from the 2021 Multicurrency Credit Facility in early 2024 was $1.5 billion (specifically $1.0 billion for the 5.00% Notes repayment on February 14, 2024, and $500 million for the 0.600% Notes repayment on January 12, 2024, both explicitly stated to be repaid using the facility). As of December 31, 2023, the facility had $6.0 billion of borrowing capacity remaining (with $3.0 billion borrowed and $2.9 billion repaid during 2023, leaving $3.1 billion outstanding as per the facility's $6.0 billion total capacity minus $2.9 billion repaid in 2023).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total principal repaid ($1.5 billion), broken down into $1.0 billion for the 5.00% Notes and $500 million for the 0.600% Notes, which matches the ground truth. The dates of repayment (January 12 and February 14, 2024) are plausible and consistent with 'early 2024' but were not specified in the original answer, so their inclusion is an over-precision that cannot be verified from the ground truth. However, the core numeric values are accurate. (2) The remaining borrowing capacity is stated as $6.0 billion, which matches the ground truth. However, the LLM incorrectly explains this figure by referencing $3.0 billion borrowed and $2.9 billion repaid during 2023, resulting in $3.1 billion outstanding, which is not supported by the original answer and introduces fabricated calculation details. The ground truth does not mention these intermediate figures or a running tally of 2023 borrowings/repayments. This undermines the quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound—correctly linking the 2021 facility to the repayment of two notes and identifying the remaining capacity. However, the invented calculation path to arrive at $6.0 billion remaining capacity shows flawed reasoning and lack of fidelity to the source. (4) Despite the incorrect justification for the $6.0 billion figure, the final number is correct, and the total repayment amount is accurate with proper breakdown. Therefore, the answer is factually correct on key outcomes but flawed in reasoning and intermediate details, warranting a score of 7. Contextual relevance is perfect as all parts of the question are addressed directly and clearly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 465,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Intel's use of EUV in its Intel 4 and Intel 3 process nodes relate to its broader roadmap for advanced transistor architectures, and what future node is expected to introduce High Numerical Aperture EUV as part of this progression?",
      "original_answer": "Intel uses EUV in its Intel 4 process node to print small features using ultra-short wavelength light, which is critical for improving performance-per-watt and enabling future client processors like Meteor Lake. Intel 3 builds on this by leveraging further FinFET optimizations and increased EUV usage to deliver additional area and efficiency improvements. This progression sets the stage for Intel 20A, which will introduce RibbonFET (Intel's implementation of gate-all-around transistor architecture) and PowerVia (backside power delivery). Beyond Intel 20A, Intel is developing Intel 18A, which will refine RibbonFET performance and incorporate next-generation High Numerical Aperture EUV in its process technology roadmap.",
      "llm_answer": "Intel's use of EUV in Intel 4 and Intel 3 nodes is a key part of its advanced transistor architecture roadmap, enabling smaller, more efficient transistors before transitioning to RibbonFET and PowerVia in Intel 20A. The next node expected to introduce High Numerical Aperture (High NA) EUV is Intel 18A, which will build on the EUV foundation established by Intel 4 and Intel 3 to further advance transistor performance and manufacturing capabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All key facts are correct: EUV is used in Intel 4 and Intel 3 to enable smaller, more efficient transistors; this progression leads to Intel 20A with RibbonFET and PowerVia; and Intel 18A is correctly identified as the node that will introduce High Numerical Aperture (High NA) EUV. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the process node names (Intel 4, Intel 3, Intel 20A, Intel 18A) are treated as critical identifiers and are all correct, satisfying the requirement for factual precision. (3) The multi-hop reasoning is sound: the answer correctly links EUV usage in current nodes (Intel 4/3) to future transistor architectures (RibbonFET, PowerVia) and identifies the next technological leap (High NA EUV) at Intel 18A. (4) The only minor shortcoming is that the LLM omits specific details about FinFET optimizations in Intel 3 and the role of PowerVia in Intel 20A beyond naming it, which slightly reduces completeness compared to the original answer. However, the semantic meaning and technical trajectory are preserved. The answer is fully contextually relevant and directly addresses both parts of the question: the role of EUV in Intel 4/3 and the future introduction of High NA EUV.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 388,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories in the 2023 10-K filing by VZ, and how does this compare to the total cash and cash equivalents?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million). This amount is significantly higher than the total cash and cash equivalents, which sum to $57 million ($30 million + $27 million).",
      "llm_answer": "The total combined value of investments in U.S. Treasuries and agencies reported across both disclosed asset categories (pension and other postretirement benefit plans) in VZ's 2023 10-K is $138 million for the pension plans and $138 million for the other postretirement benefit plans, yielding a combined total of $276 million. This combined amount is modest relative to the overall cash and cash equivalents reported, which total $27 million in the other postretirement benefit plans and $1,956 million in the pension plans, for a total cash and cash equivalents of $1,983 million. Thus, the combined U.S. Treasuries and agencies holdings represent roughly 14 % of the total cash and cash equivalents.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The ground truth states that the total combined value of investments in U.S. Treasuries and agencies is $239 million ($101 million + $138 million), but the LLM incorrectly reports $138 million for both pension and other postretirement benefit plans, summing to $276 million. This misstates both individual components and the total. Furthermore, the LLM claims total cash and cash equivalents are $1,983 million ($1,956 million in pension plans + $27 million), whereas the ground truth reports only $57 million ($30 million + $27 million). The comparison direction is also reversed: the LLM says Treasuries holdings are 14% of cash, but in reality, Treasuries ($239M) are over four times larger than cash ($57M), making the LLM's entire quantitative narrative false. (2) All key numbers are incorrect: $138M (vs $101M and $138M), $276M total (vs $239M), $1,983M cash (vs $57M). Calculations are internally consistent but based on wrong inputs. (3) The multi-hop reasoning fails: the model does not correctly extract or synthesize values from the two disclosed asset categories (pension and other postretirement) for both investments and cash. It invents a $1,956 million figure with no basis in the ground truth. (4) Scores are low due to pervasive factual inaccuracies in numbers, miscalculations relative to ground truth, incorrect entity values, and flawed logic. Contextual relevance is slightly above zero because the model attempts the right categories (pension and postretirement), but content is largely fabricated.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 436,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total net cash consideration paid by DHR for Aldevron and the other 11 businesses acquired in 2021, and how much of the total goodwill from these acquisitions was attributed specifically to Aldevron?",
      "original_answer": "DHR paid a total net cash consideration of $9,561 million for Aldevron and $1,340 million for the other 11 businesses acquired in 2021, totaling $10,901 million. Of the total goodwill of $7,187 million recorded for these acquisitions, $6,149 million was attributed specifically to Aldevron.",
      "llm_answer": "The total net cash consideration paid by Danaher for Aldevron and the other 11 businesses acquired in 2021 was $9.561 billion, and the goodwill attributed specifically to Aldevron was $6.149 billion.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer contains a significant quantitative error in the total net cash consideration. The ground truth states that DHR paid $9,561 million for Aldevron and $1,340 million for the other 11 businesses, totaling $10,901 million. However, the LLM reports the total net cash consideration as $9.561 billion, which incorrectly conflates the amount paid for Aldevron alone with the total for all 12 acquisitions. This is a critical omission and miscalculation, as the total should be approximately $10.9 billion, not $9.561 billion. The goodwill attributed to Aldevron ($6.149 billion) is correctly reported. While the model identifies the correct entities (DHR, Aldevron, 2021 acquisitions) and the right financial metrics (net cash consideration, goodwill), it fails to properly synthesize the multi-hop information by summing the two components of cash consideration. The reasoning is partially sound but flawed in aggregation. The answer is semantically relevant and addresses the core question, but the major numerical inaccuracy in the total cash consideration reduces its correctness significantly. Format variations (billion vs million) are acceptable and handled correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 332,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was GM's total committed capital contribution to Ultium Cells Holdings LLC as of December 31, 2023, and how does this compare to the carrying amount of GM's investment in Ultium Cells Holdings LLC on its balance sheet for the same date?",
      "original_answer": "GM had a committed capital contribution of $0.8 billion to Ultium Cells Holdings LLC as of December 31, 2023, while the carrying amount of its investment in Ultium Cells Holdings LLC was $2,268 million on the same date. This indicates that GM had not fully funded its committed capital contribution as of year-end.",
      "llm_answer": "As of December 31 2023, GM’s total committed capital contribution to Ultium Cells Holdings LLC was **$0.8 billion** (the amount disclosed in Note 11 for committed capital contributions). This commitment is reflected on GM’s balance sheet as an **investment carrying amount of $2.268 billion** in Ultium Cells Holdings LLC, which represents the equity‑method carrying value of the investment at that date. Consequently, the committed capital contribution is substantially lower than the carrying amount of the investment reported on GM’s balance sheet.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Quantitatively, the LLM answer is fully accurate: it correctly reports GM's committed capital contribution as $0.8 billion and the carrying amount as $2.268 billion (equivalent to $2,268 million in the ground truth). The dates (December 31, 2023) and entities (GM, Ultium Cells Holdings LLC) are correct. However, the reasoning and qualitative interpretation are flawed. The LLM states that the 'committed capital contribution is substantially lower than the carrying amount,' which misrepresents the relationship. In reality, the carrying amount under the equity method reflects cumulative contributions, earnings, and adjustments over time and is expected to exceed the remaining committed amount. The ground truth correctly notes that GM had not fully funded its commitment, implying the carrying amount should be less than or equal to total commitment if only contributions were considered—but under equity method accounting, it can exceed due to earnings. The LLM fails to explain this nuance and incorrectly frames the comparison, suggesting a contradiction where there may be none. Thus, while all numbers are correct and contextually relevant, the reasoning is partially unsound, leading to a misleading conclusion. This justifies a 7 in correctness and qualitative accuracy despite perfect quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 366,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What is the total amount of depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023, and how does it compare to the net book value of proved and unproved properties in that region as of December 31, 2023?",
      "original_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 was $5,729 million. The net book value of proved and unproved properties in the Lower 48 region as of December 31, 2023, was $37,185 million. This means that the accumulated depreciation, depletion, and amortization for the Lower 48 region, which was $36,829 million, when added to the 2023 depreciation, depletion, amortization, and impairments of $5,729 million, results in a total accumulated value of $42,558 million. This represents a significant portion of the original total property value of $74,014 million for the Lower 48 region.",
      "llm_answer": "The total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 were **$5,729 million**. This amount represents roughly **13.5 %** of the Lower 48’s net book value of proved and unproved properties, which totaled **$42,415 million** as of December 31, 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total depreciation, depletion, amortization, and impairments for the Lower 48 region in 2023 as $5,729 million, which matches the ground truth. However, it reports the net book value of proved and unproved properties as $42,415 million, which is incorrect — the correct value from the ground truth is $37,185 million. This error affects the subsequent comparison and percentage calculation. (2) The claimed percentage of 13.5% is based on the incorrect net book value. Using the correct values: $5,729 million / $37,185 million ≈ 15.4%, not 13.5%. Additionally, the LLM omits key multi-hop elements from the original answer, such as the accumulated DDA of $36,829 million, the resulting total accumulated value of $42,558 million, and the original total property value of $74,014 million — all of which are essential for full context. (3) While the model attempts reasoning by providing a percentage comparison, it fails to synthesize the full chain of information across time (accumulated vs. current year) and value layers (net book vs. original cost), which is required for accurate multi-hop understanding. (4) The contextual relevance is high because the answer addresses the core question parts and uses appropriate financial concepts. Qualitative accuracy is moderate due to correct identification of the 2023 DDA figure and logical intent, but with significant gaps in synthesis. Quantitative accuracy is low due to the incorrect net book value and derived percentage. Correctness score is 5 due to partial factual correctness but major omissions and numerical inaccuracies in critical comparisons.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 452,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total amount repaid under the 2021 Multicurrency Credit Facility in 2023, including both USD and EUR-denominated repayments, and how did this repayment activity affect the company's overall revolving indebtedness under this facility?",
      "original_answer": "The total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $919.1 million from the repayment of 842.6 million EUR. This significant repayment activity reduced the company's revolving indebtedness under the facility, contributing to a net decrease despite borrowing $3.0 billion during the year for purposes such as repaying the 2021 USD Two Year Delayed-Draw Term Loan and for general corporate purposes.",
      "llm_answer": "Based on the provided document pages, the total amount repaid under the 2021 Multicurrency Credit Facility in 2023 was $6.1 billion, which included $842.6 million EUR ($919.1 million at the repayment date). This repayment activity reduced the outstanding revolving indebtedness under the facility, as evidenced by the subsequent disclosure of the facility's outstanding principal balance of $723.4 million as of December 31, 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total repayment amount of $6.1 billion and accurately breaks down the EUR-denominated repayment as 842.6 million EUR, converted to $919.1 million at the repayment date, matching the ground truth. All numeric values are factually correct and properly formatted. (2) Quantitative accuracy is perfect: $6.1 billion total repayment, 842.6 million EUR, and $919.1 million USD equivalent are all consistent with the original answer. There are no calculation errors. (3) The reasoning is sound and demonstrates correct multi-hop synthesis: the model links the repayment activity to the reduction in revolving indebtedness and supports this with a specific post-repayment balance ($723.4 million as of December 31, 2023), which strengthens the conclusion even if that specific balance wasn't in the ground truth. However, the original answer adds context about $3.0 billion in new borrowings during the year and their purpose (e.g., repaying the 2021 USD Two Year Delayed-Draw Term Loan), which the LLM omits. This makes the answer slightly less complete in explaining the net effect on revolving indebtedness despite correct directional logic. (4) The answer is highly relevant, directly addressing both parts of the question—total repayment amount and its effect on revolving indebtedness. The omission of the borrowing activity prevents a perfect score, but the core facts and synthesis are accurate and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 406,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014, as referenced in both the glossary and the business section, impact its operational costs and closure activities at coal ash impoundments?",
      "original_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 directly impacts its operational costs and closure activities at coal ash impoundments. According to the business section, Duke Energy has completed excavation of coal ash at three of the four high-priority North Carolina sites and has begun closure activities at all of its jurisdictions. These activities involve moving coal combustion residuals (CCR) to engineered landfills or for reuse, which requires significant planning, permitting, and execution. The costs associated with these closure activities are included in rate proceedings and partially recovered through amended wholesale contracts approved by FERC in 2017. Additionally, the glossary explicitly defines the Coal Ash Act, indicating its regulatory significance and the necessity for Duke Energy to factor compliance into its financial planning and operational timelines.",
      "llm_answer": "Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014 requires the company to develop and obtain regulatory approval for coal ash impoundment closure plans, which are integrated into its rate-making processes. This compliance has led to significant operational costs, including excavation, transportation, and disposal of coal ash at high-priority sites, as well as long-term financial commitments for closure activities. These costs are recovered through retail and wholesale rate adjustments approved by state utility commissions, ensuring that compliance expenses are passed on to customers while supporting the company's closure activities at coal ash impoundments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of Duke Energy's compliance with the North Carolina Coal Ash Management Act of 2014. (1) It correctly identifies that compliance involves closure plans requiring regulatory approval, excavation, transportation, and disposal—all of which are significant operational costs. It also accurately states that these costs are recovered through rate adjustments, specifically mentioning retail and wholesale mechanisms approved by regulators, which aligns with the original answer's reference to FERC-approved amended wholesale contracts in 2017. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2014 Act) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information from both the business section (closure activities at high-priority sites) and the glossary (regulatory significance), and correctly infers the financial impact and cost recovery mechanism. (4) The only minor omission is that the original answer specifies Duke Energy has completed excavation at three of four high-priority sites and is moving CCR to engineered landfills or for reuse—details absent in the LLM response. While not critical to the overall correctness, their inclusion would have made the answer more complete. Otherwise, the semantic meaning and factual content are equivalent, and the response is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 411,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does Intel's FPGA technology, specifically the Agilex family, contribute to its IPU platforms and what role does the Intel eASIC N5X play in this context?",
      "original_answer": "Intel's Agilex FPGA family, built on Intel 10nm SuperFin technology, plays a critical role in its IPU platforms by enabling cloud and communications service providers to reduce overhead and free up CPU performance. The Agilex FPGA is already being deployed in IPU platforms at multiple cloud service providers. Additionally, the Intel eASIC N5X, as the next-generation Intel eASIC device, complements this ecosystem by offering a structured ASIC solution that provides lower unit cost and lower power compared to FPGAs, while still enabling fast time-to-market and reduced non-recurring engineering costs. This combination allows Intel to offer scalable, high-performance, and power-efficient solutions tailored for evolving infrastructure demands in cloud and communications.",
      "llm_answer": "Intel's Agilex FPGA family provides the programmable fabric and transceiver performance needed to build IPU platforms that offload infrastructure workloads from CPUs, enabling cloud and communications providers to increase efficiency and performance. The Intel eASIC N5X complements this by offering a structured ASIC solution for low-latency 5G network acceleration and cloud/storage applications, further enhancing the IPU platform's capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the role of Intel's Agilex FPGA family in IPU platforms—offloading infrastructure workloads from CPUs to improve efficiency and performance for cloud and communications providers. It also accurately describes the complementary role of the Intel eASIC N5X as a structured ASIC solution. However, it omits key details from the ground truth, such as the use of Intel 10nm SuperFin technology in Agilex FPGAs, deployment status at multiple cloud service providers, and specific advantages of eASIC N5X in terms of lower unit cost, lower power, fast time-to-market, and reduced non-recurring engineering costs. These omissions reduce completeness but do not introduce factual errors. (2) There are no numeric values, dates, or financial figures in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes the relationship between Agilex FPGAs and IPUs, and the complementary nature of eASIC N5X within the same ecosystem. The logic aligns with the ground truth, though with less depth. (4) The answer is contextually fully relevant and semantically aligned with the question, conveying the core technological contributions accurately, albeit with less detail on cost, power, and scalability aspects. Hence, correctness and qualitative accuracy are high but not perfect due to missing nuances.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 402,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How many employees does Danaher have in Other Developed Markets compared to North America, and what percentage of the total global workforce do these regions collectively represent?",
      "original_answer": "Danaher has 3,000 employees in Other Developed Markets and 24,000 employees in North America, collectively representing approximately 42.86% of the company's total global workforce of 63,000 employees.",
      "llm_answer": "Danaher had approximately 2,000 employees in other developed markets and about 24,000 employees in North America, together representing roughly 10 percent of its total global workforce.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It states Danaher has 2,000 employees in Other Developed Markets, but the ground truth is 3,000—a material discrepancy. The North America employee count (24,000) is correct. The percentage stated (10%) is wildly inaccurate; the correct collective percentage is approximately 42.86%, based on 27,000 employees (3,000 + 24,000) out of a total global workforce of 63,000. (2) Quantitative accuracy is low: two of the three key numbers are wrong (employees in Other Developed Markets and the final percentage). The calculation of the percentage is incorrect—27,000 / 63,000 = 42.86%, not 10%. The LLM likely miscalculated or pulled incorrect total workforce data. (3) The reasoning is partially sound in that it attempts to combine employee counts from two regions and express them as a percentage of the total workforce, but the underlying data synthesis is flawed. It fails the multi-hop requirement because it does not correctly retrieve or compute the employee count for Other Developed Markets or the total workforce. (4) Contextual relevance is high because the answer addresses the right regions, company, and workforce metric, and attempts the correct comparative and percentage calculation. However, due to major numerical inaccuracies, the correctness and quantitative scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1105,
        "completion_tokens": 378,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, and how does this compare to the total derivative assets reported on the balance sheet for the same year?",
      "original_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31, 2023, is $557 million. This matches the total derivative assets reported on the balance sheet for the same year, indicating that all derivative assets were composed of foreign exchange forwards and options.",
      "llm_answer": "The total fair value of Nike's foreign exchange forwards and options as of May 31 2023 was $557 million (shown as “DERIVATIVEASSETS” for foreign exchange forwards and options). This amount is larger than the total derivative assets reported on the balance sheet for the same date, which were $343 million (the combined fair‑value of all derivative assets, including foreign exchange forwards, options, and interest‑rate swaps). Thus, the foreign‑exchange‑only fair value ($557 million) exceeds the overall derivative‑asset figure reported on the balance sheet ($343 million).",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. While it correctly states the total fair value of Nike's foreign exchange forwards and options as $557 million, it incorrectly claims that the total derivative assets on the balance sheet were $343 million. The ground truth states that the total derivative assets were also $557 million, meaning they are equal, not different. The LLM falsely asserts that the foreign exchange component ($557M) exceeds the total derivative assets ($343M), which is logically and factually incorrect. (2) The numbers are partially correct—$557 million is accurate, but $343 million is not supported by the ground truth and appears to be fabricated or misattributed. The comparison (larger than) is therefore invalid. (3) The multi-hop reasoning fails: the model should have recognized that the fair value of foreign exchange forwards and options equals the total derivative assets, implying these instruments constitute 100% of the derivative assets. Instead, it introduces unrelated instruments like interest-rate swaps not mentioned in the original answer and creates a contradiction. (4) The correctness score is very low due to the critical error in both quantitative data and logical comparison. Quantitative accuracy is low because of the incorrect $343M figure. Qualitative accuracy is poor due to flawed reasoning and synthesis. Contextual relevance is moderate because the answer addresses the right topic and timeframe but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 413,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much did the depreciation, depletion, amortization, and impairments expense in the Lower 48 region increase from 2021 to 2023, and what was the corresponding change in the number of productive wells in that region over the same period?",
      "original_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region increased by $1,662 million from 2021 ($4,067 million) to 2023 ($5,729 million). Over the same period, the number of productive wells in the Lower 48 region decreased by 49, from 87 in 2021 to 38 in 2023.",
      "llm_answer": "The depreciation, depletion, amortization, and impairments expense in the Lower 48 region rose from $5,729 million in 2022 to $5,729 million in 2023 (i.e., it remained unchanged), while the number of productive wells in that region increased from 7,864 net wells in 2022 to 7,864 net wells in 2023 (no net change).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively, it states that the depreciation, depletion, amortization, and impairments (DD&A) expense was $5,729 million in both 2022 and 2023, claiming no change, but the question asks for the change from 2021 to 2023. The ground truth shows the expense increased from $4,067 million in 2021 to $5,729 million in 2023—an increase of $1,662 million. The LLM incorrectly references 2022 instead of 2021 and fails to compute the correct multi-year change. (2) Regarding productive wells, the LLM claims 7,864 net wells in both 2022 and 2023 with no change, which contradicts the ground truth: the number of productive wells in the Lower 48 region decreased from 87 in 2021 to 38 in 2023—a drop of 49 wells. The LLM cites incorrect values, wrong years, and wrong trends. (3) The multi-hop reasoning is completely flawed: the model fails to extract and compare data across the correct years (2021 vs 2023) and uses incorrect figures for both financial and operational metrics. (4) Contextual relevance is low because the answer discusses 2022–2023 instead of 2021–2023 and introduces net well counts (7,864) that do not match the ground truth (87 to 38). The answer does not align with the original data in any meaningful way. Minor relevance credit is given for addressing the general topic (DD&A and well count in Lower 48).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 379,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total combined value of investments in U.S. Treasuries and agencies reported across both tables from Verizon's 2023 10-K filing, and how does this allocation compare between the two different categorizations of investments at fair value?",
      "original_answer": "The total combined value of investments in U.S. Treasuries and agencies from both tables is $2,953 million. In the first table, U.S. Treasuries and agencies are valued at $1,412 million and are categorized under fixed income securities with $1,274 million in Level 1 and $138 million in Level 2. In the second table, U.S. Treasuries and agencies are valued at $1,541 million, with $1,312 million in Level 1 and $229 million in Level 2. This indicates a slight increase in the value of U.S. Treasuries and agencies between the two categorizations, with a corresponding shift in the distribution between Level 1 and Level 2 assets.",
      "llm_answer": "The total combined value of investments in U.S. Treasuries and agencies reported across both tables in Verizon's 2023 10-K filing is $1,412 million for 2023 and $1,541 million for 2022. This allocation represents a larger share of the fair‑value hierarchy (Level 1) in 2023 (1,274 million) compared with 2022 (1,312 million), indicating a slightly higher proportion of the total portfolio allocated to U.S. Treasuries and agencies when measured against the overall fair‑value breakdown.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The original answer states that the total combined value across both tables is $2,953 million ($1,412M + $1,541M), but the LLM incorrectly interprets the two values as being from different years (2023 and 2022), which is not supported by the context—both tables are from the same 2023 10-K filing and represent different categorizations (e.g., by type and by fair value hierarchy), not year-over-year data. This misinterpretation fundamentally undermines the correctness. (2) While the individual numbers mentioned—$1,412M, $1,541M, $1,274M, $1,312M—are numerically accurate and match the ground truth, their interpretation is wrong. The LLM incorrectly assigns $1,412M to 2023 and $1,541M to 2022, when in fact both values are from 2023 and refer to different classification schemes in the same filing. Additionally, the claim that Level 1 was higher in 2023 (1,274M) than 2022 (1,312M) reverses the actual comparison and misrepresents the trend. In reality, Level 1 increased from $1,274M to $1,312M, indicating improved valuation transparency, but the LLM draws an opposite and incorrect conclusion. (3) The multi-hop reasoning fails because the model does not recognize that the two tables are complementary views within the same year rather than a time series. It fails to synthesize the correct relationship between the categorizations (fixed income securities vs. fair value hierarchy levels) and instead imposes a temporal comparison that does not exist. (4) Despite the use of correct numbers, the misinterpretation of time periods and direction of comparison leads to a mostly incorrect answer. The contextual relevance is moderate because it discusses the right topic and uses real data from the document, but the core reasoning and conclusions are flawed, warranting low scores in correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 516,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "By how much did Nike's timed deposits classified as cash and equivalents decrease from fiscal year 2023 to 2024?",
      "original_answer": "Nike's timed deposits classified as cash and equivalents decreased by $155 million from fiscal year 2023 to 2024.",
      "llm_answer": "Based on the provided document pages, Nike's timed deposits classified as cash and equivalents decreased by $137 million from fiscal year 2023 to 2024. This is calculated by subtracting the 2024 amount of $347 million (from page 73, \"Timedeposits\" under \"CASH AND CASH EQUIVALENTS\") from the 2023 amount of $484 million (from page 73, \"Timedeposits\" under \"CASH AND CASH EQUIVALENTS\" for 2023). The decrease is $484 million - $347 million = $137 million.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final result. The ground truth states that Nike's timed deposits decreased by $155 million, but the LLM calculates a decrease of $137 million. This discrepancy indicates a clear factual error, despite the model attempting the correct type of calculation. (2) The quantitative accuracy is low because the numbers used in the calculation ($484 million in 2023 and $347 million in 2024) do not align with the ground truth data. The correct values should result in a $155 million decrease, meaning either the input figures or the source data referenced by the LLM are wrong. The arithmetic itself ($484M - $347M = $137M) is correct, but based on incorrect inputs. (3) The reasoning process is sound—multi-hop synthesis is attempted by identifying values from two different years and computing the difference—but it fails due to reliance on inaccurate data. The model correctly identifies the metric (timed deposits classified as cash and equivalents), the years (2023 to 2024), and the necessary operation (subtraction). (4) Contextual relevance is high because the answer addresses the exact question, cites document pages, and uses appropriate financial terminology. However, the core factual inaccuracy in the numbers severely undermines the correctness score, which is primarily based on factual alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 385,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How much did the combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations total in 2023, and how does this compare to the combined total from 2022?",
      "original_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations totaled $6,790 million in 2023, compared to $5,795 million in 2022. This represents an increase of $995 million.",
      "llm_answer": "The combined depreciation, depletion, amortization, and impairments for Alaska and Lower 48 operations were $6,790 million in 2023 and $5,795 million in 2022. This represents an increase of $1,0 billion (approximately $1,0 million) from 2022 to 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 and 2022 values ($6,790 million and $5,795 million) and conveys the correct direction and approximate magnitude of the increase. However, the calculated difference is inaccurately stated as '$1,0 billion (approximately $1,0 million)', which is internally inconsistent and incorrect. The exact increase is $6,790M - $5,795M = $995 million, which should be approximately $1.0 billion (not $1,0 million). The phrase 'approximately $1,0 million' is a significant error, likely a typo, as $1 million is far too low. Despite this, the core data is accurate, and the multi-hop synthesis (aggregating Alaska and Lower 48 operations across two years and comparing) is correctly performed. The entities, years, and metrics are all accurate. The answer is semantically mostly equivalent but penalized for the numerical inaccuracy in the difference. Contextual relevance is perfect—directly addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 276,
        "total_tokens": 1403
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total fair value of the crypto asset safeguarding liability and corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022, and how is this reflected in the fair value measurement disclosures?",
      "original_answer": "PayPal Holdings, Inc. reported a total fair value of $604 million for both the crypto asset safeguarding liability and the corresponding safeguarding asset as of December 31, 2022. This is disclosed in both the financial assets and liabilities table and the related notes to consolidated financial statements, where the crypto asset safeguarding liability is listed under financial liabilities and the safeguarding asset is listed under financial assets, with both categorized under 'Significant Other Observable Inputs (Level 2)' for fair value measurement.",
      "llm_answer": "The total fair value of the crypto asset safeguarding liability and the corresponding safeguarding asset reported by PayPal Holdings, Inc. as of December 31, 2022 is $1,241 million for each, as shown in the fair‑value tables (Note 9) where the crypto asset safeguarding asset is recorded at $1,241 million and the crypto asset safeguarding liability is also $1,241 million. This fair‑value measurement is disclosed in the “Fair Value Measurement of Assets and Liabilities” note, which categorizes the asset and liability as Level 2 (quoted prices for similar assets in active markets) and provides the detailed reconciliation of the amounts.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numeric values. The ground truth states that PayPal reported a total fair value of $604 million for both the crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2022. However, the LLM claims the amount is $1,241 million for each, which is more than double the correct value. This major discrepancy invalidates the quantitative accuracy. (2) The numbers are not just incorrect but appear to be sourced from a different context or company—$1,241 million does not match any known disclosed value from PayPal’s 2022 10-K related to crypto safeguarding. There is no indication in the original filings that these assets/liabilities were each valued at $1.241 billion. Additionally, the total fair value should be $604 million for each (asset and liability), not $1,241 million. (3) The qualitative reasoning is partially sound in structure—the LLM correctly identifies that both an asset and a liability are recorded at fair value and that they should be disclosed in Note 9 under Level 2 inputs. However, it fails the multi-hop synthesis by pulling incorrect data, possibly confusing PayPal with another firm or misreading the filing. (4) Contextual relevance is moderate because the answer addresses the right sections (fair value tables, Note 9, Level 2 classification) and the right concepts (safeguarding asset/liability symmetry), but the severe factual error in the dollar amount renders the response misleading and incorrect overall. The answer would score higher if the numbers were accurate, even with different wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 446,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net financial impact on Walmart from its ownership changes in PhonePe during fiscal 2024, considering both the cash outflow to increase ownership and the cash inflow from new equity funding?",
      "original_answer": "Walmart paid $0.9 billion to former noncontrolling interest holders of PhonePe to increase its ownership during fiscal 2024, while also receiving $0.7 billion from new equity funding rounds in PhonePe, which resulted in a net cash outflow of $0.2 billion.",
      "llm_answer": "Based on the provided financial disclosures, Walmart's net financial impact from its PhonePe ownership changes during fiscal 2024 was a $0.7 billion cash inflow from new equity funding in PhonePe, partially offset by a $3.5 billion cash outflow to acquire additional shares from Flipkart non‑controlling interest holders and settle related liabilities. This resulted in an overall net cash outflow of approximately $2.8 billion for the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Walmart paid $0.9 billion to increase its ownership in PhonePe and received $0.7 billion from new equity funding, resulting in a net cash outflow of $0.2 billion. However, the LLM claims a $3.5 billion cash outflow and a $2.8 billion net outflow, which are not supported by the original data. The $0.7 billion inflow is correctly mentioned but misrepresented as the net impact rather than one component. (2) Quantitative accuracy is severely compromised: the outflow amount is off by over 280% ($3.5B vs $0.9B), and the net outflow is $2.8B vs the correct $0.2B. The inflow of $0.7B is accurate, but this is overshadowed by the major error in outflow. (3) The reasoning is flawed in multi-hop synthesis: the model incorrectly attributes the outflow to 'acquiring shares from Flipkart non-controlling interest holders'—the original answer specifies the payment was to former noncontrolling interest holders of PhonePe, not Flipkart. This reflects a confusion between corporate entities and ownership layers. (4) Contextual relevance is moderate—the answer addresses the right topic (Walmart, PhonePe, ownership changes, cash flows) and attempts the correct calculation structure (inflow vs outflow), but the incorrect entities and numbers undermine the entire response. The core financial conclusion is therefore false.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 394,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the net change in total wholesale revenues (both affiliate and non-affiliate sales) for Southern Company in 2024 compared to 2023, and how did the IIC-approved affiliate sales mechanism influence this outcome?",
      "original_answer": "The net change in total wholesale revenues for Southern Company in 2024 compared to 2023 was an increase of $69 million. This is calculated by combining the $77 million increase in affiliate and non-affiliate wholesale revenues from one segment and the $79 million increase in affiliate sales offset by the $87 million decrease in non-affiliate sales from another segment. Specifically, affiliate sales increased by $79 million due to a 165.5% rise in the volume of KWH sales, which were conducted in accordance with the IIC-approved FERC pricing mechanism, ensuring energy was sold at marginal cost and stabilizing the financial impact of these internal transactions.",
      "llm_answer": "Southern Company's total wholesale revenues increased by $77 million (41 %) in 2024 versus 2023, driven by higher volumes and capacity from wholesale contracts, partially offset by lower average prices. The IIC‑approved affiliate sales mechanism enabled the company to sell additional electricity to affiliated entities, boosting wholesale revenues from affiliates by $79 million (131.7 %) and supporting the overall revenue growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual and calculation errors. The ground truth states the net change in total wholesale revenues was an increase of $69 million, derived from a combination of a $77 million increase in one segment and a net $-8 million change in another (due to $79M increase in affiliate sales offset by $87M decrease in non-affiliate sales). However, the LLM incorrectly reports the total increase as $77 million, omitting the offsetting $87 million decrease in non-affiliate sales and thus misrepresenting the net outcome. It also incorrectly attributes the $77 million to overall wholesale revenue growth without clarifying it's from one segment, leading to a misleading synthesis. (2) The LLM correctly identifies the $79 million increase in affiliate sales and links it to the IIC-approved mechanism, which aligns with the ground truth. However, the percentage increase in affiliate sales is reported as 131.7%, whereas the ground truth states a 165.5% rise in KWH volume (not revenue), making the LLM's percentage inaccurate or misapplied. Additionally, the $77 million figure is presented as total wholesale growth, but in the ground truth, it is only part of the calculation. (3) The multi-hop reasoning is partially sound—linking the IIC-approved mechanism to increased affiliate sales is correct—but fails to fully synthesize the complete picture across segments. The model does not account for the $87 million decrease in non-affiliate sales, which is critical for calculating the net $69 million change. This omission breaks the multi-hop logic required to arrive at the correct net figure. (4) The contextual relevance is high because the answer addresses both parts of the question—revenue change and the role of the IIC mechanism—but the factual inaccuracies in key numbers and incomplete synthesis reduce correctness. Quantitative accuracy is medium due to some correct figures but major errors in net change and percentages. Qualitative accuracy is moderate because reasoning is plausible but incomplete. Correctness score is 5 due to partial facts but significant omissions and calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 583,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What is the total amount Intel plans to invest in manufacturing expansion under the IDM 2.0 strategy, based on the investments announced for Arizona, Ohio, and the global packaging sites?",
      "original_answer": "Intel plans to invest a total of $50.5 billion in manufacturing expansion under the IDM 2.0 strategy. This includes $20 billion for two new fabs in Arizona, more than $20 billion for two leading-edge fabs in Ohio, and $10.5 billion to equip the Rio Rancho, New Mexico and Malaysia sites for advanced packaging manufacturing.",
      "llm_answer": "Based on the document, Intel plans to invest approximately **$20 billion** to build two new fabs in Arizona and **more than $20 billion** for two new leading-edge fabs in Ohio, totaling **over $40 billion** for these U.S. expansions. Additionally, it announced **approximately $10.5 billion** for advanced packaging manufacturing at Rio Rancho, New Mexico, and Malaysia sites. Combined, these investments under the IDM 2.0 strategy amount to **over $50 billion** across Arizona, Ohio, and the global packaging sites.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key investment figures: $20 billion for Arizona, more than $20 billion for Ohio, and $10.5 billion for advanced packaging in Rio Rancho and Malaysia. The total is stated as 'over $50 billion', which is semantically consistent with the ground truth of $50.5 billion, given that the Ohio investment is described as 'more than $20 billion'. The exact sum ($20B + >$20B + $10.5B) does exceed $50B, so 'over $50 billion' is a reasonable and accurate characterization. (2) All numeric values match the ground truth: $20B (Arizona), >$20B (Ohio), $10.5B (packaging). The total calculation is logically sound and correctly synthesized. Only minor imprecision is the use of 'over $50 billion' instead of the exact $50.5 billion, but this is justified due to the 'more than $20 billion' phrasing for Ohio. (3) Multi-hop reasoning is correctly applied: the model synthesizes investments across three geographic/strategic components (Arizona, Ohio, global packaging) and aggregates them into a total, which is required by the question. (4) Scores reflect high accuracy: full marks for contextual relevance as the answer directly addresses the question; minor deduction in quantitative accuracy due to rounding up instead of stating the precise total, though this is defensible given input uncertainty in the Ohio amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 379,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total goodwill did Danaher record from the acquisition of Abcam and what was the impact of the Veralto separation on Danaher's cash position prior to the distribution date?",
      "original_answer": "Danaher preliminarily recorded approximately $3.9 billion of goodwill related to the acquisition of Abcam. Additionally, Danaher received net cash distributions of approximately $2.6 billion from Veralto prior to the distribution date, which was partially used to redeem $1.0 billion of commercial paper.",
      "llm_answer": "Danaher recorded approximately $3.9 billion of goodwill related to its acquisition of Abcam. The Veralto separation generated about $2.6 billion in net cash distributions to Danaher prior to the distribution date, which the company used partly to redeem $1.0 billion of commercial paper and to fund bond maturities and dividend payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Danaher recorded approximately $3.9 billion of goodwill from the Abcam acquisition, matching the ground truth. It also accurately reports $2.6 billion in net cash distributions from Veralto prior to the distribution date and correctly notes that $1.0 billion was used to redeem commercial paper. These quantitative figures are all correct and match the original answer. (2) All numeric values—$3.9 billion, $2.6 billion, and $1.0 billion—are factually accurate and properly contextualized. Format variations (e.g., using 'billion' vs 'B') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the answer synthesizes information about two separate events (Abcam acquisition goodwill and Veralto separation cash impact) as required by the question. The additional detail about using cash to fund bond maturities and dividend payments is plausible and consistent with typical corporate behavior, though not explicitly mentioned in the ground truth. This addition does not contradict the original answer but provides slight elaboration. (4) The answer is semantically equivalent to the ground truth, with only minor expansion on the use of funds. The core facts, entities (Danaher, Abcam, Veralto), financial metrics (goodwill, net cash distributions, commercial paper redemption), and timeline (prior to distribution date) are all correctly identified and logically connected. The qualitative accuracy is slightly reduced due to the unverified addition about bond maturities and dividends, but this does not undermine the correctness of the main response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 447,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024, and how does this compare to the fair value of these derivatives assets and liabilities reported at year-end?",
      "original_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million. At year-end, the fair value of these derivatives was $557 million in assets and $180 million in liabilities. This indicates that while Nike held significant foreign exchange derivative positions, the net gain recognized during the year was relatively small compared to the overall fair value of these instruments.",
      "llm_answer": "The total net gain recognized in income from foreign exchange forwards and options in fiscal year 2024 was $24 million, which is reflected in “Other (income) expense, net” on the consolidated statements of income. This gain is part of the $270 million total gain on designated cash‑flow hedges, and it is offset by the fair‑value amounts of the derivatives reported at year‑end ($343 million in derivative assets and $151 million in derivative liabilities).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $24 million net gain from foreign exchange forwards and options in fiscal year 2024, which matches the ground truth. However, the fair value figures for derivative assets and liabilities at year-end are incorrect: the LLM states $343 million in assets and $151 million in liabilities, whereas the ground truth reports $557 million in assets and $180 million in liabilities. These numbers are significantly off, indicating a failure in multi-hop retrieval or synthesis. (2) The quantitative accuracy is low because while the $24 million gain is correct, the year-end fair value figures are wrong. There is no indication that $343 million and $151 million are related to the correct entities or filings—these values do not align with the ground truth and may stem from a different context or misattribution. Additionally, the mention of a '$270 million total gain on designated cash-flow hedges' is not part of the original question or answer and introduces unverified information, potentially conflating different derivative categories. (3) The reasoning is partially sound in linking the gain to income and referencing cash-flow hedges, but it fails the multi-hop requirement by not accurately connecting the year-end fair value of the specific derivatives (foreign exchange forwards and options) to the gain recognized. The comparison between the net gain and the fair value is therefore flawed due to incorrect magnitude. (4) Contextual relevance is high because the LLM addresses the right topic, fiscal year, and financial instruments, and attempts to provide meaningful context (e.g., income statement classification and hedge accounting). However, the incorrect fair value data undermines the factual core of the answer, leading to a low correctness score despite relevant structure and partial accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 503,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates, and how does this compare to the 2022 depreciation, depletion, amortization, and impairments for the same region?",
      "original_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million, as equity affiliates contributed no discounted future net cash flows from the Lower 48. This is significantly higher than the 2022 depreciation, depletion, amortization, and impairments for the Lower 48, which amounted to $4,854 million. This indicates that the future cash flow potential of the Lower 48 region is much greater than the costs recognized during 2022.",
      "llm_answer": "The combined total of the 2022 discounted future net cash flows from the Lower 48 region for both consolidated operations and equity affiliates is $55,912 million (consolidated) plus $13,272 million (equity affiliates) = $69,184 million. This exceeds the 2022 depreciation, depletion, amortization, and impairments for the Lower 48 region, which total $4,854 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers and calculations. The ground truth states that equity affiliates contributed *no* discounted future net cash flows from the Lower 48 region, so the combined total is $55,912 million (entirely from consolidated operations). However, the LLM incorrectly adds $13,272 million from equity affiliates, which is not supported by the ground truth and results in a false total of $69,184 million. This number is entirely incorrect and undermines the core of the answer. (2) The 2022 depreciation, depletion, amortization, and impairments figure of $4,854 million is correctly stated, so that part is quantitatively accurate. However, the incorrect sum for cash flows leads to a misleading comparison. (3) The multi-hop reasoning fails because the model did not correctly synthesize the fact that equity affiliates had zero contribution from the Lower 48 region. It appears to have either misattributed data from another region or entity or hallucinated a value. The conclusion that future cash flows exceed DD&A is directionally correct but based on flawed inputs. (4) Scores reflect major factual and quantitative errors that compromise the answer’s correctness, though the response is contextually relevant and attempts the right structure. The error in core data synthesis severely limits accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 382,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What was the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023, and how does this compare to the fair value of these receivables based on the level of unobservable inputs?",
      "original_answer": "PayPal reported a total value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023. This entire amount was measured using significant unobservable inputs (Level 3), indicating that the fair value of these receivables is entirely based on Level 3 inputs.",
      "llm_answer": "Based on the provided document pages, the total value of Loans and Interest Receivable, Held for Sale reported by PayPal in December 2023 is $563 million, as disclosed in Note 16 (page 68) and confirmed in the fair value hierarchy table on page 96, which classifies this item as Level 3 with a fair value of $563 million. The fair value is determined using significant unobservable inputs, specifically the price at which the Company expects to sell the loans based on its agreement with the global investment firm, and is classified as Level 3 in the fair value hierarchy due to the use of unobservable inputs for valuation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the reported value of $563 million for Loans and Interest Receivable, Held for Sale as of December 31, 2023, is accurate and correctly attributed to PayPal. The format ($563 million) matches the ground truth, and no calculations are required beyond correct reporting. (2) The answer correctly identifies that the entire fair value of these receivables is based on Level 3 inputs (significant unobservable inputs), which aligns with the ground truth stating the amount is 'entirely measured using significant unobservable inputs (Level 3)'. (3) The multi-hop reasoning is sound: the LLM synthesizes information from Note 16 (page 68) and the fair value hierarchy table (page 96), correctly linking the carrying value to its fair value classification and explaining the use of unobservable inputs tied to the sale agreement with a global investment firm. (4) All entities—PayPal, the financial instrument, the date (December 2023), and the Level 3 classification—are accurately identified and contextually relevant. The explanation adds contextual detail (e.g., the pricing based on the agreement) that enhances understanding without introducing error. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 358,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How much total revolving indebtedness was borrowed and repaid under the 2021 Multicurrency Credit Facility during the year ended December 31, 2023, and how does this compare to the amounts borrowed and repaid under the 2021 Credit Facility in the same period?",
      "original_answer": "During the year ended December 31, 2023, $3.0 billion was borrowed and $6.1 billion was repaid under the 2021 Multicurrency Credit Facility. Under the 2021 Credit Facility, $3.1 billion was borrowed and $2.6 billion was repaid during the same period. This results in a net repayment of $3.1 billion for the 2021 Multicurrency Credit Facility and a net borrowing of $0.5 billion for the 2021 Credit Facility.",
      "llm_answer": "During 2023 the company borrowed $3.0 billion and repaid $6.1 billion of revolving indebtedness under the 2021 Multicurrency Credit Facility, while it borrowed $3.1 billion and repaid $2.6 billion of revolving indebtedness under the 2021 Credit Facility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values from the ground truth: $3.0 billion borrowed and $6.1 billion repaid under the 2021 Multicurrency Credit Facility, and $3.1 billion borrowed and $2.6 billion repaid under the 2021 Credit Facility. These figures match the original answer exactly, with acceptable formatting (e.g., 'billion' written out, use of thin space). (2) All numbers are quantitatively accurate, and no calculations were required beyond what was directly reported. The net repayment and net borrowing figures mentioned in the ground truth are implied by the borrowings and repayments but were not explicitly requested in the question, so their absence does not constitute an error. (3) The multi-hop reasoning is sound—information is correctly attributed to two different credit facilities (2021 Multicurrency Credit Facility vs. 2021 Credit Facility) for the same fiscal period (year ended December 31, 2023). The model correctly distinguishes between the two facilities and synthesizes the relevant data points. (4) The answer is semantically equivalent to the original, conveying all key facts requested: amounts borrowed and repaid under each facility during 2023. The only minor shortcoming is the lack of explicit comparison language (e.g., 'this represents a net repayment' vs. 'net borrowing'), but since the question asks for the amounts and how they compare, including the raw figures suffices for a high score. The omission of net figures is not a factual error, just a slight reduction in completeness. Thus, correctness is rated 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 453,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What specific audit procedures were applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs, and how do these procedures reflect the subjectivity involved in assessing future regulatory orders?",
      "original_answer": "Both Georgia Power and Mississippi Power underwent similar audit procedures to evaluate the impact of regulatory rate changes on incurred costs. These procedures included testing the effectiveness of management's controls over the evaluation of the likelihood of recovery in future rates of certain incurred costs, refunds, or future reductions in rates. Auditors also reviewed regulatory orders and publicly available information to assess precedents for similar cost treatments. These procedures reflect the high degree of subjectivity involved in assessing the potential impact of future regulatory orders on incurred costs, as management must make significant judgments regarding the likelihood of recovery, disallowance, or refund obligations.",
      "llm_answer": "The audit procedures applied to both Georgia Power and Mississippi Power to evaluate the impact of regulatory rate changes on incurred costs focused on testing management’s judgments regarding the likelihood of recovery of costs, potential refunds, and future rate reductions through regulatory orders. These procedures included assessing controls over regulatory asset/liability evaluations, reviewing relevant regulatory orders and public filings to gauge recovery prospects, testing the completeness and accuracy of recorded regulatory assets and liabilities, and obtaining management representations about recoverability—procedures that inherently involved subjectivity due to the uncertain outcomes of future regulatory decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: both Georgia Power and Mississippi Power were subject to audit procedures involving management's judgments on cost recovery, refunds, and future rate reductions; auditors reviewed regulatory orders and public information; controls over regulatory assets/liabilities were tested; and subjectivity due to uncertainty in future regulatory decisions was acknowledged. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the answer correctly synthesizes that similar procedures were applied across both entities and links those procedures to the inherent subjectivity in regulatory forecasting. (4) The only minor difference is that the LLM answer mentions 'testing completeness and accuracy of recorded regulatory assets and liabilities' and 'management representations,' which are not explicitly stated in the original, but these are reasonable components of audit procedures and do not contradict the ground truth. Overall, the semantic meaning and factual content align closely with the original answer, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 363,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the decline in Comirnaty's global revenue in 2023 and the collaboration agreement terms with BioNTech impact Pfizer's operational results and future financial obligations?",
      "original_answer": "The decline in Comirnaty's global revenue from $37,806 million in 2022 to $11,220 million in 2023, a 70% drop, significantly affected Pfizer's operational results, driven by lower contracted deliveries and demand in international markets and the transition to traditional U.S. commercial market sales. This decline was compounded by Pfizer's ongoing collaboration agreement with BioNTech, under which Pfizer agreed to pay BioNTech tiered royalties and share gross profits from Comirnaty sales globally, excluding certain regions. Despite the revenue drop, Pfizer retained global commercialization rights (excluding Germany, Turkey, and certain Asian regions) and continued to share development and commercialization profits with BioNTech, creating ongoing financial obligations even as revenue declined.",
      "llm_answer": "The decline in Comirnaty revenue in 2023—driven by reduced contracted deliveries and lower demand, especially outside the U.S.—directly reduced Pfizer’s total revenue and operating results, while the collaboration agreement with BioNTech required Pfizer to share development costs and royalty payments, creating ongoing financial obligations that offset some of the lost revenue. Consequently, Pfizer recorded lower alliance revenues and higher restructuring costs, impacting its overall financial performance and future cash flow expectations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general trend of Comirnaty revenue decline and its impact on Pfizer's operational results, correctly identifying reduced contracted deliveries and lower international demand as drivers. It also acknowledges the ongoing financial obligations under the BioNTech collaboration. However, it fails to include any of the specific quantitative figures from the ground truth—namely, the exact revenue drop from $37,806 million in 2022 to $11,220 million in 2023 (a 70% decline)—which is a major omission given the question's focus on financial impact. (2) No numeric values are provided in the LLM answer, making it impossible to verify calculations or trends quantitatively. The absence of these key figures significantly undermines the answer's factual accuracy, especially since the original answer hinges on the magnitude of the revenue drop. (3) The multi-hop reasoning is partially sound: the model correctly links the revenue decline to operational results and recognizes that the BioNTech agreement creates ongoing profit-sharing and cost obligations. However, it mischaracterizes the nature of the agreement by stating Pfizer shares 'development costs'—the ground truth specifies Pfizer pays tiered royalties and shares gross profits, not development costs. Additionally, the LLM mentions 'lower alliance revenues and higher restructuring costs,' which are not supported by the original answer and introduce unsupported claims. (4) While the qualitative understanding of the situation is reasonable and the response is contextually relevant, the lack of key numbers and minor inaccuracies in describing the collaboration agreement reduce the correctness score. The answer conveys a plausible narrative but lacks the precise financial data and contractual details required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 497,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the year-over-year change in the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, compared to May 31, 2023?",
      "original_answer": "The value of U.S. Agency securities held as short-term investments by NKE decreased by $11 million year-over-year, from $46 million as of May 31, 2023, to $35 million as of May 31, 2024.",
      "llm_answer": "Based on the provided document pages, the value of U.S. Agency securities held as short-term investments by NKE as of May 31, 2024, is $35 million (as shown in the \"U.S. Agency securities\" line item under Level 2 in the fair value measurement table on page 73), and as of May 31, 2023, it was $46 million (shown in the same line item for 2023). Therefore, the year-over-year change is a decrease of $11 million ($35 million - $46 million = -$11 million).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all factual elements: the value of U.S. Agency securities as $35 million as of May 31, 2024, and $46 million as of May 31, 2023, with a year-over-year decrease of $11 million. These values match the ground truth exactly. (2) The calculation ($35M - $46M = -$11M) is accurate and correctly framed as a decrease of $11 million. Number formats are consistent and acceptable. (3) The reasoning is sound and demonstrates proper multi-hop synthesis by extracting data from two different fiscal years (2023 and 2024) for the same metric (U.S. Agency securities under Level 2 fair value measurements) and computing the change. The model correctly attributes the data source (page 73, fair value table), indicating accurate grounding. (4) The answer is semantically equivalent to the original answer, with added transparency about the source location. All scores are maximized because the response is factually correct, complete, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 291,
        "total_tokens": 1453
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024, considering both new issuances and repayments?",
      "original_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was an increase of $423 million.",
      "llm_answer": "The net change in the total principal amount of Guaranteed Senior Notes issued by Costco's Japanese subsidiary in 2024 was a decrease of $77, as the subsidiary repaid $77 of its notes in July 2024, reducing the outstanding balance from approximately $500 to $423.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the net change. The ground truth states an increase of $423 million, while the LLM claims a decrease of $77 (apparently $77 million, though written as $77), which is completely wrong. (2) The numbers are inaccurate: the repayment amount is misrepresented, and the LLM incorrectly frames a reduction from $500 to $423 as the full story, ignoring new issuances. More critically, the net change should be +$423 million, not a decrease. The LLM also fails to mention any new issuances, which is essential for the net calculation. (3) The multi-hop reasoning is flawed: the question requires synthesizing both new issuances and repayments to compute net change. The LLM only considers repayments and misinterprets the result as a net decrease, failing to perform the correct synthesis. (4) The contextual relevance is partially present—it discusses the right entity (Costco's Japanese subsidiary) and the right instrument (Guaranteed Senior Notes)—but the core quantitative and logical components are incorrect, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1110,
        "completion_tokens": 322,
        "total_tokens": 1433
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 3M's stand-alone letters of credit, bank guarantees, and similar instruments, and how does this compare to the amount of cash, cash equivalents, and marketable securities held by the company in the U.S. as of December 31, 2024?",
      "original_answer": "3M had $0.5 billion in stand-alone letters of credit, bank guarantees, and other similar instruments issued and outstanding as of December 31, 2024. At the same date, the company held $4.2 billion in cash, cash equivalents, and marketable securities in the United States. Therefore, the stand-alone instruments represent approximately 11.9% of the U.S.-held liquidity.",
      "llm_answer": "The total value of 3M’s stand‑alone letters of credit, bank guarantees and similar instruments was **$0.5 billion** as of December 31 2024. This amount is modest compared with the company’s cash, cash equivalents and marketable securities of **$7.7 billion**, of which about **$4.2 billion** was held in the United States.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.5 billion in stand-alone letters of credit, bank guarantees, and similar instruments as of December 31, 2024, which matches the ground truth. It also correctly states that $4.2 billion of cash, cash equivalents, and marketable securities were held in the U.S., aligning with the original answer. However, it introduces a new figure of $7.7 billion in total cash, cash equivalents, and marketable securities (global), which is not present in the ground truth and was not requested in the question. This figure may be factually incorrect or at least unsupported by the provided truth, leading to potential misinformation. (2) The core numbers requested—stand-alone instruments ($0.5B) and U.S.-held liquidity ($4.2B)—are accurate. However, the comparison in the original answer computes that the instruments represent approximately 11.9% of U.S. liquidity, a calculation the LLM omits. Instead, it makes a vague qualitative comparison ('modest compared with'), which lacks the precision of the original. The introduction of $7.7B is unverified and distracts from the required U.S.-specific comparison. (3) The multi-hop reasoning is partially sound: the model correctly retrieves two key data points from different parts of the knowledge base (liabilities and assets by geography). However, it fails to perform or report the percentage calculation that is central to the comparative analysis requested. Adding an unsupported global cash figure suggests possible confusion or data blending beyond the scope. (4) The contextual relevance is high as it addresses the main entities and time frame. Qualitative accuracy is good due to correct entity and metric identification, but quantitative accuracy is reduced due to the inclusion of an unverified total cash figure and omission of the correct comparative calculation. Correctness is scored 7 because the key facts are present and accurate, but the answer includes extraneous, unverified data and misses the precise quantitative comparison expected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 550,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What percentage of Meta's worldwide MAUs were estimated to be duplicate accounts in Q4 2023, and how does this compare to the percentage of false accounts during the same period?",
      "original_answer": "In Q4 2023, duplicate accounts were estimated to represent approximately 10% of Meta's worldwide MAUs, while false accounts were estimated at approximately 4% of worldwide MAUs. This means duplicate accounts were more than twice as prevalent as false accounts during the same period.",
      "llm_answer": "In Q4 2023, Meta estimated that duplicate accounts represented roughly 10 % of its worldwide MAUs, while false accounts accounted for about 4 % of worldwide MAUs. The duplicate‑account share was noted to be “meaningfully higher” in developing markets such as the Philippines and Vietnam compared with more mature markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that in Q4 2023, duplicate accounts represented approximately 10% of Meta's worldwide MAUs and false accounts accounted for about 4%, which matches the ground truth exactly. These percentages are quantitatively accurate. (2) All numbers and time periods are correct—10% for duplicates and 4% for false accounts in Q4 2023—with no calculation errors. The comparison that duplicates are more than twice as prevalent is implied by the correct percentages, though not explicitly stated. (3) The reasoning is sound and the entities (Meta, worldwide MAUs, Q4 2023, duplicate and false accounts) are accurately identified. The answer adds contextual detail about developing markets (Philippines and Vietnam), which is factually consistent with Meta's reporting and enhances relevance without contradicting the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that duplicate accounts were 'more than twice as prevalent' as false accounts, which was part of the original conclusion. However, the numerical values provided allow this inference, so the omission is not a factual error but a slight reduction in completeness. Thus, the answer is highly accurate and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 381,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How much did Pfizer pay upfront in cash to BioNTech for the shingles mRNA vaccine collaboration, and how does this compare to the upfront payment made to Biohaven for migraine treatment rights outside the U.S.?",
      "original_answer": "Pfizer paid $75 million upfront in cash to BioNTech for the shingles mRNA vaccine collaboration and $150 million upfront to Biohaven for migraine treatment rights outside the U.S., resulting in a $75 million difference in favor of the Biohaven deal.",
      "llm_answer": "Based on the provided document pages, Pfizer paid BioNTech a $75 million upfront cash payment (plus a $150 million equity investment) for the shingles mRNA‑vaccine collaboration. This upfront cash amount is significantly smaller than the $150 million upfront cash payment (plus equity) Pfizer made to Biohaven for the migraine‑treatment rights outside the U.S.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $75 million upfront cash payment to BioNTech for the shingles mRNA vaccine collaboration and the $150 million upfront cash payment to Biohaven for migraine treatment rights outside the U.S., both of which match the ground truth. The comparison stating that the BioNTech upfront is 'significantly smaller' is qualitatively accurate. (2) All numeric values are correct and precisely match the ground truth; format variations (e.g., $75 million) are acceptable and do not affect accuracy. The implied $75 million difference is accurate, though not explicitly stated as a difference, the comparison is still valid. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two separate deals (BioNTech and Biohaven), identifies the correct nature of payments (upfront cash), and compares them appropriately. The mention of additional equity investments adds context not required by the question but does not detract from accuracy. (4) The answer is contextually fully relevant and conveys the same core information as the original answer, with only minor omission of the explicit $75 million difference calculation. However, the comparative statement suffices for semantic equivalence. Thus, the answer is highly accurate with only a slight deduction in qualitative accuracy for not explicitly quantifying the difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 388,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, when considering both hedging instruments and non-hedging instruments?",
      "original_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31, 2024, is $115 million. This includes $110 million from derivatives designated as hedging instruments and $5 million from derivatives not designated as hedging instruments.",
      "llm_answer": "The total amount of liabilities related to foreign exchange forwards and options as of May 31 2024, when combining both hedging and non‑hedging instruments, is $151 million. This figure represents the aggregate of the derivative liabilities reported in Note 12 (derivative liabilities at fair value), which includes $110 million for foreign‑exchange forwards and options designated as hedging instruments and $5 million for those not designated as hedges, plus $31 million for interest‑rate swaps that are also recorded as liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the total liabilities as $151 million instead of the correct $115 million. While it correctly identifies $110 million for hedging instruments and $5 million for non-hedging instruments, it erroneously adds $31 million for interest-rate swaps, which are not part of the question. The question specifically asks only for liabilities related to foreign exchange forwards and options, not interest-rate swaps. (2) The calculation is therefore flawed: $110M + $5M = $115M (correct), but the LLM computes $110M + $5M + $31M = $151M, which introduces a significant quantitative error. The individual components for FX forwards and options are accurate, but the inclusion of unrelated derivatives invalidates the total. (3) The multi-hop reasoning fails because the model does not properly scope the required instruments. It references Note 12 correctly but misinterprets the composition of derivative liabilities by including interest-rate swaps, indicating a failure in synthesizing only the relevant data. (4) The contextual relevance is moderate because the answer discusses derivative liabilities and breaks down hedging vs. non-hedging, but it introduces irrelevant information that changes the answer's meaning. Scores reflect major factual and calculation errors despite partial correctness in component values.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 378,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does PayPal's recognition of a crypto asset safeguarding liability connect to its disclosure of risk concentrations, and what does this imply about the company's exposure to credit risk in relation to customer-held crypto assets?",
      "original_answer": "PayPal recognizes a crypto asset safeguarding liability to reflect its obligation to safeguard cryptocurrencies held on behalf of customers, and it discloses that its cash, cash equivalents, customer accounts, and other financial assets are subject to concentration of credit risk. Since crypto assets held for customers are not PayPal's assets but are safeguarded through a liability mechanism, the company's exposure to credit risk arises not from the crypto assets themselves but from the financial institutions where these customer funds are held. PayPal places these funds in high-quality financial institutions but acknowledges that balances may exceed FDIC insurance limits, creating a credit risk concentration that could impact the company if those institutions fail.",
      "llm_answer": "PayPal records a crypto‑asset safeguarding liability and a corresponding safeguarding asset to reflect its obligation to protect cryptocurrencies held for customers; this liability is disclosed within its broader risk‑concentration disclosures that highlight credit‑risk exposure related to customer‑held crypto balances. By recognizing the liability, the company explicitly acknowledges potential credit losses if it cannot safeguard or return those assets, underscoring that its exposure to credit risk is tied to the safeguarding of customer‑held crypto assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PayPal recognizes a crypto asset safeguarding liability and connects it to risk disclosures, which is factually accurate. However, it mischaracterizes the nature of PayPal's credit risk exposure. The ground truth states that crypto assets themselves are not PayPal's assets and that the credit risk arises from the financial institutions where customer funds (not crypto) are held, particularly because those balances may exceed FDIC insurance limits. The LLM incorrectly implies that the credit risk is tied directly to the safeguarding of customer-held crypto assets, suggesting potential losses if PayPal cannot return those assets—this misrepresents the actual risk, which is institutional credit risk on cash holdings, not custodial failure or crypto volatility. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors in this regard. (3) The multi-hop reasoning is partially sound: the model correctly links the liability to risk disclosures but fails to synthesize the key point that the credit risk concentration stems from cash and financial assets held at institutions, not the crypto assets themselves. This breaks the chain of correct inference regarding exposure. (4) The correctness score is 5 due to this significant conceptual error in risk attribution, despite correct terminology and structure. Qualitative accuracy is low for the same reason. Contextual relevance is high because the answer addresses the right concepts and framework, just with flawed reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 437,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How many LTIP units were issued net of forfeitures under the 2019 Plan, and what was the impact of these units on potential stock dilution for the year ended December 31, 2024?",
      "original_answer": "689,202 LTIP units were issued net of forfeitures under the 2019 Plan, and these units were considered potentially dilutive securities. However, they did not have a material dilutive effect on the company's stock for the year ended December 31, 2024.",
      "llm_answer": "The 2019 Plan issued 871,680 LTIP units net of forfeitures, and the company noted that no securities, including those LTIP units, had a material dilutive effect for the year ended December 31, 2024. Consequently, the LTIP units did not materially affect stock dilution in that year.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that 871,680 LTIP units were issued net of forfeitures under the 2019 Plan, whereas the ground truth is 689,202 units. This is a significant numerical discrepancy that affects the factual accuracy of the response. However, the second part of the answer — that the LTIP units did not have a material dilutive effect on stock dilution for the year ended December 31, 2024 — is consistent with the original answer and factually correct. (2) The quantitative inaccuracy is critical: 871,680 vs. 689,202 represents an overstatement of approximately 26.5%, which is not a minor rounding or formatting difference but a substantial error in reported figures. No calculation is required in the question, but the reported number must match the source. (3) The reasoning is partially sound: the model correctly identifies that LTIP units are considered potentially dilutive securities and correctly concludes no material dilutive effect occurred. However, it fails to explicitly state that these units are considered potentially dilutive (though implied), and more importantly, it uses an incorrect base number, undermining the multi-hop synthesis. (4) The contextual relevance is high because the answer addresses both parts of the question and discusses the correct concept of dilution. Qualitative accuracy is moderate due to correct logic and terminology but incomplete factual alignment. Quantitative accuracy is low due to the incorrect unit count. Correctness score reflects partial credit for accurate qualitative outcome but major deduction for wrong key number.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 441,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products, and how did this compare to the impact in 2022?",
      "original_answer": "The total financial impact on 3M's earnings per diluted share from manufactured PFAS products was a reduction of $0.20 in 2024 and a reduction of $0.90 in 2022, resulting in a total combined impact of $1.10 over the two years.",
      "llm_answer": "Based on the provided document pages, the total financial impact on 3M's earnings per diluted share in 2024 from manufactured PFAS products was **$0.28**, compared to **$0.90** in 2023. This represents a significant decrease in the PFAS-related impact on diluted earnings per share year-over-year. The document specifically states: \"Manufactured PFASproducts: 0.28\" for 2024 and \"0.90\" for 2023 in the earnings per share reconciliation table (page 23), confirming the 2024 impact was $0.28 versus $0.90 in 2022 (though the question compares to 2022, the document shows 2023 as $0.90, and the 2024 impact is explicitly $0.28). Thus, the 2024 impact ($0.28) was substantially lower than the 2023 impact ($0.90).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The ground truth states the 2024 impact was a reduction of $0.20 per diluted share, but the LLM claims $0.28, which is incorrect. While the 2022 impact is correctly stated in the original answer as $0.90, the LLM incorrectly references 2023 ($0.90) instead of 2022, despite the question explicitly asking for a comparison to 2022. The document citation (page 23) is referenced, but the LLM misreads or misreports the 2024 figure as $0.28 instead of $0.20. (2) Quantitative accuracy is low: the $0.28 figure for 2024 is wrong, and the comparison is made to 2023 rather than 2022 as required. The calculation of year-over-year change is not possible due to incorrect data. (3) The reasoning is partially sound in that the model attempts to cite a specific table and reconcile impacts year-over-year, but it fails the multi-hop requirement by using the wrong year (2023 vs 2022) and misreporting the 2024 value. It also does not mention the combined $1.10 impact over the two years, which is part of the ground truth. (4) Contextual relevance is moderate because the answer addresses PFAS impact on EPS and attempts to compare across years, but it uses incorrect data and the wrong comparison year, undermining the validity of the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 365,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did the volume changes in KWH sales to affiliates and non-affiliates in 2024, governed by the Intercompany Interchange Contract (IIC), impact the overall wholesale revenue performance for the Southern Company system?",
      "original_answer": "The Southern Company system experienced a $87 million (20.5%) decrease in wholesale revenues from non-affiliate sales due to a 30.8% drop in KWH volume after power agreements ended in May 2023. This was partially offset by a $79 million (131.7%) increase in affiliate sales driven by a 165.5% rise in KWH volume, largely due to increased affiliated energy demand. These affiliate sales were conducted under the IIC approved by FERC, showing that while external market conditions reduced non-affiliate revenue, internal energy transfers under the IIC helped mitigate some of the overall revenue decline.",
      "llm_answer": "The volume shifts under the IIC drove a 165.5% surge in wholesale KWH sales to affiliates (from 5.6 billion to 12.1 billion KWH) and a 30.8% drop in sales to non‑affiliates (from 6.5 billion to 4.5 billion KWH), contributing to a $79 million increase in wholesale revenue from affiliates and an $87 million decline from non‑affiliates; these changes helped lift total wholesale revenues by $476 million in 2024, offsetting part of the retail revenue growth and shaping the Southern Company system’s overall wholesale performance.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. While it correctly identifies the 165.5% increase in affiliate KWH volume and the 30.8% drop in non-affiliate volume, and the $79M increase and $87M decrease in revenues, it incorrectly states that these changes led to a $476 million *increase* in total wholesale revenues. The ground truth indicates that non-affiliate revenue *decreased* by $87M and affiliate revenue *increased* by $79M, resulting in a net *decline* of $8M in wholesale revenue, not a $476M increase. The $476M figure appears to be a confusion with another metric (possibly total revenue or retail revenue) not mentioned in the original answer. (2) Quantitative accuracy is partially correct: the percentages (165.5%, 30.8%), dollar impacts ($79M increase, $87M decrease), and volume shifts (5.6B to 12.1B KWH, 6.5B to 4.5B KWH) are accurate. However, the net revenue impact is completely wrong—$79M gain minus $87M loss is an $8M net loss, not a $476M gain. The LLM’s calculation is fundamentally flawed. (3) Multi-hop reasoning fails: the model incorrectly synthesizes the outcome, suggesting the volume changes improved wholesale revenue performance, while the truth is that they resulted in an overall decline, partially mitigated by affiliate sales. The role of the IIC is mentioned but misrepresented in outcome. (4) Contextual relevance is moderate—the answer addresses wholesale revenue, affiliates, non-affiliates, and the IIC, but the conclusion is opposite to the truth. Due to severe quantitative and reasoning errors, the correctness score is low despite some accurate inputs.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 445,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total financial penalty imposed by the Irish Data Protection Commission alongside the corrective orders related to unlawful data transfers, and how might compliance with these orders affect Meta's operational costs in Europe?",
      "original_answer": "The Irish Data Protection Commission imposed a financial penalty of €1.2 billion alongside the corrective orders requiring Meta Platforms Ireland to suspend unlawful data transfers and cease the processing of EEA Facebook user data in the United States. Compliance with these corrective orders could increase the cost and complexity of delivering Meta's products and services in Europe, as the company may be required to take additional steps to align its data processing operations with Chapter V of the GDPR.",
      "llm_answer": "The Irish Data Protection Commission has imposed a €1.2 billion administrative fine on Meta Platforms Ireland together with corrective orders that require the company to suspend certain data‑transfer mechanisms and bring its processing practices into compliance with Chapter V of the GDPR. If Meta must implement additional technical and operational measures to meet those orders—such as redesigning data‑transfer processes, enhancing consent mechanisms, or increasing privacy‑by‑design controls—its compliance costs in Europe are likely to rise, potentially affecting operating expenses and the overall cost structure of its European business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the €1.2 billion financial penalty imposed by the Irish Data Protection Commission, matching the ground truth exactly in both amount and currency. This satisfies the quantitative requirement with full accuracy. (2) The LLM accurately describes the corrective orders related to suspending unlawful data transfers and aligning with Chapter V of the GDPR, though it does not explicitly mention the 'cessation of processing EEA Facebook user data in the United States' as specified in the original answer. However, the reference to bringing processing into compliance with Chapter V implies this requirement. (3) The reasoning is sound and reflects multi-hop understanding: the LLM correctly infers that compliance could require technical and operational changes (e.g., redesigning data transfers, enhancing consent), which would increase costs—directly aligning with the original answer’s assertion about increased cost and complexity. (4) The LLM answer is semantically equivalent and contextually appropriate, using slightly more detailed language (e.g., 'privacy-by-design controls') but preserving factual integrity. The only minor omission is the specific mention of Facebook user data and U.S. processing cessation, which slightly affects completeness but not overall correctness. Hence, a score of 9 is justified—very high accuracy with negligible detail reduction.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 392,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does The Home Depot's emphasis on product depth and job lot quantities specifically support its strategy to meet the needs of professional customers (Pros), and what risks are highlighted in the document if this aspect of competitiveness is not effectively maintained?",
      "original_answer": "The Home Depot emphasizes product depth and job lot quantities to meet the complex purchase needs of professional customers (Pros), who require larger volumes and dedicated sales support. If the company fails to maintain these offerings alongside competitive delivery and pickup options, it could negatively impact demand for products and services and reduce profit margins.",
      "llm_answer": "The Home Depot’s strategy to meet the needs of professional customers (Pros) relies on offering a deep product assortment and the ability to source job‑lot quantities of specialized items—both highlighted as key advantages in its merchandising approach. If the company fails to maintain this depth and availability, it risks losing Pros to competitors, which could erode sales, market share, and overall profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies The Home Depot's strategy of offering product depth and job lot quantities to serve professional customers (Pros), which aligns with the ground truth. It accurately captures the core risk of failing to maintain these offerings—loss of Pros, leading to reduced sales, market share, and profitability. While the original answer specifies additional consequences such as negative impacts on demand and profit margins due to failure in maintaining competitive delivery and pickup options, the LLM answer generalizes the risk as erosion in sales and profitability, which is semantically close but omits the specific linkage to delivery/pickup competitiveness. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed correct by default. The reasoning is sound and contextually appropriate, with accurate entity identification (The Home Depot, Pros, product depth, job lot). The omission of the specific operational elements (delivery and pickup) prevents a perfect score, but the overall meaning and intent are preserved. Hence, the answer is mostly correct with minor gaps in completeness regarding the full scope of risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 339,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy across both disclosures, and what might this exclusion indicate about the complexity of valuing these specific investments?",
      "original_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $177 million ($94 million + $83 million). The exclusion of these interests indicates that the valuation of these specific investments is complex and not easily categorized within the standard fair value hierarchy, likely due to the lack of observable market data or the presence of restrictions that limit the company’s ability to readily redeem these investments.",
      "llm_answer": "The total value of the participating interest in the insurance annuity contracts excluded from the fair value hierarchy is $83 million (as reported on page 133 for 2021 and $94 million for 2020). This exclusion likely reflects the complexity of valuing these investments, which requires a combination of quoted market prices, recent transactions, and actuarial present‑value calculations to determine their fair value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies both values ($94 million for 2020 and $83 million for 2021) and accurately sums them to $177 million, which matches the ground truth total. The individual amounts are correctly attributed to their respective years, and the total is implied through summation even though not explicitly stated as $177 million. (2) Quantitative accuracy is perfect: $94M and $83M are correct, and their sum is accurate. Format variations (e.g., '83 million' vs $83 million) are acceptable and semantically equivalent. (3) The reasoning is sound: the model correctly explains that the exclusion indicates valuation complexity, citing the use of quoted market prices, recent transactions, and actuarial present-value calculations. While the original answer emphasizes lack of observable market data and redemption restrictions, the LLM's explanation is consistent with complex, unobservable inputs (Level 3 characteristics), making it a valid interpretation. It slightly misses the emphasis on 'restrictions limiting redemption' but captures the core idea of complexity. (4) The answer is fully contextually relevant, addressing both the quantitative total and the qualitative implication of the exclusion. The minor omission in elaborating on redemption restrictions or lack of market data prevents a perfect 10, but the response is factually correct, well-reasoned, and complete in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 394,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does PayPal's use of loss curves in conjunction with macroeconomic forecasts impact its allowance for credit losses on both merchant and consumer receivables, and what specific macroeconomic factors are applied in each category?",
      "original_answer": "PayPal applies loss curves to both merchant and consumer receivables to estimate the allowance for credit losses, incorporating macroeconomic forecasts. For merchant receivables, the loss curves are applied by geography, delinquency, and origination period, and the macroeconomic factors include forecasted trends in unemployment rates and retail e-commerce sales. For consumer revolving credit receivables, the loss curves are also used, and macroeconomic factors such as forecasted trends in household disposable income and retail e-commerce sales are applied. These macroeconomic inputs directly influence the projected loss rates, which are then applied to the principal amounts of receivables to determine the allowance for credit losses, ensuring that economic conditions are factored into the financial estimates.",
      "llm_answer": "PayPal's allowance for credit losses on merchant receivables relies on loss curves calibrated with macroeconomic forecasts that incorporate factors such as unemployment rates and retail e‑commerce sales trends, while the allowance for consumer receivables applies loss curves informed by macroeconomic variables like household disposable‑income trends and unemployment rates. In both cases, the macroeconomic forecasts are sourced externally and used to generate projected loss rates that feed directly into the allowance calculations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and structure. (1) It correctly identifies that PayPal uses loss curves in conjunction with macroeconomic forecasts for both merchant and consumer receivables to estimate the allowance for credit losses. It accurately specifies that for merchant receivables, the key macroeconomic factors are unemployment rates and retail e-commerce sales trends, and for consumer receivables, household disposable income and unemployment rates are used. However, the original answer specifies that for consumer revolving credit receivables, retail e-commerce sales (not unemployment) are applied alongside household disposable income, whereas the LLM incorrectly includes unemployment and omits retail e-commerce sales for the consumer category. This is a minor but notable discrepancy in entity accuracy and reasoning synthesis. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound overall: the model correctly links loss curves, macroeconomic forecasting, and their application to allowance calculations across two receivable types. The synthesis across categories is logical, though slightly flawed in the consumer receivables factor mapping. (4) Contextual relevance is perfect—the answer directly addresses all parts of the question with appropriate financial terminology and structure. The omission of retail e-commerce sales for consumer receivables and inclusion of unemployment (which is more relevant to merchant) reduces qualitative accuracy slightly, but core facts and mechanisms are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 468,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How does Costco's investment in the development and protection of Kirkland Signature, as well as its reliance on manufacturing and distribution facilities for private-label items, expose the company to risks that could affect both brand loyalty and gross margin performance?",
      "original_answer": "Costco has invested significantly in the development and protection of its private-label brand, Kirkland Signature, which contributes to higher margins and helps differentiate its merchandise offerings. However, the company relies on processing, packaging, and manufacturing facilities to produce these private-label items, and any disruptions in these operations—such as extreme weather, pandemics, or labor issues—could delay production and delivery. If such disruptions occur, Costco risks inconsistent product availability and quality, which could reduce member acceptance of Kirkland Signature products. Since these products represent a growing portion of overall sales and carry higher margins, any loss of member confidence could negatively impact both brand loyalty and gross margin performance.",
      "llm_answer": "Costco’s reliance on Kirkland Signature—built through substantial investment in its development and protection—means that any erosion of the brand’s reputation or loss of member confidence could directly diminish sales and reduce the higher‑margin contribution of private‑label items. At the same time, the company’s dependence on its own manufacturing, packaging, and distribution facilities (including third‑party logistics) creates supply‑chain vulnerabilities; disruptions or quality lapses can impair product availability, trigger costly recalls, and force price concessions, all of which can weaken member loyalty and compress gross margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no issues here. (2) The LLM correctly identifies the key elements: Costco's investment in Kirkland Signature, its reliance on manufacturing and distribution facilities (including third-party logistics), and the associated risks to brand loyalty and gross margins. It accurately links disruptions—such as quality lapses or supply chain issues—to potential outcomes like product unavailability, recalls, price concessions, and erosion of member confidence. (3) The multi-hop reasoning is sound: it connects investment in private label → higher margins and brand differentiation → supply chain dependencies → operational risks → impact on availability/quality → consequences for loyalty and margins. The only minor gap is that the original answer specifies examples of disruptions (extreme weather, pandemics, labor issues), while the LLM uses more general terms like 'disruptions or quality lapses' without listing specific causes. This does not impair the correctness but slightly reduces completeness in contextual detail. (4) The LLM uses 'its own manufacturing' facilities, which may slightly overstate Costco’s vertical integration—the company relies on third-party suppliers, though it does manage specifications and logistics. However, the inclusion of 'third-party logistics' mitigates this. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 434,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total grant date fair value of the performance-based LTIP units across the 2021 and 2022 LTI Programs, and how does this compare to the time-based restricted stock units granted in those same years?",
      "original_answer": "The total grant date fair value of the performance-based LTIP units for the 2021 and 2022 LTI Programs is $39.0 million ($18.4 million in 2021 and $20.6 million in 2022). In comparison, the time-based restricted stock units granted in those years totaled $11.2 million ($4.3 million in 2021 and $6.9 million in 2022). Therefore, the performance-based LTIP units had a significantly higher total grant date fair value than the time-based restricted stock units across both programs.",
      "llm_answer": "The total grant date fair value of performance-based LTIP units awarded under the 2021 and 2022 LTI Programs is $18.4 million for 2021 and $20.6 million for 2022, for a combined total of $39.0 million. This exceeds the $4.3 million grant date fair value of the time‑based restricted stock units granted in 2021, but is substantially lower than the $6.9 million fair value of the time‑based restricted stock units granted in 2022.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the grant date fair values for performance-based LTIP units in both 2021 ($18.4M) and 2022 ($20.6M), totaling $39.0M, which matches the ground truth. It also correctly reports the time-based restricted stock unit values for 2021 ($4.3M) and 2022 ($6.9M). However, the comparison is factually incorrect: the LLM states that the performance-based value is 'substantially lower' than the 2022 time-based value, which is false—the $20.6M (performance) is higher than $6.9M (time-based). This misrepresents the relationship and undermines the conclusion. (2) All individual numbers are accurate and formatting is acceptable. The total for performance-based units ($39.0M) is correctly calculated. However, the qualitative comparison fails: the LLM incorrectly implies that $20.6M < $6.9M, which is a critical error. (3) The multi-hop reasoning requires aggregating values across years and comparing total compensation components. While the model retrieves correct values, it fails to synthesize them correctly—specifically, it misjudges the magnitude comparison in 2022 and does not compute or state the total for time-based units ($11.2M), which is necessary for a full comparison. (4) The contextual relevance is high as it addresses the same entities and years. Quantitative accuracy is high due to correct numbers, but qualitative accuracy is low due to flawed reasoning and incorrect comparative statements. Correctness score is moderate because while data is accurate, the conclusion is misleading and factually wrong on a key point.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 433,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "What is the total fair value of U.S. municipal securities held by 3M as of December 31, 2024, and how are these securities classified in terms of fair value hierarchy due to their valuation methodology?",
      "original_answer": "As of December 31, 2024, 3M holds $16 million in U.S. municipal securities, which are classified as Level 3 in the fair value hierarchy because their valuation references the carrying value of the corresponding finance lease obligation.",
      "llm_answer": "The total fair value of U.S. municipal securities held by 3M as of December 31 2024 is $20 million (shown as $20 million in current marketable securities and $16 million in non‑current marketable securities). These securities are classified as Level 3 in the fair‑value hierarchy because they are valued using a method that references the carrying value of the related finance lease obligation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the total fair value of U.S. municipal securities as $20 million, combining $20 million in current and $16 million in non-current marketable securities. However, the ground truth specifies only $16 million total, with no breakdown suggesting a sum of two components. This results in a significant quantitative error. The classification as Level 3 is correct, and the reasoning—valuation based on the carrying value of the finance lease obligation—is semantically equivalent and accurate. (2) The dollar amounts are inconsistent with the ground truth: the LLM reports $20 million total (implying a sum of $20M + $16M, which would actually be $36M if both were components, but this is not stated clearly), while the correct amount is $16 million. There is a clear miscalculation or misinterpretation of the data. (3) The multi-hop reasoning is partially sound—the model correctly links the valuation methodology to the fair value hierarchy classification (Level 3 due to use of carrying value from lease obligation), which requires synthesis across accounting concepts and disclosure details. However, it fails in accurately retrieving or aggregating the correct security value. (4) The correctness score is 4 due to the major factual error in the dollar amount, despite correct classification and reasoning. Quantitative accuracy is low (3) because the numbers are incorrect and the implied calculation is flawed. Qualitative accuracy is moderate (6) because the conceptual reasoning and entity identification (3M, U.S. municipal securities, Level 3, finance lease linkage) are correct. Contextual relevance is high (8) as the answer addresses both parts of the question and stays focused on the required information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1171,
        "completion_tokens": 480,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What percentage of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts, and how does this estimation process reflect the challenges in identifying such accounts across encrypted platforms like WhatsApp?",
      "original_answer": "Approximately 3% of Meta's worldwide Monthly Active Users (MAP) in Q4 2023 consisted solely of violating accounts. This estimation process reflects challenges in identifying such accounts across encrypted platforms like WhatsApp due to limited visibility and reliance on fewer data signals such as phone numbers and device information, which increases the difficulty of accurate detection at scale.",
      "llm_answer": "In Q4 2023 Meta estimated that roughly 3 percent of its worldwide MAP was made up of accounts that solely violated its terms of service. This estimate is derived from internal reviews of limited account samples and calibrated against survey data, but it relies heavily on limited visibility into encrypted platforms like WhatsApp—where activity cannot be directly observed—so the true proportion may differ substantially.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 3% figure for violating accounts among Meta's worldwide Monthly Active Users (MAUs) in Q4 2023, matching the ground truth. The percentage is accurate and properly attributed. (2) Quantitatively, the 3% value is correct, and the time period (Q4 2023) and metric (worldwide MAUs) are accurately referenced. No calculations are required, but the numerical claim is factually sound. (3) The reasoning around challenges in detection on encrypted platforms like WhatsApp is well-articulated: the LLM correctly notes limited visibility and reliance on indirect signals (e.g., phone numbers, device info), though it frames the limitation in terms of 'activity cannot be directly observed' rather than explicitly mentioning the use of phone numbers and device information as per the original. This is a minor omission in specificity but does not undermine the correctness. The LLM adds that estimates are based on 'internal reviews of limited account samples and calibrated against survey data,' which aligns with plausible methodology and does not contradict the ground truth. (4) The answer is contextually fully relevant, addressing both the quantitative estimate and the qualitative challenge of detection on encrypted platforms. The slight difference in wording—emphasizing 'true proportion may differ substantially'—adds interpretive caution not in the original but does not reduce accuracy. Overall, the answer is factually correct, complete, and semantically equivalent, warranting a high score with only minor room for more precise alignment on detection signals.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 442,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for both the shingles vaccine and the Comirnaty (COVID-19 vaccine) programs as of December 31, 2023?",
      "original_answer": "The total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine and the Comirnaty vaccine programs was $375 million.",
      "llm_answer": "Based on the provided document pages, the total amount of upfront payments and equity investments made by Pfizer in its collaborations with BioNTech for the shingles vaccine program and the Comirnaty (COVID-19 vaccine) program as of December 31, 2023, is $225 million. This includes a $75 million upfront cash payment and a $150 million equity investment under the December 30, 2021 agreement for the shingles vaccine program, as detailed in the collaboration agreement with BioNTech on page 74. The document does not specify additional upfront payments or equity investments for the Comirnaty program beyond the initial $225 million total for the shingles collaboration, which is the only specific figure provided for BioNTech-related upfront payments and equity investments in the context of the question.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final total of $225 million, whereas the ground truth states the total amount is $375 million. The LLM incorrectly limits the total to only the shingles vaccine program components ($75M upfront + $150M equity investment), but fails to include the additional $150 million related to the Comirnaty program, which is necessary for the correct total. (2) The quantitative values mentioned for the shingles agreement ($75M and $150M) are accurate and correctly cited from the document, but the synthesis across programs is incomplete. The calculation of $225M is correct for the shingles program alone, but the question asks for both shingles and Comirnaty programs. The missing $150M (presumably from the Comirnaty collaboration) results in a significant undercount. (3) The reasoning is partially sound in identifying the shingles program components and citing the correct document page, but it fails the multi-hop requirement by not incorporating the Comirnaty-related upfront or equity components. The statement that 'the document does not specify additional upfront payments or equity investments for the Comirnaty program' contradicts the ground truth and suggests a failure to retrieve or synthesize the full set of relevant data. (4) The contextual relevance is fair because the answer addresses the right companies, programs, and types of payments, and cites a relevant document section. However, the omission of a key component of the Comirnaty collaboration leads to a materially incorrect conclusion, warranting low scores in correctness and quantitative accuracy despite some accurate subcomponents.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 455,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What was the total net income contribution from COP's operations in Europe, Middle East, and North Africa (EMENA) over the three-year period from 2019 to 2021, and how did it compare to the net loss reported in the Lower 48 region during the same period?",
      "original_answer": "COP's operations in the EMENA region contributed a total net income of $1 million in 2019, $6 million in 2020, and a net loss of $24 million in 2021, resulting in a cumulative net loss of $17 million over the three-year period. In contrast, the Lower 48 region reported a net income of $402 million in 2019, $804 million in 2020, and a net loss of $8 million in 2021, resulting in a total net income of $1,206 million over the same period. Therefore, the EMENA region underperformed significantly compared to the Lower 48 region, with a difference of $1,223 million in total net results.",
      "llm_answer": "The net income contribution from ConocoPhillips' operations in Europe, Middle East, and North Africa (EMENA) was a $24 million credit to impairment in 2021, a $6 million charge in 2020, and a $1 million charge in 2019, resulting in a cumulative net gain of $1 million over the three‑year period. In contrast, the Lower 48 region recorded net losses of $804 million in 2020 and $402 million in 2019 (with a $8 million credit in 2021), leading to an overall net loss of $1.206 billion across the same three years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual and directional errors in both the EMENA and Lower 48 financial results. It incorrectly states that EMENA had a 'cumulative net gain of $1 million' when the ground truth shows a cumulative net loss of $17 million. The individual year figures are also misrepresented: while the LLM correctly identifies $1 million and $6 million charges (which it interprets as losses), it incorrectly treats the $24 million impairment credit in 2021 as a 'gain' or positive contribution, when in fact it was a net loss of $24 million. The correct calculation is $1M + $6M - $24M = -$17M, not +$1M. (2) For the Lower 48 region, the LLM reverses the interpretation of profits and losses: it claims net losses of $804M in 2020 and $402M in 2019, when these were actually net income values. It also mischaracterizes the $8 million credit in 2021 as a loss, when it was a smaller loss than prior years but still part of a positive cumulative total. The LLM calculates an overall 'net loss of $1.206 billion' when the correct result is a net income of $1,206 million. This is a critical error in both magnitude and direction. (3) The multi-hop reasoning fails completely: the model does not correctly synthesize the three-year trends, misidentifies the nature of financial results (income vs. loss), and draws an invalid comparison. The conclusion that EMENA outperformed Lower 48 is the opposite of the truth. (4) Scores are low due to pervasive quantitative and qualitative inaccuracies. Contextual relevance is moderate because the answer addresses the right regions and time frame, but the substance is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 454,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024, and how does this change contribute to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' over the same period?",
      "original_answer": "The dollar amount decrease in 'Other noncontrolling redeemable interests' from 2023 to 2024 is $3,720 (from $172,912 in 2023 to $169,192 in 2024). This contributes to the overall decrease in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' from $195,949 in 2023 to $184,729 in 2024, a total decrease of $11,220. The decrease in 'Other noncontrolling redeemable interests' accounts for approximately 33.1% of the total decline in the combined metric.",
      "llm_answer": "The dollar amount decrease in \"Other noncontrolling redeemable interests\" from 2023 to 2024 is $3.72 million (down from $172,912 thousand to $169,192 thousand). This reduction accounts for a $11,220 thousand ($11.22 million) decline in the combined total of \"Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties\" over the same period.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar decrease in 'Other noncontrolling redeemable interests' as $3,720 thousand ($3.72 million), which matches the ground truth (from $172,912 to $169,192). However, it incorrectly states that this reduction accounts for a $11,220 thousand decline in the combined total, which is factually wrong. The $11,220 thousand is the total decline in 'Total preferred units, at liquidation value, and noncontrolling redeemable interests in properties' (from $195,949 to $184,729), not the contribution from 'Other noncontrolling redeemable interests'. The LLM conflates the total decline with the contribution, failing to note that the $3,720 decrease is only a portion (33.1%) of the $11,220 total decline. (2) Numeric values for the decrease and starting/ending amounts are accurate, but the causal relationship in the second part is incorrect. The calculation of the total decrease ($195,949 - $184,729 = $11,220) is correct in the background but misattributed. (3) The multi-hop reasoning fails: the model should have stated that the $3,720 decrease contributes to the overall $11,220 decrease, not that it accounts for it entirely. The ground truth includes the percentage contribution (33.1%), which the LLM omits, indicating incomplete synthesis. (4) Correctness and quantitative accuracy are scored at 6 due to correct numbers but major error in interpretation and attribution. Qualitative accuracy is 6 due to flawed reasoning in connecting the partial decrease to the total. Contextual relevance is high (9) as the answer addresses the right metrics and time period, just with incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 450,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "What is the total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, and how does this compare to the combined fair value of these two asset categories from the prior year?",
      "original_answer": "The total fair value of foreign corporate debt and asset-backed securities held by MMM as of December 31, 2024, is $55 million ($31 million in foreign corporate debt + $24 million in asset-backed securities). As of December 31, 2023, the combined fair value of these two assets was $0 million, as both categories had no value reported in that year.",
      "llm_answer": "As of December 31 2024, the fair value of foreign corporate debt held by 3M was $31 million and the fair value of asset‑backed securities was $24 million, for a combined total of $55 million. This compares with $0 million for both categories in the prior year (2023), meaning the combined fair value increased from $0 million to $55 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $31 million for foreign corporate debt and $24 million for asset-backed securities in 2024, summing to $55 million; both categories were $0 in 2023. The calculation of the combined total ($31M + $24M = $55M) is correct. (2) The answer is complete, addressing both parts of the question: the total fair value as of December 31, 2024, and the comparison to the prior year (2023). (3) Entity accuracy is correct—'3M' is an accepted reference to MMM, and the years (2024 and 2023) are properly identified. (4) The multi-hop reasoning is sound: the model correctly synthesized data across two asset categories and two years, noting the absence of values in 2023 and the emergence of $55 million in 2024. The comparison ('increased from $0 million to $55 million') is logically and factually accurate. (5) Semantic equivalence is maintained—wording differs slightly but conveys the same precise information as the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 298,
        "total_tokens": 1490
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do technical errors and data limitations in Meta's Family metrics estimation process affect the accuracy of its monthly active people (MAP) and average revenue per person (ARPP) metrics, and by what approximate margin could these metrics vary due to such inaccuracies?",
      "original_answer": "Meta acknowledges that its Family metrics, including monthly active people (MAP) and average revenue per person (ARPP), are based on internal data and are inherently subject to statistical variances, uncertainties, and technical errors in their estimation process. The company uses complex algorithms, machine learning models, and user survey data calibrated against signals like IP addresses and device information to estimate the number of unique individuals using its platforms. These models require significant judgment and are affected by data limitations. Meta estimates that the potential error margin for its Family metrics is generally around 3% of its worldwide MAP. Given that Meta reported approximately 3.3 billion worldwide MAP in 2023, this 3% error margin implies that the actual number of unique users could vary by about 99 million. This level of inaccuracy can significantly affect the reliability of ARPP calculations, which depend on MAP for per-user revenue averaging, and could distort business decisions, investor perceptions, and advertising investments.",
      "llm_answer": "The technical errors and data limitations in Meta's Family metrics estimation process—such as algorithmic inaccuracies, reliance on limited samples and surveys, and challenges in measuring duplicate/false accounts and user geography—can cause MAP and ARPP metrics to vary by approximately 3% of worldwide MAP (around 3% error margin), potentially leading to significant discrepancies from actual user numbers and revenue trends.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core information from the ground truth. (1) It correctly identifies the 3% error margin in Meta's Family metrics estimation process, which aligns with the original answer. It also correctly links this to worldwide MAP, noting that the variation could be around 3%, though it does not explicitly calculate the 99 million user variance from the 3.3 billion MAP figure—this is a minor omission but does not detract significantly from correctness. (2) Quantitatively, all numbers (3%, worldwide MAP reference) are correct and consistent with the ground truth; the absence of the explicit 99 million calculation is not a numerical error but a slight reduction in completeness. (3) The reasoning is sound: it acknowledges technical limitations (algorithmic inaccuracies, survey reliance, duplicate accounts, geography issues) and correctly traces their impact on MAP and ARPP. It synthesizes the cause-effect relationship between estimation errors and downstream business metrics appropriately. (4) The answer is fully contextually relevant, directly addressing how technical and data limitations affect MAP and ARPP and providing the approximate margin of variation. The only reason it doesn't score a 10 is the lack of explicit mention of the 3.3 billion MAP baseline and resulting ~99 million user uncertainty, which adds concrete context in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 389,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does The Home Depot's strategic use of BOPIS, as defined in the glossary, contribute to the fulfillment of 50% of U.S. online orders through stores, as stated in the supply chain section?",
      "original_answer": "The Home Depot's strategic use of BOPIS (Buy Online, Pickup In Store), as defined in the glossary, enables customers to place orders online and pick them up in-store, which directly supports the company's supply chain goal of fulfilling 50% of U.S. online orders through stores. This interconnected retail program is part of a broader set of store-based fulfillment options that enhance customer convenience and optimize inventory distribution across the network.",
      "llm_answer": "The Home Depot’s strategic use of BOPIS—Buy Online, Pickup In Store—directly enables the fulfillment of roughly 50 % of U.S. online orders through its stores by leveraging the company’s interconnected retail network, which integrates store locations as pickup points and forms part of the broader BOPIS/BODFS/BORIS ecosystem described in the supply‑chain section. This approach allows customers to receive the speed and convenience of store‑based fulfillment, driving the high percentage of online orders that are completed at physical locations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The 50% figure for U.S. online orders fulfilled through stores is correctly cited, matching the original answer. (2) Completeness: The response addresses how BOPIS contributes to store-based fulfillment, referencing the interconnected retail network and broader ecosystem (BOPIS/BODFS/BORIS), which is consistent with the supply chain section. (3) Entity accuracy: 'The Home Depot', 'BOPIS', and 'U.S. online orders' are correctly identified. (4) Reasoning: The logic is sound—BOPIS leverages store locations as fulfillment points, enabling faster pickup and supporting the 50% target. The mention of the 'broader BOPIS/BODFS/BORIS ecosystem' adds context not in the original but is consistent with the source material and enhances the explanation without introducing inaccuracies. (5) Semantic equivalence: The core message—that BOPIS enables store fulfillment of half of online orders by using stores as fulfillment nodes—is preserved. The only minor gap is that the original emphasizes 'customer convenience and inventory optimization' as outcomes, which the LLM touches on ('speed and convenience') but could have more fully reflected the inventory distribution aspect. This slight omission prevents a perfect 10 on qualitative accuracy, but overall the answer is highly accurate and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 386,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Morgan Stanley's approach to recognizing compensation expense for Deferred Cash-Based Compensation (DCP) awards differ from its recognition of carried interest compensation, particularly in terms of timing and the nature of the awards?",
      "original_answer": "Morgan Stanley recognizes compensation expense for DCP awards over the vesting period, adjusted for changes in the fair value of referenced investments selected by employees. In contrast, carried interest compensation is recognized immediately for any portion of carried interest (both realized and unrealized) allocated to employees, without being tied to a vesting schedule. This distinction reflects the different nature of the awards: DCP awards are deferred and tied to vesting conditions, while carried interest compensation is directly linked to performance-based allocations that are recognized as they occur.",
      "llm_answer": "Morgan Stanley recognizes compensation expense for Deferred Cash-Based Compensation (DCP) awards based on the notional value of the award adjusted for changes in the fair value of referenced investments, recognizing the expense over the vesting period relevant to each separately vesting portion of the deferred award. In contrast, for carried interest compensation, the Firm generally recognizes expense for any portion of carried interest (both realized and unrealized) allocated to employees, without the same deferred recognition over a vesting period tied to specific award terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that DCP awards have compensation expense recognized over the vesting period, adjusted for changes in the fair value of referenced investments, while carried interest compensation is recognized immediately for both realized and unrealized portions allocated to employees, without deferral over a vesting schedule. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no issues here. (3) The multi-hop reasoning is sound: the model correctly synthesizes the difference in timing (over vesting period vs. immediate) and nature (deferred with vesting conditions vs. performance-based allocation) of the two types of awards. (4) The only minor shortcoming is that the LLM answer does not explicitly state that carried interest is 'not tied to a vesting schedule' in the same direct way as the original, though it implies this by saying there is 'no...deferred recognition over a vesting period.' It also omits the explicit characterization of the 'nature of the awards' in comparative terms (deferred vs. performance-linked), which slightly weakens qualitative completeness. However, the semantic meaning and factual content are substantially equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 407,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, based on the information provided?",
      "original_answer": "The total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, as neither entity reported any such interests redeemable at amounts in excess of fair value.",
      "llm_answer": "Based on the provided document pages, the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $184,729 (in thousands). This figure represents the combined carrying amount of the 7.50% cumulative redeemable preferred units ($15,537) and other noncontrolling redeemable interests ($169,192) as reported in the table summarizing these items on page 129. The document explicitly states this total as $184,729 for 2024, with the corresponding 2023 amount being $195,949.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The ground truth states that the total amount of noncontrolling redeemable interests in properties classified as temporary equity by both Simon Property Group and the Operating Partnership as of December 31, 2024, is $0, because neither entity reported any such interests redeemable at amounts in excess of fair value. The LLM answer incorrectly reports a figure of $184,729,000 (in thousands), citing a table on page 129 that appears to include preferred units and other interests. However, this misinterprets the classification criteria: only interests redeemable at amounts in excess of fair value are classified as temporary equity. The original answer explicitly states that no such interests exist, hence the correct amount is $0. The LLM fails to apply the correct accounting principle (temporary equity classification threshold), leading to a completely incorrect quantitative result. The reasoning is flawed, as it simply sums disclosed redeemable interests without evaluating their classification basis. This represents a failure in multi-hop reasoning and understanding of financial reporting standards. Even if the cited numbers ($15,537k and $169,192k) exist in the document, their inclusion is contextually inappropriate for this specific question about temporary equity classification. Therefore, the answer is factually wrong, lacks correct reasoning, and misrepresents the financial reality.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 398,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, and how does this compare to the carrying amount of NEE's special use funds on its consolidated balance sheet for the same date?",
      "original_answer": "The total estimated fair value of NEE's nuclear decommissioning fund assets and FPL's storm fund assets combined as of December 31, 2021, is $8,922 million ($8,846 million for NEE and $76 million for FPL). This amount represents the fair value of the special use funds, which are primarily composed of equity and available-for-sale debt securities. However, on NEE's consolidated balance sheet, these special use funds are reported at their carrying amount of $2,505 million as of December 31, 2021. The significant difference between the fair value and carrying amount reflects the accounting treatment where certain investments are carried at fair value, while others are reported at amortized cost or adjusted based on regulatory treatment.",
      "llm_answer": "The total estimated fair value of NEE’s nuclear decommissioning fund assets and FPL’s storm fund assets combined as of December 31 2021 was approximately **$8,922 million** ($8,846 million for the nuclear fund plus $76 million for the storm fund). This exceeds the carrying amount of NEE’s special‑use funds on its consolidated balance sheet for the same date, which was reported as **$906 million** for NEE and **$672 million** for FPL (totaling $1,578 million), meaning the fair‑value estimate is substantially higher than the recorded carrying amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total estimated fair value of $8,922 million, broken down into $8,846 million for NEE's nuclear decommissioning fund and $76 million for FPL's storm fund, which matches the ground truth. However, it incorrectly reports the carrying amount of NEE's special use funds as $906 million for NEE and $672 million for FPL (totaling $1,578 million), which is factually wrong. The ground truth states the consolidated carrying amount is $2,505 million, not $1,578 million. The LLM appears to have misattributed or miscalculated the components of the carrying amount, possibly confusing individual fund values or pulling incorrect data points. (2) The fair value calculation is accurate: $8,846M + $76M = $8,922M. However, the carrying amount is incorrect: the LLM reports $1,578M vs. the correct $2,505M, a significant error. The individual figures of $906M and $672M do not align with the ground truth and introduce major quantitative inaccuracies. (3) The multi-hop reasoning is partially sound — the model correctly combines fair values from two entities (NEE and FPL) and compares them to the carrying amount on the consolidated balance sheet. However, the failure to report the correct consolidated carrying amount undermines the comparison and indicates a breakdown in synthesis or data retrieval. (4) The contextual relevance is high — the answer addresses both parts of the question and uses appropriate financial terminology. However, due to the major error in the carrying amount, the correctness and quantitative accuracy scores are significantly reduced. The qualitative accuracy is moderate because the reasoning structure is logical but based on incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 467,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "What is the significance of APJC as both a geographic segment in which Cisco operates and as a region tied to Cisco's consolidated financial reporting, and how does this dual role influence Cisco's internal performance measurement?",
      "original_answer": "Cisco reports its operations across three geographic segments: the Americas, EMEA, and APJC. APJC is not only a key operating segment where Cisco generates revenue but also a region whose financial results are fully incorporated into Cisco’s consolidated financial statements. This dual role means that performance metrics such as revenue and gross margin from the APJC segment directly feed into Cisco’s overall financial reporting, even though certain expenses like R&D and restructuring charges are not allocated to the segment for internal management review. Therefore, APJC's financial performance influences both strategic decisions and consolidated earnings.",
      "llm_answer": "APJC serves as both a geographic segment in Cisco's internal management structure and a key region for consolidated financial reporting. Cisco allocates revenue and gross margin to APJC based on customer ordering location, but does not allocate R&D, sales/marketing, or G&A expenses to segments, meaning APJC's performance is measured solely on its revenue and gross margin without internal cost allocations. This dual role allows Cisco to track APJC's contribution to overall segment performance while ensuring its financial results are directly reflected in the consolidated statements used by the CODM.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies APJC as both a geographic operating segment and a region tied to consolidated financial reporting, and accurately describes how revenue and gross margin are attributed to APJC while certain expenses (R&D, sales/marketing, G&A) are not allocated to segments—consistent with the original answer. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a traditional sense, but all financial concepts (revenue, gross margin, expense allocation) are used correctly. (3) The multi-hop reasoning is sound: the model synthesizes the dual role of APJC in internal performance measurement and external financial reporting, correctly noting that performance is assessed on revenue and gross margin only, which directly feed into consolidated results. (4) The only minor omission is that the original answer explicitly mentions the three geographic segments (Americas, EMEA, APJC), which the LLM omits, slightly reducing completeness. However, this does not detract significantly from the core explanation. The LLM captures the essence of APJC’s influence on strategic decisions and consolidated earnings through its unallocated performance metrics. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 382,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What percentage of Verizon Business Group's total revenues in 2024 came from Business Markets and Other, and how does this segment specifically incorporate FWA broadband into its offerings?",
      "original_answer": "Business Markets and Other generated $13.1 billion in revenues in 2024, which represented 44% of the Verizon Business Group's total revenues. This segment incorporates FWA broadband as one of its wireless services, offering fixed connectivity solutions comparable to residential services but tailored for small and medium businesses.",
      "llm_answer": "In 2024, Business Markets and Other contributed $13.1 billion in revenue, which is roughly 44 % of Verizon Business Group’s total $29.5 billion revenue. This segment incorporates FWA broadband by offering fixed wireless access connectivity—using its 5G or 4G LTE networks—to both Consumer and Business customers, providing fixed broadband services as part of its portfolio of wireless and wireline solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Business Markets and Other generated $13.1 billion in revenue in 2024, representing 44% of Verizon Business Group's total revenues. It also correctly infers the total revenue as $29.5 billion (since $13.1B is ~44% of $29.5B), which aligns with the ground truth. All numeric values and percentages are accurate. (2) Quantitative accuracy is perfect: $13.1 billion, 44%, and implied total of $29.5 billion are consistent and correct. Format variations (e.g., '44 %' with space) are acceptable. (3) The reasoning is sound and reflects multi-hop synthesis: linking revenue figure to percentage of total, and correctly identifying FWA broadband as part of the segment’s offerings. The only minor deviation is that the original answer specifies FWA is tailored for small and medium businesses, while the LLM generalizes it to both Consumer and Business customers. This slightly overgeneralizes, as the Business Markets segment focuses on business clients, not consumers. However, the core fact that FWA is offered as a fixed connectivity solution via wireless networks is correct. (4) Scores reflect near-perfect factual accuracy, with only a small nuance missing in audience specificity, not affecting overall correctness. Contextual relevance is full, as all parts of the question are addressed accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 377,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the total fair value of Abbott's interest rate hedge contracts in 2024, and how does this compare to the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $50 million (payable position of $51 million offset by a $1 million receivable position). This is significantly smaller than the total notional amount of all foreign currency forward exchange contracts, which was $23.2 billion as of December 31, 2024.",
      "llm_answer": "The total fair value of Abbott's interest rate hedge contracts in 2024 is $1 billion (shown as a $1 million fair‑value asset), while the total notional amount of all foreign currency forward exchange contracts held by Abbott as of the same date is $16.2 billion.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total fair value of Abbott's interest rate hedge contracts is stated as $1 billion (with a $1 million asset), but the ground truth is $50 million (a net payable of $51 million offset by a $1 million receivable). This is off by two orders of magnitude. The notional amount of foreign currency forward contracts is reported as $16.2 billion, whereas the correct value is $23.2 billion as of December 31, 2024. Both key figures are incorrect. (2) Quantitative accuracy is very low: the fair value is wrong by $950 million (claiming $1B vs actual $50M), and the notional amount is off by $7 billion. No correct calculations or comparisons can be derived from these numbers. (3) The multi-hop reasoning is flawed—while the model attempts to compare two financial instruments (interest rate hedges vs. foreign exchange forwards), it fails to correctly extract or synthesize the data from the underlying documents. The mention of a '$1 million fair-value asset' may reflect confusion with the $1 million receivable in the ground truth, but it is misrepresented as the total fair value rather than a component of a net $50 million liability. (4) Contextual relevance is moderate—the answer addresses the right entities (Abbott, interest rate hedges, foreign currency forwards) and the correct year (2024), and attempts the required comparison. However, due to severe numerical errors, the conclusion about the relative sizes of the two positions is unreliable. The qualitative reasoning structure is present but built on incorrect data, leading to a mostly incorrect answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 449,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What does the relationship between proved undeveloped reserves and net acreage in Asia suggest about Equity Companies' development potential in the region, and how does this compare to their consolidated subsidiaries' efficiency in utilizing land for reserves?",
      "original_answer": "Equity Companies in Asia reported 1,503 million barrels of proved undeveloped reserves against 19 thousand net acres. This results in a reserves-to-acre ratio of approximately 79.1 million barrels per thousand acres. In comparison, XOM's consolidated subsidiaries in Asia reported 1,315 million barrels of proved undeveloped reserves against 640 thousand net acres, yielding a reserves-to-acre ratio of approximately 2.05 million barrels per thousand acres. This indicates that Equity Companies are significantly more efficient in terms of reserves per acre in Asia, suggesting a potentially higher development potential in the region.",
      "llm_answer": "The data shows that in Asia, proved undeveloped reserves (1,186 million barrels of crude oil equivalent) are roughly 33 % of the region’s total undeveloped acreage (3,563 thousand acres), indicating a relatively high reserve‑to‑acreage ratio that points to strong development potential. In contrast, the consolidated subsidiaries’ overall undeveloped acreage (61,948 thousand acres) supports only about 3.2 million barrels of undeveloped reserves, reflecting a much lower reserve‑to‑acreage efficiency. Thus, Equity Companies appear to be leveraging their Asian acreage far more effectively to generate reserves than the broader consolidated operation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It reports 1,186 million barrels of proved undeveloped reserves and 3,563 thousand net acres for Equity Companies in Asia, which contradicts the ground truth of 1,503 million barrels and 19 thousand net acres. Similarly, it claims consolidated subsidiaries have 61,948 thousand net acres supporting only 3.2 million barrels of reserves, whereas the truth is 640 thousand net acres with 1,315 million barrels. These numbers are not only wrong but drastically misrepresent the scale and efficiency. (2) Calculations are therefore invalid: the claimed 33% ratio and '3.2 million barrels' are unsupported. In reality, the correct reserves-to-acre ratios are ~79.1 million per thousand acres (Equity Companies) vs ~2.05 million per thousand acres (XOM subsidiaries), showing Equity Companies are more efficient—opposite to the LLM’s implication. (3) The multi-hop reasoning is flawed: the model fails to correctly identify the entities (confusing Equity Companies with consolidated subsidiaries), misattributes data, and draws an incorrect comparative conclusion about efficiency. It does not compute or reference the correct ratios that support the ground truth conclusion. (4) Despite incorrect numbers and reasoning, the answer attempts to address the question’s structure—comparing development potential via reserve-to-acreage efficiency—and maintains relevant context, hence moderate contextual relevance. However, due to severe quantitative and qualitative errors, the correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 432,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What is the significance of the Parent Company's unconditional guarantee of securities issued by Morgan Stanley Finance LLC, and how does this guarantee relate to the Firm's broader obligations under its amended and restated support agreement in the context of a resolution scenario?",
      "original_answer": "The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary, which ensures that these securities are backed by the full credit of the Parent Company. In the context of a resolution scenario, the Parent Company is also obligated under an amended and restated support agreement to contribute all of its contributable assets to its supported entities and/or the Funding IHC. The Funding IHC, in turn, would be obligated to provide capital and liquidity to its supported entities. These mechanisms are interconnected, as the guarantee of Morgan Stanley Finance LLC's securities represents one of the Parent Company's financial commitments that could be called upon during a resolution event, and the support agreement formalizes the process for distributing capital and liquidity across the organization during such a scenario.",
      "llm_answer": "The Parent Company’s unconditional guarantee of the securities issued by Morgan Stanley Finance LLC is a key component of its broader resolution‑planning framework. Under the amended and restated support agreement with its material entities—including the Funding IHC—the Parent Company is required to contribute all of its contributable assets (subject to certain exclusions) to its supported entities in a resolution scenario, and the Funding IHC must provide the necessary capital and liquidity. This guarantee therefore ensures that, if a resolution event occurs, the Parent Company’s obligation to support its subsidiaries is enforceable on a senior, secured basis against its own assets and those of the Funding IHC.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core elements of the ground truth. (1) All factual components are correct: the Parent Company's unconditional guarantee of Morgan Stanley Finance LLC's securities, the existence of the amended and restated support agreement, the obligation to contribute contributable assets in a resolution scenario, and the role of the Funding IHC in providing capital and liquidity are all correctly identified. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links the guarantee to the broader resolution framework and connects it to the support agreement and capital/liquidity distribution mechanism. The only minor shortcoming is that the LLM states the guarantee is enforceable 'on a senior, secured basis' against the Parent Company’s and Funding IHC’s assets—a detail not present in the ground truth and potentially overreaching, as the original answer does not specify the seniority or security status of the guarantee. This introduces a slight factual assumption not supported by the source. (4) Despite this nuance, the answer remains contextually precise, comprehensive, and aligned with the intent and substance of the original answer. The connection between the guarantee and the support agreement in a resolution context is correctly synthesized. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy due to absence of numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 437,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does the Bipartisan Budget Act of 2015's partnership tax audit rules potentially affect Simon Property Group's (SPG) financial obligations through its joint venture investments, including those managed by third parties such as Klépierre and The Taubman Realty Group, LLC?",
      "original_answer": "The Bipartisan Budget Act of 2015 introduced partnership tax audit rules that assess taxes, interest, or penalties at the partnership level for audit adjustments to income, gain, loss, deduction, or credit items. Simon Property Group (SPG), through its investments in 84 joint venture properties and entities like Klépierre and The Taubman Realty Group, LLC, could be required to bear the economic burden of these taxes, interest, and penalties even though SPG and its subsidiary REITs may not otherwise have been subject to additional corporate-level taxes had they owned the assets directly. This financial exposure arises because SPG applies the equity method of accounting to these joint ventures, and as a direct or indirect partner, SPG may be liable for partnership-level assessments without the ability to opt out of the rules, potentially resulting in material adverse effects on SPG's financial position.",
      "llm_answer": "The Bipartisan Budget Act of 2015 subjects partnership investments—including those in joint ventures such as those managed by Klépierre and The Taubman Realty Group, LLC—to partnership‑level tax audits; any audit adjustments that increase a partnership’s tax liability can flow through to Simon Property Group as a partner, obligating it to bear the resulting taxes, interest and penalties even though the REIT structure may not incur corporate‑level tax on the same items. Consequently, audit‑related liabilities could increase SPG’s overall financial obligations and affect the profitability of its joint‑venture holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the Bipartisan Budget Act of 2015 introduced partnership-level tax audit rules; SPG, as a partner in joint ventures including Klépierre and The Taubman Realty Group, LLC, may bear the economic burden of taxes, interest, and penalties from audit adjustments. The answer correctly notes that SPG's REIT structure typically avoids corporate-level taxes, but partnership-level assessments can still impose financial obligations. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., 84 joint ventures) are mentioned in the LLM answer, their absence does not detract from correctness, as the focus is on the mechanism and impact of the rules rather than enumerating investments. The omission of '84 joint venture properties' is a minor completeness gap but does not affect the core reasoning or factual accuracy. (3) Multi-hop reasoning is sound: the model correctly links the 2015 Act's rules → application to joint ventures → SPG's partnership interest → potential tax liability at partnership level → economic burden on SPG despite REIT status. Entities (SPG, Klépierre, Taubman, REIT structure) are accurately identified and logically connected. (4) The answer is highly contextually relevant, directly addressing how the Act affects SPG’s financial obligations through third-party-managed joint ventures. Wording differs slightly but meaning is preserved. A score of 9 is given because the LLM omits the detail about SPG applying the equity method of accounting and the inability to opt out of the rules—nuances present in the original that strengthen the explanation—but the core financial exposure and reasoning are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 479,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Lockheed Martin's investment impairment in AMMROC in 2020 and restructuring charges in RMS in 2021 collectively impact net earnings and per-share results in those respective years?",
      "original_answer": "Lockheed Martin's noncash impairment charge of $128 million in 2020 on its investment in AMMROC decreased net earnings from continuing operations by $96 million, or $0.34 per share after tax. In 2021, Lockheed recorded a $36 million severance and restructuring charge ($28 million, or $0.10 per share after tax) associated with plans to close and consolidate facilities and reduce the workforce within the RMS business segment. Together, these events reduced net earnings by $96 million in 2020 and $28 million in 2021, with per-share impacts of $0.34 and $0.10, respectively.",
      "llm_answer": "The $1.7 billion non‑cash pension settlement charge recorded in 2021 (reflected in the RMS restructuring actions) reduced net earnings from continuing operations by about $1.3 billion after tax, while the $225 million loss on a classified Aeronautics program also weighed on results.  In 2020, the $128 million impairment of the AMMROC investment (recorded as an other‑non‑operating expense) lowered earnings, and the 2021 severance and restructuring charges of $36 million further pressured net earnings and diluted earnings per share in both years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. It incorrectly states a '$1.7 billion non-cash pension settlement charge in 2021' and a '$225 million loss on a classified Aeronautics program', neither of which are mentioned in the ground truth and are not part of the question about AMMROC impairment and RMS restructuring. The only correct numeric value is the $128 million AMMROC impairment in 2020 and the $36 million severance/restructuring charge in 2021. However, it fails to report the correct after-tax impacts: $96 million (or $0.34 per share) in 2020 and $28 million (or $0.10 per share) in 2021. Instead, it vaguely states the charges 'lowered earnings' and 'pressured net earnings' without specifying the exact per-share or after-tax effects. (2) Quantitative accuracy is very low: the $1.7B and $225M figures are entirely fabricated or misattributed, and the correct after-tax amounts ($96M, $28M, $0.34, $0.10) are missing. The pre-tax $36M charge is correct but not sufficient without the after-tax impact. (3) Multi-hop reasoning is flawed: the model conflates unrelated charges (pension, Aeronautics loss) with the RMS restructuring, failing to isolate the specific impacts of AMMROC and RMS as required. It does not correctly synthesize the tax effects or per-share impacts across years. (4) Contextual relevance is moderate because it addresses Lockheed Martin, AMMROC, RMS, and the correct years, but introduces irrelevant and incorrect financial events that distort the answer. The core required synthesis of after-tax and per-share impacts is missing, leading to a largely incorrect response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 447,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "What was the year-over-year change in the balance of channel partner financing subject to guarantees, and how does this relate to Cisco's overall liquidity and capital resource requirements as stated in the MD&A section?",
      "original_answer": "The balance of channel partner financing subject to guarantees decreased from $1.7 billion in fiscal 2023 to $1.2 billion in fiscal 2024, representing a year-over-year decrease of $0.5 billion. Cisco states in its MD&A that it believes its cash and cash equivalents, investments, and cash generated from operations will satisfy its liquidity requirements, including working capital needs, capital expenditures, investment requirements, and commitments such as financing guarantees. This indicates that despite the decrease in guaranteed financing balances, Cisco remains confident in its ability to support such obligations through existing resources.",
      "llm_answer": "The year‑over‑year change in the balance of channel‑partner financing subject to guarantees is a decrease of $0.5 billion (from $1.7 billion at July 29 2023 to $1.2 billion at July 27 2024). This reduction is reflected in the MD&A discussion of liquidity and capital resources, which notes that the company’s cash, operating cash flow, and access to capital markets will continue to meet its working‑capital, capital‑expenditure, investment, dividend, repurchase and contractual‑obligation needs, implying that the lower guaranteed financing balance lessens near‑term cash‑outflow pressure and supports overall liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the year-over-year decrease in channel partner financing subject to guarantees as $0.5 billion, with accurate starting and ending balances of $1.7 billion in fiscal 2023 and $1.2 billion in fiscal 2024. The dates (July 29, 2023, and July 27, 2024) align with Cisco's fiscal year-ends and are consistent with SEC filing conventions, though the original answer does not specify exact dates—this addition is accurate and adds precision without introducing error. (2) The calculation of the $0.5 billion decrease is correct: $1.7B - $1.2B = $0.5B. All numeric values match the ground truth in both amount and direction (decrease). Format variations (e.g., $0.5 billion vs. $500 million) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the LLM correctly links the quantitative change to Cisco’s MD&A discussion on liquidity and capital resources. It accurately reflects Cisco’s stated confidence in meeting obligations through cash, investments, and operating cash flow. The LLM adds interpretive value by noting that the lower guaranteed financing balance 'lessens near-term cash-outflow pressure,' which is a reasonable inference from the reduction in contingent liabilities and aligns with the intent of the MD&A disclosure. While the original answer emphasizes Cisco’s belief in its ability to support obligations, the LLM extends this to imply improved liquidity due to reduced exposure—a logical and contextually appropriate interpretation. (4) The answer is fully contextually relevant, addressing both the quantitative change and its implication for liquidity. The only minor deviation from the original is the slightly more interpretive tone regarding reduced cash-outflow pressure, but this does not contradict the ground truth and enhances the explanation without introducing inaccuracy. Thus, the answer is factually correct, complete, and well-reasoned, warranting a high score with only a slight deduction in qualitative accuracy due to the added inference not explicitly stated in the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 561,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories in the 2024 10-K filing of VZ, and which category has the higher value?",
      "original_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,653 million. The first asset category reports 'Investments measured at NAV' at $2,656 million, while the second reports it at $3 million. Therefore, the first category has the higher value.",
      "llm_answer": "The difference in the total value of 'Investments measured at NAV' between the two disclosed asset categories is $2,656 million, and the Pension Plans category has the higher value.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major quantitative error: it states the difference is $2,656 million, which is incorrect. The correct difference is $2,653 million (from $2,656 million minus $3 million). The LLM incorrectly reports the difference as equal to the larger value rather than the result of the subtraction. (2) While the LLM correctly identifies that one category has a significantly higher value (implied by stating 'Pension Plans' has the higher value), the ground truth does not name the categories (e.g., 'Pension Plans')—this introduces an unverified entity name not present in the original answer, reducing entity accuracy. (3) The multi-hop reasoning is partially sound: the model identifies that a comparison between two categories is needed and concludes the correct direction (which is higher), but fails the calculation step, which is central to the question. (4) The contextual relevance is high because the answer addresses the core question about difference and relative magnitude, but the numerical inaccuracy severely undermines correctness. The qualitative accuracy is moderate because reasoning structure is present but based on flawed data or logic. Quantitative accuracy is low due to the critical miscalculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 352,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does Abbott's production focus on Diabetes Care Devices, as stated in its 2024 10-K filing, relate to the 18.1% revenue increase in its Diabetes Care business, and what accounting policy supports the recognition of this revenue?",
      "original_answer": "Abbott's Diabetes Care business generated $6.805 billion in revenue in 2024, representing an 18.1% increase from the prior year. This growth aligns with Abbott's core business of producing health care products, including Diabetes Care Devices. The revenue from these devices is recognized upon the transfer of control, which occurs upon shipment or delivery, depending on the customer contract terms. This revenue recognition policy ensures that sales from Diabetes Care Devices are recorded in the period when control is transferred to the customer, supporting the reported increase in revenue.",
      "llm_answer": "Abbott's 2024 10‑K notes that its Diabetes Care business contributed to an 18.1 % rise in total net sales for the Diabetes Care segment, driven by continued growth in its CGM systems and related sales. The revenue from this segment is recognized under Abbott’s revenue‑recognition policy, which records product sales when control transfers—generally upon shipment or delivery—while allocating the transaction price to each performance obligation based on estimated standalone selling prices.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor omissions affecting completeness. (1) Quantitatively, the 18.1% revenue increase is correctly stated, and the revenue recognition timing (upon shipment or delivery) is accurate. However, the LLM omits the specific revenue figure of $6.805 billion mentioned in the original answer, which is a key quantitative detail. While not always required, the absence of this number reduces quantitative completeness. (2) The accounting policy is accurately described: revenue is recognized when control transfers, generally upon shipment or delivery, and the mention of allocating transaction price to performance obligations based on standalone selling prices adds detail consistent with ASC 606, though not explicitly in the ground truth. This is correct but slightly beyond the scope of the original answer. (3) The reasoning correctly links Abbott's production focus (CGM systems) to the revenue increase and ties it to the revenue recognition policy, demonstrating sound multi-hop logic across business focus, performance, and accounting policy. (4) Contextually, the answer is fully relevant, addressing all parts of the question—growth driver, business focus, and accounting policy. The omission of the exact revenue amount prevents a higher score, but core facts and synthesis are accurate. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 390,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does The Home Depot's emphasis on project planning tools influence its competitive positioning with Pros, based on the specific customer expectations outlined in both sections of the 2024 10-K filing?",
      "original_answer": "The Home Depot's emphasis on project planning tools directly supports its competitive positioning with Pros by addressing their specific needs for dedicated sales support, product depth, and job-lot quantities for complex purchase needs, as outlined in both sections of the 2024 10-K. This focus enhances the interconnected shopping experience, which is critical for retaining and attracting Pros who require tailored solutions and streamlined purchasing processes.",
      "llm_answer": "The Home Depot’s 2024 10‑K highlights that its “project planning tools” and other digital capabilities are central to delivering a differentiated, interconnected shopping experience for Pros—offering tailored product assortments, faster delivery, and specialized credit and loyalty programs. These tools help Home Depot meet the high‑expectation, project‑focused needs of professional customers, strengthening its competitive positioning against other retailers that lack comparable planning and fulfillment infrastructure. Consequently, the ability to provide robust project‑planning and execution tools is a key differentiator that reinforces Home Depot’s market share and growth with Pros.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth in terms of the core message: The Home Depot's project planning tools strengthen its competitive positioning with Pros by addressing their complex, project-focused needs. The answer correctly identifies the interconnected shopping experience, tailored solutions, and digital capabilities as key differentiators, which are consistent with the 2024 10-K's emphasis. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM omits specific mention of 'dedicated sales support, product depth, and job-lot quantities'—key elements explicitly outlined in the original answer as customer expectations directly addressed by project planning tools. While the LLM captures the general idea of tailored assortments and fulfillment, it does not fully synthesize all the specific customer expectations mentioned in both sections of the 10-K, resulting in a minor gap in multi-hop reasoning completeness. However, the overall reasoning is sound, logically structured, and contextually highly relevant, clearly linking project tools to Pro customer retention and competitive advantage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 350,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total number of shares available for award under the 2003 Incentive Program, the 2004 Non-Employee Director Restricted Stock Plan, and the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan as of the end of 2024?",
      "original_answer": "The total number of shares available for award under the three plans is 56,689,904. This includes 47,088,821 shares under the 2003 Incentive Program, 238,700 shares under the 2004 Non-Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer LTIP.",
      "llm_answer": "The total number of shares available for award as of the end of 2024 is 47 million under the 2003 Incentive Program, 238,700 shares under the 2004 Non‑Employee Director Restricted Stock Plan, and 9,362,383 shares under the Pioneer Natural Resources Company Amended and Restated 2006 Long Term Incentive Plan.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of shares for the 2004 Non-Employee Director Restricted Stock Plan (238,700) and the Pioneer 2006 LTIP (9,362,383), which match the ground truth. However, it states '47 million' shares for the 2003 Incentive Program instead of the precise figure 47,088,821. While '47 million' is a reasonable approximation, it lacks the precision required for full quantitative accuracy, especially in financial reporting contexts. (2) The total sum in the ground truth is 56,689,904, which results from adding 47,088,821 + 238,700 + 9,362,383. The LLM does not provide the total, nor does it use the exact figure for the 2003 plan, so the calculation cannot be verified from the response and is effectively omitted. (3) The multi-hop reasoning is partially sound—the model identifies all three plans and associates each with a share amount, showing correct entity mapping and cross-plan synthesis. However, it fails to compute or report the total, which is the central requirement of the question. (4) The contextual relevance is perfect as all entities and timeframes (end of 2024) are correctly addressed. Qualitative accuracy is high due to correct plan identification and mostly accurate data, but quantitative accuracy is reduced due to rounding and missing total. Correctness score is 7 because the core components are present and directionally accurate, but key precision and completeness are lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 401,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the impact of the reclassification of Customer receivables in 2023 on both interest income and interest expense in the Institutional Securities segment, and which specific financial adjustment amount is explicitly tied to this change?",
      "original_answer": "The reclassification of Customer receivables in 2023 resulted in a $4,432 million decrease to both interest income and interest expense in the Institutional Securities segment. This adjustment had no effect on net interest income but was entirely recorded within the Institutional Securities segment as part of aligning prior-year amounts to the current presentation.",
      "llm_answer": "The 2023 reclassification of Customer receivables reduced both interest income and interest expense by $4,432 million, and this $4,432 million adjustment is explicitly tied to the change.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the reclassification occurred in 2023, affected both interest income and interest expense in the Institutional Securities segment, and the adjustment amount was $4,432 million. The answer correctly identifies that this exact amount is explicitly tied to the change. (2) Quantitatively, the figure $4,432 million is correctly stated, matching the ground truth precisely, with acceptable formatting (using 'million' instead of 'M' or full numeric form). (3) The multi-hop reasoning is sound—the model correctly synthesizes that the reclassification led to equal reductions in both interest income and expense, which aligns with the nature of reclassifications not affecting net interest income. Although the LLM answer omits the explicit mention of 'no effect on net interest income' and 'aligning prior-year amounts', these are contextual details rather than core components of the question, which focused on the impact on interest income/expense and the tied adjustment amount. (4) The answer is contextually relevant, directly addressing all parts of the question without extraneous information. The omission of segment-level context about presentation alignment does not detract from factual correctness on the specific impacts asked. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 385,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What were the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined, and what types of contracts are included in the category of net investment hedge derivatives according to the disclosures?",
      "original_answer": "The total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined were $208 million ($133 million in 2019 and $75 million in 2021). According to the disclosures, net investment hedge derivatives include cross-currency interest rate swaps and forward contracts.",
      "llm_answer": "Based on the disclosures in the provided pages, the total amounts excluded from hedge effectiveness for net investment hedge derivative contracts in 2019 and 2021 combined are $133 million (2019) plus $75 million (2021), which equals $208 million. The net investment hedge derivatives primarily consist of cross‑currency interest rate swaps and forward contracts, and the company also designates certain non‑U.S. dollar‑denominated debt as a net investment hedge for its non‑U.S. operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total amount excluded from hedge effectiveness in 2019 and 2021 as $208 million, accurately breaking it down into $133 million (2019) and $75 million (2021), which matches the ground truth. The calculation (133 + 75 = 208) is correct. (2) The types of contracts included in net investment hedge derivatives are correctly stated as cross-currency interest rate swaps and forward contracts. However, the LLM added information not present in the original answer — that the company designates certain non-U.S. dollar-denominated debt as a net investment hedge. While this may be true in the broader context of hedging practices, it was not part of the ground truth answer and slightly exceeds the scope of what was asked or disclosed in the reference. (3) The multi-hop reasoning is sound: the model correctly synthesized data from two different years and linked them to the correct derivative categories. (4) The correctness score is 9 because all quantitative facts are accurate and the core answer is complete, but the addition of extra detail (debt designation) not in the original answer prevents a perfect 10. Quantitative accuracy is 10 as all numbers and calculations are correct. Qualitative accuracy is 9 due to the minor over-inclusion. Contextual relevance is 10 as the answer directly addresses the question with highly relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 388,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What is the total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021, and how does this relate to the maximum aggregate outstanding balance observed during the year ended December 31, 2021?",
      "original_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their respective amendments in 2021 is $9.5 billion. This is calculated as $5.0 billion for the Credit Facility (initial $4.0 billion plus an optional $1.0 billion increase) and $4.5 billion for the Supplemental Facility (initial $3.5 billion increased to $4.5 billion). The maximum aggregate outstanding balance observed during the year ended December 31, 2021, was $2.1 billion, which is significantly lower than the total borrowing capacity, indicating conservative leverage usage.",
      "llm_answer": "The total combined borrowing capacity of Simon Property Group's Credit Facility and Supplemental Facility after their 2021 amendments was $5.8 billion, and the maximum aggregate outstanding balance observed during the year ended December 31, 2021 was $2.1 billion.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claim. The total combined borrowing capacity is stated as $5.8 billion, but the ground truth is $9.5 billion. This major error undermines the core of the answer. The maximum aggregate outstanding balance of $2.1 billion is correctly reported. (2) Calculation verification: The correct total capacity is $5.0 billion (Credit Facility: $4.0B base + $1.0B optional) + $4.5 billion (Supplemental Facility increased from $3.5B to $4.5B) = $9.5 billion. The LLM's $5.8 billion figure does not match any documented sum in the source data and appears to be a fabrication or miscalculation. (3) Multi-hop reasoning assessment: The question requires synthesizing information from two amended facilities across potentially multiple filings. The LLM failed to correctly identify or combine the post-amendment capacities, indicating a failure in multi-hop synthesis. It correctly pulled the $2.1 billion peak balance, showing partial data retrieval ability. (4) Justification for scores: Correctness is low (3/10) due to the critical error in the main calculation. Quantitative accuracy is poor (3/10) because the primary number is wrong. Qualitative accuracy is slightly higher (4/10) as the model understood the structure of the question and retrieved one correct figure. Contextual relevance is high (8/10) because the answer addresses both parts of the question and uses appropriate financial terminology, despite factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 414,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the increase in risk retirements on Black Hawk and CH-53K helicopter programs in 2021 contribute to the overall increase in RMS' operating profit, and what was the specific dollar amount of this contribution?",
      "original_answer": "The increase in risk retirements on the Black Hawk and CH-53K helicopter programs contributed $140 million to the overall increase in RMS' operating profit in 2021. This, along with other factors like higher production volume and lower charges on the CRH program, led to a total $183 million (11%) increase in RMS' operating profit compared to 2020.",
      "llm_answer": "The increase in risk retirements on the Black Hawk and CH-53K programs contributed approximately $80 million to RMS’s operating profit in 2021, which was part of the $183 million total increase in RMS operating profit that year. This $80 million represented the specific dollar amount of the contribution from those risk retirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the contribution from risk retirements on the Black Hawk and CH-53K programs as $80 million, whereas the ground truth specifies $140 million. This is a significant factual error in a key quantitative figure. (2) The total increase in RMS' operating profit is correctly cited as $183 million, matching the original answer. However, the $80 million figure for risk retirements is not only wrong but also inconsistent with the stated total increase and other contributing factors (e.g., production volume, CRH charges) mentioned in the ground truth. The correct $140 million contribution is a major component of the $183 million total, which the LLM underrepresents. (3) The reasoning structure is sound—identifying risk retirements as a contributor to operating profit and situating it within the broader context of the $183 million increase—but fails in multi-hop synthesis by pulling an incorrect value, possibly from a different context or due to hallucination. (4) Scores reflect the major quantitative inaccuracy (correctness: 3, quantitative accuracy: 3), partially correct reasoning and entity identification (qualitative accuracy: 5), and appropriate framing and relevance to the question (contextual relevance: 8).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 356,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas in 2021, and how did this compare to the combined impact in 2019?",
      "original_answer": "The total financial impact of energy-related derivatives on Southern Company's (SO) natural gas revenues and cost of natural gas was a loss of $144 million in 2021. In 2019, the combined impact was a gain of $233 million. This represents a difference of $377 million between the two years.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, the total financial impact of energy-related derivatives on Southern Company's natural gas revenues and cost of natural gas in 2021 was a combined negative impact of $144 million (specifically, a $117 million negative impact on natural gas revenues and a $27 million negative impact on cost of natural gas, totaling $144 million). This compared to a combined positive impact of $233 million in 2019 (a $223 million positive impact on natural gas revenues and a $10 million positive impact on cost of natural gas, totaling $233 million). Thus, the 2021 impact was the opposite of the 2019 impact, with 2021 showing a net negative effect while 2019 showed a net positive effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $144 million loss in 2021 and $233 million gain in 2019, matching the ground truth exactly. It further breaks down the components ($117M and $27M for 2021; $223M and $10M for 2019), which are accurate and consistent with the source data. (2) All numeric values are correct, and the totals are accurately calculated. The comparison between 2021 and 2019 is qualitatively accurate—highlighting the reversal from gain to loss—though it does not explicitly compute the $377 million difference mentioned in the ground truth. This omission is minor as the core quantitative facts are present and correct. (3) The multi-hop reasoning is sound: the model synthesizes derivative impacts across two years and correctly distinguishes between revenues and cost of natural gas, aggregating them appropriately. (4) The answer is contextually fully relevant, addressing both parts of the question—impact in 2021 and comparison to 2019. The only reason for not scoring a 10 is the lack of explicit mention of the $377 million difference, which is part of the ground truth comparison. However, since the components are correct and the reversal is clearly explained, this is a minor omission. Thus, scores reflect high accuracy with near-perfect completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 367,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "What was the change in Cisco's losses from privately held investments between 2023 and 2024, and how did this impact the overall net gains (losses) on investments?",
      "original_answer": "Cisco's losses from privately held investments decreased from $193 million in 2023 to $164 million in 2024, resulting in a $29 million improvement. This improvement contributed to the overall net gains (losses) on investments improving from a loss of $177 million in 2023 to a loss of $166 million in 2024, a $11 million positive shift.",
      "llm_answer": "The change in Cisco's losses from privately held investments improved by $29 million (from a $193 million loss in 2023 to a $164 million loss in 2024), which contributed to a $11 million increase in net gains (losses) on investments, shifting the total from a $177 million loss to a $166 million loss. This reduction in the private‑investment loss was one of the factors that helped narrow the overall net gains (losses) on investments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the loss decreased from $193 million in 2023 to $164 million in 2024, a $29 million improvement, and the overall net gains (losses) on investments improved from a $177 million loss to a $166 million loss, a $11 million positive shift. These values and calculations are correctly reported. (2) The answer addresses both parts of the multi-part question: the change in losses from privately held investments and its impact on overall net gains (losses). (3) Entities—Cisco, privately held investments, years 2023 and 2024, and financial metrics—are correctly identified and used. (4) The reasoning is sound: the reduction in losses from private investments is correctly linked as a contributing factor to the narrower overall net loss, demonstrating proper multi-hop synthesis. Wording differs slightly but maintains semantic equivalence. No errors in facts, calculations, or logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 287,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What was the total principal repayment made by VZ in connection with anticipated redemptions of ABS Notes in 2024, and how does this compare to the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024?",
      "original_answer": "VZ made a total principal repayment of $4.5 billion in 2024 in connection with anticipated redemptions of ABS Notes. The aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities as of December 31, 2024, was $8.0 billion and $5.0 billion, respectively. Therefore, the total outstanding balance across both facilities was $13.0 billion, which is significantly higher than the $4.5 billion in principal repayments made during the year.",
      "llm_answer": "The total principal repayment made by Verizon in connection with anticipated redemptions of ABS Notes in 2024 was $4.5 billion, which is less than the aggregate outstanding balance of the 2021 and 2022 ABS Financing Facilities—$8.0 billion and $5.0 billion respectively, totaling $13.0 billion as of December 31 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $4.5 billion principal repayment in 2024, $8.0 billion outstanding balance for the 2021 ABS Financing Facility, $5.0 billion for the 2022 facility, and a correctly calculated total of $13.0 billion. These match the original answer exactly, with acceptable formatting (e.g., use of 'billion' and spacing). (2) The answer is complete, addressing both parts of the multi-part question: the 2024 principal repayment amount and the comparison to the aggregate outstanding balance as of December 31, 2024. (3) Entity accuracy is correct—Verizon (VZ) is properly identified, and the financial instruments (ABS Notes, ABS Financing Facilities) and years (2021, 2022, 2024) are all accurate. (4) The reasoning is sound: the LLM correctly synthesizes data across time and facilities, and the comparison (repayment being less than the total outstanding balance) is logically valid and clearly stated. The semantic meaning is equivalent to the original answer, with concise but complete expression. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 329,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do the CECL capital transition provisions impact the calculation of the Tier 1 leverage ratio and the application of the Standardized approach to First Republic-related assets at JPMorgan Chase?",
      "original_answer": "The CECL capital transition provisions directly affect the calculation of the Tier 1 leverage ratio by adjusting quarterly average assets to account for on-balance sheet assets that must be deducted from Tier 1 capital, such as goodwill and intangible assets. Additionally, these provisions permit the application of the Standardized approach to certain assets associated with First Republic, influencing how those assets are treated within the capital metrics. Together, these effects shape the firm's regulatory capital reporting and leverage ratio computation.",
      "llm_answer": "The CECL capital transition provisions affect the Tier 1 leverage ratio by requiring adjustments to adjusted average assets and total leverage exposure—specifically, the inclusion of $720 million of remaining CET1 benefit and the exclusion of certain goodwill and intangible deductions—while the Standardized approach to First Republic‑related assets is applied only under the transition rules, meaning those assets are treated with the Standardized RWA methodology (and any applicable allowance adjustments) rather than the full Advanced approach. Consequently, the leverage ratio calculations reflect the reduced RWA and modified asset definitions mandated by the CECL transition provisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures—namely a '$720 million of remaining CET1 benefit'—that are not present in the original answer and cannot be verified from the provided ground truth. This number is unsupported and likely incorrect in this context, as the original answer makes no mention of any dollar amounts related to CECL transition benefits or CET1. This is a critical error in quantitative accuracy. (2) There are no verifiable calculations in the original answer to assess, but the introduction of a precise $720M figure in the LLM response where none exists in the ground truth constitutes a fabrication or hallucination, severely undermining trust in the numerical claims. (3) The qualitative reasoning partially aligns with the original: the LLM correctly identifies that CECL transition provisions affect the Tier 1 leverage ratio through adjustments to average assets and treatment of goodwill/intangibles, and that the Standardized approach applies to First Republic-related assets under transition rules. This reflects some correct multi-hop synthesis between CECL, capital rules, and asset treatment. However, the original answer does not specify that the Standardized approach is applied 'only under the transition rules' or that assets are excluded from the Advanced approach—this is an over-interpretation. (4) Contextual relevance is high because the LLM addresses both parts of the question—impact on Tier 1 leverage ratio and Standardized approach application—and uses appropriate regulatory terminology. However, the inclusion of unverified quantitative data significantly reduces factual correctness. While the direction of reasoning is plausible, the unsupported number and over-specific claims reduce the correctness score to 4, as core facts are partially right but major errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 502,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What governance policies has Simon implemented to maintain board independence and ethical conduct, and how do these align with NYSE listing requirements?",
      "original_answer": "Simon has adopted governance principles that outline the function, conduct, selection, orientation, and duties of its subsidiaries, Board of Directors, and the Company. These governance principles are supported by written charters for each of the standing committees of the Board. Additionally, Simon maintains a Code of Business Conduct and Ethics that applies to all officers, directors, and employees, including those of its subsidiaries. The NYSE listing standards require that a majority of the Board qualify as independent, and Simon ensures this by mandating that at least a majority of the Board are independent and not affiliated with the Simon family. Furthermore, the Audit and Compensation and Human Capital Committees consist entirely of independent members who meet the NYSE’s additional independence and financial expert requirements.",
      "llm_answer": "Simon maintains board independence through its governance principles and NYSE listing standards, requiring a majority of directors to be independent and composed of independent members on its Audit and Compensation and Human Capital Committees. The company’s Code of Business Conduct and Ethics applies to all officers, directors, and employees, and its charter mandates that at least three-fourths of independent directors must approve any transaction involving the Simon family or related parties to avoid conflicts of interest. These policies align with NYSE requirements for independent directors and committee composition.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Simon's governance principles, Code of Business Conduct and Ethics, board independence requirements, and independent committee composition, which aligns with the original answer and addresses most aspects of the question. However, it introduces a specific quantitative requirement—that 'at least three-fourths of independent directors must approve any transaction involving the Simon family'—which is not present in the ground truth. This detail is factually incorrect and unsupported by the original answer, which only states that the board ensures independence by requiring a majority of independent directors unaffiliated with the Simon family. (2) The quantitative inaccuracy is significant: the 'three-fourths' figure is fabricated or misremembered, and no such threshold appears in the ground truth. This affects the correctness of the policy description and undermines trust in the response. (3) The multi-hop reasoning is partially sound—the model correctly links Simon’s governance policies to NYSE listing requirements regarding independent directors and committee composition. It accurately notes that Audit and Compensation and Human Capital Committees are composed entirely of independent members, satisfying NYSE standards. However, the erroneous three-fourths rule indicates a failure in accurate synthesis or retrieval, suggesting either hallucination or incorrect inference. (4) Despite the major quantitative error, the answer remains contextually relevant and captures key qualitative elements: governance principles, code of ethics, board and committee independence, and alignment with NYSE rules. Hence, correctness is reduced to 6 due to the critical false claim, quantitative accuracy is low (4), qualitative accuracy is moderate (7), and contextual relevance is high (9).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 500,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the use of the percentage-of-completion cost-to-cost method impact Lockheed Martin's (LMT) profit booking rates when changes in cost estimates occur, and what is the financial effect of recognizing these changes in the period they are determined?",
      "original_answer": "Lockheed Martin's use of the percentage-of-completion cost-to-cost method directly affects its profit booking rates when there are changes in cost estimates. If the company successfully retires risks related to technical, schedule, and cost aspects of a contract, the estimated total costs to complete decrease, which increases the profit booking rate. Conversely, if estimated costs increase, the profit booking rate decreases. These changes are recognized in the period they are determined and reflect the inception-to-date effect of such revisions. This has a direct impact on segment operating profit and margin, which can be either favorable or unfavorable depending on the direction of the change in estimates.",
      "llm_answer": "The percentage‑of‑completion cost‑to‑cost method requires Lockheed Martin to update the estimated total cost of each long‑term contract whenever its cost estimates change; profit booking rates are adjusted accordingly, and any resulting change in the rate is recognized in the period the estimate is revised. Because the change is recorded in the period it is determined, profit‑booking‑rate adjustments flow directly to segment operating profit and margin in that same reporting period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly explains that changes in cost estimates under the percentage-of-completion cost-to-cost method lead to adjustments in profit booking rates, which are recognized in the period the estimate is revised. This aligns with the original answer's emphasis on the immediate recognition of inception-to-date effects on segment operating profit and margin. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in terms of calculations, but the absence of incorrect numbers supports a full score. (3) The reasoning is sound and captures the multi-hop logic: the method links cost estimate revisions to profit recognition timing and impacts segment-level financials. The only minor omission is not explicitly stating that decreased costs increase profit rates (and vice versa), though the concept is implied by saying 'adjusted accordingly.' (4) The answer is fully relevant to the question, directly addressing both how the method impacts profit booking rates and the financial effect of estimate changes. Overall, the response is semantically equivalent to the ground truth with only slight room for added specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 360,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024, and how does this compare to the percentage growth in Services Revenue for the same region?",
      "original_answer": "The combined increase in both Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $8,447 million, which includes a $89 million increase in Services Revenue and an $8,358 million increase in Total Balance. This corresponds to a 4% growth in Services Revenue for the APJC region.",
      "llm_answer": "The combined increase in Services Revenue and Total Balance for the APJC region from 2023 to 2024 is $89 million (Services Revenue rose by $89 million, and the APJC goodwill balance grew from $5,382 million to $8,208 million, a $2,826 million increase; however, the net increase in the reported Total Balance for APJC is $89 million when accounting for the $2,737 million rise in purchased intangible assets and other adjustments). This $89 million increase in Services Revenue corresponds to a 5 % growth, matching the percentage growth in Services Revenue for the APJC region.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its quantitative claims. The ground truth states the combined increase in Services Revenue and Total Balance is $8,447 million, with $89 million from Services Revenue and $8,358 million from Total Balance. The LLM incorrectly calculates the combined increase as $89 million, conflating it solely with the Services Revenue increase. It introduces unrelated details about goodwill rising from $5,382M to $8,208M ($2,826M increase) and purchased intangible assets, which are not mentioned or supported in the ground truth. (2) The Services Revenue increase of $89 million is correct and matches the ground truth, but the percentage growth is wrong: the LLM states 5%, while the correct figure is 4%. The Total Balance increase is grossly understated due to incorrect adjustments. (3) The reasoning fails on multi-hop synthesis: instead of summing the two reported increases ($89M + $8,358M), the LLM fabricates an explanation involving goodwill and intangible assets not present in the original answer, indicating a failure to correctly identify or aggregate the relevant financial metrics. (4) Despite addressing the right region (APJC) and correctly identifying the $89M Services Revenue increase, the answer is fundamentally flawed in calculation, logic, and data sourcing, warranting a low correctness score. Contextual relevance is moderate as it attempts the right question structure but with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 405,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What is the total notional value of Abbott's interest rate hedge contracts and foreign currency forward exchange contracts as of December 31, 2024, and how does this combined financial instrument exposure reflect Abbott's strategy to manage market risk?",
      "original_answer": "As of December 31, 2024, Abbott had $2.2 billion in notional value for interest rate hedge contracts and $23.2 billion in notional value for foreign currency forward exchange contracts (comprising $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables). This totals $25.4 billion in financial instrument exposure. Abbott uses these instruments to manage exposure to interest rate and foreign exchange rate fluctuations, with interest rate hedges converting fixed-rate debt to variable-rate debt and foreign exchange contracts hedging both anticipated purchases and existing foreign currency denominated obligations.",
      "llm_answer": "The total notional value of Abbott's interest rate hedge contracts was $2.2 billion and the total notional value of its foreign currency forward exchange contracts was $23.2 billion as of December 31, 2024. These instruments are used to manage exposure to interest‑rate fluctuations and foreign‑exchange movements, respectively, allowing Abbott to hedge cash‑flow variability and reduce the impact of market‑price changes on its financial position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the notional values of Abbott's interest rate hedge contracts ($2.2 billion) and foreign currency forward exchange contracts ($23.2 billion) as of December 31, 2024, matching the ground truth exactly. The total exposure of $25.4 billion is implied by the sum of these values, though not explicitly stated, which is a minor omission. (2) All numeric values are accurate and properly formatted; no calculation errors. The ground truth breaks down the $23.2 billion into $7.0 billion for intercompany purchases and $16.2 billion for intercompany loans and trade payables/receivables, which the LLM omits. However, this detail is not required to answer the primary question about total notional value. (3) The reasoning is sound: the LLM correctly identifies that these instruments are used to manage interest rate and foreign exchange rate risks, aligning with the ground truth's explanation of hedging cash flow variability and reducing market-price impacts. It accurately reflects Abbott's strategy, though it does not mention the conversion of fixed-rate debt to variable-rate debt via interest rate hedges, a minor gap in qualitative completeness. (4) The answer is contextually fully relevant, directly addressing both parts of the question—quantitative exposure and risk management strategy. The omission of the detailed breakdown and one specific hedging mechanism slightly reduces qualitative accuracy, but core facts and synthesis are correct. Hence, correctness is 9/10, with full marks on quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 437,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does McDonald's (MCD) accounting treatment of franchisees impact its consolidated financial statements, particularly in terms of operational materiality and consolidation policy as stated in the 2024 10-K filing?",
      "original_answer": "McDonald's (MCD) does not consolidate the results of operations of restaurants purchased and sold in transactions with franchisees into its consolidated financial statements because these results are deemed immaterial both individually and in aggregate. Additionally, MCD explicitly states that it does not consolidate variable interest entities, such as those involving franchisees, joint ventures, and licensees, due to the application of a scope exception under variable interest entity consolidation guidance. This treatment ensures that franchisee-related operations do not directly affect MCD's consolidated financial results.",
      "llm_answer": "McDonald's consolidates franchisee-operated restaurants only when it exercises control (e.g., through ownership of the underlying assets or governance rights), and it records these acquired restaurants as part of its consolidated financial statements. The company's consolidation policy, as disclosed in the 2024 10-K, requires that franchisee restaurants be included in the consolidated entity only when control is transferred, and it explicitly states that the results of operations of restaurants purchased from franchisees were not material to the consolidated financial statements. This policy ensures that the company's consolidated financial statements reflect only its controlled operations, with franchisee-owned restaurants remaining separate unless control is obtained.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable; however, since there are no incorrect numbers, it is scored as 10. The main issue lies in qualitative accuracy. The LLM incorrectly states that McDonald's consolidates franchisee-operated restaurants when control is transferred (e.g., through asset ownership or governance rights), which contradicts the ground truth. According to the 2024 10-K, McDonald’s explicitly does not consolidate variable interest entities (VIEs), including franchisee arrangements, due to a scope exception under VIE consolidation guidance—regardless of control. The LLM misrepresents the core accounting policy: MCD does not consolidate franchisee operations even when it may have some control indicators, because of the scope exception. While the LLM correctly notes that the results of operations from restaurants purchased from franchisees are immaterial and not material to the consolidated financial statements, this is a secondary point. The primary reasoning about consolidation based on control is factually wrong. The answer is contextually relevant and addresses the question’s focus on consolidation policy and materiality, but the multi-hop reasoning fails because it misapplies the accounting logic from the 10-K. The ground truth emphasizes immateriality *and* a scope exception for VIEs as the dual basis for non-consolidation, while the LLM focuses solely on control, which is not the stated rationale in the filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 410,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the inclusion of off-balance sheet exposures and adjusted average assets impact JPMorgan Chase's Supplementary Leverage Ratio (SLR) calculation, and what are the consequences if the SLR falls below the required threshold?",
      "original_answer": "JPMorgan Chase's SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes adjusted average assets (accounting for on-balance sheet assets like goodwill and intangible assets) and off-balance sheet exposures averaged over the reporting quarter. If the SLR falls below the required 3.0% minimum plus the 2.0% leverage buffer (totaling 5.0%), the Firm would face restrictions on capital distributions such as dividends, share repurchases, and discretionary bonuses for certain executive officers.",
      "llm_answer": "The SLR is calculated using Tier 1 capital divided by total leverage exposure, which includes on‑balance‑sheet assets (adjusted for deductions such as goodwill) plus certain off‑balance‑sheet exposures. Because the leverage exposure figure adds off‑balance‑sheet items, a higher SLR can be achieved if those exposures are modest, but any shortfall forces the firm to curb dividend, share‑repurchase and bonus payments. Moreover, the SLR calculation incorporates adjusted average assets that are reduced by capital‑related adjustments (e.g., goodwill, intangibles, CECL transition provisions), so the inclusion of these adjustments can affect the numerator and denominator and thus the resulting ratio. If the SLR falls below the required 5 % (or the 6.1 % observed in 2024), the firm would face regulatory limits on capital distributions and executive compensation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the SLR formula (Tier 1 capital / total leverage exposure) and the inclusion of adjusted average assets and off-balance sheet exposures. It accurately notes that adjusted average assets are reduced by deductions like goodwill and intangibles, and that SLR impacts capital distributions. However, it incorrectly states the required threshold as '5%' or '6.1% observed in 2024', while the ground truth specifies a minimum of 3.0% plus a 2.0% leverage buffer, totaling 5.0%—but does not mention a 6.1% requirement. The 6.1% figure may reflect a firm-specific or year-specific target not in the ground truth, making this a factual overreach. (2) Quantitative accuracy is partially compromised: while 5.0% is correctly noted as a threshold, the introduction of 6.1% is unsupported by the original answer and could mislead. No other numbers (e.g., buffer breakdown) are provided in the LLM answer, so the calculation logic is incomplete. (3) Multi-hop reasoning is sound—the model connects off-balance sheet exposures and adjusted assets to the denominator, recognizes capital adjustments in both numerator and denominator, and links SLR shortfalls to regulatory consequences. This shows good synthesis across financial concepts. (4) The answer is contextually relevant and covers both parts of the question: the impact of off-balance sheet items and adjusted assets on SLR, and the consequences of falling below the threshold. The core facts are correct, but the unsupported 6.1% figure and lack of explicit buffer breakdown reduce quantitative accuracy. Hence, correctness is scored 7/10—minor factual error with no major omissions in reasoning or entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 463,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total amount of borrowings under the Credit Facilities as of December 31, 2021, and how does this compare to the maximum borrowing capacity of the Supplemental Facility as outlined in its amended terms?",
      "original_answer": "The total amount of borrowings under the Credit Facilities as of December 31, 2021, was $1.175 billion ($125 million under the Credit Facility and $1.05 billion under the Supplemental Facility). The maximum borrowing capacity of the Supplemental Facility, as outlined in its amended terms, was $3.5 billion, which could be increased to $4.5 billion during its term.",
      "llm_answer": "As of December 31, 2021, the Company had borrowed $125.0 million under the $4.0 billion revolving Credit Facility and $1.05 billion under the $3.5 billion Supplemental Facility. The Supplemental Facility’s borrowing capacity can be increased from its initial $3.5 billion to $4.5 billion during its term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All numeric values are correct: $125 million under the Credit Facility and $1.05 billion under the Supplemental Facility, totaling $1.175 billion in total borrowings as of December 31, 2021—this sum is implied correctly. The maximum borrowing capacity of the Supplemental Facility is accurately stated as $3.5 billion, with the ability to increase to $4.5 billion during its term. (2) Quantitative accuracy is perfect: all dollar amounts and dates match the ground truth, with acceptable formatting variations (e.g., $1.05 billion = $1,050 million). (3) The multi-hop reasoning is sound—information is correctly synthesized across the two facilities and their respective terms. The only minor omission is that the LLM does not explicitly state the total borrowings ($1.175 billion) as a single figure, though it provides both components, allowing for easy inference. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the total borrowings as of the specified date and the comparison to the Supplemental Facility’s maximum capacity. The qualitative score is slightly reduced due to the lack of explicit summation, but this does not impair factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 362,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "What was the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021, and how does this compare to the amount reported for 2020 as a percentage decrease?",
      "original_answer": "The total notional amount of Lockheed Martin's outstanding interest rate swaps was $500 million at the end of 2021 and $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "llm_answer": "Based on the provided document pages, the total notional amount of Lockheed Martin's outstanding interest rate swaps at the end of 2021 was $500 million, compared to $572 million at the end of 2020. This represents a decrease of approximately 12.6% from 2020 to 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All factual information is accurate: the notional amounts of $500 million in 2021 and $572 million in 2020 are correctly reported. (2) The percentage decrease is accurately calculated: (572 - 500) / 572 ≈ 0.12587, which rounds to 12.6%, and this is correctly stated. (3) The multi-hop reasoning—comparing two years of data and computing the percentage change—is sound and properly executed. (4) The entities (Lockheed Martin, interest rate swaps, notional amount, years 2020 and 2021) are correctly identified and used. (5) The answer is semantically equivalent to the original, with no omissions or distortions. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 225,
        "total_tokens": 1358
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the disagreement between Georgia Power and the other Vogtle Owners over cost-sharing provisions impact its financial exposure, and what specific charges illustrate this effect?",
      "original_answer": "The disagreement between Georgia Power and the other Vogtle Owners over the interpretation of cost-sharing and tender provisions under the Global Amendments has led to Georgia Power recording significant unrecoverable charges. Specifically, Georgia Power recorded a $440 million pre-tax charge in the fourth quarter of 2021 related to these provisions, and may face an additional $460 million in charges based on the current project capital cost forecast. These costs will not be recovered from retail customers, directly increasing Georgia Power’s financial exposure. This disagreement centers on differing interpretations of the starting dollar amount for cost increases subject to the provisions, with Georgia Power asserting $18.38 billion as the threshold, while the other owners claim the cost-sharing thresholds have been met and the tender provisions have been triggered.",
      "llm_answer": "The disagreement between Georgia Power and the other Vogtle Owners over cost‑sharing thresholds has resulted in significant pre‑tax charges to income—$440 million in Q4 2021 and up to an additional $460 million based on the current capital‑cost forecast—charges that will not be recovered from retail customers. These cost‑sharing and tender provisions, which remain unsettled, directly increase Georgia Power’s financial exposure by forcing it to absorb the incremental costs of the Vogtle project.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core financial impact of the disagreement between Georgia Power and the other Vogtle Owners. (1) All key facts are correct: the $440 million pre-tax charge in Q4 2021 and the potential additional $460 million in charges are accurately reported, matching the ground truth. Number formats are consistent and acceptable. (2) Quantitative accuracy is perfect—both dollar amounts and the time period (Q4 2021) are correct, with no calculation errors. (3) The reasoning is sound: the LLM correctly links the disagreement over cost-sharing provisions to unrecoverable charges and increased financial exposure for Georgia Power. However, it omits the specific detail about the differing interpretations of the starting threshold ($18.38 billion) and whether tender provisions have been triggered, which is a key element of the dispute and present in the original answer. This is a minor omission in context but slightly reduces completeness in multi-hop synthesis. (4) The answer is fully relevant, directly addressing both parts of the question—impact on financial exposure and specific charges. Despite the missing nuance on the threshold dispute, the LLM captures the essential financial consequences and causal logic. Thus, the correctness score is 9 due to high accuracy with a minor gap in qualitative completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 377,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How much total Digital Media ARR did Adobe report at the end of fiscal 2021, and which specific Adobe Experience Cloud solution is designed to manage customer journeys and deliver intelligence for businesses as part of Adobe's strategy to strengthen its competitive advantage?",
      "original_answer": "Adobe reported a total Digital Media ARR of $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud, specifically through the Adobe Experience Platform, is designed to manage customer journeys and deliver intelligence for businesses, thereby strengthening Adobe's differentiation and competitive advantage.",
      "llm_answer": "Adobe reported total Digital Media ARR of approximately $12.24 billion at the end of fiscal 2021. The Adobe Experience Cloud solution designed to manage customer journeys and deliver intelligence for businesses is the Adobe Experience Platform.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total Digital Media ARR as $12.24 billion at the end of fiscal 2021, matching the ground truth exactly in value and context. The specific Adobe Experience Cloud solution, Adobe Experience Platform, is accurately named as the tool designed to manage customer journeys and deliver intelligence. (2) The numeric value '$12.24 billion' is correct and matches the ground truth; formatting variations (e.g., spacing) do not affect accuracy. (3) The reasoning is sound and reflects proper multi-hop synthesis: linking Adobe's financial reporting (Digital Media ARR) with strategic product capabilities (Adobe Experience Platform within Experience Cloud). (4) All parts of the question are fully addressed—both the quantitative financial figure and the qualitative strategic component—with precise, semantically equivalent information. No omissions or inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 269,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total fair value of interest rate hedge contracts reported by Abbott as of December 31, 2024, and how does this compare to the fair value of these contracts in 2023, considering both the receivable and (payable) positions?",
      "original_answer": "The total fair value of Abbott's interest rate hedge contracts as of December 31, 2024, is -$50 million, calculated as the difference between the $1 million receivable position and the $51 million (payable) position. In 2023, the fair value was -$95 million, based on a $0 receivable position and a $95 million (payable) position. This indicates an improvement in the fair value of these contracts by $45 million year-over-year.",
      "llm_answer": "The total fair value of Abbott’s interest‑rate hedge contracts as of December 31 2024 is $1 million in receivable positions and $51 million in payable positions, for a combined fair‑value amount of $52 million; in 2023 the corresponding amounts were $‑ (no receivable) and $95 million in payables, for a total fair‑value of $95 million. Thus, the fair‑value of these contracts decreased from $95 million in 2023 to $52 million in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and calculation errors. While it correctly identifies the 2024 receivable ($1M) and payable ($51M) positions and the 2023 payable ($95M), it fundamentally misunderstands how fair value is calculated for hedge contracts. The correct fair value is netted (receivable minus payable), resulting in -$50M in 2024 and -$95M in 2023. Instead, the LLM incorrectly adds the absolute values, claiming a 'combined' $52M in 2024 and $95M in 2023. This leads to a completely wrong conclusion that fair value 'decreased' when in fact it improved (became less negative) by $45M. (2) Number verification: Receivable 2024: correct ($1M); Payable 2024: correct ($51M); Net 2024: incorrect (LLM says $52M, should be -$50M); 2023 payable: correct ($95M); Net 2023: incorrect (LLM says $95M, should be -$95M); Year-over-year change: incorrect (LLM implies $43M decrease, actual improvement is $45M). (3) Multi-hop reasoning: The model fails to synthesize the correct financial logic—fair value for such contracts is net, not gross. It also misinterprets the direction of change, failing to recognize that a reduction in net liability is an improvement. (4) Scores justified: Correctness 3/10 due to mostly incorrect quantitative conclusion despite some correct inputs; Quantitative accuracy 3/10 for correct individual values but wrong net calculation and comparison; Qualitative accuracy 3/10 for flawed reasoning and misinterpretation of financial concepts; Contextual relevance 6/10 as it addresses the right company, instruments, and years, but draws wrong conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 440,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the combined total of discounted future net cash flows from equity companies in Asia as a percentage of total proved reserves (oil-equivalent) for equity companies in Asia, based on ExxonMobil's 2024 10-K filing?",
      "original_answer": "The combined total of discounted future net cash flows from equity companies in Asia is 60,780 million dollars, and the total proved reserves (oil-equivalent) for equity companies in Asia is 1,276 million barrels. The cash flow per barrel is approximately $47.63 (60,780,000,000 / 1,276,000,000).",
      "llm_answer": "Based on the ExxonMobil 2024 10‑K filing, the combined discounted future net cash flows from equity‑company reserves in Asia equal **$35,186 million**, and the total proved reserves (oil‑equivalent) for those equity companies in Asia amount to **13,006 million barrels**.  \n\nTherefore, the discounted future net cash flows from Asian equity‑company reserves represent **approximately 0.27 %** of the total proved reserves (oil‑equivalent) for those equity companies in Asia.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The numbers provided—$35,186 million in discounted future net cash flows and 13,006 million barrels of proved reserves—are completely wrong. The ground truth values are $60,780 million and 1,276 million barrels, respectively. These discrepancies are massive and not due to formatting differences. (2) The calculation of 0.27% as a percentage of cash flows relative to reserves is nonsensical—the question asks for cash flows as a percentage of reserves, but the correct approach is to compute cash flow per barrel (a unit value), not a percentage of volume. Even so, the LLM incorrectly computes a percentage (35,186 / 13,006,000?) which results in ~0.27%, but this is both numerically and conceptually flawed. The correct cash flow per barrel is ~$47.63 (60,780,000,000 / 1,276,000,000), which the LLM fails to report. (3) The multi-hop reasoning is broken: the model fails to correctly extract the two key figures from the 10-K and then performs an illogical calculation. (4) Contextual relevance is low but not zero—the answer attempts to address the right region (Asia), company (ExxonMobil), and filing (2024 10-K), and mentions the correct types of metrics (discounted future net cash flows, proved reserves). However, the severe factual and computational errors render the answer highly inaccurate. Thus, the correctness and quantitative accuracy scores are near-minimal.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 403,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does JPMorgan Chase's allocation of capital to its Lines of Business and Corporate, influenced by Basel III Standardized RWA and GSIB surcharge, reflect its adherence to the leverage-based capital regulatory requirements, particularly the supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer?",
      "original_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate by considering Basel III Standardized RWA and the GSIB surcharge, which directly affects its ability to meet the minimum supplementary leverage ratio (SLR) of 3.0% and the additional 2.0% leverage buffer. The SLR is calculated as Tier 1 capital divided by total leverage exposure, which includes quarterly average assets adjusted for certain deductions and off-balance sheet exposures. Capital allocations are also influenced by simulations of capital depletion in severe stress scenarios, ensuring that the Firm maintains sufficient Tier 1 capital relative to its leverage exposure to satisfy both the SLR requirement and the buffer. Failure to maintain this 5.0% combined SLR threshold would restrict capital distributions such as dividends and share repurchases.",
      "llm_answer": "JPMorgan Chase allocates capital to its Lines of Business and Corporate using Basel III Standardized RWA together with the GSIB surcharge and a stress‑scenario simulation, ensuring that the resulting capital levels meet the 3.0% minimum SLR and the additional 2.0% leverage buffer required by the supplementary leverage ratio framework. This allocation reflects compliance with the leverage‑based capital requirements, as the firm’s capital is held in excess of the 3 % SLR threshold and the 2 % buffer, thereby satisfying the regulatory leverage standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: JPMorgan Chase allocates capital considering Basel III Standardized RWA, GSIB surcharge, and stress simulations to meet the 3.0% minimum supplementary leverage ratio (SLR) and the additional 2.0% leverage buffer. The combined 5.0% threshold is implied by referencing both components. (2) Quantitative accuracy is perfect: percentages (3.0%, 2.0%) match exactly, and no calculations are misstated. Format variations (e.g., '3 %' vs '3.0%') are minor and do not affect meaning. (3) Multi-hop reasoning is sound—capital allocation is correctly tied to regulatory requirements (SLR and buffer), with influencing factors (RWA, GSIB, stress testing) properly synthesized. (4) The only minor shortcoming is that the LLM omits explicit mention of the SLR formula (Tier 1 capital / total leverage exposure) and the consequence of failing to meet the threshold (restriction on dividends and buybacks), which are in the original. However, the essence of compliance and buffer maintenance is clearly conveyed. Thus, while slightly less detailed, the answer remains factually and semantically equivalent on all critical points.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 346,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "What is the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their respective amendments in 2021, and how does the interest rate structure under Daily SOFR Loans compare between the two facilities?",
      "original_answer": "The total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post their amendments in 2021 is $9.5 billion. The interest rate structure under Daily SOFR Loans is identical for both facilities, at SOFR plus 72.5 basis points, plus a spread adjustment to account for the transition from LIBOR to SOFR.",
      "llm_answer": "Based on the provided document pages, the total potential borrowing capacity available to Simon Property Group after considering both the Credit Facility and the Supplemental Facility post-amendments in 2021 is $5.8 billion. This figure represents the aggregate available borrowing capacity under the Facilities as of December 31, 2021, reflecting the combined capacity of the amended Credit Facility and Supplemental Facility.  \n\nRegarding the interest rate structure for Daily SOFR Loans, both facilities use the same framework: borrowings under either facility may be denominated as Daily SOFR Loans, with interest calculated as the Adjusted Floating Overnight Daily SOFR Rate plus a margin determined by the company's corporate credit rating (between 0.650% and 1.400% for Term Benchmark Loans, and between 0.000% and 0.400% for Base Rate loans). The specific rate applied depends on the facility and the borrower's credit rating, but the structure for Daily SOFR Loans is identical in both the Credit Facility and the Supplemental Facility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the total potential borrowing capacity: it states $5.8 billion, whereas the ground truth is $9.5 billion. This significant discrepancy undermines the quantitative accuracy. The interest rate structure for Daily SOFR Loans is partially correct—the LLM correctly notes that the structure is identical across both facilities and references SOFR plus a margin. However, it fails to specify the exact basis point spread (72.5 bps) and omits the spread adjustment for the LIBOR-to-SOFR transition, which is a key component of the ground truth. Instead, it provides a range of margins based on credit ratings, which may be present in the documents but does not directly answer the specific rate under Daily SOFR Loans as defined in the ground truth. (2) The calculation of total borrowing capacity is incorrect: $5.8B vs $9.5B is a material difference with no indication of how the LLM arrived at its figure. There is no support for this number in the ground truth, suggesting a failure in multi-hop synthesis or misreading of source data. (3) The reasoning shows partial understanding—LLM recognizes that both facilities were amended in 2021 and attempts to aggregate capacity and compare rate structures. It correctly identifies that the Daily SOFR framework is the same across both facilities, demonstrating some synthesis. However, it substitutes precise figures with broader ranges and misses the exact SOFR spread, indicating incomplete extraction or misinterpretation. (4) Correctness score is 4 due to major quantitative error but partial qualitative accuracy on structure and intent. Quantitative accuracy is low (3) due to wrong total capacity and imprecise rate specification. Qualitative accuracy is moderate (6) because the framework understanding is sound but lacks precision. Contextual relevance is high (8) as the response addresses both parts of the question and stays focused on the facilities and their terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 536,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the increase in production volume of Sikorsky helicopter programs in 2021 impact both net sales and product costs for RMS, and by how much did these two metrics increase as a result of this production growth?",
      "original_answer": "The increase in production volume of Sikorsky helicopter programs in 2021 contributed to a $540 million increase in RMS' net sales and a $560 million increase in product costs. This reflects the direct relationship between higher production output and both revenue growth and cost escalation for the RMS segment.",
      "llm_answer": "The increase in Sikorsky helicopter program production volume in 2021 drove a $794 million (5%) rise in RMS net sales and contributed to an $183 million (11%) increase in RMS operating profit, with the growth attributed to higher production volume, risk retirements, and improved profit booking on those programs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that the increase in production volume led to a $540 million increase in net sales and a $560 million increase in product costs. However, the LLM claims a $794 million (5%) increase in net sales and an $183 million (11%) increase in operating profit — none of which match the ground truth. The LLM introduces operating profit, which was not asked about and is not part of the original answer. Additionally, it omits any mention of the $560 million increase in product costs, which is a key part of the question. (2) The numbers provided in the LLM answer ($794M, 5%, $183M, 11%) are factually incorrect and do not align with the ground truth values of $540M and $560M. There is no indication these figures are derived from the correct data source, and the percentages do not correspond to the actual reported impacts. (3) The reasoning is flawed because the LLM fails to perform the correct multi-hop synthesis — it should have identified the specific impact of Sikorsky production volume on both net sales and product costs for RMS in 2021. Instead, it conflates the effect with other factors like risk retirements and profit booking, which, while possibly related, are not the focus of the question and distract from the direct quantitative impact. (4) The contextual relevance is moderate because the answer discusses the right segment (RMS), the correct company (Sikorsky), and the right year (2021), and addresses the general theme of production volume impact. However, due to major factual inaccuracies and omission of required metrics (especially product costs), the overall correctness score is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 467,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do McDonald's recurring transactions with franchisees, as reflected in both the operating income and consolidation policy, impact the financial reporting of gains and losses from restaurant business sales?",
      "original_answer": "McDonald's recurring purchases and sales of restaurant businesses with franchisees result in gains or losses that are consistently recorded in operating income, as these transactions are a regular part of the company's business model aimed at maintaining an optimal ownership mix. Additionally, the company does not consolidate franchisee entities into its financial statements, as they are evaluated under variable interest entity guidelines and generally excluded from consolidation, which means the financial impact of these transactions is reflected only through the gains or losses recognized at the point of sale rather than through ongoing consolidated operations.",
      "llm_answer": "Gains and losses from sales of restaurant businesses are recorded in operating income because such transactions are a recurring part of McDonald’s business model. The company’s consolidation policy requires that these gains and losses be reflected in the consolidated financial statements, and they are included in the “Other operating (income) expense, net” line item, where they are presented separately as “Gains on sales of restaurant businesses.” This treatment ensures that the financial reporting of these recurring gains and losses is consistent with the company’s overall revenue recognition and consolidation practices.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that gains and losses from sales of restaurant businesses are recorded in operating income due to their recurring nature, which aligns with the ground truth. It accurately references the specific financial statement line item 'Other operating (income) expense, net' and notes that gains are presented separately as 'Gains on sales of restaurant businesses,' which is factually consistent with McDonald's reporting practices. There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10. However, the LLM omits a key part of the original answer regarding the consolidation policy: that franchisee entities are not consolidated under variable interest entity guidelines. While it mentions the gains are reflected in consolidated financial statements, it does not clarify that the franchisees themselves are not consolidated, which is a critical aspect of how McDonald's financial reporting is structured. This missing element affects the completeness and qualitative accuracy of the multi-hop reasoning, as the full picture requires linking both the income statement treatment and the lack of consolidation. Despite this omission, the answer remains contextually relevant and factually sound on the aspects it covers, hence a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 371,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the impact on Chevron's (CVX) financial position in 2023 from its use of derivative commodity instruments, and how does this relate to the company's risk management practices and fair value measurements as monitored by its internal Risk Control group?",
      "original_answer": "Chevron's use of derivative commodity instruments in 2023 had no material impact on its financial position, results of operations, or liquidity. This conclusion is supported by both the fair value measurements and the company's internal risk management practices. Specifically, the fair value of derivative commodity instruments was not material to Chevron's Consolidated Balance Sheet or Consolidated Statement of Income. Additionally, the company's internal Risk Control group monitored market exposure on a daily basis, and the Audit Committee reviewed compliance with risk management policies, ensuring that derivative activities remained within acceptable risk thresholds.",
      "llm_answer": "Chevron's 2023 financial position showed a significant improvement in liquidity and reduced leverage due to its use of derivative commodity instruments for risk management. The company's internal Risk Control group monitors fair value measurements of these derivatives through daily mark-to-market assessments and VaR modeling, ensuring alignment with risk management policies. This prudent approach, reflected in the $152 million net derivative assets and $262 million liabilities at fair value, supported a stronger balance sheet with a net debt ratio of 7.3% and enhanced financial flexibility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that Chevron's use of derivative commodity instruments had *no material impact* on its financial position, results of operations, or liquidity in 2023. In contrast, the LLM claims a 'significant improvement in liquidity and reduced leverage,' which directly contradicts the original answer. This fundamental misrepresentation invalidates the correctness of the response. (2) The LLM introduces specific numbers—$152 million net derivative assets and $262 million liabilities, and a net debt ratio of 7.3%—that are not present in the ground truth and cannot be verified from the provided information. The original answer explicitly states that the fair value of derivatives was *not material* to the balance sheet or income statement, implying such precise quantifications are either irrelevant or misleading. There is no support for using these figures to claim a 'stronger balance sheet' or 'enhanced financial flexibility.' (3) The multi-hop reasoning is flawed. While the LLM correctly identifies that Chevron has an internal Risk Control group that monitors market exposure and that fair value measurements are used, it fails to conclude the key point: that these controls ensured derivatives remained within acceptable risk thresholds and thus had no material impact. Instead, it inverts the conclusion to suggest active financial benefit, which is unsupported. (4) Contextual relevance is moderate—the response addresses derivative instruments, risk management, fair value, and the Risk Control group, so it stays on topic. However, due to major factual and interpretive errors, especially in quantitative claims and overall impact assessment, the scores for correctness, quantitative, and qualitative accuracy are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 494,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What is the total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, considering both the net benefit from AOCI and the allowance for credit losses included in Tier 2 capital?",
      "original_answer": "The total impact of the CECL capital transition provisions on JPMorgan's Basel III CET1 capital as of December 31, 2024, is $1.261 billion. This includes a $720 million benefit from AOCI related to the CECL capital transition provisions and a $541 million incremental allowance for credit losses on certain assets associated with First Republic, which is included in Tier 2 capital and impacts CET1 capital through regulatory capital calculations.",
      "llm_answer": "The CECL capital transition provisions contributed a $720 million net benefit to CET1 capital and added $20.992 billion of allowance for credit losses to Tier 2 capital as of December 31 2024. Consequently, the total impact on JPMorgan’s Basel III CET1 capital is a $720 million increase, while the allowance for credit losses included in Tier 2 capital reflects the $20.992 billion figure.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states the total impact on CET1 capital is $1.261 billion, composed of a $720 million AOCI benefit and a $541 million incremental allowance from First Republic included in Tier 2 capital. However, the LLM claims a $720 million total impact and incorrectly states the allowance for credit losses in Tier 2 as $20.992 billion—this number is entirely fabricated and not present in the original answer. (2) Quantitative accuracy is severely lacking: the $20.992 billion figure is wrong, and the total impact is understated by over $500 million. The only correct number is the $720 million AOCI benefit. (3) The reasoning is flawed: the model fails to correctly synthesize the two components of the capital impact. It treats the Tier 2 allowance as a separate large figure rather than understanding that only the $541 million related to First Republic is the incremental impact affecting CET1 through regulatory treatment. The model does not demonstrate correct multi-hop reasoning between CECL provisions, AOCI, Tier 2 allowances, and their combined effect on CET1. (4) Contextual relevance is moderate because the answer addresses the right topic and regulatory framework (CECL, CET1, Tier 2), but the incorrect numbers and misunderstanding of how the components interact severely undermine the response. The answer misrepresents the core financial impact and thus fails the primary objective of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 411,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What was the total financial impact on GE from its AerCap-related transactions in 2023, considering both the net income contribution and the realized/unrealized gains or losses during that year?",
      "original_answer": "The total financial impact on GE from its AerCap-related transactions in 2023 was $2,654 million, combining the net income attributable to GE of $2,525 million and the realized/unrealized gain of $129 million in 2023.",
      "llm_answer": "Based on the financial statements and related disclosures in the provided 10-K pages, the total financial impact of GE's AerCap-related transactions in 2023 was a net income contribution of $38 million from the AerCap investment, combined with realized and unrealized gains of $129 million (reflected in \"Investment in and note with AerCap realized and unrealized gain (loss)\" under Note 19). This $167 million total reflects both the earnings contribution and the fair‑value adjustments associated with the AerCap stake during 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its core quantitative claim. The ground truth states that the total financial impact was $2,654 million, composed of $2,525 million in net income attributable to GE and $129 million in realized/unrealized gains. However, the LLM claims only $38 million in net income contribution from AerCap, which is factually wrong. This results in a total of $167 million ($38M + $129M), far below the correct total of $2,654 million. (2) The $129 million in realized/unrealized gains is correctly identified and matches the ground truth, so this component is accurate. However, the net income contribution is grossly understated—$38 million vs. the correct $2,525 million—indicating a failure to extract or interpret the correct figure from the source data. (3) The reasoning appears partially sound in structure—attempting to sum net income contribution and gains—but fails at the multi-hop synthesis because it uses an incorrect income figure. It likely confused the AerCap-related investment income with a different line item or misread the financial statement. (4) Scores are low due to major factual and quantitative errors, especially in the net income component, which constitutes over 95% of the total impact. While the structure and one component ($129M gain) are correct, the answer fundamentally misrepresents the scale and composition of the financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 393,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total consideration did Merck transfer in its acquisition of Immune Design, and what portion of this amount was allocated to goodwill, based on the fair value of net assets acquired?",
      "original_answer": "Merck transferred a total consideration of $301 million in its acquisition of Immune Design. Out of this, $20 million was allocated to goodwill, as it represented the excess of the consideration transferred over the fair value of net assets acquired.",
      "llm_answer": "Based on the provided document pages, Merck transferred total consideration of $301 million to acquire Immune Design, and of that amount $20 million was allocated to goodwill (the excess of consideration transferred over the fair value of net assets acquired).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total consideration transferred ($301 million) and the amount allocated to goodwill ($20 million), matching the ground truth exactly. (2) Both numeric values are accurate and presented in a standard financial format; no calculations are required beyond what is stated, and the explanation that goodwill represents 'the excess of consideration transferred over the fair value of net assets acquired' is factually correct. (3) The reasoning is sound and reflects proper understanding of acquisition accounting principles; the answer synthesizes the key financial metrics from the acquisition event correctly, demonstrating accurate multi-hop logic by linking total consideration to goodwill allocation based on fair value of net assets. (4) The response is fully complete, addressing both parts of the question, uses correct entities (Merck, Immune Design), and conveys the same information as the original answer with semantic equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 303,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What specific financial contributions do franchisees make to McDonald's revenue, and how does the co-investment by McDonald's in franchisee restaurant improvements impact the depreciation expense recorded by the Company?",
      "original_answer": "Franchisees contribute to McDonald's revenue primarily through the payment of rent (including minimum rent payments) and royalties based on a percentage of sales, along with initial fees upon the opening of a new restaurant or grant of a new franchise. McDonald's may co-invest with franchisees to fund restaurant improvements, where it generally manages the project and provides upfront funding. During these co-investment projects, McDonald's estimates which costs are its responsibility and which belong to the franchisee, allocating costs between Property and equipment and Accounts Receivable. Upon project completion, final cost allocations may result in immaterial adjustments to balances and associated depreciation expense, directly impacting the Company's financial statements.",
      "llm_answer": "Franchisees contribute to McDonald's revenue primarily through rent and royalties based on a percentage of sales, along with initial franchise fees. Additionally, McDonald's may co-invest with franchisees to fund restaurant improvements; these costs are initially recorded by the Company as property and equipment and accounts receivable, and once the project is complete, the costs are allocated and depreciated, resulting in depreciation expense reflecting the Company's share of the investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) It correctly identifies that franchisees contribute to McDonald's revenue through rent, royalties based on sales percentage, and initial franchise fees—this matches the original answer exactly. (2) It accurately describes McDonald's co-investment in restaurant improvements, noting that costs are initially recorded as property and equipment and accounts receivable, with allocation upon completion affecting depreciation expense. The only minor omission is the explicit mention of 'minimum rent payments' and the clarification that final cost allocations may lead to 'immaterial adjustments' to depreciation expense, which adds nuance about the financial impact. (3) There are no numbers, dates, or percentages in the question or ground truth, so quantitative accuracy is not applicable—no errors here. (4) The multi-hop reasoning is sound: the model correctly synthesizes how franchisee payments generate revenue and how co-investment affects asset recording and depreciation. The explanation of cost allocation and its impact on depreciation aligns with the original. (5) Semantic equivalence is strong—wording differs slightly but meaning is preserved. The LLM omits 'managing the project' and 'estimating responsibilities during the project,' but still conveys the essential financial mechanics. Overall, this is a factually correct, complete, and contextually appropriate response with only minor qualitative omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 415,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "By how much did the value of Goldman Sachs' securities backed by real estate decrease from December 2023 to December 2024, and what was a primary cause of unrealized losses on Level 3 investments in 2023 related to this category?",
      "original_answer": "The value of Goldman Sachs' securities backed by real estate decreased by $120 million, from $689 million in December 2023 to $569 million in December 2024. A primary cause of unrealized losses on Level 3 investments in 2023 was weakness in the commercial real estate market, which specifically affected securities backed by real estate.",
      "llm_answer": "The value of Goldman Sachs’ securities backed by real estate fell by **$81 million** from December 2023 to December 2024 (declining from $569 million to $569 million? actually from $689 million in 2023 to $569 million in 2024, a $120 million drop – the document indicates a $81 million decrease when measured at fair value).  \n\nA primary cause of the unrealized losses on Level 3 investments in 2023 was the **significant decline in commercial‑real‑estate values**, which drove lower valuations and contributed to the unrealized losses on Level 3 securities backed by real estate.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in stating the decrease as $81 million, while the ground truth confirms a $120 million decrease (from $689M to $569M). Although the correct values ($689M and $569M) are mentioned later, the initial conflicting statement and the incorrect $81M figure undermine accuracy. (2) The calculation of the difference is straightforward: $689M - $569M = $120M. The LLM incorrectly references a '$81 million decrease when measured at fair value', which contradicts the ground truth and introduces confusion without justification. This is a critical error in a financial context. (3) The qualitative reasoning is mostly sound: the cause of unrealized losses—'significant decline in commercial-real-estate values'—is semantically equivalent to the ground truth's 'weakness in the commercial real estate market', correctly identifying the driver for Level 3 unrealized losses related to real estate-backed securities. The multi-hop synthesis between the asset category, valuation impact, and market condition is logically coherent. (4) Contextual relevance is high, as the answer addresses both parts of the question and stays focused on Goldman Sachs, the correct time frame, and Level 3 investments. However, the incorrect dollar amount significantly reduces overall correctness despite accurate contextual and causal reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 385,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much additional cost did American Tower incur beyond the principal amount when repaying the CoreSite Debt, and how does this compare to the previously reported outstanding balance as of December 31, 2021?",
      "original_answer": "American Tower incurred an additional $87.9 million beyond the principal amount when repaying the CoreSite Debt, which includes $80.1 million in prepayment consideration and $7.8 million in accrued interest. This repayment was based on the $875 million principal amount outstanding as of December 31, 2021, which had increased to a total redemption price of $962.9 million due to these additional costs.",
      "llm_answer": "The Company repaid the entire $962.9 million of CoreSite Debt on January 7 2022, which included $80.1 million of prepayment consideration and $7.8 million of accrued interest.  Consequently, the total additional cost incurred beyond the principal amount was $87.9 million.  This amount is comparable to the previously reported outstanding balance of $955.1 million as of December 31 2021.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the additional cost incurred beyond the principal amount ($87.9 million), breaking it down into $80.1 million prepayment consideration and $7.8 million accrued interest, which matches the ground truth. The repayment date of January 7, 2022, is contextually accurate and adds relevant detail not in the original answer. However, the LLM incorrectly states the previously reported outstanding balance as of December 31, 2021, as $955.1 million, whereas the ground truth specifies the principal amount was $875 million. This is a significant quantitative error. The total redemption price of $962.9 million is correctly reported and consistent with $875 million + $87.9 million. The reasoning is otherwise sound: it correctly calculates the additional cost and links it to the components. The answer addresses both parts of the question—additional cost and comparison to prior balance—but the comparison is flawed due to the incorrect prior balance figure. While the core financial breakdown is accurate, the error in the previously reported balance affects the validity of the comparison, warranting a moderate correctness score. Semantic equivalence is mostly preserved except for this key discrepancy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 345,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much did GE's collections from CFM International contribute to the change in cash impacts from current receivables in 2024, and what was the nature of GE's business relationship with CFM International that supported this financial interaction?",
      "original_answer": "GE reported that increased collections from CFM International partially offset a $(0.9) billion impact from current receivables in 2024. CFM International is a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines, and GE makes substantial sales of parts and services to CFM International, which explains the significant receivables relationship.",
      "llm_answer": "Based on the provided document pages, the question asks about the contribution of CFM International collections to the change in cash impacts from current receivables in 2024 and the nature of GE's business relationship with CFM International. \n\nFrom page 13 (Cash Flows from Continuing Operations table), the cash impacts from changes in working capital were $(0.4) billion in 2024, driven by \"current receivables of $(0.9) billion, driven by higher volume partially offset by higher collections, including increased collections from CFM International.\" This indicates that increased collections from CFM International contributed positively to offsetting the negative impact on current receivables, thereby influencing the overall change in cash impacts. Specifically, the $0.9 billion decrease in current receivables (a reduction in the amount owed) was partially offset by higher collections from CFM International, which helped mitigate the negative cash flow impact.\n\nRegarding the business relationship, page 44 (Note 1) states: \"We enter into related party transactions with certain equity method investments, of which, the most significant are with CFM International, a non-consolidated company jointly owned with Safran Aircraft Engines, a subsidiary of Safran Group of France. We make substantial sales of parts and services to CFM International.\" This confirms that GE's relationship with CFM International is that of a significant equity method investment (20-50% ownership) and a key customer, involving substantial sales of parts and services, which supports the financial interaction reflected in the cash flow data.\n\nThus, CFM International's collections contributed to the reduction in the negative cash impact on current receivables by increasing cash inflows, and the relationship is defined as a major equity method investment with substantial commercial transactions for parts and services. \n\n(Word count: 249)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly identifies that the negative impact from current receivables was $(0.9) billion in 2024 and that increased collections from CFM International partially offset this impact. While the exact dollar contribution of CFM collections is not quantified in either answer, both acknowledge it as a partial offset, which matches the source. (2) The LLM accurately cites document pages and correctly interprets the cash flow impact: higher collections, including from CFM, reduced the negative effect of receivables on cash flow. (3) On qualitative accuracy, the LLM correctly identifies CFM International as a non-consolidated equity method investee jointly owned by GE and Safran Aircraft Engines and notes the substantial sales of parts and services from GE to CFM, which explains the receivables relationship. This reflects proper multi-hop reasoning linking ownership structure (equity method investee) to commercial transactions (sales) to financial impact (collections reducing receivables). (4) The only minor shortcoming is that the LLM does not explicitly state that CFM is a 'non-consolidated equity method investee' in the same concise way as the ground truth, though it does convey the same meaning by referencing 'equity method investments' and 'jointly owned.' Wording differences are acceptable under semantic equivalence. All parts of the question are addressed with high fidelity. Contextual relevance is excellent, with direct support from cited document sections.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1603,
        "completion_tokens": 430,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "What was the total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments?",
      "original_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case was $276 million, as stated in the detailed variance drivers for the year ended December 31, 2023.",
      "llm_answer": "The total financial impact on Duke Energy's operating revenues in 2023 from the Ohio tax reform deferrals and the Duke Energy Ohio electric rate case, combining prior year deferrals and current year pricing adjustments, was $70 million. This reflects the net increase in operating revenues driven by the Ohio tax reform deferrals and the Ohio electric rate case adjustments as detailed in the company's 2023 filings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core numerical claim. The ground truth states the total financial impact was $276 million, but the LLM reports $70 million, which is significantly off. No explanation or calculation is provided to justify this number, and it contradicts the documented variance drivers from Duke Energy's 2023 filings. (2) The quantitative accuracy is very low because the dollar amount is wrong by $206 million. Even allowing for format variations, $70 million is not equivalent to $276 million under any reasonable interpretation. There is no indication of correct calculation or sourcing. (3) The qualitative accuracy is low because the model fails to correctly synthesize the multi-hop components—Ohio tax reform deferrals and the Duke Energy Ohio electric rate case—despite referencing them. It identifies the correct entities (Duke Energy, Ohio tax reform, electric rate case, 2023) and context (operating revenues), but the reasoning collapses due to the incorrect financial figure. (4) Contextual relevance is high because the answer addresses the right question structure, time period, and relevant regulatory events, showing understanding of what was being asked, even though the factual output is wrong. The answer cites the appropriate context (2023 filings), but draws an incorrect conclusion from them.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 378,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How much total revenue did Adobe's Digital Media segment generate in fiscal 2021, and what percentage of this revenue came from Creative Cloud and Document Cloud individually, based on the specific figures disclosed in the 10-K filing?",
      "original_answer": "Adobe's Digital Media segment generated $11.52 billion in revenue in fiscal 2021. Of this, Creative Cloud contributed $9.55 billion (83%) and Document Cloud contributed $1.97 billion (17%).",
      "llm_answer": "Adobe’s Digital Media segment generated **$9.55 billion** in revenue for fiscal 2021. Of that amount, **$8.81 billion** (≈ 92 % of the segment’s subscription revenue) came from **Creative Cloud**, and **$1.97 billion** (≈ 20 % of the segment’s subscription revenue) came from **Document Cloud**. These figures are taken from the segment‑revenue tables in the 10‑K filing (pages 41‑45).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The total Digital Media segment revenue is incorrectly stated as $9.55 billion, which is actually the Creative Cloud revenue, not the total. The correct total is $11.52 billion per the ground truth. The Document Cloud revenue is correctly reported as $1.97 billion, but the percentage is miscalculated and misattributed — it is stated as ≈20% of 'segment’s subscription revenue', but the correct figure is 17% of total Digital Media revenue. The Creative Cloud percentage is given as ≈92% of subscription revenue, but the correct share of total Digital Media revenue is 83% ($9.55B / $11.52B). (2) Calculation verification: $9.55B + $1.97B = $11.52B — the sum matches the correct total, but the LLM fails to report this total correctly. Instead, it incorrectly equates Creative Cloud revenue with total segment revenue. The percentages provided are not aligned with the total segment revenue, and the reference to 'subscription revenue' introduces a different metric not asked for in the question. (3) Multi-hop reasoning is flawed: the model correctly identifies Document Cloud revenue but fails to synthesize the total Digital Media revenue before breaking down percentages. It incorrectly uses subscription revenue as the base for percentages, which is not what the question asked — the question requires percentages of total Digital Media revenue. (4) Scores are low due to major quantitative and reasoning errors. Contextual relevance is moderate because the answer discusses the right segment, company, year, and services, and cites the correct document section, but the core financial figures and synthesis are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 462,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the total increase in combined advertising and personnel-related costs for NFLX in 2021, specifically attributed to advertising expenses and headcount growth in both marketing and technology departments?",
      "original_answer": "The total increase in combined advertising and personnel-related costs for NFLX in 2021 was $722 million. This includes a $222 million increase in advertising expenses from the marketing department and a combined $500 million increase in personnel-related costs, with $116 million from marketing and $384 million from technology departments.",
      "llm_answer": "Based on the provided financial data, the total increase in combined advertising and personnel-related costs for NFLX in 2021 is **$316,784 thousand** (or **$316.8 million**), specifically attributed to advertising expenses and headcount growth in both marketing and technology departments. This increase is derived from the marketing expenses line item, which rose by $316,784 thousand from 2020 to 2021, with $222 million of that increase driven by advertising expenses and $116 million from personnel-related costs (headcount growth) across marketing and technology functions. The document explicitly states: \"The increase in marketing expenses for the year ended December 31, 2021 as compared to the year ended December 31, 2020 was primarily due to a $222 million increase in advertising expenses, partially offset by increased payments to our marketing partners. In addition, personnel-related costs increased $116 million, primarily due to growth in average headcount to support the increase in our production activity and continued improvements in our streaming service.\"",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its final total, reporting $316.8 million instead of the correct $722 million. While it correctly identifies the $222 million increase in advertising expenses and the $116 million increase in personnel-related costs from marketing, it omits the $384 million increase in technology department personnel costs entirely. This omission leads to a major quantitative error. (2) The calculation in the LLM answer incorrectly treats the $316.784 million as the total combined increase, but this figure appears to conflate marketing expense increases without including all relevant personnel costs. The ground truth clearly states that personnel-related cost increases were $116M (marketing) + $384M (technology) = $500M, plus $222M in advertising, totaling $722M. The LLM fails to include the $384M technology headcount cost increase, which is a critical component of the multi-hop synthesis. (3) The reasoning is flawed because it does not properly separate advertising from personnel-related costs across both departments. It incorrectly implies that the total increase in marketing expenses ($316.8M) is the sum of $222M advertising and $116M personnel costs, but $222M + $116M = $338M, which already exceeds the stated $316.8M, indicating internal inconsistency. Furthermore, the technology department's $384M personnel cost increase is completely missing, showing a failure in multi-hop reasoning across departments. (4) The contextual relevance is moderate because the answer addresses the right company (NFLX), time period (2021), and cost categories, but due to major factual and computational errors, the correctness and accuracy scores are low. The answer misrepresents the data and fails to synthesize information across all required entities (marketing and technology departments).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 500,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does General Motors' equity earnings from Ultium Cells Holdings LLC influence its Automotive and other cost of sales, and what does this indicate about the financial treatment of this stake in relation to its electric vehicle production strategy?",
      "original_answer": "General Motors reports equity earnings from Ultium Cells Holdings LLC within its Automotive and other cost of sales, indicating that the entity is integral to its electric vehicle (EV) production strategy. This financial treatment shows that GM views its stake in Ultium Cells as a core operational component rather than a separate investment, aligning its battery cell supply directly with its automotive cost structure to support EV manufacturing.",
      "llm_answer": "General Motors' equity earnings from Ultium Cells Holdings LLC are recorded in \"Automotive and other cost of sales\" and were positive $975 million in 2024, $293 million in 2023 and $8 million in 2022.  This treatment reflects that Ultium Cells is integral to GM’s EV strategy, providing battery cells that are essential to its electric‑vehicle production, and therefore its earnings are included in the cost of sales rather than shown as a separate investment gain.  Consequently, the stake is accounted for using the equity method and embedded in the automotive cost structure, underscoring its strategic role in GM’s EV rollout.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that General Motors reports equity earnings from Ultium Cells Holdings LLC within 'Automotive and other cost of sales' and accurately explains the financial treatment and strategic rationale—namely, that Ultium Cells is integral to GM’s EV production strategy and is accounted for via the equity method, embedded in the cost structure. This aligns with the ground truth and shows strong qualitative and contextual understanding. (2) However, the quantitative accuracy is severely flawed: the LLM provides specific figures—$975 million in 2024, $293 million in 2023, and $8 million in 2022—which are not present in the original answer or implied by the ground truth. There is no indication in the ground truth that these specific numbers were reported, making their inclusion factually unsupported. Since the original answer contains no financial figures, adding them constitutes a hallucination, significantly undermining factual correctness. (3) The multi-hop reasoning is otherwise sound: the model correctly infers the strategic implication of the financial classification and connects the accounting treatment to GM’s broader EV strategy. (4) The correctness score is 7 because the core explanation and reasoning are accurate and complete, but the inclusion of fabricated numbers reduces confidence in the answer’s reliability. Quantitative accuracy is low (4) due to the invented figures, while qualitative accuracy and contextual relevance remain high as the conceptual explanation is fully aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 433,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What was the percentage decrease in the average price of U.S. Henry Hub natural gas in 2023 compared to 2022, and how did this price trend compare to Chevron's international natural gas realizations during the same period?",
      "original_answer": "The average price of U.S. Henry Hub natural gas decreased by 59.8% from $6.36 per MCF in 2022 to $2.56 per MCF in 2023. Chevron's international natural gas realizations also declined, but at a more moderate rate of 21.1%, from $9.75 per MCF in 2022 to $7.69 per MCF in 2023. This indicates that the drop in U.S. natural gas prices was significantly steeper than the decline in international prices, which are often linked to crude oil benchmarks.",
      "llm_answer": "The average price of U.S. Henry Hub natural gas fell 59.8% in 2023 compared to 2022 (from $6.36 to $2.56 per MCF). This decline was driven by high storage levels and strong production, while Chevron's international natural gas realizations averaged $7.69 per MCF in 2023, down only 21% from $9.75 per MCF in 2022, reflecting a less severe decline than the U.S. market due to regional market dynamics and long-term contract pricing linked to crude oil.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the U.S. Henry Hub price decreased from $6.36 to $2.56 per MCF, representing a 59.8% decline, and Chevron's international natural gas realizations fell from $9.75 to $7.69 per MCF, a 21.1% decrease. The LLM reports 21% instead of 21.1%, but this is a negligible rounding difference and does not affect factual accuracy. (2) The answer addresses both parts of the question: the percentage decrease in U.S. Henry Hub prices and the comparison to Chevron's international realizations. (3) Entities are correctly identified—'U.S. Henry Hub natural gas' and 'Chevron's international natural gas realizations'—with correct years (2022 vs 2023) and metrics (price per MCF). (4) The reasoning is sound: the LLM correctly infers that the U.S. price drop was steeper than the international decline and provides context—high storage, strong production, and long-term oil-linked contracts—that aligns with the knowledge graph's explanation. The answer demonstrates proper multi-hop synthesis across market data and corporate financials. (5) Semantic equivalence is maintained: though the LLM adds brief explanatory context, the core facts and comparisons match the original answer exactly. No factual errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 370,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does Goldman Sachs' sensitivity of fair value measurements to changes in credit spreads impact the valuation of its level 3 credit derivatives, given the range of credit spreads and recovery rates used as significant unobservable inputs?",
      "original_answer": "Goldman Sachs' fair value of level 3 credit derivatives is directly impacted by changes in credit spreads and recovery rates. Specifically, the fair value of purchased credit protection increases when credit spreads or upfront credit points increase or when recovery rates decrease. This directional sensitivity is compounded by the broad variability in the underlying risk factors across different reference obligations, such as leverage, volatility, industry, borrowing costs, and macroeconomic conditions, which contribute to the wide range of credit spreads and recovery rates used as inputs in the valuation models.",
      "llm_answer": "Goldman Sachs' sensitivity analysis shows that fair value measurements of its Level 3 credit derivatives are highly sensitive to changes in credit spreads, upfront credit points, and recovery rates—key unobservable inputs used in their valuation. Specifically, the fair value of purchased credit protection increases as credit spreads or upfront credit points rise or recovery rates fall, meaning that wider credit spreads or lower recovery rates would significantly decrease the measured fair value of these instruments. The document notes that credit spreads for Level 3 derivatives ranged from 8 to 1,328 basis points (with an average of 134 bps and median of 91 bps as of December 2024), and these inputs are critical drivers of valuation for credit derivatives within the firm's Level 3 portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the directional sensitivity of Goldman Sachs' Level 3 credit derivatives to credit spreads, upfront credit points, and recovery rates—specifically, that the fair value of purchased credit protection increases with higher credit spreads or upfront points and lower recovery rates. This aligns with the ground truth. However, the LLM introduces specific quantitative data (credit spreads ranging from 8 to 1,328 bps, average 134 bps, median 91 bps as of December 2024) that are not present in the original answer and cannot be verified against the ground truth. Since the original answer does not include any numerical ranges or statistics, the inclusion of these figures reduces quantitative accuracy. (2) There are no calculations in the original or LLM answer, but the LLM fabricates precise basis point ranges and a future date (December 2024), which is inconsistent with typical reporting timelines and absent from the ground truth. This is a significant quantitative inaccuracy. (3) The multi-hop reasoning is sound in terms of causal relationships: the model correctly synthesizes how unobservable inputs affect valuation and acknowledges the variability across reference obligations. However, it adds unsupported specifics not present in the source, which undermines factual reliability. (4) Despite the invented numbers, the core qualitative reasoning and directional sensitivities are correct, and the answer remains highly relevant to the question. The answer would have scored higher if it had avoided hallucinated data and stuck to the conceptual framework provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 450,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the repayment of CoreSite Debt in January 2022 impact AMT's capital structure, and what does the alignment between the repayment amount and the carrying value of $955.1 million indicate about the valuation of this debt on AMT's balance sheet?",
      "original_answer": "The repayment of CoreSite Debt in January 2022, which totaled $955.1 million, directly reduced AMT's long-term obligations, thereby improving its debt-to-equity ratio and overall capital structure by eliminating a significant portion of its liabilities. The fact that the repayment amount matches the carrying value of $955.1 million, as disclosed in the detailed debt schedule, indicates that the debt was carried at its fair value or close to its redemption value on the balance sheet, suggesting minimal unamortized discounts or premiums on this debt at the time of repayment.",
      "llm_answer": "The January 7 2022 repayment of CoreSite Debt reduced AMT’s short‑term leverage and eliminated the $955.1 million of CoreSite senior unsecured notes from its balance sheet; the repayment amount of $962.9 million (including $7.8 million of accrued interest) was essentially equal to the debt’s carrying value of $955.1 million, indicating that the debt was carried at its fair market value on the balance sheet.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The repayment amount is stated as $962.9 million (including $7.8 million in accrued interest), but the ground truth specifies the repayment amount as $955.1 million, which matches the carrying value. There is no mention in the original answer of a $962.9 million total or accrued interest, so this introduces incorrect data. The date 'January 7, 2022' is more specific than the ground truth's 'January 2022', but unless this exact date is verifiable from the source, it may be an over-precision. (2) The carrying value of $955.1 million is correctly cited, and the alignment between repayment and carrying value is correctly interpreted to suggest the debt was carried at or near fair value. However, the introduction of a higher repayment amount including interest contradicts the ground truth, which treats $955.1 million as both repayment and carrying value. This undermines the calculation accuracy and factual consistency. (3) The reasoning about capital structure impact is partially correct—reducing liabilities improves leverage metrics—but the answer incorrectly frames the impact as on 'short-term leverage' when CoreSite debt was long-term, and thus the effect is on long-term capital structure and debt-to-equity ratio, not short-term leverage. The synthesis of the valuation implication (fair value due to matched carrying value) is sound and reflects correct multi-hop reasoning. (4) The contextual relevance is high because the answer addresses both parts of the question: impact on capital structure and valuation implication. However, due to the incorrect repayment amount and mischaracterization of the debt as affecting short-term leverage, the factual correctness is compromised. The core insight about fair value alignment is preserved, but the numerical errors reduce confidence in the overall accuracy. Thus, the correctness score is moderate at 5, with lower quantitative accuracy dragging down an otherwise reasonable qualitative interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 550,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How might the potential adjustments from ongoing tax examinations focusing on intercompany transfer pricing practices impact Adobe's financial position, given the range of estimated potential decreases in unrecognized tax benefits and the company's established reserves?",
      "original_answer": "The potential adjustments from ongoing tax examinations focusing on Adobe's intercompany transfer pricing practices could have an adverse effect on Adobe's financial position. Adobe has estimated a range of potential decreases in unrecognized tax benefits of up to $5 million over the next 12 months. These adjustments could result in increased tax liabilities, which would directly impact Adobe's consolidated financial statements. Adobe has established reserves to address potential exposures from tax audits, but due to the high uncertainty surrounding the timing and outcome of these examinations, the actual adjustments could exceed these reserves, leading to significant fluctuations in tax assets and liabilities on the balance sheet.",
      "llm_answer": "The ongoing tax examinations that focus on Adobe’s intercompany transfer‑pricing practices could require adjustments to the company’s unrecognized tax benefits.  Based on the disclosed range of potential decreases—approximately $0 to $5 million over the next 12 months—and the $289 million of gross unrecognized tax benefits recorded as of the end of fiscal 2021, such adjustments would modestly reduce the reserve for uncertain tax positions, but the company’s established tax reserves would still be sufficient to absorb the impact without materially affecting its overall financial position.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the range of potential decreases in unrecognized tax benefits as up to $5 million over the next 12 months, aligning with the ground truth. However, it introduces a fact not present in the original answer — the $289 million of gross unrecognized tax benefits as of fiscal 2021 — which was not mentioned in the ground truth and cannot be verified from the provided context. This addition misleads the assessment by implying a larger reserve context that may not be relevant. (2) The quantitative accuracy is partially correct: the $0 to $5 million range matches the ground truth (allowing for 'up to $5 million' as equivalent), but the inclusion of the $289 million figure is unsupported and potentially inaccurate in this context. No calculation errors are present, but the comparison to the $289 million reserve alters the interpretation. (3) The multi-hop reasoning is flawed: while the LLM correctly links transfer pricing audits to potential adjustments in unrecognized tax benefits, it incorrectly concludes that the impact would be 'modest' and 'not material' to Adobe's financial position. This contradicts the ground truth, which emphasizes that adjustments could exceed reserves and lead to 'significant fluctuations' in tax assets and liabilities due to high uncertainty. The reasoning downplays the risk, missing the adverse and uncertain financial impact emphasized in the original. (4) Contextual relevance is high — the answer addresses transfer pricing, tax reserves, and financial impact — but the qualitative inaccuracy in tone and unsupported data lowers correctness. The conclusion diverges significantly in implication despite some factual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 482,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020, and how does this growth relate to Merck's broader oncology strategy as exemplified by Keytruda's combination therapies?",
      "original_answer": "The alliance revenue related to Lenvima grew by 21% in 2021 and 44% in 2020, resulting in a combined growth of 65% over the two years. This growth is aligned with Merck's broader oncology strategy, which emphasizes combination therapies to expand indications and improve patient outcomes. For instance, Keytruda is approved in combination with Lenvima for the treatment of certain patients with endometrial carcinoma and renal cell carcinoma (RCC), demonstrating Merck's focus on leveraging synergies between its oncology assets to drive revenue and therapeutic innovation.",
      "llm_answer": "The combined growth percentage of alliance revenue related to Lenvima in 2021 and 2020 was 21% in 2021 and 44% in 2020. This growth reflects Merck's strategic expansion of Lenvima's use in combination therapies, particularly with Keytruda, to enhance oncology treatments—such as in advanced endometrial carcinoma and renal cell carcinoma—aligning with Merck's broader focus on leveraging Keytruda's combination approaches to drive innovation and market leadership in oncology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the alliance revenue growth percentages for Lenvima: 21% in 2021 and 44% in 2020, matching the ground truth. However, it does not explicitly state the combined growth of 65% over the two years, which is a direct calculation (21% + 44%) requested in the question. While the individual yearly growth figures are accurate, the omission of the summed total reduces completeness. 2) Quantitatively, all numbers are correct and properly attributed to the right years and metric (alliance revenue related to Lenvima). The format is consistent and clear. 3) The reasoning is sound: the LLM correctly links the revenue growth to Merck’s oncology strategy centered on combination therapies, specifically citing Keytruda + Lenvima combinations in endometrial carcinoma and renal cell carcinoma. This demonstrates accurate multi-hop synthesis between Lenvima revenue, Merck’s strategic focus, and Keytruda’s role. 4) The answer is contextually highly relevant, addressing both the financial performance and strategic implications. The only shortcoming is the missing explicit mention of the 65% combined growth, which slightly affects qualitative and overall correctness. Semantic equivalence is otherwise strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 344,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did GM's investment in Ultium Cells Holdings LLC in 2024 directly impact its EBIT-adjusted performance, and by how much was this contribution quantified?",
      "original_answer": "GM's investment in Ultium Cells Holdings LLC contributed $0.7 billion in equity earnings, which directly increased GM's EBIT-adjusted performance in 2024. This favorable cost impact was explicitly noted as part of the EBIT-adjusted improvement due to increased equity earnings from Ultium Cells Holdings LLC.",
      "llm_answer": "GM’s 2024 investment in Ultium Cells Holdings LLC added roughly **$0.7 billion** to EBIT‑adjusted profit, as disclosed in the “EBIT‑adjusted – excluding Equity income (loss)” line on page 35 and reinforced by the discussion of “increased equity earnings related to Ultium Cells Holdings LLC of $0.7 billion” on page 36. This contribution helped offset other headwinds and was a key factor in the EBIT‑adjusted margin improvement noted for GM North America.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $0.7 billion equity earnings contribution from GM's investment in Ultium Cells Holdings LLC in 2024 is accurately reported, with no calculation or numerical errors. The format '$0.7 billion' is equivalent to '$0.7 billion' and matches the ground truth. (2) The answer addresses both parts of the question: it identifies the impact on EBIT-adjusted performance and quantifies it correctly. (3) Entity accuracy is perfect—GM, Ultium Cells Holdings LLC, and the 2024 time frame are all correctly referenced. (4) The reasoning is sound and reflects multi-hop synthesis by referencing specific disclosure locations (pages 35 and 36) and linking increased equity earnings directly to EBIT-adjusted improvement, which aligns with the original answer’s explanation. The additional context about offsetting headwinds and margin improvement in GM North America is consistent with and supports the core fact without introducing inaccuracies. All information is semantically equivalent and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 311,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the SEC's monthly short position reporting requirement for institutional investment managers, effective January 2025, interact with Goldman Sachs' regulatory obligations as a registered security-based swap dealer to influence its derivatives reporting practices?",
      "original_answer": "The SEC's monthly short position reporting requirement, applicable to institutional investment managers meeting specified thresholds starting in January 2025, complements Goldman Sachs' existing obligations as a registered security-based swap dealer. As a registered dealer, Goldman Sachs must comply with SEC rules on capital, margin, record-keeping, business conduct, and regulatory trade reporting. The new short position reporting rule adds another layer of transparency and accountability, requiring Goldman Sachs to ensure that its short position data in equity securities is accurately reported monthly. This enhances the firm's existing reporting practices by aligning them with broader SEC oversight goals, particularly in monitoring large positions and short-selling activity in the market.",
      "llm_answer": "The SEC’s new monthly short‑position reporting rule for institutional investment managers (effective January 2025) obligates Goldman Sachs’ institutional investment‑manager subsidiaries to disclose short‑position data each month. Because Goldman Sachs is also a registered security‑based swap dealer under SEC rules, it must incorporate these reporting obligations into its broader derivatives‑reporting framework, ensuring that short‑position disclosures are captured alongside its security‑based swap position reporting, margin and clearing requirements, and cross‑border regulatory obligations. This integration enhances the firm’s overall derivatives transparency and compliance posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the SEC's monthly short-position reporting requirement starts in January 2025, applies to institutional investment managers, and Goldman Sachs is a registered security-based swap dealer with associated regulatory obligations. There are no numeric values requiring calculation, and the date (January 2025) is correctly stated. (2) The LLM correctly identifies the entities involved—Goldman Sachs, the SEC, institutional investment managers—and their relevant regulatory roles. (3) The reasoning is sound: the LLM synthesizes the new short-position reporting rule with Goldman Sachs' existing derivatives reporting framework as a swap dealer, noting integration with position reporting, margin, clearing, and cross-border obligations. While the original answer emphasizes capital, record-keeping, and business conduct rules, the LLM focuses more on operational integration into reporting systems, margin, and cross-border aspects—slightly different emphasis but still valid. (4) The answer is contextually relevant and addresses both parts of the multi-hop question: the interaction between the new short-position rule and Goldman’s existing swap dealer obligations. The only minor gap is that the LLM implies the obligation falls on 'subsidiaries' rather than clearly stating that Goldman Sachs itself may be subject as both a manager and dealer, but this does not materially misrepresent the situation. Overall, the answer is semantically equivalent in intent and accuracy, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 437,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What was the financial impact on PepsiCo from the remeasurement of its 39% noncontrolling interest in TBG at fair value following the sale of its juice brands, and how does this reflect the structure of the transaction involving both cash and retained equity?",
      "original_answer": "PepsiCo recorded a $520 million gain from the remeasurement of its 39% ownership in TBG at fair value following the sale of its Tropicana, Naked, and other select juice brands to PAI Partners for approximately $3.5 billion in cash. This gain reflects the combination of the cash proceeds from the divestiture and the retained economic interest through the 39% noncontrolling stake, which was valued using a combination of the transaction price, discounted cash flows, and an option pricing model. The structure of the transaction allowed PepsiCo to realize immediate value while maintaining a financial stake in TBG’s future performance.",
      "llm_answer": "The remeasurement of PepsiCo’s 39% noncontrolling interest in TBG to fair value following the sale of its juice brands resulted in a $520 million gain recorded in 2022, driven by the transaction price, discounted cash‑flow and option‑pricing models that reflected PepsiCo’s liquidation preference in TBG. This gain was offset by $71 million of acquisition‑ and divestiture‑related charges, and the net impact of $2.8 billion on PepsiCo’s consolidated income (after tax) was reflected in a $2.08 per‑share reduction in net income attributable to PepsiCo. The transaction combined cash proceeds of approximately $3.5 billion with retained equity in TBG, allowing PepsiCo to monetize the sold brands while maintaining a strategic stake and ongoing distribution rights.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $520 million gain from remeasurement of the 39% noncontrolling interest in TBG and the $3.5 billion cash proceeds, it introduces incorrect figures not present in the ground truth: a $71 million charge and a net impact of $2.8 billion on consolidated income with a $2.08 per-share reduction. These numbers are unsupported by the original answer and contradict its narrative. There is no mention in the ground truth of any offsetting charges or per-share impact, nor a net income effect of $2.8 billion. (2) The calculation verification fails on these introduced metrics—no basis for the $2.8 billion net impact or the per-share reduction exists in the source. The $520 million gain and $3.5 billion cash are accurate and correctly attributed. (3) The multi-hop reasoning is partially sound: the model correctly links the sale of juice brands to the remeasurement gain and recognizes the dual structure of cash proceeds plus retained equity. It also correctly notes the use of valuation models (discounted cash flows, option pricing), though it adds 'liquidation preference' not mentioned in the original. However, it fails to accurately reflect the financial outcome by fabricating downstream impacts. (4) The contextual relevance is high—the answer addresses the transaction structure, retained interest, and valuation methodology. But due to major quantitative errors and unsupported financial claims, the correctness score is low. The qualitative accuracy is moderate because core concepts are understood but not fully accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 458,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How much did GE's financial performance from its retained ownership interests, including its stake in Baker Hughes, contribute to its total other income in 2023, and how does this compare to 2024?",
      "original_answer": "In 2023, GE's retained and sold ownership interests contributed $5,778 million to its total other income, which included a $10 million realized and unrealized gain from its investment in Baker Hughes. In 2024, this contribution dropped significantly to $518 million, with no gain recorded from Baker Hughes. This represents a decrease of $5,260 million in contributions from these ownership interests year-over-year.",
      "llm_answer": "Based on the provided 10-K pages, GE's retained ownership interests (including its stake in Baker Hughes) contributed **$518 million** to total other income in 2024, compared to **$5,778 million** in 2023. This represents a significant decline, as the 2024 amount reflects only the realized gains from the full monetization of its remaining GE Healthcare shares ($5.2 billion proceeds) and smaller gains from AerCap, while 2023 included substantial unrealized gains from retained stakes in GE Healthcare, AerCap, and Baker Hughes. The drop is primarily attributed to the complete exit from GE Healthcare and partial exits from AerCap and Baker Hughes in 2024, eliminating the large unrealized gains recorded in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 contribution as $5,778 million, which matches the ground truth. However, it incorrectly states that the 2024 contribution from retained ownership interests is $518 million — while this number appears in the ground truth, it refers to the total contribution from retained and sold ownership interests in 2024, not just retained interests. The LLM misattributes this amount as being from retained interests when in fact GE had largely exited these holdings (including Baker Hughes), meaning the $518 million comes from realized gains on sold interests, not retained ones. This is a critical factual misrepresentation. Additionally, the LLM claims the $518 million includes gains from 'full monetization of its remaining GE Healthcare shares ($5.2 billion proceeds)', but this figure ($5.2 billion) is not equivalent to the $518 million in other income — conflating proceeds with income is a significant error. (2) The year-over-year comparison is partially accurate in magnitude (drop from $5,778M to $518M) but misrepresents the nature of the income: the ground truth specifies that in 2024, there was no gain from Baker Hughes and the total contribution dropped to $518M, which the LLM repeats but incorrectly contextualizes. The calculation of the decrease ($5,260M) is implied but not stated. (3) The multi-hop reasoning is partially sound — the model recognizes that exits from GE Healthcare, AerCap, and Baker Hughes impacted other income — but it fails to distinguish between income from retained versus sold interests, which is central to the question. The original answer emphasizes that 2023 included a $10M gain from Baker Hughes, which disappeared in 2024; this detail is omitted. (4) The contextual relevance is high because the answer addresses the time periods, companies, and general trend. However, due to material misstatements about the source and nature of the income, especially conflating proceeds with income and mislabeling sold interest gains as retained, the quantitative and overall correctness scores are reduced significantly. Semantic equivalence is not achieved on key financial interpretations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 584,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "What is the total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, and what percentage of the total assets measured at fair value do they represent?",
      "original_answer": "The total fair value of Mortgage-Backed Obligations is $358 million ($236 million from the first disclosure and $122 million from the second). These obligations represent approximately 2.97% of the total assets measured at fair value, calculated as $358 million divided by the combined total assets of $12,079 million and $12,010 million from the two disclosures.",
      "llm_answer": "The total fair value of Mortgage-Backed Obligations held by the company as of January 31, 2024, based on the two separate disclosures in the 10-K filing, is $236 million (as reported on page 76 under \"Mortgage-backed obligations\" in the fair value hierarchy table for January 31, 2024). This represents 1.96% of the total assets measured at fair value ($12,079 million) as of January 31, 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is incorrect in both the total fair value and the percentage calculation. The ground truth states that the total fair value is $358 million, combining $236 million from the first disclosure and $122 million from the second. The LLM only includes the $236 million figure and omits the second $122 million, leading to a significant undercount. (2) The percentage calculation is also wrong: the LLM computes 1.96% using $236M / $12,079M, but the correct total assets measured at fair value should be the average or combined total from both disclosures—$12,079M and $12,010M. The ground truth uses a combined total of $12,079M and $12,010M (likely averaged or summed depending on context) to compute 2.97%. However, the exact method isn't fully clarified in the ground truth, but the LLM fails to acknowledge the second disclosure entirely. (3) The multi-hop reasoning is flawed—the question explicitly refers to 'two separate disclosures,' requiring synthesis across both. The LLM only uses one, failing the core multi-hop requirement. (4) Contextual relevance is moderate because the answer addresses the right metric and date, and cites a plausible document location, but misses critical data. Scores reflect major factual and reasoning errors, especially in quantitative and qualitative accuracy, though the response is not irrelevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 380,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Netflix's strategy of offering varied membership plans across different countries contribute to the 7% increase in average monthly revenue per paying membership in 2021, and how did this impact the overall 19% revenue growth for the year?",
      "original_answer": "Netflix's strategy of offering varied membership plans tailored to different countries allowed for pricing flexibility based on regional market conditions. This approach enabled the company to implement price changes that contributed to a 7% increase in average monthly revenue per paying membership. As a result of this pricing strategy and the expansion of paying memberships by 11%, consolidated revenues grew by 19% in 2021. The ability to adjust pricing models across different regions directly supported the overall revenue growth, demonstrating how localized membership plan strategies can drive global financial performance.",
      "llm_answer": "Netflix’s strategy of offering varied membership plans across countries helped lift average monthly revenue per paying member by 7% in 2021, driven by price adjustments and favorable foreign‑exchange effects. This increase, combined with an 11% rise in the number of paying members, contributed to the overall 19% growth in total revenue for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 7% increase in average monthly revenue per paying membership and the 19% overall revenue growth in 2021, both of which match the ground truth. It also accurately references the 11% increase in paying memberships, which is critical to explaining the revenue growth. (2) All numeric values—7%, 19%, and 11%—are factually correct and consistent with the original answer. There are no calculation errors. (3) The reasoning is sound and captures the multi-hop logic: varied pricing strategies led to higher revenue per member, which, combined with membership growth, drove total revenue up. However, the LLM mentions 'favorable foreign-exchange effects' as a contributing factor, which is not present in the ground truth and slightly deviates from the original explanation that emphasizes pricing flexibility due to regional plan variations. This addition, while plausible, introduces a minor inaccuracy in emphasis. (4) Despite this small overreach, the core facts, synthesis, and logic are correct, and the answer fully addresses both parts of the question—how the strategy contributed to the 7% increase and how that impacted the 19% revenue growth. Thus, the answer is highly accurate with only a minor qualitative deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 359,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Merck's collaboration with Eisai on Lenvima, specifically through the LEAP clinical program, influence Merck's pharmaceutical segment revenue, given the current status of key trials and alliance revenue model?",
      "original_answer": "Merck's collaboration with Eisai on Lenvima through the LEAP clinical program influences its pharmaceutical segment revenue by shaping the future commercial potential of the Keytruda plus Lenvima combination across multiple tumor types. Although the FDA issued a CRL for the first-line treatment of unresectable HCC based on the KEYNOTE-524/Study 116 trial, Merck and Eisai are conducting the Phase 3 LEAP-002 trial to demonstrate substantial evidence of effectiveness. The discontinuation of LEAP-007 and LEAP-011 due to futility assessments negatively impacts near-term revenue potential for Lenvima combinations in NSCLC and urothelial carcinoma. However, Merck's alliance revenue model, which includes shared profits from product sales net of costs, means that if any Lenvima-based combinations gain approval and succeed commercially, Merck will receive a portion of the revenue generated. This revenue stream is integral to the Pharmaceutical segment, which includes oncology products like Keytruda and its combinations, such as with Lenvima in approved indications like endometrial carcinoma and RCC.",
      "llm_answer": "Merck's collaboration with Eisai on Lenvima, particularly through the LEAP clinical program, directly influences its Pharmaceutical segment revenue via alliance revenue sharing. Specifically, Merck reports alliance revenue from Lenvima (e.g., $704 million in 2021, up from $580 million in 2020 and $404 million in 2019), which represents its share of profits from Lenvima sales under the Eisai partnership. This revenue stream is explicitly tied to the LEAP trials, including ongoing Phase 3 studies like LEAP-002 for hepatocellular carcinoma and combinations with Keytruda across 14 tumor types. While the collaboration has faced setbacks (e.g., halted LEAP-007 and LEAP-011 trials due to futility), the alliance revenue model ensures Merck earns a share of Lenvima's commercial success, contributing to overall Pharmaceutical segment growth. The document confirms Lenvima's development status and alliance revenue reporting but does not quantify its direct revenue impact beyond the reported figures.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact the correctness score, particularly in quantitative accuracy. (1) The reported alliance revenue figures ($704M in 2021, $580M in 2020, $404M in 2019) are not present in the original answer (ground truth) and cannot be verified from the provided context; these numbers are likely fabricated or misattributed, which is a critical error. The ground truth does not include any specific revenue amounts for the Merck-Eisai collaboration. (2) While the LLM correctly identifies the LEAP-002 trial for hepatocellular carcinoma and mentions the discontinuation of LEAP-007 and LEAP-011 due to futility, it fails to mention the FDA's Complete Response Letter (CRL) for first-line unresectable HCC based on KEYNOTE-524/Study 116—a key regulatory event that directly affects commercial potential and revenue outlook. (3) The LLM correctly describes the alliance revenue model (profit-sharing from Lenvima sales) and its relevance to Merck's Pharmaceutical segment, showing sound qualitative understanding of the partnership structure and its strategic importance. (4) It also accurately notes the broad scope of the LEAP program across 14 tumor types and ties alliance revenue to clinical development progress, demonstrating good contextual and multi-hop reasoning. However, the inclusion of unverified financial figures undermines trust in the response and constitutes a major factual deviation. (5) The answer is semantically relevant and well-structured, addressing the influence on revenue, the status of key trials, and the alliance model—thus scoring high on contextual relevance. In summary: qualitative reasoning is mostly sound, but quantitative inaccuracy severely limits correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 476,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How much did Chevron's total cost incurred by consolidated companies in 2023 exceed the combined total of expensed exploration costs and the PDC Energy, Inc. acquisition cost?",
      "original_answer": "Chevron's total cost incurred by consolidated companies in 2023 was $24.6 billion. The combined total of expensed exploration costs ($0.5 billion) and the PDC Energy, Inc. acquisition cost ($10.5 billion) was $11.0 billion. Therefore, the total cost exceeded this combined amount by $13.6 billion.",
      "llm_answer": "Based on the provided financial data, Chevron's total cost incurred by consolidated companies in 2023 was $24,559 million. The combined total of expensed exploration costs ($0.5 million) and the PDC Energy acquisition cost ($10.5 million) was $11.0 million. Therefore, Chevron's total cost exceeded this combined amount by $13,549 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains critical quantitative errors. While Chevron's total cost incurred ($24,559 million ≈ $24.6 billion) is approximately correct, the expensed exploration costs and PDC acquisition cost are grossly misstated: the LLM lists them as $0.5 million and $10.5 million instead of $0.5 billion and $10.5 billion. This results in a combined total of $11.0 million instead of $11.0 billion, which is off by a factor of 1,000. The final difference is therefore $13,549 million (~$13.5 billion) instead of the correct $13.6 billion. (2) Calculations are internally consistent but based on incorrect inputs: $24,559M - ($0.5M + $10.5M) = $13,548M, which rounds to $13,549M. However, because the units are wrong, the conclusion is factually incorrect. (3) The multi-hop reasoning structure is sound—the model identifies the need to sum two components and subtract from the total cost—but fails due to incorrect data retrieval for two key values. (4) Contextual relevance is high as the answer follows the correct structure and references the right entities and metrics. However, the quantitative inaccuracy severely undermines factual correctness, warranting a low correctness score despite proper reasoning framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 348,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does American Tower determine the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component, and what specific market metric is used in this valuation?",
      "original_answer": "American Tower determines the fair value of its 2024 PSUs with a market condition component using a Monte Carlo simulation model. This model evaluates the probability of satisfying the market condition requirements, which for the 2024 PSUs is based on relative total shareholder return measured against the REIT constituents included in the S&P 500 Index.",
      "llm_answer": "American Tower determines the fair value of its 2024 performance-based restricted stock units (PSUs) that include a market condition component using a Monte Carlo simulation model. This model incorporates multiple input variables to estimate the probability of achieving the market condition requirements, and the grant date fair value assigned to the market condition component of the 2024 PSUs is $216.11. The specific market metric used is relative total shareholder return measured against the S&P 500 REIT Index.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that American Tower uses a Monte Carlo simulation model to determine the fair value of its 2024 PSUs with a market condition component, which matches the ground truth. It also correctly states that the market metric used is relative total shareholder return. However, there is a discrepancy in the benchmark index: the ground truth specifies 'REIT constituents included in the S&P 500 Index', while the LLM states 'S&P 500 REIT Index'. These are not equivalent—the former refers to REITs within the broader S&P 500, while the latter typically refers to a dedicated REIT index (e.g., S&P 500 REIT Index or S&P United States REIT Index), which is a narrower benchmark. This is a meaningful distinction in financial contexts and affects the accuracy of the market metric description. (2) The LLM introduces a specific dollar value—$216.11—as the grant date fair value of the market condition component. This figure is not present in the original answer (ground truth), and there is no indication it was derived from the knowledge graph. Since this number cannot be verified and was not part of the source truth, it constitutes a factual addition that reduces quantitative accuracy. (3) The multi-hop reasoning is otherwise sound: the model connects the valuation method (Monte Carlo) to the market condition and identifies the relevant performance metric. The core logic and structure align with the required synthesis. (4) The correctness score is 7 because the key method and general metric are correct, but the specific benchmark is inaccurately stated and an unverified number is introduced. Quantitative accuracy is penalized due to the unsupported $216.11 figure. Qualitative accuracy remains high due to correct reasoning and entity identification (except the index name). Contextual relevance is perfect—the answer directly addresses the question with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 519,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How many amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan are documented across the disclosed filings, and what is the effective date of the fourth amendment?",
      "original_answer": "There are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, with the fourth amendment effective as of July 1, 2022.",
      "llm_answer": "Based on the provided filings, the Caterpillar Inc. Supplemental Employees' Investment Plan has been amended four times, with the fourth amendment becoming effective on **July 1, 2022**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that there are four documented amendments to the Caterpillar Inc. Supplemental Employees' Investment Plan, which aligns with the original answer. (2) The effective date of the fourth amendment is correctly identified as July 1, 2022, matching the ground truth exactly. (3) The reasoning is sound and demonstrates proper synthesis of information across filings, correctly identifying both the count and the specific date for the fourth amendment. (4) The answer is semantically equivalent to the original, with no factual discrepancies, omissions, or errors in entity or date identification. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1095,
        "completion_tokens": 225,
        "total_tokens": 1320
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "What is the difference between the amortized cost and fair value of Corporate Notes and Obligations held by CRM in 2024, and how does this compare to the fair value of these securities as categorized under Level 2 inputs in active markets?",
      "original_answer": "The amortized cost of Corporate Notes and Obligations is $3,014 million, while the fair value is $2,978 million, resulting in a $36 million unrealized loss. According to the second source, the fair value of these securities categorized under Level 2 inputs in active markets is $2,557 million, which is significantly lower than the overall fair value of $2,978 million, indicating a difference of $421 million between the total fair value and the Level 2 categorized value.",
      "llm_answer": "The amortized cost of Corporate Notes and Obligations held by CRM as of January 31 2025 is $5,215 million, while their fair value is $5,184 million. This fair value is classified as Level 2 in the fair‑value hierarchy, meaning it is derived from observable market inputs other than quoted prices for identical assets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The amortized cost and fair value figures provided ($5,215 million and $5,184 million) do not match the ground truth values of $3,014 million and $2,978 million, respectively. The resulting unrealized loss of $36 million in the original answer is accurate, but the LLM fails to compute or mention this correctly. Furthermore, the LLM claims the fair value is entirely classified as Level 2, which contradicts the ground truth stating that only $2,557 million of the $2,978 million fair value is categorized under Level 2, with a significant $421 million difference. (2) All key numbers are wrong: amortized cost (LLM: $5,215M vs truth: $3,014M), fair value (LLM: $5,184M vs truth: $2,978M), and Level 2 fair value (LLM omits $2,557M). The LLM also references January 31, 2025, while the question is about 2024, introducing a wrong fiscal period. (3) The multi-hop reasoning is completely flawed. The question requires comparing amortized cost vs fair value, computing the unrealized gain/loss, and then comparing total fair value to Level 2 fair value across sources. The LLM fails to perform any correct cross-source synthesis and instead presents data from an unverified or incorrect source. (4) The contextual relevance is low because the answer discusses the right type of securities (Corporate Notes and Obligations) and mentions Level 2 inputs, but with incorrect values and conclusions. Due to massive quantitative and qualitative errors, the correctness score is near the lowest.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 432,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What is the total amount of financing Disney has secured for its new cruise ships, including both the Disney Treasure and the anticipated Disney Destiny, and how does the interest rate on these facilities compare?",
      "original_answer": "Disney has secured a total of $2.2 billion in financing for its new cruise ships, with $1.1 billion borrowed for the Disney Treasure at a fixed interest rate of 3.80% and another $1.1 billion facility available for the Disney Destiny at a slightly lower fixed interest rate of 3.74%.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, Disney has secured financing for its new cruise ships through dedicated credit facilities. The company borrowed $1.1 billion under a facility for the Disney Treasure (delivered October 2024) with a fixed 3.80% interest rate over 12 years, and has a second $1.1 billion facility available for the Disney Destiny (scheduled for fiscal 2026 delivery) with a fixed 3.74% interest rate over 12 years. These facilities allow borrowing at fixed rates, with early repayment permitted subject to cancellation fees. The document does not specify a combined total financing amount, but indicates these are the primary financing mechanisms for the two new ships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: $1.1 billion for Disney Treasure at 3.80% and $1.1 billion available for Disney Destiny at 3.74%, matching the ground truth. The total financing of $2.2 billion is implied by summing the two $1.1 billion facilities, though not explicitly stated as a total. This is a minor omission but does not make the answer incorrect. (2) All numeric values—dollar amounts ($1.1 billion each), interest rates (3.80% and 3.74%), and delivery timelines (October 2024, fiscal 2026)—are accurate and match the ground truth. The calculation of total financing as $2.2 billion is straightforward and correct, even if not explicitly mentioned. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about two separate financing facilities for two different ships, identifies their respective terms, and compares the interest rates. It correctly notes that the Disney Destiny facility is 'available' rather than drawn, which aligns with the forward-looking nature in the source. (4) The answer is semantically equivalent to the ground truth, with only a slight lack of explicit summation of the total $2.2 billion. However, given that both components are clearly stated, the total can be easily inferred. Wording differences (e.g., 'facility available' vs. 'secured') do not affect factual accuracy. The contextual relevance is perfect, addressing both parts of the question: total financing (implicitly) and interest rate comparison (explicitly).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 419,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What percentage of Chevron's total equity method investments does its Tengizchevroil stake represent, and how does this relate to its production volumes from the Kazakhstan joint venture?",
      "original_answer": "Chevron's investment in Tengizchevroil represents $27,368 million of its total equity method investments of $46,618 million, which is approximately 58.7%. This significant stake directly supports Chevron's production volumes, as Tengizchevroil is one of the key international affiliates contributing to Chevron's oil-equivalent production in Kazakhstan.",
      "llm_answer": "Chevron's Tengizchevroil stake represents **50 % of its total equity‑method investments** (the $27.4 billion carrying value of the Tengizchevroil investment is a major component of the $46.6 billion total equity‑method portfolio).  This 50 % ownership translates into a significant share of the company’s production from the Kazakhstan joint venture, accounting for roughly **one‑third of Chevron’s worldwide oil‑equivalent output** (about 45 % of its total oil‑equivalent production comes from the Tengizchevroil project).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the percentage calculation. The ground truth states that Chevron's Tengizchevroil stake of $27,368 million represents approximately 58.7% of its total equity method investments of $46,618 million. The LLM incorrectly calculates this as 50%, which is a major quantitative error despite using correctly rounded figures ($27.4B and $46.6B). (2) The production claims are unsupported and factually incorrect: the LLM states that Tengizchevroil accounts for 'roughly one-third of Chevron’s worldwide oil-equivalent output' and 'about 45% of its total oil-equivalent production'—these figures are not in the original answer and contradict it. The original only states that Tengizchevroil is a key contributor to production in Kazakhstan, not global output. (3) The multi-hop reasoning is partially sound in linking investment value to production relevance, but fails in accurate synthesis: while it correctly identifies Tengizchevroil as a major asset in Kazakhstan and ties investment to production, it fabricates specific production percentages without basis in the source. (4) Contextual relevance is high because the answer addresses both parts of the question—investment percentage and production relationship—and uses appropriate entities (Chevron, Tengizchevroil, equity-method investments). However, the quantitative inaccuracy severely undermines correctness, warranting a low score. Minor formatting variations like $27.4 billion vs $27,368 million are acceptable, but incorrect percentages and invented production shares are not. Thus, correctness is scored at 4 (partially correct but major errors), quantitative accuracy at 3 (core numbers are close but calculation is wrong), qualitative accuracy at 5 (entities and logic are reasonable but reasoning leads to false conclusions), and contextual relevance at 8 (answer is on-topic and attempts full synthesis).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 527,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does a change in credit spreads or upfront credit points impact the fair value measurement of Goldman Sachs' level 3 credit derivatives, and what valuation techniques are used to determine this fair value?",
      "original_answer": "An increase in credit spreads or upfront credit points leads to an increase in the fair value measurement of purchased credit protection for Goldman Sachs' level 3 derivatives. These derivatives are valued using a combination of option pricing, correlation, and discounted cash flow models.",
      "llm_answer": "A change in credit spreads or upfront credit points directly affects the fair value of Goldman Sachs' level 3 credit derivatives, with higher credit spreads or upfront points generally decreasing the value of purchased credit protection. The fair value of these derivatives is determined using valuation techniques that incorporate significant unobservable inputs, including credit spreads, upfront credit points, and recovery rates, as detailed in the sensitivity analysis provided in the document.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the direction of the impact: it states that higher credit spreads or upfront points decrease the value of purchased credit protection, while the ground truth states that an increase in credit spreads or upfront credit points increases the fair value of purchased credit protection. This is a major qualitative and conceptual error that reverses the economic relationship. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify or calculate. The LLM does not introduce any incorrect figures, so it does not fail on numerical grounds. (3) The multi-hop reasoning is partially sound in that the model identifies the relevant factors (credit spreads, upfront points) and valuation techniques involving unobservable inputs. However, it fails in synthesizing the correct directional impact, which is central to the question. The mention of sensitivity analysis and unobservable inputs adds context but does not compensate for the incorrect directional logic. (4) Contextual relevance is high because the answer addresses the right topic, entity (Goldman Sachs), instrument type (level 3 credit derivatives), and valuation techniques. However, due to the reversal of the economic effect, the core of the answer is factually wrong, warranting a low correctness and qualitative accuracy score despite correct terminology and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 404,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does the potential failure to meet the Minimum DSCR impact AMT's ability to fund the construction of communications sites globally as outlined in their 2024 10-K filing?",
      "original_answer": "If AMT fails to meet the Minimum Debt Service Coverage Ratio (DSCR) of 1.15x, an amortization period will commence, during which all excess cash flow and any amounts in the Cash Trap Reserve Account will be applied to pay down the principal of the Series 2015-2 Notes or the Loan. This would prevent AMT from receiving distributions needed to fund capital expenditures, including the construction of 1,950 to 2,550 communications sites globally. As a result, AMT may be unable to proceed with its planned tower construction, which could hinder its growth and expansion initiatives.",
      "llm_answer": "The potential failure to meet the Minimum DSCR (1.15x) under the 2015 Securitization and Trust Securitizations would trigger an \"amortization period,\" diverting all excess cash flow to repay debt principal instead of distributing it to AMT. This would restrict AMT’s ability to access cash for capital expenditures, including global communications site construction, and could jeopardize its capacity to meet REIT distribution requirements and debt service obligations, as highlighted in the document’s discussion of DSCR covenants and cash flow restrictions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key consequence of failing to meet the Minimum DSCR of 1.15x: the initiation of an amortization period that diverts excess cash flow to debt repayment, limiting AMT's access to funds for capital expenditures like global communications site construction. The quantitative accuracy is perfect—1.15x DSCR is correctly cited, and there are no numerical errors. The reasoning is logically sound and reflects the multi-hop connection between covenant compliance, cash flow restrictions, and impact on capital projects. However, the LLM omits specific details from the original answer about the Cash Trap Reserve Account and the exact range of planned tower construction (1,950 to 2,550 sites), which are material to the completeness of the response. While the general impact on REIT distributions and debt obligations is mentioned, this slightly extends beyond the original answer’s focus, which centered on capital funding for construction. Despite this minor omission and slight shift in emphasis, the core factual chain is accurate and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 310,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Caterpillar's use of historical claim rates in determining its product warranty liability influence the critical audit matter identified by PricewaterhouseCoopers LLP, and what is the resulting financial estimate of this liability as of December 31, 2024?",
      "original_answer": "Caterpillar determines its product warranty liability by applying historical claim rate experience to the current field population and dealer inventory, which involves significant judgment by management. This method was identified as a critical audit matter by PricewaterhouseCoopers LLP due to the high degree of auditor judgment, subjectivity, and effort required to evaluate the reasonableness of management's assumptions. As of December 31, 2024, the resulting financial estimate of the product warranty liability was $1,700 million.",
      "llm_answer": "Caterpillar determines its product warranty liability by applying historical claim rates—derived from actual warranty experience for each machine model/engine size and customer/dealer location—to the current field population and dealer inventory, updating these rates monthly. This significant management judgment and the reliance on historical claim rates were identified by PricewaterhouseCoopers LLP as a critical audit matter due to the high degree of auditor judgment and subjectivity involved. The resulting financial estimate of the product warranty liability as of December 31, 2024 is $1.7 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Caterpillar uses historical claim rates applied to field population and dealer inventory to estimate warranty liability, a process involving significant management judgment. This was identified by PricewaterhouseCoopers LLP as a critical audit matter due to the high degree of auditor judgment and subjectivity. (2) The financial estimate of $1.7 billion as of December 31, 2024, matches the ground truth of $1,700 million—equivalent in value with acceptable format variation ($1.7 billion = $1,700 million). (3) The multi-hop reasoning is sound: the answer correctly links Caterpillar's estimation method to the audit firm's identification of it as a critical audit matter, and provides the resulting financial figure. (4) The LLM adds slightly more detail (e.g., updating rates monthly, breakdown by machine model/engine size and location), which is consistent with plausible elaboration and does not contradict the ground truth. All entities—Caterpillar, PricewaterhouseCoopers LLP, product warranty liability, December 31, 2024—are correctly identified and contextualized. No errors in reasoning, numbers, or relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 346,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference between Disney's stated interest rate on Asia Theme Parks borrowings and the effective interest rate on its senior unsecured notes reflect the company's relative cost of capital across these debt categories?",
      "original_answer": "The stated interest rate on Asia Theme Parks borrowings is 7.93%, while the effective interest rate on Disney's senior unsecured notes is 4.71%. This indicates that the Asia Theme Parks debt carries a significantly higher cost of capital compared to the senior unsecured notes. The difference of 3.22 percentage points highlights the premium Disney pays for this specific borrowing, potentially due to factors such as risk profile, collateralization, or market conditions at the time of issuance.",
      "llm_answer": "The document shows that Disney's Asia Theme Parks borrowings carry a stated interest rate of 7.93% (as noted in the \"Asia Theme Parks borrowings\" line item on page 99), while the effective interest rate on its senior unsecured notes is 4.71% (reflecting the impact of swaps and hedges, per the \"Effective Interest Rate\" column on page 99). This disparity indicates that the stated rate on the Asia Theme Parks debt is significantly higher than the effective cost of capital for the broader senior debt, reflecting the higher perceived risk or longer-term nature of the park-specific borrowing compared to the company's diversified, investment-grade senior notes. Consequently, the effective interest rate on the senior notes (4.71%) represents a lower, more favorable cost of capital for Disney overall, while the Asia Theme Parks debt's stated rate (7.93%) underscores a more expensive, specialized financing arrangement tied to those assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the stated interest rate on Asia Theme Parks borrowings as 7.93% and the effective interest rate on Disney's senior unsecured notes as 4.71%, matching the ground truth exactly. The difference of 3.22 percentage points is implied (7.93 - 4.71 = 3.22), though not explicitly stated, but the qualitative comparison of 'significantly higher' is accurate and appropriate. (2) All numeric values are correct and properly attributed to the source document (page 99), with correct interpretation of 'stated' vs 'effective' interest rates, including the impact of hedges and swaps on the senior notes. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different debt instruments (Asia Theme Parks borrowings and senior unsecured notes) and draws a valid conclusion about relative cost of capital. It appropriately infers that the higher rate reflects greater risk or structural differences, aligning with the ground truth's implication of a risk or market-condition premium. (4) The answer is semantically equivalent to the ground truth, with slightly more elaboration on possible reasons (e.g., 'longer-term nature', 'specialized financing'), which are reasonable interpretations and do not contradict the original. The only minor shortcoming is the lack of explicit mention of the 3.22 percentage point difference, which slightly reduces completeness in quantitative presentation, but the core comparison remains accurate. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 447,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was Chevron's capitalized cost associated with the PDC acquisition in 2023, and in which U.S. basin was this acquisition primarily responsible for contributing 2.2 TCF of purchases in 2023?",
      "original_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $10,487 million, and this acquisition was primarily responsible for contributing 2.2 TCF of purchases in the DJ Basin in 2023.",
      "llm_answer": "Chevron's capitalized cost associated with the PDC acquisition in 2023 was $21 billion, and the acquisition primarily contributed 2.2 TCF of purchases in the DJ basin.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the DJ Basin as the U.S. basin where the PDC acquisition contributed 2.2 TCF of purchases, which matches the ground truth. However, the capitalized cost is incorrect: the LLM states $21 billion, while the ground truth is $10,487 million (~$10.5 billion). This is a significant numerical error—off by more than double the actual amount. (2) Quantitative accuracy is low because the dollar amount is factually wrong despite correct formatting (billion vs million is acceptable if value is accurate). $21 billion vs $10.487 billion is a major discrepancy. The 2.2 TCF figure is correct. (3) Qualitatively, the reasoning appears sound in linking the PDC acquisition to the DJ Basin and associating it with the 2.2 TCF purchase volume, indicating proper multi-hop synthesis between acquisition, location, and resource volume. The entity identification (Chevron, PDC acquisition, 2023, DJ Basin) is accurate. (4) Contextual relevance is high because the answer addresses both parts of the question and uses appropriate terminology. The core error is quantitative, dragging down correctness. A score of 5 reflects partial correctness: one major fact wrong, one major fact right, with otherwise solid structure and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 355,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and how does this retrospective application reflect the impact of the guidance on MetLife's consolidated financial reporting?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of comprehensive income as a result of the adoption of the new LDTI accounting guidance. This retrospective application demonstrates that the LDTI guidance had a material effect on MetLife's financial reporting, specifically requiring restatement of prior period financial statements to align with the new accounting standards for long-duration insurance contracts.",
      "llm_answer": "The adoption of the new LDTI accounting guidance required MetLife to retrospectively adjust its previously reported consolidated financial statements, primarily impacting the presentation of future policy benefits, policyholder account balances, and accumulated other comprehensive income (AOCI). This adjustment resulted in a $17.0 billion reduction in future policy benefits, a $7.5 billion increase in policyholder account balances, and a $4.5 billion increase in AOCI, reflecting the transition from legacy reserving models to LDTI-compliant frameworks. These changes were implemented through adjustments to opening retained earnings and AOCI, with corresponding reclassifications of $7.4 billion in fixed policy benefits to policyholder accounts at the transition date. The retrospective application ensured that MetLife's consolidated financial reporting now aligns with LDTI requirements, providing a consistent basis for comparing pre- and post-adoption financial results.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative figures such as a $17.0 billion reduction in future policy benefits, a $7.5 billion increase in policyholder account balances, and a $4.5 billion increase in AOCI, along with a $7.4 billion reclassification. However, these numbers are not present in the original ground truth answer and cannot be verified as accurate based on the provided knowledge graph. The original answer does not include any numerical data, so the inclusion of precise dollar amounts represents unverified, potentially hallucinated information. (2) Since the ground truth contains no quantitative data, all cited figures in the LLM response fail verification, resulting in significant quantitative inaccuracies. There is no way to confirm whether these numbers align with MetLife’s actual filings, making the quantitative accuracy low. (3) On qualitative grounds, the LLM correctly identifies that retrospective adjustments were made to consolidated financial statements and mentions relevant balance sheet items impacted by LDTI (e.g., future policy benefits, AOCI), which aligns with typical LDTI impacts. It also correctly notes that the retrospective application affects comparability and requires restatement—consistent with the intent of the guidance. However, the original answer specifically names the consolidated statement of operations and consolidated statements of comprehensive income as the adjusted statements, which the LLM fails to explicitly identify, missing a key factual component. (4) The response is contextually relevant and demonstrates understanding of LDTI's implications, but the fabrication of specific financial figures and omission of the exact financial statements named in the ground truth significantly reduce correctness. The model adds detail beyond the source, undermining factual reliability despite plausible reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 512,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How many amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and what is the effective date of the most recent amendment?",
      "original_answer": "Two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing. The most recent amendment is the Second Amendment, which became effective on January 1, 2022.",
      "llm_answer": "Based on the provided pages from the Caterpillar Inc. 2024 10-K filing, **two amendments** to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented:  \n1. The **Second Amendment** (effective January 1, 2022), referenced in *Page page_128* (Item 10.31).  \n2. A **Third Amendment** is not explicitly listed in the provided pages, but the *Page page_128* also references a *First Amendment* (effective December 10, 2014) and *Second Amendment* (effective January 1, 2022), with no further amendments detailed in the given excerpts.  \n\nThe **most recent amendment** documented is the **Second Amendment**, effective **January 1, 2022** (as stated in *Page page_128*, Item 10.31). No later amendments (e.g., 2023 or 2024) are referenced in the provided pages.  \n\n**Answer**:  \nTwo amendments are documented, with the most recent effective date being **January 1, 2022**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that two amendments to the Solar Turbines Incorporated Managerial Retirement Objective Plan are documented in the Caterpillar Inc. 2024 10-K filing, and accurately states that the most recent amendment is the Second Amendment, effective January 1, 2022. All quantitative details (dates, amendment numbers) match the ground truth exactly. The answer is factually correct and semantically equivalent to the original answer. The only minor issue is a slightly confusing statement: 'A Third Amendment is not explicitly listed...' — while technically accurate, it introduces a hypothetical (a third amendment) that could mislead if not properly contextualized, though the conclusion remains correct. This does not affect factual accuracy but slightly weakens reasoning clarity. Multi-hop synthesis is sound, as the model correctly pulls and correlates information from the referenced document (Page page_128, Item 10.31). Contextual relevance is high, with all information directly addressing the question. No calculation errors; entity names and dates are precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 310,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "What was the total financial impact of the North Carolina Rate Case Order on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress, and how was this reflected in the consolidated statements of operations?",
      "original_answer": "The North Carolina Rate Case Order resulted in a total financial impact of $68 million on Duke Energy's Impairment of Assets and Other Charges across both Duke Energy Carolinas and Duke Energy Progress. Specifically, $35 million was recorded by Duke Energy Carolinas and $33 million by Duke Energy Progress under Impairment of Assets and Other Charges, as stated in the consolidated statements of operations.",
      "llm_answer": "The North Carolina Rate Case Order reduced Duke Energy’s impairment of assets and other charges by $22 million at Duke Energy Progress, and this reduction was reflected in the consolidated statements of operations as a $23 million decrease in impairment of assets and other charges (from $29 million in 2023 to $6 million in 2024). This decrease contributed to the overall reduction in operating expenses and helped drive the increase in operating income and net income reported for the year ended December 31, 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude. The ground truth states that the North Carolina Rate Case Order resulted in a total *positive* impact of $68 million on Impairment of Assets and Other Charges ($35M by Duke Energy Carolinas and $33M by Duke Energy Progress), meaning charges increased. However, the LLM claims a *reduction* of $22 million at Duke Energy Progress and a $23 million decrease overall, which contradicts the ground truth. (2) The numbers are entirely inaccurate: the LLM introduces figures not present in the original answer (e.g., $29M in 2023, $6M in 2024) and misrepresents the nature of the impact as a reduction rather than an addition to impairment charges. There is no mention of Duke Energy Carolinas in the LLM response, omitting half of the required multi-hop synthesis. (3) The reasoning is flawed: the LLM incorrectly frames the rate case order as reducing impairments, when in fact it triggered additional charges. It also introduces forward-looking data (2024 results) and operational impacts (increase in net income) not mentioned or supported by the original answer. (4) The contextual relevance is low because the answer discusses financial statement effects but misattributes the event's impact and omits key entities and figures. Due to complete factual inaccuracy in numbers, direction of impact, and missing core components, the correctness score is 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 399,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "What is the financial impact on Starbucks from the 12% of total net revenues generated by licensed stores, considering the structure of payments received from licensees including margins on products, royalties, and license fees?",
      "original_answer": "Starbucks receives a combination of product margins, royalties, and license fees from its licensed stores, which accounted for 12% of total net revenues in fiscal 2024. This revenue contribution is derived from the sale of branded products, supplies, and equipment to licensees, along with ongoing royalty payments based on retail sales. Despite lower per-store revenues compared to company-operated stores, the licensed model benefits Starbucks by shifting operating costs and capital investments to the licensees, thereby improving overall operating margins.",
      "llm_answer": "The licensed store model generates a modest but strategically important 12% of Starbucks' total net revenue, contributing through multiple streams: a margin on branded products sold to licensees, ongoing royalties on retail sales, and license fees. While licensed stores operate with lower gross margins than company-operated stores, their higher operating margins and the ability to leverage local partners' market expertise and access to prime retail locations help offset this, supporting the company's long-term growth objectives without requiring direct capital investment in those locations. This structure allows Starbucks to expand its global footprint efficiently while maintaining focus on its core company-operated stores as the primary revenue driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that licensed stores account for 12% of total net revenues, matching the ground truth. It accurately describes the revenue structure—margins on products sold to licensees, royalties on retail sales, and license fees—aligning with the original answer. The strategic benefits (shifting operating costs and capital investment to licensees, improving operating margins) are correctly inferred and well-articulated, though the LLM emphasizes 'higher operating margins' and 'local partners' expertise' slightly more than the original, which is a nuance rather than an error.\n\n2) Quantitatively, the 12% figure is correct and matches the ground truth. No other numerical values (e.g., dollar amounts, years) are present, but the fiscal year 2024 is implied in the original; however, the LLM does not specify the year. This is a minor omission but not a factual error since the percentage is consistent and the context is current. The absence of the explicit fiscal year prevents a perfect score but does not undermine correctness.\n\n3) The multi-hop reasoning is sound: the model synthesizes the revenue contribution (12%) with the payment structure (product margins, royalties, fees) and correctly infers the financial and strategic implications (capital efficiency, margin profile, global expansion). It connects the dots between revenue streams and business model advantages, demonstrating strong qualitative reasoning.\n\n4) The LLM answer is semantically equivalent to the original, with slightly more emphasis on strategic growth and market expertise. All key facts are present and correctly represented. The only minor gap is the lack of explicit mention of 'fiscal 2024', but the 12% figure is contextually accurate. Thus, the answer is highly accurate, complete, and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 523,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "Given that Target's owned and exclusive brands account for approximately one-third of its sales and carry higher margins than national brands, what financial risk does Target face if it fails to successfully develop, source, and market these brands, particularly considering the longer lead times and increased responsible sourcing risks involved?",
      "original_answer": "If Target fails to successfully develop, source, and market its owned and exclusive brands—which represent approximately one-third of its overall sales and generally carry higher margins—its results of operations could be significantly adversely affected. This risk is amplified by the fact that owned brand products involve greater responsible sourcing risk due to the selection of vendors and longer lead times between order placement and product delivery. These longer lead times require earlier ownership of products in the supply chain and longer-term forecasting of consumer demand, which increases exposure to supply chain disruptions and the risk of misjudging rapidly changing consumer preferences. Since these brands contribute meaningfully to revenue and profitability, any failure in this area could directly impact financial performance.",
      "llm_answer": "Target faces significant financial risk if it fails to successfully develop, source, and market its owned and exclusive brands—approximately one-third of sales and higher-margin than national brands—because these products require longer lead times and involve greater responsible sourcing complexities that can amplify supply chain disruptions, inventory shrink, and reputational harm, ultimately threatening its competitive differentiation and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial risk Target faces if it fails to develop, source, and market its owned and exclusive brands. (1) Quantitatively, the statement that these brands represent 'approximately one-third of sales' is correct and matches the ground truth. There are no calculations in this question, so numerical precision is fully maintained. (2) The LLM correctly identifies that these brands carry higher margins than national brands, which is a key profitability driver. (3) The reasoning accurately reflects the multi-hop synthesis: longer lead times increase forecasting risk and earlier ownership of inventory, while responsible sourcing risks can lead to supply chain disruptions and reputational harm. The LLM links these operational challenges to financial and strategic consequences—profitability, competitive differentiation—aligning with the ground truth's emphasis on adverse effects on results of operations. (4) The only minor omission is that the ground truth explicitly mentions 'longer-term forecasting of consumer demand' and 'misjudging rapidly changing consumer preferences,' which the LLM implies but does not state directly. Additionally, 'inventory shrink' is mentioned in the LLM answer but not in the original; while plausible, it's not part of the documented risk in the source. Overall, the answer is semantically equivalent, contextually precise, and demonstrates sound reasoning across entities and cause-effect chains.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 409,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many amendments to the Caterpillar Inc. Deferred Employees' Investment Plan were incorporated into the 2024 10-K filing by reference from prior SEC filings, and which specific SEC filings contained the most recent two amendments?",
      "original_answer": "There were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K filing. The most recent two amendments were: the Third Amendment, effective January 1, 2022, which was incorporated by reference from Exhibit 10.28 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021; and the Fourth Amendment, effective as of July 1, 2022, which was incorporated by reference from Exhibit 10.6 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022.",
      "llm_answer": "Based on the provided pages, the Caterpillar Inc. Deferred Employees' Investment Plan has been amended four times, with the most recent amendments incorporated by reference in the 2024 10-K filing. The specific SEC filings containing the most recent two amendments are the Company's Annual Report on Form 10-K for the year ended December 31, 2021 (which includes the Third Amendment effective January 1, 2022) and the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2022 (which includes the Fourth Amendment effective July 1, 2022).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that there were four amendments to the Caterpillar Inc. Deferred Employees' Investment Plan incorporated into the 2024 10-K, which aligns with the original answer. (2) The two most recent amendments are correctly identified: the Third Amendment effective January 1, 2022, and the Fourth Amendment effective July 1, 2022. The SEC filings from which they were incorporated by reference are also exactly correct: the 10-K for the year ended December 31, 2021 (Exhibit 10.28) and the 10-Q for the quarter ended September 30, 2022 (Exhibit 10.6), though the exhibit numbers are omitted in the LLM answer, this does not affect factual correctness as the question only asks for the specific SEC filings. (3) The multi-hop reasoning is sound—information is synthesized across multiple filings and time periods, and the LLM correctly traces the amendments to their source documents. (4) The answer is semantically equivalent to the original, with no factual discrepancies, omissions, or inaccuracies. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 319,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How many shares remain available for future grant or issuance under the 2013 Equity Incentive Plan, and what types of equity awards were outstanding related to this plan according to the 2024 10-K filing?",
      "original_answer": "73 shares remain available for future grant or issuance under the 2013 Equity Incentive Plan. The types of equity awards outstanding related to this plan include options outstanding and restricted stock awards and units and performance-based stock units outstanding.",
      "llm_answer": "Based on the provided pages from the 2024 10-K filing, the number of shares remaining available for future grant or issuance under the 2013 Equity Incentive Plan is **73 million** (as shown in the \"Common Stock\" table on page 87). Additionally, the types of equity awards outstanding related to this plan include **stock options**, **restricted stock awards and units**, and **performance-based stock units** (as detailed in the \"Stock Options Outstanding\" and \"Restricted Stock Activity\" tables on pages 85 and 86).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in quantitative accuracy: it states '73 million' shares remain available, while the ground truth is '73 shares'. This is a massive discrepancy—off by a factor of one million—and fundamentally misrepresents the financial reality. Although the types of equity awards (stock options, restricted stock awards and units, performance-based stock units) are correctly identified and match the original answer, the numerical error severely undermines the correctness of the response. The reasoning appears logically structured and contextually relevant, citing specific tables and pages, suggesting proper multi-hop synthesis of document details. However, the failure to accurately report the number of shares (73 vs. 73 million) indicates either a misreading of the data or a formatting error that cannot be overlooked. While the qualitative identification of award types is accurate and the answer addresses both parts of the question, the magnitude of the numerical error results in a low correctness and quantitative accuracy score. Semantic equivalence is not achieved due to this major factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 324,
        "total_tokens": 1534
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What percentage of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, given that most of these revenues come from product sales and royalties through this partnership?",
      "original_answer": "The majority of Starbucks' Channel Development revenues in fiscal 2024 are derived from the Global Coffee Alliance with Nestlé, as stated in the document. While an exact percentage is not provided, the document specifies that 'most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.' This indicates that the percentage is greater than 50% but the exact figure is not disclosed.",
      "llm_answer": "Based on the provided financial disclosures, Starbucks' Channel Development revenues in fiscal 2024 totaled $1,769.8 million, and the filing explicitly states that \"most of our Channel Development revenues are from product sales to, and royalty revenues from, Nestlé through the Global Coffee Alliance.\" This confirms that the vast majority of these revenues derive from the partnership with Nestlé, though the exact percentage is not quantified in the document. The text does not provide a specific percentage figure for the portion of Channel Development revenue attributable to Nestlé.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that the exact percentage of Starbucks' Channel Development revenues from the Global Coffee Alliance with Nestlé is not disclosed, but that 'most' revenues come from this partnership—consistent with the original answer's assertion that the share is greater than 50% without a precise figure. (2) The dollar amount of $1,769.8 million for Channel Development revenues in fiscal 2024 is factually correct and matches the disclosed data in the 10-K, demonstrating strong quantitative accuracy. (3) The reasoning is sound: it correctly synthesizes the information that 'most' revenues come from Nestlé via product sales and royalties, fulfilling the multi-hop requirement of linking the revenue segment to the partnership without overclaiming precision. (4) The only minor shortcoming is a slight omission of explicitly stating that 'most' implies 'over 50%', which would have made the qualitative reasoning fully complete. However, the use of 'vast majority' is semantically close and contextually acceptable. Overall, the answer is factually correct, contextually relevant, and properly cautious about the lack of an exact percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 343,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "What specific financial statements of MetLife were retrospectively adjusted as a result of the adoption of the new LDTI accounting guidance, and which specific effects are illustrated in tables presented as of December 31 according to the 2023 10-K filing?",
      "original_answer": "MetLife retrospectively adjusted both its consolidated statement of operations and consolidated statements of cash flows as a result of the adoption of the new LDTI accounting guidance. These adjustments are illustrated in tables presented as of December 31 in the 2023 10-K filing.",
      "llm_answer": "Based on the provided 2023 10-K filing pages, the specific financial statements retrospectively adjusted due to the new LDTI accounting guidance were the **Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets, Consolidated Statements of Operations, Consolidated Statements of Equity, and Consolidated Statements of Cash Flows**. The effects of the LDTI adoption are illustrated in tables presented as of **December 31, 2022**, in the 2023 10-K filing. These tables show the retrospective application adjustments to previously reported balances, including impacts on net income, unrealized investment gains/losses, future policy benefits, and accumulated other comprehensive income, as detailed in the provided pages.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly identifies that retrospective adjustments were made due to LDTI adoption and that tables as of December 31 are presented, it incorrectly lists *five* financial statements as adjusted (Consolidated Statements of Comprehensive Income, Balance Sheets, Operations, Equity, and Cash Flows), whereas the ground truth specifies only two: the Consolidated Statement of Operations and Consolidated Statements of Cash Flows. This overstatement represents a major error in entity accuracy. Additionally, the LLM specifies adjustments are shown as of December 31, 2022, which, while plausible contextually, is more specific than the ground truth, which only states 'December 31' without a year—this introduces a potential date inaccuracy. The mention of specific effects like net income and unrealized gains may reflect details from the filing but are not part of the original answer and do not align with the scope of the ground truth, which focuses only on *which statements* were adjusted and *that* effects are illustrated in tables. Thus, while the answer demonstrates relevant context and some correct elements (e.g., cash flows and operations being adjusted), it adds unverified statements and misses the precise scope, leading to a partial correctness score. Quantitative accuracy is moderate due to correct reference to December 31 (though with added specificity), and qualitative accuracy suffers from overinclusion and lack of precision in matching the source truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 428,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the value of equity method investment contracts compare to total asset derivatives in 2022, and what does this indicate about their relative significance in MDLZ's derivative portfolio?",
      "original_answer": "In 2022, the value of equity method investment contracts was $3 million, while the total value of asset derivatives was $393 million. This indicates that equity method investment contracts represented less than 1% of the total asset derivatives portfolio, highlighting their minimal relative significance in MDLZ's overall derivative holdings.",
      "llm_answer": "In 2022, the equity method investment contracts had a fair value of $(3) million, while total asset derivatives were valued at $161 million. This indicates that equity method investment contracts represented a negligible portion of the overall derivative portfolio, accounting for less than 2% of the total derivative value.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numerical values. The ground truth states that equity method investment contracts were valued at $3 million and total asset derivatives at $393 million, whereas the LLM incorrectly reports total asset derivatives as $161 million. This major discrepancy affects all downstream analysis. (2) The calculation of relative significance is also incorrect: $3M is less than 1% of $393M (specifically ~0.76%), but the LLM claims less than 2% of $161M, which is based on wrong inputs. While stating 'negligible portion' aligns qualitatively with 'minimal relative significance', the quantitative foundation is flawed. (3) The multi-hop reasoning—comparing two derivative categories to assess relative importance—is conceptually sound and addresses the question structure correctly. The model identifies the relevant entities (equity method investment contracts, asset derivatives) and performs a comparative analysis as required. (4) Despite correct fiscal year (2022) and proper metric types, the severe quantitative errors undermine the factual correctness. Contextual relevance is high because the answer attempts the right comparison and draws a reasonable conclusion given its incorrect numbers. However, the incorrect total asset derivatives value suggests either misextraction or confusion with another data point, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 395,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the freezing of U.S. pension benefits as of December 31, 2019, specifically impact the actuarial assumptions used by CAT in its postemployment benefit plan accounting?",
      "original_answer": "The freezing of U.S. pension benefits as of December 31, 2019, directly affected the actuarial assumptions used by CAT, particularly resulting in the discontinuation of the 'expected rate of compensation increase' assumption, as this was no longer applicable under the new frozen benefit structure.",
      "llm_answer": "The freezing of U.S. pension benefits effective December 31 2019 eliminated the “rate of compensation increase” assumption from Caterpillar’s post‑employment benefit accounting. Consequently, the actuarial assumptions used for the frozen U.S. pension plan no longer include a compensation‑increase component, and any future changes to that assumption are no longer applicable. This change is noted in the sensitivity tables and footnote 1 of the 2024 post‑retirement benefit disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately identifies the freezing date (December 31, 2019) and correctly states that the 'rate of compensation increase' assumption was eliminated as a result of the freeze, which aligns with the original answer's claim about the discontinuation of the 'expected rate of compensation increase' assumption. The mention of Caterpillar (CAT) is appropriate, and the reference to 2024 disclosures and footnote 1 adds contextual detail not in the ground truth but does not contradict it—this likely reflects updated reporting visibility and enhances completeness. The reasoning is sound: freezing benefits logically removes the need to project future compensation growth. The only minor gap is that the original answer specifically names the assumption as 'expected rate of compensation increase,' while the LLM uses the slightly simplified 'rate of compensation increase'—a negligible difference in meaning but a small loss in precise terminology. All entities (CAT, U.S. pension plan, actuarial assumptions), dates, and logic are correct. No numerical inaccuracies; dates and financial concepts are properly used. The answer fully addresses the question about the impact on actuarial assumptions with accurate multi-hop synthesis (linking benefit freeze to assumption change).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 377,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as reflected in its hardware revenue structure, impact its ability to manage supply chain disruptions and maintain profitability in its hardware business?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which constitute a significant portion of its hardware revenues, makes the company more vulnerable to supply chain disruptions because these systems are complex and rely on timely delivery of components from third-party suppliers. According to the 10-K filing, supply chain shortages have increased production costs and led to higher inventory purchases to secure manufacturing capacity, which in turn has increased inventory excess and obsolescence risk and negatively impacted operating cash flows. This dynamic directly affects Oracle's ability to maintain profitability in its hardware business, as it cannot always pass these increased costs on to customers, and delays in manufacturing can lead to lost sales and delayed revenue recognition.",
      "llm_answer": "Oracle's focus on Oracle Engineered Systems—highlighted by its strategy of concentrating on higher‑margin, engineered hardware and related support contracts—helps it manage supply‑chain volatility by allowing tighter integration of hardware design, sourcing and logistics, reducing reliance on multiple commodity vendors. This vertical integration, together with a disciplined product‑mix that emphasizes strategic systems over low‑margin commodity items, enables Oracle to better control inventory, negotiate component availability and adjust pricing, thereby preserving profitability even when supply‑chain disruptions occur.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core reasoning and contradicts the ground truth from the 10-K filing. While there are no specific numeric values to verify (so quantitative accuracy is neutral), the qualitative analysis is fundamentally flawed. The original answer states that Oracle's focus on Engineered Systems *increases vulnerability* to supply chain disruptions due to complexity and reliance on third-party components, leading to higher costs, inventory risks, and negative impacts on cash flow and profitability. In contrast, the LLM claims that this focus enables *better control*, reduced reliance on commodity vendors, and improved ability to manage disruptions—directly opposing the documented risk. The LLM incorrectly frames vertical integration as a mitigating factor, while the 10-K explicitly describes increased risk from supply chain shortages. There is no evidence in the ground truth supporting claims of pricing power or successful cost mitigation. The answer fails the multi-hop reasoning requirement by drawing an unsupported conclusion that contradicts the source material. Although it addresses the general topic (hardware strategy and supply chains), the semantic meaning is opposite to the truth, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 355,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What is the combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area, and how does this total compare in percentage growth to the overall Pulmonary Hypertension category's 2023 growth rate?",
      "original_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is $3,555 million ($1,973 million for OPSUMIT and $1,582 million for UPTRAVI). This represents a 10.6% growth for OPSUMIT and a 19.7% growth for UPTRAVI, which are both higher than the overall Pulmonary Hypertension category's 11.6% growth rate in 2023.",
      "llm_answer": "The combined 2023 global sales revenue for UPTRAVI and OPSUMIT in the Pulmonary Hypertension therapeutic area was $3.164 billion, reflecting an 11.6 % increase from 2022. This growth outpaced the overall Pulmonary Hypertension category’s 2023 growth rate of 11.6 % (the same figure reported for the category), indicating that the UPTRAVI/OPSUMIT segment performed in line with the category’s growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The combined 2023 global sales revenue for UPTRAVI and OPSUMIT is stated as $3.164 billion, but the ground truth is $3,555 million ($3.555 billion), a difference of nearly $400 million. This major error undermines the answer's credibility. Additionally, the LLM claims the combined growth is 11.6%, but the ground truth shows UPTRAVI grew at 19.7% and OPSUMIT at 10.6%—neither matches the reported combined growth, and no correct combined growth rate is provided in the LLM answer. The overall Pulmonary Hypertension category growth rate is correctly stated as 11.6%. (2) The calculation of combined revenue is incorrect: $1,973M (OPSUMIT) + $1,582M (UPTRAVI) = $3,555M, not $3,164M. The LLM also fails to report individual growth rates and instead fabricates a combined growth figure that does not match either product’s actual growth or their weighted average. (3) The multi-hop reasoning is flawed: the model should have retrieved individual revenues and growth rates for both drugs, summed the revenues, and compared each drug’s growth to the category. Instead, it incorrectly aggregates revenue and falsely equates the category growth with the drugs’ growth, concluding they 'performed in line' when in fact UPTRAVI (19.7%) outpaced the category (11.6%) and OPSUMIT (10.6%) slightly underperformed. (4) Contextual relevance is moderate—the answer addresses the right therapeutic area, drugs, and year, and attempts the comparison, but due to severe quantitative and qualitative errors, the conclusion is misleading. Correctness and quantitative accuracy are low due to wrong numbers and calculations; qualitative accuracy is low due to flawed reasoning and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 475,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "By how much did the full-year contribution from legacy PDC Energy assets increase U.S. upstream earnings for CVX in 2024, and what was the corresponding impact on net oil-equivalent production?",
      "original_answer": "The full-year contribution from legacy PDC Energy assets increased U.S. upstream earnings for CVX by $2.2 billion in 2024, and it contributed to a 19% increase in net oil-equivalent production, or 250,000 barrels per day.",
      "llm_answer": "The full‑year contribution from legacy PDC Energy assets added roughly **$3.5 billion** to Chevron’s 2024 U.S. upstream earnings, and it drove a **250,000‑barrel‑per‑day (≈19 %) increase** in net oil‑equivalent production in the United States.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a significant factual error in the dollar amount. The ground truth states the increase in U.S. upstream earnings was $2.2 billion, but the LLM reports $3.5 billion, which is materially incorrect. However, the production impact — 250,000 barrels per day and approximately 19% — is accurately reported. (2) Quantitative accuracy is compromised due to the incorrect earnings figure; while 250,000 bpd and ~19% are correct and semantically equivalent to the original, the $3.5B vs $2.2B discrepancy is substantial and not attributable to rounding or formatting. (3) The multi-hop reasoning appears sound in structure — linking PDC Energy assets to Chevron's upstream earnings and production — and correctly synthesizes two metrics (earnings impact and production increase), but the erroneous earnings figure suggests flawed input data or miscalculation. (4) Contextual relevance is high as the answer addresses both parts of the question and uses appropriate terminology. The qualitative accuracy is moderate because entities (CVX/Chevron, PDC Energy, U.S. upstream, oil-equivalent production) and time frame (2024) are correct, and the reasoning logic is coherent despite the factual error in magnitude.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 354,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific financial statements were adjusted as a result of MetLife's retrospective application of the new LDTI accounting guidance, and what does this imply about the scope of the guidance's impact on the company's financial reporting?",
      "original_answer": "MetLife adjusted both its previously reported consolidated statements of equity and consolidated statements of comprehensive income as a result of the retrospective application of the new LDTI accounting guidance. This implies that the guidance had a broad impact on the company's financial reporting, affecting not only comprehensive income but also the presentation of equity, which reflects the materiality and foundational nature of the changes required under the new accounting rules.",
      "llm_answer": "The retrospective application of the new LDTI accounting guidance required adjustments to **all three primary financial statements**—the consolidated statements of operations (income), comprehensive income, and equity—as well as the balance sheet and cash flow statement. These adjustments, detailed across pages 162–167, reflect changes to revenue recognition, expense classification, and liability measurements (e.g., future policy benefits and market risk benefits), resulting in a $3.5 billion reduction in total assets and a $6.3 billion reduction in total liabilities post-adoption. This scope underscores that the LDTI guidance fundamentally reshaped MetLife’s financial reporting, impacting both the magnitude and presentation of key line items across all statements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that all three primary financial statements were adjusted, including the consolidated statement of operations (income), balance sheet, and cash flow statement, which is not supported by the ground truth. The original answer specifies only the consolidated statements of equity and comprehensive income were adjusted. This is a significant factual error in entity accuracy and scope. (2) The LLM introduces specific quantitative figures—$3.5 billion reduction in total assets and $6.3 billion reduction in liabilities—which are not present in the ground truth and cannot be verified as correct; these numbers appear fabricated or misattributed, severely undermining quantitative accuracy. (3) The multi-hop reasoning is partially sound in inferring broad impact from adjustments to equity and comprehensive income, but the LLM overreaches by extrapolating unverified impacts across all financial statements and introducing unsupported details about revenue recognition, expense classification, and liability measurements. The implication about 'fundamentally reshaping' reporting aligns conceptually with the ground truth's 'broad impact' and 'materiality,' but this is overshadowed by factual inaccuracies. (4) Contextual relevance is high because the response addresses the question's intent regarding scope and implications, but correctness is low due to major factual and quantitative errors. The LLM appears to hallucinate details beyond the source material, likely due to overgeneralization from typical LDTI impacts rather than the specific disclosures in MetLife’s filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 445,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What was the total fair value of equity method investment contracts as disclosed in the derivatives fair value table as of December 31, 2022, and how does this compare to the total fair value of net investment hedge contracts in the same period?",
      "original_answer": "The total fair value of equity method investment contracts as of December 31, 2022, was $(3) million, while the total fair value of net investment hedge contracts was $24 million. Therefore, the equity method investment contracts had a significantly smaller fair value compared to net investment hedge contracts during the same period.",
      "llm_answer": "The total fair value of equity method investment contracts disclosed in the derivatives fair value table as of December 31 2022 was **$3 million**. This is the same amount reported for net investment hedge contracts in that period, so the two values are equal.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. The ground truth states that the fair value of equity method investment contracts was $(3) million (a negative value), while the LLM reports it as $3 million (positive), which is incorrect in both magnitude and sign. Additionally, the LLM claims the net investment hedge contracts had the same value ($3 million), but the ground truth reports this as $24 million, making the comparison entirely wrong. (2) Quantitative accuracy is severely compromised: the negative sign in $(3) million is critical and was omitted, and $3 million vs $24 million is a large numerical discrepancy. Calculations or comparisons based on these numbers are therefore invalid. (3) The reasoning is flawed—instead of identifying a significant difference (with net investment hedges being much larger), the LLM incorrectly concludes the values are equal. This shows a failure in multi-hop synthesis: the model did not correctly extract or compare the two distinct values from the derivatives fair value table. (4) Contextual relevance is high because the answer addresses the right table, time period (December 31, 2022), and types of contracts, but the core financial data and conclusion are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 359,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What was the change in Universal Beijing Resort's net assets from December 31, 2023, to December 31, 2024, and how does this reflect the financial activity reported in Comcast's consolidated balance sheets?",
      "original_answer": "The net assets of Universal Beijing Resort decreased by $0.5 billion, from $0.6 billion on December 31, 2023 ($7.8B assets - $7.2B liabilities), to $0.3 billion on December 31, 2024 ($7.3B assets - $7.0B liabilities). This reflects a reduction in both assets and liabilities, indicating potential ongoing operational or investment adjustments during the year.",
      "llm_answer": "The net assets of Universal Beijing Resort declined from $58.2 billion on December 31 2023 to $58.2 billion on December 31 2024, reflecting a $1.0 billion decrease in the consolidated balance‑sheet amounts reported for the resort. This change is captured in Comcast’s consolidated balance sheets under the Theme Parks segment, where the resort’s assets and liabilities are included, and the net reduction is evident in the “Balance, December 31, 2024” row of the segment table.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It states that Universal Beijing Resort's net assets were $58.2 billion on both December 31, 2023, and December 31, 2024, which contradicts the ground truth that net assets were $0.6 billion in 2023 and $0.3 billion in 2024. The claimed $1.0 billion decrease is inconsistent with these stated values (which show no change) and also does not match the actual $0.3 billion decrease ($0.6B to $0.3B). (2) The numbers are grossly inaccurate: the ground truth reports assets of $7.8B and $7.3B and liabilities of $7.2B and $7.0B, leading to net assets of $0.6B and $0.3B respectively. The LLM's $58.2B figure appears to be a confusion with unrelated data, possibly total company-wide assets or a misread of segment totals. (3) The reasoning is flawed: while the LLM correctly identifies that Universal Beijing Resort is included in Comcast’s Theme Parks segment and that changes would appear in consolidated balance sheets, it fails to perform the correct multi-hop calculation using the actual asset and liability figures for the resort. The conclusion about a $1.0 billion decrease is unsupported by its own stated numbers and by the ground truth. (4) The contextual relevance is moderate because it references the correct company (Comcast), segment (Theme Parks), and reporting structure, but the core financial data and change in net assets are completely wrong, undermining the answer’s usefulness. Thus, the correctness and quantitative accuracy scores are very low, qualitative accuracy is minimal due to partial structural understanding, and relevance is mid-level due to correct context framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 460,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What is the total value of Starbucks' Japanese yen-denominated credit facilities in USD as of September 29, 2024, and how does the 2021 Revolving Credit Agreement explicitly support the commercial paper program in terms of borrowing capacity and usage?",
      "original_answer": "The total value of Starbucks' Japanese yen-denominated credit facilities as of September 29, 2024, is $103.6 million, consisting of a ¥5.0 billion ($34.5 million) facility maturing on December 30, 2024, and a ¥10.0 billion ($69.1 million) facility maturing on March 27, 2025. The 2021 Revolving Credit Agreement supports the commercial paper program by requiring that all outstanding amounts under the program be backstopped by available commitments under the 2021 credit facility. The commercial paper program allows Starbucks to issue unsecured notes up to $3.0 billion, with proceeds used for working capital needs, capital expenditures, business expansion, cash dividends, and share repurchases.",
      "llm_answer": "As of September 29 2024, Starbucks’ Japanese‑yen‑denominated credit facilities total $34.5 million (a ¥5.0 billion facility maturing Dec 30 2024) plus $69.1 million (a ¥10.0 billion facility maturing Mar 27 2025), for an aggregate of **$103.6 million** in USD.  \n\nThe 2021 Revolving Credit Agreement explicitly backs the commercial‑paper program by providing a backstop commitment of up to $3 billion; borrowings under the program must be backed by available commitments under this facility, thereby linking the program’s borrowing capacity and usage to the revolving credit line.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the individual yen-denominated facilities are accurately reported: ¥5.0 billion = $34.5 million (maturing Dec 30, 2024) and ¥10.0 billion = $69.1 million (maturing Mar 27, 2025), with the correct sum of $103.6 million. These values match the original answer exactly, and formatting variations (e.g., spacing, decimal points) are acceptable. (2) The explanation of the 2021 Revolving Credit Agreement's role is accurate: it explicitly backstops the commercial paper program up to $3.0 billion, with borrowings required to be supported by available commitments under the facility. The LLM correctly captures the linkage between the credit agreement and the commercial paper program’s borrowing capacity and usage. (3) Multi-hop reasoning is sound—information is synthesized correctly across the two credit facilities and the credit agreement’s relationship to the commercial paper program. (4) All entities (Starbucks, Japanese yen-denominated facilities, 2021 Revolving Credit Agreement, commercial paper program) are correctly identified and contextualized. The answer is semantically equivalent to the ground truth, with no omissions or inaccuracies. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 358,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Oracle's strategic focus on Oracle Engineered Systems, as part of its hardware business, impact both its infrastructure technologies revenue and its exposure to supply chain risks?",
      "original_answer": "Oracle's strategic focus on Oracle Engineered Systems, which are part of its hardware business, contributes to its infrastructure technologies revenue by offering integrated, high-performance solutions such as the Oracle Exadata Database Machine. These systems are designed to improve performance, availability, and scalability for Oracle Database workloads, which supports Oracle's broader infrastructure technologies offerings. Infrastructure cloud services and license support revenues represented 58% of Oracle's total cloud services and license support revenues in fiscal 2022, indicating the importance of these technologies to Oracle's financial performance. However, this strategic emphasis also increases Oracle's exposure to supply chain risks. As noted in the second chunk, Oracle depends on suppliers for critical technologies and components, some of which are sourced from single vendors. The company experienced manufacturing and fulfillment delays during fiscal 2022 due to supply chain disruptions, particularly those caused by the COVID-19 pandemic. These delays led to increased inventory purchases, which in turn raised inventory excess and obsolescence risk and negatively impacted operating cash flows. Thus, while Oracle Engineered Systems are a key part of Oracle's infrastructure technologies and contribute to revenue, they also expose the company to material risks related to supply chain constraints and logistics delays.",
      "llm_answer": "Oracle’s strategic focus on Oracle Engineered Systems—integrated hardware platforms that combine its database, middleware and cloud infrastructure—drives a substantial share of its infrastructure‑technology revenue, especially through the sale of high‑margin Engineered Systems and related support contracts. At the same time, this hardware‑centric approach makes Oracle more exposed to supply‑chain disruptions, as its ability to deliver Engineered Systems depends on limited‑source components and third‑party manufacturers, a risk highlighted by recent component shortages and pandemic‑related delays.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's strategic focus on Oracle Engineered Systems and their role in driving infrastructure technology revenue, as well as the associated supply chain risks. It accurately notes the hardware-centric model increases exposure to supply chain disruptions due to reliance on limited-source components and third-party manufacturers, and references pandemic-related delays—consistent with the ground truth. However, it omits specific quantitative data from the original answer, such as the 58% contribution of infrastructure cloud services and license support revenues to total cloud services and license support revenues in fiscal 2022, which is a key financial metric demonstrating the importance of these systems. (2) There are no incorrect numbers, but the absence of the 58% figure and details about increased inventory purchases, inventory obsolescence risk, and negative impacts on operating cash flows reduces completeness and quantitative precision. The answer does not include any erroneous calculations, but fails to report key figures present in the ground truth. (3) The multi-hop reasoning is partially sound: the model connects Oracle Engineered Systems to revenue and supply chain risk, but does not fully synthesize the downstream financial consequences (e.g., cash flow impact, inventory risks) that result from supply chain dependencies, which weakens the qualitative depth. (4) Scores reflect that the core facts and entities (Oracle, Engineered Systems, supply chain risks, hardware business) are correct and contextually relevant, but the answer lacks key financial metrics and secondary impacts, reducing completeness and accuracy relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 471,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "What was the change in Universal Beijing Resort's debt from 2023 to 2024, and how did this affect the total 'Debt Not Guaranteed' category?",
      "original_answer": "The Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a reduction of $0.1 billion. This contributed to the overall 'Debt Not Guaranteed' category decreasing from $5.0 billion in 2023 to $4.8 billion in 2024, alongside a decrease in 'Other' debt from $1.5 billion to $1.4 billion.",
      "llm_answer": "The debt at Universal Beijing Resort decreased slightly from $3.5 billion in 2023 to $3.4 billion in 2024, a $0.1 billion reduction. This reduction lowered the total amount of “Debt Not Guaranteed” from $5.0 billion in 2023 to $4.8 billion in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all quantitative aspects: Universal Beijing Resort's debt decreased from $3.5 billion in 2023 to $3.4 billion in 2024, a $0.1 billion reduction, and the 'Debt Not Guaranteed' total decreased from $5.0 billion to $4.8 billion. These numbers match the ground truth exactly, and the calculation of the $0.1 billion decrease is accurate. The entity names (Universal Beijing Resort, 'Debt Not Guaranteed'), years (2023, 2024), and financial metrics are correctly identified. The reasoning correctly links the resort's debt reduction to the overall category decrease, demonstrating sound multi-hop logic. The only minor omission is that the ground truth mentions an additional contributor to the 'Debt Not Guaranteed' decrease—'Other' debt decreasing from $1.5 billion to $1.4 billion—which the LLM answer does not include. While this detail adds context, its absence does not invalidate the core correctness of the answer, as the main causal relationship and numerical changes are accurately conveyed. Therefore, the answer is semantically equivalent in substance, with full quantitative accuracy and high qualitative accuracy, warranting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 335,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Honeywell's use of the cost-to-cost input method for long-term contracts influence the complexity of its audit procedures, particularly in relation to the estimation of contract costs and the recognition of revenue over time?",
      "original_answer": "Honeywell's use of the cost-to-cost input method for long-term contracts significantly increases the complexity of its audit procedures because it requires extensive auditor judgment to evaluate the reasonableness and consistency of management's estimates of total contract costs and progress toward completion. Given that contract costs can span several years and are influenced by factors such as inflationary trends, technical and schedule risk, subcontractor performance, and labor agreements, auditors must perform detailed procedures to test controls, validate assumptions, and profile contracts with longer durations or significant gross margin changes. This complexity is further heightened by the fact that revenue recognition under this method depends on the proportion of costs incurred to date relative to total estimated costs, which can lead to material adjustments if estimates change over time.",
      "llm_answer": "Honeywell’s use of the cost‑to‑cost input method for long‑term contracts requires management to estimate total contract costs and revenue at completion, which introduces significant judgment and subjectivity. Because these estimates drive the timing of revenue recognition and the assessment of contract profitability, auditors must perform extensive testing of controls and substantive procedures—evaluating the reasonableness of cost assumptions, monitoring revisions, and assessing potential bias—to obtain sufficient audit evidence over the complex, multi‑year contract estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Honeywell's use of the cost-to-cost method introduces significant judgment in estimating total contract costs and revenue, which directly impacts revenue recognition and audit complexity—this aligns with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either response, so quantitative accuracy is not compromised; both avoid unsupported figures. (3) The multi-hop reasoning is sound: the model correctly links the cost-to-cost method to estimation challenges, auditor procedures, and the need for judgment in evaluating assumptions—mirroring the causal chain in the ground truth. It mentions controls, substantive testing, cost assumptions, revisions, and bias, which reflect the required audit rigor. (4) Minor deduction in qualitative accuracy because the LLM omits specific risk factors mentioned in the original (e.g., inflationary trends, technical/schedule risk, subcontractor performance, labor agreements) and does not explicitly note that contracts span several years or that material adjustments can arise from estimate changes—details that add depth to the audit complexity argument. However, the essence of increased audit effort due to estimation uncertainty is preserved. Contextual relevance is perfect—the response directly addresses how the cost-to-cost method affects audit procedures in relation to cost estimation and revenue recognition over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 422,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "In NEE's 2023 financial results, what was the difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains included in net income and FPL's $300 million of gains included in net income, and how does this reflect the different treatment of derivative transactions between the two business units as disclosed in the 10-K filing?",
      "original_answer": "The difference in magnitude between NEER's $1,729 million of non-qualifying hedge gains and FPL's $300 million of gains included in net income was $1,429 million. This significant difference reflects the distinct treatment of derivative transactions between the two business units. According to the 10-K filing, NEER's non-qualifying hedge activity was a primary driver of its improved results in 2023 compared to 2022, with approximately $1,729 million of gains included in NEER's net income. In contrast, FPL's derivative transactions are largely deferred as regulatory assets or liabilities until contract settlement, with only $300 million of gains passed through to net income in 2023. This reflects FPL's regulatory framework where most changes in fair value of energy derivatives are deferred rather than immediately impacting earnings, unlike NEER's market-oriented operations where non-qualifying hedges directly affect net income volatility.",
      "llm_answer": "The 2023 financial results show that NEER recorded $1,729 million of non‑qualifying hedge gains in net income, while FPL recorded $300 million of gains in net income. This $1,429 million difference reflects that NEER’s hedges are treated as non‑qualifying and marked‑to‑market, causing gains to flow directly through earnings, whereas FPL’s gains are largely deferred in regulatory assets or liabilities and only recognized when realized, resulting in a much smaller impact on its reported net income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: NEER's $1,729 million and FPL's $300 million gains, and calculates the difference as $1,429 million, which is accurate (1,729 - 300 = 1,429). These values match the ground truth exactly, with acceptable formatting (e.g., $1,729 million). (2) Quantitative accuracy is perfect—numbers, units, and the subtraction are correct. (3) The reasoning correctly captures the multi-hop synthesis: NEER’s non-qualifying hedges are marked-to-market and flow directly into earnings, increasing volatility, while FPL defers most derivative gains under its regulatory framework, resulting in minimal net income impact. This aligns with the 10-K disclosure about differing treatment. (4) The answer is semantically equivalent to the ground truth, though slightly less detailed—specifically, it omits the explicit mention that NEER’s hedges were a 'primary driver' of improved results year-over-year and does not restate that FPL’s treatment is due to regulatory deferral 'until contract settlement.' However, the core explanation about deferral versus immediate recognition is present and accurate. These omissions are minor and do not affect the factual correctness of the response. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 380,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Comcast's ownership stake in Universal Beijing Resort influence the assets and liabilities reported in its consolidated balance sheets as of December 31, 2024, and what proportion of the total debt financing does Comcast's maximum risk of financial loss represent?",
      "original_answer": "Comcast owns a 30% interest in Universal Beijing Resort, which it consolidates due to its determination that Universal Beijing Resort is a VIE and Comcast has the power to direct its major activities. As of December 31, 2024, Universal Beijing Resort had $7.3 billion in assets and $7.0 billion in liabilities, which are fully included in Comcast’s consolidated balance sheet. Universal Beijing Resort had $3.4 billion in debt outstanding, and Comcast’s maximum risk of financial loss is limited to its 30% equity interest, which equates to 30% of the total debt, or $1.02 billion.",
      "llm_answer": "Comcast's 30% ownership stake in Universal Beijing Resort is reflected in its consolidated balance sheet as part of the Theme Parks segment assets and liabilities, with the resort's $7.3 billion in assets and $7.0 billion in liabilities (including $3.4 billion of debt) being fully consolidated. This VIE relationship means Comcast's maximum financial risk is limited to its 30% equity interest, which represents a relatively small portion of its overall balance sheet. The resort's debt financing is secured by its own assets, and Comcast's exposure is therefore confined to its equity stake and any related commitments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Comcast's 30% ownership stake, the consolidation of Universal Beijing Resort as a VIE, and the inclusion of $7.3 billion in assets and $7.0 billion in liabilities on Comcast’s consolidated balance sheet. It also correctly notes that the resort has $3.4 billion in debt and that Comcast’s risk is limited to its equity interest. However, it fails to explicitly calculate or state that Comcast’s maximum risk of financial loss represents 30% of the total debt, or $1.02 billion, which is a required part of the question. This omission significantly affects quantitative accuracy. (2) All provided numbers ($7.3B assets, $7.0B liabilities, $3.4B debt, 30% stake) are correct and match the ground truth. But the critical derived figure—$1.02 billion (30% of $3.4B)—is missing. The answer implies the risk is proportional to the equity stake but does not quantify it as a share of debt, which is specifically asked. (3) The multi-hop reasoning is sound: the model correctly links Comcast’s VIE consolidation, full inclusion of assets/liabilities, and the concept that risk is limited to equity interest. It correctly contextualizes the debt as non-recourse and secured by resort assets. However, it does not complete the final analytical step—applying the 30% stake to the $3.4B debt to compute the $1.02B exposure. (4) The answer is contextually relevant and well-structured, addressing both the balance sheet impact and risk exposure. The qualitative reasoning is strong, but the missing calculation prevents a higher score. Correctness is penalized because the question explicitly asks for the proportion of total debt financing represented by Comcast’s maximum risk, which requires a numerical answer the model does not provide.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 483,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the cumulative goodwill impairment charges recognized for OpenTable in 2020 compare to its 2021 revenue contribution to Booking Holdings' advertising and other segment?",
      "original_answer": "In 2020, Booking Holdings recognized cumulative goodwill impairment charges of $1,062 million ($489 million in Q1 and $573 million in Q3) related to OpenTable. In 2021, OpenTable contributed to the 'advertising and other' revenue category, which totaled $1.1 billion for the full year. This means the impairment charges over the course of 2020 were nearly equivalent to the entire annual revenue contribution from OpenTable's restaurant reservation and related services in 2021.",
      "llm_answer": "The cumulative goodwill impairment charges recognized for OpenTable in 2020 totaled $1.057 billion ($489 million in the March 31 2020 interim test plus $573 million in the September 30 2020 annual test). This impairment amount was recorded as a non‑tax‑deductible charge and reduced the carrying value of OpenTable’s goodwill to $1.0 billion, but the document does not disclose any specific revenue contribution from OpenTable to Booking Holdings’ advertising and other segment for 2021, so a direct quantitative comparison cannot be provided.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the cumulative goodwill impairment charges for OpenTable in 2020 as $1.057 billion (comprising $489 million in Q1 and $573 million in Q3), which is nearly identical to the ground truth value of $1,062 million (a negligible $5 million difference, likely due to rounding). This demonstrates strong quantitative accuracy. However, the LLM incorrectly states that the document does not disclose OpenTable’s 2021 revenue contribution to Booking Holdings’ advertising and other segment, which contradicts the ground truth. The ground truth confirms that OpenTable contributed to the 'advertising and other' segment, which totaled $1.1 billion in 2021 — a figure explicitly attributed to OpenTable’s revenue contribution in the context of the comparison. (2) The numbers for the impairment charges are accurate with only a minor discrepancy in total ($1,057M vs $1,062M), possibly due to reporting variations, but the core components ($489M and $573M) match exactly. The failure to report the $1.1 billion revenue figure — a key part of the comparison — is a major factual omission. (3) The multi-hop reasoning fails because the model does not synthesize the connection between OpenTable’s goodwill impairment and its subsequent revenue contribution, despite this being directly inferable from the knowledge graph. The LLM incorrectly asserts lack of disclosure, indicating a failure in information retrieval or synthesis. (4) While the quantitative accuracy is high due to correct impairment figures, the correctness score is low because the answer omits the central comparative insight — that the 2020 impairment was nearly equivalent to OpenTable’s 2021 revenue contribution — which is the core of the question. The qualitative accuracy is low due to flawed reasoning and failure to make the required comparison. Contextual relevance is moderate because the answer discusses relevant concepts but fails to deliver the key comparative conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 534,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does ExxonMobil incorporate greenhouse gas emission costs into its Corporate Plan when assessing the recoverability of asset groups, and what specific future emission-reduction goal is factored into these assessments?",
      "original_answer": "ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan by including them in the future cash flow assessments used to determine the recoverability of asset groups. These costs are considered even for jurisdictions without current greenhouse gas pricing policies. Specifically, the Corporation factors in costs related to its 2030 greenhouse gas emission-reduction plans, including the goal of achieving net-zero Scope 1 and 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin.",
      "llm_answer": "ExxonMobil incorporates estimated future greenhouse‑gas emission costs—even in jurisdictions without a current carbon price—into its Corporate Plan assumptions when projecting cash flows for impairment testing of long‑lived assets. These emission‑cost assumptions are part of the discounted cash‑flow models used to assess recoverability and determine any required asset impairments. The specific emission‑reduction target factored into these assessments is the company’s goal of achieving net‑zero Scope 1 and Scope 2 greenhouse‑gas emissions from unconventional operated assets in the Permian Basin by 2030.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correctly addressed: ExxonMobil incorporates estimated greenhouse gas emission costs into its Corporate Plan for assessing recoverability of asset groups via future cash flow projections, even in jurisdictions without current carbon pricing. (2) The specific emission-reduction goal—achieving net-zero Scope 1 and Scope 2 greenhouse gas emissions from unconventional operated assets in the Permian Basin by 2030—is correctly identified with accurate terminology and timeframe. (3) The multi-hop reasoning is sound: the answer connects emission cost assumptions to impairment testing (via discounted cash flow models) and links those assumptions to a concrete corporate target, demonstrating proper synthesis across financial and sustainability domains. (4) Minor wording differences (e.g., 'Scope 1 and Scope 2' vs 'Scope 1 and 2') are stylistic and do not affect meaning. All entities (ExxonMobil, Permian Basin, 2030 target, Scope 1 and 2 emissions) are accurate. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 320,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and how does this affect its capital conservation buffer requirements for the period from October 1, 2023 through September 30, 2024?",
      "original_answer": "As of December 31, 2023, $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in. This amount will be phased in equally at $600 million per year on January 1, 2024 and 2025. Capital One's capital conservation buffer requirements for CET1, Tier 1, and total capital are 2.5% under the Federal Reserve's regulations, which are separate from the stress capital buffer framework. The stress capital buffer requirement for the period from October 1, 2023 through September 30, 2024, is 4.8%, and Capital One currently exceeds the minimum capital requirements and conservation buffers, maintaining a 'well-capitalized' status.",
      "llm_answer": "Based on the document, Capital One added back $2.4 billion of regulatory capital under the CECL Transition Rule, and as of December 31 2023 it had phased in 50 % of that amount. Consequently, $1.2 billion remains to be phased in, with $600 million scheduled for each of 2024 and 2025. This phased‑in amount is reflected in the CET1 capital ratio, which would have been 12.6 % on a fully phased‑in basis, and it supports the Company’s capital‑conservation buffer requirements for the period October 1 2023 through September 30 2024, when the stress‑capital‑buffer framework raises the minimum CET1, Tier 1 and total capital ratios to 9.3 %, 10.8 % and 12.8 %, respectively.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that $1.2 billion of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule remains to be phased in after December 31, 2023, and that it will be phased in at $600 million per year in 2024 and 2025 — this matches the ground truth exactly. However, the LLM introduces new information not present in the original answer: specifically, the claim that the fully phased-in CET1 ratio would be 12.6%, and that minimum CET1, Tier 1, and total capital ratios are raised to 9.3%, 10.8%, and 12.8% under the stress capital buffer framework. While the stress capital buffer requirement of 4.8% is implied in the original answer (as part of the buffer on top of the 2.5% conservation buffer), the LLM incorrectly presents these combined totals as if they were direct regulatory minimums without clarifying the composition. (2) Quantitatively, the $1.2 billion remaining and $600 million annual phase-in are accurate. However, the 12.6% CET1 ratio and the 9.3%/10.8%/12.8% thresholds are not mentioned in the ground truth and cannot be verified from the provided information, introducing potential inaccuracies. (3) The multi-hop reasoning is partially sound — the model correctly links the CECL phase-in status to capital adequacy, but it overreaches by specifying exact capital ratios that were not in the original answer, suggesting synthesis beyond the provided data. (4) The answer is contextually relevant and addresses both parts of the question: the amount remaining to be phased in and its effect on capital buffers. However, it substitutes precise regulatory buffer explanations with inferred numerical thresholds, reducing qualitative accuracy. The original answer correctly separates the 2.5% capital conservation buffer from the 4.8% stress capital buffer and notes Capital One exceeds requirements, while the LLM conflates these into absolute ratio floors. Thus, while core facts are correct, the addition of unverified metrics lowers correctness and qualitative scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 550,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What was the total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023, and how did this reduction compare to the change in their Euro notes over the same period?",
      "original_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million ($11,275 million to $9,562 million). During the same period, Euro notes increased by $250 million ($7,666 million to $7,916 million). Therefore, the reduction in U.S. dollar notes and term loans was significantly larger than the increase in Euro notes.",
      "llm_answer": "The total decrease in U.S. dollar notes and term loans for MDLZ from 2022 to 2023 was $1,713 million, calculated as $11,275 million in 2022 minus $9,562 million in 2023. This reduction was larger than the change in Euro notes, which declined only $250 million over the same period (from $7,666 million to $7,916 million).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total decrease in U.S. dollar notes and term loans as $1,713 million, with accurate 2022 ($11,275 million) and 2023 ($9,562 million) values, which matches the ground truth. However, it incorrectly stated that Euro notes 'declined' by $250 million when in fact they increased from $7,666 million to $7,916 million—an increase of $250 million. This reverses the direction of the change and leads to an incorrect comparison. (2) All numerical values are accurate, and the calculation for the U.S. dollar decrease is correct. The Euro note values are also numerically correct ($7,666M to $7,916M), but the characterization as a 'decline' is factually wrong, undermining the conclusion. (3) The multi-hop reasoning fails in the comparative analysis: while the model pulls correct data from both debt instruments across years, it misinterprets the direction of change for Euro notes, leading to flawed synthesis. The conclusion that the reduction in U.S. dollar debt was 'larger than the change in Euro notes' is ambiguous but framed as if both were reductions, which is incorrect. (4) The answer is contextually relevant and addresses both parts of the question, but the critical error in interpreting the Euro note trend significantly reduces factual correctness, warranting a moderate score of 6. Quantitative accuracy is high (8) due to correct numbers and calculations. Qualitative accuracy is low (5) due to flawed reasoning and mischaracterization. Contextual relevance is strong (9) as the structure and intent align well with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 436,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What is the maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell under the indemnification agreement, and how does this payment relate to Honeywell's net spending on environmental matters?",
      "original_answer": "The maximum annual payment that the Resideo subsidiary is obligated to make to Honeywell is $140 million, which represents 90% of Honeywell's annual net spending on environmental matters at certain defined sites.",
      "llm_answer": "The Resideo subsidiary is obligated to make annual cash payments to Honeywell equal to 90% of Honeywell’s net spending on environmental matters at certain sites, subject to a $140 million cap per year and continuing until the earlier of December 31, 2043, or the third consecutive year in which the payment falls below $25 million. This payment is tied directly to Honeywell’s net environmental expenditures, with Resideo reimbursing 90% of those costs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the $140 million annual cap and the 90% reimbursement of Honeywell's net spending on environmental matters at certain defined sites. (2) Quantitative elements are precise: the $140 million cap and 90% figure match the original answer exactly; the additional context about the payment term (until 2043 or three consecutive years below $25M) is accurate and adds detail without contradicting the ground truth. (3) The multi-hop reasoning is sound—the answer correctly links Resideo's payment obligation to Honeywell's environmental spending through the indemnification agreement, demonstrating synthesis across entities and financial terms. (4) The wording differs slightly but preserves and even enhances the meaning by clarifying the duration and conditions of the payment, which are consistent with the source data. No factual errors, omissions, or misstatements are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 287,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the changes in Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses impact NEE's total financial position for FPL and NEER segments between December 31, 2022, and December 31, 2023?",
      "original_answer": "The total financial position for FPL's Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses decreased from $3 million in 2022 to $2 million in 2023, a $1 million drop. For NEER, the amount tied to these clauses fell from $148 million in 2022 to $114 million in 2023, a decrease of $34 million. Combined, the reduction in FPL and NEER segments led to a total $35 million decline in NEE's obligations tied to these clauses over the period.",
      "llm_answer": "Between December 31 2022 and December 31 2023, the fair‑value of NEE’s non‑qualifying hedges and the hedges that are accounted for in FPL’s cost‑recovery clauses shifted markedly.  The “Total mark‑to‑market energy contract net liabilities” fell from a $2,728 million deficit in 2022 to a $128 million deficit in 2023, driven by a $2,178 million gain in non‑qualifying hedges and a $2,523 million gain overall, while the FPL‑specific cost‑recovery‑clause position moved from a $154 million deficit to a $9 million deficit.  Consequently, the aggregate exposure of these hedges to interest‑rate and commodity‑price risk was reduced, improving NEE’s total financial position for both the FPL and NEER segments over the one‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of specific financial figures and misrepresents the scope of the changes. The ground truth states that FPL's position decreased from $3M to $2M (a $1M drop) and NEER's from $148M to $114M (a $34M drop), totaling a $35M decline. The LLM instead cites massive figures like a reduction in 'Total mark-to-market energy contract net liabilities' from $2,728M to $128M and overall gains exceeding $2 billion, which are not supported by the original answer and appear to conflate different financial metrics. These numbers do not align with the specific 'Non-Qualifying Hedges and Hedges in FPL Cost Recovery Clauses' positions for FPL and NEER segments as required. (2) The calculation errors are severe: the LLM reports a $2,523M gain and $2,178M gain in non-qualifying hedges, which are not mentioned or inferable from the ground truth. The FPL-specific cost-recovery clause shift from $154M deficit to $9M deficit contradicts the ground truth ($3M to $2M). There is no mention of NEER-specific figures in the LLM response, omitting a core part of the answer. (3) The multi-hop reasoning is flawed. The question asks for the impact on NEE's total financial position through changes in two specific hedge categories across two segments (FPL and NEER) over a defined period. The LLM fails to isolate and synthesize the correct data points for each segment and instead introduces unrelated aggregate liabilities and gains, suggesting a failure to correctly identify and link the relevant entities and metrics. (4) While the general direction (improvement in financial position due to reduced liabilities) is plausible, the magnitude, specific values, and segment-level breakdown are incorrect. The contextual relevance is moderate because it addresses hedges and financial position impacts, but the factual inaccuracies severely undermine correctness. Quantitative accuracy is very low due to fabricated numbers; qualitative accuracy is low due to incorrect entity-metric mapping and missing synthesis; correctness score is low because the core answer does not match the ground truth in any quantifiable way.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 579,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the change in Universal Beijing Resort's net assets from 2023 to 2024, and how does this compare to the change in its debt obligations over the same period?",
      "original_answer": "Universal Beijing Resort's net assets decreased by $0.7 billion from 2023 to 2024, while its debt obligations decreased by $0.1 billion over the same period. In 2023, Universal Beijing Resort had $7.8 billion in assets and $7.2 billion in liabilities, resulting in net assets of $0.6 billion. In 2024, it had $7.3 billion in assets and $7.0 billion in liabilities, resulting in net assets of -$0.3 billion. This represents a decrease in net assets of $0.9 billion. However, liabilities (debt) decreased from $7.2 billion to $7.0 billion, a $0.2 billion reduction, indicating that while the resort reduced its debt slightly, its overall financial position weakened.",
      "llm_answer": "The net assets of Universal Beijing Resort increased by $0.1 billion from 2023 to 2024 (from $3.5 billion to $3.4 billion, a $0.1 billion decrease; however, the provided table shows $3.4 billion in 2024 versus $3.5 billion in 2023, indicating a $0.1 billion decline). In contrast, the company’s total debt obligations rose by $2.0 billion over the same period (from $97.1 billion in 2023 to $99.1 billion in 2024). Thus, while Universal Beijing Resort’s net assets saw a modest decline, debt obligations grew substantially, reflecting a significant increase in overall leverage.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. It claims net assets increased by $0.1 billion, but actually decreased by $0.9 billion (from $0.6B to -$0.3B), and incorrectly states that debt obligations rose by $2.0 billion (from $97.1B to $99.1B), which are not only wrong but involve implausibly large figures for the entity. The ground truth shows debt decreased by $0.2 billion (from $7.2B to $7.0B). (2) All key numbers are factually wrong: net assets in 2023 and 2024 are misstated ($3.5B and $3.4B vs actual $0.6B and -$0.3B), liabilities are off by an order of magnitude ($97.1B vs $7.2B), and resulting calculations (change in net assets and debt) are therefore invalid. Even the direction of change for net assets is mischaracterized despite the LLM noting a decrease but then calling it an increase. (3) The multi-hop reasoning failed completely—there is no evidence the model correctly synthesized balance sheet data across years or calculated net assets (assets minus liabilities) properly. The entities (Universal Beijing Resort) and years (2023–2024) are correct, but all financial metrics are wildly inaccurate. (4) Due to pervasive factual and quantitative errors, the correctness and quantitative accuracy scores are near the lowest. The qualitative accuracy is also extremely low due to flawed logic and synthesis. Contextual relevance is slightly higher only because the answer attempts to address the right question structure (change in net assets vs debt), but with entirely wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 426,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What specific new patient population became eligible for treatment with EDURANT (rilpivirine) according to JNJ's 2023 10-K filing, and which regulatory regions were targeted for filing as indicated in the same report?",
      "original_answer": "According to JNJ's 2023 10-K filing, EDURANT (rilpivirine) was targeted for treatment of pediatric patients aged 2-12 years with HIV. The filing was specifically targeted at the US and EU regulatory regions.",
      "llm_answer": "According to J&J's 2023 10-K filing, EDURANT (rilpivirine) received regulatory approval for the pediatric population (ages 2–12 years) with HIV, as indicated in the product approval table on page 33. The filing also notes that filings for EDURANT were submitted in both the United States and the European Union, targeting those regulatory regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies the new patient population as pediatric patients aged 2–12 years with HIV, which matches the original answer. It also correctly states that regulatory filings were targeted at the US and European Union (EU), consistent with the ground truth. The mention of 'page 33' and 'product approval table' adds contextual detail not in the ground truth but does not contradict it and may reflect actual document structure. There are no numeric inaccuracies—age range and regions are correctly reported. The reasoning is sound, demonstrating proper synthesis of information from JNJ's 2023 10-K. The only minor deviation is the use of 'received regulatory approval' versus the original answer's 'was targeted for treatment' and 'filing was specifically targeted', which implies intent rather than confirmed approval. This subtle difference in tense could imply a slightly stronger claim (approval vs. intended filing), but given the context of a 10-K disclosure, it may be interpreted as forward-looking or factual depending on exact wording in the source. This small ambiguity prevents a perfect 10 on qualitative accuracy, but overall the answer is highly accurate, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 357,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How do Booking.com's merchant-based transaction model and regulatory investigations in Switzerland and the EU collectively impact Booking Holdings' operating margins and business strategy as reported in 2022?",
      "original_answer": "Booking.com's increasing use of a merchant-based transaction model leads to higher expenses related to personnel, payment processing, and chargebacks, which negatively affects operating margins despite incremental revenues such as credit card rebates. Additionally, regulatory investigations, such as the ongoing Swiss Price Surveillance Office investigation into Booking.com's commission rates, could force Booking.com to reduce commissions in Switzerland, further compressing margins. In the EU, the proposed Digital Markets Act could classify Booking.com as a 'gatekeeper,' imposing additional restrictions on data usage, service bundling, and parity clauses, which could reduce competitive flexibility and increase compliance costs. Together, these financial pressures and regulatory uncertainties constrain both short-term profitability and long-term strategic initiatives like the Connected Trip platform.",
      "llm_answer": "Booking.com’s merchant‑based transaction model adds payment‑processing, fraud‑loss and related costs that compress operating margins, especially as the share of merchant‑facilitated bookings grows. At the same time, the company is under regulatory scrutiny in Switzerland and the EU—particularly around commission levels and competition rules—requiring costly compliance measures and posing the risk of fines or forced business‑practice changes. Together, these pressures force Booking Holdings to balance margin‑squeezing investments in payment and “Connected Trip” initiatives against the need to adapt its strategy to a more regulated, higher‑cost environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: the merchant-based model increases costs (payment processing, fraud/chargebacks), which compresses margins despite potential incremental revenues. Regulatory pressures in Switzerland (commission scrutiny) and the EU (competition rules, Digital Markets Act implications) are correctly identified as creating compliance costs and strategic constraints. (2) There are no numeric values in the question or answers requiring verification—both responses are qualitative and consistent in that regard, so quantitative accuracy is not compromised. (3) Multi-hop reasoning is sound: the model correctly synthesizes impacts from Booking.com’s transaction model and two distinct regulatory environments (Switzerland and EU), linking them to Booking Holdings’ operating margins and strategic initiatives like Connected Trip. The only minor omission is not explicitly naming the Swiss Price Surveillance Office or specifying that the EU’s Digital Markets Act could impose restrictions on data usage, parity clauses, and service bundling—details present in the original. However, the essence (regulatory risks affecting competitive flexibility and compliance costs) is captured. (4) Contextual relevance is perfect—the response directly addresses the impact on operating margins and business strategy in 2022 as required. Wording differs but meaning aligns closely with the original. Thus, a high correctness score of 9 is warranted, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 438,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the maximum total duration of a petroleum retention license in Papua New Guinea, considering both the initial term and possible extensions, and how does this regulatory framework potentially influence ExxonMobil's long-term LNG development strategy in the region as outlined in its 2022 10-K filing?",
      "original_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, which includes an initial 5-year term and up to two extensions at the Minister's discretion. This regulatory framework influences ExxonMobil's long-term LNG development strategy by allowing the Corporation to maintain rights over gas resources that are not currently commercially viable but may become so within that 15-year window. This aligns with ExxonMobil's strategy of selectively developing attractive natural gas resources and pursuing long-term LNG projects such as the one in Papua New Guinea.",
      "llm_answer": "The maximum total duration of a petroleum retention license in Papua New Guinea is 15 years, comprising an initial five‑year term that may be extended twice for up to five years each (with a cumulative extension ceiling of 10 years). This regulatory framework, which limits the license term to a maximum of 15 years, underpins ExxonMobil’s long‑term LNG strategy in the region as reflected in its 2022 10‑K filing, where the company cites Papua New Guinea’s gas resources as a key component of its global LNG growth portfolio and emphasizes the need for stable, long‑term contractual arrangements to support project economics and investment planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the maximum total duration of a petroleum retention license in Papua New Guinea as 15 years, with an initial 5-year term and up to two 5-year extensions (totaling 10 years of possible extensions), which aligns with the ground truth. The quantitative breakdown is accurate and consistent with the regulatory framework. (2) All numbers are correct: initial 5-year term and two possible 5-year extensions (cumulative 10 years), summing to a maximum of 15 years. The calculation is sound and matches the ground truth. (3) The reasoning is strong: the LLM correctly links the 15-year license window to ExxonMobil’s long-term LNG strategy, noting the importance of maintaining rights over non-commercially viable resources for future development. While the LLM does not explicitly state that the extensions are 'at the Minister's discretion' (a minor omission), it accurately captures the strategic implication—supporting investment planning and long-term project development—as reflected in ExxonMobil’s 2022 10-K. (4) The answer is semantically equivalent and contextually complete, with only a slight lack of detail on the discretionary nature of extensions preventing a perfect 10. Overall, the response is factually correct, well-reasoned, and directly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 365,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What is the year-over-year change in Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets, and how does this shift compare to the change in their Hedge funds/limited partnerships investments?",
      "original_answer": "Coca-Cola's investment in Mutual, pooled and commingled funds categorized under Level 2 assets decreased by $46 million year-over-year (from $83 million in 2022 to $37 million in 2023). Meanwhile, their investment in Hedge funds/limited partnerships remained relatively stable, increasing slightly by $4 million (from $14 million in 2022 to $18 million in 2023). This indicates a significant reallocation away from Level 2 pooled funds while maintaining a consistent position in alternative investments like hedge funds.",
      "llm_answer": "The year‑over‑year change in Coca‑Cola’s investment in Mutual, pooled and commingled funds classified as Level 2 assets was an increase of **$55 million** (from $202 million in 2022 to $257 million in 2023).  \n\nDuring the same period, the Company’s Hedge funds/limited partnerships investment remained unchanged at **$0 million** (both 2022 and 2023 show a $‑ entry for Level 2), so there was **no change** in that category.  \n\nThus, the Level 2 mutual‑fund investment grew by $55 million, while the hedge‑fund/limited‑partnership investment showed no year‑over‑year change.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, Coca-Cola's investment in Mutual, pooled and commingled funds under Level 2 assets decreased by $46 million (from $83M in 2022 to $37M in 2023), but the LLM claims an increase of $55M from $202M to $257M — all of which are factually wrong. Additionally, the ground truth states that Hedge funds/limited partnerships increased slightly by $4M (from $14M to $18M), but the LLM incorrectly claims these were $0 in both years with no change. (2) Quantitative accuracy is severely lacking: the dollar amounts, changes, and starting/ending values are all incorrect. The claimed $55M increase and $202M base have no correspondence to the actual $83M and $37M figures. The assertion of zero investment in hedge funds contradicts the documented $14M and $18M values. (3) The multi-hop reasoning is flawed — the model fails to correctly identify or synthesize data across the two investment categories and time periods. Instead, it fabricates numbers and draws incorrect conclusions about reallocation trends. (4) Contextual relevance is partially maintained because the answer addresses the right categories (Level 2 mutual/pooled funds and hedge funds/limited partnerships) and attempts a year-over-year comparison, but the complete factual inaccuracy renders the response misleading. Due to total failure in numerical correctness and reasoning, the correctness score is 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 409,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "What was the total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023, considering both the reduction in net income at gas distribution operations and the additional earnings adjustment mentioned in the financial statements?",
      "original_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was a $53 million reduction, combining the $29 million decrease in net income at gas distribution operations and the additional $24 million earnings adjustment.",
      "llm_answer": "The total financial impact of the regulatory disallowances at Nicor Gas on Southern Company Gas' net income in 2023 was an $88 million estimated loss recorded in the \"Estimated loss on regulatory disallowance\" line item, which directly reduced net income. This disallowance was part of the broader $43 million net income increase for Southern Company Gas in 2023, which was partially offset by the $29 million decrease in net income at gas distribution operations due to the disallowance and other factors.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both magnitude and direction of impact. The ground truth states a total reduction of $53 million ($29M + $24M), but the LLM claims an $88 million 'estimated loss' that is not supported by the original answer. Additionally, the LLM incorrectly states that this disallowance was part of a 'broader $43 million net income increase,' which contradicts the ground truth and introduces unsupported figures. (2) Quantitative accuracy fails: the $88M loss, $43M net income increase, and lack of mention of the $24M adjustment are all factually wrong. The only correct number mentioned is the $29M decrease in net income at gas distribution operations. Calculations are absent or incorrect—no indication that $29M + $24M = $53M. (3) Multi-hop reasoning is flawed: the model fails to synthesize the two components of the financial impact (the $29M operational reduction and the $24M additional adjustment) into the correct total. Instead, it introduces a new and incorrect line item ('Estimated loss on regulatory disallowance') and misrepresents the overall financial context. (4) Contextual relevance is moderate because the answer addresses Nicor Gas, Southern Company Gas, regulatory disallowances, and net income in 2023—but the factual inaccuracies severely undermine usefulness. The answer misleads rather than informs due to fabricated numbers and incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 393,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "Which businesses, in addition to WarnerMedia, were classified as discontinued operations by AT&T as part of its strategic shift, and what was the significance of this classification in relation to AT&T's broader restructuring efforts?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift. This classification was significant because it reflected AT&T’s comprehensive restructuring plan that involved divesting multiple business units, even those that did not individually meet the materiality threshold for discontinued operations. The combined divestiture of these businesses was treated as a single strategic shift, enabling AT&T to focus on its core communications segment while exiting non-core or underperforming businesses.",
      "llm_answer": "AT&T classified WarnerMedia, Vrio, Xandr, and Playdemic as discontinued operations as part of its strategic shift to focus on core telecommunications businesses. This classification was significant because these units represented a strategic divestiture that allowed AT&T to streamline its portfolio and concentrate on its core Communications segment, which accounted for nearly all of its operating revenue and income in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all businesses classified as discontinued operations—WarnerMedia, Vrio, Xandr, and Playdemic—matching the ground truth. This satisfies the entity accuracy and completeness requirements. The significance of the classification is accurately conveyed: AT&T's strategic shift to focus on its core communications segment through divestiture of non-core units. The LLM mentions the portfolio streamlining and strategic focus, which aligns with the ground truth's emphasis on restructuring and exiting non-core businesses. While the original answer highlights the important accounting nuance—that these divestitures were combined into a single strategic shift even though some individually didn't meet materiality thresholds—the LLM omits this specific technical detail. However, the core reasoning and strategic intent are correctly captured. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed perfect. The answer is contextually relevant and semantically equivalent, with only a minor omission in depth of accounting rationale. Thus, the correctness score is 9 due to high factual accuracy with a slight gap in completeness regarding the materiality threshold explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 352,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What was the change in the fair value of Medtronic's auction rate securities from April 30, 2021, to April 29, 2022, and how did this impact the total available-for-sale debt securities' fair value over the same period?",
      "original_answer": "The fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022. However, the total available-for-sale debt securities' fair value decreased from $7,257 million to $6,893 million, a decline of $364 million. This indicates that while auction rate securities held stable, other components of available-for-sale debt securities experienced significant unrealized losses, contributing to the overall decline in fair value.",
      "llm_answer": "The fair value of Medtronic's auction rate securities remained $33 million at both April 29 2022 and April 30 2021, so there was no change in their fair value over the period. Consequently, the total available‑for‑sale debt securities' fair value increased from $7,257 million at April 30 2021 to $6,893 million at April 29 2022, reflecting a $364 million decrease attributable to other securities rather than the unchanged auction‑rate securities.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the fair value of Medtronic's auction rate securities remained unchanged at $33 million from April 30, 2021, to April 29, 2022, which is factually accurate. However, it incorrectly states that the total available-for-sale debt securities' fair value 'increased' from $7,257 million to $6,893 million, when in fact this is a decrease. The calculation of the $364 million difference is numerically correct ($7,257M - $6,893M = $364M), but the direction of change is reversed, leading to a misleading conclusion. (2) All numeric values (dates, $33M, $7,257M, $6,893M, and $364M) are accurate and properly formatted. The calculation of the $364 million decline is correct, but the mischaracterization as an 'increase' undermines the quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly isolates auction rate securities as stable and attributes the change to other securities. However, the flawed interpretation of the direction of change in total fair value indicates a failure in logical synthesis. (4) Contextual relevance is high, as the answer addresses both parts of the question and discusses the right entities and time periods. The core error in describing a decrease as an increase reduces correctness and qualitative accuracy, but not enough to fail entirely. Hence, scores reflect partial correctness with a significant factual misstatement.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 397,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did the goodwill impairment charges related to OpenTable and KAYAK in 2020 affect the adjusted carrying value of goodwill by September 30, 2020, and what was the cumulative impact of these charges?",
      "original_answer": "The goodwill impairment charge of $489 million recognized in March 2020 and the additional charge of $573 million recognized in September 2020 cumulatively reduced the carrying value of goodwill for the OpenTable and KAYAK reporting unit from its initial value to $1.0 billion by September 30, 2020. This represents a total impairment of $1,062 million over the two periods.",
      "llm_answer": "The 2020 annual goodwill impairment test resulted in a $573 million non‑tax‑deductible charge for the OpenTable and KAYAK reporting unit, lowering the adjusted carrying value of that goodwill to $1.0 billion as of September 30, 2020. Combined with the earlier $489 million interim impairment, the cumulative goodwill impairment related to OpenTable and KAYAK reached approximately $1.06 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $489 million interim impairment charge in March 2020 and the $573 million annual impairment charge in September 2020 are correctly stated. The adjusted carrying value of goodwill is accurately given as $1.0 billion as of September 30, 2020. (2) The cumulative impairment is correctly calculated: $489 million + $573 million = $1,062 million, which the LLM reports as 'approximately $1.06 billion'—an acceptable rounding and format variation. (3) The multi-hop reasoning is sound: the answer synthesizes two separate impairment events (interim and annual) affecting the same reporting unit (OpenTable and KAYAK) and correctly traces their combined impact on the carrying value. (4) Entities (OpenTable, KAYAK, goodwill, reporting unit), time periods (March and September 2020), and financial metrics (impairment charges, carrying value) are all correctly identified and used. The answer addresses all parts of the question: the effect on adjusted carrying value and the cumulative impact. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 329,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Nicor Gas's regulatory disallowances affect Southern Company Gas's 2023 financial performance across both net income and revenue?",
      "original_answer": "Nicor Gas's regulatory disallowances contributed to a $29 million decrease in net income at gas distribution operations for Southern Company Gas in 2023. Additionally, these disallowances reduced revenues, as noted in the report of revenue declines due to lower volumes sold and the regulatory disallowances at Nicor Gas. Therefore, the disallowances had a dual negative financial impact by reducing both net income and revenue.",
      "llm_answer": "Southern Company Gas's 2023 net income increased by $43 million (7.5%) to $615 million, primarily due to a $88 million estimated loss on regulatory disallowance recorded in 2022 related to Nicor Gas infrastructure investments, partially offset by lower revenue and higher depreciation at Nicor Gas. However, operating revenues decreased by $1.26 billion (21.1%) to $4.702 billion in 2023, driven by $1.323 billion in lower gas cost and other cost recovery due to reduced natural gas prices and volumes, as well as $93 million in lower gas marketing services revenue.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Nicor Gas's regulatory disallowances caused a $29 million decrease in net income for Southern Company Gas in 2023. However, the LLM claims net income *increased* by $43 million to $615 million due to a prior-year loss on disallowance, implying the disallowance had a positive effect in 2023, which contradicts the ground truth. This is a major error in both direction and magnitude. (2) Quantitatively, the LLM introduces numbers not present in the ground truth: a $43M increase in net income, $615M total net income, $1.26B revenue decline, and $93M lower marketing revenue. While it correctly notes revenue declined due to lower volumes and gas prices, it fails to quantify the specific impact of Nicor's regulatory disallowances on revenue—only the ground truth links disallowances directly to revenue reduction. The $29M net income impact from disallowances is entirely omitted. (3) The multi-hop reasoning is flawed: the LLM correctly identifies Nicor Gas and regulatory disallowances as relevant but misattributes the financial impact across years, incorrectly framing the 2022 disallowance loss as a favorable year-over-year swing that boosted 2023 income. It fails to state that the 2023 disallowances themselves reduced 2023 net income and revenue. (4) Contextual relevance is moderate—the answer discusses Southern Company Gas’s 2023 financials and mentions Nicor Gas and regulatory disallowances, but misrepresents the causal relationship and direction of impact. Due to major factual and directional errors in financial impact, especially on net income, the correctness score is low despite some relevant context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 470,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How many Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP as of August 31, 2022, and what percentage of the total shares authorized does this represent?",
      "original_answer": "As of August 31, 2022, 16,191,228 Accenture plc Class A ordinary shares remained available for issuance under the 2010 ESPP, representing 17.99% of the total 90,000,000 shares authorized.",
      "llm_answer": "As of August 31 2022, 1,032,000 Class A ordinary shares remained available for issuance under the 2010 ESPP, which represents roughly 5.1 % of the total 20 million shares authorized for the plan.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of quantitative accuracy. According to the ground truth, 16,191,228 shares remained available under the 2010 ESPP as of August 31, 2022, representing 17.99% of the 90,000,000 authorized shares. The LLM incorrectly states only 1,032,000 shares remained, representing 5.1% of 20 million authorized shares. Both the number of shares available and the total authorized shares are wrong, leading to an incorrect percentage. The date (August 31, 2022) and the plan (2010 ESPP) are correctly identified, which supports minimal contextual relevance. However, the core numerical data and calculations are factually incorrect, indicating a failure in multi-hop synthesis—likely pulling data from an incorrect source or misinterpreting the filing. The reasoning is unsound due to incorrect entity-data mapping. While the structure of the answer matches the question format, the factual foundation is flawed, resulting in a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1107,
        "completion_tokens": 284,
        "total_tokens": 1391
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment, as outlined in its 2023 10-K, influence its 2024 expense trends and longer-term operational efficiency goals?",
      "original_answer": "AT&T's collaboration with Ericsson for commercial-scale Open RAN deployment will pressure 2024 expense trends due to the spending required to support growth and efficiency initiatives, including the deployment of Open RAN and associated accelerated depreciation. However, the software benefits of 5G wireless technology, enabled by Open RAN, are expected to result in a more efficient use of capital and lower network-related expenses in the coming years. This aligns with AT&T's longer-term operational efficiency goals by fostering lower network costs and improved operational efficiencies through a more robust ecosystem of network infrastructure providers and suppliers.",
      "llm_answer": "AT&T's 2023 10-K notes that its collaboration with Ericsson to accelerate Open RAN deployment—aimed at building a more robust supplier ecosystem, lowering network costs, and improving operational efficiency—will require significant 2024 spending on fiber and 5G infrastructure, including accelerated depreciation. This investment is expected to pressure near-term expense trends but is positioned to enhance long-term efficiency by enabling a more agile, software-driven network that supports future 5G advancements and drives higher-value broadband revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AT&T's collaboration with Ericsson on Open RAN deployment is accurately described as pressuring 2024 expenses due to infrastructure spending and accelerated depreciation. The long-term benefits—lower network costs, improved operational efficiency, and a more robust supplier ecosystem—are correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all time references (2023 10-K, 2024 spending) are consistent. (3) Multi-hop reasoning is sound: the model correctly synthesizes the cause-effect relationship between near-term spending (due to Open RAN deployment) and long-term efficiency gains, linking collaboration with Ericsson to both expense trends and strategic goals. (4) The only minor gap is that the LLM answer mentions 'higher-value broadband revenue growth,' which, while plausible, is not explicitly stated in the ground truth and slightly extends beyond the provided information. Otherwise, the semantic meaning, entity accuracy (AT&T, Ericsson, Open RAN, 2023 10-K, 2024), and contextual relevance are fully aligned. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 386,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What was the total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, and how did this compare to the discounted future net cash flows from this region in the same year?",
      "original_answer": "The total proved developed bitumen reserves in Canada/Other Americas for XOM's consolidated subsidiaries as of December 31, 2021, were 2,635 million barrels. This corresponds to a discounted future net cash flow of $28,710 million from Canada/Other Americas in 2021. The reserves represent a significant portion of XOM's future cash flow projections from the region.",
      "llm_answer": "The total proved developed bitumen reserves for XOM's consolidated subsidiaries in Canada/Other Americas as of December 31, 2021 were 3,844 million barrels.  The discounted future net cash flows from these reserves were $3,809 million, which is the same amount reported as the results of producing activities for the consolidated subsidiaries in that region for 2021.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in both key numbers. The ground truth states that the total proved developed bitumen reserves in Canada/Other Americas for XOM as of December 31, 2021, were 2,635 million barrels, but the LLM incorrectly reports 3,844 million barrels. Similarly, the discounted future net cash flow from this region in 2021 was $28,710 million according to the original answer, whereas the LLM reports only $3,809 million, which is off by over $24 billion. These discrepancies are substantial and materially incorrect. (2) Number verification: 2,635 vs 3,844 (reserves) and $28,710M vs $3,809M (cash flows) — both are grossly inaccurate. There is no plausible formatting or rounding explanation for such large differences. Additionally, the LLM incorrectly equates the discounted future net cash flows with the 'results of producing activities,' which is not supported by the original answer and introduces a misleading interpretation. (3) Multi-hop reasoning: The question requires synthesizing two data points — reserves and corresponding cash flows — from the same region and year for XOM’s consolidated subsidiaries. The LLM fails this synthesis because it pulls incorrect values, suggesting either misattribution or failure to retrieve the correct data from the knowledge graph. It does not demonstrate accurate cross-referencing of financial and reserve metrics. (4) Despite the severe quantitative inaccuracies, the answer is contextually relevant — it addresses the correct company (XOM), the correct region (Canada/Other Americas), the correct time (December 31, 2021), and the correct metrics (proved developed bitumen reserves and discounted future net cash flows). However, the core factual content is entirely wrong, warranting a very low correctness and quantitative accuracy score. The qualitative accuracy is slightly higher only because the structure and intent of the response align with the question, though the reasoning is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 537,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the adoption of ASU No. 2022-02 impact Capital One's allowance for credit losses and loan modification reporting practices as of December 31, 2023?",
      "original_answer": "The adoption of ASU No. 2022-02 led to a $2.1 billion increase in Capital One's allowance for credit losses, bringing the total to $15.3 billion as of December 31, 2023. Additionally, the standard eliminated the classification of loan modifications as Troubled Debt Restructurings (TDRs), replacing them with a new framework for reporting modified loans, which affects how loan modifications are disclosed and managed under the new accounting guidance.",
      "llm_answer": "The adoption of ASU No. 2022-02 required Capital One to modify its allowance for credit losses methodology for loans held for investment, particularly by eliminating the accounting guidance for troubled debt restructurings (TDRs) and establishing new disclosure requirements for modifications to borrowers experiencing financial difficulty. This change impacted how the company estimates expected credit losses over the contractual terms of its loans, including adjustments for reasonable and supportable forecasts and reversion to historical loss experience, while also affecting loan modification reporting practices by reclassifying certain modifications as Financial Difficulty Modifications (FDMs) rather than TDRs. As detailed in the \"Allowance for Credit Losses - Loans Held for Investment\" and \"Loan Modifications and Restructurings\" sections of the 10-K, the policy election under ASU 2022-02 required Capital One to assess credit losses based on updated contractual terms and forward-looking forecasts, with specific guidance on how modifications granted after January 1, 2023, are evaluated and reported.",
      "correctness_score": 5,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in describing the qualitative impact of ASU No. 2022-02, such as the elimination of TDR classification and the introduction of new reporting frameworks for loan modifications. It correctly references changes in allowance methodology, forward-looking forecasts, and disclosure requirements. However, it introduces the term 'Financial Difficulty Modifications (FDMs)', which is not present in the original answer or standard terminology associated with ASU 2022-02—this is an unsupported detail. (2) Critically, the LLM answer fails to include any of the required quantitative information from the ground truth: the $2.1 billion increase in the allowance for credit losses and the resulting total of $15.3 billion as of December 31, 2023. These figures are central to the question and entirely missing, making the response factually incomplete. (3) The multi-hop reasoning is partially sound—the model connects ASU 2022-02 to changes in both allowance estimation and loan modification reporting, which reflects correct synthesis of accounting standard impacts. However, without the numerical impact, the answer does not fulfill the full scope of the query. (4) The contextual relevance is high because the response stays on topic and references appropriate sections of the 10-K. Qualitative accuracy is moderate due to correct conceptual understanding but penalized for introducing non-standard terminology. Quantitative accuracy is very low because no correct numbers are provided. Correctness score is 5 due to strong conceptual alignment but major omission of key financial figures required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 453,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland impact GE's liquidity position as reported in its 2023 10-K filing?",
      "original_answer": "The potential increase in contingent liabilities from Bank BPH's ongoing litigation in Poland could negatively impact GE's liquidity position. GE reported total cash, cash equivalents, and restricted cash of $17.0 billion at December 31, 2023. However, $14.2 billion of this amount was held outside the U.S., with $1.7 billion in countries with currency control restrictions. If additional contingent liabilities from Bank BPH become payable, GE may face challenges in accessing sufficient liquidity without incurring substantial costs or repatriation taxes. This could constrain its ability to meet business needs and financial obligations, especially under stressed conditions.",
      "llm_answer": "The 2023 10‑K notes that “it is possible that additional contingent liabilities and loss estimates for Bank BPH, in connection with the ongoing litigation in Poland related to its portfolio of residential mortgage loans (see Note 24), will need to be recognized (or loss estimates may increase in the future) and will become payable.” This language indicates that the unresolved Polish litigation could give rise to further contingent liabilities for GE. Because such liabilities would represent potential cash outflows that must be reserved or paid, they could constrain the cash that remains available for other purposes, thereby weakening GE’s overall liquidity position as reported in the filing. In short, the litigation adds a risk of future cash‑draining obligations that could impair GE’s liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the risk that potential contingent liabilities from Bank BPH's litigation in Poland could negatively impact GE's liquidity, which aligns with the ground truth. It accurately cites the 10-K language from Note 24 regarding possible recognition of additional liabilities, demonstrating correct entity and context identification (GE, Bank BPH, Poland litigation, 2023 10-K). The reasoning is logically sound in connecting contingent liabilities to potential cash outflows and reduced liquidity. However, the LLM answer omits key quantitative details present in the original answer: the total cash position of $17.0 billion, the $14.2 billion held outside the U.S., and the $1.7 billion in countries with currency controls. These figures are critical to assessing the actual magnitude of liquidity risk and GE's ability to access funds. While the qualitative risk is well explained, the absence of these specific numbers reduces quantitative accuracy. The answer is semantically aligned in direction and logic but lacks the numerical foundation needed for full completeness and precision. Thus, while the core reasoning and relevance are strong, the missing data points prevent a higher score on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 352,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How many total shares were both issued upon exercise of outstanding options and still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as disclosed in the 2022 10-K filing?",
      "original_answer": "The Amended and Restated 2010 Share Incentive Plan had 14,830,623 shares issued upon exercise of outstanding options and 27,381,461 shares still available for future issuance, totaling 42,212,084 shares.",
      "llm_answer": "Based on the information in the provided pages from the 2022 10-K filing, specifically the table in **Part III, Item 12 (page 49)**, the Amended and Restated 2010 Share Incentive Plan had **27,381,461 shares remaining available for future issuance** as of August 31, 2022. This figure represents the number of shares still available under that plan after accounting for shares reserved for outstanding options, warrants, and rights.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the 27,381,461 shares still available for future issuance under the Amended and Restated 2010 Share Incentive Plan as of August 31, 2022, which matches the ground truth. However, it fails to mention the 14,830,623 shares that were issued upon exercise of outstanding options, which is a required part of the question. The question asks for the *total* shares that were both issued upon exercise *and* still available, implying a need to report both figures and potentially their sum (42,212,084). While the available shares number is accurate, the absence of the issued shares figure makes the response incomplete. The reasoning is partially sound as it correctly interprets the 'available for future issuance' data from the correct section of the 10-K, but it does not perform the multi-hop synthesis of combining issued and available shares. The context and entity (plan name, filing year) are accurate, and the citation to Part III, Item 12 is appropriate. Due to the missing component of the answer, the correctness and qualitative accuracy scores are reduced, though quantitative accuracy is high for the portion provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 326,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total amount of the 2025 Term Loan that AT&T paid off in 2023, and on what date was this loan terminated according to the disclosures?",
      "original_answer": "AT&T paid off the $2,500 million 2025 Term Loan in full and terminated it on March 30, 2023.",
      "llm_answer": "The 2025 Term Loan was paid off on March 30 2023, and the total amount of that loan that AT&T settled was $2.5 billion.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key information is accurate: the loan amount is correctly stated as $2.5 billion, which is equivalent to $2,500 million (format variation is acceptable). The termination date is correctly identified as March 30, 2023. (2) Quantitative accuracy is perfect: the dollar amount and date match the original answer exactly in substance, with only a standard format difference ($2.5 billion = $2,500 million). (3) The reasoning is sound and demonstrates correct synthesis of the multi-hop information — identifying both the amount and the termination date of the 2025 Term Loan paid by AT&T in 2023. (4) The answer is fully relevant and complete, addressing both sub-questions: the total amount paid and the termination date. No factual, numerical, or contextual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1053,
        "completion_tokens": 254,
        "total_tokens": 1307
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023, and how much of the 2023 investment was categorized under Level 2 valuation inputs?",
      "original_answer": "KO's investment in mutual, pooled and commingled funds decreased by $47 million from 2022 to 2023. In 2023, $37 million of the $39 million investment was categorized under Level 2 valuation inputs.",
      "llm_answer": "The change in KO's investment in mutual, pooled and commingled funds from 2022 to 2023 was an increase of $11 million (from $767 million in 2022 to $778 million in 2023). Of the 2023 investment, $509 million was categorized under Level 2 valuation inputs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively: The ground truth states that KO's investment decreased by $47 million from 2022 to 2023, but the LLM claims an increase of $11 million (from $767M to $778M), which is factually wrong. Additionally, the ground truth states that $37 million of the $39 million 2023 investment was categorized under Level 2, whereas the LLM reports $509 million under Level 2—this number is vastly inflated and unsupported. (2) Calculations: The LLM's implied calculation (778 - 767 = +11) contradicts the true decrease of $47 million. The Level 2 portion cannot exceed the total investment, yet $509M > $39M, indicating a fundamental error. (3) Multi-hop reasoning: The question requires comparing two years' investments and identifying the Level 2 portion in 2023. The LLM failed both steps, suggesting a failure to retrieve or synthesize the correct data from the knowledge graph. (4) Entity and contextual accuracy: While the company (KO) and metric (investment in mutual, pooled, and commingled funds) are correctly identified, the years (2022–2023) and all numerical values are wrong. The answer is on-topic but factually baseless. Hence, the correctness, quantitative, and qualitative scores are very low. Contextual relevance is slightly above zero because the structure and intent of the response match the question's domain.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 380,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "What was the total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, and how much net cash did GE pay to AerCap related to continuing involvement with the company during the same period?",
      "original_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million. Additionally, GE paid $203 million in net cash to AerCap related to continuing involvement activities.",
      "llm_answer": "The total pre-tax charge related to ongoing borrower litigation for the year ended December 31, 2023, was $1,189 million, as disclosed in Note 24 and reflected in the earnings (loss) from discontinued operations before income taxes for discontinued operations. Net cash paid to AerCap related to continuing involvement with the company during the same period was $203 million, as stated in the results of discontinued operations for 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, both key figures are accurate: $1,189 million for the pre-tax charge and $203 million in net cash paid to AerCap, with no calculation or numerical discrepancies. Minor formatting differences (e.g., 'million' vs 'M') are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the multi-part question: the pre-tax litigation charge and the net cash payment to AerCap. (3) Entity accuracy is correct—GE and AerCap are properly identified, the time period (year ended December 31, 2023) is accurate, and the financial metrics (pre-tax charge, net cash related to continuing involvement) are correctly named. (4) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly references Note 24 and the discontinued operations section, indicating proper sourcing and integration of information across financial statement components. The additional contextual details (e.g., disclosure in Note 24, placement in discontinued operations) enhance accuracy without introducing errors. Overall, the answer is factually precise, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1186,
        "completion_tokens": 339,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Accenture's investment in research and development and its focus on delivering 360° value contribute to its competitive positioning in the global IT services market, especially when compared to its competitors' offerings?",
      "original_answer": "Accenture invested $1.1 billion in research and development during fiscal 2022, which supports its ability to innovate and deliver advanced solutions. This investment underpins its strategy of delivering 360° value—defined as providing financial business cases, inclusion and diversity progress, employee reskilling, and sustainability support to clients. This differentiates Accenture in a competitive market where competitors include multinational IT providers, offshore firms, consultancies, and in-house corporate departments. Accenture claims no other firm offers the same breadth of services at scale, and its 360° value approach, backed by R&D and global ecosystem partnerships, enables it to deliver outcomes across strategy, execution, and transformation, giving it a unique competitive edge.",
      "llm_answer": "Accenture’s sustained investment in research and development—$1.1 billion in fiscal 2022 and a portfolio of over 8,300 patents—fuels its 360° value proposition by delivering cutting‑edge, industry‑specific solutions and accelerating client transformation. Combined with its broad global footprint, deep cross‑industry expertise, and focus on inclusion, sustainability and talent development, this R&D‑driven innovation differentiates Accenture from competitors who lack the same scale, ecosystem partnerships, and integrated service model, enabling it to win and retain top talent and trusted, long‑term client relationships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Accenture's $1.1 billion R&D investment in fiscal 2022, matching the ground truth. It adds the detail of 'over 8,300 patents,' which is not in the original answer but does not contradict it and may reflect additional accurate context; however, since this fact is not in the ground truth and cannot be verified from the provided knowledge graph, it is considered extra but not erroneous. All other numerical and factual claims are consistent. (2) Quantitative accuracy is perfect: the $1.1 billion figure is correct in amount and fiscal year, and no incorrect calculations are made. (3) The multi-hop reasoning is sound—LLM correctly links R&D investment to the 360° value proposition and uses that to explain competitive differentiation. It accurately identifies the components of 360° value (inclusion, sustainability, talent development) and contrasts Accenture with competitors lacking scale, ecosystem partnerships, and integrated models, aligning with the ground truth’s claim of unmatched breadth at scale. (4) The answer is contextually fully relevant, addressing both R&D’s role and the 360° value in competitive positioning. The only minor gap is that the original answer explicitly defines 360° value as including 'financial business cases' and 'employee reskilling,' which the LLM implies but does not state verbatim. However, 'talent development' can be considered semantically equivalent to reskilling. Overall, the answer is factually correct, well-reasoned, and comprehensive, warranting a high score with only slight deduction for not fully enumerating all elements of 360° value as defined in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 457,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What specific entities, in addition to WarnerMedia, were classified as discontinued operations by AT&T in 2023, and how does this classification affect the presentation of their financial results?",
      "original_answer": "In addition to WarnerMedia, AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in 2023. This classification means that the financial results of these entities are excluded from ongoing operations and are instead reported separately as discontinued operations, including for periods prior to the consummation of the WarnerMedia/Discovery transaction.",
      "llm_answer": "AT&T classified Vrio, Xandr, and Playdemic as discontinued operations in addition to WarnerMedia. This classification requires these businesses to be presented separately in the financial statements, with their results of operations and assets/liabilities shown as discontinued, allowing investors to assess AT&T's core Communications and Latin America segments without the impact of these divested businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all entities classified as discontinued operations by AT&T in 2023: Vrio, Xandr, and Playdemic, in addition to WarnerMedia, which matches the ground truth. There are no numeric values, dates, or calculations in the question or answer that require verification, so quantitative accuracy is not applicable beyond correct entity identification and year (2023), which is accurate. The explanation of the financial reporting impact is semantically equivalent to the original answer: it correctly states that these entities are presented separately in financial statements as discontinued operations, allowing investors to evaluate core segments independently. The only minor shortcoming is that the LLM answer does not explicitly mention that prior period results are reclassified, which is a key aspect of discontinued operations accounting (i.e., retrospective presentation). This omission slightly affects completeness and reasoning depth, but the core financial reporting implication is accurately conveyed. Therefore, the answer is highly accurate with only a small loss in qualitative precision, warranting a 9/10 in correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 328,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, and how does this loss distribute across the maturity periods according to the 2022 10-K filing?",
      "original_answer": "The total unrealized loss attributed to Auction Rate Securities held by MDT as of April 29, 2022, is $3 million. This loss is entirely associated with securities having maturity periods of more than 12 months, as no unrealized loss is reported for securities with maturity periods of less than 12 months.",
      "llm_answer": "The 2022 10‑K filing shows that the total unrealized loss on the Company’s available‑for‑sale debt securities—including auction‑rate securities—was **$245 million** as of April 29, 2022. This loss is broken out in the “Unrealized Losses” column of the table summarizing securities in a continuous unrealized‑loss position: $56 million on U.S. government and agency securities, $139 million on corporate debt securities, $35 million on mortgage‑backed securities, $11 million on other asset‑backed securities, and $3 million on auction‑rate securities, which together total $244 million; rounding yields the disclosed $245 million. The loss is further categorized by maturity: $56 million of the loss relates to securities maturing in less than one year, $139 million to those maturing after one year through five years, $35 million to those maturing after five years through ten years, and $3 million to securities maturing after ten years.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly reports the total unrealized loss as $245 million, which refers to the total unrealized loss across all available-for-sale debt securities, not just Auction Rate Securities (ARS). The ground truth specifies that the unrealized loss *attributed specifically to Auction Rate Securities* is $3 million. The LLM conflates the total portfolio loss with the ARS-specific loss. (2) While the $3 million unrealized loss on auction-rate securities is correctly mentioned, it is buried within a breakdown of much larger categories (e.g., corporate debt, mortgage-backed securities), and the LLM incorrectly presents $245 million as the total unrealized loss *on ARS*, which is factually wrong. The maturity distribution is also misapplied: the $3 million ARS loss is entirely in the 'more than 12 months' category, but the LLM assigns $3 million to 'after ten years' without clarifying that this *is* the full ARS loss and that no loss exists for ARS with maturities under 12 months. (3) The multi-hop reasoning fails because the model does not isolate the ARS-specific data from the broader debt securities table. It misattributes aggregated loss and maturity data to ARS as a whole, when only the $3 million figure and its maturity placement (>12 months) are relevant. (4) Despite using correct filing and date, the answer is mostly incorrect in quantitative terms and reasoning, hence low scores in correctness, quantitative, and qualitative accuracy. Contextual relevance is moderate because it discusses the right document and a related table, but misapplies the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 440,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How many shares of Class B-2 common stock were issued during the Class B-1 common stock exchange offer in May 2024, and what percentage of the total shares issued in that exchange consisted of Class B-2 common stock?",
      "original_answer": "In May 2024, 120 million shares of Class B-2 common stock were issued during the exchange offer for Class B-1 common stock. A total of 168 million shares were issued in that exchange (120 million Class B-2 and 48 million Class C). Therefore, Class B-2 shares accounted for approximately 71.4% of the total shares issued.",
      "llm_answer": "During the May 2024 Class B‑1 common‑stock exchange offer, Visa issued approximately **120 million shares of Class B‑2 common stock**. This amount represented **about 33 % of the total shares issued in that exchange** (the exchange resulted in roughly 360 million shares overall, comprising 241 million tendered Class B‑1 shares exchanged for ~120 million Class B‑2 shares and ~48 million Class C shares).",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 120 million shares of Class B-2 common stock issued, which matches the ground truth. However, it incorrectly states that Class B-2 shares represented 'about 33%' of the total shares issued, which is factually wrong. The correct percentage is approximately 71.4%, as Class B-2 shares (120M) made up 120M out of 168M total shares (120M B-2 + 48M C). The LLM also fabricates a total of 360 million shares issued, which is not supported by the ground truth. (2) Number verification: 120 million Class B-2 shares = correct. 48 million Class C shares = correct (mentioned in LLM answer). Total shares: LLM says ~360M, but correct total is 168M. Percentage: LLM says ~33%, but correct is 120/168 ≈ 71.4%. The calculation error is significant and stems from using an incorrect total. (3) Multi-hop reasoning: The model attempts to synthesize the composition of shares issued but fails in aggregation. It introduces an unsupported total (360M) possibly conflating tendered shares (241M Class B-1) with issued shares, which is a conceptual error—tendered shares are not the same as newly issued shares. This breaks the reasoning chain. (4) Correctness score is 4 due to one major correct number but a critical error in percentage and total shares, which undermines the core of the question. Quantitative accuracy is low (4) due to incorrect totals and percentages. Qualitative accuracy is moderate (5) because entities and context are mostly right, but reasoning is flawed. Contextual relevance is high (8) as the answer addresses the right event and exchange structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 440,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What is the total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023, and how does this reflect in the change in the number of Wind Turbines sold during the same period?",
      "original_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 (11.7 GW) to 2023 (8.5 GW) is 3.2 GW. During the same period, the number of Wind Turbines sold decreased from 3,590 units in 2021 to 2,225 units in 2023, a reduction of 1,365 units. This indicates a decline in both the volume of turbines sold and the overall capacity of wind energy systems delivered by GE.",
      "llm_answer": "The total decrease in Wind Turbine Gigawatts capacity sold by GE from 2021 to 2023 was 3.2 GW (11.7 GW in 2021 to 8.5 GW in 2023), and this reflects a 1,365-unit decrease in the number of Wind Turbines sold during the same period (3,590 in 2021 to 2,225 in 2023).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the decrease in capacity is correctly calculated as 3.2 GW (11.7 GW - 8.5 GW), and the reduction in units sold is correctly stated as 1,365 (3,590 - 2,225). (2) The answer addresses both parts of the multi-hop question: the change in GW capacity and the corresponding change in number of turbines sold, with correct years (2021 to 2023) and entities (GE). (3) The reasoning is sound—by reporting both the capacity and unit declines with accurate figures, the model correctly synthesizes the trend of reduced sales volume and energy output. (4) The semantic meaning is equivalent to the original answer, even though slightly more concise; no key information is omitted. All metrics, years, and calculations are precise and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 254,
        "total_tokens": 1427
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "What was the total amount paid by AT&T for C-Band licenses, including all incentive and relocation costs through 2023, and how does this reflect in the company's cash flow classification?",
      "original_answer": "AT&T paid a total of $26,477 million for C-Band licenses, including $23,406 million in auction deposits and payments, $3,067 million in incentive and relocation costs ($955 million for Phase I, $2,112 million for Phase II, and $1,100 million in compensable relocation costs over several years, of which $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023). These payments are classified under 'Acquisitions, net of cash acquired' on AT&T's consolidated statements of cash flows.",
      "llm_answer": "AT&T paid a total of **$23,406** for C-Band licenses (including $22,856 cash payments in Q1 2021, $955 incentive payments in 2021, $2,112 incentive payments in 2023, and $650 relocation costs paid in 2023), and these expenditures are classified as **\"Acquisitions, net of cash acquired\"** in the company's consolidated statements of cash flows.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the total amount paid and misallocates key payments. The correct total is $26,477 million, but the LLM states $23,406 million, which only reflects auction deposits and payments, omitting the full scope of incentive and relocation costs. The LLM incorrectly aggregates $22,856 in cash payments (not mentioned in the ground truth) and misattributes $2,112 million in incentive payments to 2023, when Phase II was $2,112 million but not necessarily all paid in 2023. It also claims $650 million in relocation costs paid in 2023, but ground truth states $650 million was paid in 2021, $98 million in 2022, and $109 million in 2023. (2) The ground truth specifies $3,067 million in incentive and relocation costs, broken into $955 million (Phase I), $2,112 million (Phase II), and $1,100 million in compensable relocation costs with specific annual payments. The LLM fails to report the total incentive and relocation costs correctly and misassigns timing. (3) The multi-hop reasoning is partially sound in linking C-Band payments to cash flow classification, correctly identifying 'Acquisitions, net of cash acquired' as the category. However, it fails to synthesize the full cost components across years and misrepresents the payment timeline and amounts. (4) The contextual relevance is high because the answer addresses both parts of the question—total cost and cash flow classification—but the quantitative inaccuracies severely undermine correctness. The qualitative accuracy is moderate due to correct identification of the cash flow line item but flawed synthesis of financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 453,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Medtronic's decision to discontinue the HVAD System impact its financial performance in fiscal year 2022, and what other product lines were highlighted as growth drivers in the same period?",
      "original_answer": "Medtronic's decision to discontinue the HVAD System in June 2021 removed a product that had generated $141 million in net sales during fiscal year 2021. This discontinuation likely contributed to the company's focus on other growth drivers in fiscal year 2022, such as the Symplicity Spyral Multi-Electrode Renal Denervation Catheter, Pulse Field Ablation, Aurora Extravascular ICD, and transcatheter mitral and tricuspid therapy products led by the Intrepid system. Despite the loss of HVAD revenue, Medical Surgical's net sales increased to $9.1 billion in fiscal year 2022, up 5% compared to the prior year, driven by recovery in global procedure volumes and strong performance in Surgical Innovations, partially offset by supply chain disruptions.",
      "llm_answer": "Medtronic's discontinuation of the HVAD System reduced net sales in the Cardiovascular segment, contributing to a 6% overall revenue increase in fiscal 2022 that was partially offset by supply chain challenges and declines in China. The document highlights Neuroscience as a key growth driver, with its net sales rising 7% due to recovery in procedural volumes, strong performance in spinal implants (including Infinity OCT System and Prestige LP cervical disc system), and adoption of robot-assisted spine technologies like Mazor X Stealth. Additionally, Structural Heart & Aortic and Cardiovascular segments showed growth from TAVR (CoreValve Evolut), Micra pacemakers, and CRT-D devices, while Neuromodulation within Neuroscience grew 8% driven by Percept PC DBS sales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Medtronic's overall revenue increased by 6% in fiscal year 2022 due to the HVAD discontinuation, while the ground truth indicates that Medical Surgical sales increased by 5% to $9.1 billion, not overall company revenue. The $141 million in lost HVAD sales from fiscal 2021 is omitted entirely, a critical quantitative error. (2) The LLM misattributes growth drivers: it highlights Neuroscience, spinal implants (Infinity OCT, Prestige LP), Mazor X, and Percept PC DBS as key growth areas, but the original answer identifies Symplicity Spyral, Pulse Field Ablation, Aurora ICD, and Intrepid transcatheter mitral/tricuspid systems as the highlighted growth drivers post-HVAD. There is no mention of these correct products in the LLM response. (3) The multi-hop reasoning is flawed: the question asks how the HVAD discontinuation impacted financial performance and what replaced it as a growth driver. The LLM fails to connect the $141M revenue loss from HVAD (a key input) to the strategic shift, and instead fabricates unrelated growth narratives in Neuroscience and Surgical Innovations without linking them to the discontinuation. (4) While the LLM attempts to discuss financial impact and growth drivers (contextually relevant), it does so with incorrect entities, numbers, and causal logic. Minor contextual elements like supply chain disruptions are correctly mentioned, but core facts are wrong, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 422,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How much total cash did Walmart pay to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024, and what was the impact on Walmart's ownership percentage in Flipkart?",
      "original_answer": "Walmart paid $3.5 billion to acquire additional shares from Flipkart noncontrolling interest holders and settle the liability to former noncontrolling interest holders of PhonePe during fiscal 2024. This increased Walmart's ownership in Flipkart from approximately 75% as of January 31, 2023, to approximately 85% as of January 31, 2024.",
      "llm_answer": "Walmart paid $3.5 billion in cash to acquire additional Flipkart shares from non‑controlling interest holders and to settle the liability to former PhonePe non‑controlling interest holders during fiscal 2024. This transaction increased Walmart’s ownership stake in Flipkart from roughly 75 % (as of January 31 2023) to approximately 85 % (as of January 31 2024).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $3.5 billion cash payment is accurately reported, along with the correct ownership percentages (75% to 85%) and corresponding dates (January 31, 2023, and January 31, 2024). Minor formatting differences (e.g., ' ' thin spaces, 'approximately' vs 'roughly') do not affect meaning. (2) The answer is complete, addressing both parts of the question: the total cash paid and the impact on Walmart's ownership in Flipkart. (3) Entities are correct: Walmart, Flipkart, PhonePe, noncontrolling interest holders, and fiscal 2024 are all accurately referenced. (4) The multi-hop reasoning is sound—synthesizing the cash outflow for both Flipkart share acquisition and PhonePe liability settlement, and correctly linking it to the ownership change. (5) The semantic meaning is equivalent to the original answer, with no factual discrepancies. All scores are 10/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 275,
        "total_tokens": 1483
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Microsoft's treatment of unearned revenue from volume licensing programs, including the timing of invoicing and revenue recognition, impact the presentation and auditability of its financial statements, given the complexity in determining standalone selling prices (SSP) and the auditor's focus on revenue recognition?",
      "original_answer": "Microsoft recognizes unearned revenue from volume licensing programs, which include Software Assurance (SA) and cloud services, by invoicing annually at the beginning of each contract period and recognizing revenue ratably over the coverage period. This creates contract balances such as receivables or unearned revenue, depending on the timing mismatch between invoicing and revenue recognition. Due to the complexity in determining standalone selling prices (SSP) for on-premises licenses sold with SA or software updates, Microsoft must use judgment and estimates based on customer size and geographic region, which affects the allocation of discounts and the pattern of revenue recognition. This complexity was a critical audit matter for Microsoft’s independent auditors, who focused on the application of revenue recognition principles, especially around transfer of control and variable consideration. Therefore, the structure and accounting treatment of volume licensing programs directly influence both the presentation of financial statements and the nature of the audit procedures performed.",
      "llm_answer": "Microsoft's treatment of unearned revenue from volume licensing programs, particularly through annual invoicing of multi-year contracts and recognition of revenue ratably over the coverage period, requires careful judgment in determining standalone selling prices (SSP) for bundled offerings like Software Assurance. This complexity impacts both the presentation of financial statements—where unearned revenue is recorded as a liability and recognized over time—and the auditability of revenue recognition, as auditors must rigorously test management's estimates of SSP, variable consideration, and the pattern of revenue delivery, especially for non-separately sold products and services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Microsoft invoices annually at the beginning of the contract period and recognizes revenue ratably, leading to unearned revenue liabilities. The complexity in determining standalone selling prices (SSP) due to bundled offerings like Software Assurance is correctly highlighted, as is the need for judgment based on customer and regional factors. The impact on financial statement presentation (liability recognition) and auditability (auditor focus on SSP, variable consideration, and revenue pattern) is accurately described. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is not applicable but assumed perfect as no numbers were misstated. (3) The multi-hop reasoning is sound: the answer correctly links invoicing timing → unearned revenue → SSP estimation challenges → revenue allocation and recognition → auditor scrutiny. It synthesizes the accounting treatment with its implications for audit and disclosure, matching the original answer’s logic. (4) The only minor shortcoming is that the LLM answer does not explicitly name 'critical audit matter' or reference 'transfer of control'—specific terms from the original that enhance precision—though the concepts are implied. This slight omission in terminology prevents a perfect 10 but does not detract from overall correctness. Contextual relevance is full, as all parts of the question are addressed with appropriate depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 430,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What were the total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, and why were no profit sharing contributions included in this total?",
      "original_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $343 million ($126 million in 2022, $110 million in 2021, and $107 million in 2020). No profit sharing contributions were included in this total because the company did not make any discretionary profit sharing contributions for the fiscal years 2022, 2021, or 2020, as stated in the plan terms.",
      "llm_answer": "The total company contributions made to Nike's 401(k) Savings and Profit Sharing Plan over the three fiscal years ended May 31, 2022, were $126 million in 2022, $110 million in 2021, and $107 million in 2020. No profit‑sharing contributions were included in this total because the plan’s terms allow for discretionary profit‑sharing contributions, but none were made by the Company for those fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three annual contribution amounts: $126 million in 2022, $110 million in 2021, and $107 million in 2020, which sum to $343 million as stated in the ground truth. While the LLM does not explicitly state the total sum of $343 million, it provides all component values, allowing for accurate inference. (2) All numeric values match the ground truth exactly and are presented with correct fiscal years and formatting. The absence of the explicit total is a minor omission but does not affect quantitative accuracy since the components are fully correct. (3) The reasoning for the absence of profit-sharing contributions is sound: the LLM correctly identifies that profit-sharing contributions are discretionary and that none were made in the relevant fiscal years, aligning with the plan terms as stated in the original answer. This demonstrates proper multi-hop synthesis between plan structure and actual contributions. (4) The answer is contextually complete and highly relevant, conveying the same factual content as the ground truth with only a slight reduction in completeness for not summing the total. The qualitative accuracy is slightly reduced for this omission, but the core reasoning and facts are fully intact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 357,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total change in Chevron's (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024, and how does this compare to the change in natural gas reserves in Africa over the same period?",
      "original_answer": "Chevron's consolidated natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet from 312 (2023) to 296 (2024). In contrast, natural gas reserves in Africa increased by 297 billion cubic feet from 172 (2023) to 468 (2024). Therefore, while reserves declined slightly in the Asia Pacific/Middle East, they significantly increased in Africa.",
      "llm_answer": "The total change in Chevron’s (COP) consolidated natural gas reserves in the Asia Pacific/Middle East region from the end of 2023 to the end of 2024 is an increase of **289 billion cubic feet** (from 296 bcf in 2023 to 457 bcf in 2024).  \n\nIn contrast, natural gas reserves in Africa declined by **57 billion cubic feet** over the same period (from 241 bcf in 2023 to 184 bcf in 2024).  \n\nThus, the Asia Pacific/Middle East region saw a net upward revision of 289 bcf, while Africa experienced a net downward revision of 57 bcf.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, Chevron's natural gas reserves in the Asia Pacific/Middle East region decreased by 16 billion cubic feet (from 312 to 296 bcf), but the LLM claims an increase of 289 bcf (from 296 to 457 bcf), which is factually wrong on both direction and magnitude. Similarly, in Africa, reserves increased by 297 bcf (from 172 to 468 bcf), but the LLM incorrectly states a decline of 57 bcf (from 241 to 184 bcf). All numbers are incorrect. (2) The calculations are also wrong: the LLM computes a +289 bcf change in Asia Pacific/Middle East (457 - 296 = 161, not 289 — even their arithmetic is flawed), and a -57 bcf change in Africa (241 - 184 = 57, which is arithmetically correct but based on false inputs). The correct changes are -16 bcf and +297 bcf respectively. (3) The multi-hop reasoning fails completely: the model does not correctly identify or synthesize the correct data points across regions and years. It uses fabricated or misremembered figures for both regions and years. (4) The contextual relevance is partially preserved because the answer addresses the right regions (Asia Pacific/Middle East and Africa), the correct company (Chevron/COP), and the correct time frame (2023 to 2024), and attempts a comparison. However, due to pervasive factual and numerical errors, the qualitative and quantitative accuracy scores are extremely low. Correctness score is 1 due to near-total factual inaccuracy despite correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 425,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How much total cash did Walmart receive from equity funding related to PhonePe during fiscal 2024, and how did this compare to the amount paid to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year?",
      "original_answer": "Walmart received $0.7 billion from equity funding related to PhonePe during fiscal 2024 and paid $3.5 billion to acquire shares from noncontrolling interest holders of PhonePe in the same fiscal year. Therefore, Walmart spent $2.8 billion more than it received in net cash related to PhonePe equity transactions during fiscal 2024.",
      "llm_answer": "Walmart received $0.7 billion of cash from equity funding related to PhonePe during fiscal 2024, and it paid $3.5 billion to acquire shares from non‑controlling interest holders of PhonePe in the same fiscal year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Walmart received $0.7 billion from equity funding and paid $3.5 billion to acquire shares from noncontrolling interest holders during fiscal 2024, matching the ground truth exactly in terms of numerical values and entities. (2) All numeric values are accurate: $0.7 billion received and $3.5 billion paid. The implied net cash outflow of $2.8 billion (difference between $3.5B and $0.7B) is factually correct, though not explicitly stated in the LLM answer. (3) The multi-hop reasoning is sound—information about two distinct equity-related cash flows (inflow from funding, outflow from acquisition) is correctly attributed to Walmart and PhonePe in fiscal 2024. However, the LLM answer omits the comparative analysis explicitly stating that Walmart spent $2.8 billion more than it received, which was part of the original question's request to 'compare' the amounts. This makes the answer slightly less complete. (4) Despite the omission of the net comparison, the core facts, numbers, and entities are fully correct, and the answer directly addresses the two main components of the question. Hence, a high score of 9 is warranted—only minor incompleteness prevents a perfect 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 347,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What is the total pre-tax charge recorded by RTX in 2024 as a result of resolving the SEC Administrative Order and related legal matters, and how long will the compliance monitor oversee RTX's obligations under these agreements?",
      "original_answer": "RTX recorded a total pre-tax charge of $918 million in 2024 related to the SEC Administrative Order and other legal resolutions. The compliance monitor will oversee RTX's obligations for a period ending three years from the date on which the monitor is engaged.",
      "llm_answer": "RTX recorded a combined pre‑tax charge of $918 million in 2024 related to the resolution of the SEC Administrative Order and the associated legal matters, and the compliance monitor appointed under those agreements will oversee RTX’s obligations for a three‑year term.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the pre-tax charge of $918 million in 2024 is accurately reported, matching the original answer exactly. The time period for the compliance monitor is correctly stated as a three-year term, which aligns with the ground truth specifying oversight for three years from the engagement date. (2) The answer addresses both parts of the multi-hop question: the financial impact (charge amount and year) and the duration of the compliance oversight. (3) Entity accuracy is correct—RTX is the proper company, 2024 is the correct year, and the SEC Administrative Order and related legal matters are accurately referenced. (4) The reasoning is sound: the LLM correctly synthesizes that the $918 million charge is tied to both the SEC order and associated legal resolutions, and that the compliance monitor’s role lasts for three years, as required. Minor wording differences (e.g., 'three-year term' vs. 'period ending three years from the date...') do not affect factual accuracy and are semantically equivalent. No errors in calculation, logic, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1152,
        "completion_tokens": 323,
        "total_tokens": 1476
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What was the total Microsoft Cloud revenue in fiscal year 2023, and which specific cloud-based offerings, including Dynamics 365, contributed to this revenue?",
      "original_answer": "The total Microsoft Cloud revenue in fiscal year 2023 was $111.6 billion. This revenue was generated from offerings such as Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties.",
      "llm_answer": "Microsoft's fiscal year 2023 total Microsoft Cloud revenue was **$137.4 billion**. This cloud revenue includes Azure and other cloud services, Office 365 Commercial, the commercial portion of LinkedIn, Dynamics 365, and other commercial cloud properties. Key cloud‑based offerings that contributed to this revenue are Dynamics 365 (cloud‑based ERP/CRM and low‑code AI applications), Azure (including Azure AI and infrastructure services), Office 365 Commercial, and the commercial side of LinkedIn.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the total Microsoft Cloud revenue for fiscal year 2023 as $137.4 billion, whereas the ground truth is $111.6 billion—a significant numerical discrepancy. All other qualitative aspects of the answer are correct: the listed cloud offerings (Azure, Office 365 Commercial, LinkedIn commercial, Dynamics 365, and other commercial cloud properties) match the ground truth and are accurately described, including Dynamics 365's role in ERP/CRM and AI applications. (2) The quantitative inaccuracy is severe: $137.4B vs $111.6B represents an overstatement of over $25 billion (about 23% higher), which cannot be attributed to formatting or rounding. No calculation is required in the question, but the reported figure must match the source. (3) The multi-hop reasoning is sound—the model correctly identifies and synthesizes the various cloud-based offerings contributing to Microsoft Cloud revenue, showing understanding across multiple services and business units. (4) The correctness score is 4 due to the major factual error in the revenue figure, which undermines the answer’s reliability despite otherwise complete and accurate component details. Quantitative accuracy is low (2) due to the large dollar amount error. Qualitative accuracy is 7 because the components and reasoning are correct but the core number is wrong. Contextual relevance is high (9) as the answer directly addresses the question and includes relevant, well-structured details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 412,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Universal Beijing Resort's $3.5 billion debt position as of December 31, 2023, reflect both its direct financing arrangements and its position within Comcast's consolidated debt structure?",
      "original_answer": "Universal Beijing Resort's $3.5 billion debt position reflects both its direct financing arrangements and its consolidated position within Comcast's debt structure. As stated in the evidence, Universal Beijing Resort secured its financing through a debt facility with a maximum borrowing limit of ¥29.7 billion RMB (approximately $4.2 billion), funded by a syndicate of Chinese financial institutions and secured by the resort's assets and investor equity interests. As of December 31, 2023, the resort had $3.5 billion of debt outstanding under this arrangement, including $3.1 billion in term loans. Despite this secured debt structure, Comcast consolidates Universal Beijing Resort as a Variable Interest Entity (VIE) due to its governance structure and its ability to direct major economic activities. However, Comcast explicitly states that there are no liquidity arrangements, guarantees, or financial commitments between itself and the resort, meaning Comcast's risk exposure is limited to its 30% equity interest. In the consolidated debt disclosures, Universal Beijing Resort's $3.5 billion debt is categorized under 'Debt Not Guaranteed,' appearing separately from Comcast's other major debt segments like NBCUniversal and Comcast Cable, which are subject to cross-guarantees.",
      "llm_answer": "Universal Beijing Resort's $3.5 billion debt is recorded on Comcast’s consolidated balance sheet as a standalone borrowing of the resort, but it is included in the “Debt Subject to Cross‑Guarantees” line item for the “Universal Beijing Resort (b)” entry, reflecting that the debt is ultimately guaranteed by Comcast and its other subsidiaries. Consequently, while the $3.5 billion appears as debt of the resort itself, it is effectively part of Comcast’s broader guaranteed debt structure, contributing to the total $94.4 billion of debt subject to cross‑guarantees reported in the consolidated tables.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and qualitative errors that severely undermine its correctness. (1) Quantitatively, while the $3.5 billion debt figure is correct and aligns with the ground truth, the claim that this debt is included in 'Debt Subject to Cross-Guarantees' is false. The original answer explicitly states that Universal Beijing Resort's debt is categorized under 'Debt Not Guaranteed' and is separate from Comcast's cross-guaranteed debt segments. The LLM incorrectly asserts that the $3.5 billion contributes to the $94.4 billion of debt subject to cross-guarantees, which contradicts the evidence. (2) Qualitatively, the LLM misrepresents the financial and legal structure: it falsely claims Comcast guarantees the resort’s debt, when the ground truth clearly states there are no guarantees, liquidity arrangements, or financial commitments from Comcast. Additionally, the VIE consolidation status is acknowledged in the original but misrepresented in the LLM response, which implies full guarantee liability. (3) The multi-hop reasoning fails: the model does not correctly synthesize the distinction between consolidation for accounting purposes (VIE) versus financial risk exposure (limited to equity interest). It conflates balance sheet inclusion with guarantee obligations, which the original answer carefully distinguishes. (4) Contextually, the answer addresses the question’s topic and mentions relevant entities and figures, so it maintains some relevance, but the core reasoning and factual claims are incorrect. Minor formatting of $3.5 billion is acceptable, but the substantive financial characterization is wrong, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 458,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What was the change in Nike's investment in commercial paper and bonds from May 31, 2021, to May 31, 2022, and how did this shift affect the composition of their short-term investments?",
      "original_answer": "Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022, representing a decline of $88 million. This reduction was part of a broader reallocation in their short-term investments, where total Level 2 short-term investments dropped from $695 million to $630 million, indicating a strategic shift toward more liquid or alternative short-term instruments such as U.S. Treasury securities and money market funds.",
      "llm_answer": "The change in Nike's investment in commercial paper and bonds was an increase of $66 million (from $691 million at May 31 2021 to $757 million at May 31 2022). This growth shifted the composition of short‑term investments, raising the share of commercial paper and bonds within the Level 2 fair‑value hierarchy and expanding the overall short‑term investment balance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key aspects. The original answer states that Nike's investment in commercial paper and bonds decreased from $748 million on May 31, 2021, to $660 million on May 31, 2022—a decline of $88 million. In contrast, the LLM claims an increase of $66 million, from $691 million to $757 million, which misstates both the baseline and ending values and inverts the direction of change. These numbers do not align with the ground truth and represent significant factual errors. (2) The calculation in the LLM answer is also incorrect: even if the numbers were accurate (which they are not), a change from $691M to $757M would be a $66M increase, but this is irrelevant because the actual figures are $748M and $660M, respectively, resulting in an $88M decrease. Additionally, the LLM misrepresents the broader short-term investment trend: the original answer notes that total Level 2 short-term investments declined from $695M to $630M, but the LLM incorrectly claims an expansion in short-term investments. (3) The multi-hop reasoning is fundamentally flawed. The question requires synthesizing changes in specific investment categories (commercial paper and bonds) and interpreting how this shift affected the composition of short-term investments. The LLM fails this synthesis by reporting incorrect data and drawing the opposite conclusion—claiming growth and increased share when the truth is a reduction and likely decreased share. (4) Due to pervasive quantitative and qualitative errors, the correctness score is 1. The answer is not semantically equivalent and conveys the opposite financial reality. Quantitative accuracy is 1 due to entirely incorrect numbers. Qualitative accuracy is 1 because the reasoning and interpretation are invalid. Contextual relevance is 3 because the answer addresses the right topic (Nike’s short-term investments) and time frame but with completely inaccurate data and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 531,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the introduction of Class B-2 common stock impact the diluted earnings per share calculation for fiscal 2023, given that no Class B-2 shares were outstanding prior to the Class B-1 exchange offer?",
      "original_answer": "The introduction of Class B-2 common stock affects the diluted earnings per share calculation by increasing the weighted-average number of as-converted Class A common stock outstanding. Since Class B-2 shares were not outstanding prior to the Class B-1 exchange offer, their assumed conversion into Class A stock in the diluted EPS calculation contributes to the as-converted equity structure, thereby potentially lowering the diluted earnings per share compared to the basic earnings per share, which does not include these conversions.",
      "llm_answer": "The introduction of Class B‑2 common stock does not affect the diluted earnings‑per‑share calculation for fiscal 2023 because no Class B‑2 shares were outstanding before the Class B‑1 exchange offer; consequently, there are no additional shares to include in the diluted‑share denominator for that year.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite using accurate terminology and contextually relevant concepts. (1) The LLM claims that the introduction of Class B-2 common stock does *not* affect diluted EPS because no shares were outstanding before the exchange offer. This is flawed reasoning: in diluted EPS calculations, potential dilution from convertible instruments (like newly introduced Class B-2 shares post-exchange) must be considered under the as-converted method if dilutive. The ground truth correctly explains that the assumed conversion of Class B-2 shares into Class A stock increases the weighted-average shares outstanding in the diluted EPS denominator, potentially lowering diluted EPS. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not at issue—no numbers were misstated. (3) The multi-hop reasoning fails: the model does not understand that the *introduction* of a new share class via exchange can still impact diluted EPS through as-converted treatment, even if those shares didn’t exist earlier in the year. The absence of prior shares doesn’t negate their dilutive effect once issued and convertible. (4) Contextual relevance is moderate because the answer discusses the correct topic (diluted EPS, share classes, exchange offer), but the conclusion contradicts accounting principles (ASC 260) on earnings per share. Thus, while entities and context are accurate, the reasoning and final claim are fundamentally wrong, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 428,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in pension cost recognition patterns under U.S. government Cost Accounting Standards (CAS) specifically impact the Raytheon segment's financial reporting compared to Collins and Pratt & Whitney?",
      "original_answer": "The Raytheon segment recognizes pension and PRB expenses under U.S. government Cost Accounting Standards (CAS), which differ in cost recognition patterns compared to Financial Accounting Standards (FAS) used by Collins and Pratt & Whitney. While the ultimate liability for pension and PRB costs under FAS and CAS is similar, the Raytheon segment adjusts its financial reporting to reflect CAS-based expenses, impacting its operating profit. Over time, Raytheon expects to recover these pension and PRB liabilities through the pricing of its products and services to the U.S. government, which is not a factor for Collins and Pratt & Whitney.",
      "llm_answer": "The Raytheon segment’s pension and postretirement benefit (PRB) expense is presented under U.S. government Cost Accounting Standards (CAS) rather than the Financial Accounting Standards (FAS) used for Collins Aerospace and Pratt & Whitney. This CAS basis results in a different cost‑recognition pattern—pension expense is generally recognized more evenly over time and aligned with the pricing of Raytheon’s government contracts—so the reported operating profit for Raytheon is higher than it would be under FAS, while Collins and Pratt & Whitney reflect the more front‑loaded FAS expense pattern. Consequently, the segment’s profitability metrics and the overall consolidated earnings are affected by this timing difference in pension cost recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Raytheon uses U.S. government Cost Accounting Standards (CAS) for pension and PRB expense recognition, while Collins and Pratt & Whitney use Financial Accounting Standards (FAS). This distinction is central to the question and accurately conveyed. (2) There are no explicit numbers (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes that CAS leads to a different cost-recognition pattern (more even over time) versus the front-loaded FAS approach, and that this affects operating profit reporting—specifically, Raytheon’s profit is higher under CAS than it would be under FAS. This timing difference impacts segment profitability and consolidated earnings, which is consistent with the original answer’s emphasis on financial reporting impact. (4) The LLM adds value by explaining *how* CAS affects profit (more even recognition, higher reported profit), which is implied but not explicitly stated in the ground truth. However, it omits the point that Raytheon expects to recover these costs through government contract pricing—a key strategic implication present in the original answer. This is a minor omission, not a factual error, so the answer remains highly accurate but not fully complete. Hence, correctness and qualitative accuracy are marked down slightly to 9. Contextual relevance is perfect: the response directly addresses the comparative impact on financial reporting between segments.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 455,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How many separate Supplemental Indentures related to the 1.850% Notes due 2020 are documented across the provided excerpts, and which trustees were involved in these agreements?",
      "original_answer": "There are two Supplemental Indentures related to the 1.850% Notes due 2020 documented across the provided excerpts. The first was part of the Ninth Supplemental Indenture dated February 12, 2015, with U.S. Bank National Association as Trustee. The second was part of the Twelfth Supplemental Indenture dated February 6, 2017, with The Bank of New York Mellon Trust Company, N.A. as Trustee.",
      "llm_answer": "Based on the provided excerpts, **three separate Supplemental Indentures** are documented for the 1.850% Notes due 2020. These are identified as:  \n- **Fourth Supplemental Indenture** (dated February 12, 2015) for 1.850% Notes due 2020, filed under Exhibit 4.12 on page 106.  \n- **Ninth Supplemental Indenture** (dated February 12, 2015) for 1.850% Notes due 2020, filed under Exhibit 4.12 on page 105.  \n- **Twelfth Supplemental Indenture** (dated February 6, 2017) for 1.850% Notes due 2020, filed under Exhibit 4.15 on page 106.  \n\nThe trustees involved across these agreements were **The Bank of New York Mellon Trust Company, N.A.** (for the 2015 and 2017 indentures) and **U.S. Bank National Association** (for the 2015 indenture). The 2023 indentures (Exhibits 4.23–4.25) relate to different note series and are not relevant to the 1.850% Notes due 2020.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both the count and details of the Supplemental Indentures, despite correctly identifying some relevant documents. (1) QUANTITATIVE ACCURACY: The LLM claims three Supplemental Indentures, but the ground truth states only two. It incorrectly lists the Fourth Supplemental Indenture as related to the 1.850% Notes due 2020, which is not supported by the ground truth. The dates (February 12, 2015, and February 6, 2017) are correct, but the association of the Fourth Supplemental Indenture with this note series is erroneous. (2) COMPLETENESS: The question asks for the number of Supplemental Indentures and the involved trustees. The LLM addresses both parts but introduces incorrect information, undermining completeness. (3) ENTITY ACCURACY: The trustees are partially correct—U.S. Bank National Association is correctly linked to the Ninth Supplemental Indenture (2015), and The Bank of New York Mellon Trust Company, N.A. to the Twelfth (2017)—but the LLM incorrectly assigns The Bank of New York Mellon as trustee for both 2015 agreements, while the ground truth specifies U.S. Bank NA for the 2015 Ninth Supplemental Indenture. (4) REASONING: The multi-hop reasoning fails because the model conflates multiple indentures filed on similar dates and exhibits without correctly mapping which apply to the 1.850% Notes due 2020. The mention of 2023 indentures being irrelevant is correct and shows good filtering. (5) SEMANTIC EQUIVALENCE: The overall meaning does not match the ground truth due to the inflated count and incorrect trustee assignments. While some elements are accurate, the core facts are compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 455,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the net gain (or loss) recognized in income from foreign exchange forwards and options in fiscal year 2022, and how did this compare to the fair value of foreign exchange forwards and options assets as of May 31, 2021?",
      "original_answer": "The net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 was $40 million. As of May 31, 2021, the fair value of foreign exchange forwards and options assets was $92 million. This indicates that while Nike held a significant fair value in these instruments at the end of fiscal 2021, the net impact on income in the following year was a relatively smaller gain of $40 million.",
      "llm_answer": "The net gain (loss) recognized in income from foreign exchange forwards and options in fiscal 2022 was $40 million, which is the amount recorded in Other (income) expense, net for the year. This gain is modest compared with the fair‑value amounts of the forwards and options that were held as of May 31 2021, where the assets were recorded at $92 million (with $16 million classified as other long‑term assets) and the liabilities at $457 million (with $41 million classified as other long‑term liabilities).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net gain recognized in income from foreign exchange forwards and options in fiscal year 2022 as $40 million, matching the ground truth. It also accurately reports the fair value of foreign exchange forwards and options assets as of May 31, 2021, as $92 million. These core quantitative facts are correct. (2) All numbers are accurate: $40 million (income impact in FY2022), $92 million (asset fair value as of May 31, 2021), and additional breakdowns ($16 million in long-term assets, $457 million liabilities with $41 million long-term) are consistent with typical 10-K disclosures and do not contradict the ground truth, even though the original answer did not include liability amounts. These additions provide context but do not detract from accuracy. (3) The multi-hop reasoning is sound: the model connects the income statement impact in FY2022 with the balance sheet fair value from the prior year-end, and appropriately compares the $40 million gain to the $92 million asset value, noting the relative modesty of the gain. This aligns with the comparative intent of the question. (4) The only reason for not scoring a perfect 10 is that the original answer focused solely on the asset side ($92 million) and did not mention liabilities, so the inclusion of $457 million in liabilities, while factually plausible and contextually helpful, slightly exceeds the scope of the original answer’s focus. However, this does not make the response incorrect—just more detailed. Thus, the answer is quantitatively precise, contextually relevant, and qualitatively strong, warranting a 9 in correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 457,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does AIG's use of loss development methods in U.S. Personal Insurance and U.S. Property differ in terms of reserving approach and what impact did prior year developments have on each segment during 2021?",
      "original_answer": "In U.S. Personal Insurance, AIG uses loss development methods in combination with frequency/severity methods, particularly for domestic personal auto, where claim counts emerge quickly, allowing for immediate analysis of loss trends. In 2021, this segment experienced $412 million of favorable prior year development, mainly due to favorable development and subrogation recoveries from the 2017 and 2018 catastrophe years. In contrast, for U.S. Property, AIG uses loss development methods along with IBNR factor methods, especially for short-tail classes, and relies on expected loss ratio methods for the latest accident year. The U.S. Property segment does not have a specific 2021 prior year development figure mentioned in the provided text, but the reserving methodology reflects a need to adjust for loss trends including inflation. The difference in methodology reflects the distinct claim emergence patterns and severity profiles between the two segments.",
      "llm_answer": "During 2021, AIG recognized $412 million of favorable prior‑year development in U.S. Personal Insurance, driven largely by subrogation recoveries and favorable loss emergence from the 2017 and 2018 catastrophe years. In contrast, the company recorded $210 million of unfavorable prior‑year development in its UK/Europe Casualty and Financial Lines, reflecting large loss activity in UK financial‑PI and European commercial D&O. Thus, prior‑year developments had a net positive impact on the U.S. Personal segment but a net negative impact on the UK/Europe liability and financial lines.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $412 million favorable prior year development in U.S. Personal Insurance and its drivers (subrogation recoveries and favorable loss emergence from 2017–2018 catastrophes), which aligns with the ground truth. However, it completely fails to address the second part of the question regarding U.S. Property's reserving approach and its 2021 prior year development. Instead, it introduces unrelated information about $210 million unfavorable development in UK/Europe Casualty and Financial Lines, which is irrelevant to the question. (2) The $412 million figure is accurate and correctly attributed, but the $210 million figure, while possibly true in another context, does not pertain to U.S. Property or the comparison requested. There is no mention in the ground truth of a specific 2021 prior year development number for U.S. Property, but the LLM does not acknowledge this absence—it fabricates a comparison by inserting an unrelated segment. (3) The multi-hop reasoning fails because the model does not compare U.S. Personal Insurance and U.S. Property as required. It misidentifies the second entity (using UK/Europe instead of U.S. Property), breaking the synthesis across the correct segments. The reserving methodology differences—central to the question—are entirely omitted. (4) Due to significant omission of key information (reserving methods for both segments and U.S. Property’s development impact) and introduction of irrelevant data, the answer is mostly incorrect despite one accurate data point. Scores reflect partial quantitative accuracy but poor qualitative reasoning and low completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 454,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does Walmart's majority stake in Flipkart, acquired in 2018, expose Walmart to potential financial risks based on ongoing regulatory proceedings initiated by India's Directorate of Enforcement, and how does this relate to Walmart's broader international investment strategy as described in its 2023 10-K filing?",
      "original_answer": "Walmart's majority stake in Flipkart, acquired in 2018, exposes it to potential financial risks due to ongoing regulatory proceedings initiated by India's Directorate of Enforcement. These proceedings investigate alleged violations of India's Foreign Direct Investment (FDI) rules by Flipkart and its subsidiaries during 2009–2015, prior to Walmart's acquisition. If the regulatory authority determines that violations occurred, it could impose monetary penalties. Walmart is unable to predict the final outcome or scope of the proceedings, and while it does not currently believe the matter will have a material adverse effect, it cannot provide assurance. This situation highlights the risks inherent in Walmart's broader international investment strategy, which includes expanding through acquisitions such as Flipkart to strengthen its global retail ecosystem and omni-channel capabilities.",
      "llm_answer": "Walmart's 2018 acquisition of a majority stake in Flipkart exposes it to regulatory risk in India, where the Directorate of Enforcement has initiated proceedings over alleged Foreign Direct Investment rule violations dating back to 2009‑2015; although the Company believes the matter will not have a material adverse effect, it cannot guarantee the outcome or any potential penalties. This risk is highlighted in the 2023 10‑K (pages 30‑34) as part of its broader international investment strategy, which includes high‑growth markets such as India while acknowledging that foreign regulatory actions could affect financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Walmart acquired a majority stake in Flipkart in 2018; the Directorate of Enforcement in India initiated proceedings over alleged FDI rule violations from 2009–2015, prior to Walmart’s acquisition; the potential for penalties exists; Walmart does not believe the matter will have a material adverse effect but cannot guarantee the outcome. (2) Quantitative accuracy is perfect: dates (2018 acquisition, 2009–2015 period) are correct, and no numerical calculations are required. Format variations (e.g., '2009‑2015') are acceptable. (3) Multi-hop reasoning is sound: the answer correctly links Walmart’s ownership of Flipkart to regulatory risk arising from pre-acquisition conduct, and connects this to Walmart’s broader international investment strategy in high-growth markets like India, as disclosed in the 2023 10-K. The mention of pages 30–34 adds specificity and supports contextual grounding. (4) The only minor shortcoming is that the LLM does not explicitly state that the FDI violations occurred *before* Walmart’s acquisition, which slightly weakens the causal clarity, though the time reference (2009–2015) implies it. Otherwise, the answer is semantically equivalent, contextually relevant, and accurately reflects the risk disclosure and strategic rationale from the 10-K.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 384,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What was the total dollar value of Class A ordinary shares issued in the 2023 fiscal year, and how did this issuance impact the total Accenture plc shareholders' equity by August 31, 2024?",
      "original_answer": "The total dollar value of Class A ordinary shares issued in the 2023 fiscal year was $7,970. This issuance, along with other changes, contributed to an increase in total Accenture plc shareholders' equity from $25,692,839 (as of August 31, 2023) to $28,288,646 (as of August 31, 2024), an increase of $2,595,807.",
      "llm_answer": "The 2023 fiscal year saw the issuance of **Class A ordinary shares increase from 664,616,285 to 672,484,852**, adding **7,869,567 shares**.  At a par value of $0.0000225 per share, this represents a **dollar value of approximately $177 thousand** (7.87 million × $0.0225).  The additional equity raised is reflected in the shareholders’ equity section of the August 31 2024 balance sheet, raising total Accenture plc shareholders’ equity from **$25,692,839 million to $28,288,646 million** – an increase of roughly **$2.6 billion**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual and quantitative errors. The total dollar value of Class A ordinary shares issued in fiscal year 2023 is stated as $7,970 in the ground truth, but the LLM calculates approximately $177 thousand based on share count increase and par value. This is off by orders of magnitude and fundamentally incorrect. Additionally, the LLM incorrectly states the par value as $0.0000225 (or $0.0225, suggesting confusion in decimal places), which is not supported by the ground truth. (2) The calculation of the number of shares issued (672,484,852 - 664,616,285 = 7,869,567) is accurate, but the resulting dollar value is wrong due to incorrect application of par value. The equity increase from $25,692,839 to $28,288,646 (an increase of $2,595,807) is correctly reported in magnitude, though the LLM adds 'million' after the numbers (e.g., $25,692,839 million), turning billions into trillions — a critical error. $25,692,839 is already in thousands (standard in 10-Ks), so adding 'million' makes it off by a factor of 1,000. (3) The multi-hop reasoning is partially sound — the model attempts to link share issuance to equity changes and references the correct balance sheet dates. However, it fails to report the correct dollar value of shares issued and misrepresents the scale of equity figures. (4) The contextual relevance is high as the answer addresses both parts of the question and uses appropriate financial logic, but the quantitative inaccuracies severely undermine correctness. Due to major errors in key numbers and calculations, the correctness score is low despite some structural adequacy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 450,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does AIG's use of loss development methods for excess casualty lines, particularly those with attachment points above $10 million, influence its reserving methodology for U.S. Property and aerospace exposures, and what role do expected loss ratios play in both analyses?",
      "original_answer": "AIG uses a layered approach in its excess casualty reserving, where losses capped at $10 million are analyzed using traditional loss development and expected loss ratio methods, and this estimate is then used to derive the expected loss estimate for losses above $10 million, reflecting the expected relationships between the layers. In U.S. Property and aerospace exposures, AIG also employs a combination of loss development methods and expected loss ratio methods, especially for aviation claims where severity drives reserving. Expected loss ratios are critical in both cases, particularly for recent accident years where reported loss data is insufficient, and projections are adjusted for inflation, rate changes, and market conditions. This shows that AIG relies heavily on expected loss ratios to bridge early uncertainty across both excess casualty and aviation lines, while layer-specific development patterns guide the ultimate loss estimation process.",
      "llm_answer": "AIG applies loss development methods and expected loss ratio techniques to its excess casualty lines that attach above $10 million, using separate analyses for losses capped at $10 million and for losses exceeding that threshold. For the higher‑attachment layer it first models losses up to $10 million with traditional development and then extrapolates the expected loss estimate for amounts above $10 million, reflecting the attachment point and limit relationships. Expected loss ratios—derived from projected ultimate loss ratios adjusted for rate changes, inflation and market trends—are used especially for the three most recent accident years, while loss development methods are applied to older layers. This combined approach shapes the reserving methodology for U.S. Property and aerospace exposures, and the expected loss ratios serve as a key input for both the loss development and the ultimate reserve estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AIG uses a layered approach for excess casualty reserving with a $10 million attachment point, analyzes losses up to $10 million using traditional loss development and expected loss ratios, and extrapolates the estimate for losses above $10 million based on layer relationships. It correctly states that expected loss ratios are used for recent accident years (specifically the three most recent, which aligns with the idea of insufficient data in early years), and that these ratios are adjusted for inflation, rate changes, and market trends. The application of similar methods to U.S. Property and aerospace exposures—especially aviation—is accurately noted. (2) Quantitatively, the $10 million threshold is correctly cited, and no calculations are required beyond correct interpretation of layering, which is handled properly. Format variations (e.g., $10 million) are acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the lower-layer analysis informs the upper layer, and extends this methodology to other lines (U.S. Property and aerospace), recognizing the role of severity in aviation. (4) Minor deduction in qualitative accuracy due to slightly less clarity on how expected loss ratios are used *in combination* with development methods across both lines—ground truth emphasizes that both methods are used together, while LLM implies a temporal split (expected ratios for recent years, development for older). This is partially correct but slightly oversimplifies the concurrent use. Otherwise, the answer is contextually complete, precise, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 467,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "What was the total dollar value of Accenture plc Class A ordinary shares repurchased during the period covered by the financial statements ending August 31, 2022, and how does this compare to the remaining share purchase authorization as of August 31, 2024?",
      "original_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, was $4,111,266. As of August 31, 2024, the remaining share purchase authorization was $2,694,281. This indicates that a significant portion of the available authorization had already been utilized prior to 2024.",
      "llm_answer": "The total dollar value of Accenture plc Class A ordinary shares repurchased during the fiscal year ended August 31 2022 was **$4,509,392** (as shown on page 72).  As of August 31 2024, the remaining share‑purchase authorization was **$6,694,281**, which represents an increase of $4 million from the prior authorization.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both key numbers. The total dollar value of Accenture plc Class A ordinary shares repurchased during the period ending August 31, 2022, is stated as $4,509,392, whereas the ground truth is $4,111,266 — a material difference of over $398,000. The remaining share purchase authorization as of August 31, 2024, is reported by the LLM as $6,694,281, but the correct amount is $2,694,281 — an overstatement of $4 million. This directly contradicts the ground truth and invalidates the comparison. (2) The LLM incorrectly claims the authorization increased by $4 million, while the ground truth implies a reduction due to prior utilization. In reality, the remaining authorization decreased from prior periods, and the LLM’s assertion of an increase is factually wrong. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the repurchase activity by period and misrepresents the trajectory of the share buyback authorization. It does identify the correct company (Accenture plc) and correct share class (Class A ordinary shares), and references a plausible document page (72), suggesting some contextual understanding. (4) Despite correct entity and metric identification, the severe quantitative inaccuracies — especially in core financial figures and the resulting misleading comparison — result in a low correctness score. The answer is partially relevant and structured appropriately, but the numbers are not trustworthy, undermining the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 425,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How do changes in META's advertising policies to comply with regulatory developments in Europe impact both user engagement and advertising revenue, particularly in relation to the shift from 'legitimate interests' to 'consent' for behavioral advertising?",
      "original_answer": "META's shift from 'legitimate interests' to 'consent' for behavioral advertising in Europe has led to the introduction of a 'subscription for no ads' alternative and an option for users to see less personalized ads, which are less relevant and effective than premium ad offerings. This change has reduced META's ability to effectively target and measure ads, which has adversely affected advertising revenue. Additionally, the implementation of these advertising policies has contributed to reduced user engagement, particularly in features like Feed and Stories that monetize at higher rates, further impacting revenue. These policy changes were made to comply with European regulations, but they have had a material adverse effect on both user engagement and advertising revenue.",
      "llm_answer": "The shift from \"legitimate interests\" to \"consent\" for behavioral advertising in Europe, driven by GDPR and ePrivacy Directive compliance, has led to reduced user engagement with personalized ads and a decline in advertising revenue effectiveness. This is evidenced by Meta's introduction of a \"subscription for no ads\" option and a \"less personalized ads\" tier for EU users, which are expected to generate lower relevance and effectiveness compared to prior targeting methods, directly impacting ad revenue despite ongoing efforts to develop privacy-preserving alternatives like AI-driven solutions and industry-wide standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies the shift from 'legitimate interests' to 'consent' under European regulations (GDPR/ePrivacy), the introduction of the 'subscription for no ads' and 'less personalized ads' options, and the resulting reduction in ad relevance, effectiveness, and revenue. It also correctly links these changes to reduced user engagement with personalized advertising and mentions Meta's efforts to develop privacy-preserving alternatives like AI-driven solutions. All entities (Meta, EU, behavioral advertising, consent framework) are accurate, and there are no numerical inaccuracies (no specific numbers in the original, so none required). The reasoning is sound and reflects multi-hop synthesis between regulatory changes, policy responses, user behavior, and financial impact. The only minor shortcoming is that it does not explicitly mention the disproportionate impact on high-monetization features like Feed and Stories, which is present in the original answer—hence a 9 instead of 10 on qualitative accuracy. Otherwise, the answer is complete, contextually relevant, and correctly reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 334,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does the redemption policy of Accenture plc Class X ordinary shares directly affect the total number of shares outstanding and what specific mechanism ensures this relationship remains aligned with the number of Accenture Canada Holdings Inc. exchangeable shares?",
      "original_answer": "The redemption policy of Accenture plc Class X ordinary shares ensures that the number of Class X ordinary shares outstanding never exceeds the number of Accenture Canada Holdings Inc. exchangeable shares. This is achieved through a mechanism where Accenture plc redeems Class X ordinary shares upon the redemption or exchange of Accenture Canada Holdings Inc. exchangeable shares on a one-for-one basis, maintaining alignment between the two share classes.",
      "llm_answer": "The redemption of Accenture plc Class X ordinary shares is directly tied to the number of Accenture Canada Holdings Inc. exchangeable shares: each Class X share is redeemed only when a corresponding exchangeable share is redeemed or exchanged, ensuring that the total outstanding Class X shares never exceed the outstanding exchangeable shares. This mechanism maintains alignment between the two share classes by tying any redemption of Class X shares to the exchange activity of the related exchangeable shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately describes the redemption policy of Accenture plc Class X ordinary shares and its direct impact on the total number of shares outstanding, noting that Class X shares are redeemed on a one-for-one basis when Accenture Canada Holdings Inc. exchangeable shares are redeemed or exchanged. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, or counts), so quantitative accuracy pertains to logical alignment—correctly stating the one-for-one mechanism ensures proper quantitative correspondence. (3) The multi-hop reasoning is sound: the answer correctly links the redemption mechanism of two distinct but related entities (Accenture plc and Accenture Canada Holdings Inc.) and explains how their share counts remain aligned. (4) All entities—Accenture plc, Class X ordinary shares, and Accenture Canada Holdings Inc. exchangeable shares—are correctly identified and their relationship accurately described. The answer fully addresses both parts of the question: the effect on shares outstanding and the specific alignment mechanism. Wording differs slightly from the original but conveys the same meaning with high precision and clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 355,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What was the change in net milestone capitalization for Jardiance between 2020 and 2021, and how does this trend reflect the amortization practices described in the filing?",
      "original_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a $20.1 million decline. This decrease reflects the amortization of capitalized milestones over time, as described in the filing. These milestone payments were capitalized as intangible assets and are being amortized to cost of sales through their respective terms under the collaboration, based on factors such as the latest of the launch date, patent expiration, or supplementary protection certificates. The reduction from 2020 to 2021 illustrates the ongoing amortization of this intangible asset over its useful life.",
      "llm_answer": "The net milestone capitalization for Jardiance decreased from $156.2 million as of December 31 2020 to $136.1 million as of December 31 2021, reflecting a $20.1 million reduction in the deferred milestone balance. This decline aligns with the amortization practice described in the filing, where milestone payments are capitalized as intangible assets and then amortized to cost of sales over the collaboration term, resulting in a lower net capitalized balance as more of the milestones are amortized.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the net milestone capitalization values of $156.2 million in 2020 and $136.1 million in 2021 are correctly stated, and the $20.1 million decrease is accurately calculated. The dates (December 31, 2020 and 2021) are consistent with the filing context. (2) The answer addresses both parts of the question: it reports the change in net milestone capitalization and explains how this trend reflects the amortization practices. (3) Entity accuracy is correct—Jardiance is properly identified, and the financial metric 'net milestone capitalization' is used appropriately. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly links the decrease in capitalized milestones to the amortization policy described in the filing, explaining that these intangible assets are amortized to cost of sales over time based on collaboration terms. The LLM uses slightly different phrasing (e.g., 'deferred milestone balance') but maintains semantic equivalence and factual precision. No errors in logic, calculation, or interpretation are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 331,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does the use of IBNR factor methods in U.S. Property and UK/Europe Property insurance lines differ in terms of claim frequency and severity characteristics, and what impact does this have on the reserving process for each region?",
      "original_answer": "The IBNR factor methods are used in both U.S. Property and UK/Europe Property insurance lines, but the reserving process reflects differences in claim frequency and severity. In the UK/Europe Property segment, IBNR factor methods are applied due to low frequency/high severity losses, where IBNR factors are applied to earned premium to estimate ultimate expected losses based on prior accident quarters adjusted for current cost levels and historical emergence patterns. In the U.S. Property segment, similar IBNR factor methods are used, but the reserving process also accounts for a shift toward non-admitted coverages that have altered the customer profile to be less severe in the aggregate. This difference in severity and customer base influences how IBNR factors are continually reevaluated and applied in each region to ensure reserve adequacy.",
      "llm_answer": "The reserving processes for U.S. Property and UK/Europe Property differ primarily in the characteristics of the loss data used to select the appropriate method.  \n- In the U.S. Property line, losses are generally low‑frequency/high‑severity, so the company relies on IBNR factor methods that are applied to earned premium to estimate ultimate expected losses, and these factors are continually updated for emerging claim trends, inflation, and rate changes.  \n- In the UK/Europe Property line, losses are also low‑frequency/high‑severity but the company typically uses a combination of loss development methods and expected loss ratios, especially for aviation and other specialty lines, rather than IBNR factor methods.  \n\nBecause of these differing loss emergence patterns, the U.S. reserving approach leans more on IBNR factor adjustments, while the UK/Europe approach places greater weight on development and expected‑ratio techniques, leading to distinct reserve‑setting practices for each region.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the use of IBNR factor methods in the UK/Europe Property segment. The original answer states that IBNR factor methods *are* used in both U.S. and UK/Europe Property lines, with differences in how they are applied due to claim frequency and severity. However, the LLM incorrectly claims that in the UK/Europe, the company 'typically uses a combination of loss development methods and expected loss ratios... rather than IBNR factor methods,' which directly contradicts the ground truth. This is a major error in entity and method attribution. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify or miscalculate, hence a score of 10 is appropriate by default. (3) The multi-hop reasoning is partially sound in that the model attempts to compare reserving processes across regions and links them to claim characteristics. However, it fails the core synthesis: it reverses the factual basis by claiming IBNR methods are *not* used in UK/Europe when they are. The U.S. description is mostly accurate—low frequency/high severity, IBNR applied to earned premium, updated for trends—but the contrast with UK/Europe is incorrect. (4) Correctness is scored at 4 because while the U.S. portion is largely accurate and the answer addresses the question’s structure, the critical error about UK/Europe methodology undermines the comparative analysis. Qualitative accuracy is low due to this key factual reversal. Contextual relevance is moderate because the answer follows the right framework and discusses relevant concepts (IBNR, severity, reserving), even if the conclusions are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 471,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "What is the combined global market share of Procter & Gamble's Grooming segment for blades and razors, and how does this compare to their global market share in male electric shavers?",
      "original_answer": "Procter & Gamble holds more than 60% global market share in blades and razors and over 25% global market share in male electric shavers, resulting in a difference of more than 35 percentage points.",
      "llm_answer": "Procter & Gamble’s Grooming segment holds a **global market share of about 60 % in blades and razors**, and it commands **over 25 % of the global male electric‑shaver market**. This share is notably larger than its overall share in the broader grooming category, underscoring a dominant position in both traditional razor blades/razors and male electric shavers.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies Procter & Gamble's global market share in blades and razors as about 60% and over 25% in male electric shavers, matching the ground truth. These percentages are quantitatively accurate and properly reflect the data.\n\n2) Quantitative accuracy is perfect: both percentages align with the original answer. However, the question asks for the 'combined global market share' and how it compares—specifically implying a need to address the difference. While the LLM notes the two shares, it does not explicitly compute or mention the 'more than 35 percentage points' difference, which is a key part of the ground truth. This omission affects completeness and reasoning.\n\n3) The multi-hop reasoning is partially sound—the model retrieves correct market shares for P&G in two product categories. However, it fails to synthesize the comparison by calculating or stating the gap between the two shares, which is central to the question’s intent. Instead, it makes a vague qualitative statement about dominance without directly answering the comparative aspect.\n\n4) Contextual relevance is high—the response stays on topic, uses correct entities (Procter & Gamble, Grooming segment, blades/razors, male electric shavers), and provides accurate figures. The only shortcoming is the missing explicit comparison (difference of >35 pp), which reduces the qualitative and overall correctness slightly. Wording differences are acceptable under semantic equivalence, but missing the numerical comparison is a meaningful gap in multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 428,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did General Dynamics invest in Aerospace segment product development in 2023, and what mechanism do they use with suppliers to offset a portion of these costs?",
      "original_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023. They use cost-sharing arrangements with suppliers to offset a portion of these financial costs, where supplier contributions are explicitly for reimbursement of development costs and are recorded as a reduction of R&D expenses.",
      "llm_answer": "General Dynamics invested $510 million in Aerospace segment product development in 2023, and it offsets a portion of these costs through cost‑sharing arrangements with suppliers—receiving reimbursements for supplier‑covered development expenses, which are recorded as a reduction of R&D expense.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that General Dynamics invested $510 million in Aerospace segment product development in 2023, matching the ground truth exactly in amount and year. The mechanism—cost-sharing arrangements with suppliers—is accurately described, including the key detail that supplier contributions are treated as reimbursements for development costs and reduce R&D expenses. (2) The numeric value '$510 million' is correct and matches the ground truth; no calculations were required, but the figure is accurately reported. (3) The multi-hop reasoning is sound: the answer synthesizes information about both the financial investment and the cost-offset mechanism from the relevant SEC filing data, correctly linking the two concepts as required by the question. (4) The LLM answer is semantically equivalent to the original answer, with only minor rephrasing (e.g., 'recorded as a reduction of R&D expense' vs. 'recorded as a reduction of R&D expenses'). All entities—General Dynamics, Aerospace segment, 2023, suppliers, R&D—are correctly identified and contextually used. No factual, quantitative, or qualitative errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 330,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How much did Accenture spend on Class A Ordinary Share purchases during fiscal 2024, and how did this affect the total value of treasury shares held by the company?",
      "original_answer": "Accenture spent $4,111,266 on Class A Ordinary Share purchases during fiscal 2024, which increased the total value of treasury shares held by the company by the same amount.",
      "llm_answer": "During fiscal 2024 Accenture spent **$4.509 billion** on purchases of its Class A ordinary shares (as reported on page 72 and summarized on page 101). This share‑repurchase activity reduced the company’s treasury‑share balance by **$4.509 billion**, bringing the total value of treasury shares held at the end of the fiscal year to **$10.565 billion** (reflected in the “Additional Treasury Shares” and “Treasury Shares” columns on the consolidated equity statement).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both the amount spent and the effect on treasury shares. The ground truth states Accenture spent $4,111,266 on Class A Ordinary Share purchases in fiscal 2024, but the LLM claims $4.509 billion, which is over 1,000% higher. Additionally, the LLM incorrectly states that the repurchase activity reduced the treasury-share balance, when in fact share repurchases increase the value of treasury shares held (as shares are bought back and held). The ground truth explicitly states the purchase increased the total value of treasury shares by the same amount. (2) The numbers are not accurate: $4.509 billion ≠ $4,111,266 (a major discrepancy), and the mention of $10.565 billion in treasury shares is unsupported by the original answer, which does not provide an ending balance. (3) The multi-hop reasoning is flawed: the model misunderstands the accounting impact of share repurchases—purchasing shares increases treasury stock (a contra equity account), so the value should increase, not decrease. The LLM fails to correctly synthesize this financial concept. (4) The contextual relevance is moderate because it addresses share purchases and treasury shares in the correct fiscal year and company, but the core facts and logic are wrong, severely undermining correctness. Quantitative accuracy is very low due to the massive numerical error and incorrect directional impact. Qualitative accuracy is poor due to fundamental misunderstanding of financial mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 418,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the year-over-year dollar increase in the value of META's Servers and Network Assets from December 31, 2023, to December 31, 2024, and how does this relate to META's depreciation policy for assets placed in service?",
      "original_answer": "The value of META's Servers and Network Assets increased by $21.559 billion year-over-year, from $46.838 billion on December 31, 2023, to $68.397 billion on December 31, 2024. According to META's depreciation policy, assets placed in service are depreciated over their estimated useful life, while assets still in construction in progress (CIP) are not depreciated until they are placed in service. This significant increase in asset value suggests that a large amount of previously unplaced CIP assets were placed into service during 2024 and are now being depreciated prospectively over their revised estimated useful lives.",
      "llm_answer": "The year‑over‑year dollar increase in the value of META’s Servers and Network Assets is $21.56 billion, rising from $46.84 billion at December 31 2023 to $68.40 billion at December 31 2024. This growth aligns with META’s depreciation policy, which depreciates servers and network assets on a straight‑line basis over their estimated useful lives (four to five years, extending to 5.5 years effective January 2025), so the higher asset balances will be expensed over the longer useful‑life periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the year-over-year dollar increase in META's Servers and Network Assets as $21.56 billion, which rounds accurately from the ground truth value of $21.559 billion. The starting value is reported as $46.84 billion (vs. $46.838 billion) and ending value as $68.40 billion (vs. $68.397 billion), both of which are appropriately rounded and semantically equivalent. All numeric values are correct within acceptable rounding tolerance. (2) The quantitative accuracy is perfect—differences are due to rounding to three significant figures, which is standard and acceptable. The calculation of the increase ($68.40B - $46.84B = $21.56B) is accurate. (3) The reasoning is mostly sound and captures the core of META’s depreciation policy: assets are depreciated over their estimated useful lives once placed in service. The LLM adds specific detail about the useful life (4–5 years, extending to 5.5 years in 2025), which is consistent with known policy and enhances the answer. However, it omits the key point from the ground truth about construction-in-progress (CIP) assets not being depreciated until placed in service, and that the large increase likely reflects a significant amount of CIP assets being commissioned in 2024. This is a minor omission in qualitative reasoning but does not invalidate the logic. (4) The answer is contextually relevant, directly addressing both parts of the question—dollar increase and relation to depreciation policy. The synthesis is strong, though slightly less complete than the ground truth in explaining the implication of the asset increase on depreciation timing. Overall, the answer is factually correct, well-reasoned, and highly accurate, warranting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 479,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How many drug indications for which Eli Lilly received FDA Breakthrough Therapy designation in 2022 are currently in the submitted status versus discontinued development, and what are the specific compounds and therapeutic areas associated with each status?",
      "original_answer": "Eli Lilly had two drug indications with FDA Breakthrough Therapy designation in 2022 that were in the submitted status: Empagliflozin (Jardiance®) for heart failure with preserved ejection fraction and Baricitinib (Olumiant®) for alopecia areata. No indications with FDA Breakthrough Therapy designation were in the discontinued status in 2022.",
      "llm_answer": "Based on the provided document pages, Eli Lilly received FDA Breakthrough Therapy designation for **empagliflozin (Jardiance)** in the indication of **heart failure with preserved ejection fraction** in 2022. This indication is currently in **submitted status** (as noted in the \"Trends Affecting Pharmaceutical Pricing\" section on page 41 and confirmed in the pipeline table on page 39). The document does not indicate any discontinuation of development for this specific indication; however, it does list **baricitinib for systemic lupus erythematosus** as discontinued (page 39), but this is unrelated to Breakthrough Therapy-designated indications. No other Breakthrough Therapy-designated indications are explicitly tied to 2022 submissions or discontinuation status in the provided materials. Thus, the submitted status applies to empagliflozin for heart failure with preserved ejection fraction, with no discontinued Breakthrough Therapy indications noted for 2022 in the given sources.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies one of the two FDA Breakthrough Therapy-designated indications for Eli Lilly in 2022 that was in submitted status: empagliflozin (Jardiance) for heart failure with preserved ejection fraction. It accurately states that no Breakthrough Therapy-designated indications were discontinued in 2022, which aligns with the ground truth. However, it omits the second submitted indication—baricitinib (Olumiant) for alopecia areata—which is present in the original answer and should have been included based on the knowledge graph. This omission affects completeness and factual accuracy, particularly in multi-hop synthesis across compounds and indications. The reasoning is sound within the scope of the provided documents, and the model correctly avoids inferring discontinuation for baricitinib in alopecia areata, noting instead its discontinuation in systemic lupus erythematosus (a different indication). Quantitatively, all dates and statuses are accurate, and no incorrect numbers are presented. The contextual relevance is high, as the response directly addresses the question and uses appropriate evidence from the document. The failure to include both submitted indications, however, prevents a higher score on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 357,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does AIG's reliance on loss development methods differ between U.S. Other Casualty lines and U.S. Property lines, and what specific reserving adjustments were made in 2021 for U.S. Personal Insurance due to prior year catastrophe recoveries?",
      "original_answer": "AIG uses a combination of loss development methods, frequency/severity, and expected loss ratio methods for U.S. Other Casualty lines, particularly for long-tail general liability or products liability lines, while giving more weight to expected loss ratio methods for recent accident years due to the long-tail nature and less credible reported losses. In contrast, for U.S. Property lines, which are short-tail, AIG primarily uses frequency/severity methods, loss development methods, and IBNR factor methods, with IBNR factors applied to earned premiums for low frequency/high severity losses. In 2021, AIG recognized $412 million of favorable prior year development in U.S. Personal Insurance due to subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "llm_answer": "AIG applied loss development methods more heavily for its U.S. Other Casualty lines, which are long‑tail and subject to significant judicial and underwriting cycle trends, whereas for U.S. Property lines it relied more on frequency/severity and IBNR factor methods given the relatively shorter tail and higher severity of natural‑disaster losses. In 2021, U.S. Personal Insurance recorded $412 million of favorable prior‑year development, largely driven by subrogation recoveries from the 2017 and 2018 catastrophe years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AIG uses loss development methods more heavily for U.S. Other Casualty lines (long-tail) and relies more on frequency/severity and IBNR factor methods for U.S. Property lines (short-tail), which aligns with the ground truth. It accurately states the $412 million favorable prior year development in U.S. Personal Insurance in 2021 due to subrogation recoveries from 2017 and 2018 catastrophes. All key facts and numbers are correct. (2) Quantitative accuracy is perfect: $412 million, 2017, 2018, and 2021 are all correctly cited with no calculation errors. Format variation (412 million) is acceptable. (3) The multi-hop reasoning is sound—linking reserving methods to line-of-business characteristics (long-tail vs. short-tail) and connecting prior year development to specific recoveries across years. The only minor omission is that the original answer specifies AIG uses a 'combination' of methods for Casualty lines including expected loss ratio, especially for recent years, which the LLM answer does not explicitly mention, slightly reducing completeness in methodological nuance. (4) Despite this, the LLM captures the core contrast in methodology and fully addresses both parts of the question with high factual fidelity, excellent contextual relevance, and correct entity mapping (AIG, U.S. Personal Insurance, catastrophe years). Thus, correctness is 9/10—excellent but with slight loss in qualitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 408,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What proportion of Procter & Gamble's fiscal year 2024 net sales was contributed by the Baby, Feminine & Family Care segment, and approximately what portion of that can be attributed to the Charmin brand given its North American toilet paper market position?",
      "original_answer": "The Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's net sales in fiscal year 2024. Within this segment, Charmin holds approximately 25% North American market share in toilet paper, which is a key component of the family care business that is predominantly concentrated in North America.",
      "llm_answer": "The Baby, Feminine & Family Care segment contributed approximately 24% of Procter & Gamble's fiscal year 2024 net sales. Within this segment, the Charmin brand—holding a leading North American toilet paper market position with over 25% market share—represents a significant portion of the family care business, which is predominantly North American and accounts for the segment's share in that region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that the Baby, Feminine & Family Care segment contributed 24% of Procter & Gamble's fiscal year 2024 net sales, matching the ground truth. It also accurately reflects Charmin's approximately 25% North American market share in toilet paper, consistent with the ground truth's 'approximately 25%' figure. The phrasing 'over 25%' is slightly more assertive than 'approximately 25%', but remains within reasonable variation and does not materially misrepresent the data. (2) All numeric values—24% segment contribution and ~25% market share—are factually correct and properly attributed. No calculations were required, and the figures align with the original answer. (3) The multi-hop reasoning is sound: the model correctly links Charmin’s market position to the Family Care subcategory within the segment and acknowledges its North American concentration, which supports the inference about its contribution. However, the LLM stops short of explicitly stating that toilet paper is a 'key component' of family care (as in the ground truth), slightly weakening the causal chain. (4) The answer is contextually complete and highly relevant, addressing both parts of the question—segment contribution and Charmin’s role—with accurate synthesis across entities and regions. The minor wording difference in market share precision prevents a perfect 10, but overall accuracy and reasoning are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 397,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "Given General Dynamics' $510 million R&D investment in 2023, how does the Combat Systems segment leverage this spending to support the development and modernization of platforms like the M1E3 Abrams tank, and what financial or strategic outcomes are tied to this investment?",
      "original_answer": "General Dynamics' Combat Systems segment leverages its $510 million R&D investment in 2023 to modernize existing platforms and develop next-generation capabilities, such as the M1E3 Abrams main battle tank. This investment supports the development of advanced systems architecture, improved communications, power generation, fuel efficiency, optics, and armor for the Abrams fleet. The M1E3 Abrams program is an engineering change that incorporates significant capability improvements to counter future threats, including quicker technology upgrades, reduced sustainment footprint, and increased tactical mobility. These R&D-driven enhancements aim to maintain General Dynamics' market-leading position in land combat systems and ensure long-term value creation through innovation, affordability, and speed-to-market. The financial outcome of this investment is reflected in the company’s ability to secure long-term contracts, support modernization programs, and drive sustained revenue from both U.S. and international defense customers.",
      "llm_answer": "General Dynamics' $510 million R&D outlay is concentrated in its Combat Systems segment, which uses the funds to modernize key platforms such as the Abrams tank (specifically the new M1E3 upgrade) and to advance next‑generation capabilities like the Stryker SEPv3, M10 Booker, and autonomous vehicle programs (e.g., MUTT and TRX). This spending is tied to long‑term contracts and backlog growth that drive revenue, while the resulting technology upgrades enhance lethality, survivability and export sales, supporting the segment’s market‑leading position and generating sustained earnings and cash‑flow benefits.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $510 million R&D investment by General Dynamics in 2023 and accurately attributes it to the Combat Systems segment, which aligns with the ground truth. The mention of the M1E3 Abrams tank as a key modernization effort is correct and directly responsive to the question. (2) Quantitatively, the $510 million figure is accurate and properly contextualized; no calculations are required, so numerical precision is fully maintained. (3) The LLM extends beyond the ground truth by referencing additional platforms (Stryker SEPv3, M10 Booker, MUTT, TRX), which, while plausible and consistent with General Dynamics' portfolio, are not mentioned in the original answer and may represent overreach or unsupported inference. However, the core multi-hop reasoning—linking R&D spending to platform modernization, strategic positioning, and financial outcomes like long-term contracts, revenue, and earnings—is sound and well-synthesized. (4) The strategic outcomes (market leadership, export sales, sustained earnings) are semantically equivalent to the original answer’s emphasis on long-term contracts, innovation, and value creation. The only minor gap is the absence of specific technical improvements listed in the ground truth (e.g., power generation, fuel efficiency, optics, armor), which slightly reduces completeness. Overall, the answer is factually strong, contextually relevant, and mostly complete, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 411,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "What was the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs?",
      "original_answer": "The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024 was $609.1 million. This includes $605 million from purchases under the publicly announced open-market share purchase program and $4.1 million from purchases unrelated to publicly announced programs.",
      "llm_answer": "Based on the provided SEC 10-K filing pages, the total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024—combining both purchases under the publicly announced open-market share purchase program and those unrelated to such programs—was **$605 million** for shares acquired under the program plus **$45 million** for unrelated transactions (e.g., employee share withholding), resulting in a **total of $650 million**. This is explicitly stated in the \"Purchases of Accenture plc Class A Ordinary Shares\" table on page 39, where the \"Total (4)\" row shows 2,072,563 shares purchased at an average price of $303.05, with $605 million allocated to the publicly announced program and $45 million attributed to unrelated transactions (as noted in footnote 4). The document confirms that the $605 million represents the aggregate price paid under the open-market program, while the unrelated purchases (e.g., for employee tax obligations) totaled $45 million, leading to the combined $650 million total value. \n\n**Answer:** The total dollar value of Class A Ordinary Shares purchased by Accenture during fiscal 2024, combining both program and unrelated purchases, was **$650 million**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key dollar amounts. The ground truth states that Accenture spent $605 million under the share purchase program and $4.1 million on unrelated purchases, totaling $609.1 million. However, the LLM incorrectly reports $45 million for unrelated purchases and a total of $650 million, which is a substantial overstatement. This error directly contradicts the ground truth and renders the answer factually incorrect. (2) The quantitative inaccuracies are critical: the unrelated purchases are off by over $40 million ($45M vs $4.1M), and the total is $650M vs the correct $609.1M. Even if the source document were misread, the calculation based on the LLM's own numbers (2,072,563 shares × $303.05 average price) equals approximately $628 million, not $650 million, indicating internal inconsistency. (3) The reasoning is partially sound in structure—attempting to combine program and non-program purchases—but fails in execution due to incorrect data extraction. The reference to 'footnote 4' and employee withholding suggests awareness of multi-hop elements, but the synthesis is based on erroneous figures. (4) Contextual relevance is high as the answer addresses the right question, cites the correct table and page, and attempts to break down components. However, due to major numerical errors, the correctness and quantitative accuracy scores are very low. Minor wording differences would be acceptable, but these are material factual and calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 420,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does AT&T's 2021 payment to Crown Castle under their sublease arrangement compare to the initial cash proceeds received from Crown Castle in the 2013 tower transaction?",
      "original_answer": "AT&T made $253 in payments to Crown Castle in 2021 under the sublease arrangement, while the initial cash proceeds received from Crown Castle in the 2013 tower transaction were $4,827. This indicates that the 2021 payment represents a small fraction of the original transaction value.",
      "llm_answer": "AT&T’s 2021 cash payment to Crown Castle under the tower sub‑lease arrangement was $253, which is far smaller than the $4,827 of cash proceeds AT&T originally received from Crown Castle in the 2013 tower transaction.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: $253 for the 2021 payment and $4,827 for the 2013 initial proceeds, with correct formatting (e.g., $253 and $4,827). (2) The answer addresses both parts of the question: the 2021 payment and the 2013 cash proceeds. (3) Entities are correctly identified—AT&T and Crown Castle—and the years (2021 and 2013) and financial arrangements (sublease payment vs. initial transaction proceeds) are accurate. (4) The reasoning is sound: the LLM correctly contrasts the two amounts, implicitly highlighting that the 2021 payment is a small fraction of the original 2013 proceeds, which aligns with the ground truth's conclusion. The semantic meaning is equivalent, even if slightly more concise. No errors in multi-hop synthesis across time, entities, and financial events.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 258,
        "total_tokens": 1389
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does General Motors' valuation methodology for Stellantis warrants and their sensitivity to equity price risk inform the potential financial impact of a 10% adverse change in Stellantis stock price on GM's equity investments in 2021?",
      "original_answer": "General Motors estimates the fair value of its Stellantis warrants using the Black-Scholes formula, which incorporates inputs such as the Stellantis stock price and estimated dividend yield. At the end of 2021, GM's investment in Stellantis warrants had a fair value of $1.5 billion. GM also assessed that a 10% adverse change in quoted security prices for Stellantis would have had an insignificant effect on its financial statements. This suggests that even though the valuation methodology is sensitive to stock price changes, the overall financial impact of a 10% adverse movement in Stellantis stock would not have been material to GM’s equity investments in 2021.",
      "llm_answer": "General Motors assesses its equity price risk from Stellantis warrants using a Black‑Scholes model and estimates that a 10% adverse move in Stellantis’ stock price would have an “insignificant” effect on the fair value of those warrants at December 31 2021. Because the warrants represent only a small portion of GM’s overall equity‑price exposure, such a shift would not materially alter the valuation of GM’s equity investments in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the use of the Black-Scholes model, the 10% adverse change in Stellantis stock price, and the characterization of the impact as 'insignificant' are all consistent with the original answer. The fair value of $1.5 billion is not explicitly mentioned in the LLM response, which is a minor omission, but this does not distort the overall conclusion. (2) The reasoning is sound: the LLM correctly identifies the valuation methodology and links it to equity price sensitivity, then concludes that the financial impact would not be material—matching the original answer’s logic. (3) The multi-hop synthesis is appropriate: it connects GM’s valuation method (Black-Scholes), the sensitivity to Stellantis stock price, and the materiality assessment in the context of GM’s broader equity investments. (4) The answer is contextually relevant and directly addresses the question about the potential financial impact of a 10% adverse price move. The only reason for not scoring a 10 is the omission of the $1.5 billion fair value figure, which was present in the ground truth and adds contextual weight to the 'insignificant effect' claim. However, since the core conclusion and all qualitative and directional assessments are correct, the answer remains highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 381,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What percentage of P&G's total global market share in the Baby, Feminine & Family Care segment is attributed to the adult incontinence sub-category, specifically through the Always Discreet brand?",
      "original_answer": "The adult incontinence sub-category, represented by the Always Discreet brand, contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment. This is derived from the stated 20% global market share of the overall Baby, Feminine & Family Care segment, where Always Discreet holds a 15% market share within its specific sub-category of adult incontinence.",
      "llm_answer": "Based on the provided document pages, specifically page 18 which details the Baby, Feminine & Family Care segment, the Always Discreet brand is identified as competing in the adult incontinence sub-category. The document states: \"We also compete in the adult incontinence sub-category behind Always Discreet, with about 15% market share in the markets in which we compete.\" This indicates that Always Discreet holds approximately 15% market share in the adult incontinence category within the Baby, Feminine & Family Care segment. However, the document does not provide the total market share percentage for the entire Baby, Feminine & Family Care segment or the specific percentage of the segment's total market share that the adult incontinence sub-category (via Always Discreet) represents. Therefore, the exact percentage of P&G's total global market share in the Baby, Feminine & Family Care segment attributed to the adult incontinence sub-category through Always Discreet cannot be determined from the provided information. The document only gives the 15% market share for the adult incontinence sub-category within the markets where P&G competes, not the proportion of the segment's total market share.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly concludes that the required percentage cannot be determined from the information provided, which contradicts the ground truth. The original answer states that Always Discreet contributes approximately 15% to P&G's total global market share in the Baby, Feminine & Family Care segment, derived from its 15% market share in the adult incontinence sub-category and the segment’s overall 20% market share. However, the LLM misinterprets the 15% figure as being only within the adult incontinence markets where P&G competes, rather than recognizing it as the contribution to the total segment market share as per the ground truth. (2) Quantitatively, the 15% figure is correctly cited, but the model fails to report the final derived percentage (15%) of the total segment attributed to adult incontinence via Always Discreet, instead claiming insufficient data. There are no calculation errors per se, but the synthesis is incorrect. (3) The multi-hop reasoning is flawed: the model had access to the key data points (Always Discreet in adult incontinence, 15% share) but failed to connect it to the broader segment share as specified in the ground truth. It incorrectly treats the 15% as a standalone sub-category share without linking it to the total segment as required. (4) Contextual relevance is moderate because the response discusses the correct brand, segment, and sub-category, and cites the right document location, but ultimately fails to provide the correct synthesized answer, leading to a low correctness score despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 437,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "What was the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024, based on the total cash outlay and the number of shares acquired through both the publicly announced open-market share purchase program and transactions unrelated to publicly announced share plans?",
      "original_answer": "The average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was approximately $299.48.",
      "llm_answer": "Based on the provided information, the average price paid per Accenture plc Class A ordinary share during the fourth quarter of fiscal 2024 was **$303.05**. This figure is derived from the total cash outlay of $605 million for 2,000,308 shares purchased under the publicly announced open-market program, plus an additional $18.7 million spent on 72,255 shares acquired in transactions unrelated to publicly announced plans (primarily for employee share withholding), resulting in a total of 2,072,563 shares purchased at an aggregate average price of $303.05 per share.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its final average price of $303.05, while the ground truth is $299.48. This is a significant quantitative error. (2) The LLM provides specific figures: $605 million for 2,000,308 shares and $18.7 million for 72,255 shares. Calculating the total cash outlay: $605M + $18.7M = $623.7M. Total shares: 2,000,308 + 72,255 = 2,072,563. The correct average price is $623,700,000 / 2,072,563 ≈ $300.93, which still does not match either the LLM's $303.05 or the ground truth $299.48. However, the ground truth implies different underlying numbers not reflected here. More critically, the LLM's calculation does not align with the verified data, indicating incorrect source data or miscalculation. (3) The reasoning structure is sound—combining shares and cash from both programs to compute a weighted average price—but it fails in execution due to incorrect input data or arithmetic. The multi-hop synthesis (aggregating two types of purchases) is conceptually correct. (4) Despite correct framing and relevance, the answer is severely penalized for factual inaccuracy in numbers and calculations. The average price is off by over $3.50 per share, which is material. Thus, correctness and quantitative accuracy scores are very low, while contextual relevance remains high due to proper structure and entity alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 380,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the difference in net milestones capitalized for Jardiance between 2020 and 2021, and how does this compare to the collaboration revenue reported for Jardiance in 2021?",
      "original_answer": "The net milestones capitalized for Jardiance decreased by $20.1 million from 2020 ($156.2 million) to 2021 ($136.1 million). This $136.1 million in 2021 net milestones capitalized for Jardiance was part of the broader collaboration and other revenue, which totaled $175.0 million for the year ended December 31, 2021.",
      "llm_answer": "The net milestones capitalized for Jardiance were $136.1 million as of December 31, 2021, compared with $156.2 million as of December 31, 2020—a decrease of $20.1 million. In 2021, collaboration revenue that included Jardiance (and Trajenta) was reported at $1,490.8 million, which encompasses both product sales and royalty/profit‑share components.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the year-over-year decrease of $20.1 million. These quantitative elements are factually correct and match the ground truth. However, the LLM introduces a major error in the second part of the answer by stating that the 2021 collaboration revenue 'that included Jardiance (and Trajenta)' was $1,490.8 million. This figure does not align with the ground truth, which specifies that the broader collaboration and other revenue for Jardiance specifically was $175.0 million in 2021. The $1,490.8 million figure appears to be either from a different context or a misattribution (possibly total Eli Lilly diabetes collaboration revenue or including other products). (2) Number verification: $156.2M (2020) and $136.1M (2021) are correct; difference of $20.1M is accurate. But $1,490.8M vs. $175.0M is a significant factual discrepancy. (3) Multi-hop reasoning: The model correctly retrieves and compares milestone data across years (first hop), but fails in the second hop by incorrectly linking Jardiance collaboration revenue. It conflates Jardiance-specific revenue with a broader revenue figure, possibly from a different product or consolidated segment. (4) Correctness score is 5 due to partial accuracy: core milestone data is correct, but the collaboration revenue comparison is fundamentally wrong, undermining the answer's validity. Quantitative accuracy is 6 because most numbers are right but one key figure is incorrect. Qualitative accuracy is 5 due to flawed entity linkage and reasoning. Contextual relevance is 7 because the answer addresses the right topic and structure but with incorrect data in a critical part.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 487,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How much in gains did GM record from its Stellantis warrants in 2021, and what ongoing business relationship with Stellantis affects GM's post-sale operations?",
      "original_answer": "General Motors recorded $316 million in gains from its Stellantis warrants in 2021. Additionally, GM continues to have an operational relationship with Stellantis, involving the purchase and supply of certain vehicles, parts, and engineering services following the sale of the Opel/Vauxhall Business.",
      "llm_answer": "GM recorded a $316 million gain from the fair‑value change of its Stellantis warrants in 2021, and the ongoing business relationship with Stellantis—specifically the supply of vehicles, parts and engineering services under a post‑sale indemnity and guarantee arrangement—continues to affect GM’s post‑sale operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the $316 million gain from Stellantis warrants in 2021, matching the ground truth exactly in amount and year. This satisfies the quantitative requirement with full accuracy. 2) The ongoing business relationship is accurately described as involving the supply of vehicles, parts, and engineering services, which aligns with the original answer. However, the LLM adds specificity by referencing a 'post-sale indemnity and guarantee arrangement,' which is not present in the ground truth. While this detail may be factually accurate, it introduces information not confirmed in the original knowledge base, slightly reducing qualitative accuracy. 3) The multi-hop reasoning is sound: the model connects GM's financial gain from warrants to the continued operational relationship post-Opel/Vauxhall sale, correctly synthesizing financial and operational impacts. 4) The answer is contextually relevant, directly addressing both parts of the question with semantically equivalent and factually correct information. The minor addition of contractual details does not detract significantly from correctness, hence a score of 9/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 327,
        "total_tokens": 1484
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What was the pre-tax loss recognized by AIG from the deconsolidation of AIG Financial Products Corp. (AIGFP), and how does this reflect the financial impact of AIGFP's Chapter 11 reorganization on AIG's consolidated financial statements?",
      "original_answer": "AIG recognized a pre-tax loss of $114 million from the deconsolidation of AIG Financial Products Corp. (AIGFP) as a result of its Chapter 11 reorganization filing on December 14, 2022. This loss was reported in the line item 'Net gain (loss) on divestitures and other' in AIG’s consolidated financial statements. Despite the deconsolidation of AIGFP and the reclassification of its $37.6 billion loan receivable to a third-party asset with a full allowance for credit losses, AIG stated that the reorganization would not have a material impact on its consolidated balance sheets or respective businesses. Therefore, while the $114 million loss reflects a direct financial consequence of the reorganization, AIG assessed that the broader financial position of the company remained largely unaffected.",
      "llm_answer": "The pre-tax loss recognized from the deconsolidation of AIGFP was $114 million, reported in \"Net gain (loss) on divestitures and other\" on page 203. This loss reflects the financial impact of AIGFP's Chapter 11 reorganization, as the subsidiary and its consolidated subsidiaries were deconsolidated from AIG's results, resulting in the write-off of the $37.6 billion AIGFP loan receivable (reclassified to a third-party asset with a full allowance for credit losses) and the recognition of the $114 million loss. The deconsolidation also led to the reclassification of AIGFP as an unconsolidated variable interest entity, though it did not materially affect AIG's consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the pre-tax loss of $114 million from the deconsolidation of AIGFP and accurately references the reporting line item 'Net gain (loss) on divestitures and other'. It also correctly notes the $37.6 billion loan receivable being reclassified with a full allowance for credit losses. All key facts from the ground truth are present and factually accurate. (2) Quantitative accuracy is perfect: the $114 million loss and $37.6 billion loan receivable are correctly stated, with no calculation errors. Date (December 14, 2022) is implied via context and not required in the LLM answer for correctness. (3) The multi-hop reasoning is sound—LLM correctly links AIGFP's Chapter 11 filing to deconsolidation, which triggered the loss recognition and reclassification of assets. It also correctly notes the lack of material impact on AIG’s consolidated balance sheet, aligning with the ground truth assessment. The only minor omission is not explicitly stating that AIG *assessed* the impact as immaterial (though 'did not materially affect' conveys the same meaning), and the page number citation (203) is extraneous but not incorrect. (4) Scores reflect near-perfect factual alignment, with full quantitative accuracy and high qualitative accuracy due to correct synthesis across entities and events. Contextual relevance is complete as all parts of the question are addressed directly and appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 400,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "What is the total net value of Acquired Franchise Rights in 2024, and how does this compare to the reported gross value of the same asset category in the prior year?",
      "original_answer": "The total net value of Acquired Franchise Rights in 2024 is $598 million. This net value is derived from the gross value of $821 million in 2024 after subtracting accumulated amortization of $223 million. In 2023, the gross value of Acquired Franchise Rights was $840 million. Therefore, the gross value of Acquired Franchise Rights decreased by $19 million from 2023 to 2024.",
      "llm_answer": "The total net value of Acquired Franchise Rights as of December 28, 2024 is $598 million, which is lower than the prior‑year net amount of $626 million. Consequently, the net value decreased by $28 million from 2023 to 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2024 net value of Acquired Franchise Rights as $598 million, which matches the ground truth. However, it introduces a prior-year net value of $626 million in 2023, which is not present in the original answer and cannot be verified from the provided ground truth. The ground truth states the 2023 gross value was $840 million and that the 2024 gross value was $821 million (a $19 million decrease), but does not provide the 2023 net value. Thus, the $626 million figure and the $28 million decrease in net value are unsupported and likely incorrect. (2) The only verified correct number is the $598 million net value in 2024. The $28 million decrease is not corroborated by the ground truth, which focuses on a $19 million decrease in gross value, not net. The LLM confuses net and gross comparisons. (3) The reasoning is flawed because it fails to address the second part of the question—comparing the 2024 net value to the prior year's *gross* value, as asked. Instead, it compares net to net, which is not what the question required. The multi-hop synthesis is incomplete: it should have retrieved 2023 gross value ($840 million) and compared it to 2024 net value ($598 million), but instead compares net values incorrectly. (4) The contextual relevance is high because the answer discusses the right asset and time period, but correctness and quantitative accuracy are compromised by unsupported numbers and incorrect metric mixing (net vs. gross).",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 413,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial commitment made by AT&T for the C-Band licenses, including both the auction payment and the estimated future costs for spectrum clearing and relocation, as disclosed in the 10-K filing?",
      "original_answer": "AT&T's total financial commitment for the C-Band licenses was $26,478, which includes $23,406 for the auction payment, $2,112 for future spectrum clearing costs, and $1,000 for compensable relocation costs.",
      "llm_answer": "Based on the 10-K disclosures in the provided pages, AT&T's total financial commitment for the C-Band licenses includes both the auction payment and the estimated future costs for spectrum clearing and relocation. Specifically, the company paid $23,406 for C-Band licenses in Auction 107 (including $550 upfront deposit and $22,856 in cash payments in Q1 2021), and is responsible for approximately $2,112 in additional clearing costs for Phase II spectrum (expected by end of 2023) plus about $1,000 in compensable relocation costs over the next several years (with $650 paid in Q4 2021). This totals a financial commitment of $23,406 (auction payment) plus approximately $3,112 in future clearing and relocation costs, as disclosed in the \"Spectrum Auction\" section on page 54 and the \"Cash Used in or Provided by Investing Activities\" discussion on page 52.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the auction payment of $23,406 and the two future cost components: $2,112 for spectrum clearing and $1,000 for relocation, which match the ground truth. However, it incorrectly calculates the total financial commitment as $23,406 + $3,112 = $26,518, while the correct total is $26,478. This $40 error is significant and stems from incorrect addition despite correct component values. (2) Number verification: $23,406 (auction) + $2,112 (clearing) + $1,000 (relocation) = $26,518 in the LLM answer, but the original answer states $26,478. The component numbers are accurate, but the sum is off by $40, indicating a calculation error. (3) Multi-hop reasoning is sound—the model correctly synthesizes information from different parts of the 10-K (e.g., auction payment, future clearing, and relocation costs) and attributes them appropriately. It even adds contextual details like timing and payments made in Q4 2021, which are consistent with disclosures. (4) The correctness score is 6 due to the incorrect total despite correct components; quantitative accuracy is penalized (5) for the arithmetic error; qualitative accuracy is 7 due to strong reasoning and entity identification; contextual relevance is 9 as the answer directly addresses the question with appropriate sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 371,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the change in net milestones capitalized for Jardiance between 2020 and 2021, and how does this reflect in the financial performance of Lilly's diabetes product portfolio?",
      "original_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million in 2020 to $136.1 million in 2021, representing a decline of $20.1 million. This reduction indicates a lower recognition of milestone-related revenue or a deferral of payments tied to Jardiance's performance metrics during this period. As Jardiance is a key diabetes product in Lilly's portfolio, this decline could signal a slowdown in the product's developmental or commercial milestone achievements, potentially affecting the overall financial performance of Lilly’s diabetes segment.",
      "llm_answer": "The net milestones capitalized for Jardiance decreased from $156.2 million at the end of 2020 to $136.1 million at the end of 2021, reflecting a $20.1 million reduction. This decline contributed to the overall increase in Lilly’s diabetes product revenue—Jardiance sales rose to $1.49 billion in 2021 (up from $1.15 billion in 2020)—showing that the lower capitalized milestone amount was offset by higher product sales and that the amortization of the remaining capitalized milestones is recorded as cost of sales, supporting the financial performance of Lilly’s diabetes portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net milestones capitalized for Jardiance in 2020 ($156.2 million) and 2021 ($136.1 million), and accurately calculates the $20.1 million decline, satisfying quantitative accuracy. However, the qualitative reasoning is flawed: the original answer states the decline in capitalized milestones may signal a slowdown in milestone achievements and could negatively affect financial performance, while the LLM claims this decline 'contributed to the overall increase in revenue' and 'supported financial performance,' which is inconsistent with typical accounting treatment—capitalized milestones are not revenue but assets, and their reduction does not directly boost revenue. (2) The sales figures for Jardiance ($1.49 billion in 2021 vs $1.15 billion in 2020) are factually correct but were not part of the original answer or question focus, and their inclusion introduces unsupported causal claims. (3) The multi-hop reasoning fails: while the model synthesizes milestone data and product sales, it misinterprets the financial impact—lower capitalized milestones do not contribute to higher revenue; instead, they may reflect fewer milestone events achieved, which the ground truth interprets as a potential negative signal. (4) Correctness is scored 5 due to accurate numbers but significant misinterpretation of financial cause-effect; quantitative accuracy is 10 as all numbers and calculations are correct; qualitative accuracy is 5 due to flawed logic and misrepresentation of accounting concepts; contextual relevance is 8 because the response addresses the question's components but adds speculative, unsupported analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 457,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants?",
      "original_answer": "General Motors recognized a total financial benefit of $1.0 billion in 2021 from its relationship with Stellantis, which included $0.8 billion in non-service pension income and $0.2 billion in gains related to Stellantis N.V. warrants.",
      "llm_answer": "Based on the provided financial documents, the total financial benefit recognized by General Motors in 2021 from its relationship with Stellantis, including both pension income and gains from Stellantis warrants, was $0.2 billion. This amount is explicitly stated in the \"Interest income and other non-operating income, net\" section on page 36, which notes that the increase was primarily due to \"an increase in gains related to Stellantis N.V. (Stellantis) warrants of $0.2 billion.\" The document does not reference any additional pension income specifically tied to Stellantis in the provided pages, making $0.2 billion the total recognized financial benefit from this relationship.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its final figure. The ground truth states that General Motors recognized a total financial benefit of $1.0 billion, composed of $0.8 billion in non-service pension income and $0.2 billion in gains from Stellantis warrants. The LLM only reports $0.2 billion, citing gains from warrants, and explicitly states that no additional pension income is referenced in the documents. However, the omission of the $0.8 billion pension income — a major component — makes the answer factually incomplete and misleading. (2) Quantitatively, the $0.2 billion figure for warrant gains matches the ground truth and is correctly cited, but the total benefit is off by $0.8 billion due to the missing pension income. This is a critical error in magnitude and composition. (3) The reasoning fails on multi-hop synthesis: the question requires combining two distinct financial benefits (pension income and warrant gains), but the model only identifies one and concludes the total based on partial data. It does not recognize or attempt to find the pension income component, indicating a failure in comprehensive document analysis or integration. (4) Contextual relevance is moderate because the answer addresses the correct companies (General Motors, Stellantis), time period (2021), and one relevant financial item (warrant gains), but it misses a core part of the financial relationship. The justification based on document limitations does not excuse the failure to report known ground truth data. Scores reflect major factual deficiency despite partial contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 443,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What was the impact of changes in Corebridge's stock price on AIG's financial statements for the period following the initial equity method investment, and how does this reflect AIG's ownership interest?",
      "original_answer": "The changes in Corebridge's stock price directly impacted AIG's financial statements by affecting the value of AIG's ownership interest in Corebridge and resulting in a gain on the sale of Corebridge shares. This is explicitly stated in the Consolidated Statements of Income under the fair value option, where the impact of changes in Corebridge's stock price is recognized. Additionally, AIG's equity method income from Corebridge, which includes changes in the stock price since the initial investment, contributes to AIG's overall financial position.",
      "llm_answer": "The impact of Corebridge's stock price changes after AIG's initial equity investment was reflected in AIG's financial statements through equity method accounting, where changes in the stock price were recognized in net investment income. Following the deconsolidation of Corebridge on June 9, 2024, AIG retained a 22.7% ownership stake and began measuring its interest at fair value using the stock price (classified as Level 1). Subsequent stock price movements directly affected the carrying value of AIG's retained interest, resulting in a $282 million gain recognized upon the sale of 120 million shares in December 2024. This equity method accounting demonstrated that AIG's ownership interest was now passive and measured at fair value, with gains and losses tied to Corebridge's market performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that changes in Corebridge's stock price impacted AIG's financial statements through fair value measurement and resulted in a gain on sale. It accurately notes the shift to fair value accounting post-deconsolidation and AIG's 22.7% ownership stake. However, the original answer emphasizes equity method income and recognition under the fair value option in the Consolidated Statements of Income, whereas the LLM conflates equity method accounting with fair value measurement. After deconsolidation, AIG's retained interest is measured at fair value, not under the equity method, so describing it as 'equity method accounting' is incorrect. (2) Quantitatively, the LLM introduces specific figures not in the ground truth: the $282 million gain and the sale of 120 million shares in December 2024. While plausible, these numbers are not present in the original answer and cannot be verified against the provided ground truth, reducing quantitative accuracy. The date June 9, 2024, for deconsolidation is also not in the original answer and appears to be an over-specific addition. (3) The multi-hop reasoning is partially sound—linking stock price changes to financial statement impact and ownership interest—but incorrectly frames the accounting method post-deconsolidation. The original answer focuses on the fair value option and equity method income including stock price changes since initial investment, while the LLM misattributes fair value gains to equity method accounting. (4) Despite the technical accounting error and unverified numbers, the LLM captures the core idea that stock price changes affect AIG's financials and reflect its ownership interest, earning high marks for contextual relevance and partial qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 487,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total net value of Other Identifiable Intangibles for PEP in 2024, and by how much did this value decrease from 2023 to 2024 according to the amortization data provided?",
      "original_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144. This value decreased by $30 from 2023 ($174) to 2024 ($144) due to amortization.",
      "llm_answer": "The total net value of Other Identifiable Intangibles for PEP in 2024 is $144 million, and it decreased by $30 million from 2023 to 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total net value of Other Identifiable Intangibles for PEP in 2024 as $144 million and the decrease from 2023 to 2024 as $30 million, which matches the ground truth. The original answer states $144 and $30 without specifying units, but the LLM appropriately adds 'million'—a standard and semantically equivalent interpretation in financial contexts. (2) Quantitatively, both values are accurate: $174 (2023) - $144 (2024) = $30 decrease, and the 2024 net value is correctly reported. Format variation ($144 vs $144 million) is acceptable per evaluation guidelines. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly inferred the change over time using amortization data across two years. (4) All entities—PEP, 'Other Identifiable Intangibles', and years 2023–2024—are accurate. The answer is complete, addressing both parts of the question. All scores are maximized due to full factual correctness, precise calculations, and appropriate contextual interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 303,
        "total_tokens": 1386
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "What is the total revenue generated from nuclear-powered submarines in 2023, and how does this compare to the revenue from surface ships, given the strategic importance of submarine programs like the Columbia-class and Virginia-class?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment generated $8,631 million in revenue from nuclear-powered submarines, compared to $2,698 million from surface ships. This results in a ratio of approximately 3.2:1 in favor of nuclear-powered submarine revenue over surface ship revenue. This significant revenue disparity reflects the strategic importance and high demand for submarine programs like the Columbia-class and Virginia-class, which are central to the U.S. Navy's long-term defense strategy and have received top acquisition priority and substantial investment.",
      "llm_answer": "The total revenue generated from nuclear-powered submarines in 2023 was $8,631 million, which exceeds the revenue from surface ships of $2,698 million. This highlights the strategic importance of submarine programs such as the Columbia‑class and Virginia‑class, which together account for the majority of the Marine Systems segment’s revenue and represent a significant portion of the company’s overall defense portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the revenue from nuclear-powered submarines ($8,631 million) and surface ships ($2,698 million) in 2023, matching the ground truth exactly. All numeric values are accurate and properly formatted. (2) Quantitative accuracy is perfect—both figures are correct, and although the LLM does not explicitly compute the 3.2:1 ratio, it correctly states that submarine revenue exceeds surface ship revenue, which is a valid qualitative comparison. The absence of the exact ratio calculation does not detract significantly from the correctness since the question asks 'how does this compare,' which can be satisfied by relative magnitude. (3) The reasoning is sound: the LLM correctly attributes the higher revenue to the strategic importance of the Columbia-class and Virginia-class programs, aligning with the ground truth's emphasis on their central role in U.S. Navy strategy. It also appropriately contextualizes these programs within the Marine Systems segment and defense portfolio, demonstrating correct multi-hop synthesis across financial data and strategic context. (4) The answer is contextually excellent—directly addressing both parts of the question (revenue figures and comparison) and linking them to strategic importance. The only minor omission is the lack of explicit ratio calculation (3.2:1), which slightly reduces qualitative accuracy but does not undermine the overall correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 434,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What was the change in the fair value of GM's investment in Stellantis warrants between December 31, 2020, and December 31, 2021, and how does this compare to the change in the fair value of marketable debt securities over the same period?",
      "original_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion (from $1.2 billion in 2020 to $1.5 billion in 2021). The fair value of marketable debt securities decreased by $0.4 billion (from $9.0 billion in 2020 to $8.6 billion in 2021). Therefore, the increase in equity investment was $0.3 billion, while the decrease in debt securities was $0.4 billion, showing contrasting trends in the valuation of these two asset classes.",
      "llm_answer": "The fair value of GM's investment in Stellantis warrants increased by $0.3 billion from $1.2 billion at December 31 2020 to $1.5 billion at December 31 2021. In contrast, the change in the fair value of marketable debt securities over the same period was not material and was considered insignificant.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in fair value of GM's investment in Stellantis warrants as $0.3 billion, rising from $1.2 billion in 2020 to $1.5 billion in 2021, which matches the ground truth. However, it incorrectly states that the change in fair value of marketable debt securities was 'not material' and 'insignificant,' which directly contradicts the ground truth: the fair value of marketable debt securities actually decreased by $0.4 billion (from $9.0 billion to $8.6 billion). This is a significant quantitative error in one of the two core components of the question. (2) The numbers for the Stellantis warrants are accurate and properly calculated. The marketable debt securities change is factually wrong—$0.4 billion is not immaterial, and the decrease is both numerically and contextually important. (3) The multi-hop reasoning fails because the model does not correctly synthesize the second part of the comparison. It identifies the correct entity (marketable debt securities) and time period, but misrepresents the financial change, undermining the comparative analysis between the two asset classes. (4) The correctness score is 5 due to partial accuracy: one major component correct, one major component incorrect. Quantitative accuracy is 8 because the Stellantis numbers are correct, but the debt securities value is entirely wrong. Qualitative accuracy is 5 due to flawed reasoning in the comparison and mischaracterization of materiality. Contextual relevance is 8 because the answer addresses both parts of the question and uses appropriate terminology, despite factual inaccuracy in one key area.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 450,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "What is the net decrease in the value of Acquired Franchise Rights for PEP from 2023 to 2024, and how does this reflect in the company's amortization expense over the same period?",
      "original_answer": "The net value of Acquired Franchise Rights for PEP decreased from $626 in 2023 to $598 in 2024, resulting in a $28 decrease. This decrease is partially attributable to the amortization expense of $74 in 2024, which contributes to the reduction in net value of the franchise rights.",
      "llm_answer": "The net decrease in the value of Acquired Franchise Rights for PepsiCo (PEP) from 2023 to 2024 was $22 million, declining from $840 million to $598 million. This reduction is reflected in the amortization expense, which increased slightly to $74 million in 2024 (up from $75 million in 2023) as recorded in the intangible‑assets table.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, the Acquired Franchise Rights value decreased from $626 in 2023 to $598 in 2024, a $28 decrease. However, the LLM states the value declined from $840 million to $598 million, resulting in a $242 million drop, which it incorrectly reports as $22 million—both the starting value and the difference are wrong. The amortization expense of $74 million in 2024 matches the ground truth, but the LLM incorrectly states it increased from $75 million in 2023 (implying a decrease, not increase), which contradicts its own claim of a 'slight increase'. (2) Quantitative accuracy is low: the initial value ($840M vs $626), the calculated decrease ($22M vs $28M), and the prior-year amortization ($75M not in ground truth) are all incorrect. Only the 2024 amortization expense ($74M) is accurate. (3) The reasoning partially captures the relationship between amortization and the decline in asset value, which shows some correct conceptual understanding. However, it fails to correctly synthesize the actual values from the data, undermining the multi-hop logic. The model attempts to link amortization expense to the change in franchise rights, but with incorrect inputs. (4) Contextual relevance is high—the answer addresses the right metric, company (PEP), years (2023–2024), and the conceptual link between amortization and asset value reduction. However, due to major numerical errors, the correctness and quantitative accuracy scores are low. The answer is on the right track but factually flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 441,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "By how much did the increase in service costs related to F-35 sustainment contracts at Aeronautics affect the overall service costs increase in 2023, and how does this compare to the corresponding increase in service sales for the same business unit and reason?",
      "original_answer": "The increase in service costs related to F-35 sustainment contracts at Aeronautics was approximately $570 million, which accounted for the majority of the overall $775 million (8%) increase in service costs in 2023. This corresponds to an increase in service sales of approximately $600 million at Aeronautics due to higher volume on F-35 sustainment contracts. Therefore, the cost increase was $30 million less than the sales increase, indicating a potential improvement in margin or profitability on these contracts.",
      "llm_answer": "The increase in service costs related to F‑35 sustainment contracts at Aeronautics added roughly $570 million to total service costs in 2023, which accounted for the bulk of the $775 million (8 %) rise in overall service costs. This contributed to the $788 million (7 %) increase in service sales for the same business unit and reason.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $570 million increase in service costs related to F-35 sustainment at Aeronautics and that it accounted for the majority of the $775 million (8%) overall service cost increase, which matches the ground truth. However, it incorrectly states that service sales increased by $788 million (7%), whereas the original answer specifies a $600 million increase in service sales. This is a significant quantitative error. (2) The correct sales increase is $600 million, not $788 million. Additionally, the ground truth includes a key comparative insight: the cost increase was $30 million less than the sales increase, implying improved margin. The LLM omits this analysis and instead introduces an incorrect figure. (3) The multi-hop reasoning is partially sound—linking F-35 sustainment costs to overall cost increases and attempting to connect to sales—but fails in accurately synthesizing the sales data and drawing the correct comparative conclusion. (4) The correctness score is 6 due to major error in sales figure but correct cost numbers and context; quantitative accuracy is low (5) due to wrong dollar amount and percentage; qualitative accuracy is 7 because reasoning structure is logical but based on incorrect data; contextual relevance is high (9) as the response stays focused on the right entities, time frame, and topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 383,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How much total share repurchase authority did Accenture plc have as of September 25, 2024, and how does this reflect the company's financial strategy regarding Class A Ordinary Shares?",
      "original_answer": "As of September 25, 2024, Accenture plc had a total outstanding share repurchase authority of $6,694 million. This reflects the company's ongoing financial strategy to actively manage its equity structure by repurchasing Class A Ordinary Shares, as demonstrated by the additional $4,000 million in authority approved by the Board of Directors, bringing the total from $2,694 million to $6,694 million. This strategy includes both open-market purchases and other share purchase programs.",
      "llm_answer": "As of September 25 2024, Accenture’s total share‑repurchase authority was $6.694 billion, following the Board’s approval of an additional $4 billion in authority that brought the outstanding authorization to that level. This expanded authority reflects the company’s ongoing strategy of returning capital to shareholders while maintaining flexibility to acquire Class A ordinary shares opportunistically, underscoring its confidence in generating strong cash flows and supporting long‑term value creation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the total share repurchase authority as $6.694 billion (equivalent to $6,694 million), matching the ground truth. It accurately references the additional $4 billion (i.e., $4,000 million) approved by the Board, which increased the prior $2,694 million to $6,694 million. All numeric values and dates (September 25, 2024) are correct, with acceptable format variation ($6.694 billion = $6,694 million).\n\n2) Quantitatively, all figures are accurate. The addition of $2,694 million + $4,000 million = $6,694 million is correct, and the LLM correctly reflects this as $6.694 billion. No calculation errors.\n\n3) The multi-hop reasoning is sound: the model correctly synthesizes that the current authority results from a prior level plus a new Board-approved increase. It correctly identifies the entity (Accenture plc), the share class (Class A Ordinary Shares), and the strategic context.\n\n4) The LLM slightly rephrases the strategic rationale, emphasizing 'returning capital to shareholders' and 'long-term value creation' rather than explicitly mentioning 'actively managing its equity structure' or 'open-market purchases and other programs' as in the original. However, the core strategic intent—opportunistic repurchases supported by strong cash flows—is semantically equivalent and contextually appropriate. The omission of 'open-market purchases' is a minor detail but does not detract from the overall accuracy.\n\nThus, the answer is factually correct, well-reasoned, and fully relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 451,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "Given Netflix's expansion into live programming and the fixed nature of its content costs, how might a failure to meet membership growth expectations directly impact its financial flexibility and profitability?",
      "original_answer": "Netflix's expansion into live programming introduces additional fixed content costs, which are largely non-adjustable regardless of membership growth rates. If Netflix fails to meet membership growth expectations, it may not be able to proportionally increase per-member revenue or adjust expenditures, thereby negatively impacting margins, liquidity, and overall profitability.",
      "llm_answer": "A shortfall in membership growth would directly pressure Netflix’s financial flexibility and profitability because its content costs are fixed; without the incremental revenue needed to offset those fixed expenses, margins would compress, limiting the company’s ability to invest in new programming, marketing, or strategic initiatives and potentially forcing cost-cutting measures to preserve cash flow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately identifies that Netflix's content costs are fixed and that failure to meet membership growth expectations would lead to margin compression due to lack of incremental revenue to offset those fixed costs. The answer correctly links this to reduced financial flexibility—specifically, constrained investment capacity and potential cost-cutting—impacting profitability. There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10. The qualitative reasoning is sound and reflects multi-hop logic: (1) live programming increases fixed costs, (2) membership growth is key to scaling revenue, (3) missing growth targets undermines margin expansion and liquidity. The only minor difference from the original answer is that the LLM does not explicitly mention 'liquidity' or 'per-member revenue,' but it captures the essence through 'margins,' 'invest,' and 'preserve cash flow.' Thus, it earns a 9 in qualitative accuracy and 9 overall for correctness due to slight omission of nuance. Contextual relevance is perfect—directly addresses the financial implications of membership shortfalls given fixed cost structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 353,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What is the total carrying value of the 5.15% 2041 Notes as a percentage of the total carrying value of all debt reported by AMGN in 2022, and how much principal of these notes was exchanged according to the debt exchange table?",
      "original_answer": "The total carrying value of the 5.15% 2041 Notes was $729 million, which represents approximately 2.19% of the total carrying value of all debt ($33,309 million) reported by AMGN in 2022. Additionally, $245 million in principal amount of these notes was exchanged.",
      "llm_answer": "The 5.15% 2041 Notes had a carrying value of $729 million, which represented roughly 2.2 % of AMGN’s total debt carrying value of $33,309 million in 2022. In the 2020 debt‑exchange, $245 million principal of the 5.15% 2041 Notes was tendered and exchanged for the new 2.77% 2053 Notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key quantitative aspects: the carrying value of the 5.15% 2041 Notes ($729 million), the total debt carrying value ($33,309 million), the percentage (2.19% rounded to 2.2% is acceptable), and the exchanged principal amount ($245 million) are all correct. The calculation of the percentage (729 / 33,309 ≈ 0.02188 or 2.188%) is correctly approximated as 2.2%, which is reasonable rounding. The answer also correctly identifies the exchange of the notes in a 2020 debt exchange, though the question did not ask for the year or the new notes issued, so this is extra but accurate context. The response addresses both parts of the question: the percentage of total debt and the principal exchanged. The only minor issue is the slight rounding of 2.19% to 2.2% without specifying 'approximately' in the same explicit way as the original, but the use of 'roughly' maintains semantic equivalence. Multi-hop reasoning is sound—synthesizing data on carrying values and debt exchange activity from different parts of the filings. All entities (AMGN, 5.15% 2041 Notes, debt exchange) are correctly identified and contextualized. The answer is fully relevant and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 344,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does McDonald's acquisition and subsequent sale of franchised restaurants impact its financial reporting of goodwill, specifically when sold within 24 months versus beyond 24 months from acquisition?",
      "original_answer": "When McDonald's acquires franchised restaurants, it records goodwill as the excess cost over the net tangible and identifiable intangible assets. If a Company-operated restaurant is sold within 24 months of acquisition, the goodwill associated with the acquisition is written off in its entirety. However, if a Company-operated restaurant is sold beyond 24 months from acquisition, the amount of goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This distinction directly affects how goodwill impacts financial reporting depending on the time of sale.",
      "llm_answer": "The Company's goodwill accounting policy states that if a Company‑operated restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off, whereas if the sale occurs beyond 24 months, the goodwill written off is based on the relative fair value of the business sold compared to the reporting unit. This is reflected in the goodwill activity table and related disclosures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It accurately describes McDonald's goodwill accounting policy regarding the sale of company-operated restaurants: full write-off of goodwill if sold within 24 months, and partial write-off based on relative fair value if sold after 24 months. (2) There are no numerical values requiring calculation, but the 24-month threshold is correctly stated and matches the original answer. (3) The reasoning correctly reflects the multi-hop synthesis of accounting policy and financial reporting impact, particularly how the timing of the sale affects goodwill treatment in financial statements. (4) All entities (e.g., 'Company-operated restaurant', 'goodwill', 'reporting unit') are accurately used, and the answer directly addresses the core question about financial reporting implications. Minor wording differences (e.g., 'the Company's goodwill accounting policy' vs. 'McDonald's') do not affect factual accuracy. The mention of 'goodwill activity table and related disclosures' adds contextual accuracy without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 315,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What was AIG's equity method income from Corebridge after the deconsolidation date in 2024, and how was this income calculated based on the post-deconsolidation period?",
      "original_answer": "AIG's equity method income from Corebridge after the deconsolidation date (June 9, 2024) was calculated as the sum of dividends received and changes in Corebridge's stock price from June 9, 2024, to December 31, 2024. This income reflects AIG's retained 48.4% ownership stake and the financial performance of Corebridge during the post-deconsolidation period.",
      "llm_answer": "AIG's equity method income from Corebridge after the deconsolidation date in 2024 was $601 million, representing the sum of dividends received and the increase in Corebridge's stock price recognized in net investment income. This income was calculated based on the fair‑value changes of AIG's retained equity interest in Corebridge from August 2024 through December 31 2024, as disclosed in the post‑deconsolidation equity method investment table.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states a specific dollar amount ($601 million) for AIG's equity method income, which is not present in the original answer (ground truth). There is no mention of this figure in the ground truth, nor is there any indication that the income was quantified numerically—instead, the original describes the *method* of calculation. This introduces a significant factual inaccuracy. Additionally, the LLM claims the income was calculated from 'August 2024 through December 31, 2024', whereas the ground truth specifies the period starting on 'June 9, 2024', the actual deconsolidation date. This incorrect start date undermines the accuracy of the time frame used for calculation. (2) The ground truth does not provide a dollar value for the income, so asserting $601 million is an unsupported addition. The format variation allowance does not apply because the number itself is not in the source. The calculation method described—dividends and stock price changes—is partially aligned, but the use of fair-value changes as the basis conflicts with the equity method, which typically involves recognizing earnings based on ownership percentage of net income, not just fair value gains. The LLM conflates fair-value accounting with equity method accounting. (3) The multi-hop reasoning is partially sound in that it identifies AIG’s retained interest in Corebridge and attempts to link post-deconsolidation income to market performance. However, it fails to accurately represent the equity method, which should reflect AIG's share of Corebridge’s earnings, not merely dividends and stock price appreciation. The reasoning mischaracterizes the accounting treatment. (4) The contextual relevance is moderate because the answer addresses the right entities (AIG, Corebridge), the general idea of post-deconsolidation income, and the retained stake. However, due to the incorrect dollar figure, wrong time period, and flawed accounting logic, the qualitative and quantitative accuracy scores are low. The correctness score is 4 due to partial credit for identifying the general components (dividends, stock price) and context, but major errors in facts and reasoning prevent a higher rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 591,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "Given that McDonald's heavily franchised business model relies on franchisee contributions to revenue and considers franchisees as a critical component of its business, by what percentage do franchisees contribute to McDonald's global workforce, and how does the company's recruitment initiative for diverse franchisees aim to influence this demographic composition?",
      "original_answer": "Franchisees contribute to over 93% of McDonald's global workforce, as over two million individuals work in franchised restaurants compared to over 150,000 company employees. McDonald's recruitment initiative for diverse franchisees aims to influence this demographic composition by reducing upfront equity requirements for eligible candidates and providing ongoing learning and development, specifically targeting underrepresented groups in both the U.S. and International Operated Markets to increase diversity among franchisees.",
      "llm_answer": "Franchisees contribute approximately 95% of McDonald's restaurants globally, which represents the vast majority of its workforce since nearly all employees work at franchised locations. To accelerate diversity in its franchisee base, McDonald's has launched a recruitment initiative that reduces upfront equity requirements for eligible candidates and provides ongoing learning and development, specifically targeting underrepresented groups in both U.S. and international markets to increase representation across its system.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that franchisees operate the vast majority of McDonald's restaurants and employ nearly all of the global workforce, aligning with the ground truth that franchisees contribute to over 93% of the workforce (over 2 million in franchised vs. over 150,000 company employees). The LLM states 'approximately 95%', which is a reasonable approximation given the actual proportion (~2M / 2.15M ≈ 93%). While not explicitly breaking down the workforce numbers, the implication that nearly all employees work in franchised locations is factually sound. (2) The recruitment initiative details are accurately reflected: reduction in upfront equity requirements and provision of learning and development for underrepresented groups in both U.S. and international markets. These match the original answer's content. (3) The multi-hop reasoning is sound—connecting franchisee ownership to workforce composition and then linking diversity initiatives to demographic influence shows appropriate synthesis across business model and HR strategy. (4) Minor deduction in quantitative accuracy due to rounding up from ~93% to 'approximately 95%'—while not incorrect per se, it slightly overstates the precise figure. However, this does not materially misrepresent the data. All other entities, initiatives, and targets are correctly identified. Overall, the answer is factually accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 402,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the unfavorable profit adjustment on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume in 2023 collectively impact the operating profit of RMS, and how does this compare to the contribution from Sikorsky programs to the backlog increase?",
      "original_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together caused a significant decrease in RMS' operating profit for Sikorsky helicopter programs in 2023. This decrease was partially offset by higher operating profit from IWSS programs, including a favorable adjustment of $65 million and increased volume on the Aegis program, resulting in an overall $41 million decrease in RMS' operating profit compared to 2022. Despite this profit decline, Sikorsky programs contributed to an increase in backlog during 2023 due to higher orders, indicating future revenue potential.",
      "llm_answer": "The unfavorable profit adjustment of $100 million on the Canadian Maritime Helicopter Program and the lower Black Hawk production volume together reduced RMS operating profit by roughly $100 million in 2023, while the segment’s backlog grew primarily due to higher orders on Sikorsky programs, which contributed to the overall backlog increase. This combined impact was offset in part by favorable profit adjustments on other RMS contracts such as IWSS and Aegis, but the net effect was a modest decline in RMS operating profit compared with the prior year.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $100 million unfavorable profit adjustment on the Canadian Maritime Helicopter Program and lower Black Hawk production volume as negative factors for RMS operating profit in 2023, and notes that Sikorsky programs contributed to backlog growth due to higher orders—both consistent with the ground truth. However, it inaccurately states the combined impact was a reduction of 'roughly $100 million', while the ground truth specifies that after partial offset from favorable adjustments (e.g., $65 million from IWSS), the net decrease in RMS operating profit was $41 million. The LLM fails to provide this exact net figure, which is a key quantitative point. (2) The $100 million figure is correct, and the mention of favorable adjustments on IWSS and Aegis is accurate, but the absence of the $65 million offset and the resulting $41 million net decline constitutes a significant omission in quantitative precision. The answer implies a net decline without specifying the calculated outcome, undermining full numerical accuracy. (3) The multi-hop reasoning is partially sound: the model connects the negative impact on profit from Sikorsky programs with the positive backlog contribution, and acknowledges offsetting factors in other RMS programs. However, it does not fully synthesize the financial netting process across these elements, which is central to the question’s demand for collective impact. (4) Despite missing the precise net profit impact, the answer captures the core dynamics—profit decline due to Sikorsky issues, partial offset from other programs, and backlog growth from Sikorsky orders—making it contextually relevant and qualitatively strong, but not fully factually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 475,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What was the total value of Broadcom's acquisition of VMware, and how does this acquisition align with Broadcom's strategic focus on infrastructure software solutions?",
      "original_answer": "Broadcom acquired VMware for a total value of $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition aligns with Broadcom's strategic focus on infrastructure software solutions by enhancing its capabilities in multi-cloud services and enabling digital innovation with enterprise control, as stated in the overview of Broadcom's business segments and strategic priorities.",
      "llm_answer": "Broadcom's acquisition of VMware was completed on November 22 2023 for approximately $30.8 billion in cash plus 544 million shares of Broadcom stock, giving a total fair‑value consideration of about $53.4 billion. The deal was pursued to strengthen Broadcom’s infrastructure‑software portfolio and accelerate its strategy of delivering a comprehensive suite of infrastructure and security software solutions that modernize and secure complex hybrid‑cloud environments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. The ground truth states the total acquisition value was $84,186 million ($84.186 billion), composed of $30,788 million in cash and $53,398 million in stock. However, the LLM incorrectly reports the total fair-value consideration as 'about $53.4 billion', conflating the stock component with the total value. It also states $30.8 billion in cash (close to the correct $30.788 billion) but then adds 544 million shares without correctly valuing them to reach the true total. The total value is off by over $30 billion, a major error. (2) The date of completion (November 22, 2023) is accurate and matches public records, so timing is correct. (3) On qualitative aspects, the LLM correctly identifies the strategic rationale—strengthening Broadcom’s infrastructure software portfolio and enhancing hybrid-cloud capabilities—which aligns semantically with the ground truth’s mention of multi-cloud services and enterprise control in digital innovation. This shows sound reasoning in intent and strategic alignment, despite numerical inaccuracies. (4) Contextually, the answer is relevant and addresses both parts of the question: the deal value and strategic alignment. However, due to the severe miscalculation of the total acquisition value—failing to sum cash and stock components correctly or cite the correct total—the correctness and quantitative accuracy scores are low. The model appears to have confused the stock component ($53.4B) with the total consideration, leading to a fundamental error in financial understanding. Minor format flexibility is allowed, but a 36% undervaluation of the total deal cannot be overlooked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 470,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the introduction of the $6.99 ad-supported tier relate to Netflix's reported 18% year-over-year increase in global paid memberships, considering the company's stated strategy of balancing average revenue per user (ARPU) with broader market penetration?",
      "original_answer": "The introduction of the $6.99 ad-supported tier contributed to Netflix's 18% year-over-year increase in global paid memberships by making the service more accessible to price-sensitive consumers, aligning with the company's strategy to prioritize broader market penetration even at the expense of lower ARPU. This pricing decision reflects Netflix's explicit acknowledgment in its filings of the tradeoff between subscriber growth and per-user revenue, as the lower price point likely accelerated membership expansion while moderating average revenue per user growth.",
      "llm_answer": "The $6.99 ad‑supported tier is part of Netflix’s strategy to grow its subscriber base while managing ARPU, which is reflected in the 18% year‑over‑year increase in global paid memberships reported in the 10‑K. By offering a lower‑priced, ad‑supported option, Netflix can attract price‑sensitive users and expand market penetration without significantly diluting overall revenue per user, thereby driving the membership growth highlighted in the filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: the $6.99 price point and 18% year-over-year increase in global paid memberships are correctly cited, with no calculation errors. (2) The answer addresses the core relationship between the ad-supported tier and membership growth, correctly identifying Netflix's strategy of balancing ARPU with market penetration. (3) The reasoning is sound but slightly less precise than the original: while the LLM states the lower tier helps grow subscribers 'without significantly diluting overall revenue per user,' the ground truth more accurately acknowledges that lower ARPU is an accepted tradeoff—implying ARPU is indeed diluted, but intentionally. The LLM's phrasing softens this tradeoff, potentially understating the ARPU impact. (4) All entities (Netflix, ARPU, ad-supported tier, 10-K reference) are correct, and the response is fully relevant to the question. The answer captures the essential multi-hop logic—linking pricing strategy to subscriber growth and strategic tradeoffs—but with a minor nuance missing in the qualitative reasoning around ARPU dilution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 331,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What is the total number of individuals working in McDonald's restaurants globally, including both Company-owned and franchised restaurants, and how does this workforce contribute to the company's stated purpose and mission?",
      "original_answer": "The total number of individuals working in McDonald's restaurants globally is over 2,150,000, which includes over 150,000 Company employees and over two million individuals working in franchised restaurants. This extensive workforce contributes to the company's purpose of feeding and fostering communities and its mission to make delicious feel-good moments easy for everyone by delivering consistent, high-quality service across the global restaurant network.",
      "llm_answer": "McDonald's employs approximately 1.9 million people globally across its Company-owned and franchised restaurants, as stated in the \"Our People\" section of the 2023 Annual Report (page 4). This workforce is central to fulfilling the company's purpose of \"feeding and fostering communities\" and its mission to \"make delicious feel-good moments easy for everyone,\" as reflected in its core values of \"Serve,\" \"Inclusion,\" \"Integrity,\" \"Community,\" and \"Family.\" The company emphasizes that its people, including both corporate employees and the two million individuals working in franchised locations, are \"at the cornerstone of the Company's business\" and essential to driving long-term value creation through its purpose and mission.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error: it states that McDonald's employs 'approximately 1.9 million people globally,' while the ground truth specifies over 2,150,000 individuals, including over 150,000 Company employees and over two million in franchised restaurants. The 1.9 million figure undercounts the total workforce, especially the franchised restaurant employees, which are correctly stated elsewhere in the LLM answer as 'two million individuals.' This contradiction reduces quantitative accuracy. (2) The numbers are inconsistent within the LLM response—citing 1.9 million total while also mentioning two million in franchised locations, which alone exceeds the total. The Company employee count (~150,000) aligns with ground truth, but the overall sum is miscalculated or misreported. (3) Qualitatively, the reasoning is sound: the LLM correctly identifies the purpose ('feeding and fostering communities') and mission ('make delicious feel-good moments easy for everyone') and links the workforce to these goals. It appropriately references core values and the centrality of people to the business, showing good multi-hop synthesis between workforce size and corporate mission. (4) Contextually, the answer is highly relevant, citing the correct document ('Our People' section of the 2023 Annual Report) and addressing both parts of the question—workforce size and its contribution to purpose and mission. However, the numerical inaccuracy in total headcount significantly impacts the correctness score, despite otherwise strong qualitative and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 441,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What was the total fair value of the VMware acquisition by Broadcom, and how does this acquisition enhance Broadcom's infrastructure software capabilities?",
      "original_answer": "The total fair value of the VMware acquisition by Broadcom was $84,186 million, which includes $30,788 million in cash and $53,398 million in Broadcom common stock. This acquisition enhances Broadcom's infrastructure software capabilities by adding VMware's multi-cloud services, which enable digital innovation with enterprise control, thereby strengthening Broadcom’s portfolio of infrastructure and security software solutions.",
      "llm_answer": "The total fair value of the VMware acquisition was $53.4 billion, as disclosed on page 38, reflecting the cash and stock consideration paid to acquire the company. This acquisition strengthens Broadcom’s infrastructure software capabilities by adding VMware’s leading multi‑cloud services and portfolio, enabling Broadcom to offer a more comprehensive suite of solutions that simplify and secure complex hybrid‑cloud environments for enterprise customers.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains a significant error in quantitative accuracy: it states the total fair value as $53.4 billion, which corresponds only to the Broadcom common stock portion ($53,398 million) of the acquisition, not the total fair value. The ground truth total fair value is $84,186 million ($84.2 billion), combining $30,788 million in cash and $53,398 million in stock. The LLM incorrectly presents the stock component as the total value, missing the cash component entirely. 2) Despite this major numerical error, the qualitative aspects are strong: the answer correctly identifies that the acquisition enhances Broadcom’s infrastructure software capabilities by adding VMware’s multi-cloud services, enabling a more comprehensive suite for hybrid-cloud environments, which aligns semantically with the ground truth. 3) The reasoning is logically sound and contextually relevant—VMware’s multi-cloud portfolio does enhance Broadcom’s enterprise software offerings, and the answer appropriately frames the strategic benefit. 4) The contextual relevance is high as it directly addresses both parts of the question and uses appropriate terminology. However, the failure to include the full fair value—especially omitting the $30.8 billion cash component—constitutes a critical factual omission, reducing the correctness score significantly despite otherwise accurate reasoning and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 385,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Netflix's pricing strategy for its membership plans, as outlined in the 2024 10-K, potentially conflict with its need to retain existing members amid rising macroeconomic pressures also mentioned in the filing?",
      "original_answer": "Netflix's pricing strategy, which includes a range of membership plans priced between $1 and $32 per month as of December 31, 2024, could conflict with its ability to retain existing members if price increases or plan adjustments are not favorably received. The 2024 10-K highlights that adverse macroeconomic conditions, such as inflation, may impact consumers' willingness or ability to continue paying for the service. If Netflix adjusts pricing or modifies membership plans in a way that is not perceived as valuable by members, it could lead to increased cancellations and negatively affect revenue and results of operations, especially since content costs are largely fixed and may not be adjusted in line with reduced growth.",
      "llm_answer": "Netflix’s 2024 10‑K shows that it raised membership fees and introduced tiered plans (including an ad‑supported option) to boost revenue, but it also notes that “unfavorable macro‑economic conditions, including inflation, may also adversely impact our ability to attract and retain members.” Because higher prices can make members more price‑sensitive amid rising cost pressures, the company risks losing subscribers if they perceive the new pricing as insufficient value or if they cut discretionary spending. Thus, the pricing strategy that seeks higher ARPU may conflict with the need to retain members when macro‑economic headwinds make price hikes more risky.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Netflix's pricing strategy in the 2024 10-K, including tiered plans and price increases, and links this to macroeconomic pressures like inflation affecting member retention. While the exact price range ($1 to $32) is not explicitly mentioned, the core idea of pricing adjustments impacting value perception is accurately conveyed. (2) There are no explicit numerical errors; the absence of the precise dollar range is a minor omission but does not distort the factual picture, especially since the focus is on the strategic tension rather than specific plan prices. Format variations are acceptable, and no calculations were required. (3) The multi-hop reasoning is sound: the model correctly synthesizes information between Netflix’s pricing actions (revenue-driven) and macroeconomic risks (subscriber retention), concluding that higher prices may lead to cancellations if perceived value lags—exactly as stated in the original answer. (4) The answer is contextually excellent, directly addressing the conflict between pricing strategy and retention under economic pressure. The mention of an ad-supported tier adds contextual detail consistent with Netflix’s strategy, even if not in the ground truth. Only a perfect score is withheld due to the slight lack of specificity on pricing tiers, but overall, the semantic meaning and factual core are preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 401,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does McDonald's financial exposure from franchisee performance impact its goodwill accounting when acquiring and subsequently selling restaurants, based on the risks described in the franchise business model and the goodwill valuation methodology?",
      "original_answer": "McDonald's financial exposure from franchisee performance impacts its goodwill accounting significantly when acquiring and selling restaurants. According to the franchise business model, McDonald's relies heavily on franchisee sales growth to drive its revenues, as franchisees contribute through rent and royalties. If franchisee sales trends worsen, it could lead to financial distress for franchisees, increasing the likelihood of restaurant closures or sales. When McDonald's acquires restaurants from franchisees, it assigns goodwill based on expected profitability and cash flows using a discounted cash flow methodology. However, if a restaurant is sold within 24 months of acquisition, the associated goodwill is written off entirely. If sold after 24 months, goodwill is written off based on the relative fair value of the business sold. Therefore, poor franchisee performance that leads to acquisition and early resale directly affects McDonald's goodwill balances and may result in material write-offs.",
      "llm_answer": "The Company’s goodwill—generated primarily when it purchases restaurants from franchisees and assigns it to reporting units based on expected synergies—is vulnerable to impairment if franchisee performance deteriorates, because declining sales or profitability of those units reduces the fair value of the unit and can trigger a write‑off of the associated goodwill. Consequently, adverse changes in franchisee results or the broader franchise business model can diminish the value of acquired assets and force the Company to record goodwill impairments, negatively affecting its financial results.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core relationship between franchisee performance and goodwill impairment, noting that declining franchisee sales or profitability can reduce the fair value of reporting units and trigger goodwill write-offs. It accurately reflects that McDonald's assigns goodwill when acquiring restaurants and that this goodwill is subject to impairment based on performance. However, the answer omits critical details from the ground truth that are essential to fully addressing the multi-hop nature of the question. Specifically: (1) It fails to mention the 24-month rule for goodwill treatment—full write-off if sold within 24 months, and relative fair value write-off after—which is a key quantitative and policy-based aspect of McDonald's goodwill accounting. (2) It does not explain the direct link between franchisee financial distress (due to poor performance) leading to restaurant acquisitions by McDonald's, which then creates goodwill exposure upon resale. (3) The answer frames goodwill as being based on 'expected synergies,' whereas the ground truth specifies it is based on expected profitability and cash flows using a discounted cash flow methodology. While the general direction of reasoning is sound and contextually relevant, these omissions and the slight mischaracterization of the goodwill valuation basis reduce the qualitative accuracy. There are no numerical inaccuracies (hence full quantitative score), and the response remains focused on the topic, earning high marks for contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 423,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How do Lockheed Martin's hypersonics programs align with its Space segment's strategic priorities and contribute to its anticipated growth through 2026?",
      "original_answer": "Lockheed Martin's hypersonics programs are a key part of its Space segment's strategic priorities, as they are explicitly mentioned among major programs such as those with the U.S. Army and U.S. Navy to design, develop, and build hypersonic strike weapons. These programs align with the Space segment's focus on advanced strike capabilities and are expected to enter early production phases through 2026. This anticipated production transition directly supports Lockheed Martin's strategic growth objective, as outlined in its 2023 10-K filing, which highlights hypersonics as one of four key growth areas in the near-to-mid-term alongside current programs of record, classified programs, and new awards.",
      "llm_answer": "Lockheed Martin's hypersonics programs are a key growth driver for its Space segment, which focuses on advanced strike and defensive systems, satellite technologies, and next‑generation missile capabilities. These programs are aligned with Space's strategic priorities of expanding resilient space‑based communications, missile warning, and hypersonic strike weapons, and they are expected to contribute to revenue growth through early production phases and new contracts extending to 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Lockheed Martin's hypersonics programs are indeed a key part of the Space segment's strategic priorities, particularly in advanced strike capabilities. The mention of early production phases through 2026 matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly links hypersonics programs to the Space segment, identifies their strategic importance, and connects them to anticipated growth through 2026. The only minor omission is that the original answer specifically cites the U.S. Army and U.S. Navy programs and references the 2023 10-K filing identifying hypersonics as one of four key growth areas. The LLM answer captures the essence but lacks these specific attributions, slightly reducing completeness. (4) Despite this, the LLM conveys semantically equivalent information with correct entity identification (Lockheed Martin, Space segment, hypersonics, 2026 timeline) and strong contextual relevance. The answer directly addresses how the programs align with strategic priorities and contribute to growth, fulfilling the core of the multi-hop query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 374,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Broadcom's valuation methodology for VMware Cloud Foundation-related developed technology reflect its projected financial contribution, and what specific technique was used to estimate its economic benefit over time?",
      "original_answer": "Broadcom used the multi-period excess earnings method under the income approach to value the developed technology related to VMware Cloud Foundation. This method estimates the present value of projected cash flows generated by the technology, subtracting charges that represent the contribution of other assets to those cash flows. The economic useful life of the technology was determined based on the technology cycle and forecasted cash flows, directly linking its expected financial contribution over time to its valuation.",
      "llm_answer": "Broadcom valued the developed technology for VMware Cloud Foundation using the multi-period excess earnings method, which estimates the present value of projected cash flows generated by the technology after deducting the contribution of other assets. The fair value of $90 million was assigned with an 11‑year weighted‑average amortization period, reflecting the technology’s useful life and anticipated cash‑flow pattern. This valuation captures the expected economic benefit of the developed technology over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the valuation technique—multi-period excess earnings method—and explains its core mechanism (estimating present value of cash flows after deducting contributions from other assets), which aligns with the ground truth. However, the LLM introduces two specific quantitative details not present in the original answer: a 'fair value of $90 million' and an '11-year weighted-average amortization period.' These figures are not mentioned in the ground truth and cannot be verified from the provided information, making them potentially incorrect or hallucinated. (2) The ground truth does not include any dollar amounts or specific amortization periods, so the inclusion of $90 million and 11 years reduces quantitative accuracy. There is no way to verify if these numbers are accurate based on the knowledge graph answer provided. (3) The reasoning is otherwise sound: the LLM correctly links the valuation method to projected cash flows and the economic benefit over time, demonstrating proper multi-hop understanding of how the methodology reflects financial contribution. It accurately captures the conceptual basis of the income approach and excess earnings logic. (4) Contextual relevance is perfect—the answer directly addresses both parts of the question (methodology and economic benefit over time). The qualitative explanation is strong and semantically aligned with the original, despite the unsupported numbers. Thus, correctness is reduced primarily due to unverified quantitative claims, warranting a 7/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 428,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the launch of Sky Glass influence Comcast's Corporate and Other segment expenses in 2021 and what strategic expectation did the company have regarding costs for 2022?",
      "original_answer": "The launch of Sky Glass contributed to increased costs in the Corporate and Other segment in 2021, as noted by the mention of 'costs related to Sky Glass and XClass TV' partially offsetting prior-year cost savings. The company expected to incur further increased costs in 2022 related to the continued rollout of Sky Glass and XClass TV, indicating a strategic anticipation of ongoing investment in these new product launches.",
      "llm_answer": "The launch of Sky Glass added material hardware‑related costs to Comcast’s Corporate and Other segment in 2021, pushing operating expenses down year‑over‑year primarily because the prior‑year period had carried COVID‑related severance and other cost‑saving initiatives; however, the company expects to incur higher costs in 2022 related to the continued rollout of Sky Glass and the launch of XClass TV.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the launch of Sky Glass increased costs in the Corporate and Other segment in 2021 and that further costs were expected in 2022 due to the continued rollout of Sky Glass and the launch of XClass TV, aligning with the ground truth. The mention of prior-year cost savings (attributed to COVID-related severance and initiatives) contextualizes the year-over-year change, which is consistent with the original answer’s reference to prior-year savings being offset. (2) There are no specific numerical values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not compromised; all dates (2021, 2022) are correct. (3) The multi-hop reasoning is sound: the model connects the product launch (Sky Glass) to segment-level cost impacts and correctly projects forward-looking expectations into 2022, synthesizing cause, effect, and strategic intent across time periods. The only minor deviation is the phrasing 'pushing operating expenses down year-over-year,' which could be misinterpreted as overall lower expenses, whereas the ground truth emphasizes that new costs partially offset prior savings—so expenses may not have decreased in absolute terms, just increased less due to prior savings. This nuance is slightly misrepresented, but the core logic remains intact. (4) The answer is contextually relevant, fully addressing both parts of the question: the 2021 impact and the 2022 strategic cost expectation. Thus, the correctness score is 9 due to this subtle but important clarification in interpretation, despite strong factual and qualitative alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 455,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's (MCD) valuation methodology for acquiring restaurants from franchisees impact the treatment of goodwill when those restaurants are sold within or beyond 24 months of acquisition, and what is the financial implication of this policy on goodwill write-offs?",
      "original_answer": "McDonald's uses a discounted cash flow methodology (Level 3 inputs) to determine the fair value of restaurants acquired from franchisees. If a restaurant is sold within 24 months of acquisition, the entire goodwill associated with that acquisition is written off. If sold beyond 24 months, only a portion of the goodwill is written off, based on the relative fair value of the business sold compared to the reporting unit. This policy directly affects the magnitude and timing of goodwill write-offs, potentially increasing write-off amounts for recently acquired restaurants.",
      "llm_answer": "The Company's acquisition valuation methodology for restaurants purchased from franchisees relies on a discounted cash flow (Level 3) approach that assigns goodwill based on expected profitability and cash flows. If a Company‑operated restaurant is sold within 24 months of acquisition, the entire associated goodwill is written off; if sold after 24 months, the goodwill write‑off is proportional to the relative fair value of the business sold versus the reporting unit. This policy can result in significant goodwill write‑offs when restaurants are flipped quickly, directly reducing earnings in the period of sale.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: McDonald's uses a discounted cash flow methodology with Level 3 inputs for valuing restaurants acquired from franchisees; goodwill treatment differs based on whether the sale occurs within or beyond 24 months of acquisition. (2) There are no numeric values requiring calculation, but the 24-month threshold is correctly stated and consistently applied. Format variations (e.g., '24 months' vs '24 months') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—linking valuation methodology to goodwill assignment, then to differential write-off treatment based on time since acquisition, and finally to financial implications on earnings. The synthesis across accounting policy and financial impact is logically coherent. (4) The LLM correctly identifies the entities (McDonald's, franchisee-acquired restaurants, goodwill) and accurately describes the policy’s effect: full write-off within 24 months, proportional after, leading to potentially large near-term earnings impacts. Wording differs slightly (e.g., 'flipped quickly' is colloquial but contextually appropriate), but the technical and financial meaning matches the original answer exactly. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 372,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the concentration risk in Boeing's customer financing portfolio, particularly in 717 and 747-8 aircraft, compound the financial vulnerability caused by the $1.8 billion portfolio defaults linked to the impact of the COVID-19 pandemic on airline revenues and cash flows?",
      "original_answer": "The concentration risk in Boeing's customer financing portfolio, especially in 717 and 747-8 aircraft, increases the financial exposure because a significant portion of the portfolio is tied to fewer customers and specific aircraft types. If these customers face financial difficulties or defaults, Boeing could suffer significant losses. This risk is compounded by the impact of the COVID-19 pandemic, which has already caused a dramatic decline in commercial air traffic, reducing airline revenues and cash flows. As a result, some airlines may not be able to make timely payments, increasing the likelihood of defaults within the $1.8 billion customer financing portfolio. This dual exposure heightens Boeing's risk of material adverse effects on its financial position, results of operations, and cash flows.",
      "llm_answer": "The $1.8 billion customer‑financing portfolio is heavily weighted toward 717 and 747‑8 aircraft and toward customers with weaker credit, so defaults on those exposures magnify the liquidity strain caused by the pandemic‑driven collapse in airline revenues and cash flow.  As a result, the pandemic‑related defaults not only drain cash but also force Boeing to write down or remarket the concentrated aircraft types, deepening the financial vulnerability tied to that concentrated financing book.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.8 billion portfolio figure is correctly stated and matches the original answer. No other numerical values (e.g., percentages, years) are mentioned in either answer, so no discrepancies exist. Format is consistent and acceptable. (2) The LLM correctly identifies the concentration risk in Boeing's customer financing portfolio, specifically highlighting the 717 and 747-8 aircraft types, which matches the entities and focus in the original answer. (3) The reasoning is sound and captures the multi-hop logic: pandemic → airline revenue/cash flow decline → increased default risk → amplified impact due to portfolio concentration → additional financial strain from write-downs or remarketing concentrated aircraft. This synthesis across causal chains is accurate and insightful. (4) While the original answer emphasizes the risk to Boeing’s financial position, results of operations, and cash flows more explicitly, the LLM conveys the same outcome through 'liquidity strain' and 'deepening financial vulnerability.' The only minor gap is the omission of the explicit phrase 'material adverse effects,' but the semantic meaning is preserved. The addition of 'weaker credit' customers and 'write down or remarket' provides useful elaboration without introducing error. Overall, the answer is factually correct, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 405,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the launch of Sky Glass in the fourth quarter of 2021 impact the financial performance of CMCSA's Corporate and Other segment in 2021, and what specific cost and revenue effects were tied to this product introduction?",
      "original_answer": "The launch of Sky Glass in the fourth quarter of 2021 contributed to increased revenue in the Corporate and Other segment in 2021 due to sales of the new televisions. However, it also led to higher expenses tied to the product's introduction, partially offsetting the financial benefit. This dual impact reflects both the revenue generation from hardware sales and the cost investment required for launching a new product line.",
      "llm_answer": "The launch of Sky Glass in Q4 2021 generated new hardware‑sale revenue and related costs that were recorded in the Corporate and Other segment.  In 2021 revenue rose ≈ 86 % (driven by Sky Glass sales) while operating expenses fell ≈ 10 % as the company offset prior‑year COVID‑related severance costs with higher expenses tied to the Sky Glass and XClass TV roll‑outs.  Consequently, the segment posted a modest improvement in Adjusted EBITDA, reflecting the revenue uplift from Sky Glass offset by the added cost of the new smart‑TV hardware and associated marketing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. The ground truth states that Sky Glass led to increased revenue and higher expenses in the Corporate and Other segment, but provides no specific percentages or figures. The LLM invents precise metrics—'revenue rose ≈ 86%' and 'operating expenses fell ≈ 10%'—which are not supported by the original answer or implied in the knowledge graph. These numbers are entirely fabricated, severely undermining factual correctness. (2) The claim that operating expenses fell is directly contradicted by the ground truth, which states that expenses increased due to costs tied to the product launch. The LLM incorrectly asserts that higher Sky Glass-related costs were offset by savings from reduced severance costs, a detail absent from the original and unsupported in context. Additionally, the mention of 'XClass TV roll-outs' introduces a product not referenced in the ground truth, adding unverified information. (3) While the LLM correctly identifies that Sky Glass impacted the Corporate and Other segment and that both revenue and costs were affected—demonstrating basic multi-hop understanding of product launch financial impacts—the reasoning is flawed due to invented data and incorrect cost trends. The conclusion about 'modest improvement in Adjusted EBITDA' is speculative and not present in the original answer. (4) Despite these issues, the response is contextually relevant, addressing the right segment, company (implied via context), time period (Q4 2021), and general nature of the financial impact (revenue up from sales, costs up from launch). However, the severe quantitative inaccuracies and introduction of unsupported details drastically reduce correctness. The qualitative reasoning is partially sound but built on false premises. Thus, the correctness score is low due to major factual and numerical errors, even though the general direction of impact (revenue and cost increases) is acknowledged.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 544,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the total fair value of commercial mortgage-backed securities held by CVS as of December 31, 2023, and how much unrealized loss does this category represent compared to its total debt securities portfolio?",
      "original_answer": "CVS held commercial mortgage-backed securities with a fair value of $675 million as of December 31, 2023, which represented $100 million in unrealized losses. This unrealized loss accounts for approximately 12% of the total unrealized losses across all debt securities, which stood at $836 million.",
      "llm_answer": "As of December 31 2023, the fair value of CVS’s commercial mortgage‑backed securities was **$975 million**. This category represented an unrealized loss of **$100 million**, which is part of the total unrealized loss of **$836 million** on the Company’s entire debt‑securities portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the fair value of commercial mortgage-backed securities: it reports $975 million instead of the correct $675 million from the ground truth. The unrealized loss of $100 million and the total debt securities unrealized loss of $836 million are correctly stated. However, the LLM omits the key comparative metric — that the $100 million unrealized loss represents approximately 12% of the total $836 million in unrealized losses — which is a required part of the question. (2) Quantitative accuracy is compromised due to the incorrect fair value figure ($975M vs $675M), though the $100M unrealized loss and $836M total are accurate. The percentage calculation (100/836 ≈ 12%) is missing, which is a key quantitative component. (3) The reasoning is partially sound: the model identifies the correct company (CVS), time period (December 31, 2023), and financial categories (commercial mortgage-backed securities, debt securities portfolio). However, it fails to perform or report the multi-hop synthesis of comparing the category's unrealized loss to the total, which requires combining two data points. (4) Contextual relevance is high as the answer addresses the right entities and structure, but the factual inaccuracy in a core number and omission of the percentage significantly reduce correctness. The answer is plausible but not accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 388,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the growth in third-party seller unit sales contribute to Amazon's overall sales increase in 2023, and what international risk related to third-party sellers could potentially impact Amazon's international expansion strategy?",
      "original_answer": "The growth in third-party seller unit sales was a key contributor to Amazon's 12% overall sales increase in 2023, particularly in both North America and International segments. However, Amazon faces international risks such as regulatory restrictions in countries like India, where foreign ownership rules limit control over online retail platforms, potentially complicating Amazon's expansion and reliance on third-party sellers in such markets.",
      "llm_answer": "The growth in third‑party seller unit sales contributed to the overall sales increase in 2023 by driving higher net sales across both North America and International segments—particularly through increased unit sales and advertising revenue—while also boosting fulfillment and shipping volumes that supported the company’s growth. However, international expansion faces significant risks, including regulatory and licensing requirements in China and India that could restrict foreign investment and operations, as well as geopolitical and trade restrictions that might impede Amazon’s ability to operate or expand in those markets.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that third-party seller unit sales contributed to Amazon's 2023 sales growth across North America and International segments, aligning with the ground truth. However, it omits the specific 12% overall sales increase figure, which is a key quantitative element in the original answer. This missing percentage reduces quantitative accuracy. (2) No explicit financial figures (e.g., dollar amounts) are provided in either answer, but the ground truth includes a precise growth rate (12%) that the LLM fails to mention. The LLM instead uses qualitative phrasing like 'driving higher net sales' without quantifying the increase, making it less factually complete. (3) The multi-hop reasoning is sound: the LLM correctly links third-party seller activity to broader sales and operational growth (fulfillment, advertising), and identifies relevant international risks such as regulatory restrictions in India and China. While the ground truth specifically highlights India's foreign ownership rules, the LLM broadens this to include China and mentions geopolitical and trade restrictions, which are contextually plausible but not explicitly stated in the original. This expansion adds relevant context but slightly deviates from the precise risk cited. (4) The answer is contextually relevant and captures the essence of both parts of the question—contribution to growth and international risk—with strong qualitative reasoning. The omission of the 12% figure prevents a higher correctness score, but the core entities (Amazon, third-party sellers, 2023, international expansion, regulatory risks) are accurate and well-synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 457,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What is the difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors at Wells Fargo in 2023?",
      "original_answer": "The difference in the number of shares remaining available for future issuance between the Deferred Compensation Plan and the Non-Qualified Deferred Compensation Plan for Independent Contractors is 1,712,810 shares.",
      "llm_answer": "The Deferred Compensation Plan has 1,853,363 shares remaining available for future issuance, while the Non-Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares remaining available for future issuance. Thus, the difference is 1,712,810 shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the Deferred Compensation Plan has 1,853,363 shares available, and the Non-Qualified Deferred Compensation Plan for Independent Contractors has 140,553 shares available. (2) The calculation of the difference (1,853,363 - 140,553 = 1,712,810) is correct and matches the ground truth exactly. (3) The multi-hop reasoning is sound—LLM correctly identified two distinct plans, retrieved the correct share amounts for each, and computed the difference. (4) Entities (plan names, share counts, company context) are accurately referenced, and the answer is semantically equivalent to the original. No errors in numbers, logic, or synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 221,
        "total_tokens": 1363
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What specific categories of products are included in PMI's reduced-risk product line, and how do heated tobacco units contribute to this classification based on the company's 2022 10-K filing?",
      "original_answer": "PMI's reduced-risk product line includes heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing products such as e-vapor and oral nicotine products. Heated tobacco units are a core component of this category, as explicitly stated in both sections of the 10-K filing, which specifically name them as part of the reduced-risk offerings.",
      "llm_answer": "PMI classifies its reduced‑risk product line as “Reduced‑Risk Products,” which includes heated‑tobacco consumables (e.g., HEETS, Marlboro HeatSticks, TEREA, etc.) and related accessories, as well as e‑vapor and oral nicotine products. According to the 2022 10‑K, heated‑tobacco units are reported under the “Reduced‑Risk Products” category and generated $9,115 million of net revenue in 2021, reflecting their contribution to the overall reduced‑risk portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the categories of PMI's reduced-risk products, including heated tobacco units, e-vapor, and oral nicotine products, as well as related accessories, which aligns with the ground truth. However, it introduces specific brand names (e.g., HEETS, Marlboro HeatSticks, TEREA) not mentioned in the original answer, which, while potentially accurate, go beyond the scope of the provided ground truth. (2) The quantitative error is significant: the LLM states that heated tobacco units generated $9,115 million in net revenue in 2021, but the question asks about the 2022 10-K filing and the ground truth does not include any financial figures. This number is factually unverifiable from the original answer and introduces a specific metric not supported by the ground truth, reducing quantitative accuracy. (3) The reasoning is logically sound in classifying heated tobacco units as a core component of reduced-risk products, and the answer reflects proper synthesis of product categories from the 10-K. However, the inclusion of revenue data not present in the ground truth suggests either hallucination or use of external data, undermining multi-hop fidelity. (4) Despite the numerical inaccuracy, the answer captures the correct product classification and correctly links heated tobacco units to the reduced-risk category, warranting a score of 7 for overall correctness. Contextual relevance is high as it directly addresses both parts of the question, and qualitative accuracy is strong in categorization and reasoning, though slightly offset by unsupported specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 441,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "What percentage of NVDA's revenue came from DirectCustomerA in fiscal year 2025, and how does this compare to the previous year for which data is available?",
      "original_answer": "In fiscal year 2025, DirectCustomerA accounted for 12% of NVDA's revenue. For the previous year with available data (fiscal year 2024), DirectCustomerA's contribution was not disclosed (marked as '*'). Therefore, a direct numerical comparison cannot be made, but we observe that DirectCustomerA became a named top customer in 2025 after not being reported in 2024.",
      "llm_answer": "Based on the provided financial statements, NVDA's revenue from DirectCustomerA was 12% of total revenue for fiscal year 2025 (Jan26,2025), compared to 13% for fiscal year 2024 (Jan28,2024). This represents a decrease in the proportion of revenue from this customer year-over-year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that DirectCustomerA accounted for 13% of NVDA's revenue in fiscal year 2024. According to the ground truth, this information was not disclosed and marked as '*', meaning no percentage should be reported. The 12% figure for fiscal year 2025 is correct. (2) The quantitative accuracy is low because the 13% figure for 2024 is false, and the implied year-over-year decrease is therefore based on incorrect data. The fiscal dates (Jan26,2025 and Jan28,2024) may reflect actual period ends but were not part of the original answer and do not affect correctness unless contradicted; however, they do not compensate for the core error. (3) The multi-hop reasoning fails because the model incorrectly assumes data availability for 2024 when the ground truth explicitly states it was not reported. Instead of recognizing the absence of data, the model fabricates a comparison. (4) Contextual relevance is high because the answer addresses the right question structure—percentage of revenue from a direct customer and year-over-year comparison—but the factual inaccuracies severely undermine correctness. The qualitative accuracy is low due to the failure in entity-data linkage and incorrect inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1163,
        "completion_tokens": 353,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How many distinct versions of the Restricted Share Rights Award Agreement were filed or incorporated by reference for grants occurring on or after January 24, 2023, and January 23, 2024, respectively, in Wells Fargo's 2023 10-K filing?",
      "original_answer": "There are two distinct versions of the Restricted Share Rights Award Agreement: one for grants on or after January 24, 2023, which was incorporated by reference, and another for grants on or after January 23, 2024, which was filed herewith.",
      "llm_answer": "Based on the exhibits listed in the 2023 10-K filing (specifically in Exhibit 10(a) and related exhibits on pages 13 and 14), Wells Fargo filed **one distinct version of the Restricted Share Rights Award Agreement for grants on or after January 24, 2023**, and **one distinct version for grants on or after January 23, 2024**. These are referenced as separate exhibits in the filing, confirming two distinct versions corresponding to the two grant dates. \n\n**Answer:**  \nTwo distinct versions were filed—one for grants on or after January 24, 2023, and another for grants on or after January 23, 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that there are two distinct versions of the Restricted Share Rights Award Agreement in Wells Fargo's 2023 10-K filing—one for grants on or after January 24, 2023, and another for grants on or after January 23, 2024—matching the ground truth in both quantity and dates. The quantitative accuracy is perfect: the dates and count (two versions) are correct. The answer correctly synthesizes information from the exhibit list (Exhibit 10(a)) to infer the existence of two separate agreements, demonstrating sound multi-hop reasoning. The only minor shortcoming is that the LLM states both versions were 'filed', while the ground truth specifies that the first was 'incorporated by reference' and the second was 'filed herewith'. This distinction in filing method is a nuanced but factual detail that the LLM omits, slightly reducing qualitative accuracy. However, the core factual content—two distinct versions tied to the correct dates—is fully accurate and relevant to the question. Semantic equivalence is maintained in intent and substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 305,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the continued uncertainty in FAA approval timelines for the 787 Program in 2022 impact Boeing's cost of sales and margin forecasting, given the reach-forward loss and contractual termination risks described in the critical audit matter?",
      "original_answer": "The continued uncertainty in the FAA approval timeline to resume 787 deliveries significantly increased estimation uncertainty in Boeing's revenue forecasts, particularly for aircraft nearing contractual termination rights. This uncertainty led to potential additional customer considerations and could result in lower margins or further material reach-forward losses. This is reflected in the 2021 cost of sales, which saw a $4,574 million decrease compared to 2020, partly due to the reach-forward loss on the 787 program, highlighting the financial impact of delayed deliveries and increased risk in forecasting.",
      "llm_answer": "The audit identified a critical audit matter on “Program Accounting Revenue Estimates for the 787 Program,” noting that continued uncertainty about the FAA’s approval timeline for resuming 787 deliveries creates significant judgment in estimating revenue, which can lead to reach‑forward losses and affect margin forecasting. This uncertainty, together with contractual termination risks, was cited as a factor that could further reduce backlog and increase order cancellations, ultimately pressuring cost of sales and margin projections.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core issue—continued uncertainty in FAA approval timelines for the 787 program impacting revenue estimation, reach-forward losses, and margin forecasting—and links it to contractual termination risks and potential order cancellations. However, it omits the key quantitative impact on cost of sales: the $4,574 million decrease in 2021 cost of sales compared to 2020, which is central to the original answer and directly addresses the financial impact. This omission significantly undermines completeness and factual accuracy. (2) No numeric values are mentioned in the LLM answer, despite the ground truth including a precise dollar amount ($4,574 million) and a clear year-over-year comparison (2021 vs 2020). The absence of this data fails the quantitative accuracy check, even though formatting variations would be acceptable—here, no number is provided at all. (3) The multi-hop reasoning is partially sound: the model connects FAA delays → estimation uncertainty → reach-forward losses → margin pressure → termination risk → impact on backlog and cost of sales. This logical chain is valid and reflects understanding of the causal relationships. However, it fails to close the loop with actual reported financial data (the cost of sales decrease), which is the evidentiary support for the impact. (4) Contextual relevance is high because the response stays focused on the 787 program, FAA approval, audit matter, and financial implications. Qualitative accuracy is moderate due to correct use of terms and entities (Boeing, 787 Program, reach-forward loss, margin forecasting, contractual termination) and reasonable inference, but the lack of grounding in actual financial figures limits correctness. Correctness score is 6 due to significant omission of key quantitative evidence despite otherwise logical and relevant reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 511,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the role of third-party sellers contribute to Amazon's North America and International sales growth in 2023, and what was the net effect of foreign exchange rate changes on these sales increases?",
      "original_answer": "Third-party sellers were a key driver of unit sales growth in both North America and International segments in 2023. In North America, sales increased by 12%, primarily due to increased unit sales by third-party sellers, advertising sales, and subscription services. Similarly, International sales increased by 11%, also largely driven by increased unit sales by third-party sellers. Foreign exchange rate changes had a mixed impact: they reduced North America net sales by $71 million but increased International net sales by $88 million, resulting in a net positive impact of $17 million on total sales growth.",
      "llm_answer": "In 2023, third‑party sellers drove growth in both North America and International net sales, accounting for the bulk of the increase in unit sales and advertising revenue that lifted those segments.  Foreign‑exchange movements had a modest positive impact on operating results – $246 million helped reduce International’s operating loss and $220 million boosted AWS operating income – but the net effect on overall sales growth was limited, with currency changes actually reducing consolidated net sales by about $71 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies third-party sellers as a growth driver in both regions, it fails to provide the specific sales growth percentages (12% for North America and 11% for International) mentioned in the ground truth. Instead, it vaguely states that third-party sellers 'drove growth' without quantifying the sales increases. Crucially, the LLM misrepresents the impact of foreign exchange rate changes: the ground truth states that FX changes reduced North America sales by $71M and increased International sales by $88M, resulting in a net positive impact of $17M. However, the LLM claims currency changes reduced consolidated net sales by $71M, which contradicts the net positive effect. Additionally, the LLM introduces irrelevant details about operating income impacts on International and AWS ($246M and $220M), which were not part of the question and are not supported by the original answer. (2) Quantitative accuracy is low: none of the correct FX impacts are accurately reported, and the $71M figure is misapplied to consolidated sales rather than North America alone. The net effect of $17M positive is entirely missing and replaced with an incorrect $71M reduction. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the regional sales growth drivers with the specific FX impacts on each region and instead conflates operating income effects with net sales, which are distinct metrics. It also introduces unrelated AWS data, indicating a failure in information retrieval and synthesis. (4) Despite the errors, the answer is contextually relevant in identifying third-party sellers as a key growth factor, which aligns with the original answer. However, the incorrect numbers, missing percentages, and introduction of irrelevant financial details severely undermine factual correctness, warranting a low correctness score of 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 525,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given Wells Fargo's obligations under the USA PATRIOT Act, how might deficiencies in its anti-money laundering program constrain its ability to pursue future bank acquisitions, and which regulatory body would assess these deficiencies during the approval process?",
      "original_answer": "Deficiencies in Wells Fargo's anti-money laundering (AML) program could constrain its ability to pursue future bank acquisitions because the Federal Reserve Board (FRB), along with other federal banking regulators, is required to evaluate the effectiveness of a financial institution's AML compliance program when determining whether to approve a proposed bank acquisition. If the FRB finds that Wells Fargo's AML program is ineffective or non-compliant, it may deny the acquisition proposal, citing risks to financial integrity and national security under the provisions of the USA PATRIOT Act.",
      "llm_answer": "Deficiencies in Wells Fargo’s anti‑money‑laundering program could trigger regulatory restrictions that limit the bank’s ability to make capital distributions—such as dividend payments or share repurchases—thereby constraining its capacity to fund or complete future acquisitions. The Federal Reserve, as the primary supervisor of bank holding companies, would evaluate these AML deficiencies during the approval process for any proposed bank acquisition.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant omission in reasoning. (1) It correctly identifies the Federal Reserve as the regulatory body that would assess AML deficiencies during the acquisition approval process, which aligns with the ground truth (Federal Reserve Board). This satisfies entity accuracy and part of the multi-hop requirement. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) However, the reasoning is flawed: while the LLM mentions that AML deficiencies could constrain acquisitions via restrictions on capital distributions, it fails to mention the core regulatory mechanism—that the FRB evaluates AML effectiveness *as a condition* for approving acquisitions under the USA PATRIOT Act. The ground truth emphasizes that the denial could occur directly due to risks to financial integrity and national security, not merely indirectly through capital constraints. This misrepresents the primary causal pathway. (4) The answer is contextually relevant and uses accurate terminology, but the absence of the direct regulatory linkage between AML compliance and acquisition approval under the PATRIOT Act reduces qualitative accuracy. Thus, while some facts are correct, the multi-hop synthesis is incomplete, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 378,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What was the percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020, and which product category does heated tobacco units fall under in PMI's financial reporting?",
      "original_answer": "The total international industry cigarette and heated tobacco unit volume increased by 2.4% in 2021 compared to 2020. Heated tobacco units fall under the 'reduced-risk products' category in PMI's financial reporting.",
      "llm_answer": "The percentage increase in PMI's total international industry cigarette and heated tobacco unit volume in 2021 compared to 2020 was 2.4%, and heated tobacco units fall under the \"Reduced-Risk Products\" category in PMI's financial reporting.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage increase of 2.4% in PMI's total international industry cigarette and heated tobacco unit volume from 2020 to 2021 is accurately reported. (2) The categorization of heated tobacco units under 'Reduced-Risk Products' in PMI's financial reporting is factually correct. (3) The answer addresses both parts of the multi-hop question: the quantitative change over time and the product classification, demonstrating proper synthesis of information. (4) All entities (PMI, 2020–2021 time frame, heated tobacco units) are correctly identified, and there are no calculation or reasoning errors. Minor wording differences (e.g., capitalization of 'Reduced-Risk Products') do not affect semantic accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 230,
        "total_tokens": 1365
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "Given the $1.8 billion customer financing portfolio and the 24.2% default rate applied to CCC-rated receivables, by how much could Boeing's potential losses increase if the ongoing impacts of the COVID-19 pandemic cause all CCC-rated receivables within this portfolio to default?",
      "original_answer": "Boeing's potential losses could increase by $435.6 million if all CCC-rated receivables within the $1.8 billion customer financing portfolio were to default, based on the 24.2% default rate applied to CCC-rated receivables.",
      "llm_answer": "Based on the provided document pages, Boeing's customer financing portfolio is $1.8 billion, and the allowance for losses on receivables with a CCC rating applies a default rate of 24.2% to that exposure. If all CCC‑rated receivables within the portfolio defaulted, the potential loss would be 24.2% of $1.8 billion, which equals approximately **$435 million**. This represents the maximum increase in Boeing’s potential losses under the scenario described.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.8 billion customer financing portfolio and applies the 24.2% default rate to calculate potential losses. The calculation is accurate: 24.2% of $1.8 billion = $435.6 million. The LLM reports 'approximately $435 million', which is a reasonable rounding and maintains quantitative accuracy. (2) All numeric values are correct or acceptably rounded. The original answer specifies $435.6 million, and the LLM's 'approximately $435 million' is semantically equivalent and commonly used in financial reporting. No calculation errors. (3) The reasoning is sound: the LLM correctly interprets that applying the 24.2% default rate to the entire CCC-rated portion of the portfolio represents the potential loss if all such receivables defaulted. It correctly synthesizes the risk exposure from the given default rate and portfolio size. (4) The answer is contextually fully relevant, directly addressing the scenario posed. The only minor shortcoming is the slight rounding without explicit 'approximately' in the original, but this does not affect correctness. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 347,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "What percentage of NVDA's revenue came from DirectCustomerC in the fiscal year ending January 26, 2025, and how does this compare to the previous year's data for the same customer?",
      "original_answer": "In the fiscal year ending January 26, 2025, DirectCustomerC accounted for 11% of NVDA's revenue. This is unchanged from the prior year, as DirectCustomerC also represented 11% of NVDA's revenue in the fiscal year ending January 28, 2024.",
      "llm_answer": "Based on the provided document pages, NVIDIA did not disclose a customer named \"DirectCustomerC\" that contributed 10% or more of total revenue in fiscal year 2025. The table on page 80 explicitly states that DirectCustomerC accounted for 11% of total revenue in fiscal year 2025 (and 11% in fiscal year 2024), but this is listed as \"* Less than 10% of total revenue\" in the footnote, indicating it did not meet the 10% threshold for material concentration. Consequently, no customer represented 10% or more of total revenue in fiscal year 2025, and the document does not provide a percentage for DirectCustomerC specifically—only that it contributed 11% (which is below the 10% materiality threshold). The document also confirms that all customers representing 10% or more of revenue were in the Compute & Networking segment, but none qualified in fiscal year 2025.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. (1) The original answer states that DirectCustomerC accounted for 11% of NVDA's revenue in both fiscal years ending January 26, 2025, and January 28, 2024. The LLM incorrectly claims that NVIDIA 'did not disclose' DirectCustomerC as contributing 10% or more, and misinterprets a footnote stating '* Less than 10%' despite the table explicitly listing 11%, which is a direct factual contradiction. (2) The quantitative error is severe: 11% is clearly above 10%, yet the model falsely concludes it is below the threshold and not disclosed—this misreads the document logic. The model also fails to report the correct percentages (11% for both years), which are explicitly stated. (3) The reasoning is flawed: the model confuses disclosure thresholds with data suppression, incorrectly assuming that a customer with 11% cannot be named or quantified, when the ground truth confirms it is both named and reported. (4) Contextual relevance is low because the answer invents a disclosure issue that does not affect the factual reporting of the percentage. The model fails the multi-hop task by rejecting accurate data due to a misinterpretation of footnotes, leading to a completely incorrect conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 354,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What is the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation as of December 31, 2023, and how does this compare to the unrealized losses associated with these securities according to the investment maturity breakdown?",
      "original_answer": "CVS Health Corporation held a total fair value of $675 million in Commercial Mortgage-Backed Securities (CMBS) as of December 31, 2023. The unrealized losses associated with these CMBS were $100 million, representing a significant portion (approximately 14.8%) of the total unrealized losses across all investment categories.",
      "llm_answer": "As of December 31, 2023, the total fair value of Commercial Mortgage-Backed Securities (CMBS) held by CVS Health Corporation was $975 million, as disclosed in the \"Debt securities\" table on page 147 (which lists \"Commercial mortgage-backed securities\" with a fair value of $975). This represents a decrease from $1,018 million in 2022. The unrealized losses associated with these securities totaled $100 million for the period ending December 31, 2023, as shown in the maturity breakdown on page 150 (where CMBS unrealized losses are listed as $100 million under \"Greater than ten years\" and \"Total\" columns for \"Supporting remaining products\"). This $100 million in unrealized losses is part of the broader $836 million total unrealized losses across all debt securities, but specifically relates to CMBS within the company's investment portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the total fair value of CMBS held by CVS Health Corporation. The ground truth states $675 million, but the LLM reports $975 million, which is incorrect. This discrepancy significantly undermines the answer's factual accuracy. However, the unrealized losses of $100 million are correctly reported and match the ground truth. (2) Quantitative accuracy is partially correct: the $100 million unrealized losses are accurate, and the percentage implied (14.8% of total unrealized losses) could be approximately correct if total unrealized losses were ~$676 million, but the LLM cites $836 million as total unrealized losses, which does not align with the ground truth context (where $100M is ~14.8% of total). This suggests either a misinterpretation of the total or an incorrect fair value input. The $975M figure appears to be a misreading of the source table—possibly confusing CMBS with another category or including additional securities. (3) The reasoning shows partial multi-hop capability: the model correctly links CMBS fair value and unrealized losses from different parts of the filing and attempts to contextualize the $100M loss within the broader portfolio. However, the foundational error in fair value breaks the chain of accurate synthesis. (4) Contextual relevance is high—the answer addresses both parts of the question (fair value and comparison to unrealized losses), cites specific pages, and uses appropriate terminology. Despite this, the major numerical inaccuracy in the primary metric (fair value) severely limits correctness. The answer would score higher if the fair value were correct, as the structure and intent are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 467,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the treatment of changes in estimated fair value of Unit-linked securities differ between net investment income and net derivative gains (losses) based on the disclosed components of MetLife's financial statements?",
      "original_answer": "Changes in the estimated fair value of Unit-linked securities are included in net investment income, while lapses associated with net embedded derivatives, which may arise from these securities, are included in net derivative gains (losses). This distinction reflects different accounting treatments for valuation changes versus derivative-related outcomes.",
      "llm_answer": "The disclosed sensitivity analysis for Level 3 fair‑value measurements shows that changes in the significant unobservable inputs are reflected differently in the two components of MetLife’s earnings.  \n\n- **Net investment income** incorporates the fair‑value changes of securities classified as “Unit‑linked and FVO securities” and other investments; these changes are recorded directly in net investment income (and, for certain securities, also in AOCI).  \n- **Net derivative gains (losses)** capture the fair‑value movements of embedded derivatives, net derivatives, and related liabilities (including those recorded in other liabilities and separate‑account liabilities). The sensitivity tables indicate that adjustments to inputs such as discount rates, mortality, lapse rates, utilization, and non‑performance spreads affect the estimated fair value of these embedded derivatives and are reported in net derivative gains (losses).  \n\nThus, while both components reflect fair‑value movements, the inputs driving changes in unit‑linked securities flow through net investment income, whereas the inputs affecting embedded derivative valuations flow through net derivative gains (losses).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of conceptual distinction between how changes in fair value of Unit-linked securities and embedded derivatives are treated. It correctly identifies that fair value changes for Unit-linked securities are included in net investment income, which matches the original answer. It also accurately states that valuation changes related to embedded derivatives (driven by inputs like lapse rates, mortality, etc.) are reported in net derivative gains (losses), and links lapses to derivative-related outcomes, consistent with the ground truth mention of 'lapses associated with net embedded derivatives'.\n\nQuantitatively, there are no specific numbers, dates, or dollar amounts in either the question or the original answer, so the LLM does not introduce any numerical inaccuracies—hence a perfect score on quantitative accuracy.\n\nThe minor deduction in qualitative accuracy is due to the LLM not explicitly stating the direct connection that lapses (from Unit-linked products) trigger the recognition in net derivative gains (losses), instead framing it more generally as sensitivity inputs affecting embedded derivatives. While this is not incorrect, it slightly abstracts the causal relationship emphasized in the ground truth: that the derivative gains/losses arise *because of* lapses tied to these securities. The LLM focuses on sensitivity analysis and inputs rather than the event-based accounting (valuation change vs. lapse event), making the explanation less precise in linking cause and accounting treatment.\n\nContextual relevance is high—the response directly addresses the question about differing treatments and correctly distinguishes the two income statement components using appropriate accounting terminology and disclosures.\n\nOverall, the answer is factually sound and well-reasoned but slightly less precise in articulating the specific cause-effect relationship (lapses from Unit-linked securities triggering derivative gains/losses) compared to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 552,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How much financial loss did Boeing record on the 787 Program in the fourth quarter of 2021, and how does the uncertainty around FAA approval for resuming deliveries potentially affect future revenue estimates for the program, based on the accounting methodology described?",
      "original_answer": "Boeing recorded a $3.5 billion loss on the 787 Program in the fourth quarter of 2021. The uncertainty around FAA approval for resuming deliveries affects future revenue estimates because Boeing uses program accounting, which requires estimating the revenue expected upon delivery of each aircraft. The timing of FAA approval is a key factor in determining which aircraft will reach contractual termination rights, and changes in the expected delivery resumption date could lead to additional customer considerations, lower margins, or further material reach-forward losses.",
      "llm_answer": "Boeing recorded a $3.5 billion loss on the 787 program in Q4 2021, driven by re‑work and delivery delays. The company’s accounting methodology ties future revenue estimates to the timing of FAA approval to resume deliveries; any further delay or additional re‑work could lower projected revenues and trigger additional losses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $3.5 billion loss in Q4 2021, matching the ground truth exactly in amount and time period. This satisfies the quantitative requirement with full accuracy. (2) The explanation of accounting methodology is partially complete: it correctly links FAA approval timing to revenue estimates under Boeing's program accounting, but omits specific mechanisms mentioned in the ground truth—namely, contractual termination rights, customer considerations, and the direct link between delivery resumption dates and forward loss recognition. These omissions reduce completeness in qualitative reasoning. (3) The multi-hop reasoning is sound—connecting financial loss, regulatory delay, and accounting implications—but lacks the full depth of synthesis regarding how program accounting propagates uncertainty into margin and loss projections. (4) Despite minor omissions in detail, the LLM captures the core causal chain and factual basis, warranting a high correctness score. Wording differences do not affect semantic equivalence on key points. Quantitative accuracy is perfect; contextual relevance is strong as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 337,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "What percentage of revenue did NVDA derive from DirectCustomerA in the fiscal year ending January 26, 2025, and how does this compare to the availability of data for the same customer in the prior fiscal year?",
      "original_answer": "NVDA derived 12% of its revenue from DirectCustomerA in the fiscal year ending January 26, 2025. The data for DirectCustomerA in the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), indicating no disclosed percentage for that year.",
      "llm_answer": "Based on the provided financial statements, NVDA derived approximately 12% of its total revenue from DirectCustomerA in the fiscal year ending January 26, 2025. This represents a significant increase compared to the prior fiscal year (January 28, 2024), where DirectCustomerA accounted for less than 10% of total revenue (indicated by an asterisk in the table). The prior year's revenue from DirectCustomerA was not material enough to meet the 10% threshold, while in the current year it represents 12% of total revenue, primarily driven by demand in the Compute & Networking segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 12% revenue percentage from DirectCustomerA in the fiscal year ending January 26, 2025, which matches the ground truth. However, it incorrectly interprets the prior year's data: the ground truth states that the data for the prior fiscal year (January 28, 2024) is marked as unavailable (denoted by '*'), meaning no percentage was disclosed. The LLM falsely claims that DirectCustomerA accounted for 'less than 10%' in the prior year and attributes the asterisk to non-materiality below a 10% threshold, which is not supported by the original answer. This is a significant factual error. (2) The quantitative accuracy is partially correct—12% is accurate, but the 'less than 10%' claim is fabricated. The dates (January 26, 2025, and January 28, 2024) are correctly used. (3) The multi-hop reasoning fails because the model infers information not present in the ground truth—specifically, the interpretation of '*' as 'less than 10%' and the claim of a 'significant increase'—which cannot be substantiated if the prior year data is simply unavailable. (4) Contextual relevance is high as the answer addresses both parts of the question and discusses the correct entities and timeframes, but the reasoning and factual accuracy are compromised by unsupported inferences. Thus, the correctness score is reduced to 4 due to major errors in interpreting missing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 391,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What was the total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023, combining the fair value of the investment and the net cost recoveries, product sales, and profit/loss sharing expenses related to the collaboration?",
      "original_answer": "The total financial impact on Amgen from its relationship with BeiGene in 2023 was $4.374 billion, combining the fair value of the investment ($4.2 billion), net cost recoveries ($109 million), product sales ($125 million), and profit/loss sharing expenses ($40 million).",
      "llm_answer": "The total financial impact on Amgen from its equity investment and collaboration with BeiGene in 2023 was $109 million, representing net cost recoveries from BeiGene that were recorded as an offset to R&D expense. This amount reflects the combined effect of fair‑value adjustments to the investment and the net cost recoveries, product sales, and profit/loss‑sharing expenses related to the collaboration.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative output and completeness. It states the total financial impact as $109 million, which is only one component (net cost recoveries) of the full $4.374 billion total. The correct total combines four elements: fair value of investment ($4.2B), net cost recoveries ($109M), product sales ($125M), and profit/loss sharing expenses ($40M). The LLM incorrectly presents $109M as the total, misrepresenting both magnitude and composition. (2) Number verification: $109 million (net cost recoveries) is accurate, but the other figures—$4.2B (investment), $125M (product sales), $40M (profit/loss sharing)—are omitted. The sum of these components is $4.374B, which the model fails to calculate or mention. The model also incorrectly implies that $109M represents a combined effect, which contradicts the ground truth. (3) Multi-hop reasoning is flawed: the question requires aggregating financial impacts across equity investment valuation and collaboration income/expenses. The model fails to synthesize these elements, instead focusing narrowly on one line item and mislabeling it as the total. It does correctly identify that fair value adjustments and collaboration items are relevant, showing partial understanding of the required components. (4) Scores justified as follows: Correctness is low (2/10) due to major factual inaccuracy in the final number and missing components. Quantitative accuracy is poor (2/10) because only one number is correct and the total is wildly off. Qualitative accuracy is slightly higher (3/10) because the model recognizes the types of financial items involved, though it misrepresents their relationships. Contextual relevance is moderate (6/10) as the answer addresses the right companies and general topic, but fails to deliver the required synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 502,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does MetLife's use of different forecast periods for commercial/agricultural versus residential mortgage loans affect the duration over which estimated lifetime loss rates are applied before reverting to historical loss experience?",
      "original_answer": "MetLife applies estimated lifetime loss rates over a two-year forecast period for commercial and agricultural mortgage loans before reverting to historical loss experience, whereas for residential mortgage loans, the forecast period is two years but reverts to industry historical loss experience over a one-year period. This means the duration before reverting to historical data is longer for commercial and agricultural loans (two-year forecast + two-year reversion = 4 years total) compared to residential loans (two-year forecast + one-year reversion = 3 years total).",
      "llm_answer": "The Company applies estimated lifetime loss rates to the amortized cost of commercial and agricultural mortgage loans over a two‑year forecast period, and then transitions to historical loss experience on a straight‑line basis over one year. For residential mortgage loans, the forecast period is one year before reverting to historical loss experience on a straight‑line basis over one year. Thus, the lifetime loss rates are used for roughly two years for commercial/agricultural loans and about one year for residential loans before the rates revert to historical experience.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MetLife uses a two-year forecast period for both commercial/agricultural and residential mortgage loans. However, the LLM incorrectly states that the forecast period for residential loans is one year, when it is actually two years. Additionally, the reversion period for commercial/agricultural loans is two years (not one), making the total duration 4 years, not 2 as implied. For residential loans, the reversion is one year after a two-year forecast, totaling 3 years—this is misrepresented in the LLM answer. (2) Quantitative accuracy is low: the LLM reports a one-year forecast for residential loans (should be two years) and fails to recognize the two-year reversion for commercial/agricultural loans. The conclusion that lifetime loss rates are used for 'roughly two years' for commercial loans is incorrect—the two-year forecast transitions over an additional two years, totaling four years. For residential, it's three years total, not one. (3) The multi-hop reasoning is flawed. The question asks about the duration over which estimated lifetime loss rates are applied before reverting to historical experience, which requires synthesizing both the forecast and reversion periods. The LLM fails to correctly identify or combine these periods for either loan type, leading to incorrect comparisons. (4) Contextual relevance is moderate—the response addresses the right topic and structure (forecast and reversion periods for different loan types), but due to factual and calculation errors, the core answer is misleading. The qualitative reasoning is unsound due to incorrect data synthesis across time periods and loan categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 474,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does Costco's self-insurance funding for employee health care benefits, as estimated through actuarial assumptions, potentially impact its financial condition in the context of unpredictable cost fluctuations and labor-related risks?",
      "original_answer": "Costco's self-insurance funding for employee health care benefits relies on historical claims experience, demographic factors, severity factors, and other actuarial assumptions. These liabilities are not discounted and are subject to significant unpredictability due to inflation rates, regulatory or legal changes, and unforeseen developments in claims. Since actual claims and costs could differ significantly from recorded liabilities, this could lead to unexpected financial burdens. Given that Costco also faces challenges in controlling labor and benefit costs—impacted by factors like healthcare costs and regulatory changes—these financial pressures could adversely affect its business, financial condition, and results of operations.",
      "llm_answer": "Costco’s self‑insurance for employee health benefits is funded through actuarial assumptions that estimate claim costs and set aside reserves accordingly. Because these assumptions are based on historical trends and projections, unexpected spikes in health‑care expenses or labor‑related claim fluctuations can cause the actual cash outlays to exceed the accrued amounts, creating unanticipated pressure on cash flow and potentially weakening the company’s overall financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth, with only minor omissions in detail. (1) All key elements are addressed: Costco's use of actuarial assumptions (based on historical trends, projections) for self-insurance funding, the risk of unexpected cost fluctuations, and the potential adverse impact on financial condition. The core reasoning—that actual costs may exceed accrued liabilities due to unforeseen changes in healthcare expenses or claims—is sound and matches the original. (2) There are no numeric values in either response, so quantitative accuracy is not applicable; however, the absence of numbers does not detract from correctness as none were required. (3) The multi-hop reasoning is logically structured: connecting self-insurance funding method → reliance on assumptions → exposure to variability in claims and healthcare costs → potential financial impact. The LLM correctly synthesizes the cause-effect chain between actuarial estimation risk and financial condition. (4) The only reason for not scoring a perfect 10 is that the LLM omits specific factors mentioned in the ground truth such as 'demographic factors', 'severity factors', 'non-discounted liabilities', and 'regulatory or legal changes'—though it broadly captures 'unexpected spikes' and 'fluctuations'. Despite this, the answer remains substantially accurate and contextually complete. Contextual relevance is full, as every part of the response directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 413,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How much did 3M's pre-tax charges related to the CAE Settlement and restructuring activities in 2023 total, and what was the impact of the reconsolidation of the Aearo Entities on 3M's balance sheet as of December 31, 2023?",
      "original_answer": "3M recorded a pre-tax charge of $4.2 billion related to the CAE Settlement and $437 million in restructuring charges in 2023, totaling $4.637 billion in charges. The reconsolidation of the Aearo Entities resulted in the removal of a $0.7 billion asset in equity and other investments and a $0.6 billion net liability for former intercompany amounts, impacting the consolidated balance sheet as of December 31, 2023.",
      "llm_answer": "The pre‑tax charges related to the CAE Settlement and restructuring activities in 2023 totaled **$4.2 billion** (the CAE Settlement charge recorded in the third quarter of 2023), and the reconsolidation of the Aearo Entities in 2023 resulted in an **immaterial income‑statement impact** but **did not change the consolidated balance‑sheet totals**; the only balance‑sheet effect noted was the removal of a $0.7 billion equity‑investment asset and a $0.6 billion net intercompany liability that had been recorded in 2022 and therefore did not appear on the 2023 balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly identifies the $4.2 billion pre-tax charge for the CAE Settlement, it omits the $437 million in restructuring charges, leading to an incorrect total of $4.2 billion instead of the correct $4.637 billion. This is a major quantitative error. (2) The balance sheet impact is partially correct in noting the removal of a $0.7 billion equity investment and a $0.6 billion net intercompany liability, but the LLM incorrectly claims these items 'did not appear on the 2023 balance sheet' because they were 'recorded in 2022'. This misrepresents the reconsolidation effect: the removal of these items *is* the balance sheet impact as of December 31, 2023, and they were eliminated *during* 2023 due to reconsolidation. The claim that the reconsolidation 'did not change the consolidated balance-sheet totals' is misleading and incorrect—removing assets and liabilities does impact balance sheet composition and structure, even if net equity or total assets/liabilities might be adjusted accordingly. (3) The multi-hop reasoning fails: the model does not correctly synthesize the two components of pre-tax charges (CAE + restructuring), missing a key part of the question. It also misinterprets the timing and effect of the reconsolidation, failing to link the elimination of intercompany balances and equity investments as a direct consequence of reconsolidation in 2023. (4) The contextual relevance is moderate because the answer addresses the right topics and entities (CAE Settlement, Aearo Entities, balance sheet impact), but the factual and logical errors severely undermine accuracy. Quantitative accuracy is low due to the missing $437M charge and incorrect total. Qualitative accuracy is poor due to flawed reasoning about balance sheet effects. Correctness score is low because core financial figures and their implications are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 521,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does Google's integration of Gemini 2.0 into its Vertex AI platform expand the capabilities available to developers on Google Cloud Platform?",
      "original_answer": "Google's integration of Gemini 2.0 into its Vertex AI platform provides developers with advanced tools to train, tune, augment, test, and deploy applications using Gemini, Imagen, Veo, and other generative AI models. This significantly enhances the development environment on Google Cloud Platform, allowing developers to build more sophisticated and multimodal applications.",
      "llm_answer": "Google's integration of Gemini 2.0 into Vertex AI expands developers’ capabilities on GCP by giving them direct access to Google’s most advanced multimodal model for building, tuning, and deploying AI‑powered applications. Through Vertex AI, developers can leverage Gemini 2.0 alongside other first‑party and open models, use built‑in services such as vector search, grounding and distillation, and consume Gemini‑powered agents that assist with code generation, testing, and cybersecurity—enabling faster, higher‑quality AI innovation at scale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the integration of Gemini 2.0 into Vertex AI as a means to expand developer capabilities on Google Cloud Platform. The key elements—training, tuning, deploying AI applications using Gemini and other models (e.g., Imagen, Veo implied through 'other first-party models')—are present, though not explicitly named. The LLM adds specific functionalities like vector search, grounding, distillation, and Gemini-powered agents for code generation, testing, and cybersecurity, which are consistent with the enhanced development environment described in the original answer. There are no numeric values to verify, so quantitative accuracy is 10. Qualitative accuracy is slightly reduced because the original answer emphasizes 'multimodal applications' and lists Imagen and Veo explicitly, which the LLM omits but partially compensates by mentioning 'multimodal model' and 'open models'. The reasoning is sound and reflects correct synthesis of the platform's expanded capabilities. Contextual relevance is perfect—the response directly addresses how the integration benefits developers on GCP.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 331,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the inclusion of FVO securities in the yield calculation for fixed maturity securities impact the reported investment income and sensitivity to fair value changes for MetLife in 2024, given the valuation techniques applied to FVO securities under Level 3 classifications?",
      "original_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities contributed $205 million in investment income for 2024, directly affecting yield performance metrics. Since FVO securities are classified under Level 3 and are subject to valuation techniques involving significant unobservable inputs (such as nonperformance risk spreads and long-term equity volatilities), changes in these inputs can materially alter the estimated fair value of these securities. This dual treatment—using FVO securities in both yield calculations and fair value measurements—means that fluctuations in market assumptions not only affect income volatility but also the sensitivity of the fair value of FVO securities, amplifying financial statement variability.",
      "llm_answer": "The inclusion of FVO securities in the yield calculation for fixed maturity securities raises the reported investment income by adding the FVO securities’ earnings (e.g., $205 million in 2024 and $188 million in 2023) to the GAAP net investment income, and it also increases the sensitivity of reported earnings to fair‑value changes because FVO securities are marked‑to‑market through the income statement; consequently, any shift in the Level 3 inputs used to value those securities (such as quoted prices, market yields, or credit spreads) directly impacts the amount of investment income recognized and the magnitude of fair‑value adjustments recorded in net income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $205 million contribution to investment income in 2024 from FVO securities, matching the ground truth. It also accurately references $188 million in 2023, which, while not required for the question, adds context without introducing error. All quantitative figures are factually correct and properly attributed to the right year and metric. (2) The numbers are accurate: $205 million for 2024 is explicitly confirmed in the original answer and correctly restated. No calculations are required, but the inclusion of a prior-year figure does not detract from accuracy. (3) The reasoning is sound and captures the multi-hop logic: FVO securities impact both yield calculations (boosting reported investment income) and fair value sensitivity due to Level 3 inputs. The LLM correctly explains that because FVO securities are marked-to-market through income, changes in unobservable inputs (e.g., credit spreads, market yields) affect both investment income and fair value adjustments. It slightly generalizes the Level 3 inputs—listing 'quoted prices' as an input, which is atypical for Level 3 (more relevant to Level 1)—but correctly emphasizes market yields and credit spreads, which align with nonperformance risk and volatility assumptions mentioned in the ground truth. (4) The answer is contextually complete and highly relevant, addressing both the income impact and sensitivity to fair value changes. The only minor shortcoming is a slight imprecision in characterizing Level 3 inputs (quoted prices are not typically part of Level 3), which prevents a perfect 10 in qualitative accuracy. Overall, the semantic meaning and factual content match the ground truth closely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 471,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What was the total pre-tax financial impact on 3M from both the initial deconsolidation of the Aearo Entities in 2022 and the subsequent reconsolidation in 2023, and how did these events relate to the Combat Arms Earplugs litigation?",
      "original_answer": "The total pre-tax financial impact on 3M from both the deconsolidation and reconsolidation of the Aearo Entities was $1.2 billion. This includes a $1.0 billion funding commitment plus $0.2 billion for projected case expenses related to the Combat Arms Earplugs litigation, which led to a pre-tax charge in 2022. The reconsolidation in 2023 had an immaterial income statement impact, but the overall litigation and settlement process directly triggered both events.",
      "llm_answer": "The total pre‑tax financial impact of the 2022 deconsolidation of the Aearo entities and the 2023 reconsolidation was a $1.2 billion charge recorded in 2022 (reflecting the $1.2 billion pre‑tax charge to fund the $1 billion trust for the Combat Arms Earplugs litigation) and a $4.2 billion pre‑tax charge recorded in 2023 related to the $5.3 billion present‑value contribution under the CAE Settlement, together representing the financial impact of both events. These charges were directly tied to the Combat Arms Earplugs litigation, as the 2022 charge funded the bankruptcy‑trust settlement and the 2023 charge reflected the settlement of that litigation after the Aearo entities were reconsolidated.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states the total pre-tax financial impact was $1.2 billion, comprising a $1.0 billion funding commitment and $0.2 billion for projected case expenses, all recognized in 2022. The LLM incorrectly claims a $1.2 billion charge in 2022 and a $4.2 billion charge in 2023, totaling $5.4 billion, which is not supported by the original answer. The $4.2 billion and $5.3 billion figures appear to be fabricated or misattributed. (2) Quantitative accuracy is severely compromised: the original answer explicitly states the reconsolidation in 2023 had an immaterial income statement impact, but the LLM reports a $4.2 billion pre-tax charge in 2023, which contradicts the ground truth. The $1.2 billion total impact is misrepresented as two separate charges across years, with incorrect magnitudes. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the link between the Aearo Entities and the Combat Arms Earplugs litigation, it fails to accurately synthesize the timing and financial impact of the deconsolidation and reconsolidation. It incorrectly attributes significant financial charges to 2023 when the original answer states the reconsolidation was immaterial to the income statement. (4) Contextual relevance is moderate—the answer addresses the right topic and litigation, and correctly ties the events to the Combat Arms Earplugs litigation, but the financial figures and their allocation across years are fundamentally wrong, undermining the overall correctness. The answer introduces unsupported details (e.g., $5.3 billion present-value contribution) not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 462,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the integration of Adobe Firefly into Creative Cloud and Document Cloud contribute to Adobe's strategy of increasing recurring revenue and expanding its customer base, as evidenced by specific product offerings and AI-driven capabilities in fiscal 2023?",
      "original_answer": "Adobe Firefly, introduced in September 2023, is integrated into Creative Cloud apps such as Photoshop and Express, providing generative AI capabilities that enhance user engagement and attract new customers, including novice creators and communicators. This integration supports Adobe's strategy to increase recurring revenue by offering new features that justify subscription renewals and attract cost-sensitive users through targeted packages like Adobe Express and Substance 3D Collection. Additionally, Firefly's generative AI features are part of Adobe's broader AI-driven tools (e.g., Adobe Sensei), which improve Document Cloud's functionality, such as making PDFs more intelligent and responsive. These innovations help Adobe expand its customer base and drive long-term revenue growth through increased product value and user retention.",
      "llm_answer": "Adobe's integration of Firefly into Creative Cloud and Document Cloud fuels its strategy of expanding recurring revenue and customer base by embedding AI-driven generative capabilities—such as Generative Fill, Recolor, Expand, and Text-to-Image—into flagship Creative Cloud apps like Photoshop, Illustrator, and Express, thereby increasing user engagement, attracting new creators, and enabling subscription upgrades through features like Generative Credits; simultaneously, Firefly enhances Document Cloud's value by adding AI-powered document workflows and automation, driving adoption of Adobe's subscription services and reinforcing a predictable, ratable revenue stream across both segments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Adobe Firefly was introduced in September 2023 (implied by fiscal 2023 context), and its integration into Creative Cloud apps like Photoshop, Illustrator, and Express is accurately described. The mention of generative AI features such as Generative Fill, Recolor, Expand, and Text-to-Image reflects actual capabilities introduced in fiscal 2023. The use of 'Generative Credits' as a subscription-based access model is a correct detail not in the original answer but factually valid and adds precision. (2) There are no numeric values, dates, or financial figures in either answer that conflict; the LLM correctly situates Firefly within fiscal 2023 without introducing incorrect timing. (3) Multi-hop reasoning is sound: the LLM correctly links Firefly's AI capabilities to increased user engagement, subscription upgrades, and customer acquisition—tying product-level features to Adobe's broader business strategy of recurring revenue growth. It also correctly extends Firefly’s impact to Document Cloud through AI-powered workflows, consistent with the original answer’s claim about making PDFs more intelligent. (4) The only minor gap is that the LLM does not explicitly mention 'Adobe Sensei' or specific targeted packages like 'Substance 3D Collection' or 'cost-sensitive users,' which are part of the original answer’s evidence for customer expansion. However, the core strategic contribution—expanding customer base and increasing recurring revenue via AI integration—is fully captured with strong qualitative and contextual accuracy. Wording differs but semantic meaning and factual content are equivalent. Minor omission prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 486,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "What is the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, and how does this value compare to the total fair value of all available-for-sale investments?",
      "original_answer": "The total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, is $4,335 million ($1,676 million + $2,659 million). This amount represents the full value of all available-for-sale investments, which also totals $4,335 million.",
      "llm_answer": "Based on the provided SEC 10-K filing data, the total fair value of U.S. Treasury bills and money market mutual funds held by Amgen as of December 31, 2022, was $4,335 million. This amount represents the total fair value of all available-for-sale investments for that year, as shown in the \"Available-for-sale investments\" table on page 133, where money market mutual funds alone had a fair value of $2,659 million and U.S. Treasury bills were $1,676 million, totaling $4,335 million. This is consistent with the consolidated balance sheet location reporting total available-for-sale investments of $4,335 million for 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the fair value of U.S. Treasury bills ($1,676 million) and money market mutual funds ($2,659 million) are correctly cited, and their sum ($4,335 million) is accurate. (2) The calculation is correct: $1,676M + $2,659M = $4,335M, and the LLM correctly states that this total equals the total fair value of all available-for-sale investments, which is also $4,335 million. (3) The multi-hop reasoning is sound—the model correctly synthesizes data from two line items (U.S. Treasury bills and money market mutual funds) and links them to the total available-for-sale investments, confirming consistency with the consolidated balance sheet. (4) The answer addresses both parts of the question: the total fair value of the specified securities and how that compares to the total available-for-sale investments. Semantic equivalence is maintained, with no irrelevant or incorrect details. Minor additions (e.g., page reference) enhance clarity without affecting accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 303,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How do the valuation techniques for Unit-linked securities described in the MetLife 2024 10-K affect the sensitivity of fair value measurements to changes in long-term equity volatility and nonperformance risk spreads?",
      "original_answer": "The valuation techniques for Unit-linked securities at MetLife involve using long-term equity volatility and nonperformance risk spreads as significant unobservable inputs. According to the 10-K filing, long-term equity volatility affects the estimated fair value of these securities, especially when observable equity volatilities are not available beyond a certain period. Additionally, nonperformance risk spreads, which vary by duration and currency, are applied to discount cash flows for purposes of valuing market risk benefits (MRBs). As a result, changes in either of these inputs directly influence the fair value of Unit-linked securities, making them sensitive to shifts in long-term market expectations and credit risk assessments.",
      "llm_answer": "The valuation of unit‑linked securities and related embedded derivatives relies on long‑term equity volatility and non‑performance risk spreads; the sensitivity analysis in the Level‑3 tables shows that increases in these inputs lead to higher estimated fair values, while decreases produce the opposite effect.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that long-term equity volatility and nonperformance risk spreads are key inputs in the valuation of unit-linked securities and that changes in these inputs affect fair value. It accurately states the direction of sensitivity—increases lead to higher fair values, decreases to lower—aligning with the concept of sensitivity described in the original answer. However, it omits key qualitative details present in the ground truth, such as the use of long-term volatility when observable data is unavailable beyond a certain period, and the specific application of nonperformance risk spreads to discount cash flows for market risk benefits (MRBs). These omissions reduce completeness and depth of reasoning. (2) There are no numeric values, percentages, or dates in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect figures. (3) The multi-hop reasoning is partially sound—the LLM connects valuation techniques to sensitivity effects but fails to explain *how* or *why* these inputs are used (e.g., unobservable inputs in Level 3, discounting MRBs), which weakens the logical synthesis across concepts. (4) The correctness score is 7 because core facts about sensitivity are correct, but important explanatory context from the original answer is missing. Quantitative accuracy is 10 due to absence of numerical errors. Qualitative accuracy is 7 due to correct identification of inputs and directional impact but missing mechanistic and contextual details. Contextual relevance is 9 because the response directly addresses the question’s focus on sensitivity, though with less depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 459,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does Adobe's introduction of Generative Credits in Adobe Firefly, as part of its Creative Cloud offering, support its broader strategy to increase customer engagement and subscription revenue across both creative professionals and non-creative stakeholders?",
      "original_answer": "Adobe introduced Generative Credits as part of Adobe Firefly within its Creative Cloud offering, allowing users to generate AI-based content after reaching a usage limit. These credits enhance the value of existing subscriptions and encourage continued engagement by offering a paid upsell option. This aligns with Adobe’s strategy to use product-led growth, infusing AI into creative apps like Photoshop and Illustrator to make workflows more efficient and accessible. By integrating Firefly’s generative AI capabilities into widely used tools and offering tiered access (free and premium), Adobe expands its customer base beyond traditional creative professionals to include communicators, marketers, and other stakeholders involved in content creation and approval. This drives higher engagement, conversion, and retention, directly supporting Adobe’s goal of increasing recurring subscription revenue and deepening customer relationships.",
      "llm_answer": "Adobe’s introduction of Generative Credits in Firefly directly advances its strategy to deepen engagement and expand subscription revenue by embedding AI-powered content creation into both Creative Cloud and Experience Cloud offerings. By granting users—ranging from creative professionals to non-creative stakeholders like marketers and enterprises—access to Firefly’s generative AI capabilities via a scalable credit system, Adobe enhances the value of existing subscriptions, attracts new users (including those outside traditional creative roles), and drives recurring revenue through premium credit purchases and enterprise adoption, all while reinforcing its AI ethics framework and differentiation in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe introduced Generative Credits in Firefly as part of Creative Cloud, the credit system supports upsell and engagement, and the strategy targets both creative professionals and non-creative stakeholders like marketers. The integration into Creative Cloud and implied expansion to broader user bases are correctly identified. (2) There are no numeric values (e.g., dollar amounts, credit counts, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly links Generative Credits → AI integration → expanded user base → increased engagement and subscription revenue, and connects this to Adobe’s broader product-led growth and enterprise strategy. It slightly extends the original by mentioning Experience Cloud and AI ethics, which are contextually plausible and consistent with Adobe’s public strategy, though not explicitly in the ground truth—this does not detract from accuracy but adds minor inferential content. (4) The answer is fully contextually relevant, addressing all parts of the question: how Generative Credits support engagement and revenue across both creative and non-creative users. The only reason for not scoring a 10 in correctness is the slight expansion beyond the provided ground truth (e.g., Experience Cloud, ethics framework), which, while reasonable, are not confirmed in the source. Overall, the semantic meaning, core facts, and strategic logic match the original answer precisely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 446,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does the integration of Gemini 2.0 across Google's billion-user products and Vertex AI platform contribute to Google Cloud's ability to generate revenue from AI-optimized infrastructure and developer services?",
      "original_answer": "Gemini 2.0 powers AI features across all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—enhancing user experiences and increasing engagement. This widespread integration supports Google's broader ecosystem, which in turn drives demand for Google Cloud's AI-optimized infrastructure and Vertex AI platform. Google Cloud offers Gemini through Vertex AI, enabling developers to train, tune, and deploy applications using advanced generative AI models. This provides scalable AI solutions for enterprises and developers, which directly contributes to Google Cloud's revenue through consumption-based fees and subscriptions for infrastructure and platform services.",
      "llm_answer": "The integration of Gemini 2.0 into Google’s billion‑user products and the Vertex AI platform lets Google leverage its AI‑optimized infrastructure—such as TPUs, data‑center efficiencies, and custom accelerators—to deliver advanced, scalable AI services. This enables the company to monetize its cloud offerings through consumption‑based fees for AI‑optimized infrastructure, developer tools on Vertex AI (including Gemini‑powered agents), and cybersecurity solutions, while also driving higher‑value advertising and subscription revenue across its ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core mechanisms by which Gemini 2.0 integration contributes to Google Cloud's revenue. However, there is a minor inaccuracy in the user base figure: the original answer specifies 'seven of Google's two billion-user products', while the LLM states 'billion-user products', understating the scale. This is a quantitative and entity accuracy issue, though not critical. The LLM correctly identifies the integration of Gemini 2.0 into both consumer products and Vertex AI, and links this to monetization via consumption-based fees and developer services. It adds value by mentioning TPUs, custom accelerators, and cybersecurity solutions, which are plausible but not explicitly in the ground truth—this is acceptable as elaboration, not error. The reasoning is sound: it connects widespread AI integration to increased demand for cloud infrastructure and developer tools. The answer addresses both parts of the question—integration across products and revenue generation—demonstrating proper multi-hop synthesis between consumer AI deployment and cloud monetization. Semantic equivalence is high, with only slight imprecision in scale. Contextual relevance is excellent, directly addressing the question with appropriate focus on infrastructure, platform services, and revenue models.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 369,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How do changes in prepayment and default rates impact MetLife's income recognition on FVO securities, and what unobservable inputs further influence the valuation of these securities?",
      "original_answer": "Changes in prepayment and default rates directly impact MetLife's income recognition on FVO securities, as income on these securities is dependent on such factors. Additionally, unobservable inputs such as long-term equity volatilities and nonperformance risk spreads are used in the valuation of FVO securities, which affect their fair value and, consequently, the financial statement presentation.",
      "llm_answer": "Changes in prepayment and default rates directly affect the timing and amount of cash flows used to estimate the fair value of fixed maturity securities classified as FVO, leading to adjustments in income recognition. Additionally, unobservable inputs such as mortality rates, lapse rates, utilization rates, withdrawal rates, long‑term equity volatilities, and non‑performance risk spreads are key drivers influencing the valuation of these securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that changes in prepayment and default rates impact income recognition on FVO securities by affecting cash flow estimates used in fair value measurement—this matches the original answer's assertion of direct impact on income recognition. (2) There are no numeric values requiring verification (e.g., percentages, dollar amounts, dates), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model connects prepayment/default rates to cash flows, then to fair value estimation, and finally to income recognition—demonstrating proper synthesis. (4) The LLM expands slightly on unobservable inputs by including mortality rates, lapse rates, utilization rates, and withdrawal rates, which are not mentioned in the ground truth. While these may be relevant to other insurance-related valuations, they are not specified in the original answer as affecting FVO securities; thus, this is a minor overextension. However, the inclusion of long-term equity volatilities and non-performance risk spreads—key unobservable inputs from the ground truth—is correct and complete. The term 'non-performance risk spreads' is used instead of 'nonperformance risk spreads'—a minor spelling variation that does not affect meaning. Overall, the answer is semantically equivalent with only slight over-specification of unobservable inputs, warranting a high but not perfect qualitative score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 412,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does Costco's investment in Kirkland Signature products influence its gross margin performance, considering the brand's role in member loyalty and the risks associated with its production and availability?",
      "original_answer": "Costco's investment in Kirkland Signature products positively influences its gross margin performance because these private-label items generally carry higher margins than national brand products and represent a growing portion of overall sales. However, this margin benefit is contingent on maintaining consistent product quality, competitive pricing, and availability. If the Kirkland Signature brand experiences a loss of member acceptance or confidence, or if there are disruptions in production and delivery, Costco's sales and gross margin results could be adversely affected due to reduced member loyalty and potential out-of-stock situations.",
      "llm_answer": "Costco’s reliance on Kirkland Signature products boosts gross margin because private‑label items typically carry higher margins than national brands, and their strong member acceptance reinforces loyalty and drives repeat visits. However, this advantage is vulnerable: any disruption in production, quality issues, or supply‑chain interruptions that affect Kirkland products can erode member confidence, reduce sales, and pressure margins, especially if the brand’s reputation or availability is compromised.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Kirkland Signature products boost gross margins due to higher profitability compared to national brands and links this to member loyalty, which aligns with the original answer. It also accurately highlights the risks: production disruptions, quality issues, and supply-chain problems can erode member confidence, hurt sales, and negatively impact margins—mirroring the original's emphasis on availability and brand perception. (2) There are no numeric values, percentages, dates, or financial figures in either answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers or fabricated data earns a perfect score by default. (3) The multi-hop reasoning is sound: the model connects private-label strategy → higher margins → member loyalty → risk exposure through supply/quality issues, synthesizing business model dynamics and risk factors across multiple implicit layers. (4) The only minor shortcoming is a slightly less explicit mention of the 'growing portion of overall sales' aspect noted in the original, which strengthens the margin impact. While implied through 'strong member acceptance,' it's not directly stated. Otherwise, the answer is fully contextually relevant, addressing all facets of the question: margin performance, loyalty, and production/availability risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 395,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What was the change in the fair value of 'Other short-term interest-bearing securities' from December 31, 2022, to December 31, 2023, and how does this shift reflect in the total available-for-sale investments for those respective years?",
      "original_answer": "The fair value of 'Other short-term interest-bearing securities' increased from $0 on December 31, 2022, to $138 million on December 31, 2023. This increase contributed to a rise in total available-for-sale investments from $4,335 million in 2022 to $10,404 million in 2023, reflecting a significant growth of $6,069 million in the company's short-term investment portfolio.",
      "llm_answer": "The fair value of “Other short‑term interest‑bearing securities” was $138 million on December 31 2023 and $0 million on December 31 2022, so it increased by $138 million year‑over‑year. This increase is reflected in the total available‑for‑sale investment balance, which rose from $4,335 million at the end of 2022 to $10,404 million at the end of 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the fair value of 'Other short-term interest-bearing securities' was $0 million on December 31, 2022, and $138 million on December 31, 2023, representing a $138 million increase—correctly stated. The total available-for-sale investments increased from $4,335 million in 2022 to $10,404 million in 2023, a difference of $6,069 million, which is accurately reflected in the LLM answer even though the exact difference is not explicitly calculated—the rise is correctly described. (2) The answer addresses both parts of the question: the change in fair value for the specific security and how it reflects in the total available-for-sale investments. (3) Entities—'Other short-term interest-bearing securities', 'available-for-sale investments', and the correct dates (December 31, 2022, and December 31, 2023)—are all correctly identified. (4) The reasoning is sound: the LLM correctly infers that the $138 million increase in the specific security contributes to the overall increase in total available-for-sale investments, demonstrating proper multi-hop synthesis between the specific asset and the broader investment category. (5) The semantic meaning is equivalent to the original answer, with no factual discrepancies, making the response fully accurate, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 392,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the developments in the Proposed Plan of compromise and arrangement, including RBH's objection filed on January 24, 2025, influence the quantitative valuation of PMI’s investment in RBH as of December 31, 2024, and what was the resulting impairment charge recorded in the consolidated statement of earnings?",
      "original_answer": "Developments in the Proposed Plan, including RBH's objection filed on January 24, 2025, narrowed the range of possible outcomes regarding the allocation of the CAD 32.5 billion aggregate global settlement amount among RBH, ITL, and JTIM. This narrowing of outcomes served as an indicator that PMI's investment in RBH may be impaired. As a result, PMI performed a quantitative valuation of its investment in RBH as of December 31, 2024, using a discounted cash flow analysis that incorporated significant assumptions such as discount rate, sales volumes, and operating margins for the combustible tobacco business in Canada, as well as estimates regarding the allocation of the settlement amount and its tax deductibility. This valuation concluded that the fair value of PMI’s investment in RBH was $714 million, significantly lower than its carrying value, leading to a non-cash impairment charge of $2,316 million recorded in the consolidated statement of earnings for the year ended December 31, 2024.",
      "llm_answer": "The Proposed Plan’s unresolved allocation of the CAD 32.5 billion settlement created an impairment indicator that led PMI to perform a quantitative valuation of its RBH equity investment as of December 31 2024. Using a discounted‑cash‑flow analysis that factored in the disputed settlement allocation, PMI estimated the fair value of the RBH investment at $714 million—significantly below its carrying amount—so it recorded a non‑cash impairment charge of $2,316 million in the consolidated statement of earnings for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: the CAD 32.5 billion settlement, the impairment indicator due to unresolved allocation, the quantitative valuation as of December 31, 2024, the use of discounted cash flow analysis, the estimated fair value of $714 million, and the resulting non-cash impairment charge of $2,316 million. All numeric values and dates are accurate and match the ground truth. Format variations (e.g., $714 million vs $714 million) are acceptable and do not affect meaning. (2) Quantitative accuracy is perfect: both the fair value and impairment charge are correct, and the implied carrying value ($714M + $2,316M = $3,030M) is consistent with the ground truth. No calculation errors. (3) The multi-hop reasoning is sound: the answer correctly links RBH's objection (implied in 'unresolved allocation') to increased uncertainty in settlement distribution, which triggered an impairment test, leading to a DCF-based valuation and ultimately the impairment charge. The only minor omission is that the original answer specifies additional DCF assumptions (discount rate, sales volumes, operating margins, tax deductibility), which the LLM answer summarizes as 'factored in the disputed settlement allocation'—this simplification reduces qualitative completeness slightly but does not introduce error. (4) Contextual relevance is excellent: the response directly addresses both parts of the question—how developments influenced the valuation and what the resulting impairment charge was. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a minor deduction in qualitative accuracy for slightly less detail in the valuation methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 481,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "Given the increase in advertising revenues from Google Network properties and the expectation that TAC paid to Google Network partners will increase as revenues grow, how much would the absolute dollar amount of TAC paid to Google Network partners increase if advertising revenues from Google Network properties grew by $10 billion in 2023 compared to 2022, assuming the TAC rate remained constant at 22% as indicated in the filing?",
      "original_answer": "$2.2 billion",
      "llm_answer": "Based on the filing, the TAC rate is explicitly stated to be 22% of advertising revenues. If advertising revenues from Google Network properties increased by $10 billion in 2023 versus 2022, the absolute dollar increase in TAC paid to Google Network partners would be 22% of that $10 billion increase, which equals **$2.2 billion**. This calculation assumes the TAC rate remains constant at 22% as indicated.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative calculation is accurate: 22% of a $10 billion increase in advertising revenue equals $2.2 billion, which is correctly computed. (2) The answer addresses all parts of the question, including the assumption of a constant TAC rate at 22% and the impact of a $10 billion revenue increase. (3) Entities such as 'Google Network properties', 'TAC rate', and the relevant time frame (2023 vs 2022) are correctly identified and used in context. (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly applies the TAC rate from the filing to the hypothetical revenue increase, demonstrating understanding of the proportional relationship between revenue and TAC payments. The answer is semantically equivalent to the original and conveys the same information with clear, precise language.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 258,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31, 2023, to December 31, 2024, and how does this compare to the change in fair value over the same period?",
      "original_answer": "The carrying value of UnitedHealth Group's long-term debt and other financing obligations increased by $14,155 million from $61,449 million in 2023 to $75,604 million in 2024. The fair value increased by $10,714 million from $59,851 million in 2023 to $70,565 million in 2024. This indicates that the carrying value increased more significantly than the fair value over the same period.",
      "llm_answer": "The change in the carrying value of UnitedHealth Group's long-term debt and other financing obligations from December 31 2023 to December 31 2024 was an increase of $14.1 billion (from $61,449 million to $75,604 million). Over the same period, the fair value of this debt increased by $10.7 billion (from $59,851 million to $70,565 million), meaning the carrying‑value increase was larger than the fair‑value increase.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures: the carrying value increased from $61,449 million to $75,604 million, a difference of $14,155 million, which the model rounds to $14.1 billion—this is an acceptable approximation. Similarly, the fair value increased from $59,851 million to $70,565 million, a $10,714 million increase, which the model rounds to $10.7 billion—again, a reasonable and common rounding. The core comparison—that the carrying value increased more than the fair value—is accurately stated. (2) All numeric values match the ground truth when accounting for rounding; no calculation errors are present. The model correctly computes and presents the changes, even though exact differences are rounded for readability. (3) The multi-hop reasoning is sound: the model synthesizes data across two time points and two valuation methods (carrying value and fair value), correctly comparing both the absolute changes and their relative magnitudes. (4) The answer is contextually complete and relevant, addressing both parts of the question. The only minor limitation is the rounding of exact dollar changes, but this does not affect factual correctness or interpretation, hence a score of 9 instead of 10 on qualitative and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 358,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in merchant transaction costs in 2022, and how does this relate to the overall growth in merchant revenues compared to agency revenues?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs in 2022. This significant rise in transaction costs indicates strong growth in merchant activity, which aligns with the observation that merchant revenues increased more than agency revenues during the same period. The growth in merchant revenues was driven by the expansion of these services, reflecting stronger demand and operational scale in the merchant model compared to the agency model.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com drove a **108.4% year-over-year increase in merchant gross bookings** (from $25.8B to $53.9B in 2022), directly contributing to a **94.6% surge in merchant revenues** (from $3.7B to $7.2B). This growth in merchant revenues significantly outpaced agency revenue growth (35.1%), reflecting the strategic shift toward merchant-facilitated transactions. Consequently, merchant transaction costs rose substantially, though the exact dollar amount of this increase is not explicitly quantified in the provided financial data. The document confirms that merchant transaction costs were a key component of the $573 million increase in sales and other expenses, driven by higher merchant transaction volumes.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative metrics—108.4% growth in merchant gross bookings (from $25.8B to $53.9B) and 94.6% revenue growth (from $3.7B to $7.2B)—that are not present in the original answer and cannot be verified against the ground truth. These figures, while plausible, are not supported by the provided knowledge graph and thus introduce unverified data. The original answer states a $573 million increase in merchant transaction costs, which is precise and directly responsive. The LLM incorrectly implies this $573M is part of 'sales and other expenses' and that the exact dollar amount of cost increase is not explicitly quantified—this contradicts the original, which clearly attributes the $573M increase directly to the expansion of merchant services. (2) The calculation of percentage increases (e.g., (53.9 - 25.8)/25.8 ≈ 108.4%) is mathematically correct based on the numbers provided, but the source of these numbers is not confirmed in the ground truth, making the quantitative claims speculative. The comparison to agency revenue growth (35.1%) also lacks grounding in the original answer, which only states that merchant revenues grew more than agency revenues without specific percentages. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that growth in merchant activity leads to higher transaction costs and that this reflects a strategic shift. However, it fails to directly link the $573M cost increase to the expansion as a causal outcome, instead downplaying the specificity of that figure. (4) The contextual relevance is high because the answer addresses both parts of the question: the contribution to transaction costs and the comparison between merchant and agency revenue growth. However, the introduction of unsupported numbers and the mischaracterization of the $573M figure significantly reduce factual accuracy. The core claim—that merchant revenue growth outpaced agency—is consistent with the original, but the precision of the LLM's numbers creates a false sense of accuracy. Therefore, while the directionality and logic are reasonable, the factual correctness is compromised by unverified data and misattribution of the cost increase.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 596,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "What is the significance of AMD introducing Zynq UltraScale+ RFSoCs in the context of its FPGA and Adaptive SoC product lines, and how does this introduction align with AMD's broader strategy to serve markets requiring high-performance RF data conversion capabilities?",
      "original_answer": "AMD's introduction of Zynq UltraScale+ RFSoCs is significant because it expands the company's FPGA and Adaptive SoC portfolio to target specialized markets such as wireless communications, radar, and cable access, which demand high-performance RF data converters. This aligns with AMD's broader strategy to offer adaptable platforms that combine hardware acceleration with domain-specific customization, enabling faster time-to-market for customers. By integrating RF data converters directly into the SoC architecture, AMD enhances its value proposition for embedded systems requiring real-time control, sensor fusion, and analytics, thereby strengthening its position in high-growth sectors like aerospace, defense, and communication infrastructure.",
      "llm_answer": "AMD’s introduction of Zynq UltraScale+ RFSoCs expands its Adaptive SoC portfolio with a dedicated RF data‑conversion capability, complementing its broader FPGA and SoC offerings. This move aligns with AMD’s strategy to capture high‑performance RF markets—such as wireless, radar and cable access—by providing integrated, software‑programmable hardware that accelerates data‑intensive applications and supports its push into data‑center, industrial and automotive segments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth, with no numeric inaccuracies (quantitative accuracy is 10). The introduction of Zynq UltraScale+ RFSoCs is correctly described as expanding AMD's Adaptive SoC portfolio with RF data conversion capabilities, targeting markets like wireless, radar, and cable access. The alignment with AMD's broader strategy to serve high-performance RF markets through integrated, programmable hardware is well articulated. However, the LLM answer omits some key elements from the original: it does not mention the integration of RF data converters directly into the SoC architecture as a value enhancer for real-time control, sensor fusion, and analytics, nor does it explicitly reference the strengthening of AMD’s position in aerospace, defense, and communication infrastructure. While the strategic direction is correctly summarized, the depth of multi-hop reasoning—linking technical integration to domain-specific customization and faster time-to-market—is slightly less developed than in the ground truth. Thus, qualitative accuracy is 8 due to minor omissions in strategic nuance and completeness. Contextual relevance is full, as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 349,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total carrying value of UnitedHealth Group's debt securities - held-to-maturity for both 2023 and 2024 combined, and how does this compare to the total fair value of those securities in those years?",
      "original_answer": "The total carrying value of UnitedHealth Group's debt securities - held-to-maturity for 2023 and 2024 combined is $1,115 million ($603 million in 2023 + $512 million in 2024). The total fair value for the same periods is $1,104 million ($596 million in 2023 + $508 million in 2024), resulting in a $11 million unrealized loss when comparing combined carrying value to combined fair value.",
      "llm_answer": "Based on the provided document pages, the total carrying value of UnitedHealth Group's debt securities held-to-maturity was $512 million as of December 31, 2024, and $603 million as of December 31, 2023. The total fair value of these securities was $508 million for 2024 and $596 million for 2023. Therefore, the combined carrying value for both years is $512 million + $603 million = $1,115 million, and the combined fair value is $508 million + $596 million = $1,104 million. The carrying value exceeds the fair value by $11 million in total across both years. \n\n(Note: The question asks for the combined total carrying value and fair value \"for both 2023 and 2024 combined,\" which requires summing the respective values across both years as presented in the tables on page 57.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all factual components: the carrying values ($603 million in 2023 and $512 million in 2024) and fair values ($596 million in 2023 and $508 million in 2024) match the ground truth exactly. The combined totals—$1,115 million for carrying value and $1,104 million for fair value—are accurately calculated. The $11 million difference (unrealized loss) is correctly derived and described. (2) All numeric values are accurate and properly summed; no calculation errors. Format variations (e.g., $512 million vs $512M) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years, identifies the correct security type (held-to-maturity), and performs cross-year aggregation as required by the question. The note referencing page 57 confirms contextual grounding in the source material. (4) The answer is fully complete, addressing both parts of the question—combined carrying value, combined fair value, and their comparison. Wording differs slightly from the original answer but conveys identical meaning. All scores are maximized due to perfect factual accuracy, correct synthesis, and clear, relevant explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 348,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "By how much did the expansion of merchant accommodation reservation services at Booking.com contribute to the increase in sales and other expenses in 2022, and how does this relate to the growth in merchant gross bookings?",
      "original_answer": "The expansion of merchant accommodation reservation services at Booking.com contributed to a $573 million increase in merchant transaction costs, which is a key component of the overall increase in sales and other expenses in 2022. This growth in merchant transaction costs was driven by the expansion of merchant accommodation reservation services, which also directly supported the greater increase in merchant gross bookings compared to agency gross bookings during the same period.",
      "llm_answer": "The expansion of merchant accommodation reservation services at Booking.com drove a **108.4% year-over-year increase in merchant gross bookings** (from $25,845 million in 2021 to $53,873 million in 2022), which directly contributed to the **94.6% rise in merchant revenues** (from $3,696 million to $7,193 million). This growth in merchant revenues accounted for a substantial portion of the overall **56.0% increase in total revenues** (from $10,958 million in 2021 to $17,090 million in 2022), underscoring how the merchant accommodation expansion fueled the company’s revenue expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in addressing the question. The question asks specifically about the contribution of the expansion of merchant accommodation reservation services to the increase in *sales and other expenses* in 2022, particularly how it relates to growth in merchant gross bookings. The ground truth states that the expansion led to a $573 million increase in *merchant transaction costs*, a component of sales and other expenses. However, the LLM answer does not mention merchant transaction costs or any increase in expenses at all. Instead, it focuses on revenue growth (merchant revenues, total revenues), which is not what was asked. (2) The quantitative figures provided by the LLM—such as 108.4% growth in merchant gross bookings (from $25,845M to $53,873M), 94.6% rise in merchant revenues, and 56.0% increase in total revenues—are not present in the ground truth and cannot be verified from the provided information. These numbers may be factually accurate in another context, but they are not supported by the original answer and are irrelevant to the specific expense-related question. (3) The multi-hop reasoning is flawed: the model incorrectly shifts focus from *expenses* (transaction costs) to *revenues*, failing to connect the expansion to the cost side of the business as required. It also fails to identify that the key metric is the $573 million increase in merchant transaction costs, which directly answers the 'by how much' part of the question. (4) While the LLM demonstrates knowledge of Booking.com’s business model and provides related financial trends, it does not answer the actual question. The contextual relevance is moderate because it discusses the same company and a related topic (merchant model growth), but it misses the core financial impact on expenses. Hence, low scores for correctness, quantitative accuracy, and qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 517,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "What is the total value of the crypto asset safeguarding asset and corresponding liability reported by PayPal as of December 31, 2023, and how does this reflect the company's involvement in crypto-related financial activities?",
      "original_answer": "PayPal reported a crypto asset safeguarding asset of $1,241 million and a corresponding crypto asset safeguarding liability of $1,241 million as of December 31, 2023. This indicates that PayPal holds crypto assets on behalf of its customers and records an equal liability to reflect its obligation to safeguard these assets, showing its active participation in crypto-related financial services.",
      "llm_answer": "PayPal reports a crypto‑asset safeguarding liability of $2,886 million and a corresponding safeguarding asset of $2,886 million as of December 31 2024 (see Note 7 and the fair‑value tables on pages 90‑93). This liability and asset reflect the company’s custodial responsibility for users’ crypto holdings, and its recognition under the new FASB guidance (effective 2025) and the recent SAB 122 rescission indicates PayPal’s active involvement in crypto‑related financial activities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both numbers and date. The ground truth states $1,241 million for both asset and liability as of December 31, 2023, but the LLM reports $2,886 million as of December 31, 2024—wrong values and a future date not relevant to the question. (2) Quantitative accuracy is severely lacking: the dollar amounts are off by over $1.6 billion and the year is incorrect (2024 vs 2023), which violates core requirements of the query. No acceptable format variation can justify this discrepancy. (3) The reasoning is flawed: the LLM references FASB guidance effective in 2025 and SAB 122 rescission, which are irrelevant to the factual reporting requirement as of 2023. It fails the multi-hop task of correctly retrieving and matching the specific year and values from PayPal’s 10-K. (4) While the general concept—that the equal asset and liability reflect custodial responsibility and crypto involvement—is semantically reasonable, the complete factual inaccuracy in numbers and time period results in a very low correctness score. Contextual relevance is moderate because the structure and intent of the explanation are aligned, but it does not answer the actual question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 344,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do the aircraft impairment charges recorded by FedEx in 2023 and 2024 reflect the company's Network 2.0 optimization strategy, and what is the cumulative financial impact of these charges on the DRIVE transformation program through 2024?",
      "original_answer": "The aircraft impairment charges of $70 million in 2023 and $157 million in 2024 reflect FedEx's strategic decision to modernize its fleet and align air network capacity with current and anticipated shipment volumes, as part of the broader Network 2.0 optimization initiative. These charges resulted from the permanent retirement of older aircraft models, including Boeing MD-11F, Boeing 757-200, and Airbus A300-600 aircraft, to support more efficient operations under the DRIVE program. The DRIVE program also includes $582 million in business optimization costs incurred in 2024 alone, bringing the total cumulative optimization-related costs (including impairment charges) to $839 million through 2024, demonstrating the significant financial investment FedEx is making to implement Network 2.0 and improve long-term profitability.",
      "llm_answer": "The 2024 aircraft impairment charge of $157 million reflects FedEx’s Network 2.0 optimization strategy, as retiring 22 Boeing 757‑200 aircraft and related engines was a deliberate step to modernize the Express fleet, improve global network alignment, and better match capacity to current and anticipated shipment volumes. Cumulatively, the impairment charges recorded through 2024—$157 million in 2024 and $70 million in 2023—represent a total of $227 million of non‑cash asset write‑downs tied to the DRIVE transformation program.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the aircraft impairment charges of $70 million in 2023 and $157 million in 2024, and accurately calculates the cumulative impairment total of $227 million. These figures match the ground truth exactly, and format variations (e.g., $157 million) are acceptable. (2) Quantitative accuracy is perfect: both individual charges and their sum are correct. However, the LLM fails to include the additional $582 million in business optimization costs from 2024, which are part of the DRIVE program and necessary to compute the full cumulative financial impact of $839 million through 2024 as stated in the original answer. This omission affects completeness and qualitative accuracy. (3) The reasoning correctly links the impairment charges to the Network 2.0 strategy and fleet modernization, citing specific aircraft retirements (Boeing 757-200), which aligns with the ground truth. However, it omits mention of other retired models (MD-11F, A300-600) and does not fully synthesize the multi-hop aspect connecting impairment charges *and* business optimization costs under DRIVE. (4) The answer is contextually relevant and well-articulated, but the missing $582 million cost component results in an incomplete picture of the total financial impact, preventing a top score. Correctness is high due to accurate numbers and solid reasoning, but not full due to the significant omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 396,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, and how much did the gross unrealized losses on these obligations increase from December 31, 2023, to December 31, 2024?",
      "original_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $3,627 million. The gross unrealized losses on these obligations increased by $40 million, from $234 million in 2023 to $274 million in 2024.",
      "llm_answer": "The total fair value of U.S. government and agency obligations held by UNH as of December 31, 2024, is $4,327 million, and the gross unrealized losses on these obligations increased from $234 million at December 31, 2023, to $274 million at December 31, 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a critical error in the total fair value of U.S. government and agency obligations. The ground truth states $3,627 million, but the LLM reports $4,327 million—a $700 million overstatement. This is a significant factual error affecting the core of the question. However, the information about gross unrealized losses is accurate: it correctly states the increase from $234 million in 2023 to $274 million in 2024, which represents a $40 million increase. (2) Quantitative accuracy is compromised due to the incorrect fair value figure, although the loss figures and implied calculation ($274M - $234M = $40M increase) are correct. The format of numbers is acceptable (e.g., $274 million is properly expressed). (3) The multi-hop reasoning is partially sound—the model correctly identifies the two time points for unrealized losses and synthesizes the change across years. However, it fails in accurately retrieving the fair value figure for UNH as of December 31, 2024, indicating a failure in data retrieval or synthesis for that specific metric. (4) Contextual relevance is high because the answer addresses both parts of the question using the correct entities (UNH, U.S. government and agency obligations, correct dates), and the terminology matches the domain. The qualitative accuracy is moderate because while the structure and logic are sound, the key financial figure is wrong, undermining the reliability of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 412,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the 54% merchant basis transaction mix in 2023 and the associated increase in merchant-related expenses impact Booking.com's operating margins compared to 2022, and what were the key cost components contributing to this effect?",
      "original_answer": "The increase in merchant basis transaction mix from 44% in 2022 to 54% in 2023 led to higher merchant-related expenses, which negatively impacted Booking.com's operating margins despite associated incremental revenues. Key cost components included personnel expenses, payment processing fees, and chargebacks (including those related to fraud), all of which are recorded in 'Personnel' expenses and 'Sales and other expenses' in the Consolidated Statements of Operations. This shift toward a greater proportion of business conducted on a merchant basis resulted in additional costs that outweighed the benefits of increased revenues such as payment card rebates, thereby compressing operating margins.",
      "llm_answer": "In 2023, Booking.com’s merchant‑basis transactions rose to **54 % of gross bookings**, up from **44 % in 2022**. This shift drove higher merchant‑related expenses—particularly personnel, payment‑processing and chargeback costs—because more transactions were settled on a merchant model. Consequently, these added costs pressured operating margins despite the incremental revenue generated from the higher‑margin merchant activities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key quantitative facts: the merchant basis transaction mix increased from 44% in 2022 to 54% in 2023, which matches the ground truth exactly. All percentages and years are accurate. (2) Quantitative accuracy is perfect—no calculations were required beyond stating the correct percentages, and they are presented accurately. (3) The reasoning is largely sound: the model correctly links the increase in merchant-basis transactions to higher expenses and margin pressure. However, it omits specific mention of where these costs are recorded in the financial statements ('Personnel' and 'Sales and other expenses') and does not explicitly name fraud-related chargebacks as a component, which are key details in the ground truth. It also does not mention that incremental revenues (e.g., payment card rebates) were outweighed by costs—a critical nuance in the causal chain. (4) Despite these omissions, the core multi-hop logic (shift in transaction mix → higher costs → margin pressure despite revenue benefits) is preserved, and all entities (Booking.com, merchant basis, years) are correct. The answer is contextually fully relevant and conveys the main impact. Thus, while factually strong and well-reasoned, it lacks minor but important qualitative details from the original, justifying a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 388,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' and the subsequent change in fair value measurement methodology impact PayPal's financial statements in 2024, particularly in terms of asset valuation and income recognition?",
      "original_answer": "The reclassification of eligible consumer installment receivables to 'Loans and Interest Receivable, Held for Sale' led to a change in valuation methodology from an unobservable price-based model to one using observable inputs such as executed prices for comparable loans sold to the global investment firm. This reclassification caused these assets to be classified within Level 2 in the fair value hierarchy starting in Q1 2024, improving transparency and reliability of valuation. Additionally, any previously recorded allowance for credit losses was reversed, decreasing transaction and credit losses in 2023. In 2024, valuation changes and charge-offs for these held-for-sale loans were recorded in 'restructuring and other' on the consolidated statements of income (loss), directly impacting income recognition.",
      "llm_answer": "The reclassification of eligible consumer installment receivables to “Loans and interest receivable, held for sale” and the shift to measuring these assets at the lower of cost or fair value (with changes recorded in restructuring and other income) reduced transaction and credit losses by reversing prior allowances, while the fair‑value‑based valuation now reflects observable market prices for comparable loan sales, moving the portfolio into Level 2 of the fair‑value hierarchy and affecting both asset valuation and income recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the key impacts of PayPal's reclassification of consumer installment receivables in 2024. (1) It correctly identifies the reclassification to 'Loans and interest receivable, held for sale' and the shift in valuation methodology to fair value using observable inputs (market prices for comparable loans), which aligns with the ground truth. It accurately notes the movement to Level 2 of the fair value hierarchy, improving valuation transparency. (2) The reversal of prior allowances reducing transaction and credit losses is correctly mentioned, though the original answer specifies this occurred in 2023—this nuance is omitted but does not misrepresent the financial impact. (3) The LLM correctly captures the multi-hop reasoning: the change in classification triggered a change in measurement methodology, which affected both asset valuation (via Level 2 classification) and income recognition (via recording valuation changes and charge-offs in 'restructuring and other'). (4) The only minor gap is that the LLM does not explicitly state that the income impact occurs in 2024 or name the specific income statement line ('restructuring and other') as clearly as the original, though it does reference it. All entities (PayPal, financial instruments, fair value hierarchy levels) and years (implied 2024 context) are correct. Wording differs but semantic meaning is equivalent. No numeric inaccuracies; dates and financial concepts are correctly applied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 412,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "What is the total combined borrowing capacity in USD from both the newly established €1.5 billion credit facility and the existing short-term credit arrangements as of December 31, 2024, and how does this compare to the borrowing capacity from short-term credit arrangements as of December 31, 2023?",
      "original_answer": "The total combined borrowing capacity as of December 31, 2024, from the newly established €1.5 billion (approximately $1.6 billion) credit facility and the existing short-term credit arrangements of $2.1 billion was $3.7 billion. This represents a decrease compared to the $2.7 billion in short-term credit arrangements available as of December 31, 2023.",
      "llm_answer": "The total combined borrowing capacity is approximately $8.6 billion, comprising the $1.6 billion (≈€1.5 billion) new revolving credit facility and the $7.0 billion of existing short‑term credit arrangements. This exceeds the $2.7 billion of short‑term credit capacity reported as of December 31 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total combined borrowing capacity is stated as $8.6 billion, but the ground truth is $3.7 billion. The LLM incorrectly reports existing short-term credit arrangements as $7.0 billion instead of $2.1 billion. Only the conversion of €1.5 billion to $1.6 billion and the 2023 short-term credit capacity of $2.7 billion are correct. (2) Calculations are fundamentally flawed: $1.6B + $7.0B = $8.6B is mathematically correct but based on incorrect inputs. The correct sum is $1.6B + $2.1B = $3.7B. The comparison to 2023 is also misleading—the correct answer notes a decrease from $2.7B to $3.7B in total capacity, but the LLM incorrectly suggests an increase due to overstated 2024 capacity. (3) Multi-hop reasoning fails: the model does not correctly synthesize the new facility with the actual 2024 short-term arrangements. It invents a $7.0B figure with no basis in the ground truth. (4) Scores reflect mostly incorrect quantitative data (2/10), poor reasoning due to fabricated numbers (3/10), partial relevance as it addresses the right question structure (6/10), and very low overall correctness (2/10) due to core factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 341,
        "total_tokens": 1542
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How much total revenue did NVIDIA's Compute & Networking segment contribute in fiscal year 2024, given that one direct customer accounted for 13% of total revenue and one estimated indirect customer accounted for 19% of total revenue, assuming total company revenue was $27 billion?",
      "original_answer": "$8.64 billion",
      "llm_answer": "Based on the provided financial data, NVIDIA's Compute & Networking segment contributed $47,405 million in revenue for fiscal year 2024, as shown in the \"Revenue by Reportable Segments\" table on page 39. This figure represents the total revenue generated by the Compute & Networking segment, which includes Data Center, Networking, and other related components. The document also confirms that one direct customer accounted for 13% of total revenue and one indirect customer accounted for 19% of total revenue, both attributed to this segment, but the segment's total revenue is explicitly stated as $47,405 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. The ground truth states that NVIDIA's Compute & Networking segment contributed $8.64 billion in fiscal year 2024, but the LLM claims $47,405 million ($47.405 billion), which is more than five times higher and exceeds the company's total revenue of $27 billion. This indicates a severe factual or data extraction error. The LLM references a 'Revenue by Reportable Segments' table on page 39 not present in the provided context, suggesting fabrication or hallucination. While the question involves multi-hop reasoning using customer concentration (13% direct, 19% indirect), the LLM incorrectly treats these as inputs to segment revenue rather than potential contextual details. In reality, the Compute & Networking segment revenue must be derived from or consistent with the total company revenue of $27 billion. The claimed segment revenue of $47.4 billion is impossible given the $27 billion total, revealing a complete breakdown in quantitative and logical consistency. The mention of Data Center, Networking, etc., adds plausible detail but does not align with the ground truth. Thus, despite referencing seemingly precise data, the answer is entirely incorrect in magnitude and reasoning, failing all key evaluation criteria.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 354,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AIG's Internal Capital Framework, as part of its Risk Appetite Framework, support the company's assessment of capital resources required to maintain consolidated target capitalization levels, particularly in relation to its stress testing framework and diversification benefits?",
      "original_answer": "AIG's Internal Capital Framework quantifies the company's aggregate economic risk at a given confidence interval by factoring in diversification benefits between risk factors and business lines. This quantification supports the assessment of resources needed at the AIG Parent level to support subsidiaries and determine the capital resources required to maintain consolidated company target capitalization levels. Additionally, AIG uses a stress testing framework to evaluate aggregate exposure to its most significant financial and insurance risks, which complements the Internal Capital Framework in guiding capital allocation decisions and ensuring financial resilience.",
      "llm_answer": "AIG's Internal Capital Framework quantifies aggregate economic risk at a given confidence level by incorporating diversification benefits across risk factors and business lines, and it directly supports the assessment of capital resources needed to maintain consolidated target capitalization levels. This framework is integrated with the company's stress testing approach, which evaluates exposure to significant financial and insurance risks to ensure sufficient capital is held to meet regulatory and strategic objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that AIG's Internal Capital Framework quantifies aggregate economic risk by incorporating diversification benefits across risk factors and business lines, which supports the assessment of capital resources needed to maintain consolidated target capitalization levels—this matches the original answer exactly in substance. (2) There are no numeric values (e.g., percentages, dollar amounts, confidence intervals) in either response, so quantitative accuracy is not compromised; the LLM does refer to 'a given confidence level,' which aligns with the implied confidence interval in the original. (3) The multi-hop reasoning is sound: the LLM correctly links the Internal Capital Framework to capital assessment and integrates the role of stress testing in evaluating significant risks, which complements the framework in guiding capital decisions. The only minor omission is that the original specifies the capital assessment occurs at the 'AIG Parent level to support subsidiaries,' which adds a structural detail slightly missing in the LLM version. Additionally, the original explicitly mentions that stress testing complements the framework in guiding 'capital allocation decisions and ensuring financial resilience,' while the LLM generalizes this as meeting 'regulatory and strategic objectives'—semantically close but slightly less precise. (4) Despite these small differences in nuance, the LLM answer remains factually correct, contextually complete, and logically coherent, warranting a high score. The contextual relevance is perfect as it directly addresses all components of the question: the Internal Capital Framework, target capitalization, diversification benefits, and stress testing integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 493,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "Given that Target's owned brands represent approximately one-third of its merchandise sales and the associated risks of developing and sourcing these brands, how might supply chain disruptions or failure to meet consumer demand impact Target's financial performance, particularly in relation to inventory management and profitability?",
      "original_answer": "Target's owned brands represent approximately one-third of its merchandise sales and generally carry higher margins than equivalent national brand products. If Target is unable to accurately forecast consumer demand for these products, it could result in insufficient or excess inventory, increased inventory markdowns, and higher costs. Additionally, because owned brand products generally require longer lead times and earlier ownership in the supply chain, supply chain disruptions or failure to meet consumer demand could lead to inventory shrink, which has historically elevated in recent years. This inventory shrink has already adversely affected, and could continue to adversely affect, Target's results of operations and financial condition. Furthermore, these issues could limit Target's ability to drive net earnings growth, especially during key seasonal moments like the November and December holiday period, where a larger portion of sales traditionally occur.",
      "llm_answer": "Target’s owned brands account for roughly one‑third of merchandise sales and carry higher margins, but they require longer lead times, more accurate demand forecasting, and expose the company to heightened supply‑chain risk. If supply‑chain disruptions prevent Target from securing or delivering these products, or if it mis‑judges consumer demand, the company can end up with excess or insufficient inventory, forcing deeper markdowns and hurting profitability. Effective inventory management is therefore critical: any failure to anticipate trends or maintain adequate stock levels can depress sales, increase shrink, and erode the margins that owned brands are meant to generate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) Quantitatively, the statement that Target's owned brands represent approximately one-third of merchandise sales is correctly reflected. No specific dollar amounts, dates, or percentages beyond this one-third figure are present in the original, so no calculations are required. (2) The LLM correctly identifies that owned brands carry higher margins, require longer lead times, and are subject to supply chain risks and demand forecasting challenges. It accurately links these factors to inventory issues (excess or insufficient stock), markdowns, shrink, and profitability impacts—mirroring the original's logic. (3) The multi-hop reasoning is sound: it connects the higher-margin nature of owned brands with operational risks (forecasting, supply chain), then correctly infers downstream financial consequences (markdowns, shrink, margin erosion). The only minor omission is the specific mention of the November–December holiday period as a critical time when these risks could limit net earnings growth, which is present in the original but absent in the LLM response. This contextual detail enhances completeness but does not undermine the overall correctness. (4) All entities (Target, owned brands, inventory management, profitability) are correctly identified and logically synthesized. The answer is semantically equivalent to the original, with slightly more concise wording. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to this small omission, full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 445,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "What is the difference in the 2024 carrying values of NVDA's 3.50% Notes Due 2050 and 3.50% Notes Due 2040?",
      "original_answer": "$397 million",
      "llm_answer": "The 2024 carrying values of NVIDIA’s 3.50% Notes Due 2050 and 3.50% Notes Due 2040 are $2,000 million and $1,000 million, respectively, giving a difference of $1,000 million.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect. It states the carrying values of NVDA's 3.50% Notes Due 2050 and 2040 are $2,000 million and $1,000 million, respectively, resulting in a difference of $1,000 million. However, the ground truth difference is $397 million. These values do not match any known public data from NVIDIA’s 2024 10-K for these notes. (2) The calculation of $2,000M - $1,000M = $1,000M is mathematically correct, but the input numbers are entirely wrong, making the quantitative result inaccurate. The correct difference is $397 million, not $1,000 million. (3) The reasoning structure is sound—multi-hop synthesis requires identifying the carrying values of two debt instruments and computing their difference—but the model fails in retrieving the correct values from the source documents. It fabricates numbers not present in the actual filings. (4) The contextual relevance is high because the answer addresses the right entities (NVIDIA, 3.50% Notes Due 2050 and 2040, carrying values, 2024), but the factual inaccuracies severely undermine correctness. Due to major errors in financial data, the correctness and quantitative accuracy scores are very low. The qualitative accuracy is slightly above minimum due to correct reasoning framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1036,
        "completion_tokens": 357,
        "total_tokens": 1394
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How many total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, and what types of awards can be issued under the 2020 Stock Incentive Plan according to the UnitedHealth Group 2024 10-K filing?",
      "original_answer": "As of December 31, 2024, 64 million total shares of common stock were available for future issuance under both the 2020 Stock Incentive Plan and the ESPP. Specifically, 48 million shares were available under the 2020 Stock Incentive Plan, and 16 million shares were available under the ESPP. Under the 2020 Stock Incentive Plan, future awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "Based on the UnitedHealth Group 2024 10-K filing (pages 70–76), the total shares of common stock available for future issuance under both the 2020 Stock Incentive Plan and the ESPP as of December 31, 2024, is **64 million shares** (comprising 48 million shares available under the 2020 Stock Incentive Plan and 16 million shares available under the ESPP). The 2020 Stock Incentive Plan permits the issuance of various types of awards, including stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total shares (64 million), breakdown (48 million under the 2020 Stock Incentive Plan and 16 million under the ESPP), and date (December 31, 2024) are all accurate. The numbers match exactly with the original answer, and the sum (48M + 16M = 64M) is correct. (2) The answer is complete, addressing both parts of the question: the total and breakdown of shares available for future issuance, and the types of awards permitted under the 2020 Stock Incentive Plan. (3) Entity accuracy is perfect: UnitedHealth Group, 2020 Stock Incentive Plan, ESPP, and the correct fiscal date are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis—combining data from two different plans and correctly identifying award types from the same document. (5) The semantic meaning is equivalent to the ground truth, with only minor, acceptable rewording (e.g., 'permits the issuance of' vs. 'may take the form of'). No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 308,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does AIG's use of the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, help address the challenges of loss emergence volatility in U.S. Workers' Compensation, which is characterized by extremely long-tail loss development patterns?",
      "original_answer": "AIG uses the Expected Loss Ratio Methods, including the Bornhuetter Ferguson approach, to address the challenges of volatility in loss emergence for U.S. Workers' Compensation, an extremely long-tail line of business. In cases where reported loss data lacks sufficient credibility—such as in long-tail lines at early stages of development—Expected Loss Ratio Methods provide a more stable estimate by applying an expected loss ratio to earned premiums. This method avoids overreacting to anomalous early-stage losses that could distort projections, unlike loss development methods that might extrapolate unusual activity onto the unreported portion of losses. This is particularly important for U.S. Workers' Compensation, where loss emergence can extend for decades and reporting patterns have slowed due to an increasing proportion of large deductible business.",
      "llm_answer": "AIG’s use of the Expected Loss Ratio Methods—specifically the Bornhuetter Ferguson approach—helps mitigate loss‑emergence volatility in U.S. Workers’ Compensation by blending the stability of an expected‑loss‑ratio estimate with the responsiveness of loss‑development factors; this hybrid method allows the company to adjust reserves more gradually when actual loss experience deviates from prior assumptions, thereby reducing the risk of over‑ or under‑reacting to the long‑tail, slow‑developing claims characteristic of that line of business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are accurate: AIG uses the Expected Loss Ratio Methods, specifically the Bornhuetter Ferguson approach, to address loss emergence volatility in U.S. Workers' Compensation, a long-tail line of business. The explanation correctly highlights the method's role in providing stability when early loss data lacks credibility by blending expected loss ratios with actual development, thus avoiding overreaction to volatile early-stage data. (2) There are no numeric values in the question or answers requiring verification; therefore, quantitative accuracy is not applicable but assumed perfect as no numbers were misstated. (3) The multi-hop reasoning is sound—linking AIG’s methodology to the characteristics of U.S. Workers’ Compensation (long-tail, slow development, volatility) and explaining why the Bornhuetter Ferguson method is appropriate. The LLM correctly synthesizes the purpose of the method in balancing prior expectations with emerging data. (4) The only reason for not scoring a perfect 10 is that the LLM omits a specific contextual detail present in the original answer: the increasing proportion of large deductible business contributing to slower reporting patterns. While the core reasoning and all technical aspects are preserved and accurate, this minor omission slightly reduces completeness in qualitative accuracy. Otherwise, the response is highly relevant, precise, and correctly framed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 424,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "What is the total number of amendments made to the Credit Card Program Agreement between Target Corporation and TDBank USA, N.A., as documented in the 10-K filings referenced, and what does this indicate about the evolution of their financial partnership?",
      "original_answer": "The Credit Card Program Agreement between Target Corporation and TDBank USA, N.A. has undergone 2 amendments, as documented in the filings. This indicates that the financial partnership has evolved over time, with modifications made in 2015 and 2019 to adapt the agreement to changing business or regulatory conditions.",
      "llm_answer": "Based on the exhibits listed in the 10-K filing (specifically pages 74–75), the Credit Card Program Agreement with TDBank USA, N.A. has been amended four times: the original agreement was dated October 22, 2012 (Exhibit 10.21), with subsequent amendments executed on February 24, 2015 (First Amendment), November 19, 2019 (Second Amendment), and November 1, 2022 (Third Amendment). This indicates a progressive evolution of the partnership, reflecting ongoing adjustments to meet operational, regulatory, and strategic needs—such as extending credit terms, modifying fee structures, or adapting to market conditions—over the past decade. The amendments demonstrate Target’s commitment to refining the financial collaboration to support its retail objectives while maintaining a stable, long-term banking relationship.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that there are four amendments (original agreement plus three amendments), but the ground truth specifies only 2 amendments. The original agreement is not an amendment, and only the 2015 and 2019 changes are counted as amendments in the ground truth. The LLM includes a third amendment from November 1, 2022, which is not mentioned in the original answer and appears to be extraneous or from a source beyond the referenced filings. Thus, the total count of amendments is incorrect. (2) The dates mentioned—February 24, 2015, and November 19, 2019—align with the ground truth and are accurate. However, the inclusion of a November 1, 2022 amendment introduces a factual discrepancy not supported by the original answer. The quantitative error in the number of amendments (3 vs. correct count of 2) is significant. (3) The reasoning about the evolution of the partnership is sound and logically consistent—amendments suggest adaptation to business or regulatory changes—but the conclusion is based on an inflated number of amendments, weakening the validity of the synthesis. The multi-hop aspect (linking amendment dates to partnership evolution) is well-executed, but the underlying data is flawed. (4) Contextually, the answer is relevant and addresses both parts of the question: number of amendments and implications for the partnership. The qualitative interpretation is reasonable, but the factual foundation is partially incorrect, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 420,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How much did FedEx spend on business optimization activities related to Network 2.0 in 2023 and 2024 combined, and what was the primary purpose of these expenditures?",
      "original_answer": "FedEx spent $273 million in 2023 and $582 million in 2024 on business optimization activities related to Network 2.0, totaling $855 million. These expenditures were primarily used for professional services and severance to support the multi-year effort to improve the efficiency with which FedEx picks up, transports, and delivers packages in the U.S. and Canada.",
      "llm_answer": "Based on the provided document pages, FedEx spent a combined total of $855 million on business optimization activities related to Network 2.0 in 2023 and 2024 ($273 million in 2023 and $582 million in 2024). The primary purpose of these expenditures was to drive long-term profitability through the DRIVE transformation program, specifically to implement Network 2.0 optimization across more than 50 U.S. locations, consolidate sortation facilities, reduce pickup-and-delivery routes, and transform digital capabilities to improve efficiency in the transportation network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the total spending of $855 million, with accurate breakdowns of $273 million in 2023 and $582 million in 2024, matching the ground truth exactly. All numeric values and the sum are correct, satisfying quantitative accuracy. (2) The primary purpose in the ground truth emphasizes professional services and severance to support efficiency improvements in pickup, transport, and delivery in the U.S. and Canada. The LLM answer captures the broader strategic goal of improving efficiency and mentions specific actions like facility consolidation and route reduction, which are consistent with Network 2.0. However, it omits explicit mention of 'professional services and severance'—a key detail in the original answer—while adding context about the DRIVE program and digital transformation, which may be related but not specified in the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two fiscal years and links expenditures to Network 2.0’s operational goals. The logic and entity mapping (FedEx, Network 2.0, 2023, 2024) are accurate. (4) The answer is contextually relevant and semantically close to the ground truth, with only minor omission of specific expenditure use cases. Thus, correctness is high but not perfect due to partial omission in qualitative detail, warranting a 9/10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 384,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the introduction of the ad-supported subscription plan, as mentioned in the context of Netflix's competitive strategy, affect the financial forecasting risks highlighted in the 2023 10-K filing?",
      "original_answer": "The introduction of the ad-supported subscription plan increases financial forecasting risks because consumer adoption of new pricing strategies like this plan is inherently difficult to predict, which could lead to material discrepancies between forecasted and actual revenues, net income, and other financial metrics.",
      "llm_answer": "The ad‑supported subscription plan is cited as a strategic initiative that can affect revenue growth and member retention, but the 2023 10‑K stresses that forecasting its impact is inherently uncertain because it relies on assumptions about consumer adoption, usage patterns and market response. Consequently, the plan adds to the financial‑forecasting risk described in the filing, as actual results may differ materially from management’s expectations and could materially affect reported revenues, margins and stock price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately identifies that the introduction of the ad-supported subscription plan increases financial forecasting risks due to uncertainty in consumer adoption, usage patterns, and market response—directly aligning with the 2023 10-K filing. The answer correctly links this uncertainty to potential material differences between forecasted and actual financial results, specifically mentioning revenues, margins, and stock price, which extends slightly beyond the original answer but remains consistent with the filing's disclosures. There are no numeric values in the question or ground truth, so quantitative accuracy is scored as 10 by default. The qualitative reasoning is sound and reflects proper multi-hop synthesis: connecting Netflix's strategic initiative (ad-supported plan) to the broader risk factors in the 10-K related to forecasting. The only minor deviation is that the original answer emphasizes 'net income' and 'other financial metrics' while the LLM mentions 'margins' and 'stock price'—a slight shift in emphasis but not a factual error. Contextual relevance is perfect, as the response directly addresses how the new plan affects financial forecasting risks as disclosed in the 2023 10-K.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 361,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the patent expiration timeline for Prevnar 13 in different regions, as listed in Pfizer's 2024 10-K, relate to the $964 million intangible asset impairment charge for Prevnar 13's developed technology rights recorded in 2023?",
      "original_answer": "The $964 million intangible asset impairment charge for Prevnar 13's developed technology rights in 2023 was driven by updated commercial forecasts reflecting a transition to vaccines with higher serotype coverage. This aligns with the patent expiration timeline showing that Prevnar 13's major Europe patent expired in 2029, while its U.S. patent expires in 2026. These expirations likely contribute to reduced long-term commercial viability, prompting the impairment charge as Pfizer transitions focus to next-generation vaccines like Prevnar 20.",
      "llm_answer": "The $964 million impairment charge recorded in 2023 for Prevnar 13’s developed‑technology rights reflects the updated commercial forecasts that were driven by the patent‑expiration timeline for Prevnar 13 in key markets. According to the 10‑K, the basic product patent for Prevnar 13 expires in 2026 in the United States and in 2026‑2029 in Europe and Japan, and the loss of that exclusivity reduces future cash‑flow projections, prompting the impairment of the associated intangible asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $964 million impairment charge, 2023 recording year, U.S. patent expiration in 2026, and European patent expiration between 2026–2029 are consistent with the original answer (note: ground truth specifies Europe expiration as 2029, while LLM says 2026–2029, which is slightly less precise but still factually acceptable given possible variation in patent families). (2) The answer correctly identifies the causal relationship between patent expirations, loss of market exclusivity, reduced cash-flow forecasts, and the resulting intangible asset impairment—this demonstrates sound multi-hop reasoning across financial and IP timelines. (3) The only minor shortcoming is that the LLM does not explicitly mention the transition to next-generation vaccines like Prevnar 20, which is a key driver in the updated commercial forecasts per the original answer. This omission slightly weakens the qualitative depth but does not invalidate the core logic. (4) All entities—Prevnar 13, developed technology rights, Pfizer (implied), 2023 charge, and geographic regions—are correctly identified. The answer is contextually fully relevant and conveys the essential mechanism linking patent expiry to impairment. Minor deduction from 10 to 9 due to incomplete explanation of the strategic transition context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 393,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does McDonald's reliance on franchisees for operational success connect with its decision not to consolidate franchisee-related entities in its financial statements, and what risk does this pose if franchisees fail to execute key customer experience initiatives?",
      "original_answer": "McDonald's explicitly states that it does not consolidate franchisee-related entities in its financial statements, as these businesses qualify for a scope exception under variable interest entity consolidation guidance. This means the financial performance of franchisee-operated restaurants is not directly reflected in McDonald's consolidated financial results. However, McDonald's acknowledges that its business success heavily depends on franchisees executing key initiatives such as digital engagement, mobile ordering, and delivery improvements. If franchisees fail to effectively implement these customer experience strategies, it could negatively impact McDonald's sales, guest counts, and market share, despite the franchisee-related entities not being consolidated in its financial statements.",
      "llm_answer": "McDonald’s relies on franchisees to run the majority of its restaurants, so it does not consolidate franchisee‑related entities in its financial statements; instead it records only the fees, rent and royalties earned from those franchisees. This creates a risk that if franchisees fail to execute key customer‑experience initiatives—such as maintaining service standards, food safety and operational consistency—the brand’s reputation and sales could suffer, and the company’s earnings from royalties and rent would decline.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core relationship between McDonald's franchise model, its financial reporting treatment, and the associated risks. (1) It correctly states that McDonald's does not consolidate franchisee-related entities and instead records fees, rent, and royalties—this aligns with the ground truth regarding the scope exception under variable interest entity guidance, though the specific accounting standard is not mentioned. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of incorrect numbers supports a full score here. (3) The multi-hop reasoning is sound: the model connects the lack of consolidation with reliance on franchisees and identifies the risk to brand, sales, and earnings if execution falters. However, it generalizes the key initiatives as 'service standards, food safety, operational consistency,' whereas the original answer specifies 'digital engagement, mobile ordering, and delivery improvements'—more strategic, forward-looking initiatives tied to modern customer experience. This is a minor but notable omission in precision. (4) Despite this, the answer remains contextually relevant and semantically close, conveying the essential risk: that even without financial consolidation, McDonald's performance is highly exposed to franchisee execution. The answer could have better reflected the specific initiatives cited in the ground truth, but the overall logic and factual basis are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 419,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's adoption of the LDTI standard impact its equity as of January 1, 2021, and what specific adjustments were made to the consolidated financial statements for the years ended December 31, 2022 and 2021?",
      "original_answer": "AIG's adoption of the LDTI standard resulted in a net decrease to beginning total equity of $1,264 million as of January 1, 2021. Additionally, the adoption adjustments included a $2 million decrease and a $983 million increase to net income for the years ended December 31, 2022 and 2021, respectively. These adjustments also led to a $1,219 million increase in total equity as of December 31, 2022. The changes were primarily due to adjustments related to market risk benefits (MRBs) and the discount rate used to measure the liability for future policy benefits.",
      "llm_answer": "AIG adopted the LDTI standard on January 1 2023 (transition date January 1 2021) using a modified‑retrospective basis (full retrospective for MRBs). The adoption reduced beginning total equity by $1.264 billion as of January 1 2021 and resulted in adjustments to prior‑period financial statements: a $2 million decrease and a $983 million increase to net income for the years ended December 31 2022 and 2021, respectively, and a $1.219 billion increase to total equity as of December 31 2022. These adjustments stemmed from changes to market‑risk‑benefit assets and liabilities and the discount‑rate methodology used for the liability for future policy benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $1,264 million decrease in beginning equity as of January 1, 2021, the $2 million decrease and $983 million increase in net income for 2022 and 2021 respectively, and the $1,219 million increase in total equity as of December 31, 2022 are all correctly reported, with acceptable format variations ($1.264 billion = $1,264 million). (2) Quantitative accuracy is perfect—every number matches the original answer, including direction (increase/decrease) and magnitude. (3) The reasoning is sound: the answer correctly identifies the transition date (January 1, 2021), adoption method (modified-retrospective with full retrospective for MRBs), and the primary drivers—adjustments to market risk benefits and discount rate methodology for future policy benefit liabilities. (4) The only minor issue is the mention of 'January 1, 2023' as the adoption date, which may cause confusion, but it is likely referring to the effective implementation date while correctly noting January 1, 2021 as the transition date for adjustments. This does not materially affect the correctness of the financial impacts, which are all tied to the correct dates. The answer fully addresses both parts of the multi-hop question: impact on equity as of January 1, 2021, and adjustments for 2022 and 2021. Semantic equivalence is strong, and contextual relevance is complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 405,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the increase in Gulfstream aircraft orders specifically impact General Dynamics' cash flow from operating activities in 2021, and what was the resulting percentage of this cash flow relative to net earnings?",
      "original_answer": "The increase in Gulfstream aircraft orders led to a rise in customer deposits, which positively affected General Dynamics' cash flow from operating activities in 2021, resulting in $4.3 billion in cash provided by operating activities. This amount represented 131% of net earnings for the year.",
      "llm_answer": "Based on the provided document pages, the increase in Gulfstream aircraft orders specifically impacted General Dynamics' cash flow from operating activities in 2021 by driving higher customer deposits and reducing inventory, which positively contributed to cash inflows. This was explicitly noted in the \"OPERATING ACTIVITIES\" section of page 47, which states that cash flows in 2021 were \"affected positively by an increase in customer deposits driven by Gulfstream aircraft orders and the continued reduction in inventory from the sale of G500 flight-test aircraft.\"\n\nThe resulting cash flow from operating activities was $4,271 million in 2021, which represented 131% of net earnings ($3,257 million) for the year. This is confirmed by the \"CASH REQUIREMENTS\" and \"OPERATING ACTIVITIES\" sections on pages 47 and 43, where it states \"Cash provided by operating activities was $4.3 billion in 2021 compared with $3.9 billion in 2020\" and \"Cash flows as a percentage of net earnings: Net cash provided by operating activities 131%.\" Thus, the cash flow from operating activities was 131% of net earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the increase in Gulfstream aircraft orders led to higher customer deposits, which positively impacted cash flow from operating activities in 2021—this aligns with the ground truth. The resulting cash flow from operating activities is reported as $4.3 billion in the original answer, and the LLM provides a more precise figure of $4,271 million (which equals $4.271 billion), a minor rounding difference but factually consistent and acceptable under format variation rules. The percentage of cash flow relative to net earnings is correctly stated as 131% in both answers, with supporting context that net earnings were $3,257 million. (2) All numeric values are accurate: $4,271 million ≈ $4.3 billion (standard rounding), 131% matches exactly, and the reference to net earnings ($3,257 million) corroborates the calculation: $4,271 / $3,257 ≈ 1.31 or 131%. (3) The multi-hop reasoning is sound—the model connects Gulfstream orders → increased customer deposits → positive impact on operating cash flow → specific dollar amount → percentage of net earnings, drawing from correct sections of the document (pages 43 and 47). It synthesizes information across locations and correctly interprets cause-effect relationships. (4) The only reason for not scoring a perfect 10 is that the LLM mentions 'reducing inventory' and 'sale of G500 flight-test aircraft' as co-contributors, which, while factually present in the document, slightly shifts focus from the *specific* impact of Gulfstream *orders* (via deposits) emphasized in the original answer. However, this addition does not contradict but rather enriches context, so the deviation is minor. Overall, the answer is quantitatively precise, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 493,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AIG's integrated bottom-up risk identification process at the product-line level, as part of its Risk Identification and Measurement framework, support the company's internal capital framework in quantifying aggregate economic risk at a given confidence interval?",
      "original_answer": "AIG's integrated bottom-up risk identification process, conducted down to the product-line level, captures material risks inherent in specific business operations. This granular risk data feeds into the internal capital framework, which quantifies AIG's aggregate economic risk at a given confidence interval. By incorporating detailed risk assessments from individual product lines, the internal capital framework can more accurately account for diversification benefits between risk factors and business lines, thereby enabling a more robust quantification of overall economic risk exposure.",
      "llm_answer": "AIG's integrated bottom‑up risk identification process, which extends to the product‑line level, feeds directly into its internal capital framework by quantifying the aggregate economic risk across all risk factors and business lines at a specified confidence interval. This quantification incorporates diversification benefits between risk factors, enabling the company to assess the capital needed to support its subsidiaries and maintain the targeted consolidated capital levels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core elements of the ground truth. (1) All factual components are correct: AIG's bottom-up risk identification at the product-line level feeds into the internal capital framework to quantify aggregate economic risk at a given confidence interval. The mention of diversification benefits between risk factors is present and correctly contextualized. (2) There are no numeric values, percentages, or dates in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numerical claims earns a perfect score by default. (3) The multi-hop reasoning is sound: the model correctly links granular risk identification with enterprise-level capital modeling and recognizes the role of diversification in shaping consolidated capital needs. (4) The only minor shortcoming is that the LLM answer does not explicitly state that the *granularity enables more accurate diversification assessment*—a key nuance in the original answer about *how* the process improves robustness. While implied, this causal link is slightly less explicit. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 349,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does the introduction of the RTX 4080 GPU, as part of NVDA's product transitions, interact with supply chain risks and demand forecasting challenges to potentially impact NVDA's financial performance?",
      "original_answer": "The introduction of the RTX 4080 GPU is part of NVDA's broader product transitions, which are complex and may result in unanticipated quality or production issues, increasing inventory provisions, warranty costs, or causing product delays. These transitions are difficult to manage and may impair NVDA’s ability to predict demand and impact supply mix, potentially leading to additional costs. Furthermore, NVDA depends on foundries to manufacture its semiconductor wafers and faces risks such as lack of guaranteed supply, higher component prices, and low manufacturing yields. These supply chain risks reduce NVDA’s control over product quantity, quality, and delivery schedules. If demand for the RTX 4080 is underestimated, NVDA may not be able to secure enough supply to meet customer orders, damaging relationships and leading to lost revenue and market share. Conversely, if demand is overestimated, NVDA may be unable to reduce inventory or contractual commitments, leading to inventory write-downs, cancellation penalties, and impairments. These factors, combined with extended lead times and geopolitical tensions, may negatively impact NVDA’s gross margins and financial results.",
      "llm_answer": "The introduction of the RTX 4080 GPU creates new supply‑chain complexity and demand‑forecasting uncertainty, as NVIDIA must secure sufficient wafer, component and capacity commitments while simultaneously managing longer product‑development cycles and multiple architecture transitions. If demand estimates prove inaccurate—or if customers shift to competing AI‑cloud or CPU offerings—the resulting mismatch between supply and demand can lead to inventory write‑downs, premium procurement costs, and reduced gross margins, directly pressuring NVDA’s financial performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, capturing the core financial risks associated with the RTX 4080 launch in relation to supply chain and demand forecasting. (1) There are no specific numbers, dates, or percentages in either the original or LLM answer, so quantitative accuracy is not compromised—score 10 is justified. (2) The LLM correctly identifies key risks: supply-chain complexity, demand uncertainty, inventory write-downs, premium procurement costs, and margin pressure. It also references broader context like product-development cycles and architecture transitions, which aligns with NVDA's product transition challenges. (3) The multi-hop reasoning is sound: it connects product introduction (RTX 4080) to supply chain commitments, demand forecasting risks, and financial outcomes (gross margins, financial performance). However, the LLM omits some specific elements from the ground truth: it does not mention reliance on external foundries, risks of low yields, lack of supply guarantees, warranty costs, inventory provisions, cancellation penalties, or geopolitical tensions. It also introduces a plausible but not explicitly supported element—'customers shift to competing AI-cloud or CPU offerings'—which is not in the original knowledge base and slightly extends beyond the documented risk factors. (4) Despite these omissions and minor extrapolation, the LLM conveys the essential causal chain and financial implications. Thus, correctness and qualitative accuracy are high but not perfect—8 is appropriate. Contextual relevance is full, as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 444,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the Starbucks Rewards loyalty program impact Starbucks' revenue recognition timing, and what was the company's total advertising expense in fiscal 2022?",
      "original_answer": "The Starbucks Rewards loyalty program causes a deferral in revenue recognition. As customers earn Stars, Starbucks defers revenue based on the estimated value of the product for which the reward is expected to be redeemed. Revenue is only recognized when the reward is actually redeemed. This deferral mechanism ensures that a portion of revenue from purchases that generate Stars is not recognized upfront but rather when the reward is used. In fiscal 2022, Starbucks incurred $416.7 million in advertising expenses.",
      "llm_answer": "The Starbucks Rewards loyalty program requires the company to defer revenue for the estimated selling price of Stars earned toward free product, establishing a liability for unredeemed Stars and rewards; this deferral impacts revenue recognition timing by spreading recognition of revenue over the period Stars are earned and redeemed. For fiscal 2022, Starbucks' total advertising expense was $416.7 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information is accurate: the explanation of revenue deferral in the Starbucks Rewards program correctly describes the timing impact—revenue is deferred based on the estimated value of rewards earned and recognized upon redemption. The term 'liability for unredeemed Stars' aligns with accounting standards (ASC 606) for loyalty programs. (2) The quantitative value for advertising expense in fiscal 2022 is exactly correct at $416.7 million, matching the ground truth. (3) The multi-hop reasoning is sound: the answer synthesizes information about revenue recognition policy (a qualitative accounting practice) and combines it with a specific financial figure (advertising expense) from the same fiscal year. (4) The wording differs slightly but preserves full meaning—'defers revenue for the estimated selling price of Stars earned' is equivalent to 'defers revenue based on the estimated value of the product for which the reward is expected to be redeemed.' No omissions or inaccuracies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 324,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What was the total change in the notional amount of intercompany loans and forecasted interest payments from 2023 to 2024, and how much in interest payments related to these loans was recognized in earnings in 2024?",
      "original_answer": "The notional amount of intercompany loans and forecasted interest payments increased by $1,546 million from 2023 to 2024 ($4,406 million in 2024 - $2,860 million in 2023). In 2024, $75 million in interest payments related to these loans was recognized in earnings under 'Interest and other expense, net.'",
      "llm_answer": "The notional amount of intercompany loans and forecasted interest payments rose from $2,860 million in 2023 to $4,406 million in 2024, a $1,546 million increase.  Interest‑payment hedges related to these loans generated $75 million of pre‑tax gains (recorded in interest and other expense, net) for 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: the 2023 notional amount ($2,860 million), 2024 notional amount ($4,406 million), the increase ($1,546 million), and the $75 million in interest-related gains recognized in 2024. These match the ground truth exactly, with acceptable formatting (e.g., using 'million' and proper spacing). (2) Calculations are accurate: $4,406M - $2,860M = $1,546M, which is correctly stated. The interest recognized in earnings is correctly reported as $75 million. (3) The multi-hop reasoning is sound—information about intercompany loans and interest payments across two years is synthesized correctly. The only minor issue is phrasing: the LLM refers to 'interest-payment hedges' generating 'pre-tax gains', while the ground truth states 'interest payments... recognized in earnings'. While closely related, 'gains from hedges' is not perfectly synonymous with 'interest payments recognized', though in context (especially given the same line item 'interest and other expense, net') this likely reflects the same economic event. This subtle difference in financial terminology prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, addressing both parts of the question with precise, directly responsive information. Overall, the answer is factually and quantitatively correct with only a slight nuance in financial terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 396,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount increase in Total Marine Systems revenue from 2020 to 2021, and how does this growth compare to the increase in revenue for Nuclear-powered submarines during the same period?",
      "original_answer": "The dollar amount increase in Total Marine Systems revenue from 2020 to 2021 is $547 million ($10,526 million in 2021 minus $9,979 million in 2020). During the same period, the revenue for Nuclear-powered submarines increased by $179 million ($7,117 million in 2021 minus $6,938 million in 2020). Therefore, the growth in Total Marine Systems revenue is significantly higher than the growth in Nuclear-powered submarines revenue, with a difference of $368 million.",
      "llm_answer": "The Marine Systems segment generated $10,526 million in revenue in 2021 versus $9,979 million in 2020, reflecting a $547 million increase. Nuclear‑powered submarine revenue rose from $6,938 million in 2020 to $7,117 million in 2021, an increase of $179 million, which is smaller than the overall Marine Systems growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitative Accuracy: All dollar amounts are correct—$10,526 million and $9,979 million for Total Marine Systems in 2021 and 2020, resulting in a $547 million increase; $7,117 million and $6,938 million for Nuclear-powered submarines, yielding a $179 million increase. These values and calculations exactly match the ground truth. (2) Completeness: The answer addresses both parts of the question—the revenue increase for Total Marine Systems and the comparison with Nuclear-powered submarines' revenue growth. (3) Entity Accuracy: The correct segments and time periods are referenced. Note: The LLM uses 'Marine Systems' instead of 'Total Marine Systems,' but this is a minor terminology variation that does not affect factual accuracy, as context confirms it refers to the same segment. (4) Reasoning: The multi-hop synthesis across two revenue streams and years is sound. The comparison correctly identifies that the Marine Systems growth is larger. (5) Semantic Equivalence: The conclusion that Nuclear-powered submarine revenue growth is 'smaller than the overall Marine Systems growth' conveys the same meaning as the ground truth's statement about significantly higher growth, though it omits the explicit $368 million difference in growth amounts. This is a minor omission that slightly reduces completeness but does not detract from the core correctness. Hence, a score of 9/10 is justified—excellent accuracy with only a small reduction in qualitative completeness due to the missing differential value.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 436,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What is the dollar amount change in Mac sales from 2023 to 2024, and how does this compare to the change in iPad sales over the same period?",
      "original_answer": "The dollar amount change in Mac sales from 2023 to 2024 is $627 million (from $29,357 million to $29,984 million). For iPad sales, the change from 2023 to 2024 is a decrease of $1,606 million (from $28,300 million to $26,694 million). This indicates that while Mac sales increased slightly, iPad sales experienced a more significant decline.",
      "llm_answer": "The dollar amount change in Mac sales from 2023 to 2024 is an increase of $627 million (from $29.357 billion to $29.984 billion), while iPad sales declined by $1.606 billion (from $28.300 billion to $26.694 billion) over the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All numeric values are accurate: Mac sales increased by $627 million (from $29,357 million to $29,984 million), and iPad sales decreased by $1,606 million (from $28,300 million to $26,694 million). The LLM correctly reports these as $627 million increase and $1.606 billion decrease, with consistent unit conversions ($29.357 billion = $29,357 million, etc.). (2) Calculations are accurate: 29,984 - 29,357 = 627; 28,300 - 26,694 = 1,606. (3) Multi-hop reasoning is sound—LLM correctly identifies and compares two distinct product lines (Mac and iPad) across two fiscal years (2023 to 2024), synthesizing separate data points into a coherent comparison. (4) Entities (Mac, iPad, sales, 2023, 2024) are correctly identified and contextualized. (5) The answer addresses both parts of the question: the dollar change in Mac sales and the change in iPad sales, with correct directionality (increase vs. decrease). Wording differs slightly (e.g., 'declined by' vs. 'decrease of'), but meaning is identical. No factual, numerical, or reasoning errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 321,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the unfavorable volume/mix in the chocolate category in 2024 impact Mondelēz International's total net revenue growth, given the prior-year favorable volume/mix in chocolate and the company's overall net revenue increase of $452 million?",
      "original_answer": "The unfavorable volume/mix in the chocolate category in 2024 contributed to a drag on total net revenue growth, despite the company reporting an overall increase of $452 million. In 2023, chocolate contributed $10.619 billion to total net revenues, and the 2024 performance saw a decline in this category, which was explicitly cited as a driver of the unfavorable volume/mix. This contrasts with 2023, where chocolate experienced favorable volume/mix, contributing to a $1,437 million increase in net revenues. The 2024 decline in chocolate volume/mix offset some of the gains from net pricing and created headwinds that limited the overall revenue growth to 3.5% ($452 million), despite pricing actions aimed at countering input cost increases.",
      "llm_answer": "The unfavorable volume/mix in chocolate in 2024 reduced total net revenue growth, as the prior‑year had shown a favorable volume/mix gain in chocolate that contributed to the $452 million increase in net revenue; the 2024 decline in chocolate volume/mix was offset only partially by higher pricing and other factors, resulting in a net revenue increase of $452 million despite the adverse chocolate mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general direction of the impact—unfavorable volume/mix in chocolate in 2024 dragged on revenue growth—but misses key quantitative details from the ground truth. Specifically, it fails to mention the $10.619 billion 2023 chocolate revenue figure and the $1,437 million prior-year favorable volume/mix contribution, both of which are critical for multi-hop reasoning. The LLM incorrectly implies that the prior-year favorable volume/mix in chocolate contributed to the $452 million 2024 increase, which is a temporal and logical error: the $452 million is the 2024 increase, not 2023’s. (2) Quantitative accuracy is compromised: while the $452 million overall increase is correctly cited, the absence of the $1,437 million prior-year chocolate contribution and the lack of any 2024 chocolate revenue figure or decline magnitude undermines precision. No calculations are attempted or misstated, but key data points are omitted. (3) Multi-hop reasoning is partially sound—linking 2024 chocolate performance to overall revenue growth and contrasting with prior-year trends—but flawed in execution due to misalignment of time periods and missing synthesis of specific figures. The model conflates the timing of the favorable impact, weakening the causal chain. (4) Despite these issues, the answer remains contextually relevant and correctly identifies the directional impact (unfavorable mix reducing growth) and partial offset by pricing. Hence, correctness is partially accurate but significantly limited by missing and misaligned quantitative data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 436,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How do initial capacity constraints related to custom components impact Apple's ability to manage supply chain risks and maintain product availability, given its reliance on single-source suppliers and outsourcing partners in Asia?",
      "original_answer": "Initial capacity constraints related to custom components directly impact Apple's ability to manage supply chain risks and maintain product availability because the company often relies on single-source suppliers for these components. As stated in the 10-K filing, when a component or product uses new technologies, initial capacity constraints may exist until suppliers' yields have matured or their manufacturing capacities have increased. This can delay the availability of components at acceptable prices, or at all, especially if suppliers choose to focus on producing more common components rather than custom ones tailored to Apple's needs. Additionally, Apple's reliance on outsourcing partners primarily located in Asia for final assembly means that any disruption in the supply of these custom components can lead to delays in finished product shipments. This combination of dependency on limited suppliers and initial capacity constraints increases the risk of supply shortages and affects Apple's ability to meet market demand, thereby impacting its business, results of operations, and financial condition.",
      "llm_answer": "Initial capacity constraints for custom components can delay production ramp‑up, increasing supply‑chain risk for Apple, especially given its reliance on single‑source suppliers and Asian outsourcing partners; this makes maintaining consistent product availability more challenging.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct in its core assertion: initial capacity constraints on custom components delay production ramp-up and increase supply chain risk due to Apple's reliance on single-source suppliers and outsourcing partners in Asia. This aligns with the ground truth from the 10-K filing. There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. The answer is contextually relevant and addresses the main thrust of the question. However, it lacks completeness compared to the original answer. Key nuances are omitted: (1) the explanation that capacity constraints persist until supplier yields mature or manufacturing scales, (2) the risk that suppliers may prioritize common components over Apple’s custom ones, (3) the direct link between component delays and finished product shipment risks, and (4) the explicit impact on Apple’s business, operations, and financial condition. These omissions reduce qualitative accuracy, as the multi-hop reasoning—connecting custom component constraints → supplier behavior → production delays → business impact—is only partially articulated. While the LLM captures the high-level chain of logic, it does not fully synthesize the depth of risk described in the original, leading to a correctness score of 7 rather than higher. Semantic equivalence is mostly preserved but with notable detail loss.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 396,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How much revenue did Disney report from TV/SVOD distribution licensing in 2022 after factoring in the content license early termination fee, and how does this compare to the previous year's TV/SVOD distribution licensing revenue?",
      "original_answer": "Disney reported $3,429 million in TV/SVOD distribution licensing revenue in 2022 after factoring in the $1,023 million content license early termination fee, compared to $5,266 million in 2021. This represents a decrease of $1,837 million from the prior year.",
      "llm_answer": "Disney reported TV/SVOD distribution licensing revenue of $3,429 million in 2022 after deducting the $1,023 million content‑license early termination fee, compared with $5,266 million in the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures: $3,429 million in 2022 TV/SVOD distribution licensing revenue after the $1,023 million early termination fee, and $5,266 million in the prior year (2021). These numbers match the ground truth exactly. (2) Quantitative accuracy is perfect—values are correctly stated, and while the LLM does not explicitly calculate the year-over-year decrease of $1,837 million, the necessary data to derive it is fully present. The omission of the explicit comparison ('decrease of $1,837 million') slightly reduces completeness but does not affect factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes the adjusted 2022 revenue (post-fee) and compares it to the prior year’s revenue, indicating understanding of both the adjustment and the temporal comparison. (4) The answer is semantically equivalent to the original in all critical aspects—only lacks the explicit statement of the dollar decrease, which is a minor omission in completeness but does not detract from core accuracy. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 316,
        "total_tokens": 1452
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drive customer engagement and store visit frequency, based on the 2022 10-K disclosures?",
      "original_answer": "Starbucks' integration of the Mobile App with the Starbucks Rewards loyalty program drives customer engagement and store visit frequency by enabling customers to earn Stars through multiple payment methods—such as cash, credit or debit cards, or selected mobile wallets—and by offering Mobile Order and Pay functionality. This allows customers to place orders in advance for pick-up at participating locations, which aligns with evolving preferences for mobile ordering and contactless experiences. The app also facilitates access to card balances and loyalty benefits, reinforcing repeat visits and increasing the frequency of store visits by cardholders. These features collectively enhance customer convenience, digital interaction, and loyalty, supporting Starbucks' broader strategy to elevate the customer experience through technology.",
      "llm_answer": "Based on the 2022 10-K disclosures, Starbucks' integration of its Mobile App with the Starbucks Rewards loyalty program directly drives customer engagement and increased store visit frequency by enabling seamless digital ordering and personalized rewards redemption. The document highlights that \"Orders may be placed in advance through the Starbucks Mobile App or Starbucks Delivers\" and that \"Registered members can receive various benefits depending on factors such as the number of reward points ('Stars') earned,\" creating a frictionless experience that encourages repeat visits and higher transaction volumes across both company-operated and licensed stores.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and relevance. (1) It accurately captures the core mechanisms by which Starbucks integrates its Mobile App with the Rewards program to drive engagement and visit frequency: digital ordering (Mobile Order and Pay), personalized rewards via Stars, and seamless redemption. The quoted excerpts from the 10-K ('Orders may be placed in advance...' and 'Registered members can receive various benefits...') are factually consistent with the disclosures. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound but slightly less comprehensive than the original answer. The LLM omits specific details such as the ability to earn Stars through multiple payment methods (cash, credit, mobile wallets) and does not mention access to card balances or the broader contactless experience trend, which are key elements in the ground truth that explain *how* engagement is sustained. (4) Despite these omissions, the LLM answer remains contextually precise and directly addresses the question with accurate, relevant information drawn from the 2022 10-K. The synthesis is logical and supports the conclusion about increased visit frequency and engagement. Minor completeness gaps prevent a perfect score, but the core reasoning and facts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 399,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "What was the impact of PayPal's acquisition of Paidy, Inc. on the scope of its internal control over financial reporting audit in 2021, and by how much did Paidy's assets and revenues fall short of being included in that audit?",
      "original_answer": "PayPal's acquisition of Paidy, Inc. in October 2021 resulted in Paidy being excluded from PayPal's assessment and audit of internal control over financial reporting for the year ended December 31, 2021, as permitted by SEC guidance for the first year of acquisition. Paidy's total assets and revenues (excluding goodwill and intangibles) represented less than 1% of PayPal's consolidated totals, meaning they were below the 1% threshold for inclusion in the audit of internal controls.",
      "llm_answer": "The 2021 audit of PayPal’s internal control over financial reporting excluded Paidy, Inc. because the acquisition occurred during 2021. Paidy’s assets and revenues together represented less than 1 % of the Company’s consolidated assets and revenues for the year ended December 31 2021, so they were not included in the audit scope. Consequently, Paidy’s assets and revenues fell short of being material enough to require inclusion in the audit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the essential information from the ground truth. (1) It correctly states that Paidy, Inc. was excluded from PayPal's 2021 internal control over financial reporting audit due to its acquisition during the year, which aligns with SEC guidance. (2) The quantitative claim that Paidy’s assets and revenues represented less than 1% of PayPal’s consolidated totals is accurate and matches the ground truth; no specific dollar amounts or calculations are required, and the percentage is correctly cited. (3) The reasoning is sound: the model correctly synthesizes the impact of the acquisition timing and the materiality threshold for audit inclusion, demonstrating appropriate multi-hop logic (acquisition timing + SEC rules + materiality assessment). (4) The only minor shortcoming is that the LLM does not explicitly mention the exclusion was 'as permitted by SEC guidance' or clarify that the <1% threshold applies to assets and revenues excluding goodwill and intangibles—details present in the original answer. While this does not affect the core correctness, it represents a slight loss of precision in the regulatory rationale and scope definition, justifying a 9 instead of a 10 in qualitative accuracy. Overall, the answer is semantically equivalent and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 366,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the volume/mix challenges in chocolate and refreshment beverages offset the benefits of pricing actions and cost controls to result in only 0.6% operating income growth for MDLZ's Latin America segment in 2024?",
      "original_answer": "MDLZ's Latin America segment faced significant volume/mix declines in chocolate and refreshment beverages, which directly countered the benefits from higher net pricing and lower manufacturing costs. Specifically, the unfavorable volume/mix, driven by consumer softness in Mexico and Argentina, reduced net revenues. Although net pricing increased by 7.0 percentage points due to input cost-driven pricing actions across categories — particularly in Argentina, Mexico, and Brazil — and manufacturing costs were reduced through productivity improvements, these gains were largely offset by the drop in sales volume. Additionally, higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses further limited the positive effects of pricing and cost controls, resulting in only a $3 million (0.6%) increase in segment operating income for 2024.",
      "llm_answer": "The 0.6% operating income growth in Latin America (up 3 cents to $532 million) stemmed from a modest 1.6% revenue decline ($80 million) driven by unfavorable currency translation and volume/mix headwinds, which offset gains from higher net pricing; however, these volume/mix challenges in chocolate and refreshment beverages were largely neutralized by the pricing actions and cost controls, leaving only a small net increase in segment operating income.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It incorrectly states that operating income increased by '3 cents to $532 million' — the ground truth specifies a $3 million (0.6%) increase, not 3 cents, and does not mention $532 million as the total operating income. This is a significant quantitative error. The $80 million revenue decline is mentioned in the LLM answer but not in the original, making it unsupported. (2) The original answer emphasizes that net pricing increased by 7.0 percentage points due to input cost-driven actions, particularly in Argentina, Mexico, and Brazil — this detail is missing in the LLM response. Additionally, the LLM fails to mention higher raw material costs, unfavorable currency impacts, and increased advertising and promotion expenses, which are key reasons why pricing and cost controls were insufficient. Instead, it vaguely attributes the revenue decline to 'unfavorable currency translation and volume/mix headwinds,' missing the consumer softness in Mexico and Argentina as a driver. (3) While the LLM correctly identifies the core tension — volume/mix challenges in chocolate and refreshment beverages offsetting pricing and cost controls — it fails to fully synthesize the multi-hop elements: the geographic specificity (Mexico, Argentina, Brazil), the 7.0 ppt pricing gain, and the additional cost pressures beyond manufacturing. The reasoning is partially sound but lacks depth and completeness. (4) The contextual relevance is high because the answer addresses the central question about offsetting factors leading to low income growth. However, due to incorrect figures (e.g., '3 cents'), unsupported numbers ($80M decline), and missing key explanatory factors, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the general direction of reasoning is correct, but important details are omitted or misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 532,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How many total city-pair speed records are held by Gulfstream's current product line, and which specific aircraft model is explicitly credited with leading this achievement?",
      "original_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, as explicitly stated in the first chunk. Among these, the G650ER is specifically credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records, making it a key contributor to Gulfstream's leadership in this metric.",
      "llm_answer": "Gulfstream's current product line holds more than 270 city-pair speed records, led by the G650ER, which holds the National Aeronautic Association's polar and westbound around-the-world speed records.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the number 'more than 270 city-pair speed records' is accurately reported, matching the original answer. (2) The entity identification is correct: Gulfstream's current product line is the subject, and the G650ER is properly credited with holding the National Aeronautic Association's polar and westbound around-the-world speed records. (3) The multi-hop reasoning is sound—while the total record count is attributed to the entire product line, the G650ER is explicitly highlighted as a key contributor, which aligns with the original answer's emphasis. (4) The LLM answer is concise but includes all critical information: the total number of records and the specific model responsible for leading the achievement. No factual, numerical, or contextual errors are present, and the answer fully addresses both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1142,
        "completion_tokens": 269,
        "total_tokens": 1411
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How much contingent consideration did Johnson & Johnson record in total in fiscal years 2024 and 2022 related to acquisitions, and what specific contribution did the Abiomed acquisition make to this total?",
      "original_answer": "Johnson & Johnson recorded a total of $704 million in contingent consideration related to Abiomed in fiscal year 2022 and $105 million related to Proteologix in fiscal year 2024. Therefore, the total contingent consideration recorded over these two years was $809 million, with Abiomed contributing $704 million to this total.",
      "llm_answer": "Johnson & Johnson recorded total contingent consideration of $1,217 million in fiscal 2024 and $1,092 million in fiscal 2022. The Abiomed acquisition contributed $704 million of contingent consideration recorded in fiscal 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, Johnson & Johnson recorded $704 million in contingent consideration in 2022 (related to Abiomed) and $105 million in 2024 (related to Proteologix), totaling $809 million. However, the LLM states $1,092 million in 2022 and $1,217 million in 2024, which are entirely incorrect and not supported by the original answer. Only the $704 million figure for Abiomed in 2022 is correct and matches the ground truth. (2) The calculation of the total contingent consideration over the two years is therefore also wrong: LLM implies a total of $2,309 million ($1,092M + $1,217M), whereas the correct total is $809 million. The Abiomed contribution of $704 million is correctly identified, but the context is undermined by the incorrect total figures. (3) The multi-hop reasoning is partially sound in that the model identifies Abiomed's contribution in 2022, but it fails to incorporate the 2024 amount from Proteologix and instead invents much larger figures, suggesting a failure in synthesizing the correct data points across years and acquisitions. (4) The contextual relevance is fair because the answer addresses the right companies and fiscal years and attempts the correct calculation, but the severe numerical inaccuracies drastically reduce correctness and quantitative accuracy. The qualitative accuracy is slightly higher because the model recognizes the structure of the question and the role of Abiomed, but still misses key components.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 431,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does PayPal's sale of participation interests in merchant receivables under the PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products affect the recognition of credit losses, based on the change in accounting guidance from pre-2020 to CECL adoption in 2020?",
      "original_answer": "PayPal sells participation interests in merchant receivables under the PPWC and PPBL products to WebBank, and these transfers are accounted for as sales, with the portion sold derecognized from PayPal’s balance sheet. Since PayPal retains servicing rights and continues to manage the receivables, it remains exposed to credit losses on the remaining retained interest. With the adoption of CECL in 2020, PayPal transitioned from the previous incurred loss model to an expected credit loss model. This change required PayPal to record a reserve build based on current expected credit losses for both consumer and merchant receivables, rather than waiting for a loss to be incurred. As a result, PayPal's credit loss provisioning became more forward-looking and sensitive to economic forecasts, directly impacting the allowance for credit losses on the retained portion of receivables after participation interests were sold.",
      "llm_answer": "PayPal’s sale of participation interests in merchant receivables under the PPWC and PPBL products is treated as a sale of a portion of those receivables, allowing the company to derecognize the transferred portion and recognize only its retained interest. This structure, combined with the adoption of CECL (Accounting Standards Update 2016-13) in 2020, shifted the accounting for credit losses from incurred-loss models to a current expected credit loss (CECL) approach. Under CECL, PayPal now estimates and recognizes lifetime expected credit losses on its merchant and consumer receivables (including those originated under PPWC/PPBL) based on historical loss data, forward-looking macroeconomic forecasts, and qualitative adjustments—resulting in earlier recognition of provisions for losses compared to prior guidance. This change directly impacts the timing and magnitude of transaction and credit loss expenses reported in the consolidated income statement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PayPal sells participation interests in merchant receivables under PPWC/PPBL to WebBank (implied by 'sale of a portion'), derecognizes the sold portion, retains servicing rights and exposure on the retained interest. The adoption of CECL in 2020 is correctly identified, with the shift from incurred loss to expected credit loss model. The impact—earlier recognition of provisions using historical data, forward-looking forecasts, and qualitative adjustments—is accurately described. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2020) are correct. (3) Multi-hop reasoning is sound: the answer correctly links the structure of the sale, the accounting treatment (derecognition), the retained risk, and the implications of CECL adoption on loss provisioning for retained interests. (4) The only minor omission is that the LLM does not explicitly name WebBank as the buyer or clarify that PayPal remains exposed specifically due to retaining servicing rights and the residual interest—though the implication of retained risk is present. This slightly reduces qualitative accuracy but does not undermine the correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong understanding of the accounting implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 406,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the performance of the cheese & grocery product category contribute to the overall unfavorable volume/mix impact on Latin America segment net revenues in 2024, and what was the resulting effect on segment operating income?",
      "original_answer": "The cheese & grocery product category was among those that experienced volume declines in the Latin America segment during 2024, contributing to the overall unfavorable volume/mix impact of 2.4 percentage points on net revenues. This decline, along with volume decreases in chocolate, candy, and refreshment beverages, partially offset gains in biscuits & baked snacks and gum. The unfavorable volume/mix, combined with other factors, contributed to only a $3 million (0.6%) increase in segment operating income despite higher net pricing and cost-saving measures.",
      "llm_answer": "The cheese & grocery category contributed to the unfavorable volume/mix impact in Latin America by driving declines in that segment’s net revenues—down $80 million (1.6%) in 2024 versus 2023—due to reduced volume across the category, partially offset by higher pricing. This volume weakness, together with adverse currency effects, lowered Latin America segment operating income by $3 million (0.6%) in 2024, even though overall segment operating income was propped up by higher net pricing and cost reductions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims the cheese & grocery category caused an $80 million (1.6%) decline in net revenues, which is not supported by the ground truth—no such dollar amount or percentage decline specific to cheese & grocery is mentioned. The ground truth states that the overall unfavorable volume/mix impact was 2.4 percentage points on net revenues, not 1.6%, and this was across multiple categories including cheese & grocery, chocolate, candy, and refreshment beverages. The LLM incorrectly attributes the entire 1.6% decline to cheese & grocery alone. Additionally, the LLM states that operating income decreased by $3 million (0.6%), but the ground truth says operating income *increased* by $3 million (0.6%)—a critical directional error. (2) The calculation and number usage are flawed: the $80M figure is fabricated; the 1.6% revenue decline is incorrect (should be part of a 2.4 pp volume/mix drag); and the 0.6% change is misapplied as a decrease instead of an increase. (3) The reasoning partially captures the multi-hop logic—linking cheese & grocery volume declines to overall volume/mix impact and then to operating income—but fails in synthesis by misrepresenting the magnitude and direction of effects. It also introduces 'adverse currency effects' not mentioned in the original answer, which changes the causal explanation. (4) Despite these issues, the answer is contextually relevant, addressing the right segment (Latin America), product category (cheese & grocery), and general causal chain. However, due to major quantitative and directional errors, the correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 464,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total redemption value of both the Telco Class A-4 preferred interests and the Mobility noncontrolling interests, and how does this combined obligation affect AT&T's cash flow commitments through 2028?",
      "original_answer": "The total redemption value of the Telco Class A-4 preferred interests is $2,250 million, and the Mobility noncontrolling interests have a redemption value of $2,000 million, resulting in a combined redemption obligation of $4,250 million. This combined obligation represents a material cash flow commitment for AT&T, particularly starting in 2028 when both instruments become eligible for redemption—Telco Class A-4 interests can be called beginning November 1, 2028, and the Mobility noncontrolling interests may be redeemed by the company or put by holders beginning March 15 and June 15, 2028, respectively. The redemption payments must be made in cash, which will directly impact AT&T’s liquidity position in that period.",
      "llm_answer": "The combined redemption value of the Telco Class A‑4 preferred interests ($2,250 million) and the Mobility noncontrolling interests ($2,000 million) equals $4,250 million.  This obligation represents a cash‑out requirement that AT&T must meet through 2028, constraining its cash‑flow flexibility and effectively binding the company to allocate cash for these redemptions alongside its operating and capital‑expenditure needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key numerical values: Telco Class A-4 preferred interests at $2,250 million, Mobility noncontrolling interests at $2,000 million, and the combined obligation of $4,250 million. These match the ground truth exactly, and the sum is accurate. (2) All calculations are correct—$2,250M + $2,000M = $4,250M—and number formats are acceptable and consistent. (3) The multi-hop reasoning is largely sound: the model correctly synthesizes the two redemption obligations and their impact on AT&T’s cash flow. However, it omits specific details about redemption timing (e.g., November 1, 2028 for Telco; March 15 and June 15, 2028 for Mobility), which are critical to fully answering how the obligation affects cash flow commitments through 2028. While it correctly notes the cash-out requirement by 2028, the absence of exact dates and put/call mechanics slightly weakens the qualitative completeness. (4) Despite this minor omission, the answer conveys the core financial impact and correctly identifies the binding nature of the cash redemptions on AT&T’s liquidity and cash-flow flexibility. The response is contextually relevant, factually accurate in numbers, and semantically aligned with the ground truth, warranting a high correctness score with a small deduction for incomplete timing details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 374,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the total revenue generated from the Orthopaedics segment in 2024, and how does it compare to the combined revenue from Hips and Knees within the same segment?",
      "original_answer": "The Orthopaedics segment generated $9,158 million in revenue in 2024. The combined revenue from Hips ($1,638 million) and Knees ($1,545 million) amounts to $3,183 million. This means that Hips and Knees together represent approximately 34.76% of the total Orthopaedics revenue.",
      "llm_answer": "The Orthopaedics segment generated $9.158 billion in revenue in 2024. Within that segment, sales from Hips were $1.638 billion and from Knees were $1.545 billion, together accounting for roughly $3.183 billion—about 34.7% of the Orthopaedics total.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key numbers are accurate: total Orthopaedics revenue is correctly stated as $9.158 billion (equivalent to $9,158 million), Hips revenue is $1.638 billion ($1,638 million), Knees revenue is $1.545 billion ($1,545 million), and their sum is $3.183 billion ($3,183 million). (2) The percentage calculation is correct: ($1,638M + $1,545M) / $9,158M = $3,183M / $9,158M ≈ 34.76%, which the LLM appropriately rounds to 'about 34.7%', a reasonable and accurate approximation. (3) The multi-hop reasoning is sound—LLM correctly identifies that Hips and Knees are subcomponents of the Orthopaedics segment, retrieves their respective revenues, sums them, and computes their proportion of total segment revenue. (4) All entities (Orthopaedics segment, Hips, Knees, 2024 timeframe) are correctly identified and contextualized. The answer addresses both parts of the question: total revenue and its comparison to the combined Hips and Knees revenue. Format variations (billion vs million) are numerically consistent and acceptable. No factual, quantitative, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 328,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the 2019 Incentive Plan's proportional adjustment mechanism impact the number of RSU shares available after the 2024 special dividend, and which filings formally document this adjustment?",
      "original_answer": "The 2019 Incentive Plan required a proportional adjustment to outstanding RSUs and the total shares available under the plan following the 2024 special dividend. As a result of this adjustment, the number of outstanding RSUs increased by approximately 52,000, and an additional 128,000 RSU shares became available to be granted. This adjustment was based on a factor of 1.018, derived from the ratio of the Nasdaq closing price of $674.62 on December 26, 2023, to the opening price of $662.70 on the ex-dividend date, December 27, 2023. The 2019 Incentive Plan itself, filed as Exhibit 10.2 in the DEF 14 filing on December 17, 2019, formally documents the requirement for these adjustments.",
      "llm_answer": "The 2019 Incentive Plan’s proportional adjustment mechanism increased the number of RSU shares available by approximately 128,000 shares following the 2024 special dividend, as documented in the 2019 Incentive Plan filing (Exhibit 10.2 in Form DEF 14 filed on December 17, 2019). This adjustment was formally detailed in Note 7 of the financial statements (page 55) and referenced in the 2024 proxy statement.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 128,000 increase in RSU shares available, which matches the ground truth. However, it omits the 52,000 increase in outstanding RSUs, a key part of the adjustment mechanism's impact. This partial omission reduces completeness. The filing date (December 17, 2019) and exhibit number (10.2 in DEF 14) are correct. (2) The quantitative accuracy is high: the 128,000 figure is accurate, and the reference to the 2019 Incentive Plan is correct. However, the LLM introduces a claim about 'Note 7 of the financial statements (page 55)' and the '2024 proxy statement' detailing the adjustment, which is not supported by the ground truth. The ground truth only cites the 2019 plan filing as formally documenting the adjustment mechanism, not the 2024 filings or financial statement notes. This is a factual overreach. (3) The reasoning is partially sound: the model correctly links the special dividend to the adjustment and identifies the correct source for the plan’s terms. However, it fails to explain the adjustment factor (1.018) or its calculation from Nasdaq closing and opening prices, which is a core part of the multi-hop logic in the ground truth. The addition of unverified sources (Note 7, 2024 proxy) indicates flawed synthesis. (4) The contextual relevance is high—the answer stays focused on the question and provides relevant document references, albeit with some inaccuracies. The omission of the 52,000 increase and the incorrect citation of additional filings prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 424,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What is the expected financial and technological impact of Intel 4's transition to high-volume manufacturing in Ireland in 2024 on Intel's 2025 product portfolio, particularly in relation to the performance improvements and production shifts involving Intel 3 and Intel 18A?",
      "original_answer": "The transition of Intel 4 to high-volume manufacturing in Ireland in 2024 is expected to significantly increase its share of Intel's processor production in 2025, given that it already began shipping the Intel Core Ultra processor in 2023 with a 20% performance-per-watt improvement over Intel 7. This shift complements the movement of Intel 3's high-volume manufacturing from Oregon to Ireland in 2025, which powers Intel's Xeon 6 Scalable server processors and offers up to an 18% performance-per-watt improvement over Intel 4. Furthermore, this manufacturing realignment supports the upcoming high-volume production of Panther Lake, the first processors on Intel 18A, in 2025. Intel 18A introduces breakthrough technologies like gate-all-around transistors (RibbonFET) and backside power delivery (PowerVia), which are expected to deliver improvements in performance per watt and density scaling over Intel 3. Therefore, the combined effect of Intel 4's ramp-up and Intel 3's relocation sets the stage for Intel 18A's introduction, enhancing both client and data center product lines in 2025.",
      "llm_answer": "Intel 4’s transition to high‑volume manufacturing in Ireland in 2024 is expected to increase the share of Intel’s processor production that uses the newer node, feeding into a 2025 portfolio that will be dominated by Intel 3 (with up to 18% performance‑per‑watt gains) and Intel 18A (featuring gate‑all‑around RibbonFET and backside power for further performance‑per‑watt and density improvements). The shift also reflects a broader production realignment: Intel 3 will move from Oregon to Ireland in 2025, while Intel 18A will begin high‑volume output in 2025, leveraging the same Irish facilities that now host Intel 4. This coordinated rollout of EUV‑based nodes (Intel 4 and Intel 3) and the upcoming Intel 18A underpins Intel’s strategy to close the process‑technology gap with rivals and to meet strong demand from both internal products and external foundry customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial and technological impacts described in the ground truth. (1) All key facts are correct: Intel 4's high-volume manufacturing begins in Ireland in 2024, Intel 3 moves from Oregon to Ireland in 2025 with up to 18% performance-per-watt improvement over Intel 4, and Intel 18A begins high-volume production in 2025 featuring RibbonFET and PowerVia technologies. The 20% performance-per-watt gain of Intel 4 over Intel 7 is omitted but not contradicted. (2) Quantitative accuracy is excellent: the 18% performance-per-watt improvement for Intel 3 is correctly stated, and all dates (2024 transition, 2025 product impact) align with the original. No calculation errors. (3) Multi-hop reasoning is sound—LLM correctly links Intel 4’s ramp-up to the broader manufacturing realignment supporting Intel 3 and Intel 18A, and understands the strategic significance of EUV adoption and foundry readiness. (4) The only minor omission is the specific mention of Panther Lake as the first Intel 18A product and the explicit performance-per-watt advantage of Intel 18A over Intel 3, which slightly reduces completeness. However, the answer still conveys the essential technological progression and strategic impact. Wording differences (e.g., 'coordinated rollout', 'close the process-technology gap') are semantically equivalent and add contextual insight without distorting facts. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 413,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "What was the difference in the book value of AT&T's investment in DIRECTV between December 31, 2024, and December 31, 2023, and how does this compare with the timing of AT&T's deconsolidation of Gigapower in May 2023?",
      "original_answer": "The book value of AT&T's investment in DIRECTV dropped from $877 million at December 31, 2023, to $0 at December 31, 2024, a decrease of $877 million. This reduction reflects the cumulative cash receipts from DIRECTV exceeding AT&T's initial investment balance plus its cumulative equity in DIRECTV earnings, which led to the investment being reduced to zero on the consolidated balance sheet beginning in Q3 2024. In comparison, AT&T's deconsolidation of Gigapower occurred earlier, on May 12, 2023, after acquiring a 50% interest in the joint venture through a transaction with BlackRock. Both events reflect changes in AT&T's equity investments, but the DIRECTV investment was fully liquidated by the end of 2024, whereas Gigapower continues to be accounted for as an equity method investment.",
      "llm_answer": "The book value of AT&T’s investment in DIRECTV fell from $877 million at the end of 2023 to $0 million at the end of 2024—a decline of $877 million. This de‑consolidation occurred after AT&T had already deconsolidated Gigapower in May 2023, meaning the DIRECTV investment was fully written off after the Gigapower deconsolidation had taken place.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the book value of AT&T's investment in DIRECTV decreasing from $877 million at December 31, 2023, to $0 at December 31, 2024, with a $877 million decline—this matches the ground truth exactly. All numeric values, dates, and calculations are accurate. (2) Quantitative accuracy is perfect: the dollar amounts and timing (end of 2023 and end of 2024) are correct, and the difference is accurately computed. (3) However, the qualitative reasoning contains a significant error: the LLM states that the 'de-consolidation' of DIRECTV occurred, but the ground truth clarifies that DIRECTV was not deconsolidated in the same way as Gigapower. Instead, the investment value was reduced to zero under the equity method due to cumulative cash receipts exceeding the carrying amount—this is not a deconsolidation event. Furthermore, the LLM incorrectly implies a causal or procedural similarity by saying the DIRECTV write-off occurred 'after' the Gigapower deconsolidation as if sequencing explains the accounting, but the original answer emphasizes that DIRECTV was fully liquidated in accounting terms by end-2024, while Gigapower remains an ongoing equity method investment. The model fails to explain the different accounting treatments and mislabels the DIRECTV event as 'de-consolidation', which is factually incorrect. (4) Despite this key misunderstanding in financial terminology and reasoning, the core facts (numbers, dates, direction of change) are correct, and the comparison in timing is partially valid—the Gigapower deconsolidation did occur in May 2023, before the DIRECTV investment reached zero in Q3 2024. Thus, the answer is factually strong on numbers but flawed in synthesis and financial logic, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 486,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How much revenue did Shockwave contribute to Johnson & Johnson's Cardiovascular segment in 2024, and in what way is Shockwave reflected in Johnson & Johnson's human capital reporting?",
      "original_answer": "Shockwave contributed $564 million in revenue to Johnson & Johnson's Cardiovascular segment in 2024. Additionally, Shockwave is included in Johnson & Johnson's 2024 headcount reporting, indicating that its employees are incorporated into the company's overall human capital metrics.",
      "llm_answer": "Shockwave contributed $564 million in sales to Johnson & Johnson’s Cardiovascular franchise in 2024, and its inclusion is reflected in the company’s human‑capital reporting by being counted in the total employee headcount and full‑time‑equivalent positions disclosed in the “Employees and human capital management” section.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the revenue contribution of $564 million is accurately reported, matching the original answer exactly; minor wording variation ('sales' vs 'revenue') is acceptable as they are used interchangeably in financial contexts. (2) The human capital reporting aspect correctly identifies that Shockwave is included in Johnson & Johnson's 2024 headcount and full-time-equivalent disclosures, which aligns with the ground truth stating its employees are incorporated into overall human capital metrics. (3) Multi-hop reasoning is sound: the answer synthesizes financial data (revenue contribution) and ESG/human capital reporting practices from potentially different sections of the 10-K or related filings. (4) All entities—Shockwave, Johnson & Johnson, Cardiovascular segment, 2024 time frame—are correctly identified and contextually accurate. No factual, numerical, or interpretive errors are present, and the response fully addresses both sub-questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 299,
        "total_tokens": 1459
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "Cisco's AppDynamics offerings declined in fiscal 2022. Given this decline, which specific offerings contributed to the 11% growth in the Optimized Application Experiences category, and by how much did the category increase in dollar terms?",
      "original_answer": "Despite the decline in Cisco's AppDynamics offerings, the Optimized Application Experiences category grew by 11%, or $75 million, driven by growth in the company's ThousandEyes and Intersight offerings.",
      "llm_answer": "The Optimized Application Experiences category grew 11% year‑over‑year, driven by strong performance of the ThousandEyes and Intersight offerings, while the decline in AppDynamics was offset by these gains. In dollar terms, the category’s revenue increased by $75 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the Optimized Application Experiences category grew by 11% and increased by $75 million in dollar terms. (2) Quantitative accuracy is perfect: the 11% growth rate and $75 million increase match the original answer exactly, with acceptable formatting ($75 million vs $75 million). (3) The multi-hop reasoning is sound—the model correctly identifies that despite AppDynamics' decline, the overall category growth was driven by ThousandEyes and Intersight, demonstrating proper synthesis across offerings. (4) Entity accuracy is maintained: Cisco, AppDynamics, ThousandEyes, and Intersight are all correctly referenced. The answer addresses both sub-questions: the contributing offerings (ThousandEyes and Intersight) and the dollar increase ($75 million). No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 270,
        "total_tokens": 1412
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much did AT&T pay in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions, and how does this redemption impact the noncontrolling interest classification on the consolidated balance sheets?",
      "original_answer": "AT&T paid $5,414 million in total to repurchase the Mobility preferred interests in April 2023, including accrued and unpaid distributions. This redemption removed the Mobility preferred interests from the 'Noncontrolling interest' classification on the consolidated balance sheets, as these interests were no longer outstanding after the repurchase.",
      "llm_answer": "AT&T paid $5,414 in total to repurchase the Mobility preferred interests in April 2023, which includes the $5,340 redemption value plus $74 of accrued and unpaid distributions.  The redemption eliminated the noncontrolling interest related to those preferred interests, so the corresponding balance was removed from the “Redeemable noncontrolling interest” line on the consolidated balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly states that AT&T paid $5,414 million (written as $5,414, but context implies millions) to repurchase the Mobility preferred interests in April 2023, matching the ground truth. It further breaks this down accurately into $5,340 million redemption value and $74 million in accrued and unpaid distributions, which sum to $5,414 million—this calculation is correct. The impact on noncontrolling interest is also accurately described: the redemption removed the related balance from the consolidated balance sheet. The only minor issue is the omission of the word 'million' after $5,414, which could cause ambiguity but is commonly understood in financial contexts where figures are reported in millions.\n\n2) Quantitatively, all numbers are correct: $5,414 total, composed of $5,340 + $74, with the correct date (April 2023). The breakdown enhances accuracy and shows proper synthesis of components.\n\n3) The reasoning is sound: the model correctly infers that repurchasing the preferred interests eliminates the associated noncontrolling interest. It correctly identifies the financial instrument (Mobility preferred interests), the transaction (repurchase), and the accounting impact (removal from balance sheet). The term used—'Redeemable noncontrolling interest'—is more specific than the ground truth's 'Noncontrolling interest', but this is a refinement rather than an error, as such interests are typically classified as redeemable prior to redemption.\n\n4) The answer is semantically equivalent to the ground truth, with slightly more detail (breakdown of payment components). The omission of 'million' is a formatting oversight, not a factual error. Contextual relevance is perfect—every part of the question is addressed with precise, relevant information. The qualitative score is 9 due to the slight imprecision in unit formatting, but all substantive content is accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 518,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What was the year-over-year revenue growth percentage specifically for the Abiomed business unit after its acquisition by Johnson & Johnson in 2022, and how does this compare to the overall growth in the Cardiovascular segment?",
      "original_answer": "The Abiomed business unit experienced a year-over-year revenue growth of 14.5% from 2023 to 2024, increasing from $1.306 billion to $1.496 billion. This growth contributed to the overall Cardiovascular segment, which saw a 21.4% increase in revenue, rising from $6.350 billion in 2023 to $7.707 billion in 2024. Therefore, Abiomed's growth was a significant but slightly lower-performing component compared to the broader Cardiovascular segment's growth.",
      "llm_answer": "The Abiomed business unit, acquired in December 2022, generated $1.5 billion in sales in 2024—a 14.5 % increase from the prior year, driven by strong adoption of Impella 5.5 and Impella RP across all regions. Within the Cardiovascular segment, total sales rose 21.4 % to $7.7 billion, so Abiomed’s growth modestly outpaced the segment’s overall expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 14.5% year-over-year revenue growth for Abiomed from 2023 to 2024, matching the ground truth. It also accurately reports the Cardiovascular segment's 21.4% growth. Dollar amounts are rounded but within acceptable variation ($1.5B vs $1.496B for Abiomed in 2024; $7.7B vs $7.707B for Cardiovascular segment). However, the LLM incorrectly states that Abiomed's growth 'modestly outpaced' the segment’s overall expansion, which contradicts the ground truth: Abiomed’s 14.5% growth is lower than the segment’s 21.4%, so it underperformed relative to the broader segment. (2) Quantitative values are accurate with minor rounding: $1.496B → $1.5B and $7.707B → $7.7B are acceptable approximations. The percentages (14.5% and 21.4%) are exact. (3) The multi-hop reasoning is mostly sound—correctly pulling Abiomed and Cardiovascular segment growth from potentially different parts of filings and comparing them. However, the final comparative conclusion is logically flawed, reversing the direction of performance. (4) The answer is highly relevant and addresses both parts of the question: Abiomed’s growth and its comparison to the Cardiovascular segment. The error in interpretation prevents a higher score, but core data is correct, warranting a strong 8/10 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 366,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How many amendments to the Lowe's Companies Benefit Restoration Plan are listed in the exhibits, and what is the date of the most recent amendment referenced in the 2022 10-K filing?",
      "original_answer": "There are seven amendments to the Lowe's Companies Benefit Restoration Plan listed in the exhibits, and the most recent amendment referenced in the 2022 10-K filing is dated April 4, 2017 (Amendment No. 7).",
      "llm_answer": "The 2022 10-K filing lists **three amendments** to the Lowe's Companies Benefit Restoration Plan in its exhibits (referenced as Exhibits 4.18, 4.19, and 4.20). The most recent amendment referenced is **Exhibit 4.20**, which is the **Nineteenth Supplemental Indenture dated September 20, 2021**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is almost entirely incorrect. (1) Quantitatively, it states there are three amendments, but the ground truth is seven amendments. It also cites a completely different date—September 20, 2021—whereas the correct most recent amendment date is April 4, 2017 (Amendment No. 7). These numbers and dates are factually wrong. (2) The exhibits referenced (4.18, 4.19, 4.20) are not the correct exhibits for the Benefit Restoration Plan amendments; Exhibit 4.20 refers to a Nineteenth Supplemental Indenture, which is unrelated to the Benefit Restoration Plan. This indicates confusion between different types of filings. (3) The multi-hop reasoning failed: the model did not correctly identify the plan in question or extract the correct number of amendments and their dates from the 2022 10-K exhibits. (4) Contextual relevance is low because the answer refers to unrelated documents and misidentifies both the count and nature of the amendments. The only relevant aspect is that it attempts to pull information from the 2022 10-K exhibits, but the content is factually disconnected from the actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1134,
        "completion_tokens": 315,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How much of the $2.4 billion CECL transition amount had Capital One Financial Corporation phased into its regulatory capital by January 1, 2024, and what percentage of CET1 capital requirement must the company maintain under the Stress Capital Buffer framework effective October 1, 2024?",
      "original_answer": "Capital One Financial Corporation had phased in 75% of the $2.4 billion CECL transition amount, which equals $1.8 billion, into its regulatory capital by January 1, 2024. Under the Stress Capital Buffer framework effective October 1, 2024, the company must maintain a CET1 capital ratio of at least 10.0%.",
      "llm_answer": "As of January 1 2024, Capital One had phased in 75 % of the $2.4 billion CECL transition amount, i.e., $1.8 billion, into its regulatory capital. Under the Stress Capital Buffer framework effective October 1 2024, the company must maintain a CET1 capital ratio of at least 10.0 % (the minimum capital requirements plus the standardized‑approach capital‑conservation buffer).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values are accurate: 75% of $2.4 billion is correctly calculated as $1.8 billion, and the CET1 capital requirement is correctly stated as 10.0%. The dates (January 1, 2024, and October 1, 2024) are also correct. Minor formatting differences (e.g., spacing in '75 %' or '$2.4 billion') do not affect accuracy. (2) The answer is complete, addressing both parts of the multi-part question: the CECL transition amount phased in and the CET1 requirement under the Stress Capital Buffer framework. (3) Entities are accurate—'Capital One Financial Corporation' is correctly identified, and the financial terms (CECL, CET1, Stress Capital Buffer) are used appropriately. (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines the phase-in percentage with the total CECL amount and correctly states the regulatory requirement effective in the future. The additional clarification about the composition of the 10.0% (minimum plus buffer) adds context without introducing error. Overall, the answer is factually precise, semantically equivalent, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 332,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How does Disney's use of time-based vesting Restricted Stock Unit Award Agreements compare to its use of performance-based vesting agreements in aligning executive compensation with long-term shareholder value creation?",
      "original_answer": "Disney utilizes both time-based vesting Restricted Stock Unit Award Agreements and multiple variations of performance-based vesting agreements. The time-based vesting agreements (listed in exhibits 10.43, 10.49, and 10.54) provide a standard approach where equity compensation vests over time, typically helping retain talent. In contrast, Disney employs at least six distinct forms of performance-based Restricted Stock Unit Award Agreements (listed in exhibits 10.44-10.48, 10.55, 10.57-10.59) that tie vesting to metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), ensuring executive compensation is more directly aligned with company performance and shareholder value creation.",
      "llm_answer": "Disney aligns executive compensation with long-term shareholder value through both time-based and performance-based Restricted Stock Unit (RSU) awards. Time-based RSUs (Exhibit 10.43) vest solely over a fixed period, providing steady equity exposure. In contrast, performance-based RSUs (Exhibits 10.44, 10.46, 10.47, 10.57, 10.59) tie vesting to measurable financial metrics like Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), directly linking compensation to sustained company performance and long-term value creation. This dual approach ensures executives are rewarded for both tenure and achieving strategic, long-term objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) Quantitatively, all referenced exhibits are correctly cited, though the original answer lists more performance-based exhibits (10.44–10.48, 10.55, 10.57–10.59), while the LLM omits 10.45, 10.48, and 10.55. This is a minor omission but does not affect the overall factual correctness. (2) The financial metrics—Total Shareholder Return (TSR) and Return on Invested Capital (ROIC)—are accurately identified as performance conditions. (3) The reasoning correctly distinguishes time-based vesting (retention focus) from performance-based vesting (performance alignment), demonstrating sound multi-hop synthesis across exhibit types and their purposes. (4) The answer addresses both parts of the question: Disney’s use of each agreement type and how they compare in aligning compensation with shareholder value. The only shortcoming is slightly less completeness in listing all performance-based exhibits, but the key forms are included, and the semantic meaning fully aligns with the ground truth. Hence, a high score is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 316,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the revenue growth of Hips and Knees products contribute to the overall growth of the Orthopaedics segment in 2024 compared to 2023?",
      "original_answer": "The Orthopaedics segment grew by $216 million (2.4%) in 2024 compared to 2023. Within this segment, the Hips product line increased by $78 million (5.0%) and the Knees product line increased by $89 million (6.1%). Combined, the Hips and Knees products contributed $167 million in revenue growth, accounting for approximately 77% of the total growth in the Orthopaedics segment. This indicates that the performance of Hips and Knees products was a significant driver of the segment's overall growth.",
      "llm_answer": "The Orthopaedics segment grew 2.4% overall in 2024, driven by strong performance in its Hips and Knees product lines, which posted increases of 5.0% and 6.1% respectively. These gains contributed directly to the segment’s 2.4% sales growth compared to the prior year.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the overall Orthopaedics segment growth (2.4%), the Hips product line growth (5.0%), and the Knees product line growth (6.1%), which matches the ground truth in terms of percentages. However, it omits all dollar amounts: the $216 million total segment growth, the $78 million Hips increase, the $89 million Knees increase, and the combined $167 million contribution. This is a significant omission because the question asks how the revenue growth of Hips and Knees 'contributed' to overall growth, which requires quantitative synthesis (e.g., the $167M out of $216M = ~77%). The answer also fails to mention that Hips and Knees together accounted for approximately 77% of the total growth, a key analytical point in the original answer. While the qualitative direction of reasoning is sound—correctly attributing segment growth to Hips and Knees—the lack of numerical detail and contribution analysis makes the response incomplete. The entities (product lines, segment, year comparison) are accurate, and the context is relevant, but the missing multi-hop quantitative synthesis reduces correctness. Minor wording differences are acceptable, but missing core numerical contributions and the derived percentage severely limits completeness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 361,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How much of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, and how does this optional transition relief specifically work according to the rule's description?",
      "original_answer": "Capital One phased in 75% of the $2.4 billion regulatory capital addition under the CECL Transition Rule by January 1, 2024, which amounts to $1.8 billion. The remaining $600 million was phased in on January 1, 2025. This optional five-year transition period was provided by the Federal Banking Agencies to allow banking institutions to gradually incorporate the impact of the CECL standard on their regulatory capital.",
      "llm_answer": "Based on the document, Capital One phased in 75% of its $2.4 billion CECL Transition Rule capital addition by January 1 2024, with the remaining $600 million scheduled to be phased in on January 1 2025. The CECL Transition Rule allows a five‑year optional period to delay and then phase in the estimated impact of adopting CECL on regulatory capital, using a 25% scaling factor each year; thus, the $2.4 billion delayed impact was added back to regulatory capital and is being recognized at 25% per year, reaching full phase‑in by 2025.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that 75% of Capital One's $2.4 billion regulatory capital addition under the CECL Transition Rule was phased in by January 1, 2024, amounting to $1.8 billion, with the remaining $600 million phased in on January 1, 2025—this matches the ground truth exactly. (2) All numeric values are accurate: 75% of $2.4 billion is $1.8 billion, and the remaining 25% is $600 million; dates (January 1, 2024 and January 1, 2025) are correct. The explanation of the five-year optional transition with a 25% annual phase-in aligns with the rule’s mechanics. (3) The multi-hop reasoning is sound: the model correctly synthesizes the phase-in schedule, the annual 25% recognition, and the regulatory purpose of the CECL Transition Rule. (4) The answer is semantically equivalent to the ground truth, with added clarity on the 25% annual scaling factor, which is consistent with the rule’s description. All aspects of the question—amount phased in by 2024 and how the transition relief works—are fully and accurately addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 303,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the issuance and partial repayment of the Guaranteed Senior Notes by Costco's Japanese subsidiary in 2023 and 2024, respectively, affect the company's overall long-term debt fair value and financing activities during that period?",
      "original_answer": "The issuance of four Guaranteed Senior Notes totaling approximately $500 by Costco's Japanese subsidiary in November 2023 increased the company's long-term debt. However, in July 2024, the subsidiary repaid $77 of these notes, reducing the outstanding amount. As a result, the fair value of Costco's long-term debt decreased from $5,738 at the end of 2023 to $5,412 at the end of 2024. Additionally, the financing activities section shows that the issuance of these notes contributed to the $10,764 net cash used in financing activities during 2024, which also included the repayment of $1,000 in principal on the 2.750% Senior Notes.",
      "llm_answer": "The issuance of $500 million in Guaranteed Senior Notes by Costco’s Japanese subsidiary in November 2023 increased the company’s long‑term debt balance, and the subsequent partial repayment of $77 million in July 2024 reduced it. These actions modestly altered the fair value of total long‑term debt (which was $5.9 billion at the end of 2024 versus $6.5 billion in 2023) and are reflected in the financing‑activities section of the cash‑flow statement, which shows net cash used in financing activities rising to $10.8 billion in 2024 due largely to debt repayments and dividend payments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly identifies the issuance of $500 million in Guaranteed Senior Notes by Costco's Japanese subsidiary in November 2023 and the partial repayment of $77 million in July 2024, it misstates the fair value of long-term debt. The ground truth states the fair value decreased from $5,738 million ($5.738 billion) at the end of 2023 to $5,412 million ($5.412 billion) at the end of 2024. However, the LLM claims the fair value was $6.5 billion in 2023 and $5.9 billion in 2024, which is incorrect. Additionally, the net cash used in financing activities is reported as $10.764 billion in the original answer, which the LLM rounds to $10.8 billion—this is acceptable—but fails to mention the specific $1,000 million repayment of the 2.750% Senior Notes, instead attributing the increase largely to dividend payments, which are not mentioned in the ground truth. (2) Number verification: Issuance amount ($500 million) and repayment ($77 million) are correct. However, the fair value figures ($6.5B and $5.9B) are factually wrong compared to the true values ($5.738B and $5.412B). The net cash used in financing activities is approximately correct ($10.8B vs $10.764B), but the explanation for the increase is inaccurate. (3) Multi-hop reasoning: The model correctly links the issuance and repayment to changes in long-term debt and financing activities, showing some synthesis across events and financial statements. However, it fails to accurately connect the specific debt instruments and their impact on cash flows, omitting key details and introducing incorrect drivers (e.g., dividend payments). (4) Correctness score is 4 due to partial factual accuracy on the issuance and repayment but major errors in fair value reporting and financing activities explanation. Quantitative accuracy is low (3) due to incorrect financial figures. Qualitative accuracy is moderate (5) as reasoning structure is sound but based on incorrect data. Contextual relevance is high (8) because the answer addresses the right concepts and entities, just with flawed specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 583,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What is the total estimated environmental remediation liability Caterpillar accrues for all sites, and how does its methodology for estimating these costs differ between individual sites and multi-party sites?",
      "original_answer": "Caterpillar estimates its total environmental remediation liability across all sites to be immaterial and includes this amount in 'Accrued expenses.' For individual sites, Caterpillar accrues costs based on available data, technologies, applicable laws, and prior remediation experience, and if no amount within a range is more likely, it accrues the minimum. When multiple potentially responsible parties are involved, Caterpillar considers its proportionate share of the probable costs rather than the full estimated liability.",
      "llm_answer": "The total estimated environmental remediation liability Caterpillar accrues for all sites is not material and is included in accrued expenses, but the exact aggregate amount is not disclosed in the provided excerpts. Caterpillar estimates remediation costs on a site‑by‑site basis, using currently available data and considering applicable laws, technologies, and prior experience; for individual sites it may accrue the minimum estimate when no single amount is more likely, while for multi‑party sites it assesses its proportionate share of probable costs and does not factor in potential recoveries from insurers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states that the total environmental remediation liability is 'not material' (synonymous with 'immaterial' in the original) and included in 'accrued expenses'—this matches the ground truth exactly. No specific dollar amount is provided in either answer, as it is intentionally undisclosed and deemed immaterial. (2) The methodology is accurately described: for individual sites, Caterpillar uses available data, laws, technologies, and experience, accruing the minimum if no amount is more likely; for multi-party sites, it considers its proportionate share of probable costs. The LLM adds a detail not in the original—that recoveries from insurers are not factored in—which may be true but is not part of the ground truth, constituting a minor addition but not an error. (3) The multi-hop reasoning is sound: the answer synthesizes Caterpillar’s general liability stance with its site-specific estimation methodologies. (4) Semantic equivalence is strong; wording differs slightly (e.g., 'not material' vs 'immaterial') but meaning is preserved. The only reason for not giving a perfect 10 is the slight expansion on insurer recoveries, which, while plausible, is not confirmed in the original. All key facts, entities (Caterpillar, environmental remediation, accrued expenses), and reasoning steps are correct and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 394,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "What was the percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022, and how does the company's updated reporting structure introduced in fiscal 2022 reflect its strategic approach to this underperforming category?",
      "original_answer": "The revenue for Cisco's 'Other Products' category decreased by 29% between fiscal years 2021 and 2022, dropping from $15 million to $11 million. Despite this decline, Cisco introduced a new reporting structure in fiscal 2022 that explicitly included 'Other Products' as a distinct category, signaling that even underperforming segments are still considered relevant to the company's strategic priorities as they align with its broader portfolio and long-term goals.",
      "llm_answer": "The percentage change in revenue for Cisco's 'Other Products' category between fiscal years 2021 and 2022 was a decline of 29% (from $15 million to $11 million), representing a $4 million decrease. This underperforming category was incorporated into the company's updated reporting structure introduced in fiscal 2022, which reorganized product categories to better align with strategic priorities—grouping it under \"Other Products\" alongside other non-core offerings like Collaboration and End-to-End Security, reflecting a deliberate shift to streamline focus away from low-growth segments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the percentage change in revenue (29% decline) and the dollar amounts ($15 million in 2021, $11 million in 2022), which matches the ground truth exactly—minor formatting like '$4 million decrease' is acceptable and accurate. All numeric values and calculations are correct, earning full marks for quantitative accuracy. (2) The entity identification is accurate: Cisco, 'Other Products', and fiscal years 2021–2022 are correctly referenced. (3) However, the qualitative inaccuracy arises in the reasoning about the reporting structure: the LLM claims that 'Other Products' was grouped alongside 'Collaboration and End-to-End Security' in the new structure, which is not supported by the ground truth and introduces incorrect categorical groupings. The original answer states that including 'Other Products' as a distinct category signaled strategic relevance, whereas the LLM interprets it as a move to de-prioritize low-growth segments—this misrepresents the strategic implication. (4) Despite this misinterpretation, the core facts are present and the answer addresses both parts of the question (percentage change and strategic reflection), so the overall correctness score is reduced only moderately. Contextual relevance remains high as the response stays focused and informative.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 371,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the timing and frequency of amendments to executive employment agreements at Costco, including the agreement with Ron Vachris effective January 1, 2024, compare to the renewal pattern of W. Craig Jelinek's agreement over the past six years?",
      "original_answer": "Costco has consistently renewed W. Craig Jelinek's Executive Employment Agreement annually from 2017 through 2023, with extensions effective each January 1, as shown by filings dated from 2016 to 2022. The agreement with Ron Vachris, effective January 1, 2024, follows this same annual renewal pattern, indicating a continuation of Costco's executive employment practices.",
      "llm_answer": "The SEC filing shows that Costco renewed W. Craig Jelinek’s executive employment agreement four times between 2019 and 2023, with each extension effective on January 1 of those years (2019, 2020, 2021, 2022, 2023). In contrast, Ron Vachris received a single new agreement effective January 1 2024, marking the first such executive contract renewal in the period covered by the filings. This illustrates a shift from the multi‑year renewal pattern used for Jelinek to a one‑time agreement for Vachris.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, it incorrectly states that W. Craig Jelinek's agreement was renewed four times between 2019 and 2023, when the ground truth indicates annual renewals from 2017 through 2023 (seven total, one each year effective January 1). The claim of 'four times' is unsupported and contradicts the documented pattern. (2) It mischaracterizes Ron Vachris's agreement as a 'one-time agreement' and suggests a 'shift' in practice, while the original answer confirms that the Vachris agreement follows the same annual renewal pattern established under Jelinek, indicating continuity, not change. (3) The reasoning is flawed: instead of recognizing that the Vachris agreement continues Costco's established annual renewal practice, the LLM incorrectly infers a change in policy based on incomplete interpretation. (4) While the answer addresses the right entities (Costco, Jelinek, Vachris) and correct time frame (January effective dates), the core conclusion about a shift in renewal pattern is false. The answer is contextually relevant and attempts multi-hop synthesis, but fails on factual accuracy and logical inference. Minor note: date formatting (e.g., 'January 1 2024') lacks comma but is semantically acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 364,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What was the change in the net value of Customer Relationships from December 31, 2020, to December 31, 2021, and how does this compare to the change in the net value of Intellectual Property over the same period?",
      "original_answer": "The net value of Customer Relationships decreased by $181 million (from $893 million in 2020 to $712 million in 2021), while the net value of Intellectual Property decreased by $86 million (from $366 million in 2020 to $280 million in 2021).",
      "llm_answer": "The net value of Customer Relationships increased by $23 million from $712 million at December 31 2020 to $735 million at December 31 2021 (a $23 million rise), while the net value of Intellectual Property rose by $24 million over the same period, moving from $366 million to $390 million. Thus, the change in Intellectual Property was slightly larger than the change in Customer Relationships.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key aspects. According to the ground truth, the net value of Customer Relationships decreased by $181 million (from $893M in 2020 to $712M in 2021), but the LLM claims it increased by $23M (from $712M to $735M). Similarly, Intellectual Property decreased by $86M (from $366M to $280M), but the LLM states it increased by $24M (to $390M). These directional and numerical errors completely contradict the ground truth. (2) All calculations are wrong: the LLM reports increases where there were significant decreases, and the dollar amounts are entirely inaccurate. For example, $712M is reported as the 2020 value when it is actually the 2021 value for Customer Relationships. (3) The multi-hop reasoning failed entirely—instead of correctly identifying the change over time for two intangible assets using data from two years, the model inverted the trend and used incorrect base values. (4) The contextual relevance is low but not zero because the answer addresses the right categories (Customer Relationships and Intellectual Property) and time frame (2020–2021), but the substance is fundamentally flawed. Due to complete failure in quantitative and qualitative accuracy, the correctness score is near the minimum.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 357,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What is the total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022, and how does its revenue recognition model differ for hardware versus SaaS arrangements?",
      "original_answer": "The 'Secure, Agile Networks' product category contributes significantly to Cisco's revenue, with distinct revenue recognition models: hardware and perpetual software revenue is recognized upfront upon transfer of control, while SaaS arrangements recognize revenue ratably over the contract term.",
      "llm_answer": "The total revenue contribution from the 'Secure, Agile Networks' product category in fiscal 2022 was $23,829 million, as reported in the disaggregated revenue table on page 104. Revenue recognition for hardware in this category is recognized upfront upon transfer of control (e.g., shipment), while SaaS arrangements are recognized ratably over the contract term as a single performance obligation, reflecting the distinct timing of revenue recognition for hardware versus subscription-based services.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes a specific revenue figure of $23,829 million for the 'Secure, Agile Networks' category in fiscal 2022, which is not present in the original answer (ground truth). This number is unverified against the ground truth, which does not provide any quantitative revenue contribution—only a qualitative description of the revenue recognition model. Therefore, the inclusion of this precise number is factually unsupported by the provided ground truth, making it incorrect or at best unverifiable. (2) There are no calculations in the question or answer, but the LLM introduces a numeric value absent from the ground truth, which violates quantitative accuracy. The ground truth does not mention any dollar amount for revenue contribution, so this addition undermines factual correctness. (3) The qualitative reasoning about revenue recognition is accurate and aligns with the ground truth: hardware and perpetual software revenue is recognized upfront upon transfer of control, and SaaS revenue is recognized ratably over the contract term. The LLM correctly synthesizes the distinction between hardware and SaaS arrangements, demonstrating sound multi-hop reasoning regarding accounting policies. (4) While the contextual relevance is high—addressing both parts of the question (revenue contribution and recognition model)—the introduction of an unsupported revenue figure significantly reduces overall correctness. The answer would have scored higher if it had omitted the unverified number and remained consistent with the qualitative nature of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 437,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What was Amazon's revenue from third-party seller fees in 2022, and how does this revenue stream align with Amazon's stated business model of enabling sellers to grow their businesses through its platform?",
      "original_answer": "Amazon's revenue from third-party seller fees in 2022 was $117,757 million. This revenue stream aligns with Amazon's business model of enabling sellers to grow their businesses by offering programs that allow them to sell products on Amazon's platform, leveraging Amazon's fulfillment and shipping services, and accessing a large customer base. The fees collected from sellers support Amazon's investment in infrastructure and services that facilitate this ecosystem.",
      "llm_answer": "Amazon's revenue from third-party seller fees in 2021 was $62,202 million, as reported in the \"Net Sales\" table on page 23. This revenue stream aligns with Amazon's stated business model of enabling sellers to grow their businesses through its platform, as described in the \"Description of Business\" section on page 41, which emphasizes programs that enable sellers to sell their products in Amazon stores and fulfill orders through the company.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key numeric claim—Amazon's revenue from third-party seller fees in 2022 was $117,757 million, but the LLM reports $62,202 million for 2021, which is both the wrong year and wrong amount. This major error undermines the core of the answer. (2) Quantitative accuracy is severely lacking: the number cited is from 2021, not 2022 as required by the question, and the value does not match the ground truth. There is no indication that the model attempted to extract or report the correct 2022 figure. (3) While the qualitative reasoning about how seller fees align with Amazon's business model is sound and reflects accurate understanding of the company's ecosystem—mentioning seller programs, fulfillment, and platform access—the multi-hop synthesis fails because it draws from the wrong time period and does not connect the correct financial data to the strategic context. (4) Contextual relevance is moderate because the explanation of Amazon's business model is relevant and accurate, but the answer fails on the primary quantitative demand of the question. The model appears to have misread or mislocated the data, possibly confusing line items or years in the filing. Due to the critical importance of correct financial figures in this type of query, the overall correctness score is low despite partially valid reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 384,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What is the difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement for this metric as of December 31, 2024?",
      "original_answer": "The difference between Capital One Financial Corp's Common Equity Tier 1 capital ratio and the Minimum Capital Adequacy requirement is 9 percentage points.",
      "llm_answer": "Based on Table 13 (regulatory capital components) and Table 12 (capital ratios), Capital One’s Common Equity Tier 1 (CET1) capital ratio was **13.5 %** as of December 31, 2024. The minimum regulatory capital adequacy requirement for CET1 under the Basel III framework is **4.5 %**. Thus, Capital One’s CET1 ratio exceeds the minimum by roughly **9 percentage points**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the CET1 ratio of 13.5% and the minimum requirement of 4.5% are accurate, and their difference is correctly calculated as 9 percentage points. The date (December 31, 2024) is correct. (2) The answer cites the relevant tables (13 and 12), demonstrating proper sourcing from the filing. (3) The multi-hop reasoning—linking Capital One's reported CET1 ratio to the Basel III minimum requirement and computing the difference—is sound and logically presented. (4) The semantic meaning exactly matches the original answer, conveying that the difference is 9 percentage points. All entities (Capital One Financial Corp, CET1, Minimum Capital Adequacy requirement) are correctly identified. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1139,
        "completion_tokens": 242,
        "total_tokens": 1381
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "What regulatory risks threaten Altria's $1.7 billion investment in JUUL as of 2021, and how could these risks financially impact Altria's strategic objectives?",
      "original_answer": "Altria faces significant regulatory risks regarding its $1.7 billion investment in JUUL, as outlined in the 2022 10-K filing. The Federal Trade Commission (FTC) has issued an administrative complaint alleging that Altria's 35% investment in JUUL and associated agreements violate antitrust laws by constituting an unreasonable restraint of trade and substantially lessening competition. The FTC is seeking remedies that include divestiture of the investment or rescission of the transaction, which could directly result in a loss of this asset. This risk is compounded by the fact that such regulatory actions could negatively impact Altria's credit ratings, increase financing costs, and hinder its ability to achieve strategic and financial objectives, including anticipated revenue improvements and cost savings from the investment.",
      "llm_answer": "Regulatory risks threatening Altria's $1.7 billion JUUL investment include potential FTC or court actions that could force divestiture or rescission of the transaction, non‑competition and stand‑still restrictions that limit Altria’s ability to invest in or compete with JUUL, and ongoing uncertainty about FDA approval and marketing of e‑vapor products—any adverse ruling could eliminate or substantially limit Altria’s rights in JUUL and impair the investment’s fair value. These outcomes could materially reduce the investment’s contribution to Altria’s strategic goal of diversifying revenue and achieving its “Vision” of growth through innovative tobacco and nicotine products.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.7 billion investment amount and the core regulatory risks, including potential divestiture or rescission of the transaction due to antitrust concerns, which aligns with the FTC's administrative complaint mentioned in the ground truth. The mention of non-competition and stand-still restrictions, while not explicitly detailed in the original answer, is contextually plausible given the nature of such investments and associated agreements. However, the LLM omits explicit mention of the FTC as the specific agency bringing the antitrust action, instead referring more generally to 'FTC or court actions,' which slightly weakens entity specificity. Additionally, the LLM introduces FDA approval uncertainty for e-vapor products, which, while a relevant broader industry risk, is not cited in the ground truth as a direct threat to the JUUL investment's value in this context. (2) Quantitatively, the $1.7 billion figure is accurate and correctly attributed; no other numbers or calculations are present, so no errors exist. (3) The multi-hop reasoning is largely sound: the LLM connects regulatory risk to potential financial impact on Altria’s strategic objectives, specifically revenue diversification and growth through innovative products (referred to as the 'Vision' in the original). This reflects synthesis between the investment, regulatory threats, and strategic goals. However, it misses the explicit linkage to credit ratings and financing costs mentioned in the ground truth, which are important financial implications. (4) The answer is contextually highly relevant and semantically close to the original, with only minor omissions and slight generalization of the regulatory actor. These do not undermine the core correctness but prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 494,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "Given NVIDIA's $500 million Notes Due 2060 as part of its long-term debt structure and the risks associated with maintaining indebtedness, how does the 2060 note specifically contribute to the potential adverse effects on NVIDIA's financial flexibility as outlined in the 10-K filing?",
      "original_answer": "NVIDIA's $500 million Notes Due 2060 is one of several long-term debt obligations that collectively total $11 billion. The 10-K filing highlights that as each series of senior notes matures, NVIDIA may face challenges in refinancing on favorable terms or at all, which could adversely affect its financial condition. Specifically, maintaining this level of indebtedness requires NVIDIA to dedicate a substantial portion of cash flows from operations toward debt service obligations and principal repayments. This allocation limits NVIDIA's flexibility in planning for or reacting to changes in its business and industry, impairs its ability to obtain future financing for working capital, capital expenditures, acquisitions, or other corporate purposes, and increases vulnerability to adverse changes in general economic conditions. Therefore, the $500 million Notes Due 2060 directly contribute to these constraints on financial flexibility as part of the broader debt structure.",
      "llm_answer": "The $500 million Notes Due 2060 are part of NVIDIA’s $11 billion of senior notes that mature through 2060, and the filing warns that maintaining such indebtedness can “adversely affect our financial position and cash flows from operations, and prevent us from implementing our strategy or fulfilling our contractual obligations.” Because the notes must eventually be repaid or refinanced, a substantial share of operating cash will be devoted to debt service and principal repayments, limiting the cash available for working‑capital needs, capital expenditures, acquisitions, or other corporate purposes and increasing vulnerability to economic downturns or rating‑agency actions. This constraint on cash flexibility is highlighted in the “Management’s Discussion and Analysis” section and the “Liquidity and Capital Resources” discussion of contractual obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the $500 million Notes Due 2060 are part of NVIDIA’s $11 billion in senior notes, which mature through 2060. The answer correctly identifies that these notes require a substantial portion of cash flow to be allocated to debt service, limiting financial flexibility. (2) Quantitative accuracy is perfect: dollar amounts ($500 million, $11 billion) and the maturity year (2060) match the original. No calculations are required, but the synthesis of the debt structure is accurate. (3) The multi-hop reasoning is sound—linking the 2060 note to the broader debt structure, explaining refinancing risks, cash flow constraints, and downstream impacts on strategic flexibility and economic vulnerability. The LLM cites relevant sections of the 10-K (MD&A, Liquidity and Capital Resources), enhancing credibility. (4) The only minor shortcoming is that the LLM does not explicitly name the $500 million note as one of 'several' series contributing to refinancing risk at maturity, though this is implied. It also quotes the filing accurately in spirit, though the exact phrasing 'prevent us from implementing our strategy' is slightly paraphrased from the original's 'impairs ability to obtain future financing.' These are minor wording differences that do not affect factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 412,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How does the expanded FDA approval of Vemlidy for younger pediatric patients impact Gilead's market potential in the treatment of chronic HBV, given its existing product portfolio for liver disease?",
      "original_answer": "The expanded FDA approval of Vemlidy for chronic HBV treatment in pediatric patients aged six years and older, who weigh at least 25 kg, significantly broadens Gilead's market reach in liver disease. Previously, Vemlidy was approved for adults and pediatric patients 12 years and older. This expansion allows Gilead to now treat a younger demographic, enhancing its position in the HBV market. Additionally, Vemlidy complements Gilead’s existing liver disease portfolio, which includes Viread (approved for patients 2 years and older) and Epclusa and Harvoni (approved for HCV in patients 3 years and older). This strategic regulatory expansion increases Gilead's commercial opportunity by extending treatment access across a wider age range of HBV patients.",
      "llm_answer": "The expanded FDA approval of Vemlidy for pediatric patients aged six years and older with chronic hepatitis B (CHB) broadens Gilead’s market reach in the pediatric HBV space, adding a sizable new indication to its existing liver‑disease portfolio that already includes Vemlidy for adults and other HBV products such as Viread. This pediatric expansion is expected to drive incremental sales and strengthen Gilead’s competitive position in the chronic HBV market, complementing its broader antiviral and liver‑disease offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately identifies the expanded FDA approval of Vemlidy for pediatric patients aged six years and older, which matches the original answer. The statement that this broadens Gilead’s market reach in the pediatric HBV space is consistent with the original. The mention of Vemlidy’s prior use in adults and its complementarity with other products like Viread is accurate. However, the LLM answer omits specific details about the weight requirement (at least 25 kg) and does not reference Epclusa and Harvoni, which are part of Gilead’s broader liver disease portfolio and mentioned in the original answer as approved for HCV in pediatric patients. While this omission slightly reduces completeness, it does not undermine the core correctness. All entities (Vemlidy, Viread, Gilead, chronic HBV) are correctly identified. There are no numerical inaccuracies—though no specific numbers (e.g., sales figures) are present, the qualitative claims about market expansion and competitive positioning are logically sound and consistent with the knowledge graph. The reasoning correctly synthesizes the impact of regulatory expansion on market potential, demonstrating valid multi-hop understanding (approval change → expanded patient population → increased commercial opportunity). The answer is highly relevant to the question and conveys the essential conclusion: broader approval enhances market potential within Gilead’s existing portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 415,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What percentage of Lowe's total sales in fiscal 2023 came from installed sales categories that are also covered by Lowe's extended protection plans, and which specific product category among these is explicitly mentioned in both contexts?",
      "original_answer": "The installed sales categories that are also covered by Lowe's extended protection plans contributed approximately 5% of total sales in fiscal 2023. The specific product category explicitly mentioned in both contexts is Appliances.",
      "llm_answer": "Based on the provided document pages, Lowe's reported that **installed sales accounted for approximately 5% of total sales in fiscal 2023** (as stated in the \"Installed Sales\" section of page 7). This 5% figure represents the share of total sales derived from installed sales categories, which are explicitly covered by Lowe's extended protection plans. Among these categories, **Kitchens & Bath** is specifically mentioned in both contexts: it is listed as one of the primary categories for installed sales (alongside Flooring, Millwork, Appliances, and Lumber) and is also explicitly cited as a category where extended protection plans are offered (in the \"Lowe's Protection Plans and Repair Services\" section of page 7).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 5% figure as the contribution of installed sales categories covered by extended protection plans to total sales in fiscal 2023, which matches the ground truth. However, it incorrectly identifies 'Kitchens & Bath' as the product category explicitly mentioned in both contexts, while the ground truth clearly states that the correct category is 'Appliances'. This is a critical factual error in entity identification. (2) Quantitative accuracy is perfect—the percentage (5%) is correctly cited and matches the original answer. (3) The multi-hop reasoning fails because although the model correctly links installed sales to extended protection plans, it synthesizes the wrong overlapping category. The model appears to rely on proximity of mentions rather than explicit dual-context presence. Appliances is the only category confirmed to be explicitly mentioned in both the installed sales and extended protection plans sections according to the ground truth, but the LLM substitutes it with Kitchens & Bath without justification. (4) While the numerical component is accurate and the response is contextually relevant, the core entity error undermines the qualitative accuracy and overall correctness, warranting a moderate score of 4 out of 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 361,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024, considering the phase-in schedule and the 25% scaling factor applied to the 'day 2' ongoing impact?",
      "original_answer": "The cumulative impact on Capital One's regulatory capital from the CECL Transition Election from 2020 through 2024 includes a 25% scaling factor applied to the 'day 2' ongoing impact of CECL during the initial two years (2020–2021), and a 25% annual phase-in of both the after-tax 'day 1' CECL adoption impact and the cumulative 'day 2' ongoing impact from 2022 through 2024. This structured phase-in delays and gradually integrates the full capital impact of CECL adoption into regulatory capital.",
      "llm_answer": "The cumulative impact of the CECL Transition Election from 2020 through 2024, accounting for the 25% scaling factor applied to the “day 2” ongoing impact, results in a total regulatory‑capital boost of roughly $2.4 billion after‑tax, which would have raised Capital One’s CET1 ratio from about 12.4% to 13.1% as of December 31, 2021.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is significantly incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM states a 'total regulatory-capital boost of roughly $2.4 billion after-tax' and claims this would have raised Capital One’s CET1 ratio from 12.4% to 13.1% as of December 31, 2021. These specific numbers ($2.4B, 12.4%, 13.1%) are not present in the ground truth and cannot be verified from the provided information. The ground truth does not provide any dollar amounts or percentage impacts on CET1 ratios, so introducing such figures constitutes a factual overreach. (2) Completeness: The question asks for the cumulative impact considering the phase-in schedule and the 25% scaling factor on 'day 2' ongoing impact. The ground truth describes a multi-year phase-in structure: 25% scaling on 'day 2' impact in 2020–2021, and 25% annual phase-in of both after-tax 'day 1' and cumulative 'day 2' impacts from 2022–2024. The LLM answer fails to describe this structured phase-in schedule, omitting all details about the 2022–2024 phase-in and the distinction between 'day 1' and 'day 2' impacts. (3) Reasoning: The LLM does not demonstrate correct multi-hop reasoning. Instead of explaining the regulatory capital impact mechanism over 2020–2024 as defined in the ground truth, it fabricates a point-in-time dollar and ratio impact as of 2021, ignoring the cumulative and phased nature of the policy. (4) Semantic Equivalence: The LLM answer is not semantically equivalent to the ground truth. While it mentions the 25% scaling factor and CECL transition, it misrepresents the nature of the impact by reducing it to a single estimated dollar figure and CET1 effect, which is not supported by the original answer. The core of the ground truth—how the phase-in works across years—is entirely missing. (5) Contextual Relevance: The answer is relevant in topic and entity (Capital One, CECL, regulatory capital, 2020–2024), but fails to deliver the required structural explanation, making it misleading despite surface-level plausibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 549,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What was the net financial impact of Altria's 2021 tobacco settlement obligations and NPM adjustment recoveries on its cost of sales?",
      "original_answer": "Altria recorded $4.6 billion in charges to cost of sales for the year ended December 31, 2021, related to the State Settlement Agreements and FDA user fees. During the same period, Altria received $21 million as a reduction to cost of sales from the 2004 NPM adjustment. This resulted in a net cost of $4.579 billion for 2021 after accounting for the NPM adjustment recovery.",
      "llm_answer": "The net financial impact of Altria’s 2021 tobacco‑settlement obligations and the related NPM‑adjustment recoveries was recorded as a reduction of cost of sales.  Altria booked roughly **$4.6 billion of charges to cost of sales** for the State Settlement Agreements and FDA user fees in 2021, and it recognized a **$21 million reduction to cost of sales** in the third quarter of 2021 for its share of the 2004 NPM‑adjustment credit.  These items together represent the net financial effect of the settlement obligations and NPM‑adjustment recoveries on Altria’s cost of sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $4.6 billion in charges to cost of sales and the $21 million NPM adjustment recovery, both of which match the ground truth in amount and context. However, it fails to explicitly calculate or state the net financial impact of $4.579 billion, which is the key requirement of the question. While the components are accurate, the synthesis into a final net figure is missing. (2) Quantitatively, both figures—$4.6 billion and $21 million—are correct and properly attributed to their respective items (State Settlement Agreements/FDA fees and 2004 NPM adjustment). The calculation of $4.6B - $21M = $4.579B is straightforward and accurate, but the LLM does not perform or report this, representing a gap in completeness. (3) The reasoning is mostly sound: the model correctly associates the two components with the cost of sales and recognizes their opposing effects (charges vs. reduction). However, it does not complete the multi-hop synthesis by computing the net effect, which is essential for answering the 'net financial impact' part of the question. (4) Contextual relevance is perfect—the response stays focused on Altria, 2021, cost of sales, settlement obligations, and NPM adjustments. Due to the omission of the net result despite correct inputs, the correctness score is 7 (core facts correct but missing final synthesis), quantitative accuracy is 9 (only minor omission, no errors), qualitative accuracy is 7 (reasoning incomplete), and contextual relevance is 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 419,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "Following the freeze of U.S. pension benefits in 2019, by how much did Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increase from 2020 to 2021?",
      "original_answer": "Caterpillar Inc.'s total liabilities for non-qualified deferred compensation plans and other postemployment benefits increased by $91 million from 2020 to 2021. In 2020, the total liability was $554 million ($63 million for other postemployment benefits + $491 million for non-qualified deferred compensation). In 2021, the total liability was $645 million ($67 million for other postemployment benefits + $538 million for non-qualified deferred compensation). The increase occurred after the pension freeze in December 2019, which eliminated service cost and shifted focus to other benefit liabilities.",
      "llm_answer": "Based on the provided document pages, the total liabilities for non-qualified deferred compensation plans and other postemployment benefits were $63 million at the end of 2020 and $67 million at the end of 2021. This represents an increase of $4 million from 2020 to 2021.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. It states that total liabilities were $63 million in 2020 and $67 million in 2021, representing a $4 million increase. However, the ground truth shows that the total liabilities were $554 million in 2020 ($63M + $491M) and $645 million in 2021 ($67M + $538M), for an actual increase of $91 million. The LLM only used the 'other postemployment benefits' figures and ignored the much larger 'non-qualified deferred compensation' component, leading to a severe undercount. (2) Quantitative accuracy is very low: the LLM reports a $4M increase instead of the correct $91M. It misidentifies the total liability amounts by excluding over $490 million in each year. While the individual components ($63M and $67M for other postemployment benefits) are numerically correct, the failure to sum across both liability types invalidates the answer. (3) The reasoning is flawed—this is a multi-hop question requiring aggregation across two liability categories. The LLM failed to synthesize the full picture, instead focusing narrowly on one line item. It did not demonstrate understanding that 'total liabilities' refers to the sum of both non-qualified deferred compensation and other postemployment benefits. (4) Contextual relevance is moderate because the answer addresses the right company, time frame, and general topic, and correctly notes an increase occurred. However, due to the major quantitative and reasoning errors, the answer is substantially misleading and does not fulfill the question's requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 433,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028, and how does this relate to the $630 million indefinite-lived intangible asset recorded for Mellanox's in-process research and development project?",
      "original_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1.889 billion. This includes $585 million in 2023, $461 million in 2024, $405 million in 2025, $121 million in 2026, $16 million in 2027, and $121 million in 2028 and thereafter. The $630 million indefinite-lived intangible asset for Mellanox's in-process research and development (IPR&D) project is not included in these estimates because it had not yet reached technological feasibility as of January 30, 2022, and therefore was not yet amortized. Instead, it was subject to annual impairment testing.",
      "llm_answer": "The total estimated amortization expense for NVIDIA's acquisition-related intangible assets from fiscal year 2023 through 2028 is $1,000 million, as shown in the lease‑obligation table (page 81). This $630 million indefinite‑lived intangible asset recorded for Mellanox's in‑process research and development project will not be amortized; it will remain on the balance sheet and be tested annually for impairment, with amortization only beginning if and when the project reaches technological feasibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the total estimated amortization expense. The correct total from fiscal years 2023 to 2028 is $1.889 billion, but the LLM states $1,000 million ($1 billion), which is substantially lower and incorrect. The breakdown by year is entirely missing in the LLM response, which undermines completeness and accuracy. Additionally, citing a 'lease-obligation table (page 81)' as the source is irrelevant and erroneous, as lease obligations are unrelated to amortization of acquisition-related intangibles. (2) Quantitatively, the $630 million figure for the indefinite-lived intangible asset is correctly stated, and the concept that it is not amortized is accurate. However, the core financial figure—the total amortization—is wrong, and no verification of the sum across years is provided. The actual sum from the ground truth ($585M + $461M + $405M + $121M + $16M + $121M) = $1.889B is not reflected. (3) The reasoning regarding the Mellanox IPR&D asset is qualitatively sound: the model correctly explains that indefinite-lived intangible assets are not amortized until technological feasibility is reached and are instead subject to annual impairment testing. This shows correct multi-hop understanding between acquisition accounting rules and the specific case of IPR&D. (4) Contextual relevance is moderate—the response addresses both parts of the question and uses appropriate financial terminology, but the incorrect dollar amount and misattributed source severely undermine reliability. The explanation of non-amortization due to indefinite life is relevant and accurate, but the primary quantitative claim is false.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 465,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the combined U.S. and EU patent expiration year for Biktarvy, and how does the expanded FDA approval of Biktarvy for people with HIV who have M184V/I resistance influence its market exclusivity timeline?",
      "original_answer": "Biktarvy has a U.S. patent expiration year of 2033 and an EU patent expiration year of 2033. The FDA-approved expanded indication for Biktarvy to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance reinforces its market exclusivity by broadening its therapeutic application, thereby supporting continued revenue generation potential through 2033 in both regions.",
      "llm_answer": "The combined U.S. and EU patent expiration for Biktarvy is 2033. The expanded FDA approval for Biktarvy to treat people with HIV who have M184V/I resistance does not alter its patent expiration timeline, as the patent protection remains unchanged at 2033.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the U.S. and EU patent expiration year for Biktarvy as 2033, which matches the ground truth. This satisfies the quantitative requirement and is factually accurate. 2) The answer correctly states that the expanded FDA approval does not alter the patent expiration timeline, which is factually sound—patent terms are not extended by new indications. However, the LLM omits the qualitative impact emphasized in the original answer: that the expanded approval reinforces market exclusivity by broadening the therapeutic application and supporting revenue generation through 2033. This is a key nuance in the reasoning chain. 3) The multi-hop reasoning is partially complete: it connects the expanded approval to the unchanged patent term but fails to synthesize how regulatory exclusivity or commercial exclusivity (distinct from patent term) can be strengthened through expanded indications, which is implied in the original answer. 4) Despite the omission of the broader commercial implication, the core facts and dates are correct, and the answer remains contextually relevant and logically sound, warranting a high score but not perfect due to incomplete qualitative synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 338,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the Federal Reserve's supervisory stress testing modeling impact Capital One Financial Corporation's (COF) ability to return capital to stockholders, and what specific regulatory requirement from the Dodd-Frank Act reinforces this limitation?",
      "original_answer": "The Federal Reserve's supervisory stress testing modeling may indicate a lower capacity for Capital One Financial Corporation (COF) to return capital to stockholders than internal projections suggest, potentially leading to restrictions on dividends and share repurchases. This limitation is reinforced by the Dodd-Frank Act's codification of the 'source of strength doctrine,' which requires COF to maintain sufficient capital to support its subsidiary banks, further constraining capital returns.",
      "llm_answer": "The Federal Reserve’s supervisory stress‑testing requirements—particularly the DFAST/CCAR framework that mandates capital‑planning and a stress‑capital buffer—limit Capital One’s ability to return capital to shareholders, as any planned dividend or share‑repurchase must be adjusted to meet the buffer determined by the Fed. This limitation is reinforced by the Dodd‑Frank Act’s “source‑of‑strength” and capital‑planning provisions, which require the company to maintain capital commensurate with the stress‑test results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that the Federal Reserve's supervisory stress testing (via DFAST/CCAR) limits Capital One's ability to return capital by requiring adherence to a stress-capital buffer, which affects dividends and share repurchases. This aligns with the original answer's point about lower capacity for capital returns compared to internal projections. The regulatory requirement from the Dodd-Frank Act is correctly identified as the 'source of strength' doctrine (referred to as 'source-of-strength' in the LLM answer), and the mention of capital-planning provisions adds contextual accuracy. While the original answer explicitly links the doctrine to supporting subsidiary banks, the LLM answer captures the essence by tying capital requirements to stress-test outcomes. There are no numeric values to verify, so quantitative accuracy is 10. The reasoning is sound and multi-hop: connecting Fed stress testing → capital return limits → Dodd-Frank reinforcement. Minor deduction in qualitative accuracy due to slightly less specificity on the 'source of strength' doctrine’s application to subsidiaries, but overall synthesis is strong. Contextual relevance is perfect—directly addresses both parts of the question with precise regulatory and financial logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 375,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What was the total amount of payments made by PM USA under the State Settlement Agreements for the years 2019, 2020, and 2021 combined, and how does this compare to the maximum potential NPM Adjustment for 2020 alone?",
      "original_answer": "PM USA paid a total of $12.8 billion under the State Settlement Agreements for the years 2019 ($4.2 billion), 2020 ($4.4 billion), and 2021 ($4.3 billion). This total is significantly higher than the maximum potential NPM Adjustment for 2020 alone, which was $572 million.",
      "llm_answer": "The total payments made by PM USA under the State Settlement Agreements for 2019, 2020 and 2021 combined were $4.3 billion (2019), $4.4 billion (2020) and $4.2 billion (2021), which together equal $12.9 billion. The maximum potential NPM Adjustment for 2020 alone was $572 million, so the 2020 NPM Adjustment is substantially smaller than the combined $12.9 billion of State Settlement Agreement payments for the three years.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has inaccuracies in the yearly breakdown and total sum. It states payments of $4.3B (2019), $4.4B (2020), and $4.2B (2021), which sum to $12.9B. However, the ground truth specifies $4.2B (2019), $4.4B (2020), and $4.3B (2021), totaling $12.8B. The total is off by $0.1B due to both misassignment of yearly values and incorrect summation (4.3+4.4+4.2=12.9, but correct sum is 4.2+4.4+4.3=12.9 — though the ground truth reports $12.8B, suggesting possible rounding or reporting differences). Despite this, the NPM Adjustment value of $572 million for 2020 is correct. (2) The comparison logic is sound — the LLM correctly notes that the three-year total is much larger than the 2020 NPM Adjustment alone. However, the quantitative foundation is slightly flawed due to incorrect year-to-amount mapping and total. (3) The multi-hop reasoning is adequate: the model synthesizes payments across three years and compares them to a separate financial figure (NPM Adjustment). Entity identification (PM USA, State Settlement Agreements, NPM Adjustment) and years are correct. (4) The answer is contextually relevant and addresses both parts of the question. Due to the minor but material numerical discrepancies in the breakdown and total, the correctness score is 7 rather than higher. Quantitative accuracy is penalized more heavily (6) due to incorrect assignment of values to years and total miscalculation, though the core figures are close.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 415,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "What is the difference between the fair value of the 2.85% Notes Due 2030 as reported in the first table and the net carrying amount of the same notes as disclosed in the second table for the fiscal year ending January 30, 2022?",
      "original_answer": "The fair value of the 2.85% Notes Due 2030 is $1,542 million according to the first table, while the net carrying amount is $1,500 million according to the second table. The difference between the two values is $42 million.",
      "llm_answer": "The fair value of the 2.85% Notes Due 2030 reported in the first table is $1,000 million, while the net carrying amount disclosed in the second table is $950 million, resulting in a $50 million difference.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its numerical values. The ground truth states the fair value is $1,542 million and the net carrying amount is $1,500 million, resulting in a $42 million difference. The LLM incorrectly reports these as $1,000 million and $950 million, respectively, leading to a $50 million difference, which is not supported by the data. (2) The calculation of the difference itself is mathematically correct ($1,000M - $950M = $50M), but the underlying numbers are wrong, making the result inaccurate. The correct difference is $42 million ($1,542M - $1,500M). (3) The reasoning structure is sound—identifying fair value and carrying amount and computing the difference—but fails on multi-hop synthesis because it pulls incorrect values from what should be the referenced tables. There is no indication that the model correctly retrieved the actual figures from the appropriate sources. (4) The contextual relevance is high because the answer addresses the right entities (2.85% Notes Due 2030, fair value, net carrying amount, fiscal year end January 30, 2022) and performs the correct type of analysis (difference calculation), but the factual inaccuracies severely undermine correctness. Hence, low scores for quantitative and qualitative accuracy, and a correctness score of 1 due to complete factual mismatch.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1127,
        "completion_tokens": 377,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the application of the Tailoring Rules impact the capital requirements for Capital One Financial Corporation (COF) as a Category III institution, particularly in relation to the Stress Capital Buffer Rule and the exclusion of certain elements of AOCI?",
      "original_answer": "As a Category III institution under the Tailoring Rules, Capital One Financial Corporation (COF) is no longer subject to the Basel III Advanced Approaches framework and certain associated capital requirements. Additionally, COF has elected to exclude certain elements of Accumulated Other Comprehensive Income (AOCI) from its regulatory capital. This exclusion, combined with the recalibration of the Stress Capital Buffer Rule—based on supervisory stress test results—reduces the complexity and burden of capital calculations for COF while maintaining a CET1 capital ratio buffer that is institution-specific and annually adjusted.",
      "llm_answer": "The Tailoring Rules classify Capital One as a Category III institution, which allows it to exclude certain elements of AOCI from its regulatory capital calculations. Because it is subject to the Stress Capital Buffer Rule, its stress‑capital buffer requirement—derived from the Federal Reserve’s supervisory stress‑test results—must be added to the standard capital‑conservation buffer, raising the minimum CET1, Tier 1 and total capital ratios (e.g., to 10.1 %, 11.6 % and 13.6 % in 2020‑21, and to 7.0 %, 8.5 % and 10.5 % in 2021‑22). Consequently, the capital requirements for COF are effectively elevated by the stress‑capital buffer, while the exclusion of specific AOCI items reduces the amount of capital that must be held under the standardized approach.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant issues in quantitative accuracy and reasoning. (1) Correct elements: The classification of Capital One (COF) as a Category III institution under the Tailoring Rules and the exclusion of certain AOCI components from regulatory capital are factually accurate and align with the ground truth. The mention of the Stress Capital Buffer (SCB) being based on supervisory stress test results is also correct. (2) Quantitative inaccuracies: The LLM provides specific capital ratio numbers (e.g., 10.1%, 11.6%, 13.6% for 2020-21 and 7.0%, 8.5%, 10.5% for 2021-22), but these are not supported by the ground truth, which does not include any specific percentages or years. More critically, these numbers misrepresent the impact of the SCB—rather than 'elevating' capital requirements, the Tailoring Rules and SCB recalibration were intended to reduce complexity and burden while maintaining a dynamic, institution-specific buffer. The cited ratios appear fabricated or misapplied, severely undermining quantitative accuracy. (3) Reasoning flaws: The LLM incorrectly concludes that capital requirements are 'effectively elevated' by the stress-capital buffer, which contradicts the ground truth stating that the rules reduce burden and complexity. This reflects a fundamental misunderstanding of the policy's intent and effect. While the model attempts multi-hop reasoning (linking category classification, AOCI exclusion, SCB, and capital ratios), the synthesis is flawed due to incorrect interpretation of the SCB's impact. (4) Contextual relevance is high—the response addresses the core topics: Tailoring Rules, Category III status, AOCI exclusion, and SCB. However, the incorrect conclusion about increased capital requirements reduces qualitative accuracy. Overall, the answer gets key concepts right but fails on critical details and interpretation, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 525,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the total change in fair value of Altria's JUUL investment from 2020 to 2021, and how was this change reflected in Altria's consolidated financial statements?",
      "original_answer": "The fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. This amount was included in 'investments in equity securities' on Altria's consolidated balance sheets at December 31, 2021, and was accounted for under the fair value option following the Share Conversion in the fourth quarter of 2020. Changes in the fair value of the JUUL investment, calculated quarterly using level 3 fair value measurements, were included in 'income (losses) from equity investments' in Altria's consolidated statements of earnings (losses).",
      "llm_answer": "The total change in fair value of Altria's JUUL investment from 2020 to 2021 was an increase of $1.7 billion, rising from $1.7 billion at December 31, 2020 to $11.9 billion at December 31, 2021. This change was reflected in Altria's consolidated financial statements through the inclusion of the investment's fair value adjustments in \"(income) losses from equity investments\" on the consolidated statements of earnings, with the fair value of the JUUL investment reported in \"investments in equity securities\" on the consolidated balance sheets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that the fair value of Altria's JUUL investment remained unchanged at $1,705 million from 2020 to 2021. However, the LLM claims an increase from $1.7 billion to $11.9 billion, which is a massive overstatement and completely inaccurate. This error invalidates the entire response. (2) Quantitative accuracy is extremely low: the reported values ($1.7B to $11.9B) and implied change (~$10.2B increase) are entirely wrong. The correct change is $0. While $1.7 billion is approximately equal to $1,705 million, the second value ($11.9B) has no basis in the truth data. (3) The qualitative reasoning is partially sound in describing how changes in fair value are reflected in financial statements—namely, that fair value adjustments are included in 'income (losses) from equity investments' and reported in 'investments in equity securities' on the balance sheet. This part aligns with the original answer and shows correct understanding of accounting treatment. However, the model fails the multi-hop synthesis by not recognizing that no change occurred post-Share Conversion in Q4 2020, and thus incorrectly infers a large change. (4) Contextual relevance is moderate because the answer addresses the correct company (Altria), investment (JUUL), and financial statement line items, but the incorrect numbers and change magnitude severely undermine usefulness. Due to the fundamental error in the key quantitative fact, the correctness score is near the lowest possible.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 429,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What percentage of Union Pacific's total locomotives are leased rather than owned, and how does this compare to the total number of switching locomotives in their fleet?",
      "original_answer": "Union Pacific leases 1,037 out of 7,154 total locomotives, which represents approximately 14.5% of their fleet. This number is significantly higher than the 132 switching locomotives in their fleet.",
      "llm_answer": "Based on the provided document pages, Union Pacific reports **7,154 total locomotives** as of December 31, 2023, with **1,037 leased** and **6,117 owned**. This means leased locomotives account for **14.5%** of the total fleet (1,037 ÷ 7,154 ≈ 0.145). Regarding switching locomotives, the document specifies **132 switching locomotives** (all owned, as indicated by \"Leased -\" in the table), which represents **1.85%** of the total locomotive fleet (132 ÷ 7,154 ≈ 0.0185). Thus, leased locomotives constitute a significantly larger portion of the total fleet than switching locomotives.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: 7,154 total locomotives, 1,037 leased, and 132 switching locomotives are correctly reported. The percentage calculation (1,037 ÷ 7,154 ≈ 14.5%) is precise and correctly interpreted. The additional calculation of switching locomotives as 1.85% of the fleet, while not in the original answer, is accurate and adds context without introducing error. (2) The answer addresses both parts of the question: the percentage of leased locomotives and how that compares to the number of switching locomotives. (3) Entity accuracy is correct—Union Pacific is the subject, and all metrics (leased, owned, switching) are properly identified with correct time context (as of December 31, 2023). (4) The reasoning is sound and demonstrates multi-hop synthesis: it combines total fleet size, ownership breakdown, and a subcategory (switching locomotives) to make a valid comparison. The conclusion that leased locomotives constitute a significantly larger portion than switching locomotives is logically and factually supported. The LLM answer is semantically equivalent to and even slightly more detailed than the ground truth, without any factual deviation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 353,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "What was the change in fair value of the 2.20% Notes Due 2021 from January 31, 2021, to January 30, 2022, and how does this reflect in both the fair value disclosures and the debt-specific maturity and interest rate table?",
      "original_answer": "The fair value of the 2.20% Notes Due 2021 decreased from $1,011 million on January 31, 2021, to $0 million on January 30, 2022, as shown in the fair value disclosures. This aligns with the debt-specific maturity and interest rate table, which indicates that the notes had an effective interest rate of 2.38% and a remaining term of 0 years by January 30, 2022, meaning the notes had matured and were no longer outstanding.",
      "llm_answer": "The change in the fair value of the 2.20% Notes Due 2021 from January 31 2021 to January 30 2022 was an increase of $18 million, which is reflected in the fair‑value disclosures as a $18 million rise in the carrying amount of the debt and is also shown in the debt‑specific maturity and interest‑rate table as a $18 million increase in the fair value of the notes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the fair value change. The ground truth states the fair value decreased from $1,011 million to $0 million, indicating the notes matured. The LLM incorrectly claims an increase of $18 million, which contradicts the actual data. (2) Quantitative accuracy is severely lacking: the correct change is a decrease of $1,011 million, not an $18 million increase. Dates (January 31, 2021, to January 30, 2022) and the interest rate (2.20% note with 2.38% effective rate) are not referenced correctly in context. The $18 million figure has no basis in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to recognize that a drop to $0 fair value aligns with maturity (0 years remaining term), which is a key logical connection made in the original answer. Instead, it fabricates an increase and misrepresents disclosures. (4) Scores are low because the core facts—change in fair value, maturity status, and supporting disclosures—are all misrepresented. The answer is partially relevant to the question's structure but fails on correctness, reasoning, and data fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 331,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does the temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks impact the calculation of Capital One's supplementary leverage ratio, and what specific regulatory framework influenced this adjustment?",
      "original_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio, as permitted under an interim final rule issued by the Federal Reserve, increased Capital One's supplementary leverage ratio. This adjustment was made under the Basel III Standardized Approach framework, which governs the company's capital ratios and regulatory requirements.",
      "llm_answer": "The temporary exclusion of U.S. Treasury securities and deposits with the Federal Reserve Banks from the denominator of the supplementary leverage ratio was permitted under an interim final rule issued by the Federal Reserve that allowed certain banking organizations to temporarily adjust the leverage ratio calculation. This adjustment was made to align with the Federal Reserve’s supervisory capital standards and prompt corrective action framework, and it was applied in the Company’s supplementary leverage ratio calculation as of December 31 2020. The exclusion was later discontinued after the interim rule expired in March 2021.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the temporary exclusion of U.S. Treasury securities and Fed deposits from the supplementary leverage ratio denominator, and attributes it to an interim final rule by the Federal Reserve—this aligns with the ground truth. It adds specific timing details (as of December 31, 2020, and expiration in March 2021) not present in the original answer, which are factually accurate and add context. However, it incorrectly identifies the regulatory framework as the 'supervisory capital standards and prompt corrective action framework' instead of the 'Basel III Standardized Approach framework,' which is a key part of the question and missing from the LLM response. (2) Quantitatively, the dates (December 31, 2020, and March 2021) are accurate and consistent with regulatory timelines, though not in the original answer. There are no numerical values to verify (e.g., ratio percentages), so no calculation errors exist. (3) The reasoning is sound in describing the regulatory adjustment and its temporary nature, but fails the multi-hop requirement of linking the interim rule to the Basel III framework, which governs Capital One’s capital ratios. This omission weakens the synthesis across regulatory layers. (4) The answer is contextually relevant and well-structured, with high qualitative accuracy except for the misattribution of the regulatory framework. The correctness score is 7 because core facts about the exclusion and rule are correct, but a significant portion of the question—identifying the correct regulatory framework—is missed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 437,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What was the total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023, and how were these assets valued?",
      "original_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million. These assets, which include Federal Government Securities valued at $1,508 million and Bonds and Debentures valued at $1,696 million, were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "llm_answer": "The total value of Union Pacific's pension plan assets classified as Level 2 investments in 2023 was $3,209 million, and these assets were valued using a bid evaluation process with bid data provided by independent pricing sources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the total value of Union Pacific's Level 2 pension plan assets in 2023 as $3,209 million and accurately describes the valuation method as a bid evaluation process using bid data from independent pricing sources. All key facts—total value, year, company, asset classification, and valuation methodology—are correct. (2) The quantitative accuracy is perfect: $3,209 million matches the ground truth. While the breakdown of components (Federal Government Securities at $1,508 million and Bonds and Debentures at $1,696 million) sums to $3,204 million—slightly less than $3,209 million due to possible rounding or unlisted minor components—the total reported value is still accurate per the source. The LLM does not attempt to reproduce the sum, so no calculation error is introduced. (3) The multi-hop reasoning is sound: the model correctly identifies Union Pacific, the 2023 fiscal year, pension plan assets, Level 2 classification, and valuation approach from likely disparate parts of a 10-K filing. (4) The only minor omission is the lack of detail on the composition of Level 2 assets (i.e., the specific categories and their values), which is included in the ground truth. However, since the question does not explicitly ask for a breakdown, this omission does not invalidate the answer. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 419,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "What specific automotive applications of NVIDIA Omniverse are mentioned in the 10-K filing, and how does its integration with the DRIVE platform support NVIDIA's end-to-end AI computing strategy?",
      "original_answer": "The 10-K filing specifically mentions that NVIDIA Omniverse Avatar software is used for real-time conversational AI capability in automotive applications, particularly as part of the DRIVE Chauffeur and DRIVE Concierge systems. This integration with the DRIVE platform supports NVIDIA's end-to-end AI computing strategy by combining Omniverse's real-time 3D simulation and collaboration capabilities with DRIVE's autonomous driving and in-vehicle experience solutions. This strategic integration allows NVIDIA to provide a comprehensive, software-defined approach to automotive computing—from training deep neural networks using GPUs to deploying AI-driven cockpit experiences and autonomous driving features, enabling continuous innovation through over-the-air updates.",
      "llm_answer": "NVIDIA Omniverse is highlighted in the 10‑K filing as a real‑time 3D design collaboration and virtual‑world simulation platform that powers automotive use cases such as virtual car showrooms, architectural walkthroughs and historical scene recreation, all built on physically‑based rendering and GPU‑accelerated simulation. Its integration with the DRIVE ecosystem—specifically the DRIVE Software stack that includes DRIVE Chauffeur, Drive Concierge and Omniverse Avatar—enables end‑to‑end AI computing for vehicles, allowing perception, planning and control functions to be trained, validated in DRIVE Sim and continuously updated over‑the‑air, thereby supporting NVIDIA’s broader strategy of delivering an integrated hardware‑software stack from data‑center training to in‑car inference.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies in specificity. (1) Correct elements: The LLM correctly identifies NVIDIA Omniverse as a real-time 3D simulation platform and links it to automotive applications through integration with DRIVE Chauffeur, DRIVE Concierge, and Omniverse Avatar—matching the original answer's core claims. It accurately describes the end-to-end AI computing strategy, including training in data centers, simulation (DRIVE Sim), over-the-air updates, and deployment of AI features in vehicles. (2) Quantitative accuracy: There are no numeric values, dates, or financial figures in the question or answers, so this dimension is not applicable; the response contains no erroneous numbers. (3) Multi-hop reasoning assessment: The LLM synthesizes information correctly across Omniverse and DRIVE platform components, showing how simulation, AI avatars, and software-defined vehicle functions support NVIDIA’s vertical AI strategy. However, it adds unmentioned applications—'virtual car showrooms, architectural walkthroughs and historical scene recreation'—which are not cited in the original 10-K-based answer and appear to be speculative or generalized uses not tied to the specific automotive context in the ground truth. (4) The original answer focuses narrowly on 'real-time conversational AI capability' via Omniverse Avatar in DRIVE Concierge and Chauffeur; the LLM broadens this to include design and simulation use cases not explicitly stated. While these may be plausible, they are not supported by the provided ground truth. Thus, while the strategic integration explanation is sound and contextually relevant, the inclusion of unsupported specific applications reduces qualitative accuracy slightly. Hence, a score of 8 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 520,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023, and how did this compare to the percentage change in Converse's operating income over the same period?",
      "original_answer": "Converse's contribution to NIKE, Inc.'s total revenues increased by 3.4% from 2022 to 2023, while its operating income decreased by 30.0% over the same period.",
      "llm_answer": "The percentage change in Converse's contribution to NIKE, Inc.'s total revenues from 2022 to 2023 was 3.5% (from $2,346 million to $2,427 million), while the percentage change in Converse's operating income over the same period was 13.2% (from $669 million to $676 million).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both key metrics. The ground truth states that Converse's contribution to NIKE's total revenues increased by 3.4%, while the LLM reports 3.5% — a minor discrepancy, possibly due to rounding, but still inaccurate. More critically, the LLM claims operating income increased by 13.2% (from $669M to $676M), which contradicts the ground truth that operating income decreased by 30.0%. This is a major factual and directional error. (2) The dollar amounts cited ($2,346M to $2,427M for revenue) are plausible and align roughly with a 3.4–3.5% increase, so revenue figures may be approximately correct. However, the operating income figures ($669M to $676M) suggest a negligible increase, whereas the ground truth indicates a significant decline — meaning either the input data was wrong or the calculation was severely flawed. A 30% decrease would imply operating income dropped to around $468M, not $676M. (3) The multi-hop reasoning failed: the model correctly identified the need to compute percentage changes in two metrics (revenue contribution and operating income), but used incorrect underlying data for operating income, leading to a completely wrong conclusion. (4) The contextual relevance is high because the answer structure matches the question and addresses both parts. However, due to severe quantitative inaccuracies — especially the reversal of a 30% decrease into a 13.2% increase — the correctness and quantitative accuracy scores are very low. The qualitative accuracy is slightly higher because the reasoning framework (calculating percentage changes) was sound, even if based on bad data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 454,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the changes to the TDR accounting guidance impact the classification of trial modifications in both the residential real estate and credit card loan portfolios for the year ended December 31, 2023?",
      "original_answer": "The changes to the TDR accounting guidance eliminated the 'reasonably expected' and 'concession' assessment criteria, which resulted in trial modifications being classified as TDRs but not FDMs in both the residential real estate and credit card loan portfolios. For residential real estate, this meant $69 million of loans under trial modification were considered TDRs but not FDMs. Similarly, for credit card loans, $27 million of loans under trial modification were classified as TDRs but not FDMs.",
      "llm_answer": "The changes to the TDR accounting guidance eliminated the “reasonably expected” and “concession” assessment criteria, causing trial modifications and Chapter 7 bankruptcy loans in both residential real estate and credit‑card portfolios to be classified as TDRs (but not as FDMs). Consequently, for the year ended December 31 2023, these trial modifications were reflected as TDR‑related balances in both portfolios, increasing the reported TDR volume compared with 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in TDR accounting guidance—elimination of the 'reasonably expected' and 'concession' criteria—and correctly states that trial modifications are now classified as TDRs but not FDMs in both residential real estate and credit card portfolios. This aligns with the ground truth and shows sound qualitative understanding. However, the LLM answer fails to include the specific dollar amounts ($69 million for residential real estate and $27 million for credit card loans), which are critical quantitative components of the original answer. The omission of these figures significantly reduces factual completeness. (2) Quantitative accuracy is low because the model does not report any numerical values, despite their centrality to the original answer. Even though format variations are acceptable, the absence of numbers constitutes a major gap. (3) The reasoning is logically sound: the model correctly traces the cause (accounting change) to the effect (classification of trial modifications as TDRs but not FDMs) and notes the impact on reported TDR volume. It also correctly limits the scope to the relevant portfolios and time period (year ended December 31, 2023). However, it introduces 'Chapter 7 bankruptcy loans'—a detail not present in the ground truth—which may reflect overgeneralization or confusion, though it doesn't directly contradict the original. (4) Contextual relevance is high because the response stays focused on the question and uses appropriate terminology. The qualitative accuracy is moderate to high due to correct logic and entity identification, but the lack of numbers and minor extraneous detail prevent a higher score. Overall, the answer captures the conceptual impact but misses key data required for full correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 492,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How many total retention shares and retention units were outstanding under Union Pacific's stock incentive plans as of December 31, 2023, and how does this compare to the number of restricted shares outstanding under the Directors Plan on the same date?",
      "original_answer": "As of December 31, 2023, Union Pacific had 954,405 retention shares and 366,046 retention units outstanding under its stock incentive plans, totaling 1,320,451. This compares to 16,000 restricted shares outstanding under the Directors Plan on the same date.",
      "llm_answer": "As of December 31 2023, Union Pacific’s stock incentive plans had **2,072,000 stock options and 996,000 non‑vested retention shares outstanding** (i.e., 2.072 million options and roughly 1.0 million retention shares).  \n\nUnder the Directors Plan, **16,000 restricted shares** were outstanding on the same date.  \n\nThus, the total of retention shares and retention units (≈2.07 million) far exceeds the 16,000 restricted shares held under the Directors Plan.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies. It reports 996,000 non-vested retention shares, but the ground truth specifies 954,405 retention shares and 366,046 retention units, totaling 1,320,451. The LLM incorrectly conflates retention shares with stock options (2,072,000 options), which are not part of the requested 'retention shares and retention units' total. The Directors Plan figure of 16,000 restricted shares is correct. (2) Quantitative accuracy is low: the retention share/unit total is off by over 700,000 units when including the erroneous inclusion of stock options. The LLM reports ~1 million retention shares instead of ~1.32 million combined retention shares and units, and introduces 2.072 million stock options not mentioned in the question or ground truth. (3) The reasoning is flawed: the model fails to correctly identify and sum retention shares and retention units as defined in the ground truth, instead substituting unrelated stock option data. It incorrectly aggregates stock options with retention shares, showing a failure in multi-hop synthesis and understanding of incentive plan components. (4) Contextual relevance is moderate because the answer addresses the structure of the question (comparing retention awards to Directors Plan shares) and correctly identifies the 16,000 restricted shares, but uses incorrect data for the primary comparison. The conclusion that retention awards far exceed Directors Plan shares is directionally correct but based on invalid numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 417,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "What was the total amount of AMD's investment in the ATMP JV as of December 28, 2024, including both the carrying value of its equity investment and the secured loan it provided to the JV?",
      "original_answer": "AMD's total investment in the ATMP JV as of December 28, 2024, was $249 million. This includes the carrying value of its equity investment, which was $149 million, and a secured term loan of $100 million provided to the JV.",
      "llm_answer": "Based on the provided document pages, AMD's investment in the ATMP JV as of December 28, 2024, consists of two components:  \n1. The carrying value of its equity investment in the ATMP JV, which was approximately $149 million (as stated in the \"NOTE 8 - Debt and Revolving Credit Facility\" section of page 75, confirming the investment value as of December 28, 2024).  \n2. A $100 million secured loan provided to the ATMP JV under a one-year term loan agreement (dated October 9, 2024), which is recorded within \"Receivables from related parties\" on the balance sheet (page 73).  \n\nThe total investment amount, combining both the equity method investment ($149 million) and the secured loan ($100 million), equals **$249 million** as of December 28, 2024. This is derived from the disclosed figures in the document, with the loan being explicitly described as secured by the JV's receivable balance due from AMD.  \n\n**Answer:**  \nAMD's total investment in the ATMP JV as of December 28, 2024, was $249 million, comprising a $149 million carrying value of its equity investment and a $100 million secured loan provided to the JV.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all factual components of AMD's total investment in the ATMP JV as of December 28, 2024. The two components—$149 million equity investment carrying value and $100 million secured loan—are exactly as stated in the ground truth. The total sum of $249 million is accurate and matches the original answer. (2) All numeric values are correct: $149M (equity), $100M (loan), and $249M (total). Calculations are accurate (149 + 100 = 249), and the date (December 28, 2024) is correctly referenced. Format variations (e.g., $100 million vs $100M) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information from different sections of the document (page 75 for equity investment, page 73 for the secured loan), identifies the nature of the loan (secured, one-year term, recorded under 'Receivables from related parties'), and links it to the JV structure. It also correctly interprets that both the equity investment and the loan constitute AMD's total investment. (4) The answer is semantically equivalent to the ground truth, with added contextual detail (e.g., citation of document sections) that enhances clarity without introducing error. All evaluation dimensions—factual accuracy, completeness, entity identification, and logical synthesis—are fully satisfied, justifying perfect scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 389,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What was the total financial impact on Danaher from the disposition of Envista Holdings Corporation, including the gain on disposition, the foreign currency translation adjustment loss, and the IPO and Separation-related costs?",
      "original_answer": "The total financial impact on Danaher from the disposition of Envista Holdings Corporation was $387 million. This includes a $451 million gain on disposition, reduced by $109 million in reclassified foreign currency translation adjustment losses and $69 million in IPO and Separation-related costs.",
      "llm_answer": "The total financial impact of the Envista Holdings Corporation disposition on Danaher was a gain on disposition of $451 million (pre‑tax), a foreign‑currency translation adjustment loss of $109 million (reclassified from accumulated OCI to discontinued‑operations earnings), and IPO/Separation‑related costs of $69 million (also recorded in discontinued‑operations earnings).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies all three quantitative components of the financial impact: the $451 million gain on disposition, the $109 million foreign currency translation adjustment loss, and the $69 million in IPO and Separation-related costs—matching the ground truth exactly in terms of numbers and entities. Therefore, quantitative accuracy is perfect (10/10), and contextual relevance is full (10/10) as all parts of the question are addressed in substance. However, the LLM fails to provide the synthesized total financial impact of $387 million, which is the net result of $451M - $109M - $69M. This omission is significant because the question explicitly asks for the 'total financial impact,' which requires combining the components. While the individual elements are correct, the lack of the final aggregated figure reduces completeness and weakens the qualitative accuracy (7/10), as the multi-hop synthesis—though implied—is not explicitly delivered. The answer provides all inputs needed for the calculation but does not complete the reasoning step to state the net impact, which is the core of the question. Thus, correctness is penalized to 7/10 despite perfect component reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 337,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the 15% currency-neutral revenue decline in Converse, driven by North America and Western Europe, impact the overall EBIT performance of the Converse segment, considering the 130 basis point gross margin contraction linked to unfavorable foreign currency exchange rates?",
      "original_answer": "The 15% currency-neutral revenue decline in Converse, primarily due to drops in North America and Western Europe, contributed to a 30% decrease in reported EBIT. This was exacerbated by a 130 basis point gross margin contraction caused in part by unfavorable changes in standard foreign currency exchange rates, which further reduced profitability.",
      "llm_answer": "The 15% currency-neutral revenue decline in Converse—driven by North America and Western Europe—directly contributed to a 30% drop in Converse’s earnings before interest and taxes (EBIT), which fell from $676 million to $474 million. This decline was amplified by a 130‑basis‑point gross‑margin contraction, largely attributable to unfavorable foreign‑currency exchange rates that pressured margins despite some offsetting factors.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the 15% currency-neutral revenue decline in Converse due to North America and Western Europe and links it to a 30% drop in EBIT, matching the original answer. (2) The dollar figures—EBIT falling from $676 million to $474 million—are consistent with a ~30% decline (exact calculation: (676 - 474) / 676 ≈ 29.9%, which rounds to 30%), so the quantitative accuracy is correct. These specific values were not in the original answer but are factually plausible and do not contradict the ground truth; their inclusion adds detail without introducing error. (3) The 130 basis point gross margin contraction is correctly attributed to unfavorable foreign currency exchange rates, and the mention of 'offsetting factors' is a minor addition but reasonable and not misleading. (4) The multi-hop reasoning—connecting revenue decline and margin pressure to EBIT performance—is sound and synthesizes the required causal链条 correctly. The only reason for not scoring a 10 is that the original answer does not specify the $676M and $474M figures, so while they are accurate and consistent, their presence introduces unverified precision. However, since they support the correct percentage and logic, the deviation is minor. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 383,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did the adoption of the new TDR accounting guidance on January 1, 2023, specifically impact JPMorgan Chase's allowance for credit losses in 2023, and what was the resulting effect on the Firm's financial position given the changes in trial modifications and Chapter 7 loans?",
      "original_answer": "The adoption of the new TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan Chase's allowance for credit losses. This change was driven by the elimination of the TDR 'reasonably expected' and 'concession assessment' criteria, which reclassified $69 million of loans subject to trial modification and $9 million of loans subject to discharge under Chapter 7 bankruptcy proceedings as non-FDMs (Financial Disincentive Modifications), although they were still considered TDRs. This reclassification reduced the allowance requirement, reflecting a change in how credit losses were estimated for these categories of loans, thereby improving the Firm's reported financial position by lowering the required reserves.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1 2023 reduced the allowance for loan losses by $489 million (a $100 million reduction for credit‑card and a $2 million increase for wholesale), as noted in Note 1 of the 10‑K. This reduction lowered the Firm’s total allowance for credit losses from $22,204 million at the end of 2022 to $24,522 million at the end of 2023, reflecting the net effect of the guidance change on trial modifications and Chapter 7 loans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states a $587 million reduction in the allowance for credit losses due to the new TDR guidance, but the LLM claims a $489 million reduction, which is incorrect. Additionally, the LLM breaks this down into a $100 million reduction for credit-card and a $2 million increase for wholesale, which is not supported by the original answer and introduces unverified details. (2) The LLM incorrectly states that the allowance increased from $22,204 million at the end of 2022 to $24,522 million at the end of 2023, implying a $2,218 million increase, which contradicts both the direction and magnitude of the actual change. This calculation is fundamentally flawed and misrepresents the financial impact. The original answer does not provide ending allowance totals, so this synthesis is erroneous. (3) The multi-hop reasoning is weak: while the LLM identifies the correct date (January 1, 2023) and references trial modifications and Chapter 7 loans, it fails to explain the mechanism of impact—namely, the elimination of the 'reasonably expected' and 'concession assessment' criteria leading to reclassification of $69M and $9M of loans as non-FDMs. This key causal logic is missing. (4) Contextual relevance is moderate because the answer addresses the general topic—TDR guidance impact on allowance—but with incorrect numbers and flawed reasoning. The mention of Note 1 of the 10-K adds specificity but cannot compensate for factual errors. Overall, major quantitative and qualitative errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 441,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What is the total amount invested in Level 2 assets by UNP's pension plan, and which specific investment categories use bid evaluation with independent pricing sources as their valuation methodology?",
      "original_answer": "The total amount invested in Level 2 assets by UNP's pension plan is $1,111 million. These Level 2 assets are specifically composed of investments in Corporate Stock, Federal Government Securities, and Bonds and Debentures, all of which use bid evaluation processes with independent pricing sources as their valuation methodology.",
      "llm_answer": "The total amount invested in Level 2 assets by UNP's pension plan was $3,209 million, which includes $1,508 million in Federal government securities, $1,696 million in bonds and debentures, and $5 million in corporate stock. These investments are valued using bid evaluation with independent pricing sources as their valuation methodology.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its total amount invested in Level 2 assets: it reports $3,209 million, whereas the ground truth is $1,111 million. The individual asset breakdowns ($1,508M in Federal Government Securities, $1,696M in Bonds and Debentures, $5M in Corporate Stock) are also incorrect and do not sum to the correct total. The sum of the LLM's reported values (1,508 + 1,696 + 5 = 3,209) matches its total, indicating internal consistency but incorrect data. (2) Quantitative accuracy is very low because all dollar amounts are wrong, despite correct formatting. The correct total of $1,111 million is significantly different from $3,209 million. (3) Qualitatively, the model correctly identifies the relevant investment categories (Corporate Stock, Federal Government Securities, Bonds and Debentures) and correctly assigns the valuation methodology (bid evaluation with independent pricing sources), showing partial understanding of the required entities and their attributes. However, it fails in the multi-hop synthesis of pulling accurate values linked to UNP's pension plan Level 2 assets. (4) Contextual relevance is high because the answer addresses both parts of the question—total investment and valuation methodology—and structures the response appropriately, even though the data is incorrect. The reasoning framework is sound but based on inaccurate input data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 391,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the growth rate of DHR's research and medical products segment revenue between 2019 and 2021 compare to the company's total revenue growth over the same period, and what does this suggest about the segment's role in DHR's overall financial performance?",
      "original_answer": "DHR's research and medical products segment grew from $13,512 million in 2019 to $24,802 million in 2021, representing a 83.5% increase over two years. Meanwhile, DHR's total revenue increased from $17,911 million in 2019 to $29,453 million in 2021, a 64.4% increase. This indicates that the research and medical products segment outperformed the company's overall growth, suggesting it was a key driver of DHR's financial performance during this period.",
      "llm_answer": "Based on the financial data provided in the document, DHR's research and medical products segment revenue grew from $13,512 million in 2019 to $24,802 million in 2021, representing a compound annual growth rate of approximately 42% over the period. This growth significantly outpaced the company's total revenue growth, which increased from $17,911 million in 2019 to $29,453 million in 2021—a compound annual growth rate of approximately 27%. The research and medical products segment's revenue growth rate was substantially higher than the overall company growth rate, indicating that this segment was a primary driver of DHR's overall financial performance during the period, contributing disproportionately to revenue expansion relative to the company's total scale.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key financial figures: research and medical products segment revenue ($13,512M in 2019, $24,802M in 2021) and total revenue ($17,911M in 2019, $29,453M in 2021), matching the ground truth exactly. (2) The percentage increases are conceptually correct, though the LLM reports compound annual growth rates (CAGR) of ~42% and ~27%, while the ground truth uses total growth over two years (83.5% and 64.4%). These are mathematically consistent: (1.42)^2 ≈ 1.835 and (1.27)^2 ≈ 1.61, with minor rounding in the LLM's CAGR for total revenue (actual CAGR is ~28.2%, so ~27% is slightly underestimated). This minor calculation imprecision prevents a perfect 10 on quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM correctly compares segment growth to total revenue growth and draws the logical conclusion that the segment outperformed and was a key driver of financial performance. (4) The answer is semantically equivalent to the ground truth, with slightly more sophisticated framing (CAGR, 'disproportionate contribution'), and fully addresses both parts of the question. Thus, correctness is 9 due to the small CAGR inaccuracy, but qualitative and contextual scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 348,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did the adoption of the revised TDR accounting guidance on January 1, 2023, specifically affect JPMorgan's allowance for credit losses and the classification of trial modifications for credit card loans during the year ended December 31, 2023?",
      "original_answer": "The adoption of the revised TDR accounting guidance on January 1, 2023, resulted in a $587 million reduction in JPMorgan's allowance for credit losses. Additionally, the changes eliminated the TDR reasonably expected and concession assessment criteria, which affected the classification of credit card loan modifications. As a result, trial modifications were considered TDRs but not FDMs (formally distressed modifications), whereas in the prior year, credit card TDRs totaled $418 million. For the year ended December 31, 2023, credit card FDMs were $648 million, and there were $27 million of loans subject to trial modifications.",
      "llm_answer": "The adoption of the revised TDR accounting guidance on January 1 2023 eliminated the “reasonably expected” and “concession” assessment criteria, causing trial modifications and Chapter 7 loans to be classified as TDRs. Consequently, the allowance for loan losses reflected a $587 million reduction attributable to this change, and the allowance for credit losses associated with First Republic was included in the December 31 2023 total. This adjustment is detailed in Note 1 and the allowance‑for‑loan‑losses table on page 120.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $587 million reduction in the allowance for credit losses and the elimination of the 'reasonably expected' and 'concession' criteria, which aligns with the ground truth. However, it introduces inaccuracies by mentioning 'Chapter 7 loans' and 'First Republic,' which are not present in the original answer and are not supported by the question or ground truth. These additions suggest a failure in entity accuracy and introduce irrelevant information. (2) The quantitative accuracy is mostly correct: the $587 million reduction is accurate and matches the ground truth. However, the LLM omits key quantitative details from the original answer: the prior year's credit card TDRs of $418 million, the 2023 FDMs of $648 million, and the $27 million in trial modifications. These omissions reduce completeness and quantitative precision. (3) The reasoning partially captures the multi-hop logic—linking the revised guidance to changes in classification and allowance—but fails to correctly synthesize the impact on trial modifications versus FDMs. The original answer clarifies that trial modifications became TDRs but not FDMs, a nuanced distinction the LLM misses. Instead, it conflates classifications and introduces unsupported entities (First Republic, Chapter 7), indicating flawed reasoning. (4) Contextual relevance is high because the response addresses the core issue—adoption of revised TDR guidance and its impact on allowances and classifications—but the inclusion of extraneous details and omission of key metrics reduce its overall correctness. The score reflects partial accuracy with significant gaps in completeness and entity fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 463,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did 3M's adoption and subsequent introduction of a new accounting principle for determining net periodic pension and postretirement plan cost impact the presentation of its pension-related financial metrics across reporting periods?",
      "original_answer": "3M adopted a new accounting principle in the first quarter of 2021 that changed how it calculates the market-related value of fixed income securities in its pension and postretirement plans. Previously, the company used a calculated value approach that deferred asset gains or losses over three years, but it switched to a fair value approach that immediately reflects changes in asset values. This change was applied retrospectively, impacting the expected return on plan assets and the amortization of net unamortized actuarial gains or losses. As a result, the presentation of pension-related financial metrics such as net periodic benefit cost, non-operating other expense (income), net income, and earnings per share was altered. Additionally, this change affected consolidated other comprehensive income, retained earnings, and accumulated other comprehensive income (loss). The fair value approach aligns the expected return on plan assets more closely with the plans' funded status and liability-driven investment strategy, resulting in a more current reflection of asset value changes in financial reporting.",
      "llm_answer": "3M changed its method for determining net periodic pension and postretirement plan cost effective in the first quarter of 2021, switching from the calculated value approach to a fair‑value approach for the fixed‑income class of plan assets. This change eliminated the three‑year deferral of asset gains or losses, so the expected return on plan assets and the amortization of unamortized actuarial gains or losses are now based on current fair values. The adjustment was applied retrospectively to all periods presented, resulting in lower other expense (net) and lower pension/postretirement expense in the affected years, and it reduced retained earnings and accumulated other comprehensive income by $5 million as of January 1 2019.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key change in accounting principle—3M's switch from a calculated value approach to a fair value approach for fixed-income securities in its pension and postretirement plans, effective Q1 2021. It accurately notes the elimination of the three-year deferral of gains/losses, the impact on expected return on plan assets and amortization of actuarial gains/losses, and the retrospective application. The answer also correctly states that the change affected retained earnings and accumulated other comprehensive income. However, the $5 million reduction in retained earnings and AOCI as of January 1, 2019, is a specific quantitative claim not present in the ground truth, and there is no verification that this exact figure is accurate—this introduces a potential factual inaccuracy. The ground truth emphasizes broader impacts on financial metrics (net periodic benefit cost, non-operating other expense, net income, EPS, OCI), which are only partially reflected in the LLM answer (mentions lower expenses but omits EPS and net income explicitly). The reasoning is sound and the entity (3M), time period (Q1 2021), and accounting concepts are correct. The answer is contextually relevant and captures the essence of the change, but lacks full completeness in describing all impacted financial metrics and introduces an unverified dollar amount, slightly reducing quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 392,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did the adoption of the new TDR accounting guidance impact JPMorgan's allowance for credit losses in 2023, and what was the specific dollar amount of this impact?",
      "original_answer": "The adoption of the changes to the TDR accounting guidance on January 1, 2023, resulted in a reduction of $587 million in JPMorgan's allowance for credit losses. This reduction occurred because the new guidance eliminated the TDR 'reasonably expected' and 'concession' assessment criteria, which affected how trial modifications were classified. Previously, trial modifications were considered TDRs (Troubled Debt Restructurings), but under the new guidance, they are no longer classified as FDMs (Financial Difficulty Modifications), leading to a lower allowance requirement.",
      "llm_answer": "The adoption of the new TDR accounting guidance on January 1 2023 reduced JPMorgan’s allowance for loan losses by **$587 million** in 2023, as explicitly noted in the “Allowance for credit losses and related information” table on page 134 (the footnote (a) reference). This $587 million reduction is the specific dollar amount of the impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $587 million reduction in JPMorgan's allowance for credit losses due to the adoption of the new TDR accounting guidance on January 1, 2023, which matches the ground truth. The dollar amount and date are accurate. (2) The quantitative accuracy is perfect: $587 million is correctly reported, with acceptable formatting (bolded and spaced as $587 million). No calculations were required beyond reporting the figure, which is exact. (3) The reasoning is mostly sound and correctly attributes the impact to the new guidance. However, while the LLM cites a specific table and footnote as evidence, this level of sourcing detail was not in the original ground truth and cannot be verified as accurate from the provided knowledge graph. Additionally, the LLM refers to 'allowance for loan losses' instead of 'allowance for credit losses'—a minor terminology discrepancy, though the terms are often used interchangeably. The original answer provides more qualitative context about the removal of the 'reasonably expected' and 'concession' criteria and explains why trial modifications are no longer classified as FDMs, which the LLM omits. Thus, while the core multi-hop synthesis (linking new TDR guidance to the financial impact) is correct, some explanatory depth is missing. (4) The correctness score is 9 because all key facts (entity, year, dollar impact, direction of effect) are accurate. The answer is contextually relevant and fully addresses the two parts of the question (impact and amount), but loses one point for slightly less completeness in explaining the mechanism of the impact compared to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 457,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the combined impact on goodwill and operating profit specifically in the Africa/Eurasia region for Colgate-Palmolive in 2023, and how does this compare to the capital expenditures made in the same region during the year?",
      "original_answer": "In 2023, Colgate-Palmolive experienced a decrease in goodwill of $19 million due to foreign currency translation in the Africa/Eurasia region, bringing the ending goodwill balance to $88 million from $107 million. At the same time, the company reported an operating profit of $254 million for the region. Capital expenditures in Africa/Eurasia totaled $10 million in 2023. Therefore, the combined impact of the goodwill decrease and capital expenditures was $29 million, which is significantly lower than the region's operating profit of $254 million.",
      "llm_answer": "The combined impact on goodwill and operating profit in the Africa/Eurasia region for Colgate-Palmolive in 2023 was a reduction of $19 in operating profit (from $254 in 2022 to $254 in 2023) and no impairment charges were recorded for goodwill in this region during the year. Capital expenditures in Africa/Eurasia for 2023 totaled $10 million, which was significantly lower than the $30 million spent in 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states there was a reduction of $19 in operating profit, implying a change from $254 million in 2022 to $254 million in 2023, which contradicts the ground truth that operating profit was $254 million in 2023 with no indication of a year-over-year decrease. The ground truth specifies a $19 million decrease in goodwill (not operating profit) due to foreign currency translation, which the LLM completely misattributes. The LLM also falsely claims no goodwill impairment charges were recorded, but the issue was foreign currency translation, not impairment—this reflects a misunderstanding of the financial concept. (2) The capital expenditure figure of $10 million is correct, but the LLM adds unsupported information that $30 million was spent in 2022, which is not in the ground truth and introduces false comparative data. The combined impact of goodwill decrease and capex ($19M + $10M = $29M) is not mentioned, and the key comparison to operating profit ($254M) is omitted. (3) The multi-hop reasoning fails: the model does not synthesize the goodwill change, operating profit, and capex correctly. It conflates goodwill with operating profit and misses the required comparison between combined impact and operating profit. (4) Due to major factual errors in numbers, misattribution of financial impacts, and failure to perform the required synthesis, the correctness and accuracy scores are very low. Contextual relevance is moderate because the answer addresses the region and company and mentions relevant metrics, albeit incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 445,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the impact on 3M's goodwill reporting structure as a result of the 2021 business segment reporting changes, and how was this evaluated in terms of impairment risk?",
      "original_answer": "As a result of the 2021 business segment reporting changes, 3M applied the relative fair value method to determine the impact on goodwill for any reporting unit changes, and these changes were found to be immaterial. Despite these changes, the Company completed its annual goodwill impairment test in the fourth quarter of 2021 and determined that no impairment existed. This indicates that the restructuring did not negatively affect the fair value of reporting units to the extent that impairment would occur.",
      "llm_answer": "The 2021 business segment reporting changes resulted in a revised reporting unit structure for goodwill testing, but 3M applied the relative fair value method to assess goodwill impacts and determined no impairment existed. The company conducted its annual goodwill impairment test in Q4 2021 across all 22 reporting units (including the ten that comprised ~94% of goodwill) and found no indicators of impairment, maintaining the same reporting unit structure for impairment assessments despite the segment reporting changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that 3M applied the relative fair value method to assess goodwill impacts from the 2021 reporting changes and found no impairment. It also correctly notes the annual impairment test was conducted in Q4 2021 with no impairment indicators. (2) Quantitatively, the mention of '22 reporting units' and 'ten that comprised ~94% of goodwill' is consistent with known 3M disclosures from its 2021 10-K, and no incorrect numbers or dates are present. The year 2021 and Q4 timing match the ground truth. (3) The reasoning is sound: the model correctly synthesizes the impact of segment changes on goodwill allocation and links it to the impairment test outcome. While the original answer emphasizes the immateriality of the changes, the LLM answer omits this specific term but still concludes no impairment—effectively capturing the practical outcome. (4) The answer is fully relevant, directly addressing both parts of the question: the impact on goodwill reporting structure and the evaluation of impairment risk. The only minor shortcoming is the absence of the explicit 'immaterial' characterization, which slightly reduces qualitative completeness, but the semantic meaning and factual correctness remain intact. Hence, a score of 9 is appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 376,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What was the strategic rationale behind AMD's investment in Silo AI, and how does it connect to AMD's goals for AI model deployment and software development?",
      "original_answer": "AMD's investment in Silo AI was strategically aimed at leveraging Silo AI's workforce to accelerate the deployment and development of AI models and software solutions on AMD hardware. This partnership aligns with AMD's broader objective to strengthen its capabilities in the AI space, particularly within its Data Center segment, by integrating Silo AI's expertise in AI research and development.",
      "llm_answer": "AMD acquired Silo AI to accelerate the deployment and development of AI models and software solutions on AMD hardware, integrating Silo AI's expertise into its Data Center segment. This investment aligns with AMD's strategic goal of expanding its AI software ecosystem and enhancing the value of its AI accelerators by enabling more efficient model deployment and development on its platforms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately captures the strategic rationale behind AMD's investment in Silo AI: accelerating AI model deployment and software development on AMD hardware by leveraging Silo AI's expertise. The connection to AMD's goals—specifically strengthening AI capabilities in its Data Center segment and enhancing its AI software ecosystem—is correctly conveyed. The only minor discrepancy is the use of 'acquired' versus 'invested in,' which may imply full ownership rather than a strategic investment; however, in industry context, 'acquisition' is often used loosely to describe significant investments or integrations, and the core intent (integration of expertise) remains accurate. There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable but assumed perfect. The reasoning is sound, multi-hop synthesis is appropriate (linking investment rationale to AMD's broader AI and data center goals), and all entities (AMD, Silo AI, Data Center segment, AI model deployment) are correctly identified. The answer fully addresses both parts of the question: the rationale and the connection to AMD's strategic goals.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 351,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How many amendments were made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015?",
      "original_answer": "6 amendments were made to the agreement during the specified period.",
      "llm_answer": "Based on the provided document pages, there were **three amendments** made to the Amended and Restated Agreement For Research & Development Alliance on Triex Module Technology between September 2, 2014, and September 1, 2015. These amendments are explicitly listed as the **Fifth Amendment (effective June 30, 2015)**, **Sixth Amendment (effective September 1, 2015)**, and the **Fourth Amendment (effective March 30, 2015)**, all referenced in Exhibit 10.51 (Sixth Amendment) and Exhibit 10.5 (Fifth Amendment) on page 109. The timeframe includes amendments effective up to and including September 1, 2015, confirming three total amendments within the specified period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states there were three amendments during the specified period, which directly contradicts the ground truth of six amendments. This is a major factual error in both quantity and completeness. (2) The LLM correctly identifies the Fourth, Fifth, and Sixth Amendments with their effective dates (March 30, 2015; June 30, 2015; September 1, 2015), but fails to account for three additional amendments that occurred between September 2, 2014, and September 1, 2015. The identification of these three is factually accurate in isolation, but incomplete. The time range includes all amendments effective up to September 1, 2015, so the Sixth Amendment (effective Sept 1) should be included — which the LLM does — but this still leaves three missing amendments unaccounted for. (3) The reasoning is internally consistent but based on incomplete document analysis. The model references Exhibits 10.5 and 10.51 and synthesizes information from page 109, suggesting some multi-hop capability, but fails to identify or acknowledge the full set of amendments, indicating a failure in comprehensive synthesis across all relevant filings. (4) The correctness and quantitative accuracy scores are low due to the significant discrepancy (3 vs 6). The qualitative accuracy is slightly higher because the model attempts proper reasoning and cites specific exhibits and dates. Contextual relevance is high as the response directly addresses the question and uses appropriate sources, despite factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 418,
        "total_tokens": 1611
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did the timing of PM's acquisition of Swedish Match impact its operational reporting scope in the 2023 10-K, and what does the separate shipment volume commentary suggest about the integration timeline?",
      "original_answer": "PMI acquired a majority position in Swedish Match on November 11, 2022, which resulted in Swedish Match's results being included in PM's financials only from that date through December 31, 2022. This limited inclusion period affected the operational reporting scope in the 2023 10-K, as Swedish Match's business operations were managed and evaluated separately from PM's geographical segments. Additionally, the separate shipment volume commentary for Swedish Match indicates that integration efforts had not yet reached a stage where its operations were fully consolidated with PM’s existing business units, suggesting a phased or ongoing integration process.",
      "llm_answer": "The 2023 10-K shows that PMI began consolidating Swedish Match’s results starting November 11 2022, so the Swedish Match operating segment’s 2023 figures reflect a full‑year inclusion of the acquired business, whereas 2022 results only covered the post‑acquisition period. The separate shipment‑volume commentary notes that Swedish Match’s oral‑product volume grew ≈ 17 % year‑over‑year, indicating that the integration was still unfolding but the business was already delivering measurable volume gains.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Swedish Match’s 2023 figures reflect a 'full-year inclusion' in PM's reporting, which contradicts the ground truth: Swedish Match was acquired on November 11, 2022, so only ~7 weeks of its results were included in the 2022 financials, and full-year 2023 inclusion is accurate—but the key point is that the 2023 10-K still reports Swedish Match separately, not integrated into geographic segments. The LLM misrepresents the operational reporting scope by implying full integration into PM’s segments, when the ground truth states it was managed and evaluated separately. (2) The ≈17% oral-product volume growth is not present in the ground truth and cannot be verified; this number is likely fabricated or misattributed, hurting quantitative accuracy. Dates (November 11, 2022) are correct, but the implication that 2023 includes a full year of Swedish Match in consolidated segment reporting is misleading—while financially consolidated, operationally it remained separate. (3) The multi-hop reasoning fails: the question asks how the *timing* of acquisition impacted *operational reporting scope* and what *separate commentary* suggests about integration. The LLM misses that separate shipment commentary implies lack of integration, instead interpreting it as evidence of 'unfolding integration' with volume gains—this inverts the correct inference that separation indicates integration is not yet complete. (4) Contextual relevance is fair because the answer discusses consolidation timing and shipment volumes, but correctness and qualitative reasoning are low due to misinterpretation of integration status and unsupported metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 472,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What was the total notional amount of interest rate swaps entered into by 3M in 2021, and how does this compare to the combined principal amount of the fixed-rate notes due in 2049 and 2050 that these swaps were designed to hedge?",
      "original_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million. These swaps were applied to a combined principal amount of $1.65 billion of fixed-rate notes due in 2049 and 2050, meaning the swaps covered approximately 48.5% of the total principal for those notes.",
      "llm_answer": "The total notional amount of interest rate swaps entered into by 3M in 2021 was $800 million, and these swaps were designed to hedge the fixed‑rate notes due in 2049 and 2050, whose combined principal amount is $1.0 billion (for 2049) and $650 million (for 2050), together totaling $1.65 billion. Thus, the $800 million of swaps hedge a portion of the $1.65 billion of fixed‑rate debt maturing in those years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $800 million notional amount of interest rate swaps in 2021, the $1.0 billion principal for 2049 notes, $650 million for 2050 notes, and their sum of $1.65 billion. These match the ground truth exactly. (2) Quantitative accuracy is perfect: the individual amounts and total are correct, and while the LLM does not explicitly calculate the 48.5% coverage ratio, it accurately states that the $800 million hedges 'a portion' of the $1.65 billion, which is semantically consistent. The omission of the exact percentage is a minor gap but does not reduce factual correctness. (3) Multi-hop reasoning is sound—the model correctly links 3M's 2021 swaps to the specific fixed-rate notes due in 2049 and 2050, and synthesizes data across these years and instruments appropriately. (4) Contextual relevance is excellent, addressing both parts of the question: the total notional amount and its comparison to the hedged debt. The answer could have been slightly stronger by explicitly stating the percentage coverage (48.5%) as in the original answer, but the information conveyed is factually equivalent and accurate. Thus, a high score is warranted with only a minor deduction in qualitative accuracy for the missing explicit comparison metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 365,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What was the total consideration transferred by AbbVie for both the acquisition of Allergan and Soliton, Inc., and how much of this combined amount was attributed to cash payments?",
      "original_answer": "The total consideration transferred by AbbVie for the acquisitions of Allergan and Soliton, Inc. was $64,619 million, of which $40,210 million was attributed to cash payments.",
      "llm_answer": "The total consideration transferred by AbbVie for both the Allergan acquisition ($64,084 million) and the Soliton, Inc. acquisition ($535 million) combined is $64,619 million. Of this combined amount, $39,675 million of cash was paid for Allergan, and the Soliton transaction involved $535 million of cash consideration, resulting in a total cash payment of $40,210 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the total consideration of $64,619 million is correctly calculated as the sum of $64,084 million (Allergan) and $535 million (Soliton, Inc.), and the total cash payments are correctly stated as $40,210 million. (2) Quantitative accuracy is perfect: the individual cash components ($39,675 million for Allergan and $535 million for Soliton) sum to $40,210 million, matching the ground truth. Minor formatting differences (e.g., thin space in $64,084 million) do not affect correctness. (3) Multi-hop reasoning is sound: the model correctly identifies both acquisitions, retrieves the correct total consideration and cash components for each, and synthesizes them into a coherent, accurate summary. (4) The answer is semantically equivalent to the original, with added clarity by breaking down the components. All entities (AbbVie, Allergan, Soliton, Inc.) and financial metrics are correctly identified and used. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 296,
        "total_tokens": 1442
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does Bank of America's adherence to Basel 3 capital requirements influence its ability to execute its $25 billion stock repurchase program authorized in 2024?",
      "original_answer": "Bank of America's adherence to Basel 3 capital requirements directly influences its ability to execute its $25 billion stock repurchase program because the program is subject to the Corporation's capital position and regulatory requirements. As of December 31, 2024, the Corporation's Common Equity Tier 1 (CET1) capital ratio under the Standardized approach was 11.9 percent, exceeding the minimum requirement of 10.7 percent, which includes a capital conservation buffer and G-SIB surcharge. This capital adequacy allows the Corporation to proceed with repurchasing $13.1 billion of common stock in 2024, as it remains above the thresholds that would trigger restrictions on capital distributions.",
      "llm_answer": "Bank of America's adherence to Basel 3 capital requirements ensures it maintains sufficient CET1, Tier 1 and total capital buffers—including the 3.2 % stress‑capital buffer and the G‑SIB surcharge—so that its capital ratios exceed the regulatory minima and buffers needed to avoid restrictions on capital distributions. This capital adequacy provides the regulatory confidence and quantitative capacity required to safely execute its $25 billion 2024 common‑stock repurchase program, subject to ongoing capital‑plan approvals and liquidity considerations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. The ground truth states that Bank of America repurchased $13.1 billion of common stock in 2024, not the full $25 billion authorized, due to capital constraints and regulatory thresholds. However, the LLM implies the full $25 billion program can proceed, which is incorrect. Additionally, the LLM mentions a '3.2% stress-capital buffer'—a specific figure not present in the original answer and not directly tied to the Basel 3 framework as described in the ground truth. The original answer cites a CET1 ratio of 11.9% under the Standardized approach as of December 31, 2024, exceeding the 10.7% requirement (including buffers), but the LLM does not include these exact figures, weakening quantitative accuracy. (2) The original answer includes precise numbers: $13.1 billion executed (not $25B), 11.9% CET1 ratio, and 10.7% minimum requirement. The LLM omits all three key metrics and introduces an unverified 3.2% buffer, which may conflate CCAR stress capital buffers with Basel 3 requirements but is not explicitly supported here. (3) The reasoning is partially sound: the LLM correctly links Basel 3 compliance to capital distribution capacity and acknowledges regulatory constraints on repurchases. It captures the multi-hop logic that regulatory capital levels affect repurchase authority. However, it fails to synthesize the actual execution amount ($13.1B) versus authorization ($25B), missing a critical nuance in the original answer. (4) Contextual relevance is high—the response addresses the relationship between capital rules and stock buybacks appropriately. Qualitative accuracy is moderate because the conceptual framework is correct, but quantitative accuracy is low due to missing or incorrect figures. Correctness score is 6 due to correct overall direction but significant factual omissions and one potentially fabricated percentage.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 523,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the total carrying value in millions of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 as reported in the MMM 2022 10-K filing?",
      "original_answer": "The total carrying value of the Medium-term note ($650 million) with maturity dates in 2023 and 2048 is $1,287 million.",
      "llm_answer": "Based on the provided pages, the specific carrying value for the Medium-term note with a $650 million principal amount and maturity in 2048 is listed in the long‑term debt table on page 87. It shows a **carrying value of $638 million** (and a 2020 carrying value of $637 million). This is the amount reported for that particular note.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is incorrect in both quantitative and qualitative aspects. The question asks for the total carrying value of Medium-term notes with maturity dates in 2023 and 2048, implying two separate notes or tranches. However, the LLM only identifies the carrying value of the 2048 note ($638 million) and completely omits the 2023 note. The ground truth states the total carrying value is $1,287 million, which suggests the sum of both notes (e.g., $638M + $649M ≈ $1,287M). The LLM fails to identify or sum both components. (2) The provided number ($638 million) may be accurate for the 2048 note alone, but it does not match the total required by the question. The calculation of total carrying value is missing, making the quantitative response incomplete and factually incorrect in context. (3) The reasoning is flawed as it does not perform the necessary multi-hop synthesis: identifying both notes (2023 and 2048), retrieving their respective carrying values, and summing them. The model treats the question as if it refers to a single note, despite the plural 'maturity dates' and known structure of such disclosures. (4) Scores are justified as follows: Correctness is low (3/10) due to major factual incompleteness and incorrect final answer; Quantitative accuracy is poor because the total is wrong despite a possibly correct component value; Qualitative accuracy is partially acceptable as the model locates relevant data but fails synthesis; Contextual relevance is moderate since it addresses the general topic and company but misses key elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1117,
        "completion_tokens": 433,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "What is the difference in interest rates between IBM's 2.900% Notes due 2030 and the highest-yielding debt instrument listed in IBM's 2024 10-K filing?",
      "original_answer": "The highest-yielding debt instrument listed in IBM's 2024 10-K filing is the 7.125% Debentures due 2096. The difference in interest rates between these instruments and the 2.900% Notes due 2030 is 4.225 percentage points.",
      "llm_answer": "The 2.900% Notes due 2030 are listed in IBM’s 2024 10‑K with an interest rate of 2.900%. The highest‑yielding debt instrument disclosed in the filing is the 7.125% Debentures due 2096, which carries a 7.125% coupon. Therefore, the spread between the two rates is 7.125% − 2.900% = 4.225 percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the 2.900% Notes due 2030 and the 7.125% Debentures due 2096 are correctly identified, with accurate interest rates and maturities. (2) The calculation of the difference (7.125% − 2.900% = 4.225 percentage points) is numerically correct and properly expressed. (3) The multi-hop reasoning—identifying the highest-yielding debt instrument from IBM's 2024 10-K and comparing it to the specified note—is sound and complete. (4) The answer is contextually relevant, directly addressing the question with precise financial data and clear logic. Minor wording differences (e.g., 'spread' vs 'difference') do not affect semantic equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 236,
        "total_tokens": 1369
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "What was the total financial value of AbbVie's acquisition of Allergan, and how much in right-of-use assets did AbbVie acquire as part of the lease obligations assumed during the acquisition?",
      "original_answer": "The total financial value of AbbVie's acquisition of Allergan was $64,084 million, which included $453 million in right-of-use assets acquired in the transaction as of December 31, 2020.",
      "llm_answer": "The acquisition of Allergan had a total financial value of $64,084 million, and AbbVie acquired $1,537 million in right‑of‑use assets as part of the lease obligations assumed.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the total financial value of AbbVie's acquisition of Allergan as $64,084 million, which matches the ground truth. However, it incorrectly states that AbbVie acquired $1,537 million in right-of-use assets, whereas the ground truth specifies $453 million as of December 31, 2020. This is a significant quantitative error. (2) The first number ($64,084 million) is accurate and correctly formatted. The second number ($1,537 million vs $453 million) is factually incorrect—this is not a formatting issue but a clear discrepancy in value. No calculation is required in the question, but the model fails to report the correct figure from the source data. (3) The reasoning is partially sound in that the model recognizes the need to report both the total acquisition value and the right-of-use assets from lease obligations, indicating awareness of the multi-hop structure (acquisition value + specific asset class from lease obligations). However, it fails in synthesizing the correct value for right-of-use assets, suggesting either a retrieval error or confusion with another figure from Allergan’s financials. (4) The correctness score is 4 due to one correct major figure but a critical error in the second, which undermines the answer’s reliability. Quantitative accuracy is low (4) because of the large deviation in the right-of-use asset amount. Qualitative accuracy is moderate (5) as the model understands the entities and structure but retrieves an incorrect data point. Contextual relevance is high (9) because the answer addresses both parts of the question and uses appropriate financial terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 453,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How many shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan according to the 2024 10-K filing, and why are no future awards or deferrals possible under this plan?",
      "original_answer": "According to the 2024 10-K filing, 391 shares of common stock were issuable upon distribution related to the Norwest Corporation Directors' Formula Stock Award Plan. No future awards or deferrals are possible under this plan because it has been closed to new deferrals and awards, as explicitly stated in the filing.",
      "llm_answer": "According to the 2024 10-K filing, the Norwest Corporation Directors' Formula Stock Award Plan allowed issuance of shares upon distribution, with the specific number of shares issuable related to that plan being 391 shares. No future stock awards or deferrals may be made under this plan because it has been fully administered and no further awards or deferrals are permitted under its terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of shares issuable upon distribution as 391, which matches the ground truth exactly. This satisfies the quantitative requirement with full accuracy. (2) The explanation for why no future awards or deferrals are possible states that the plan has been 'fully administered' and no further activity is permitted. While the ground truth specifies the plan is 'closed to new deferrals and awards,' the LLM's phrasing ('fully administered' and 'no further awards or deferrals are permitted') conveys a semantically equivalent and reasonable interpretation, though slightly less precise in legal/administrative terminology. (3) The multi-hop reasoning is sound—information about the number of shares and the status of the plan is correctly synthesized from the 2024 10-K filing context. (4) The answer is fully contextually relevant, addressing both sub-questions directly. The only minor deviation is in the wording of the reason for closure, which does not contradict but slightly rephrases the original without loss of meaning. Thus, the answer is factually correct and complete, warranting a high score with only a small deduction in qualitative accuracy for wording imprecision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 346,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did the amortization of intangible assets associated with the Allergan acquisition impact AbbVie's gross margin in 2021, and what was the total amortization expense for definite-lived intangible assets in that same year?",
      "original_answer": "The amortization of intangible assets associated with the Allergan acquisition negatively impacted AbbVie's gross margin in 2021, as noted in the 10-K filing. Although lower amortization of inventory fair value step-up adjustments and favorable product mix contributed to an increase in gross margin, the expense from amortizing intangible assets related to the Allergan acquisition partially offset these gains. In 2021, the total amortization expense for definite-lived intangible assets was $7.7 billion.",
      "llm_answer": "The amortization of intangible assets related to the Allergan acquisition reduced AbbVie’s gross margin in 2021, as noted in the “Gross margin” discussion that attributes the margin increase to “lower amortization of inventory fair value step‑up adjustment … partially offset by higher amortization of intangible assets associated with the Allergan acquisition.” The total amortization expense for definite‑lived intangible assets in 2021 was $7.7 billion, as disclosed in Note 7 (page 100) which states “Amortization expense was $7.7 billion in 2021.”",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the total amortization expense for definite-lived intangible assets in 2021 is correctly stated as $7.7 billion, with an accurate reference to Note 7 on page 100 of the 10-K filing. This matches the ground truth exactly. (2) The answer addresses both parts of the multi-part question: it explains how the amortization of intangible assets from the Allergan acquisition negatively impacted gross margin in 2021, and it provides the total amortization expense for that year. (3) Entity accuracy is correct—AbbVie, Allergan acquisition, 2021 fiscal year, gross margin, and definite-lived intangible assets are all properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly interprets that while other factors improved gross margin, the Allergan-related amortization partially offset those gains, which requires connecting two pieces of information from the filing. The answer also cites specific textual evidence from the 10-K, enhancing its credibility. (5) Semantic equivalence is achieved—the wording differs slightly from the original answer but conveys the same factual content with no omissions or distortions. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 360,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the specific purpose of the Restoration Plans as it relates to the Benefit Plans, and how does The Home Depot fund these Restoration Plans according to the 2023 10-K filing?",
      "original_answer": "The Restoration Plans are designed to provide certain associates with deferred compensation that they would have received as a matching contribution under the Benefit Plans if not for the maximum compensation limits set by the Internal Revenue Code. The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "llm_answer": "The Restoration Plans are defined as the Home Depot FutureBuilder Restoration Plan and the HD Supply Restoration Plan, which are deferred compensation arrangements that provide certain associates with a matching contribution that they would have received under the Benefit Plans if not for the maximum compensation limits under the Internal Revenue Code. According to the 2023 10-K filing, The Home Depot funds these Restoration Plans through contributions made to grantor trusts, which are then used to purchase shares of the company's common stock in the open market.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately describes the purpose of the Restoration Plans as providing deferred compensation in the form of matching contributions that certain associates would have received under the Benefit Plans but for the Internal Revenue Code's compensation limits. (2) It correctly states that The Home Depot funds these plans through contributions to grantor trusts, which are then used to purchase the company's common stock in the open market. (3) The answer includes specific plan names (Home Depot FutureBuilder Restoration Plan and HD Supply Restoration Plan), which are consistent with the type of detail found in the 10-K and add precision without introducing error. (4) There are no numerical values in the question or answer, so quantitative accuracy pertains to the correct use of financial concepts and structures, which are accurately represented. (5) The multi-hop reasoning is sound: the answer connects the Restoration Plans to the Benefit Plans, references tax code limitations, and explains the funding mechanism via grantor trusts and stock purchases. (6) The semantic meaning is equivalent to the original answer, with slightly more detail that enhances rather than distorts accuracy. All components of the question are addressed completely and correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 374,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What is the percentage change in the value of Variable Rate Notes from December 31, 2023, to December 31, 2024, and how does this reflect in the overall change in total borrowings over the same period?",
      "original_answer": "The value of Variable Rate Notes remained unchanged at $22 million from December 31, 2023, to December 31, 2024. However, total borrowings increased from $20,443 million to $31,099 million, representing a $10,656 million increase. Therefore, the percentage change in Variable Rate Notes is 0%, while the overall percentage increase in total borrowings is approximately 52.1%.",
      "llm_answer": "The Variable Rate Notes total $22 million at both December 31 2023 and December 31 2024, so there is no percentage change in their value over that period. Consequently, the overall change in total borrowings—from $20.4 billion in 2023 to $31.1 billion in 2024—is driven entirely by increases in other debt components (fixed‑rate notes, commercial paper, term loan, etc.), not by the Variable Rate Notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all numbers are correct: Variable Rate Notes are correctly stated as $22 million for both dates (implying 0% change), and total borrowings are accurately represented as increasing from $20.4 billion to $31.1 billion, which aligns with the ground truth values of $20,443 million and $31,099 million when rounded. The percentage increase in total borrowings (~52.1%) is not explicitly calculated in the LLM answer, but the use of rounded figures ($20.4B to $31.1B) implies an increase of about $10.7B, which is close to the actual $10,656 million increase. (2) The LLM correctly infers that the change in total borrowings is driven by other debt components since Variable Rate Notes did not change—this reflects sound reasoning and proper synthesis across multiple debt instruments. (3) The multi-hop reasoning is solid: it connects the stability of Variable Rate Notes with the overall increase in total borrowings, correctly attributing the change to other sources. (4) The only minor shortcoming is the lack of explicit percentage change statements (0% for Variable Rate Notes and ~52.1% for total borrowings), which were present in the original answer. However, the meaning is semantically equivalent, especially given the clear implication of no change in Variable Rate Notes and the correct directional and quantitative context for total borrowings. Thus, the answer is factually correct, well-reasoned, and fully relevant, warranting a high score with only a slight deduction for incompleteness in explicit percentage reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 448,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, according to the provided financial data?",
      "original_answer": "The total carrying amount of HD's 4.95% Senior Notes due in September 2026 and September 2052 as of January 28, 2024, is $1,726 million.",
      "llm_answer": "Based on the provided financial data, the carrying amount of HD's 4.95% Senior Notes due in September 2026 is $744 million and the carrying amount of the 4.95% Senior Notes due in September 2052 is $980 million as of January 28, 2024. These figures are explicitly listed in the Long-Term Debt table on page 59 of the document.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the carrying amounts of HD's 4.95% Senior Notes due in September 2026 ($744 million) and September 2052 ($980 million), both of which match the ground truth data. The total sum (744 + 980 = 1,724 million) is within $2 million of the stated ground truth total of $1,726 million, which may reflect rounding differences in reporting and is acceptable under the evaluation criteria allowing format and minor rounding variations. (2) All numeric values are accurate and correctly attributed to the right debt instruments and time period (as of January 28, 2024). The individual components are explicitly correct, and the implied total is effectively accurate. (3) The reasoning is sound and demonstrates multi-hop synthesis by identifying two separate notes with the same coupon rate but different maturities and aggregating their carrying amounts. The reference to the Long-Term Debt table on page 59 adds contextual support, indicating proper sourcing. (4) The answer is factually correct, complete, and semantically equivalent to the ground truth, with no omissions or errors. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 328,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What percentage decrease did PM experience in its net derivative asset position from 2022 to 2023, and how does this align with the changes in its total gross amount of derivative contracts?",
      "original_answer": "PM experienced a 45.7% decrease in its net derivative asset position from $186 million in 2022 to $101 million in 2023. This aligns with a reduction in the total gross amount of derivative contracts from $873 million in 2022 to $584 million in 2023, indicating a strategic reduction in overall derivative exposure.",
      "llm_answer": "Based on the provided document pages, PM experienced a **64% decrease** in its net derivative asset position from 2022 to 2023 (from $186 million to $101 million). This aligns with the gross derivative notional amount increase of **7%**, rising from $40,401 million in 2022 to $43,265 million in 2023, as reported on page 128. The net derivative asset decline occurred despite the growth in gross derivative contracts, reflecting the impact of fair value adjustments and hedging activities detailed in the financial statements.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. The percentage decrease in PM's net derivative asset position is incorrectly calculated as 64%, while the correct value is 45.7% (from $186M to $101M: (186-101)/186 ≈ 0.457 or 45.7%). This is a significant quantitative error. Additionally, the LLM claims a 7% increase in gross derivative notional amount from $40,401M to $43,265M, which contradicts the ground truth stating a reduction from $873M to $584M. These numbers do not match any data in the ground truth and appear fabricated or misread. (2) The dollar amounts for net derivative assets ($186M and $101M) are correct, but the gross derivative figures are entirely wrong—off by an order of magnitude—and the direction of change (increase vs. decrease) is opposite to the truth. The calculation of the percentage decrease is also mathematically incorrect: (186-101)/186 = 85/186 ≈ 45.7%, not 64%. (3) The multi-hop reasoning fails because the LLM draws conclusions about alignment between net and gross derivative positions using incorrect data. The ground truth shows both net and gross positions decreased, indicating reduced exposure, while the LLM incorrectly states gross contracts increased, leading to flawed reasoning about fair value adjustments despite net decline. (4) Due to severe inaccuracies in numbers, calculations, and directional trends, the correctness and quantitative accuracy scores are very low. Qualitative accuracy is also poor due to incorrect synthesis and logic. Contextual relevance is slightly higher because the answer attempts to address the right entities (PM, derivative positions) and structure, but with wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 456,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, and how does this compare to the number of shares of Common Stock to be issued for options and RSUs under these plans?",
      "original_answer": "The total number of shares available for future issuance under both the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non-Employee Directors as of December 31, 2024, is 27.9 million (27.1 million from the 2016 Stock Incentive Plan and 0.8 million from the 2016 Stock Plan for Non-Employee Directors). This is in addition to 10,221,113 shares of Common Stock to be issued for options and 2,005,555 RSUs subject to continued employment under the 2016 Stock Incentive Plan, as well as 129,854 shares of Common Stock to be issued for options under the 2016 Stock Plan for Non-Employee Directors.",
      "llm_answer": "As of December 31 2024, the 2016 Stock Incentive Plan and the 2016 Stock Plan for Non‑Employee Directors together have **29,345,020 shares of Common Stock available for future issuance**. This figure includes the shares that may be issued upon exercise of options and vesting of RSUs under those plans. The number of shares that will actually be issued when those options and RSUs are exercised or vest is lower—approximately **12,926,938 shares** are currently outstanding (options, warrants, and rights), and the remaining **29,345,020 shares** represent the total pool that could be issued in the future.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total number of shares available for future issuance is stated as 29,345,020, which does not match the ground truth of 27.9 million (27.1 million + 0.8 million). This is a major quantitative error. Additionally, the LLM incorrectly states that the 29.3 million figure 'includes' shares for options and RSUs, which contradicts the correct understanding that 'available for future issuance' is separate from already outstanding awards. (2) The ground truth specifies 10,221,113 shares for options and 2,005,555 RSUs under the 2016 Stock Incentive Plan, plus 129,854 shares for options under the Non-Employee Directors plan, totaling 12,356,522 shares to be issued. The LLM rounds this to approximately 12,926,938, which is incorrect and inconsistent with the source data. (3) The multi-hop reasoning is flawed: the model fails to correctly distinguish between 'shares available for future issuance' and 'shares already committed via outstanding options and RSUs'. It incorrectly conflates the two, suggesting the larger number includes the smaller, when in fact they are additive components. The model also does not correctly attribute the breakdown between the two plans. (4) The contextual relevance is moderate because the answer addresses the right plans and the general concept of share issuance, but the factual and quantitative errors severely undermine correctness. Due to major errors in numbers and financial logic, the correctness score is low at 2 out of 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 425,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What was the growth in Dynamics 365 revenue in fiscal year 2022, and how does this contribute to the overall Dynamics products and cloud services revenue growth of 25%?",
      "original_answer": "Dynamics 365 revenue grew by 39% in fiscal year 2022, which significantly contributed to the overall Dynamics products and cloud services revenue growth of 25%. This indicates that Dynamics 365 was a key driver behind the broader Dynamics suite's performance, suggesting strong adoption and demand for Microsoft's integrated business applications platform.",
      "llm_answer": "In fiscal year 2022, Dynamics 365 revenue grew 25% (the same 25% growth reported for the broader “Dynamics products and cloud services” category). This 25% increase in Dynamics 365 revenue contributed directly to the overall 25% growth in Dynamics products and cloud services revenue that Microsoft reported for the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Dynamics 365 revenue grew by 25%, while the ground truth specifies a 39% growth. This is a major factual error in a key quantitative figure. The LLM also incorrectly equates the 25% overall Dynamics products and cloud services growth with the specific growth of Dynamics 365, implying they are the same, which contradicts the ground truth that shows Dynamics 365 grew faster (39%) and was a driver of the broader 25% category growth. (2) The calculation and numerical accuracy are flawed: the 25% figure is misapplied to Dynamics 365 specifically, when it should be 39%. No correct calculation is performed, and the conflation of metrics undermines the quantitative integrity. (3) The multi-hop reasoning is unsound: the model fails to recognize that Dynamics 365 is a component of the broader 'Dynamics products and cloud services' segment and that its higher growth rate (39%) contributed to the lower overall growth (25%), likely due to slower growth in other parts of the segment. Instead, it assumes identity between the two metrics, breaking the logical synthesis required. (4) Contextual relevance is moderate—the answer addresses the right topic, company, and fiscal year, and attempts to explain contribution—but due to the core factual and reasoning errors, the conclusion is misleading. The qualitative accuracy is low because the entity relationships and causal contribution are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 403,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "By how much did Tesla's Energy Generation and Storage revenue increase specifically due to the deployment of Megapack in 2021 compared to 2020, and what role does Megapack play in Tesla's broader energy storage product portfolio?",
      "original_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million, or 40%, in 2021 compared to 2020, primarily driven by the deployment of Megapack along with growth in solar cash and loan jobs, Powerwall, and Solar Roof. Megapack is a key component of Tesla's energy storage product lineup, designed for commercial, industrial, utility, and energy generation customers, and can be grouped to form large-scale installations of gigawatt hours or greater capacity.",
      "llm_answer": "Tesla's Energy Generation and Storage revenue increased by $795 million (about 40 %) in 2021 versus 2020, driven primarily by higher deployments of Megapack, solar cash and loan projects, Powerwall and Solar Roof, while Powerpack deployments fell as the product was phased out. Megapack serves as the flagship utility‑scale battery offering that anchors Tesla’s broader energy‑storage portfolio, which also includes residential Powerwall units and other storage solutions for commercial, industrial and grid‑scale applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states the $795 million increase and 40% growth in Tesla's Energy Generation and Storage revenue from 2020 to 2021, matching the ground truth exactly. These figures are accurate and properly attributed to the deployment of Megapack along with other factors like solar projects, Powerwall, and Solar Roof. (2) Quantitatively, all numbers are correct—$795 million and 40%—and the time frame (2021 vs 2020) is accurate. The format variation (using 'million' and % symbol) is acceptable and semantically equivalent. (3) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly identifies Megapack as a primary driver of revenue growth and situates it within Tesla’s broader energy storage portfolio. It adds a relevant detail not in the ground truth—Powerpack being phased out—which is factually accurate and enhances the answer, though not required. (4) The answer is contextually fully relevant, addressing both the quantitative increase and Megapack’s strategic role. The only minor deviation from the original answer is the phrasing of Megapack as the 'flagship utility-scale battery offering' and 'anchors' the portfolio, which is a slightly stronger characterization than 'key component,' but still reasonable and not factually incorrect. Thus, the answer is highly accurate with only negligible wording differences, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 396,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What was the total pre-tax loss recognized by Walmart in fiscal 2021 and 2022 related to the divestiture of Asda, including both the initial loss estimate and the additional adjustments upon closing, and how does this reflect the financial impact of pension-related obligations tied to the disposal group?",
      "original_answer": "Walmart recognized a total pre-tax loss of $5.7 billion related to the divestiture of Asda. This includes the $5.5 billion estimated pre-tax loss recognized in the fourth quarter of fiscal 2021, which incorporated $2.3 billion of accumulated pension components, and an additional $0.2 billion loss recorded in the first quarter of fiscal 2022 upon closing, primarily due to changes in net assets, currency exchange rate fluctuations, and purchase price adjustments. The pension-related obligations significantly contributed to the overall loss, illustrating the financial impact of legacy liabilities in international divestitures.",
      "llm_answer": "Walmart recognized a total pre‑tax loss of $5.5 billion in fiscal 2021 when Asda was classified as held‑for‑sale (including $2.3 billion of pension‑related derecognition), and an additional $0.2 billion loss in fiscal 2022 related to post‑closing adjustments and currency impacts. These losses reflect the financial impact of pension obligations tied to the disposal group, as the $2.3 billion pension component was derecognized and contributed to the overall loss on the Asda divestiture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $5.5 billion pre-tax loss in fiscal 2021 (including $2.3 billion pension-related component) and an additional $0.2 billion loss in fiscal 2022, totaling $5.7 billion. These match the ground truth exactly. The mention of pension derecognition aligns with the original answer's emphasis on accumulated pension components. (2) Quantitatively, all numbers are accurate: $5.5B + $0.2B = $5.7B total loss, and the $2.3B pension component is correctly attributed. No calculation errors. Format variations (e.g., 'billion' vs 'B') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—LLM connects the initial loss recognition, pension impact, and post-closing adjustments across fiscal 2021 and 2022. It correctly attributes the fiscal 2022 adjustment to post-closing and currency factors, as in the ground truth. However, it omits explicit mention that the $5.5B was recognized in the 'fourth quarter' and the $0.2B in the 'first quarter,' slightly reducing precision in timing. Also, the term 'classified as held-for-sale' is contextually correct but not mentioned in the original answer, introducing a minor interpretive addition. (4) Despite minor wording differences and slight omission of quarterly timing, the LLM conveys the same core facts, synthesis, and financial implications. The answer is contextually fully relevant, directly addressing both the total loss and the role of pension obligations. A score of 9 is justified due to high accuracy with only negligible omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 435,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 was represented by the combined revenue from Surface devices and Windows OEM licensing, given that the segment reported $56.5 billion in revenue and Windows OEM contributed 42% of that segment's revenue?",
      "original_answer": "The combined revenue from Surface devices and Windows OEM licensing represented 58% of the More Personal Computing segment's $56.5 billion in fiscal year 2022. Windows OEM contributed 42% ($23.73 billion) and Devices (primarily Surface) contributed 16% ($9.04 billion), totaling $32.77 billion or 58% of the segment's total revenue.",
      "llm_answer": "Based on the provided document pages, the question asks for the percentage of Microsoft's More Personal Computing segment revenue in fiscal year 2022 that was represented by the combined revenue from Surface devices and Windows OEM licensing. The document states that the More Personal Computing segment reported $56.5 billion in revenue, and Windows OEM contributed 42% of that segment's revenue. However, the document does not provide specific revenue figures for Surface devices or the combined revenue from Surface devices and Windows OEM licensing. It only mentions that Windows OEM contributed 42% of the segment's revenue, and Surface devices are part of the \"Devices\" category within the More Personal Computing segment. Since the exact revenue from Surface devices is not provided, and the question asks for the combined percentage of Surface devices and Windows OEM licensing, the available information only allows us to state that Windows OEM licensing alone represented 42% of the segment's revenue. Without specific data on Surface device revenue, the combined percentage cannot be determined from the given information. The document does not provide the necessary details to calculate the combined percentage of Surface devices and Windows OEM licensing revenue as a portion of the $56.5 billion segment revenue.\n\nAnswer: The provided information only states that Windows OEM licensing contributed 42% of the More Personal Computing segment's $56.5 billion revenue in fiscal year 2022, but it does not provide specific revenue figures for Surface devices or the combined revenue from Surface devices and Windows OEM licensing. Therefore, the exact combined percentage cannot be determined from the given document pages.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect and fails to match the ground truth. The original answer states that Windows OEM contributed 42% and Devices (primarily Surface) contributed 16%, totaling 58% of the segment's revenue. However, the LLM claims that the data for Surface revenue is not provided and concludes the combined percentage cannot be determined — this is false, as the ground truth explicitly includes these figures. (2) Quantitatively, the LLM fails to report any correct numbers beyond the 42% from Windows OEM. It omits the 16% from Devices (Surface) and the resulting 58% combined total, which are critical to the correct answer. Calculations like 42% + 16% = 58% are straightforward and supported by the ground truth. (3) The multi-hop reasoning is flawed: the LLM incorrectly assumes missing data when the necessary information (implied or explicit) should have been synthesized. The ground truth treats Surface as part of Devices contributing 16%, which is a known and standard breakdown in Microsoft’s reporting. The model fails to make this connection, indicating poor reasoning. (4) Contextual relevance is moderate because the LLM addresses the right segment, time frame, and companies, and correctly notes Windows OEM’s 42% contribution. However, its failure to include available or inferable data on Surface revenue severely undermines accuracy. The answer should have recognized that Devices (including Surface) are a reported category within More Personal Computing and that their contribution (16%) is part of public disclosures aligned with the knowledge graph. Thus, the LLM’s claim of insufficient data is incorrect, leading to a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 464,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "What was the total financial impact on Walmart's pension-related obligations and gains/losses from the Asda pension contribution and subsequent sale, combining the $1.0 billion cash contribution made by Asda in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda?",
      "original_answer": "The total financial impact on Walmart from the Asda pension-related activities was $3.3 billion, combining the $1.0 billion cash contribution made by Asda to its pension plan in fiscal 2020 and the $2.3 billion accumulated pension components included in the disposal group upon the sale of Asda. This amount reflects the full pension-related exposure transferred as part of the divestiture.",
      "llm_answer": "The total financial impact is $3.3 billion, representing the $1.0 billion cash contribution made by Asda in fiscal 2020 plus the $2.3 billion of accumulated pension components that were included in the disposal group when the Asda stake was sold.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the $1.0 billion cash contribution by Asda in fiscal 2020 and the $2.3 billion in accumulated pension components included in the disposal group upon sale are correctly identified. (2) The quantitative calculation is accurate: $1.0B + $2.3B = $3.3B, and the formatting variations (e.g., ' billion' vs 'billion') are acceptable. (3) The multi-hop reasoning is sound—information from two distinct events (pension contribution and divestiture) is correctly synthesized to determine the total pension-related financial impact on Walmart. (4) The entities (Asda, Walmart, fiscal 2020, disposal group) and financial concepts (pension contributions, disposal group components) are accurately used. The answer is concise, relevant, and captures the full scope of the question without omissions or errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 265,
        "total_tokens": 1470
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "By how much did the value of pre-owned aircraft inventories increase from December 31, 2023, to December 31, 2024, and what specific valuation method does the company use for these pre-owned aircraft?",
      "original_answer": "The value of pre-owned aircraft inventories increased by $8 million from December 31, 2023 ($15 million) to December 31, 2024 ($23 million). The company values pre-owned aircraft at the lower of the trade-in value or the estimated net realizable value.",
      "llm_answer": "The value of pre-owned aircraft inventories increased by $8 million, from $15 million at December 31 2023 to $23 million at December 31 2024. The company records pre‑owned aircraft at the lower of trade‑in value or estimated net realizable value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values are accurate: $15 million on December 31, 2023, and $23 million on December 31, 2024, resulting in an $8 million increase—correctly calculated and reported. (2) The answer is complete, addressing both parts of the question: the dollar increase and the valuation method. (3) Entity accuracy is correct—no company name was specified in the question or ground truth, and the financial metrics and dates are properly identified. (4) The reasoning is sound: the model correctly synthesized the inventory values across the two years and accurately described the valuation method as 'lower of trade-in value or estimated net realizable value,' which is semantically equivalent to the ground truth phrasing. Minor wording differences (e.g., 'records' vs 'values') do not affect factual meaning. All criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1138,
        "completion_tokens": 271,
        "total_tokens": 1409
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the growth in Xbox Game Pass's curated game library relate to the 3% increase in Xbox content and services revenue, and what broader strategic investments does Microsoft highlight that could influence this gaming segment's performance?",
      "original_answer": "The Xbox Game Pass, which offers access to a curated library of over 100 first- and third-party titles, contributes to the 3% increase in Xbox content and services revenue. This growth is tied to Microsoft's broader strategic investments in gaming, including the acquisition of ZeniMax Media and the planned acquisition of Activision Blizzard, both of which expand the company's content portfolio and community engagement. These investments align with Microsoft's focus on transforming gaming through cloud services like Xbox Cloud Gaming, which enhances accessibility and user engagement across multiple platforms.",
      "llm_answer": "The growth in Xbox Game Pass’s curated library—highlighted as a community offering “access to a curated library of over 100 first‑ and third‑party console and PC titles” and complemented by Xbox Cloud Gaming—directly contributed to the modest 3% rise in Xbox content and services revenue, as noted in the financial highlights. Microsoft underscores broader strategic investments in “inventing new gaming experiences that bring people together around their shared love for games on any devices” and in expanding its cloud‑based gaming infrastructure, both of which are positioned to drive continued growth in the gaming segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 3% increase in Xbox content and services revenue and links it to the growth in Xbox Game Pass's curated library of over 100 titles, which matches the ground truth. The mention of Xbox Cloud Gaming as a complementary service is accurate and contextually relevant. (2) Quantitatively, the 3% revenue growth is correctly stated, and the 'over 100' titles figure aligns with the original answer. No calculations are required, and all numeric references are accurate. (3) The multi-hop reasoning is sound: the LLM connects Game Pass growth to revenue and ties it to broader strategic investments. However, while it references Microsoft's focus on 'inventing new gaming experiences' and cloud infrastructure, it omits explicit mention of the ZeniMax Media acquisition and the planned Activision Blizzard acquisition—key strategic moves highlighted in the ground truth. This is a minor omission in entity completeness but does not undermine the overall accuracy. (4) The answer is contextually excellent, directly addressing both parts of the question—how Game Pass growth relates to revenue and what strategic investments are influencing performance. The reasoning is logically structured and semantically equivalent to the original, with only slight incompleteness in naming specific acquisitions. Thus, a high score is warranted, with a small deduction from 10 to 9 in qualitative accuracy due to the missing entity references.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 408,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How much revenue did Eli Lilly recognize in 2023 specifically from the sale of rights for the olanzapine portfolio, and how does this transaction factor into the broader collaboration and other revenue category for the same year?",
      "original_answer": "Eli Lilly recognized revenue from the 2023 sale of rights for the olanzapine portfolio, including Zyprexa, which is part of the broader 'collaboration and other revenue' category. This category includes revenue from collaborations such as the one with Boehringer Ingelheim and the sale of rights for the olanzapine portfolio and Baqsimi. The sale of the olanzapine portfolio rights directly contributed to the collaboration and other revenue in 2023.",
      "llm_answer": "In 2023 Eli Lilly recognized **$5.311 billion of collaboration and other revenue**, which includes the $1.615 billion received from the July 2023 sale of the olanzapine (Zyprexa) portfolio rights. This amount is reported in the “Collaboration and other revenue” line of the company’s revenue table and is part of the broader “Collaboration and other revenue” category that totaled $5.311 billion for the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer (ground truth) states that Eli Lilly recognized revenue from the sale of the olanzapine portfolio rights as part of the 'collaboration and other revenue' category, but it does not specify any dollar amounts—neither $1.615 billion for the olanzapine sale nor $5.311 billion for the total collaboration and other revenue. These figures are entirely fabricated and not supported by the ground truth. (2) There is no verification of numbers in the original answer; thus, any specific dollar amounts in the LLM response are incorrect. The ground truth does not provide quantitative data, so asserting precise figures undermines factual correctness. (3) The multi-hop reasoning is partially sound in structure—the LLM correctly identifies that the olanzapine portfolio sale falls under 'collaboration and other revenue' and links it to the broader category—but fails because it invents data not present in the source. This undermines the integrity of the synthesis. (4) While the LLM addresses the right categories and entities (Eli Lilly, olanzapine/Zyprexa, collaboration and other revenue), the inclusion of false quantitative details severely reduces correctness. The contextual relevance is moderate because the framework of the answer aligns with the question, but accuracy is critically compromised by hallucinated numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 393,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the structure of Tesla's 5.45% Solar Bonds, as evidenced by multiple Supplemental Indentures in 2015, reflect Tesla's (via SolarCity) financing strategy for solar energy projects, and what does this imply about the role of bond-specific trustee agreements in supporting recurring capital needs?",
      "original_answer": "Tesla, through its acquisition of SolarCity, issued multiple tranches of 5.45% Solar Bonds in 2015 (Series 2015/C122-15, 2015/C127-15, 2015/C132-15, and 2015/C137-15), each governed by distinct Supplemental Indentures (4.72, 4.74, 4.76, and 4.78) dated at different points in November through December 2015. This repeated issuance of the same interest rate bond with separate indentures suggests a deliberate financing strategy to raise capital in tranches, allowing SolarCity to match funding with project deployment timelines and investor demand. The use of multiple Supplemental Indentures under the same bond rate indicates that Tesla (via SolarCity) prioritized flexibility in structuring solar project financing, with trustee agreements playing a critical role in enabling discrete funding events while maintaining consistent yield terms for investors.",
      "llm_answer": "The structure of Tesla's 5.45% Solar Bonds, evidenced by multiple Supplemental Indentures filed in 2015 (e.g., Exhibits 4.50, 4.52, 4.54, 4.56, 4.57, 4.58, 4.59, 4.60), reflects a financing strategy where SolarCity (a Tesla subsidiary) raised capital through asset-backed securities tied to its solar energy projects, using a series of indentures to add new bond series with identical terms but distinct series numbers. This approach enabled recurring capital inflows by issuing incremental tranches of bonds under the same trust structure, supported by trustee agreements that provided legal enforceability and operational flexibility for managing multiple bond series. The reliance on supplemental indentures and trustee arrangements underscores how bond-specific legal frameworks were critical for addressing Tesla's ongoing need for project-level financing in the solar sector.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the exhibit numbers and structure of the bond issuances. The ground truth specifies four Supplemental Indentures (4.72, 4.74, 4.76, 4.78) tied to four specific bond series (2015/C122-15, 2015/C127-15, 2015/C132-15, 2015/C137-15), all at 5.45% interest. In contrast, the LLM cites eight exhibits (4.50, 4.52, etc.) that do not match the ground truth, and implies more than four tranches without evidence. These exhibit numbers are incorrect and undermine quantitative accuracy. (2) While the interest rate (5.45%) and the general concept of multiple tranches are correct, the specific dates (November–December 2015) are omitted, and the bond series identifiers are missing or wrong. The LLM incorrectly suggests broader issuance than supported by the data. (3) The reasoning about Tesla’s financing strategy—using repeated tranches under a common trust structure to align with project deployment and investor demand—is qualitatively sound and reflects correct multi-hop synthesis: linking bond structure to capital strategy and trustee roles. The role of trustee agreements in enabling recurring, flexible financing is well articulated and semantically aligned with the original answer. (4) Despite strong contextual relevance and reasonable interpretation of strategic intent, the incorrect exhibit numbers and bond series undermine factual reliability. The answer is partially correct but contains key factual errors in documentation references, warranting a moderate correctness score. Quantitative accuracy is penalized heavily due to incorrect exhibit numbers and implied number of tranches; qualitative accuracy is higher due to sound logic and conceptual alignment; contextual relevance is strong as all parts of the question are addressed in spirit.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 496,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "By how much did the increase in Megapack deployments contribute to Tesla's Energy generation and storage revenue growth in 2021 compared to 2020, and what other product's decline partially offset this growth?",
      "original_answer": "The increase in Megapack deployments contributed to a $795 million, or 40%, growth in Tesla's Energy generation and storage revenue in 2021 compared to 2020. This growth was partially offset by a decrease in Powerpack deployments as Tesla phased out the product following the introduction of Megapack.",
      "llm_answer": "The increase in Megapack deployments contributed $942 million to the $795 million rise in Energy generation and storage revenue from 2020 to 2021, while a decline in Powerpack deployments partially offset that growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in stating that Megapack deployments contributed '$942 million to the $795 million rise', which is logically and quantitatively impossible—$942M cannot contribute to a $795M increase. The ground truth states that Megapack growth accounted for the entire $795M (40%) increase. This major numerical inconsistency severely undermines the answer's correctness. (2) The $795M figure is correct, and the mention of Powerpack decline as an offsetting factor is accurate and matches the original answer. However, the erroneous $942M figure suggests a reversal of causality or confusion in data sourcing, indicating a failure in quantitative reasoning. (3) The multi-hop reasoning partially works—Tesla's Energy revenue growth and the product transition from Powerpack to Megapack are correctly framed—but the synthesis fails because the model incorrectly positions Megapack’s contribution as exceeding the total reported revenue growth. (4) Contextually, the answer addresses both parts of the question (contribution of Megapack and offsetting decline), so relevance is high. However, due to the severe quantitative inaccuracy, the correctness score is low despite some accurate elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 349,
        "total_tokens": 1494
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "What was the combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024?",
      "original_answer": "$20 million",
      "llm_answer": "The combined total of Capital Expenditures and Depreciation and Amortization for the Africa/Eurasia region in 2024 is $12 + 8 = $20 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The quantitative values are accurate: $12 million for Capital Expenditures and $8 million for Depreciation and Amortization, with the correct sum of $20 million. The calculation ($12 + $8 = $20 million) is explicitly shown and accurate. (2) The answer is complete, addressing both components of the question (Capital Expenditures and Depreciation and Amortization) for the specified region (Africa/Eurasia) and year (2024). (3) Entity accuracy is correct—no incorrect companies, metrics, or time periods are mentioned. (4) The reasoning is sound and demonstrates proper multi-hop synthesis by combining two distinct financial figures from the same region and year to arrive at the total. The answer is semantically equivalent to the ground truth, with added clarity in showing the breakdown and arithmetic. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1032,
        "completion_tokens": 270,
        "total_tokens": 1302
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does TI's policy regarding retiree health care benefit plan investments compare to the actual TI common stock holdings in non-U.S. defined contribution plans as of December 31, 2024?",
      "original_answer": "TI maintains a policy that none of the assets related to the retiree health care benefit plan are directly invested in TI common stock, as stated in the disclosures. In contrast, TI's non-U.S. defined contribution plans held TI common stock valued at $34 million as of December 31, 2024. This highlights a clear distinction in investment strategy, where the retiree health care benefit plan avoids direct company stock investment, while the non-U.S. defined contribution plans do include TI stock holdings.",
      "llm_answer": "Based on the provided document pages, TI's policy for retiree health care benefit plan investments specifies that none of the plan assets related to the defined benefit pension plans and retiree health care benefit plan are directly invested in TI common stock. The investments are primarily low-cost, broad-market index funds aligned with liability-matching strategies, with target allocations of 60%-75% fixed income and 25%-40% equity for U.S. defined benefit plans, and 75%-85% fixed income and 15%-25% equity for U.S. retiree health care plans. The document explicitly states: \"None of the plan assets related to the defined benefit pension plans and retiree health care benefit plan are directly invested in TI common stock.\"",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies TI's policy that no assets from the retiree health care benefit plan are directly invested in TI common stock, which matches the ground truth. It also accurately describes the investment strategy involving fixed income and equity allocations for U.S. plans. However, the LLM fails to mention the key quantitative fact required by the question: the $34 million in TI common stock held in non-U.S. defined contribution plans as of December 31, 2024. This omission severely limits the completeness of the comparison. (2) While the percentages and policy description are accurate, the critical dollar amount ($34 million) and the specific reference to non-U.S. defined contribution plans are missing, making the quantitative accuracy incomplete. (3) The reasoning correctly explains the policy side of the comparison but fails the multi-hop requirement by not synthesizing the contrast between the retiree health care plan policy and the actual holdings in non-U.S. defined contribution plans. The model provides only one side of the comparison. (4) The answer is contextually relevant and well-structured, but due to the missing key data point and incomplete synthesis, the correctness score is reduced to 5—partially correct but significantly incomplete on a core element of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 371,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did LLY's revenue from Baqsimi change between 2023 and 2024, considering both U.S. and Outside U.S. sales, and what does the collaboration and other arrangements disclosure indicate about the shift in revenue recognition for Baqsimi?",
      "original_answer": "LLY's total revenue from Baqsimi dropped significantly from $677.6 million in 2023 (U.S. $645.7 million + Outside U.S. $31.9 million) to only $29.2 million in 2024 (U.S. $2.5 million + Outside U.S. $26.7 million). This sharp decline is explained by the company's disclosure that it sold the rights for Baqsimi in 2023, shifting the revenue recognition from product sales to collaboration and other arrangements, which typically involve milestone payments or profit-sharing agreements.",
      "llm_answer": "Based on the provided financial statements, LLY's revenue from Baqsimi (a product listed under \"Other\" in the revenue breakdown) shifted significantly between 2023 and 2024. In 2023, Baqsimi generated $645.7 million in U.S. revenue and $31.9 million outside the U.S., totaling $677.6 million. In 2024, this dropped sharply to $2.5 million in U.S. revenue and $26.7 million outside the U.S., totaling $29.2 million—a decline of approximately 95.7% year-over-year. This dramatic reduction aligns with the \"Collaboration and other revenue\" disclosure in Note 2, which states that revenue from Baqsimi (along with olanzapine portfolio rights) was part of the $5,310.2 million collaboration revenue in 2023 but is now included in the broader \"Other\" category with minimal current-period recognition. The \"Revenue\" table (page 69) shows Baqsimi's total revenue declining from $645.7 (U.S.) + $31.9 (Outside U.S.) = $677.6 in 2023 to $2.5 + $26.7 = $29.2 in 2024, while the \"Net product revenue\" figure (page 64) confirms Baqsimi's revenue is now negligible in the consolidated revenue stream. The collaboration revenue decline (from $5,310.2M in 2023 to $4,294.8M in 2024) further reflects this shift, driven by the exit from the olanzapine portfolio sale and reduced Baqsimi-related collaboration income. The accounting policy in Note 4 explains that revenue from such collaborations is recognized upon transfer of control or when products have no alternative use, but the disposal of the olanzapine rights and the diminished commercial focus on Baqsimi (now only $2.5M U.S. revenue) indicate a structural shift away from Baqsimi as a meaningful revenue source, with the company now primarily recognizing revenue from its core products like Mounjaro and Trulicity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: U.S. and Outside U.S. revenues for Baqsimi in 2023 ($645.7M and $31.9M, totaling $677.6M) and 2024 ($2.5M and $26.7M, totaling $29.2M) match the original answer exactly. The year-over-year decline of approximately 95.7% is correctly calculated: (677.6 - 29.2) / 677.6 ≈ 0.957. (2) The explanation about the shift in revenue recognition is substantiated by referencing the collaboration and other arrangements disclosure, correctly noting that Baqsimi’s revenue moved from product sales to collaboration income in 2023, which explains the drop in direct product revenue in 2024. The mention of the $5,310.2 million collaboration revenue in 2023 and its decline in 2024 supports this reasoning. (3) Multi-hop reasoning is sound: the model synthesizes data from product revenue tables, collaboration revenue disclosures, and accounting policies across different sections (e.g., Note 2, Note 4, page 69, page 64), correctly inferring the structural shift in revenue recognition. (4) The only minor shortcoming is a slight overreach in attributing part of the collaboration revenue decline to 'reduced Baqsimi-related collaboration income'—the ground truth emphasizes the sale of rights as the primary cause, not ongoing collaboration income reduction. However, this does not materially misrepresent the core explanation. Wording differs but semantic meaning and factual content are equivalent. All parts of the question are addressed: revenue change (quantitative), U.S./Outside U.S. breakdown, and the disclosure’s implication on revenue recognition. Thus, the answer earns a 9 for correctness due to excellent quantitative accuracy and strong qualitative reasoning, with only a minor nuance in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1583,
        "completion_tokens": 489,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What classification of revenue does Mastercard specifically include for its 'Processing and Gateway' services, and how does this align with the broader categories of revenue generation described in the company's 10-K filing?",
      "original_answer": "Mastercard classifies revenue from its 'Processing and Gateway' services under the broader category of 'value-added services and solutions,' which are distinct from its primary 'payment network' revenue source. This classification includes revenues generated through either fixed or transaction-based fees and is recognized in the period in which the related services are performed or transactions occur.",
      "llm_answer": "Mastercard classifies revenue from its “Processing and Gateway” services within the broader “value‑added services and solutions” category, recognizing it as part of the company’s diversified revenue streams alongside payment‑network fees and other value‑added offerings. This aligns with the 10‑K’s description of revenue sources, where payment‑network revenue is derived from volume‑based fees, while value‑added services—including processing, gateway, data, cyber‑intelligence, open‑banking and digital‑identity solutions—are billed on a fixed or transaction basis and recognized as they are performed.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that Mastercard classifies 'Processing and Gateway' revenue under the broader category of 'value-added services and solutions,' distinguishing it from the primary 'payment network' revenue—this matches the original answer exactly in substance. (2) There are no numerical values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable; however, the absence of any incorrect numeric claims preserves full accuracy. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes how this specific service fits within Mastercard’s broader revenue classification framework as described in the 10-K, referencing both the categorization and the revenue recognition principle (fixed or transaction-based fees recognized when services are performed). (4) The answer includes additional but accurate context—such as examples of other value-added services (data, cyber-intelligence, open-banking, digital identity)—that are consistent with typical disclosures in Mastercard’s 10-K filings, enhancing completeness without introducing error. All entities (Mastercard, Processing and Gateway services, value-added services, payment-network fees) are correctly identified and logically connected. The response fully addresses both parts of the question: the specific classification and its alignment with broader revenue categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 406,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the year-over-year change in CL's pension plan investments in international common stocks, and how does this shift reflect in the total international investments across both reporting periods?",
      "original_answer": "CL's pension plan investments in international common stocks increased by $5 million year-over-year, from $15 million to $20 million. This increase contributed to a broader rise in total international investments, which grew from $537 million to $566 million, reflecting a $29 million year-over-year change. The growth in international common stocks accounted for 17.2% of the total year-over-year increase in international investments.",
      "llm_answer": "The year-over-year change in CL's pension plan investments in international common stocks was a decrease of $5 million (from $20 million at the end of 2023 to $15 million at the end of 2024). This reduction is reflected in the total international pension‑plan investments, which declined from $566 million in 2023 to $537 million in 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in direction and magnitude for the key metric. (1) The year-over-year change in CL's pension plan investments in international common stocks is stated as a $5 million decrease (from $20M to $15M), but the ground truth shows a $5 million increase (from $15M to $20M). This reverses the factual trend. (2) The total international investments are reported as declining from $566M to $537M, but the truth is they increased from $537M to $566M — a $29M rise. All core financial figures are numerically correct in value but reversed in time period, indicating a critical error in year-to-year assignment. (3) The multi-hop reasoning fails: the model incorrectly infers that a decrease in international common stocks drove a decline in total international investments, when in fact the increase in this asset class contributed to overall growth. The claim that international common stocks accounted for 17.2% of the total increase is missing entirely, reducing completeness. (4) While the entities (CL, pension plan, international common stocks) and general context are relevant and correctly identified, the reversal of temporal data and resulting flawed causality severely undermines factual accuracy. Minor point: the use of '2023' and '2024' is a reasonable inference if those were the reporting years, but the directionality must match the source. Due to complete inversion of trends and incorrect synthesis, the correctness score is very low despite correct raw numbers and contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 419,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What was the total increase in General Dynamics' (GD) Restricted Stock/RSUs expense from 2022 to 2024, and how did this trend contribute to the overall change in equity-based compensation expense during the same period?",
      "original_answer": "The total increase in Restricted Stock/RSUs expense from 2022 ($59M) to 2024 ($85M) was $26M. Over the same period, total equity-based compensation expense increased from $130M to $145M, an increase of $15M. Therefore, the rise in Restricted Stock/RSUs expense accounted for more than the total increase in overall equity-based compensation, indicating that the increase in RSUs was a primary driver of the overall compensation expense growth.",
      "llm_answer": "The total increase in General Dynamics' Restricted Stock/RSUs expense from 2022 to 2024 was $29 million, rising from $59 million in 2022 to $85 million in 2024. This increase contributed to the overall rise in equity-based compensation expense, which grew from $130 million in 2022 to $145 million in 2024, reflecting higher compensation costs associated with restricted stock and RSUs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the increase in Restricted Stock/RSUs expense as $29M instead of the correct $26M (from $59M in 2022 to $85M in 2024; 85 - 59 = 26). This is a clear calculation error, impacting quantitative accuracy. All other numbers (2022 and 2024 RSU expense values, total equity-based compensation of $130M to $145M) are correctly cited. (2) The calculation of the overall equity-based compensation increase ($15M) is implied correctly, but the key error in the RSU increase undermines the precision. (3) The reasoning is otherwise sound: the LLM correctly identifies that the rise in RSUs contributed to the overall increase in equity-based compensation and contextualizes it within broader compensation trends. However, it fails to make the critical inference present in the ground truth — that the $26M RSU increase exceeded the $15M total equity compensation increase, meaning RSUs alone accounted for more than 100% of the growth, thus being the primary driver. This insight is missing, reducing qualitative accuracy despite correct entity and year identification. (4) Contextual relevance is high as the answer addresses both parts of the question and uses correct entities (General Dynamics, Restricted Stock/RSUs, equity-based compensation, correct years). The error is primarily quantitative and in depth of reasoning, not relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 383,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "Given Amazon's use of an $8.0 billion unsecured 364-day term loan in early 2023, how does this borrowing decision reflect a strategic preference in short-term liquidity management considering the availability of its $20.0 billion Commercial Paper Programs?",
      "original_answer": "Amazon's decision to enter into an $8.0 billion unsecured 364-day term loan in January 2023, despite having access to a $20.0 billion Commercial Paper Program, suggests a strategic choice in liquidity management. The term loan, classified as short-term debt and fully repaid by December 31, 2023, was likely used to meet specific funding needs with a defined maturity, offering more certainty in repayment terms. In contrast, the Commercial Paper Program provides flexibility with variable issuance and maturities up to 397 days, but as of the reporting period, no borrowings had been drawn. This indicates that Amazon opted for a committed term facility for this particular financing need rather than tapping into its broader commercial paper capacity, possibly to preserve flexibility under the program for other short-term obligations.",
      "llm_answer": "Amazon’s $8.0 billion unsecured 364‑day term loan taken in early 2023 illustrates its preference for short‑term, readily accessible financing to meet immediate liquidity needs, even though it could have relied on the larger $20 billion commercial‑paper program. The term loan was classified as short‑term debt and fully repaid by year‑end 2023, indicating that Amazon uses such borrowings as a tactical bridge—providing cash flexibility for working‑capital or acquisition purposes—while the commercial‑paper program remains available for broader, longer‑term corporate funding.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $8.0 billion unsecured 364-day term loan taken by Amazon in early 2023 and notes the existence of the $20.0 billion Commercial Paper Program, both of which match the ground truth. The classification of the loan as short-term and its full repayment by year-end 2023 is accurate. (2) All numeric values—$8.0 billion, $20 billion, 364-day term, and 2023 timing—are factually correct and consistent with the original answer. No calculations are required, and all figures are presented accurately. (3) The reasoning is mostly sound: the LLM correctly infers that Amazon used the term loan for immediate liquidity needs while preserving the commercial paper program for broader use. However, it misses a key nuance in the original answer: that the term loan offers more certainty in repayment terms due to its committed nature, whereas commercial paper is more flexible but was unused at the time. The LLM instead frames the decision as tactical for working capital or acquisitions, which is plausible but not explicitly supported in the ground truth. (4) The answer is contextually relevant and addresses the core question about strategic liquidity management. While it captures the essence of Amazon’s strategic preference, it lacks the precise reasoning about committed facilities versus flexible programs, leading to a slight deduction in qualitative accuracy. Overall, the answer is factually strong and well-aligned, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 416,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "What was the impact on American Express's Membership Rewards liability in 2024 from changes in redemption costs and third-party partner arrangements, and how did the company adjust its liability estimation methodology to account for these changes?",
      "original_answer": "In 2024, American Express adjusted its Membership Rewards liability estimation methodology in response to changes in redemption costs and developments in third-party partner arrangements. The company uses the weighted average cost (WAC) per point and the ultimate redemption rate (URR) as key assumptions to estimate the liability. These assumptions are derived from statistical and actuarial models that consider redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes. The WAC per point is based on 12 months of redemptions and is adjusted when changes in redemption costs are not representative of future expectations or when there are expected developments in redemption patterns. These adjustments were necessary due to evolving redemption options and mix of proprietary cards-in-force, which directly affect the company's financial obligations under the program. The liability is recorded based on these updated assumptions, ensuring that the financial statements reflect the most accurate estimate of future redemption costs.",
      "llm_answer": "The Membership Rewards liability was $14,752 million as of December 31 2024, up from $13,742 million in 2023. The company updated its liability estimation methodology by periodically evaluating the weighted‑average cost per point and the Ultimate Redemption Rate based on redemption trends, partner contract changes, and cost‑per‑point adjustments, ensuring that the liability reflects current redemption cost expectations and patterns.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific dollar amounts for the Membership Rewards liability in 2024 and 2023 ($14,752 million and $13,742 million), which are not present in the original answer (ground truth). Since these figures are not confirmed by the ground truth and were likely hallucinated, they severely undermine quantitative accuracy. The original answer does not provide any numerical value for the liability, so introducing these numbers is a factual overreach. (2) While the LLM correctly identifies that American Express updated its liability estimation methodology using the weighted-average cost per point and Ultimate Redemption Rate (URR), it omits key details about the actuarial and statistical models used, the factors influencing assumptions (e.g., card product type, enrollment tenure, spend levels, credit attributes), and the specific rationale for adjustments (e.g., evolving redemption options, mix of proprietary cards-in-force). (3) The reasoning is partially sound: the model correctly links changes in partner arrangements and redemption costs to methodology updates, which aligns with the multi-hop synthesis required. However, it fails to explain how these changes affect the liability estimation process in depth, such as the 12-month redemption basis for WAC or when adjustments are triggered. (4) Despite the hallucinated numbers, the answer remains contextually relevant and captures the general direction of the company’s response. The qualitative accuracy is moderate because core concepts (WAC, URR, periodic evaluation) are correct, but important nuances are missing. The contextual relevance is high because the response directly addresses the question’s focus on methodology changes and redemption cost impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 479,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does Colgate-Palmolive's use of selling price increases, as stated in its 2024 10-K, interact with its foreign exchange risk management strategy involving derivative contracts, and what specific financial exposure does this combined approach aim to mitigate?",
      "original_answer": "Colgate-Palmolive uses selling price increases as part of its strategy to manage foreign exchange risk, alongside derivative contracts such as forward and swap contracts, option contracts, and local currency borrowings. This combined approach is designed to offset the earnings impact from currency fluctuations in the over 200 countries where it operates. Specifically, the company aims to mitigate the impact of foreign currency rate movements on its net sales and costs, which could otherwise be significantly affected due to translation of foreign subsidiary assets and liabilities into U.S. dollars and the volatility of exchange rates.",
      "llm_answer": "Based on the 2024 10-K disclosures, Colgate-Palmolive manages foreign exchange risk through a combination of **selling price increases** (explicitly cited as a key strategy to offset currency pressures) alongside derivative hedges. Its combined approach—using **foreign currency contracts (e.g., forwards, swaps) to hedge costs/assets** and **selling price adjustments**—aims to mitigate **exposure to foreign currency exchange rate volatility** that could impact earnings and cash flows from international operations. This strategy specifically targets minimizing earnings volatility from currency movements in its global supply chain and sales.  \n\n*(Synthesized from pages 53, 54, 55, 56, 57, 88, 89, 90, 91, 92, with key references to foreign exchange risk management on pages 54, 55, 57, 88, 90, 91 and derivative details on pages 88, 90, 91.)*",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Colgate-Palmolive uses both selling price increases and derivative contracts (forwards, swaps, options) as part of its foreign exchange risk management strategy. The LLM correctly identifies the dual approach and the types of derivatives used, though it does not explicitly mention 'option contracts' and 'local currency borrowings' from the original, which slightly reduces completeness. (2) There are no numbers, dates, or calculations in the question or answer that need verification—both responses are qualitative and consistent in that regard. (3) The multi-hop reasoning is sound: the LLM synthesizes information about pricing strategy and derivative usage from the 10-K to explain how they jointly mitigate FX risk. It correctly identifies the goal as reducing earnings volatility from currency fluctuations in international operations. (4) The answer is contextually fully relevant, directly addressing how price increases interact with derivatives and what exposure is mitigated. The only minor gap is the omission of 'local currency borrowings' and less specificity on 'translation of foreign subsidiary assets and liabilities into USD,' which slightly affects qualitative completeness. However, the core financial exposure—earnings and cash flow volatility from FX movements—is accurately conveyed. Thus, the answer earns a 9/10 for correctness due to high factual and semantic alignment with minor omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 419,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did the increase in business-to-business activity and residential demand in 2022 impact the average daily volume and revenue per piece for UPS's Next Day Air product, and what factors partially offset this revenue growth?",
      "original_answer": "In 2022, the average daily volume for UPS's Next Day Air product increased due to growth in business-to-business activity from SMBs and large customers, as well as higher residential demand. This volume growth contributed to increased revenue per piece, which was also driven by higher base rates and demand-related surcharges. However, the revenue per piece growth was slightly offset by a reduction in average billable weight per piece.",
      "llm_answer": "The increase in business-to-business activity and residential demand in 2022 drove growth in UPS’s Next Day Air product, boosting both average daily volume and revenue per piece. However, this revenue growth was partially offset by higher operating expenses, including increased fuel costs, higher employee benefit expenses for the union workforce, and productivity-related cost pressures that moderated the overall impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that increased business-to-business activity and residential demand in 2022 led to higher average daily volume and revenue per piece for UPS's Next Day Air product, which aligns with the ground truth. However, it incorrectly states that the revenue growth was partially offset by higher operating expenses—including fuel costs, employee benefits, and productivity pressures—whereas the original answer specifies that the offsetting factor was a reduction in average billable weight per piece. This is a critical factual error in the qualitative reasoning and multi-hop synthesis, as the LLM introduces cost-side pressures not mentioned in the ground truth as offsetting factors to revenue per piece growth. While the directional impact on volume and revenue per piece is correct, the explanation for what offset revenue growth is factually wrong. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. Contextual relevance is moderate because the answer addresses the right product and year and attempts to explain the dynamics, but misattributes the offsetting factor. The model fails the multi-hop reasoning by substituting an incorrect causal factor from potentially related but inaccurate contextual knowledge.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 362,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the regulatory exclusivity risk for Opdivo in the U.S., as described in the Biologic products section, interact with the multiple international approvals Opdivo received in 2021 to influence BMY's strategic positioning in global oncology markets?",
      "original_answer": "Opdivo faces potential biosimilar competition in the U.S. after 12 years of regulatory data protection, with patent litigation possibly starting as early as four years post-approval. Given Opdivo received multiple international approvals in 2021 (e.g., Japan for cancer of unknown primary, gastric cancer, and esophageal cancer; EC for gastric, esophageal, CRC, and mesothelioma indications), BMY must strategically manage its patent enforcement and market expansion efforts globally to maximize revenue before biosimilar entry. This global regulatory diversification may help offset potential U.S. market erosion.",
      "llm_answer": "The regulatory exclusivity risk for Opdivo in the U.S.—stemming from patent and data‑protection limits that can be eroded by biosimilar or generic challenges—is offset by the multiple international approvals Opdivo received in 2021, which broaden its market reach and diversify revenue sources across regions with differing exclusivity regimes. This global footprint helps mitigate U.S. exclusivity uncertainty and strengthens BMY’s strategic positioning in the worldwide oncology market.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core interaction between U.S. regulatory exclusivity risk and international approvals in shaping BMY's global oncology strategy. It accurately conveys that U.S. exclusivity risk from biosimilar competition (due to patent and data protection limits) is mitigated by expanded international market access from 2021 approvals. While the original answer includes specific details—such as the 12-year U.S. data protection period, potential patent litigation as early as four years post-approval, and exact indications approved in Japan and the EC (e.g., gastric, esophageal, CRC, mesothelioma)—the LLM answer omits these quantitative and entity-specific details. However, the absence of exact numbers and indications does not distort the overall meaning; instead, it generalizes accurately. The reasoning is sound: the global diversification of approvals helps offset U.S. market risks, which strengthens BMY’s strategic positioning. This reflects proper multi-hop synthesis between U.S. regulatory risk and international growth opportunities. The answer is contextually fully relevant and semantically aligned with the ground truth, but loses points on quantitative precision and completeness of entity-specific details. Hence, scores are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 359,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What is the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, and how does this valuation compare to the total amount invested in those notes by that date?",
      "original_answer": "As of December 31, 2024, the estimated fair value of Amazon's convertible note investments in Anthropic, PBC was $13.8 billion. By that date, Amazon had invested a total of $5.3 billion across three convertible notes ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024). This indicates that the fair value of the investment increased significantly, reflecting a valuation uplift in the notes based on Anthropic's subsequent financing activities and market expectations.",
      "llm_answer": "Based on the provided document pages, the total estimated fair value of Amazon's convertible note investments in Anthropic, PBC as of December 31, 2024, was approximately $13.8 billion. This valuation is significantly higher than the total amount invested in those notes by that date, which was $5.3 billion ($1.25 billion in Q3 2023, $2.75 billion in Q1 2024, and $1.3 billion in Q4 2024, with an additional $2.7 billion planned by Q4 2025). The fair value estimate reflects market-based adjustments and valuation methodologies applied to the notes, which exceeded the cumulative cash investments made.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value of Amazon's convertible note investments in Anthropic, PBC as $13.8 billion and the total amount invested by December 31, 2024, as $5.3 billion, broken down into $1.25 billion (Q3 2023), $2.75 billion (Q1 2024), and $1.3 billion (Q4 2024). All numeric values match the ground truth exactly. (2) The calculation of the total invested ($1.25B + $2.75B + $1.3B = $5.3B) is accurate. The fair value of $13.8B is correctly stated and compared to the $5.3B invested, showing a significant increase. (3) The multi-hop reasoning is sound—information about multiple investments across different quarters is synthesized correctly, and the conclusion about valuation uplift is logically supported. However, the LLM adds that an 'additional $2.7 billion planned by Q4 2025'—this detail is not in the original answer and, while possibly true, introduces information beyond the scope of the question, which only asks about the status as of December 31, 2024. This does not affect the core correctness but slightly impacts qualitative accuracy. (4) The answer is contextually relevant, complete for the question asked, and semantically equivalent to the ground truth, with only minor over-addition of forward-looking investment plans. Thus, correctness is high but not perfect due to the extra, unverified detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 378,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does Colgate-Palmolive's accounting treatment of pension enhancements differ from other Employee-Related Costs under its severance policies, and why is this distinction reflected differently on the balance sheet?",
      "original_answer": "Colgate-Palmolive accounts for pension enhancements differently from other Employee-Related Costs such as severance and termination benefits. While severance costs are calculated based on written severance policies, local statutory requirements, and voluntary termination arrangements, pension enhancements are specifically reflected as 'Charges against assets' within Employee-Related Costs. This distinction arises because the balance sheet treatment of pension enhancements is recorded as either a reduction of pension assets or an increase in pension liabilities, unlike other severance-related costs which are treated as operating expenses. This separate classification ensures that the financial impact of pension enhancements is directly tied to asset or liability adjustments, rather than being netted into general operating charges.",
      "llm_answer": "Colgate-Palmolive distinguishes pension enhancements within its severance-related Employee-Related Costs by classifying them as \"Charges against assets\" in the restructuring accrual schedule, reflecting the offsetting impact on pension plan assets and liabilities rather than as direct cash severance expenses. This treatment is reflected differently on the balance sheet as a reduction in pension assets or an increase in pension liabilities, whereas other severance costs (e.g., cash severance payments) are recorded as accrued liabilities within Employee-Related Costs and reduce cash balances. Consequently, pension enhancements do not appear as separate line items in the income statement but are embedded in the balance sheet's pension accounting, aligning with how pension plan changes are inherently reflected in the company's pension asset/liability positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Colgate-Palmolive classifies pension enhancements as 'Charges against assets' within Employee-Related Costs, distinguishing them from other severance costs like cash payments. The balance sheet treatment—reduction in pension assets or increase in pension liabilities—is correctly described, as is the contrast with other severance costs, which are recorded as accrued liabilities and reduce cash. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations, but all referenced financial treatments are factually sound. (3) The multi-hop reasoning is strong: the model correctly synthesizes the distinction in accounting treatment (income statement vs. balance sheet), links pension enhancements to pension asset/liability adjustments, and contrasts this with standard severance accruals. (4) The only minor shortcoming is that the LLM does not explicitly state that this separate classification ensures the financial impact is tied to asset/liability adjustments rather than netted into operating charges—a nuance present in the original answer. However, this is implied in the explanation about balance sheet treatment and income statement embedding. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 401,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the regulatory data protection period for biologic products in the U.S. impact the market exclusivity of Opdivo, and what financial risk does this pose to BMY based on the rate of revenue decline observed after exclusivity expiration in developed markets?",
      "original_answer": "The U.S. provides 12 years of regulatory data protection for innovative biologics like Opdivo, meaning biosimilar versions cannot be approved until 12 years after initial FDA approval. However, BMY faces financial risk because when market exclusivity ends, the product typically experiences a significant and rapid revenue decline. In developed markets like the U.S. and certain EU countries, revenue can drop sharply—often losing a major portion in a short period—especially for products used in large patient populations or those that are simpler to manufacture. This decline threatens BMY's long-term revenue stability for Opdivo if biosimilar competition emerges after the 12-year protection period.",
      "llm_answer": "The U.S. provides 12 years of regulatory data‑protection for innovative biologics such as Opdivo, which extends the period of market exclusivity beyond the underlying patent term. Once this exclusivity ends, BMY has observed that revenue from similar products in developed markets can fall sharply—often by more than 50 % within a year—so BMY faces a significant risk of a rapid revenue decline once Opdivo’s data‑protection period expires.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states the 12-year regulatory data protection period for biologics in the U.S., which is the key regulatory framework impacting Opdivo's market exclusivity. (2) The quantitative claim that revenue can fall by 'more than 50% within a year' after exclusivity ends is consistent with observed patterns in developed markets, though the original answer does not specify an exact percentage—this addition is plausible and contextually supported, representing a reasonable inference from the general 'sharp' decline described. (3) The reasoning correctly links the end of data protection to biosimilar entry and subsequent revenue risk, demonstrating sound multi-hop logic: regulatory protection → market exclusivity → revenue decline upon expiration → financial risk to BMY. (4) All entities (Opdivo, BMY, U.S. regulatory environment) are correctly identified and synthesized. The only minor deviation is the introduction of a specific 'more than 50%' decline figure not present in the original, but this does not contradict it and falls within the semantic scope of 'sharp' and 'major portion' decline. Wording differs slightly but meaning is equivalent. No factual errors; minor lack of mention of EU markets slightly reduces completeness, but U.S. focus satisfies the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 378,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What percentage of Amazon's total advertising services revenue in 2024 was derived from display advertising, given that display advertising revenue was $35 billion and advertising services revenue totaled $40 billion?",
      "original_answer": "87.5%",
      "llm_answer": "Based on the provided financial data, display advertising revenue was $35 billion and total advertising services revenue was $40 billion for 2024. Therefore, display advertising accounted for 87.5% of Amazon's total advertising services revenue in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that display advertising revenue was $35 billion and total advertising services revenue was $40 billion, both matching the input data. The calculated percentage of 87.5% is accurate and matches the ground truth. (2) The calculation is correct: ($35 billion / $40 billion) * 100 = 87.5%. All numeric values are precise and properly formatted. (3) The reasoning is sound and complete—although this is a single-hop calculation, the model correctly interprets the relationship between the two financial figures and derives the correct percentage. (4) The answer is fully contextually relevant, directly addressing the question with accurate data, correct terminology, and a clear conclusion. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1082,
        "completion_tokens": 239,
        "total_tokens": 1322
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What is the dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on the Level 1 quoted prices in active markets for identical assets?",
      "original_answer": "The value of U.S. government and agency debt securities held by UPS decreased by $16 million from 2020 to 2021 based on Level 1 quoted prices. In 2020, the value was $184 million, and in 2021, it was $200 million.",
      "llm_answer": "The dollar amount decrease in the value of U.S. government and agency debt securities held by UPS from 2020 to 2021, based on Level 1 quoted prices, is $16 million (from $184 million in 2020 to $200 million in 2021).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer contains a critical factual error in both the direction of change and the calculation. The ground truth states that the value increased from $184 million in 2020 to $200 million in 2021, which is an increase of $16 million, not a decrease. The question asks for the 'dollar amount decrease', but there was no decrease — the value increased. Therefore, stating a '$16 million decrease' is factually incorrect. The LLM incorrectly interprets the direction of the change despite providing the correct endpoint values. This fundamental error in quantitative reasoning and interpretation of basic financial trends invalidates the answer. While the entity (UPS), metric (U.S. government and agency debt securities), and years (2020 to 2021) are correct, the core numerical conclusion is wrong. The answer fails on quantitative accuracy due to incorrect calculation logic (reporting a decrease where there is an increase), fails on qualitative accuracy due to flawed reasoning, and lacks contextual relevance because it misrepresents the financial movement. Even though the raw numbers ($184M and $200M) are correctly cited, their synthesis is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1120,
        "completion_tokens": 329,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the joint development and cost-sharing structure between BMS and Ono for Yervoy impact the financial risk exposure of BMS in the context of potential biosimilar competition under the U.S. regulatory framework?",
      "original_answer": "Under the joint development agreement between BMS and Ono for Yervoy, development costs and profits are shared equally when combination therapies involve compounds from both parties. This equal cost-sharing reduces BMS's individual financial burden in developing Yervoy. However, under the U.S. regulatory framework, Yervoy, as a biologic, faces a risk of biosimilar competition after 12 years of regulatory data protection. Since BMS markets Yervoy in the U.S., potential biosimilar entry could erode its revenue share. Despite this risk, the joint cost-sharing arrangement with Ono limits BMS’s upfront investment and thus partially mitigates financial exposure in the event of market exclusivity loss due to biosimilar approval.",
      "llm_answer": "The joint development and cost‑sharing arrangement between BMS and Ono for Yervoy shifts a portion of the product’s development and commercial expenses onto Ono, thereby reducing BMS’s absolute financial outlay. However, because BMS remains the principal marketer and bears the bulk of sales‑related costs, it still retains significant exposure to revenue volatility; any erosion of Yervoy’s market share from biosimilar entry—whether in the U.S. or abroad—will directly affect BMS’s top‑line and profit margins, even though the cost‑sharing mitigates some of the expense burden. Consequently, while the structure lessens BMS’s upfront cash commitment, the company’s profitability remains tightly linked to Yervoy’s competitive position in a landscape increasingly threatened by biosimilar challengers.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the joint development and cost-sharing structure between BMS and Ono for Yervoy, correctly noting that the arrangement reduces BMS's financial outlay. It accurately reflects that BMS markets Yervoy in the U.S. and would bear the brunt of revenue erosion from biosimilar competition. However, the LLM answer introduces the claim that BMS 'bears the bulk of sales-related costs' and is the 'principal marketer'—details not present in the original answer and not verifiable from the provided knowledge graph. While this may be contextually plausible, it adds unsupported specificity. Additionally, the original answer emphasizes the 12-year U.S. regulatory data protection period for biologics, a key regulatory detail that the LLM omits, weakening the multi-hop synthesis between cost-sharing and biosimilar risk under the U.S. framework. The reasoning is otherwise sound and semantically aligned, with no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are stated). The answer addresses the core financial risk and mitigation via cost-sharing, but misses the precise regulatory timeline that grounds the biosimilar threat, slightly reducing qualitative accuracy. Contextual relevance remains high as the response directly engages the question’s financial and regulatory dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 382,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What percentage of the $6.03 billion decline in Automotive Sales Revenue was offset by the $596 million of FSD (Supervised) revenue recognized in 2024, and how does this relate to the deferred revenue and guarantee liabilities associated with over-the-air software updates and vehicle residual values?",
      "original_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offset approximately 9.9% of the $6.03 billion decline in Automotive Sales Revenue ($596M ÷ $6,030M = 0.0988 or 9.9%). This FSD revenue is part of the broader category of automotive sales that includes access to over-the-air software updates, for which deferred revenue is tracked. Additionally, Tesla’s maximum exposure for resale value guarantees under leasing programs, which can be affected by residual values influenced by software features like over-the-air updates, increased to $1.45 billion in 2024, up from $166 million in 2023.",
      "llm_answer": "The $596 million of FSD (Supervised) revenue recognized in 2024 offsets roughly 9.9 % of the $6.03 billion decline in Automotive Sales Revenue (596 ÷ 6,029 ≈ 0.099). This revenue is recorded as part of the transaction price allocated to the ongoing performance obligations for connectivity, Supercharging and FSD maintenance, and it is reflected in the deferred‑revenue balance that will be recognized over the expected vehicle ownership period. The related guarantee liabilities for resale‑value commitments and the deferred‑revenue amounts tied to these software services are accounted for in other liabilities and deferred‑revenue balances, respectively, and are monitored each quarter for changes in market residual values and usage patterns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly calculates the percentage of the $6.03 billion decline offset by $596 million in FSD revenue: 596 ÷ 6,030 = 0.0988 ≈ 9.9%, which matches the ground truth. The slight discrepancy in the denominator (6,029 vs 6,030) is negligible and does not affect the final rounded percentage. All numeric values (596 million, 6.03 billion, 9.9%) are accurate and correctly formatted.\n\n2) The answer addresses the first part of the question fully—quantifying the offset. For the second part, it correctly links FSD revenue to deferred revenue and performance obligations related to over-the-air software updates, which aligns with the ground truth. It also references guarantee liabilities tied to resale value commitments, consistent with the original answer’s mention of Tesla’s exposure under leasing programs.\n\n3) However, the LLM answer omits the specific figures for the guarantee liabilities: the increase from $166 million in 2023 to $1.45 billion in 2024. This is a meaningful detail present in the ground truth and directly relevant to the question about how the FSD revenue relates to guarantee liabilities. While the LLM acknowledges the existence and monitoring of these liabilities, it fails to provide the key quantitative change, which weakens completeness.\n\n4) The reasoning is sound and reflects proper multi-hop synthesis: connecting FSD revenue to automotive sales decline, explaining its recognition over time via deferred revenue, and linking software features to residual value guarantees. The omission of the exact liability amounts prevents a perfect score, but the conceptual framework is accurate and relevant. Wording differences are acceptable and do not impact semantic equivalence.\n\nJustification: A score of 9 is appropriate because all quantitative elements in the calculation are correct (hence 10 for quantitative accuracy), the logic and entities are accurate, and the response is contextually fully relevant. The only deficiency is the missing specific liability amounts, which reduces completeness but not core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 556,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "What non-GAAP financial measure does PepsiCo adjust for items affecting comparability in its 2022 10-K filing, and how does this adjustment account for currency fluctuations when evaluating operating profit growth?",
      "original_answer": "PepsiCo adjusts operating profit for items affecting comparability to evaluate performance on a comparable basis, and further adjusts this metric for currency fluctuations to assess operating profit growth on a constant currency basis, as disclosed in the 2022 10-K filing.",
      "llm_answer": "PepsiCo adjusts for items affecting comparability in its 2022 10-K by using a non-GAAP \"Core\" operating profit measure that excludes mark-to-market net impacts, restructuring and impairment charges, and acquisition/divestiture-related charges. This adjustment accounts for currency fluctuations by reporting the \"Core Constant Currency %Change, Non-GAAP Measure\" alongside the standard \"Core %Change, Non-GAAP Measure,\" allowing evaluation of operating profit growth on a constant currency basis to isolate the impact of currency movements from underlying business performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that PepsiCo uses a non-GAAP 'Core' operating profit measure adjusted for items affecting comparability, such as mark-to-market impacts, restructuring charges, and acquisition/divestiture-related items—consistent with disclosures in the 2022 10-K. (2) There are no numeric values (e.g., percentages, dollar amounts) in the question or ground truth, so quantitative accuracy is not compromised; the LLM appropriately avoids fabricating numbers. (3) The multi-hop reasoning is sound: it correctly links the adjustment for comparability items to the further adjustment for currency fluctuations via the 'Core Constant Currency %Change' metric, demonstrating understanding of how PepsiCo evaluates operating profit growth on a constant currency basis. (4) While the original answer is more concise, the LLM provides additional context (specific examples of adjusted items and the formal name of the metric) that enhances completeness without introducing errors. The only minor gap is that the LLM introduces the term 'Core' operating profit without explicitly citing that this terminology comes from the 10-K, but this is a nuance in sourcing rather than factual inaccuracy. Overall, the semantic meaning and factual content match the ground truth closely.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 374,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How many amendments to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology are documented across the two exhibits, and what is the time span between the earliest and latest effective dates of these amendments?",
      "original_answer": "There are 12 total amendments documented across the two exhibits. The time span between the earliest effective date (September 2, 2014) and the latest effective date (May 1, 2021) is 6 years and 8 months.",
      "llm_answer": "The document shows **12 amendments** to the Amended and Restated Agreement for Research & Development Alliance on TriexModule Technology across the two exhibits (Exhibits 10.31 – 10.36 and Exhibits 10.37 – 10.42). The earliest effective date is **September 2, 2014** (the original agreement), and the latest is **July 22, 2020** (the eleventh amendment), giving a time span of **approximately 6 years and 10 months** between the first and last amendments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total number of amendments (12), which matches the ground truth. However, it incorrectly states the latest effective date as July 22, 2020 (the eleventh amendment), while the ground truth specifies May 1, 2021 as the latest effective date. This leads to an incorrect time span calculation: the LLM reports approximately 6 years and 10 months, whereas the correct span is 6 years and 8 months. The error in the latest date undermines the quantitative accuracy. (2) Number verification: '12 amendments' is correct. Date verification: earliest date (September 2, 2014) is correct; latest date is wrong (July 22, 2020 vs. May 1, 2021). Time span calculation is therefore incorrect—6 years and 10 months is longer than the actual 6 years and 8 months. (3) Multi-hop reasoning: the model correctly synthesizes information across exhibits and identifies the need to compare earliest and latest dates, but fails to retrieve the correct final amendment date, indicating a data extraction or synthesis error in the final hop. (4) Scores justified as correctness is partially accurate due to the correct count but flawed timeline; quantitative accuracy penalized due to incorrect date and resulting miscalculation; qualitative reasoning is sound in approach but flawed in execution; contextual relevance is high as the answer structure and intent align well with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 392,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What was the combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022?",
      "original_answer": "The combined percentage impact on net revenue growth in the AMESA division from the acquisition of Pioneer Foods and favorable foreign exchange in 2022 was 18.5 percentage points.",
      "llm_answer": "The combined percentage impact on net revenue growth in the AMESA division from the Pioneer Foods acquisition and favorable foreign exchange in 2022 was 14 percentage points from the acquisition and 4.5 percentage points from favorable foreign exchange, for a total of 18.5 percentage points.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the acquisition of Pioneer Foods contributed 14 percentage points and favorable foreign exchange contributed 4.5 percentage points to net revenue growth in the AMESA division in 2022. The sum of these contributions (14 + 4.5) correctly totals 18.5 percentage points, which is the exact combined impact stated in the original answer. (2) Quantitative accuracy is perfect: both component values and the final total are correct, with no calculation errors. Format variations (e.g., 'percentage points' vs numerical representation) are semantically equivalent and acceptable. (3) The multi-hop reasoning is sound—LLM correctly identified and synthesized the two contributing factors (acquisition and FX impact) from potentially separate data points and combined them appropriately to answer the 'combined' impact question. (4) Entity accuracy is preserved: 'Pioneer Foods', 'AMEXA division', '2022', and 'net revenue growth' are all correctly referenced. The answer is complete, precise, and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1121,
        "completion_tokens": 316,
        "total_tokens": 1438
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does Opdivo's regulatory data protection timeline in the U.S. and EU interact with its patent expiration pattern to influence market exclusivity, particularly in light of its 2021 U.S. revenue growth of 7%?",
      "original_answer": "Opdivo, as a biologic product, benefits from 12 years of regulatory data protection in the U.S., meaning the earliest a biosimilar could be approved is 12 years after its initial FDA approval. In the EU, Opdivo is subject to the '8+2+1' regime, allowing a generic to file an MAA after 8 years and commercialize after 10 or 11 years, depending on additional indications. In the U.S., formulation and additional patents for Opdivo expire in 2026 and beyond, extending market exclusivity despite the expiration of method of use patents in 2021. The 7% U.S. revenue growth in 2021 for Opdivo highlights the continued demand and commercial strength of the product, which is preserved by these extended patent protections and regulatory exclusivity. This regulatory and patent framework ensures that despite the 2021 patent expiration, market exclusivity for Opdivo remains intact through the 2020s, supporting sustained revenue generation.",
      "llm_answer": "Opdivo’s U.S. revenue grew 7% in 2021, driven by higher demand and pricing, while its EU market faced generic entry and declining sales, reflecting a broader pattern of market exclusivity erosion due to patent and regulatory data protection expirations. This dynamic underscores how Opdivo’s 7% U.S. growth was partially offset by declining international performance amid intensifying competition and shortened exclusivity periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states Opdivo's 7% U.S. revenue growth in 2021 (matching the ground truth), it incorrectly claims that the EU market faced generic entry and declining sales due to patent/regulatory expirations. The ground truth states that Opdivo’s market exclusivity remains intact through the 2020s due to extended patent protections and regulatory data exclusivity in both the U.S. and EU. In reality, no generic (biosimilar) entry occurred in the EU by 2021, and the '8+2+1' data protection regime means commercialization of biosimilars could only begin after 10–11 years, with additional patents further delaying entry. (2) Quantitatively, the 7% U.S. revenue growth is accurate, but the answer fabricates unverified claims about EU sales decline and generic entry without supporting data. There are no numbers cited for EU performance, and the assertion of 'shortened exclusivity periods' contradicts the ground truth. (3) The multi-hop reasoning is flawed: the model fails to synthesize the interaction between regulatory data protection (12 years in U.S., 8+2+1 in EU) and patent expiration (method of use patents expiring in 2021 but formulation patents extending to 2026+). Instead, it incorrectly infers that patent expiration in 2021 led to immediate market erosion, when the ground truth emphasizes that exclusivity was preserved. (4) Contextual relevance is moderate because the answer addresses Opdivo’s revenue and exclusivity, but the incorrect portrayal of biosimilar impact and market dynamics severely undermines factual correctness. The conclusion that U.S. growth was 'partially offset by declining international performance' is unsupported and contradicts the original answer’s emphasis on sustained revenue due to strong exclusivity. Thus, the answer is mostly incorrect despite one accurate data point.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 514,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the systemic risk regime specifically constrain Morgan Stanley's capital distribution policies and liquidity management, given its status as a large bank holding company with over $250 billion in consolidated assets?",
      "original_answer": "The systemic risk regime imposes heightened capital and liquidity requirements on Morgan Stanley as a large bank holding company, which directly constrains its capital distribution policies and liquidity management. Specifically, the Federal Reserve mandates internal liquidity stress tests, requires maintenance of unencumbered highly liquid assets to meet 30-day projected net cash outflows, and enforces risk management and corporate governance standards. These requirements can limit the firm’s ability to distribute capital through dividends or stock repurchases, especially if such actions would be deemed unsafe or unsound by regulators. Additionally, Morgan Stanley must comply with single-counterparty credit limits (15% of Tier 1 capital for major counterparties and 25% for other unaffiliated counterparties), further constraining its liquidity risk exposure.",
      "llm_answer": "Morgan Stanley's capital distribution policies and liquidity management are constrained by the Federal Reserve's systemic risk regime for large bank holding companies, which imposes heightened capital and liquidity requirements, restrictions on activities under the Volcker Rule, and limitations on dividend payments or stock repurchases if regulators deem them unsafe or unsound. These rules, including mandatory stress testing, single-counterparty credit limits, and the need to maintain unencumbered highly liquid assets, directly restrict the firm's ability to distribute capital to shareholders or engage in certain financial activities without prior regulatory approval.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the systemic risk regime constrains Morgan Stanley via heightened capital and liquidity requirements, mandatory stress testing, single-counterparty credit limits, and restrictions on capital distributions if deemed unsafe or unsound. The mention of unencumbered highly liquid assets and regulatory approval for distributions aligns with the original. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., 30-day outflows, 15%/25% counterparty limits) are explicitly repeated in the LLM answer, it correctly references 'single-counterparty credit limits' without misstating any values. The omission of the exact percentages (15% and 25%) is a minor gap but does not constitute an error—these specifics were present in the ground truth but not misrepresented by the LLM. (3) Multi-hop reasoning is sound: the model correctly links Morgan Stanley’s status as a large bank holding company (> $250B assets) to enhanced prudential standards under the systemic risk regime, and synthesizes how these affect both capital distributions and liquidity management. (4) Contextual relevance is excellent—the response directly addresses the question’s focus on capital distribution policies and liquidity management constraints. The inclusion of the Volcker Rule adds context not in the original answer, but this is not incorrect; however, it slightly distracts from the core constraints emphasized in the ground truth (e.g., liquidity stress tests, 30-day outflows). Overall, the answer is semantically equivalent and factually sound, warranting a 9/10 due to minor omission of specific counterparty limit percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 474,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the interest rate of the 0.750% Senior Note due 2033 compare to the interest rate of the 1.950% Senior Note due 2031, and what might this indicate about PepsiCo's long-term debt strategy across different maturities?",
      "original_answer": "The interest rate of the 0.750% Senior Note due 2033 is lower than the interest rate of the 1.950% Senior Note due 2031 by 1.200 percentage points. This suggests that PepsiCo may have pursued a strategy of issuing debt at lower interest rates for longer-term maturities during the respective periods these notes were issued, potentially reflecting favorable market conditions or improved credit perception over time.",
      "llm_answer": "The interest rate on PepsiCo's 0.750% Senior Note due 2033 is lower than the 1.950% rate on its 1.950% Senior Note due 2031, reflecting a strategic shift toward cheaper long-term borrowing for newer debt issuances. This suggests PepsiCo is actively managing its debt maturity profile, likely leveraging favorable market conditions to issue new debt at lower rates while extending maturities to reduce refinancing risks and optimize its overall cost of capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 0.750% Senior Note due 2033 has a lower interest rate than the 1.950% Senior Note due 2031. The difference is accurately implied (though not explicitly calculated) as 1.200 percentage points, which matches the ground truth. All numeric values (0.750%, 1.950%, 2033, 2031) are correct. (2) Quantitative accuracy is perfect: rates and maturities are correctly cited, and the comparison direction (lower) is accurate. The exact 1.200 percentage point difference is not stated but is logically implied in the comparison. (3) The reasoning is sound and aligns with the ground truth: the LLM infers a strategic move toward cheaper long-term borrowing, likely due to favorable market conditions, which matches the original answer’s interpretation. It adds value by mentioning refinancing risk and cost of capital optimization—reasonable inferences that do not contradict the ground truth. (4) The answer is contextually excellent, addressing both the rate comparison and strategic implications. The only minor shortcoming is the lack of explicit numerical difference (1.200 pp), which slightly reduces qualitative completeness, but the core multi-hop synthesis—comparing rates across maturities and inferring strategy—is correct and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 362,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "By how much did the fair value of Medtronic's partnership units increase from fiscal year 2023 to fiscal year 2024, and what was the impact on total investments measured at net asset value?",
      "original_answer": "The fair value of Medtronic's partnership units increased by $159 million (from $992 million in fiscal year 2023 to $1,151 million in fiscal year 2024). This contributed to an overall increase of $1,187 million in investments measured at net asset value, which rose from $2,179 million in 2023 to $3,366 million in 2024.",
      "llm_answer": "The fair value of Medtronic's partnership units increased by $159 million from fiscal year 2023 to fiscal year 2024 (rising from $992 million to $1,151 million). This increase contributed to a $46 million rise in total investments measured at net asset value, which grew from $1,571 million in 2023 to $1,617 million in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the $159 million increase in the fair value of Medtronic's partnership units from $992 million in fiscal year 2023 to $1,151 million in 2024, which matches the ground truth. However, it incorrectly reported the impact on total investments measured at net asset value. The LLM states a $46 million increase (from $1,571 million to $1,617 million), which is factually wrong. The ground truth shows a $1,187 million increase in total investments measured at net asset value, rising from $2,179 million in 2023 to $3,366 million in 2024. This is a major quantitative error. (2) The calculation for the partnership units increase is correct: $1,151M - $992M = $159M. But the total investments at net asset value are completely inaccurate—both the starting and ending values are wrong, leading to an incorrect change. (3) The multi-hop reasoning fails at the second step: while the model correctly retrieves the change in partnership units, it fails to correctly synthesize the broader impact on total investments measured at NAV, indicating a failure to pull or connect the correct aggregate figures from the source data. (4) The correctness score is 4 due to partial accuracy on the first part but major error on the second; quantitative accuracy is 5 because half the numbers are correct but the critical aggregate impact is wrong; qualitative accuracy is 5 due to sound reasoning structure but flawed data synthesis; contextual relevance is 9 as the answer addresses the right entities and question components, just with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 433,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the use of activity-based costing methods affect the presentation of depreciation and amortization totals for UPS's reportable segments, particularly in relation to the allocation of expenses between segments as described in the 2024 10-K filing?",
      "original_answer": "The use of activity-based costing methods directly affects the presentation of depreciation and amortization totals for UPS's reportable segments by determining how expenses are allocated between segments. According to the 2024 10-K filing, these totals are presented 'after applying activity-based costing methods to allocate expenses between segments.' This means that the final depreciation and amortization figures disclosed for each reportable segment are not raw totals but are instead adjusted based on the allocation methodology. Changes in these estimates directly impact the amount of expense allocated to each segment and therefore the operating profit of each reporting segment.",
      "llm_answer": "The 2024 10-K filing explains that UPS uses activity-based costing to allocate operating expenses between its reportable segments, particularly U.S. Domestic Package and International Package. This allocation methodology requires estimates that directly impact the amount of depreciation and amortization attributed to each segment, as disclosed in Note 14 of the financial statements (page 126). The filing specifically states that depreciation and amortization totals presented for each segment are \"presented after applying activity based costing methods to allocate expenses between segments,\" meaning the reported depreciation and amortization figures for reportable segments are derived from this allocation process rather than being directly derived from segment-specific asset values.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the use of activity-based costing (ABC) to allocate expenses, the impact on depreciation and amortization totals, and the fact that these figures are presented 'after applying activity-based costing methods'—a direct quote from the 10-K. The reference to Note 14 on page 126 adds specificity and matches the source context. (2) There are no numeric values in the question or ground truth requiring calculation, so quantitative accuracy is not applicable in terms of computations, but all references (e.g., Note 14, page 126) are factually consistent with the filing. (3) The multi-hop reasoning is sound: the model correctly synthesizes that ABC affects expense allocation, which in turn impacts segment-level depreciation and amortization and ultimately operating profit—even though operating profit is not explicitly mentioned in the LLM answer, the focus on allocation impact is sufficient. (4) The only minor omission is that the LLM does not explicitly state that changes in estimates affect operating profit, which is included in the original answer. However, the core mechanism—allocation affecting segment expense totals—is clearly and correctly explained. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect, directly addressing how ABC affects the presentation of depreciation and amortization in segment reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 406,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "What was the total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest, and how did this affect their other income and interest expense?",
      "original_answer": "The total financial impact on Qualcomm in fiscal 2022 from the reversal of the European Commission fine and the associated interest was $1.162 billion, which included a $1.1 billion benefit in other income and a $62 million reduction in interest expense.",
      "llm_answer": "The reversal of the European Commission fine and associated interest had a positive financial impact on Qualcomm in fiscal 2022, resulting in a $1.1 billion benefit recorded in other income and a $62 million reduction in interest expense. This reversal eliminated the prior accrued fine and interest that had been recorded as other expenses and interest costs, respectively.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.1 billion benefit in other income and the $62 million reduction in interest expense, which matches the ground truth. The total financial impact of $1.162 billion is implied by the sum of these two components, though it is not explicitly stated as a total in the LLM answer. This is a minor omission but does not detract from factual correctness. (2) All numeric values are accurate: $1.1 billion and $62 million match the original answer. The formatting with thin spaces ( ) is acceptable and does not affect meaning. (3) The reasoning is sound—correctly attributing the reversal to a benefit in other income and reduced interest expense, and explaining that it reversed previously accrued liabilities. The multi-hop synthesis across the fine and interest components is logically presented. (4) The answer is contextually fully relevant, addressing both parts of the question: the total financial impact (via component breakdown) and the effect on other income and interest expense. The only reason for not scoring a 10 in correctness is the lack of explicit summation into a total $1.162 billion figure, which was part of the original answer. However, since the components are correct and sum to that total, the error is minor.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 360,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "By how much did the fair value of Fixed Income Commingled Trusts held by MDT increase from fiscal year 2023 to fiscal year 2024, and what was the proportion of this increase relative to the total increase in fair value across all investment categories?",
      "original_answer": "The fair value of Fixed Income Commingled Trusts increased by $305 million (from $968 million in 2023 to $1,273 million in 2024). The total increase in fair value across all investment categories was $153 million (from $3,398 million in 2023 to $3,551 million in 2024). However, since the increase in Fixed Income Commingled Trusts alone ($305 million) exceeds the total portfolio increase ($153 million), it indicates that other investment categories collectively decreased in value over the same period.",
      "llm_answer": "The fair value of Fixed Income Commingled Trusts held by the Medtronic Defined Contribution Plan (MDT) increased by $305 million from fiscal year 2023 to fiscal year 2024 (from $968 million to $1,273 million). This $305 million increase represented approximately 14 % of the total fair‑value increase across all investment categories in the plan.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM correctly identifies the $305 million increase in the fair value of Fixed Income Commingled Trusts (from $968M to $1,273M), which matches the ground truth. However, it incorrectly states that this $305M increase represents 14% of the total fair-value increase across all investment categories. This is factually wrong because the total increase across all categories was only $153 million (from $3,398M to $3,551M), meaning the $305M increase in Fixed Income Commingled Trusts exceeds the total portfolio increase. Therefore, the proportion cannot be 14%—it is mathematically impossible for a component increase to be a fraction of a smaller total increase. (2) The quantitative values for the Fixed Income Commingled Trusts are accurate, but the implied calculation of proportion (305 / total_increase) is incorrect. If the total increase were $153M, then 305 / 153 ≈ 199%, not 14%. The LLM likely inverted the ratio or used incorrect total increase data. (3) The multi-hop reasoning fails: the model should have recognized that the increase in this one category exceeds the total portfolio increase, implying declines in other categories. Instead, it presents a nonsensical proportion, indicating flawed synthesis. (4) Contextual relevance is high—the answer addresses the right entities, years, and metric—but the critical error in proportion calculation and reasoning severely undermines factual correctness, warranting a moderate score of 4 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 406,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does Morgan Stanley's SPOE strategy, as described in its resolution plan, specifically ensure adequate liquidity for its subsidiaries during a resolution scenario, and what role does Morgan Stanley Holdings LLC play in this process?",
      "original_answer": "Morgan Stanley's SPOE strategy ensures adequate liquidity for its subsidiaries during a resolution scenario by requiring the Parent Company to provide capital and liquidity through a secured amended and restated support agreement. Morgan Stanley Holdings LLC (Funding IHC) acts as a resolution funding vehicle, receiving ongoing asset transfers from the Parent Company. In a resolution scenario, the Parent Company is obligated to contribute all of its material assets (excluding shares in subsidiaries and certain other assets) to the Funding IHC, which then provides capital and liquidity to supported subsidiaries under the terms of the agreement.",
      "llm_answer": "Morgan Stanley’s resolution plan relies on an SPOE strategy that requires the Parent Company to provide capital and liquidity to its supported subsidiaries through a secured, amended and restated support agreement, ensuring they have the resources needed to execute the resolution. Morgan Stanley Holdings LLC (Funding IHC) acts as the resolution‑funding vehicle, receiving transferred assets from the Parent and being obligated to supply capital and liquidity to these subsidiaries under the same support agreement, thereby safeguarding adequate liquidity for the subsidiaries during a resolution scenario.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Morgan Stanley's SPOE strategy uses a secured amended and restated support agreement through which the Parent Company provides capital and liquidity; Morgan Stanley Holdings LLC (Funding IHC) serves as the resolution funding vehicle receiving asset transfers and distributing liquidity. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—score reflects absence of numerical errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes the roles of the Parent Company, the Funding IHC, and the support agreement across the resolution process. (4) The only minor omission is that the ground truth specifies the Parent Company must contribute 'all of its material assets (excluding shares in subsidiaries and certain other assets)' to the Funding IHC during resolution, which adds specificity not fully captured in the LLM response. However, the essence—that assets are transferred and used to support subsidiaries—is preserved. Wording differs slightly but meaning is semantically equivalent. Contextual relevance is perfect as all parts of the question are addressed with precise, relevant information.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 361,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Qualcomm's 2022 10-K projects that 60% of vehicles produced in 2028 will feature 5G connectivity, and also states that if Chinese OEMs shift away from using Qualcomm's integrated circuit products due to government actions, the company's revenues could be materially harmed. Given Qualcomm's dependency on Chinese markets and its strategic investments in 5G technologies, how does the company's growth strategy in automotive 5G adoption depend on maintaining access to Chinese OEMs?",
      "original_answer": "Qualcomm's growth strategy in automotive 5G adoption hinges on maintaining access to Chinese OEMs because the company projects that 60% of vehicles produced in 2028 will feature 5G connectivity, a market it aims to serve through its 5G technology investments. However, the 10-K explicitly states that if Chinese OEMs shift to using competitors' integrated circuit products or develop their own due to U.S. or Chinese government actions, Qualcomm's revenues could be materially harmed. Since China represents a major revenue source, any disruption in access to Chinese OEMs would directly undermine Qualcomm's ability to capitalize on the anticipated growth in 5G-enabled automotive platforms, thereby threatening its strategic expansion into this sector.",
      "llm_answer": "Qualcomm’s growth strategy in automotive 5G adoption hinges on its ability to retain access to Chinese OEMs, as the company projects that 60 % of vehicles produced in 2028 will include 5G connectivity and a substantial share of its revenue depends on those markets. If Chinese OEMs shift away from Qualcomm’s integrated circuit products due to government actions, the company warns that its revenues could be materially harmed, underscoring that maintaining relationships with Chinese OEMs is essential for realizing its automotive 5G growth ambitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: Qualcomm projects 60% of vehicles produced in 2028 will feature 5G connectivity, and a shift by Chinese OEMs away from Qualcomm’s integrated circuits due to government actions could materially harm revenues. These match the ground truth exactly. (2) Quantitative accuracy is perfect: the 60% figure is correctly cited, and no other numerical values or calculations are involved. Format (60 % vs 60%) is acceptable variation. (3) The multi-hop reasoning is sound—LLM correctly links Qualcomm’s strategic growth in automotive 5G to its dependency on Chinese OEMs, synthesizing the projection with the risk disclosure from the 10-K. The answer captures the cause-effect relationship: loss of access to Chinese OEMs threatens revenue and undermines growth in 5G automotive adoption. (4) The only minor shortcoming is slight omission of detail about U.S. or Chinese government actions being the potential trigger (the LLM mentions 'government actions' generally, while the original specifies both sides), and a brief mention of competitors or in-house development by OEMs is missing. However, the core logic and factual content are preserved with high fidelity. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 on correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 391,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the change in the total fair value of investments measured at net asset value for Medtronic (MDT) from fiscal year 2023 to 2024, and which category of investment contributed the most to this change?",
      "original_answer": "The total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024. The largest contributor to this change was the increase in equity commingled trusts, which rose by $269 million.",
      "llm_answer": "The total fair value of investments measured at net asset value increased by $46 million from fiscal year 2023 to 2024, and the category of investment that contributed the most to this change was registered investment companies.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both the quantitative change and the contributing investment category. The ground truth states that the total fair value of investments measured at net asset value for Medtronic (MDT) increased by $1,187 million from fiscal year 2023 to 2024, whereas the LLM reports only a $46 million increase, which is off by over 95%. Additionally, the largest contributing category was equity commingled trusts with a $269 million increase, but the LLM incorrectly identifies registered investment companies as the top contributor, without specifying any amount. (2) The calculation of the change in total fair value is severely inaccurate. The correct figure of $1,187 million is not close to the $46 million stated, indicating a failure in either data retrieval or synthesis. Furthermore, the LLM does not provide any supporting numbers for the claimed top category, making verification impossible. (3) The multi-hop reasoning is flawed. The question requires pulling data from two fiscal years (2023 and 2024) for Medtronic (MDT), computing the difference in total fair value of NAV-measured investments, and identifying which investment category had the largest increase. The LLM fails on both the calculation and entity identification, suggesting it either accessed incorrect documents or misidentified the relevant data points. (4) Despite the factual inaccuracies, the answer is contextually relevant—it addresses the right company (Medtronic), the right metric (fair value of investments at NAV), and attempts to name a contributing category. However, due to major errors in numbers and entity identification, the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 466,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What is the valuation basis for Schwab's repurchase liabilities related to client-held fractional shares, and how does this valuation approach ensure no income statement impact despite market value fluctuations?",
      "original_answer": "Schwab values its repurchase liabilities related to client-held fractional shares based on quoted market prices or other observable market data consistent with the related client-held fractional shares. Unrealized gains and losses on these repurchase liabilities exactly offset the unrealized gains and losses on the corresponding client-held fractional shares, resulting in no net impact to the consolidated statements of income. This offset mechanism ensures that despite market value fluctuations, there is no income statement effect.",
      "llm_answer": "Schwab values its repurchase liabilities for client‑held fractional shares at fair value, using observable market prices or other quoted market data consistent with the valuation of the underlying fractional shares. Because the liabilities are marked‑to‑market in the same direction as the related client assets, any unrealized gains or losses offset each other, resulting in no net impact on the income statement despite fluctuations in market value.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that Schwab values repurchase liabilities based on fair value using observable market prices or quoted market data consistent with the underlying fractional shares—matching the original answer's 'quoted market prices or other observable market data.' (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a strict sense, but the absence of incorrect numbers supports full credit. (3) The reasoning is sound: the LLM correctly explains the offsetting mechanism—unrealized gains/losses on liabilities mirror those on the corresponding client-held assets, leading to no net income statement impact—which reflects accurate multi-hop synthesis of valuation method and financial statement effect. (4) The answer fully addresses both parts of the question: the valuation basis and the reason for no income statement impact. Wording differs slightly (e.g., 'marked-to-market' vs 'fair value'), but these are standard financial synonyms and do not affect meaning. All entities (Schwab, repurchase liabilities, client-held fractional shares) are correctly identified and contextually used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 358,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan from December 31, 2020, to December 31, 2021, based on the disclosed annual expenses and deferred compensation liabilities?",
      "original_answer": "The total change in Schwab's projected benefit obligation for the Financial Consultant Career Achievement Plan was $18 million, increasing from $176 million at December 31, 2020, to $194 million at December 31, 2021.",
      "llm_answer": "The projected benefit obligation for the Financial Consultant Career Achievement Plan increased from $92 million at the beginning of 2020 to $119 million at the end of 2021, reflecting a $16 million benefit cost, an $11 million actuarial loss, and the prior‑year $83 million beginning balance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states the projected benefit obligation increased from $176 million on December 31, 2020, to $194 million on December 31, 2021, a change of $18 million. The LLM incorrectly reports the obligation as $92 million at the beginning of 2020 and $119 million at the end of 2021, which misrepresents both the starting point and the time frame. The LLM also references a 'prior-year $83 million beginning balance,' which contradicts the ground truth and introduces incorrect data. (2) The quantitative values are entirely incorrect: the correct starting balance is $176M (not $92M), ending balance is $194M (not $119M), and change is $18M (not $27M implied by $119M - $92M). The LLM's cited components ($16M benefit cost, $11M actuarial loss) do not align with the disclosed change of $18M and are not verifiable from the ground truth. (3) The multi-hop reasoning is flawed: the question asks for the change between Dec 31, 2020, and Dec 31, 2021, but the LLM uses a different time frame (beginning of 2020 to end of 2021) and fails to isolate the correct two-year change. It also introduces unverified components of the obligation change without proper synthesis. (4) The contextual relevance is moderate because the answer discusses the correct plan and type of obligation, but the incorrect numbers, time frame, and reasoning severely undermine accuracy. Correctness and quantitative accuracy are low due to fundamental factual and calculation errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1151,
        "completion_tokens": 422,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What is the combined revenue contribution of the Beauty segment, where Pantene holds a 20% global market share in hair care, and the Fabric & Home Care segment, which contributes 36% of net sales, as a percentage of Procter & Gamble's total net sales for the fiscal year?",
      "original_answer": "The combined revenue contribution is 54% of Procter & Gamble's total net sales for the fiscal year.",
      "llm_answer": "The Beauty segment's revenue contribution is not explicitly stated as a percentage of total net sales in the provided documents. However, the Fabric & Home Care segment contributes 36% of net sales. The question asks for the combined revenue contribution of Beauty and Fabric & Home Care as a percentage of total net sales. Since Beauty's exact percentage is not provided, but the document indicates Beauty holds a 20% global market share in hair care (which is part of its segment), and Fabric & Home Care is 36%, the combined contribution cannot be precisely determined from the given data. The document does not provide Beauty's segment revenue as a percentage of total net sales, only its market share in hair care. Therefore, the combined percentage cannot be calculated from the provided information. \n\n(Note: The document states Fabric & Home Care contributes 36% of net sales, but Beauty's segment contribution percentage is not specified. The 20% market share refers to hair care within Beauty, not the segment's overall revenue contribution.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect and contradicts the ground truth. The original answer states that the combined revenue contribution is 54%, implying that the Beauty segment contributes 18% (54% - 36%). However, the LLM claims that the Beauty segment's percentage of net sales is not provided and that the 20% market share in hair care cannot be used to determine segment revenue, concluding that the combined percentage cannot be calculated. This is incorrect reasoning because the question and ground truth imply that within the context of the knowledge graph, the Beauty segment’s revenue contribution is known and can be combined with Fabric & Home Care’s 36%. (2) The LLM fails to report the correct quantitative result of 54%, which is explicitly stated in the ground truth. It also does not perform the simple addition (18% + 36%) that underlies the answer, despite the necessary data being inferable from the context. (3) The multi-hop reasoning is flawed: the model confuses 'market share in a product category' (hair care) with 'segment revenue as a percentage of total sales', but in the context of the knowledge graph, these are treated as separate, known values. The model should have recognized that the Beauty segment’s revenue contribution is implicitly defined by the final answer, even if not directly stated in the prompt. (4) The contextual relevance is moderate because the LLM attempts to interpret the segments and percentages, but its failure to align with the ground truth data renders the response substantially incorrect. The answer should have matched the known combined percentage of 54% rather than asserting insufficiency of data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 459,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "What was the total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis, and how does this connect to the separation event described?",
      "original_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 specifically related to Carrier and Otis was $-410 million, which includes $187 million from Otis and $196 million from Carrier. This connects to the separation event described where, on April 3, 2020, UTC separated into three independent, publicly traded companies—UTC, Carrier, and Otis—and distributed all of the outstanding common stock of Carrier and Otis to UTC shareowners.",
      "llm_answer": "The total income (loss) from discontinued operations attributable to common shareowners in 2020 related to Carrier and Otis was **$ (410) million**, reflecting a $196 million loss from Carrier and a $187 million loss from Otis (plus $33 million of separation‑related transaction costs). This amount is presented in the “Income (loss) from discontinued operations attributable to common shareowners” line of the consolidated statement of operations and is part of the company’s restructuring of UTC into three independent entities—UTC, Carrier and Otis—completed on April 3 2020, which required reclassifying these businesses as discontinued operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the total income (loss) from discontinued operations as $-410 million, which matches the ground truth. It also correctly breaks this down into $196 million from Carrier and $187 million from Otis, aligning with the original answer. However, the LLM introduces an additional $33 million in separation-related transaction costs not present in the ground truth, which implies a calculation or sourcing error—this alters the interpretation of the components even if the total remains correct. (2) The total amount is accurate ($196M + $187M = $383M; the remaining $27M discrepancy is not explained in either answer, but the LLM attributes $33M to transaction costs, suggesting possible over-attribution). The ground truth does not mention transaction costs, so this addition is unverified and potentially incorrect. (3) The multi-hop reasoning is sound: the LLM correctly connects the financial impact to the April 3, 2020 separation event and explains that the businesses were reclassified as discontinued operations due to the restructuring into three independent companies. This demonstrates proper synthesis across financial reporting and corporate action data. (4) Despite the extraneous $33M detail, the core facts—total loss, component amounts, companies involved, and connection to the April 3, 2020 separation—are correct. The answer is highly relevant and well-reasoned, warranting a high score, but the unsupported transaction cost figure prevents a perfect quantitative and overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 424,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "Given the Diabetes Pump Retainer Ring Litigation details, what is the total number of individual plaintiffs that have filed lawsuits against Medtronic's Diabetes operating unit as of May 14, 2024, and how does this litigation compare in terms of potential future claimants to the hernia mesh-related lawsuits mentioned in the document?",
      "original_answer": "As of May 14, 2024, a total of 107 individual plaintiffs have filed lawsuits against Medtronic's Diabetes operating unit related to the Series 600 insulin pumps with allegedly defective clear retainer rings. Additionally, law firms have indicated that they may file lawsuits on behalf of thousands of additional claimants in the future. In comparison, there are approximately 6,700 plaintiffs in Massachusetts state court, 500 in Minnesota state court, and 1,150 in a federal Multidistrict Litigation (MDL) related to hernia mesh products, with more cases potentially being filed. Both litigations involve allegations tied to Medtronic products, and the company has not recorded any expense for damages in either case due to the uncertainty of probable and estimable loss.",
      "llm_answer": "As of May 14 2024, 27 lawsuits have been filed on behalf of a total of 107 individual plaintiffs in the Diabetes Pump Retainer Ring litigation.  This exposure is comparable to the hernia‑mesh cases, where roughly 8,350 individual plaintiffs are currently involved in coordinated litigation, and the company expects that additional future claimants could join those actions as well.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: 107 individual plaintiffs in the Diabetes Pump litigation is accurately reported. The hernia mesh litigation numbers are correctly synthesized: 6,700 (Massachusetts) + 500 (Minnesota) + 1,150 (federal MDL) = 8,350 total plaintiffs, which matches the LLM's statement. The mention of potential future claimants in both litigations is also consistent. (2) The date (May 14, 2024) is correctly referenced. (3) The reasoning is sound: the LLM correctly compares the current scale of both litigations and acknowledges the possibility of future claimants in both cases, showing proper multi-hop synthesis across the two product-related lawsuits. (4) The only minor shortcoming is that the LLM omits the detail that Medtronic has not recorded any expense for damages in either case due to uncertainty—this is a small but relevant contextual point from the original answer. However, this does not detract significantly from the overall correctness. Wording differences (e.g., 'exposure is comparable') are semantically equivalent and acceptable. All entities (Medtronic, Diabetes operating unit, insulin pump models, litigation types) are correctly identified. The answer fully addresses both parts of the question: the number of plaintiffs in the diabetes pump litigation and the comparison to hernia mesh cases.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 397,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the IDA agreement impact Schwab's capital management strategy, particularly in relation to off-balance sheet treatment of client deposits and Schwab's internal capital policy target range of 6.75%-7.00%?",
      "original_answer": "The IDA agreement requires that certain brokerage client deposits be swept off-balance sheet to TD Depository Institutions, reducing Schwab's on-balance sheet liabilities and affecting its capital utilization. Schwab manages capital to maintain a Tier 1 Leverage Ratio within a target range of 6.75%-7.00%, which is higher than the minimum regulatory requirement of 4%. The offloading of IDA balances helps Schwab optimize its balance sheet and maintain capital ratios above internal and regulatory thresholds, even during periods of balance sheet growth.",
      "llm_answer": "The IDA agreement allows Schwab to move client deposits off‑balance‑sheet, which directly affects its capital‑management strategy: by keeping those deposits off‑balance‑sheet, Schwab can preserve its Tier 1 Leverage Ratio and maintain the internal target range of 6.75%–7.00% for that ratio. This off‑balance‑sheet treatment of client cash is a key factor in Schwab’s effort to stay within its capital‑management objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) All key facts are accurate: the IDA agreement enables off-balance-sheet treatment of client deposits, which supports Schwab's capital management by preserving its Tier 1 Leverage Ratio; the internal target range of 6.75%-7.00% is correctly stated. (2) Quantitative accuracy is perfect: the percentage range (6.75%-7.00%) matches the original, and no calculations are required. (3) Multi-hop reasoning is sound—linking the IDA agreement to off-balance-sheet treatment, then to capital ratio management and internal policy targets. The only minor omission is that the original specifies TD Depository Institutions as the recipient of swept deposits and notes the regulatory minimum (4%), which adds context about why the internal target is conservative. While this enhances completeness, its absence does not undermine the core correctness. (4) The answer is highly relevant, directly addressing both parts of the question: impact on capital management and relation to the capital policy target. Wording differs but meaning is preserved. Thus, a high score is warranted with only slight deduction for minor contextual incompleteness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 341,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "What was the total net cash inflow from RTX's disposition of the Forcepoint business and how did it contribute to the overall net cash provided by investing activities in 2021 compared to 2020?",
      "original_answer": "The disposition of the Forcepoint business contributed to the $1.9 billion in net cash inflows from dispositions of businesses in 2021. This was part of the $4.7 billion improvement in cash flows from investing activities in 2021 compared to 2020, which was primarily due to the absence of the Raytheon Merger cash acquisition of $3.2 billion in the prior year and the proceeds from the Forcepoint and other business dispositions.",
      "llm_answer": "The total net cash inflow from RTX's disposition of the Forcepoint business was $1.9 billion, and this cash inflow contributed $1.9 billion to the net cash provided by investing activities in 2021, compared with $2.6 billion contributed in 2020.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1.9 billion net cash inflow from the disposition of the Forcepoint business in 2021, which matches the ground truth. However, it incorrectly states that $2.6 billion was contributed to investing activities in 2020, which is not supported by the original answer and introduces a false comparison. The original answer does not provide a specific figure for net cash from dispositions in 2020, nor does it state that $2.6 billion was contributed by dispositions that year. (2) The quantitative accuracy is partially correct—$1.9 billion is accurate, but the $2.6 billion figure is fabricated or misattributed, and the comparison is therefore invalid. There is no calculation error per se, but the introduction of an unsupported number undermines accuracy. (3) The multi-hop reasoning is flawed: the original answer explains that the $4.7 billion improvement in investing cash flows in 2021 vs 2020 was due to the absence of the $3.2 billion outflow from the Raytheon merger in 2020 and proceeds from dispositions like Forcepoint. The LLM fails to capture this causal structure and instead creates a direct year-over-year comparison of disposition contributions that is not in the source. It misses the key point that the improvement was driven by both reduced outflows (no merger) and increased inflows (dispositions). (4) The correctness score is 4 due to one major factual error (the $2.6B 2020 figure) and failure to explain the actual comparative dynamics. Quantitative accuracy is 5 because half the numbers are correct but the comparison is wrong. Qualitative accuracy is 4 due to flawed reasoning and incomplete synthesis. Contextual relevance is 7 because the answer addresses the right topic and company but misrepresents the comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 489,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Oracle's reliance on third-party colocation suppliers for global data centers impact the financial risk associated with Oracle Cloud Services, especially considering the long-term lease commitments and potential contract termination fees?",
      "original_answer": "Oracle delivers Oracle Cloud Services through global data centers, substantially all of which are leased through third-party colocation suppliers. Oracle has entered into long-term operating lease commitments with these providers, which often include significant contract termination fees if Oracle needs to exit these obligations early due to strategic changes. This creates financial risk, as Oracle may be locked into costly lease agreements even if demand for Oracle Cloud Services does not meet expectations or if market conditions change unfavorably. Additionally, Oracle depreciates these leased assets over their estimated useful lives, which could be shortened if Oracle's cloud strategy shifts, further impacting profitability.",
      "llm_answer": "Oracle's reliance on third‑party colocation providers for its global data‑center infrastructure creates significant financial risk for its Cloud Services. The company enters into long‑term lease commitments with these suppliers and may incur substantial termination fees if it needs to exit early, which can pressure profitability and cash flow. Additionally, any disruption or inability to renew these contracts could impair Oracle’s ability to deliver cloud services, further jeopardizing revenue and margins.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies Oracle's reliance on third-party colocation providers and the financial risks associated with long-term lease commitments and termination fees, which aligns with the ground truth. It accurately captures the core financial risk: being locked into costly leases even if demand or strategy changes, which could impact profitability and cash flow. The answer also appropriately highlights operational risks related to contract renewals and service delivery. However, it omits a key element from the original answer: Oracle depreciates leased assets over their useful lives, and a shift in cloud strategy could shorten these lives, further affecting profitability. This is a notable omission in the multi-hop reasoning, as it involves the interplay between lease commitments, asset depreciation, and strategic flexibility. There are no numerical inaccuracies (quantitative accuracy is perfect, though no specific numbers are cited), and all entities (Oracle, third-party colocation providers, lease commitments) are correct. The reasoning is sound but slightly incomplete. Contextual relevance is strong, as the response directly addresses the financial risk question with appropriate focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 342,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "What is the total number of shares available for future grants under both the 2020 Stock Incentive Plan and the 1993 Employee Stock Purchase Plan as of December 31, 2021, and how does this availability support UnitedHealth Group's share-based compensation strategy?",
      "original_answer": "As of December 31, 2021, UnitedHealth Group had 64 million shares available under the 2020 Stock Incentive Plan and 18 million shares available under the 1993 Employee Stock Purchase Plan, totaling 82 million shares available for future grants. This availability supports the company's share-based compensation strategy by ensuring sufficient shares are available for future stock options, restricted stock, and other equity awards, which are key tools in compensating employees and aligning their interests with shareholders.",
      "llm_answer": "As of December 31 2021, 64 million shares remained available for future grants under the 2020 Stock Incentive Plan and 18 million shares were available under the 1993 Employee Stock Purchase Plan, for a combined total of 82 million shares that could be issued for future equity awards. This reserve of shares provides the company with sufficient equity authorizations to continue rewarding employees and align executive interests with shareholders, supporting UnitedHealth Group’s broader share‑based compensation strategy of maintaining a robust, flexible equity pool to attract, retain and motivate talent while managing dilution.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 64 million shares under the 2020 Stock Incentive Plan and 18 million under the 1993 Employee Stock Purchase Plan, totaling 82 million shares—this sum is correct (64 + 18 = 82). The date 'December 31, 2021' is correctly stated. (2) The answer addresses both parts of the question: it provides the total number of shares available (82 million) and explains how this supports UnitedHealth Group's share-based compensation strategy. (3) Entity accuracy is perfect: both plan names are correctly identified, and the company (UnitedHealth Group) is properly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: it connects the availability of shares to strategic objectives like employee retention, motivation, and alignment with shareholders, while also mentioning dilution management—adding contextual depth beyond the original answer without introducing inaccuracies. The semantic meaning is equivalent to the ground truth, with slightly enhanced strategic context that remains factually consistent. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 331,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Schwab account for client-held fractional shares and their corresponding repurchase liabilities under GAAP, and where are these liabilities reflected on the consolidated balance sheet according to the 2022 10-K filing?",
      "original_answer": "Schwab accounts for client-held fractional shares as part of 'other securities owned' on the consolidated balance sheets, recording them at fair value based on quoted market prices or other observable market data. These shares are included in other assets, and unrealized gains and losses are recognized in earnings. For client-held fractional shares where off-balance sheet treatment under ASC 940 or derecognition criteria under ASC 860 are not met, Schwab recognizes related repurchase liabilities that are accounted for at fair value. These repurchase liabilities are reflected in 'accrued expenses and other liabilities' on the consolidated balance sheet, as disclosed in the 2022 10-K filing.",
      "llm_answer": "Schwab records client‑held fractional shares at fair value in “Other securities owned” and records an equal repurchase liability for those shares in accrued expenses and other liabilities on the consolidated balance sheet. This liability is presented within accrued expenses and other liabilities (see Note 2 and Note 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) It correctly identifies that Schwab records client-held fractional shares at fair value in 'Other securities owned' and recognizes a corresponding repurchase liability in 'accrued expenses and other liabilities'—this aligns with the original answer. The mention of Note 2 and Note 18 supports the disclosure location, which is consistent with the 2022 10-K. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic way; the absence of specific numbers is appropriate given the nature of the question. (3) The multi-hop reasoning is sound: the model correctly synthesizes accounting treatment (fair value), balance sheet presentation (asset and liability placement), and GAAP considerations (implied failure to meet derecognition criteria under ASC 940/860), even if not explicitly naming the standards. However, it omits explicit mention of the 'other assets' classification and the recognition of unrealized gains/losses in earnings, which are part of the full accounting treatment described in the original answer—hence a minor deduction in qualitative accuracy. (4) The answer is contextually precise, directly addressing how fractional shares and repurchase liabilities are accounted for and where they appear on the balance sheet. Overall, the response is factually correct, concise, and well-aligned with the 2022 10-K disclosures, missing only minor contextual details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 425,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Oracle's integration of Autonomous Database with OCI enable both cost reduction for customers and strategic growth in its cloud and license business?",
      "original_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by automating routine database administration tasks such as maintenance, tuning, patching, scaling, security, and backup, while also using machine learning-driven diagnostics to reduce human error and operational costs. This automation and efficiency lowers labor costs and allows for consumption-based pricing, where customers pay only for resources used. These cost-saving features directly support Oracle's strategic growth in its cloud and license business by encouraging customer migration to Oracle Cloud, particularly among existing Oracle customers using on-premise applications. The integration with other Oracle Cloud services like Java Cloud and Oracle APEX further enhances this migration by offering developers a modern, open platform for building cloud-native applications. As a result, Oracle can expand its cloud and license business by leveraging these technical capabilities to attract both new customers and a broader ecosystem of developers and partners.",
      "llm_answer": "Oracle's integration of Autonomous Database with OCI enables cost reduction for customers by providing automated, self-driving database operations that lower labor costs and eliminate human error, while its consumption-based pricing model ensures customers only pay for the resources they use. This integration also drives strategic growth in Oracle's cloud and license business by accelerating cloud adoption through seamless migration pathways, expanding the addressable market with flexible deployment options (including dedicated and sovereign cloud), and creating cross-sell opportunities for Oracle Cloud Services, SaaS applications, and license support contracts, as highlighted by the company's emphasis on \"material migration\" of its existing customer base to the cloud and the resulting increase in cloud services revenue share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the core mechanisms of cost reduction: automation of database operations (maintenance, tuning, patching, etc.), reduction of human error, and consumption-based pricing. These match the original answer's emphasis on automated administration and pay-per-use pricing. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly links cost savings to strategic growth via cloud migration, particularly among existing Oracle customers, and notes cross-sell opportunities with Oracle Cloud Services and SaaS, which is consistent with the original answer’s focus on expanding the cloud and license business. The mention of 'dedicated and sovereign cloud' and 'material migration' adds context supported by Oracle's public strategy, even if not in the original answer—this is a reasonable expansion, not a factual error. (4) The only minor gap is that the LLM omits specific examples of integrated services like Java Cloud and Oracle APEX, which the original answer cites as developer-facing tools enabling cloud-native development. This omission slightly reduces completeness but does not undermine the core factual or logical accuracy. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 409,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the financial implication for UnitedHealth Group if the AARP Program contract is transferred to another entity, considering the management and classification of AARP Program assets as described in the 10-K filing?",
      "original_answer": "If the AARP Program contract is transferred to another entity, UnitedHealth Group would be required to transfer cash equal to the fair value of the AARP Program assets at the date of transfer. These assets, which are managed separately from the company's general investment portfolio and used to fund medical costs payable and other related liabilities, are classified as current assets consistent with the liabilities they support. This would result in a direct reduction of both the company's current assets and the associated liabilities tied to the AARP Program, potentially impacting short-term liquidity depending on the fair value of the investments at the time of transfer.",
      "llm_answer": "The 10‑K indicates that AARP Program assets are held separately and, if the contract were transferred, the Company would have to transfer cash equal to the fair value of those assets at the transfer date — a liability that would be recorded as part of the RSF and other related AARP liabilities. Consequently, any such transfer would require a cash outflow equal to the fair‑value of the program’s assets, which is classified as a current liability (RSF) on the balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial implication: UnitedHealth Group would have to transfer cash equal to the fair value of the AARP Program assets if the contract is transferred. It accurately notes that these assets are held separately and that a cash outflow would result. However, there is a critical error in classification: the LLM incorrectly states that the obligation would be recorded as a current liability under 'RSF and other related AARP liabilities' and that the cash outflow corresponds to a liability. In the original answer, the assets are classified as *current assets*, not liabilities, and are used to fund liabilities — they are not liabilities themselves. The transfer would reduce both current assets and associated liabilities, not stem from a liability. This mischaracterization of the accounting treatment undermines the reasoning and shows a misunderstanding of the balance sheet impact. While the mention of RSF (Risk Sharing Fee) may be contextually related, the LLM misattributes the nature of the obligation. There are no numerical inaccuracies (hence high quantitative score), and the response is contextually relevant, but the qualitative reasoning is flawed in a way that affects the correctness of the financial interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 356,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "What is the fair value of Card Member and Other Loans, and how does it compare to the carrying value in relation to the Level 3 fair value hierarchy classification?",
      "original_answer": "The fair value of Card Member and Other Loans is $113 billion, while the carrying value is $110 billion. This fair value is entirely classified under Level 3 of the fair value hierarchy, indicating that it is based on unobservable inputs rather than market data.",
      "llm_answer": "The fair value of Card Member and Other Loans is not disclosed in the provided pages, but the document indicates that the fair value hierarchy classification for derivatives (which includes hedging instruments related to these loans) is Level 3. This is supported by the detailed discussion of fair value measurements for derivatives in Note 13, where derivatives are carried at fair value and their valuation involves significant judgment and unobservable inputs, consistent with Level 3 classification. The fair value of hedging instruments for fixed-rate debt is tracked separately (e.g., $11.7 billion of fixed-rate debt designated in fair value hedges as of December 31, 2023), but the loan portfolio itself is not explicitly valued at fair value in the disclosed notes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of factual content. The ground truth states that the fair value of Card Member and Other Loans is $113 billion and the carrying value is $110 billion, with the entire fair value classified under Level 3. However, the LLM claims this information is 'not disclosed' and instead discusses derivatives and hedging instruments, which are not the focus of the question. This represents a fundamental failure to retrieve and report the correct figures. (2) Quantitatively, the LLM fails to provide the correct numbers ($113B fair value, $110B carrying value) and instead cites $11.7 billion related to fixed-rate debt in fair value hedges — a figure that, while possibly accurate in context, is irrelevant to the specific question about Card Member and Other Loans. No correct calculations or comparisons between fair and carrying values are made. (3) The reasoning is flawed: the question requires a direct extraction and comparison of fair vs. carrying value for a specific asset class (Card Member and Other Loans) and its Level 3 classification. The LLM incorrectly shifts focus to derivatives and hedging instruments, suggesting a failure in multi-hop reasoning — it did not correctly identify or synthesize the relevant data points from the source material. (4) Contextual relevance is moderate because the LLM does engage with fair value hierarchy concepts and mentions Level 3, showing some understanding of the framework, but it applies the concept to the wrong financial instrument, making the response misleading despite partial topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 441,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How many shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan as of December 31, 2021, and what types of awards can these shares become the subject of?",
      "original_answer": "As of December 31, 2021, 64 million shares were available for future issuance under the UnitedHealth Group 2020 Stock Incentive Plan. These shares can become the subject of future awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards.",
      "llm_answer": "As of December 31, 2021, the UnitedHealth Group 2020 Stock Incentive Plan had 64 million shares remaining available for future issuance, and these shares may be used for a variety of award types—including stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock‑based awards.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual information matches: the number of shares available (64 million) and the date (December 31, 2021) are accurate. (2) The quantitative accuracy is perfect—'64 million shares' is correctly reported with no calculation required. (3) The qualitative accuracy is strong: the types of awards listed—stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, and other stock-based awards—are complete and correctly identified. (4) The answer addresses both parts of the multi-hop question: the quantity of shares available and the permissible award types under the plan. Wording differs slightly (e.g., 'remaining available' vs 'available for future issuance', 'may be used for' vs 'can become the subject of') but the meaning is identical. No factual, numerical, or contextual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 269,
        "total_tokens": 1450
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total estimated fair value of foreign government bonds and obligations held by the company in 2023, and how did this compare to the estimated fair value of the same category in 2022 for maturities of 12 months or more?",
      "original_answer": "The company held foreign government bonds and obligations with a total estimated fair value of $770 million in 2023. In comparison, the estimated fair value of the same category for maturities of 12 months or more in 2022 was $549 million, showing an increase of $221 million.",
      "llm_answer": "The total estimated fair value of foreign government bonds and obligations held by the company was $770 million as of December 31 2023 and $632 million as of December 31 2022. This represents an increase of $138 million in fair value from 2022 to 2023 for maturities of 12 months or more.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 fair value of foreign government bonds and obligations as $770 million, which matches the ground truth. However, it incorrectly reports the 2022 value as $632 million, whereas the ground truth specifies $549 million. This leads to an incorrect year-over-year increase of $138 million instead of the correct $221 million. (2) The calculation of the difference is mathematically correct based on the numbers provided by the LLM, but the underlying 2022 figure is wrong, making the comparison inaccurate. The correct increase should be $770M - $549M = $221M, not $138M. (3) The reasoning structure is sound—multi-hop comparison across two years for the same category with maturities of 12 months or more is appropriately addressed—but the model fails in retrieving the correct 2022 value, undermining the synthesis. (4) Scores reflect that core facts (2023 value) are correct and the response is contextually relevant, but major quantitative inaccuracies in the 2022 figure and resulting delta significantly reduce correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 316,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "What was the total capital expenditure in the Africa/Eurasia region in 2021, and how does this compare to the capital expenditure in the same region in 2019?",
      "original_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $8 million in 2019. This represents an increase of $25 million over the two-year period.",
      "llm_answer": "The total capital expenditure in the Africa/Eurasia region was $33 million in 2021 and $13 million in 2019. This represents an increase of $20 million from 2019 to 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the capital expenditure for 2021 ($33 million), which matches the ground truth. However, it incorrectly reported the 2019 capital expenditure as $13 million, whereas the ground truth is $8 million. This error leads to an incorrect difference calculation: the LLM states an increase of $20 million, but the actual increase is $25 million ($33M - $8M). (2) Quantitative accuracy is compromised due to the incorrect 2019 figure and resulting miscalculation. While $33 million in 2021 is accurate, the $13 million for 2019 is off by $5 million, significantly affecting the comparison. (3) The reasoning structure is sound—multi-hop synthesis is attempted by comparing two time points in the same region—and the logic of computing the difference is correct, but it operates on flawed data. (4) Contextual relevance is high because the answer addresses both parts of the question (expenditure in 2021, comparison with 2019) and uses the correct metric (capital expenditure) in the correct region (Africa/Eurasia). However, due to the significant numerical error in the 2019 value and the resulting incorrect delta, the overall correctness score is reduced to 4, reflecting partial accuracy with major factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1088,
        "completion_tokens": 352,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the percentage change in Johnson & Johnson's worldwide sales of Contact Lenses/Other within the Vision segment from 2020 to 2021, and how did this performance compare to the overall growth rate of the broader Vision segment during the same period?",
      "original_answer": "The worldwide sales of Contact Lenses/Other grew by 14.9% from 2020 to 2021, while the broader Vision segment grew by 19.6% during the same period. This indicates that the Contact Lenses/Other category underperformed relative to the overall Vision segment's growth rate.",
      "llm_answer": "The worldwide sales of Johnson & Johnson's Contact Lenses/Other within the Vision segment grew by 14.9% from 2020 to 2021, increasing from $2,994 million to $3,440 million. This growth outpaced the overall Vision segment sales increase of 19.6% over the same period.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 14.9% growth in Contact Lenses/Other sales from 2020 to 2021 and provides accurate dollar figures ($2,994 million to $3,440 million), which align with the ground truth. The overall Vision segment growth rate of 19.6% is also correctly stated. However, the LLM makes a critical error in the qualitative comparison: it states that the Contact Lenses/Other growth 'outpaced' the overall Vision segment, when in fact 14.9% is less than 19.6%, meaning it underperformed. This reverses the correct conclusion. (2) Quantitatively, all numbers are accurate—percentage change and dollar amounts match the ground truth (with acceptable formatting). The 14.9% and 19.6% figures are correct, and the dollar values support the stated growth rate. (3) The multi-hop reasoning fails at the synthesis stage: while the model retrieves correct data for both the subcategory and the broader segment, it incorrectly interprets the comparative performance. This indicates a flaw in logical reasoning despite correct data retrieval. (4) Scores reflect high quantitative accuracy and contextual relevance (all data points are on-topic and correctly extracted), but reduced qualitative accuracy due to the incorrect comparative conclusion, which is central to the question. The correctness score is moderately reduced because the core numerical facts are right, but the key inference is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 393,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What was the total weighted-average grant price for Service and Performance-Based RSUs that were outstanding as of December 31, 2021, considering both the beginning balance and new grants during the year?",
      "original_answer": "$114.22 million for the outstanding shares as of December 31, 2021, which includes the impact of new grants at $125.02 million during the year.",
      "llm_answer": "The total weighted‑average grant price for Service and Performance‑Based RSUs outstanding as of December 31 2021, reflecting both the beginning balance and new grants during the year, was $114.22 per share.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states the total weighted-average grant price as $114.22 per share, while the original answer specifies $114.22 million as the total value for outstanding shares. This is a critical error in both unit (per share vs. total value) and magnitude (the answer should be a total dollar amount, not a per-share price). The ground truth also mentions new grants during the year were $125.02 million, which the LLM omits entirely. (2) Quantitatively, the number $114.22 is present but misinterpreted as a per-share price rather than a total value in millions. The absence of the $125.02 million figure for new grants further reduces quantitative accuracy. (3) The reasoning partially captures the correct endpoint (total value as of December 31, 2021) but fails to reflect the multi-hop synthesis of beginning balance and new grants, and misrepresents the nature of the metric (total value vs. per-share price). (4) Contextual relevance is high because the answer addresses the correct metric type and time frame, and qualitative accuracy is moderate due to correct identification of the $114.22 million figure, albeit with incorrect interpretation. However, the failure to accurately report units and missing data on new grants significantly undermines correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1101,
        "completion_tokens": 363,
        "total_tokens": 1465
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "By how much did Boeing's outstanding balance for its 1.43%-2.50% unsecured bonds due through 2032 decrease from 2023 to 2024, and what percentage did this tranche represent of the company's total debt in 2024?",
      "original_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million (from $10,135 million in 2023 to $6,159 million in 2024). In 2024, this tranche represented approximately 11.43% of Boeing's total debt of $53,864 million.",
      "llm_answer": "The outstanding balance for Boeing's 1.43%-2.50% unsecured bonds due through 2032 decreased by $3,976 million from 2023 to 2024, falling from $10,135 million to $6,159 million. This tranche represented approximately 11.4% of the company's total debt in 2024, based on the total debt of $53,864 million reported at the end of 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the decrease in outstanding balance is correctly stated as $3,976 million, calculated from $10,135 million in 2023 to $6,159 million in 2024. (2) The percentage of total debt in 2024 is reported as approximately 11.4%, which is a valid rounding of the exact value (11.43%) from the ground truth; this is semantically equivalent and acceptable. The total debt figure of $53,864 million is correctly cited. (3) The multi-hop reasoning—linking the bond tranche balance in two years, computing the difference, and calculating its proportion of total debt—is sound and accurately synthesized across required data points. (4) All entities (Boeing, unsecured bonds with specified coupon and maturity range, years 2023 and 2024) are correctly identified and referenced. The answer is complete, precise, and contextually appropriate, addressing both sub-questions in the multi-part query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 282,
        "total_tokens": 1447
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What was the combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021, and what percentage did this represent of the total Orthopaedics revenue for that year?",
      "original_answer": "The combined revenue from Knees and Hips in 2021 was $2,810 million ($1,325 million from Knees and $1,485 million from Hips). This represented 32.7% of the total Orthopaedics revenue of $8,588 million in 2021.",
      "llm_answer": "The combined revenue from Knees and Hips in Johnson & Johnson's Orthopaedics segment in 2021 was $2,810 million ($1,325 million for Knees + $1,485 million for Hips). This represented approximately 10.4 % of the total Orthopaedics revenue of $27.1 billion for that year.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the combined revenue from Knees and Hips as $2,810 million, with accurate component values of $1,325 million (Knees) and $1,485 million (Hips), which matches the ground truth. However, the percentage calculation is incorrect. The LLM states this represents approximately 10.4% of total Orthopaedics revenue, but uses a total revenue figure of $27.1 billion, which is wrong. The correct total Orthopaedics revenue in 2021 was $8,588 million, not $27.1 billion. Using the correct total, the percentage is $2,810 / $8,588 ≈ 32.7%, as stated in the ground truth. The $27.1 billion figure appears to be a confusion with Johnson & Johnson's total company-wide revenue, not the Orthopaedics segment. (2) Number verification: $1,325M + $1,485M = $2,810M — correct. $2,810M / $8,588M = 32.7% — correct. LLM used $2,810M / $27,100M ≈ 10.4% — mathematically correct but based on wrong denominator. (3) Multi-hop reasoning: The model correctly retrieved product-line revenues but failed to correctly identify the total revenue for the Orthopaedics segment, breaking the synthesis chain. This indicates a failure in entity scoping (segment vs. company-level revenue). (4) Correctness score is 4 due to one major factual error in total segment revenue that invalidates the percentage, despite correct component numbers. Quantitative accuracy is 5 because half the numbers are correct but the key derived metric is wrong. Qualitative accuracy is 5 due to flawed reasoning in segment revenue identification. Contextual relevance is 9 as the answer addresses the right question with mostly relevant data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 446,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "What is the total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing, and why were these shares excluded?",
      "original_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 20.8 million. These shares were excluded because the effect would have been antidilutive due to Boeing incurring a net loss in those periods.",
      "llm_answer": "The total number of potential common shares excluded from the computation of diluted loss per share for the three fiscal years covered in Boeing's 2024 10-K filing is 11.6 million for 2024, 5.7 million for 2023, and 3.5 million for 2022. These shares were excluded because the effect of including them would have been antidilutive due to the company incurring a net loss in each of these periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer provides a breakdown of excluded shares per year (11.6M in 2024, 5.7M in 2023, 3.5M in 2022), which sum to 20.8 million—the same total as the ground truth. However, the ground truth does not provide a year-by-year breakdown, and the total is the key figure requested. The LLM introduces specific annual figures that are not confirmed in the original answer, and there is no indication in the ground truth that these individual values are correct. Therefore, while the sum of the LLM's numbers matches, the individual components may be inaccurate or fabricated, which undermines quantitative accuracy. (2) The explanation for exclusion—antidilutive effect due to net losses—is semantically equivalent and correct, satisfying the qualitative reasoning component. (3) The multi-hop reasoning is partially sound: the model correctly identifies the concept of antidilution in the context of net losses and applies it across multiple years. However, the introduction of unverified annual figures suggests potential hallucination or incorrect sourcing, weakening the synthesis. (4) The correctness score is 4 because the total is accurate only if the sum is inferred, but the answer presents disaggregated data not in the ground truth, risking misinformation. Quantitative accuracy is low (3) due to unverified component numbers despite correct total sum. Qualitative accuracy is moderate (6) as the reasoning and terminology are correct. Contextual relevance is high (9) because the response directly addresses both parts of the question with relevant logic and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 437,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "By how much did the amendment to the Retirement Value formula in 2021 reduce the Projected Benefit Obligation as of January 3, 2021, and how does this change affect the calculation of pension benefits for U.S. non-union employees hired before 2015?",
      "original_answer": "The amendment to the Retirement Value formula in 2021 reduced the Projected Benefit Obligation as of January 3, 2021 by approximately $1.8 billion. This change affects the calculation of pension benefits for U.S. non-union employees hired before 2015 by transitioning them from the Final Average Pay formula to the Retirement Value formula for benefits earned after January 1, 2026, while preserving the Final Average Pay formula for service before that date.",
      "llm_answer": "The amendment to the Retirement Value formula reduced the Projected Benefit Obligation as of January 3, 2021 by approximately **$1.8 billion**. This change affects U.S. non‑union employees hired before 2015 by shifting their future pension accruals from the Final Average Pay formula to the Retirement Value formula, but it does not alter the benefits already earned under the Final Average Pay formula for service prior to January 1, 2026.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the $1.8 billion reduction in Projected Benefit Obligation as of January 3, 2021 is accurately reported. (2) The answer correctly addresses both parts of the multi-hop question: the financial impact of the amendment and its effect on pension benefit calculations for U.S. non-union employees hired before 2015. (3) The reasoning is sound: it correctly explains that future accruals after January 1, 2026 will use the Retirement Value formula, while preserving the Final Average Pay formula for prior service, which matches the original answer’s meaning. (4) All entities (e.g., U.S. non-union employees, Final Average Pay, Retirement Value formula, correct effective date) are accurately identified and synthesized. Minor wording differences (e.g., 'shifting future pension accruals' vs 'transitioning for benefits earned after') do not affect factual accuracy. No errors in logic, numbers, or context.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 287,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "Given that American Express's financial assets and liabilities carried at amortized cost are based on market conditions and perceived risks as of specific dates, why does the filing state that the fair value of the company cannot be estimated by aggregating these figures?",
      "original_answer": "The filing explains that the fair value figures for financial assets and liabilities measured at amortized cost are estimates based on market conditions and perceived risks as of December 31, 2021 and 2020. These estimates require management judgment and are not indicative of future fair values. Furthermore, the filing explicitly states that the fair value of American Express as a whole cannot be estimated by aggregating the fair values of individual financial instruments because doing so would not capture the company's overall valuation, which includes non-financial factors and the complexities of the business as a whole.",
      "llm_answer": "The filing states that the fair value of the company cannot be estimated by aggregating the amortized‑cost figures because those figures are only estimates based on market conditions and perceived risks as of specific dates, and they do not reflect the full range of assets and liabilities or the dynamic market conditions that determine overall fair value. Consequently, combining them would not provide a reliable measure of the company’s total fair value.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core reason why American Express's fair value cannot be estimated by aggregating amortized-cost figures—namely, that these values are only estimates based on specific dates and do not reflect the full complexity of the company's overall valuation. The answer accurately reflects that fair value estimates rely on market conditions and perceived risks as of a point in time, which aligns with the ground truth mentioning December 31, 2021 and 2020. While the LLM does not explicitly name those dates, it correctly refers to 'specific dates,' preserving semantic equivalence. (2) There are no numerical inaccuracies; the response avoids citing specific dollar amounts or percentages, so no calculation errors occur. The absence of exact dates is acceptable under semantic equivalence since the concept of 'as of specific dates' is preserved. (3) The multi-hop reasoning is sound: the model correctly infers that aggregating individual financial instrument values does not equate to company-level fair value due to omissions like non-financial assets and business complexities. However, the LLM omits explicit mention of non-financial factors and the business-as-a-whole concept, which are key elements in the original answer. This is a minor but notable omission affecting completeness. (4) The contextual relevance is perfect—the response directly addresses the question and stays focused. The qualitative accuracy is slightly reduced due to the missing emphasis on non-financial components, but the reasoning remains logically consistent and factually aligned in substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 445,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How many amendments to the Benefits Plan for Members of the Board of Directors are explicitly listed in the exhibit index, and what were the effective dates of the original plan and its first amendment?",
      "original_answer": "There are two explicitly listed amendments to the Benefits Plan for Members of the Board of Directors. The original plan was effective on April 14, 2004, and the first amendment was dated December 16, 2005.",
      "llm_answer": "The exhibit index lists **one amendment** to the Benefits Plan for Members of the Board of Directors (Amendment Number One, dated December 16, 2005). The original Benefits Plan for Members of the Board of Directors was adopted effective January 1, 2004, and its first amendment became effective December 16, 2005.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a critical error in the count of amendments. The ground truth states there are two explicitly listed amendments, but the LLM reports only one, missing the second. This is a significant factual omission affecting correctness. (2) Regarding dates, the LLM correctly identifies the first amendment date as December 16, 2005. However, it incorrectly states the original plan's effective date as January 1, 2004, whereas the ground truth specifies April 14, 2004—this is a factual error in quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model correctly links the amendment to the plan and provides effective dates where available, but fails to fully extract all amendments from the exhibit index, indicating incomplete synthesis or parsing of the document. (4) Despite the wrong amendment count and original date, the answer addresses all parts of the question and uses appropriate financial/legal terminology, earning high marks for contextual relevance. The qualitative accuracy is reduced due to incorrect entity (date) identification and incomplete information retrieval.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1143,
        "completion_tokens": 329,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Oracle's hybrid deployment model contribute to the cloud and license business representing 84% of total revenues in fiscal 2024?",
      "original_answer": "Oracle's hybrid deployment model, which combines on-premise and cloud-based deployment options, provides customers with flexibility and choice, enabling them to select the deployment model that best suits their needs. This flexibility enhances customer retention and satisfaction, as evidenced by the high renewal rate of license support contracts. The cloud and license business, which includes these support contracts priced as a percentage of the net fees paid by customers, accounted for 84% of Oracle's total revenues in fiscal 2024. This indicates that the hybrid model not only supports customer adoption but also directly drives a significant portion of Oracle's revenue through recurring license support streams.",
      "llm_answer": "Oracle's hybrid deployment model—combining on-premise, cloud, and hybrid configurations—enabled customers to leverage existing on-premise investments while adopting cloud services, driving higher adoption of subscription-based cloud and license offerings. This flexibility increased cloud services revenue recognition (recognized ratably over contract terms) and boosted the proportion of cloud and license revenues, which represented 84% of total fiscal 2024 revenue, as customers migrated workloads to Oracle Cloud and renewed support contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 84% figure for cloud and license revenue as a portion of total revenue in fiscal 2024 is correctly stated, with no numerical errors. (2) The entity identification is correct—Oracle, fiscal 2024, cloud and license business—and the financial metric is accurately represented. (3) The reasoning is sound: the hybrid deployment model's flexibility is correctly linked to customer adoption and revenue generation through subscription and support contracts. The LLM emphasizes revenue recognition over contract terms and migration to Oracle Cloud, which complements the ground truth's focus on renewal rates and recurring revenue. (4) The only minor gap is that the LLM does not explicitly mention the high renewal rate of license support contracts or that support fees are priced as a percentage of net fees—details present in the original answer that explain *why* the revenue stream is recurring and stable. However, the core causal chain—hybrid model → customer flexibility → increased adoption and renewals → 84% revenue contribution—is correctly synthesized. Wording differs but semantic meaning and factual content are substantially equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 381,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How much of American Express's December 31, 2021 deferred fees are specifically tied to Membership Rewards program participants, and how does this relate to the methodology used to estimate the future redemption liability for these points?",
      "original_answer": "The deferred fees tied to Membership Rewards program participants are specifically called out in the $8,737 million total deferred card and other fees as of December 31, 2021. This connects to the methodology used to estimate the future redemption liability, which relies on statistical and actuarial models using the weighted average cost (WAC) per point and the Ultimate Redemption Rate (URR) based on factors like redemption trends, card product type, and credit attributes.",
      "llm_answer": "Based on the provided document pages, specifically page 129, the Membership Rewards liability as of December 31, 2021, was $11,398 million. This liability represents management's estimate of the cost of points expected to be redeemed, with the estimation methodology relying on the Ultimate Redemption Rate (URR) and weighted average cost (WAC) per point assumptions. The URR is statistically modeled using redemption trends, card product type, enrollment tenure, card spend levels, and credit attributes, while the WAC per point is derived from 12 months of redemption data and adjusted for future cost expectations. The document does not specify the exact portion of the $11,398 million liability directly attributable to Membership Rewards program participants versus other components, but it clarifies that the liability is tied to the program's redemption estimates. The methodology for estimating future redemption liability is explicitly described as using URR and WAC assumptions within the Membership Rewards section on page 129.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the Membership Rewards liability as of December 31, 2021, was $11,398 million, which directly contradicts the ground truth stating that the total deferred card and other fees were $8,737 million, with a portion of that tied to Membership Rewards participants. The $11,398 million figure does not appear in the ground truth and is therefore factually incorrect. Additionally, the LLM fails to specify the exact amount of deferred fees tied to Membership Rewards participants, which is a key part of the question. Instead, it incorrectly implies that the entire liability is $11,398 million without confirming how much of the $8,737 million total deferred fees is attributable to Membership Rewards. (2) The quantitative inaccuracy is severe: the core dollar amount is wrong, and no correct breakdown is provided. The ground truth clearly identifies $8,737 million as the total deferred fees, with Membership Rewards being a component of that, not a larger separate liability. There is no indication in the ground truth that the Membership Rewards liability exceeds the total deferred fees. (3) The reasoning regarding the methodology (use of URR and WAC) is accurate and reflects correct multi-hop understanding of how American Express estimates future redemption liability. The explanation of statistical modeling based on redemption trends, card product type, and credit attributes aligns with the ground truth. However, this correct qualitative reasoning cannot compensate for the fundamental error in the key financial figure. (4) The contextual relevance is moderate because the LLM addresses the right topic and correctly explains the estimation methodology, but the answer is built on a false quantitative foundation. Due to the major factual error in the dollar amount and the failure to identify the specific portion of deferred fees tied to Membership Rewards, the overall correctness score is low despite some accurate conceptual explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 540,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How many different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021, based on filings listed in the 2024 10-K report?",
      "original_answer": "16 different forms of award agreements under The Coca-Cola Company 2014 Equity Plan were documented between February 18, 2015, and February 17, 2021.",
      "llm_answer": "Based on the provided pages from the 2024 10-K filing, the Company documented **10 distinct forms of award agreements** under The Coca-Cola Company 2014 Equity Plan between February 18, 2015, and February 17, 2021. These are explicitly listed in the \"10.5\" section of the filing, covering agreements adopted on February 17, 2016 (10.5.3–10.5.4), February 15, 2017 (10.5.5–10.5.7), February 14, 2018 (10.5.9–10.5.10), February 20, 2019 (10.5.11–10.5.13), February 19, 2020 (10.5.14–10.5.16), and February 17, 2021 (10.5.18–10.5.21). Each entry corresponds to a unique agreement type (e.g., Stock Option, Restricted Stock Unit, Performance Share), totaling 10 documented forms within the specified date range.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer states 10 distinct forms of award agreements, while the ground truth is 16, making the core quantitative claim incorrect. This is a significant factual error. (2) The LLM provides specific exhibit numbers (e.g., 10.5.3–10.5.4, up to 10.5.21) and maps them to dates and agreement types, but the total count is wrong. The listed ranges suggest more than 10 entries (e.g., 10.5.18–10.5.21 alone is 4 agreements), and the sequence skips 10.5.1, 10.5.2, 10.5.8, 10.5.17—potentially unaccounted agreements. The LLM fails to recognize that the full set of exhibits between 10.5.1 and 10.5.21 (excluding only gaps due to re-adopted forms) totals 16, not 10. (3) The reasoning appears structured and attempts multi-hop synthesis by linking dates, exhibit numbers, and agreement types, but it miscounts the total number of forms, indicating a failure in either document interpretation or aggregation. The logic of counting each exhibit as a unique form is sound, but the execution is flawed. (4) Despite correct contextual framing and relevant section citation (Item 10.5), the answer is factually inaccurate on the key metric. Quantitative accuracy is low due to the incorrect count. Qualitative accuracy is partially correct in method but flawed in conclusion. Contextual relevance is high as the response directly addresses the question scope and cites appropriate filing sections.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 389,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "Considering AMD's purchases from and equity gains with the ATMP JV in 2021, what was the total financial value of AMD's relationship with the ATMP JV that year, and how does this reflect the strategic importance of the joint venture?",
      "original_answer": "The total financial value of AMD's relationship with the ATMP JV in 2021 was $1.106 billion, combining $1.1 billion in purchases and a $6 million equity gain. This reflects the strategic importance of the joint venture as AMD relies on ATMP JV for critical assembly, test, mark, and packaging (ATMP) services, and maintains a 15% equity stake that gives it significant influence without the obligation to fund further investments.",
      "llm_answer": "Based on the provided document pages, AMD's total financial relationship with the ATMP JV in 2021 was $1.1 billion in purchases from the JV, supplemented by $28 million in sales to the JV and a $6 million equity gain recognized in income. This substantial transaction volume, combined with the $69 million carrying value of AMD's investment and the strategic management of inventory through the partnership, underscores the ATMP JV's critical role in AMD's supply chain and operational strategy, reflecting its importance in securing manufacturing capabilities and cost efficiencies.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that AMD had $1.1 billion in purchases and a $6 million equity gain, totaling $1.106 billion. However, the LLM claims $1.1 billion in purchases (correct), but adds $28 million in sales *to* the JV — a figure not mentioned in the ground truth and not relevant to the 'total financial value of AMD's relationship' from AMD's side. This inflates the perceived value and misrepresents the nature of the financial flows. Additionally, the LLM mentions a $69 million carrying value of the investment, which is absent from the original answer and not requested in the question. (2) The calculation of total value is incorrect: the LLM does not sum purchases and equity gain into a single total ($1.106B), and instead introduces irrelevant figures. The core total value of $1.106B is missing from the response. (3) The reasoning partially reflects multi-hop understanding — it recognizes that purchases, equity gains, and strategic influence matter — but fails to synthesize the correct components. It correctly infers strategic importance but bases it on extraneous data (e.g., sales to JV, carrying value). (4) Despite incorrect numbers, the answer captures the strategic rationale — that the JV is important for ATMP services and supply chain stability — which aligns with the original's conclusion. Contextual relevance is high because it addresses both financial value and strategic importance, but quantitative accuracy is low due to fabricated or misapplied figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 430,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Given that DARZALEX and DARZALEX FASPRO together accounted for 6.4% of Johnson & Johnson's total revenues in fiscal 2021 and their respective patent protections expire in 2029 (U.S.) and 2032 (Europe) for DARZALEX and are covered by a separate Janssen-owned portfolio for DARZALEX FASPRO, what is the earliest year that patent expiration could begin to materially impact this combined revenue stream?",
      "original_answer": "The earliest year that patent expiration could begin to materially impact the combined revenue stream of DARZALEX and DARZALEX FASPRO is 2029, when the U.S. patents for DARZALEX expire, potentially allowing competitors to introduce biosimilars in the U.S. market, which accounts for a significant portion of Johnson & Johnson's global sales.",
      "llm_answer": "Based on the document, the combined DARZALEX and DARZALEX FASPRO revenue represented 6.4% of J&J's total 2021 sales, and the patents covering them expire in 2029 (U.S.) and 2032 (Europe). The earliest year patent expiration could begin materially impacting this revenue stream is 2029.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: DARZALEX and DARZALEX FASPRO accounted for 6.4% of Johnson & Johnson's 2021 revenues, and the U.S. patent for DARZALEX expires in 2029, which is the earliest point at which patent expiration could materially impact the combined revenue stream. The quantitative accuracy is perfect—6.4%, 2029, and 2032 are all correctly cited. The reasoning is sound: since the U.S. market is a major contributor to global pharmaceutical sales and the U.S. patent expires first in 2029, that is the earliest year for material impact. The only minor shortcoming is that the LLM does not explicitly mention the potential entry of biosimilars or the significance of the U.S. market, which the ground truth includes for context. However, the omission does not detract from the factual correctness or the logical conclusion. The answer is semantically equivalent and contextually appropriate, with accurate multi-hop synthesis between revenue contribution, patent expiration timelines, and geographic markets.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 296,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "What is the total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented across both 2015 and 2018, as disclosed in the 2022 10-K filing?",
      "original_answer": "The total number of amendments to The Bank of New York Company, Inc. Excess Benefit Plan documented in the 2022 10-K filing for the years 2015 and 2018 is two: one amendment effective June 30, 2015, and another effective November 1, 2018.",
      "llm_answer": "The 2022 10-K filing discloses that The Bank of New York Company, Inc. Excess Benefit Plan was amended twice: once effective January 1, 2009 (documented as Amendment to The Bank of New York Company, Inc. Excess Benefit Plan in Exhibit 10.23 on page 18), and again effective November 1, 2018 (documented as Amendment effective as of Nov. 1, 2018 to The Bank of New York Company, Inc. Excess Benefit Plan in Exhibit 10.37 on page 20). These are the only two amendments to this specific plan referenced in the provided pages covering both 2015 and 2018 disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in identifying the amendments. The ground truth states there were two amendments—one in 2015 (effective June 30, 2015) and one in 2018 (effective November 1, 2018). However, the LLM incorrectly identifies the first amendment as effective January 1, 2009, which is outside the requested years (2015 and 2018). While the 2018 amendment is correctly identified, the 2015 amendment is entirely missing and replaced with an irrelevant 2009 amendment. (2) Quantitative accuracy is low: the years 2009 and 2015 are not interchangeable, and the omission/misstatement of the 2015 amendment leads to an incorrect basis for the total count—even though the total number of amendments cited (two) matches, one of the two is wrong in date and context, making the count misleading. The model fails to correctly extract the 2015 amendment, which invalidates the quantitative accuracy. (3) The reasoning is flawed in multi-hop synthesis: the question specifically asks for amendments documented in the 2022 10-K filing *for the years 2015 and 2018*. The model locates two amendments in the filing but fails to filter them by the correct years, instead including a 2009 amendment and omitting the 2015 one. This shows a failure in cross-temporal entity alignment and proper filtering based on the question’s constraints. (4) Contextual relevance is moderate—the answer discusses the correct plan and filing, references exhibit numbers and pages, and attempts to list amendments, so it is on-topic. However, due to the critical error in dates and missing the correct 2015 amendment, the factual core is incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 459,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How do FedEx's Network 2.0 optimization expenditures and European workforce reduction costs relate to the company's overall 2025 capital expenditure plan and strategic DRIVE transformation program?",
      "original_answer": "FedEx's 2025 capital expenditure plan totals $5.2 billion, with a portion allocated to Network 2.0 optimization. Specifically, the company is investing in network optimization and facility modernization as part of this initiative. Additionally, FedEx Express announced a European workforce reduction plan tied to cost-cutting efforts, with expected cash expenditures ranging from $250 million to $375 million through fiscal 2026. These workforce reduction costs are classified as business optimization expenses and support the DRIVE transformation program, which aims to improve long-term profitability. The capital allocation for Network 2.0 and the European workforce reductions are strategic components of FedEx's broader efforts under the DRIVE initiative to enhance operational efficiency and reduce structural costs.",
      "llm_answer": "FedEx's Network 2.0 optimization spending and the European workforce‑reduction costs are classified as business‑optimization expenses within the company’s broader 2025 capital‑expenditure framework and its DRIVE transformation program. These costs are being funded from operating cash flow and the firm’s available liquidity, and they are incorporated into the 2025 capital‑expenditure plan that calls for roughly $5.2 billion of capex—consistent with 2024 levels—while supporting the ongoing Network 2.0 rollout and the European cost‑reduction initiative.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.2 billion 2025 capital expenditure plan and links both Network 2.0 optimization and European workforce reduction costs to the DRIVE transformation program as business optimization expenses. However, it omits the specific range of expected cash expenditures for the European workforce reduction ($250M to $375M through fiscal 2026), which is a key quantitative detail from the ground truth. This omission affects completeness and quantitative accuracy but does not invalidate the overall correctness. (2) The $5.2 billion capex figure is accurately reported and correctly attributed to 2025. The absence of the $250M–$375M range for workforce reduction costs is a notable gap, though the answer correctly frames these as part of business optimization. No incorrect numbers are presented—only a partial omission. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Network 2.0 spending and workforce reductions are components of the DRIVE program and are funded within the capital expenditure framework. It appropriately connects capital allocation, operational efficiency, and strategic transformation. However, it fails to specify that the workforce costs extend through fiscal 2026, slightly weakening the temporal precision. (4) The answer is contextually excellent—directly addressing how these expenditures relate to the capex plan and DRIVE program. The reasoning is coherent and well-structured. The correctness score is 8 due to the missing expenditure range, but qualitative and contextual accuracy remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 439,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How does AMD's dependency on third-party suppliers for graphics cards and AIB partners affect its financial risk exposure in terms of inventory management and price protection obligations?",
      "original_answer": "AMD's dependency on third-party suppliers for graphics cards and its reliance on AIB partners exposes it to significant financial risk due to price protection obligations. If there is a significant decline in product prices, AMD must honor price protection rights for AIB partners' inventory, which can materially reduce revenue and gross margins. Additionally, AIB partners can return products removed from the price book within 12 months of manufacturing, further impacting financial stability during market fluctuations.",
      "llm_answer": "AMD's reliance on third-party suppliers for graphics cards and AIB partners creates significant financial risk exposure through inventory management and price protection obligations. The company's agreements with distributors and AIB partners include inventory protection provisions that shield partners from price reductions and allow product returns for items less than 12 months old, which directly materializes as reduced revenue and gross margins when prices decline. Additionally, distributors maintain shadow inventory through gray market channels that complicates demand forecasting, while the company's need to maintain appropriate inventory levels based on customer estimates increases the risk of excess or obsolete inventory that must be written down, thereby adversely impacting gross margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies AMD's financial risk exposure due to price protection obligations and product return rights for AIB partners, specifically noting the 12-month return window, which matches the original answer. The statement that these obligations lead to reduced revenue and gross margins during price declines is factually correct and well-reasoned. The LLM adds contextual detail not in the original—such as shadow inventory in gray markets and risks from demand forecasting inaccuracies—which is consistent with AMD's business model and enhances completeness without introducing error. All entities (AMD, AIB partners, distributors) and timeframes (12 months) are accurate. There are no numerical inaccuracies, and while the original answer does not mention 'distributors' explicitly, the LLM correctly infers their role from broader supply chain dynamics. The only minor deviation is the expansion beyond the original scope with 'shadow inventory' and 'gray market' details, which, while plausible and contextually relevant, are not confirmed in the ground truth. This does not reduce accuracy but slightly extends beyond the provided facts. Multi-hop reasoning is sound: connecting third-party reliance → price protection → financial impact. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 385,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What is AbbVie's total cost of products sold related to Venclexta, considering both its shared U.S. profits with Genentech and the royalties paid on net revenues outside the United States?",
      "original_answer": "AbbVie's total cost of products sold related to Venclexta includes Genentech's 50% share of U.S. profits from Venclexta and the royalties paid on net revenues outside the United States. Both components are explicitly included in AbbVie's cost of products sold, as stated in the filing.",
      "llm_answer": "AbbVie's total cost of products sold related to Venclexta includes both its share of U.S. profits paid to Genentech and royalties paid on net revenues outside the United States. Based on the collaboration table, Genentech's share of profits (included in cost of products sold) was $869 million for 2023, while AbbVie's share of profits outside the U.S. (also part of cost of products sold) was $931 million. Therefore, the combined Venclexta‑related cost of products sold amounts to roughly $1.8 billion for 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer (ground truth) states that AbbVie's cost of products sold includes Genentech's 50% share of U.S. profits and royalties on non-U.S. net revenues, but it does not provide specific dollar amounts or mention 2023 figures. The LLM fabricates precise numbers—$869 million for Genentech's U.S. profit share and $931 million for non-U.S. royalties—without any support from the original answer. These figures are not present in the ground truth, making them incorrect. (2) The calculation of $1.8 billion is therefore also invalid, as it is based on made-up inputs. There is no quantitative data in the original answer to support any numerical total. (3) The multi-hop reasoning is partially sound in structure—recognizing that U.S. profit sharing and non-U.S. royalties both contribute to cost of products sold—but fails in execution because it invents data not present in the source. The model incorrectly assumes that 'AbbVie's share of profits outside the U.S.' is part of cost of products sold, while the original answer specifies that royalties paid on non-U.S. revenues are included, not AbbVie's own profits. This reflects a misunderstanding of the financial structure. (4) The contextual relevance is moderate because the answer addresses the right components (U.S. profit share and non-U.S. royalties), but the qualitative accuracy is low due to incorrect entity relationships and invented metrics. The correctness score is low due to complete lack of quantitative support in the original and misrepresentation of financial flows.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 444,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What specific governance document related to board members does BNY make publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and who is this document explicitly applicable to?",
      "original_answer": "BNY makes its Directors' Code of Conduct publicly available in addition to the Corporate Governance Guidelines and Committee Charters, and this document is explicitly applicable to all directors of BNY.",
      "llm_answer": "BNY makes its Corporate Governance Guidelines publicly available in addition to its Committee Charters and Corporate Governance Guidelines, and this document is explicitly applicable to its directors.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in identifying the additional governance document. The question asks for a document *in addition to* the Committee Charters and Corporate Governance Guidelines. The LLM incorrectly states that the 'Corporate Governance Guidelines' are made available in addition to themselves, which is logically and factually wrong. The correct document, according to the ground truth, is the 'Directors' Code of Conduct'. (2) There are no numeric values, dates, or calculations in this question, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning fails: the model must identify a third distinct document beyond the two mentioned (Committee Charters and Corporate Governance Guidelines), but it fails to do so. It also misidentifies the document's applicability by referring vaguely to 'directors' without specifying 'all directors of BNY' as in the ground truth, though this part is partially correct. (4) The contextual relevance is moderate because the answer discusses governance documents and directors, which are relevant, but the core factual error undermines correctness. Due to the major factual and logical error, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 349,
        "total_tokens": 1467
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "Given AMD's 68% year-over-year revenue growth and 3 percentage-point gross margin improvement in 2021, how did the launch of the AMD Radeon RX 6600 XT and broader gaming-focused graphics strategy specifically contribute to these financial outcomes?",
      "original_answer": "The launch of the AMD Radeon RX 6600 XT in July 2021, designed for high-frame rate 1080p gaming, was part of a broader product strategy that contributed to AMD's 68% revenue growth from $9.8 billion in 2020 to $16.4 billion in 2021. This gaming-focused graphics strategy, which included the Radeon RX 6000M series for laptops and the AMD Advantage Design Framework, helped drive strong demand in the gaming segment. The improved gross margin from 45% to 48% reflects the company's success in scaling high-performance product lines like RDNA 2-based GPUs, which delivered both performance and power efficiency gains that enhanced AMD's competitive positioning and pricing power in the gaming market.",
      "llm_answer": "The Radeon RX 6600 XT and the broader gaming‑focused graphics strategy helped lift AMD’s revenue by expanding its product lineup for 1080p gaming and driving demand for higher‑performance GPUs, which contributed to the 68% year‑over‑year revenue growth and the 3‑percentage‑point gross‑margin improvement in 2021.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Radeon RX 6600 XT launch and broader gaming strategy as contributors to AMD's 68% year-over-year revenue growth and 3-percentage-point gross margin improvement in 2021, aligning with the ground truth. However, it omits key supporting details such as the actual revenue figures ($9.8 billion in 2020 to $16.4 billion in 2021), the July 2021 launch date, and specific product initiatives like the Radeon RX 6000M series and AMD Advantage Design Framework. (2) Quantitatively, the 68% revenue growth and 3-percentage-point gross margin increase (from 45% to 48%) are accurately referenced, though the LLM does not explicitly state the base and final margin percentages or revenue amounts, which are present in the ground truth. These omissions reduce completeness but do not introduce numerical inaccuracies. (3) The reasoning is logically sound in linking the product launch and strategy to financial outcomes, but lacks the multi-hop synthesis of specific product rollouts (e.g., laptop GPUs) and architectural advantages (RDNA 2 efficiency gains) that underpin the margin expansion. The answer captures the directional impact but not the full causal chain. (4) The contextual relevance is high, as the response directly addresses the question’s focus on how the RX 6600 XT and gaming strategy influenced financial performance. Scores reflect high factual alignment but partial completeness and reasoning depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 405,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was AbbVie's net revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta sales in the United States did Genentech receive as part of their collaboration agreement?",
      "original_answer": "AbbVie reported total net revenue of $2,288 million from Venclexta in 2023. As part of the collaboration agreement with Genentech, the pre-tax profit from Venclexta sales in the United States is shared equally between AbbVie and Genentech. Therefore, Genentech received 50% of the United States pre-tax profit from Venclexta, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's net revenue from Venclexta in 2023 was $2,288 million, and under the collaboration agreement Genentech received 50 % of the pre‑tax profit from Venclexta sales in the United States.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately reports AbbVie's 2023 net revenue from Venclexta as $2,288 million, matching the original answer. It also correctly states that Genentech received 50% of the pre-tax profit from U.S. sales, which aligns with the collaboration agreement described. (2) All numeric values—$2,288 million and 50%—are factually accurate and properly formatted; minor typographic differences (e.g., thin spaces in '$2,288 million' and '50 %') do not affect meaning or correctness. (3) The reasoning is sound: the answer correctly synthesizes the financial outcome (revenue) and the profit-sharing arrangement, reflecting multi-hop understanding between AbbVie’s reporting and the Genentech collaboration. (4) The answer is contextually precise, addressing both sub-questions directly and completely without extraneous information. No critical details are omitted, and all entities (AbbVie, Genentech, Venclexta, 2023) are correctly identified and used.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 294,
        "total_tokens": 1448
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "Despite issuing 48 million new Class C common shares in the May 2024 exchange offer, why does Visa's 10-K report only 10 Class C common shares outstanding as of September 30, 2024?",
      "original_answer": "Visa issued 48 million new Class C common shares in the May 2024 exchange offer in connection with the exchange of 241 million Class B-1 shares. However, the 10-K filing shows only 10 Class C common shares outstanding as of September 30, 2024. This discrepancy is explained by the fact that the 10 shares figure in the equity section is presented in millions, as noted in the table's header (\"millions, except per share data\"). Therefore, the 10 shares reported actually represent 10 million shares outstanding. This means that although 48 million Class C shares were newly issued in May 2024, the total outstanding amount was subsequently reduced by 38 million shares, likely through share repurchases, retirements, or other corporate actions not detailed in the provided excerpts.",
      "llm_answer": "The 10-K shows that Visa issued 48 million new Class C shares in the May 2024 exchange offer, but the “Class C common stock” line in the September 30 2024 balance‑sheet section of the filing lists only **10 million shares outstanding** (the same 10 million reported for 2023). This apparent discrepancy is explained by the conversion mechanics described in the filing: the newly issued Class C shares are part of the “as‑converted” class A share count used for earnings‑per‑share calculations, but they are not reflected as separate “Class C common stock” shares on the balance sheet because they are treated as part of the broader class A conversion pool. Consequently, the balance‑sheet figure of 10 million remains unchanged, while the total as‑converted share count (including the 48 million newly issued Class C shares) is reflected in the diluted‑share calculations and earnings‑per‑share tables.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly notes the issuance of 48 million Class C shares in May 2024 and the 10 million shares outstanding figure in the 10-K, it incorrectly claims that the 10 million shares are not reflected on the balance sheet due to 'conversion mechanics' and 'as-converted' treatment. This contradicts the ground truth, which explains that the 10 in the table represents 10 million shares (not 10 shares), as the table is labeled 'millions, except per share data'. The LLM misinterprets the accounting presentation, falsely attributing the discrepancy to EPS conversion logic rather than unit scaling. (2) Quantitatively, the LLM correctly identifies 48 million issued and 10 million outstanding, but fails to recognize that the '10' in the report is in millions—this is a critical error in interpreting financial statements. The ground truth correctly identifies the unit issue and notes a net reduction of 38 million shares likely due to repurchases, which the LLM omits entirely. (3) The multi-hop reasoning is flawed: instead of recognizing a simple unit labeling issue (a common feature in SEC filings), the LLM invents a complex and incorrect explanation involving as-converted shares and balance sheet classification. This shows a failure to synthesize the correct rationale from the document structure. (4) The answer is contextually relevant—it addresses the right document, company, and event—but the core reasoning and factual basis are incorrect, severely undermining the response. Hence, low scores for correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 449,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How much total cost did FedEx incur in 2024 for both Network 2.0 implementation and DRIVE transformation-related business optimization activities, and what is the expected range of future costs for the European workforce reduction plan announced in June 2024?",
      "original_answer": "FedEx incurred $582 million in 2024 for business optimization activities related to Network 2.0 and the DRIVE transformation. The European workforce reduction plan announced in June 2024 is expected to cost between $250 million and $375 million in cash expenditures through fiscal 2026.",
      "llm_answer": "The total cost incurred in 2024 for Network 2.0 implementation and DRIVE transformation-related business optimization activities was $582 million (net of tax $444 million), as disclosed in Note 3 of the financial statements.  \n\nThe expected pre‑tax cost of the European workforce reduction plan announced in June 2024 ranges from $250 million to $375 million, to be incurred through fiscal 2026.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $582 million cost for 2024 business optimization activities related to Network 2.0 and DRIVE transformation is accurately reported, and the expected future cost range of $250 million to $375 million for the European workforce reduction plan is correctly stated. The mention of 'net of tax $444 million' is an additional detail not in the original answer but does not contradict it and may reflect further disclosure from Note 3; its inclusion does not reduce accuracy. (2) The timeframes—2024 for incurred costs and through fiscal 2026 for future expected costs—are correct. (3) The entities (FedEx, Network 2.0, DRIVE transformation, European workforce reduction plan) are accurately identified and correctly associated with their respective financial impacts. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly separates the actual 2024 costs from the forward-looking European restructuring costs, and correctly attributes each to the appropriate program and time period. (5) The semantic meaning is equivalent to the original answer, with slightly more detail (e.g., reference to Note 3, net-of-tax amount), which enhances rather than detracts from accuracy. All components of the multi-part question are fully addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 377,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "What was the total value of AMD's (AMD) unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021?",
      "original_answer": "$329 million was the total value of AMD's unbilled accounts receivable related to custom products and development services revenue recognized over time in fiscal year 2021.",
      "llm_answer": "Based on the provided document pages, the total value of AMD's unbilled accounts receivable specifically related to custom products and development services revenue recognized over time in fiscal year 2021 is $329 million. This figure is explicitly stated in the \"Accounts Receivable, net\" section of page 62, which notes that unbilled accounts receivable (primarily representing work completed for development services and custom products where revenue was recognized but not yet invoiced) totaled $329 million as of December 25, 2021. The document further clarifies that this amount is expected to be billed and collected within 12 months, and it is directly tied to the revenue recognized over time for these services, which accounted for approximately 23% of the Company's revenue in 2021.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) The key numeric value of $329 million is accurately reported, with the correct fiscal date (December 25, 2021), which aligns with AMD's 2021 fiscal year. The format ($329 million) matches the ground truth semantically. (2) The answer is complete, addressing the specific query about unbilled accounts receivable tied to custom products and development services revenue recognized over time. It correctly identifies the source (page 62) and provides relevant context, such as the revenue recognition method and the 12-month collection expectation. (3) Entity accuracy is perfect: AMD is correctly identified, the fiscal year 2021 is accurate, and the financial metric 'unbilled accounts receivable' is properly defined and applied. (4) The reasoning is sound and demonstrates multi-hop synthesis by linking unbilled receivables to revenue recognized over time and contextualizing it within the 23% of total revenue, which reinforces the relevance of the figure. All information is factually consistent with the ground truth and adds appropriate supporting detail without introducing errors. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 338,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was AbbVie's total revenue from Venclexta in 2023, and how much of the pre-tax profit from Venclexta's U.S. sales did AbbVie share with Genentech as part of their collaboration agreement?",
      "original_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. As part of the collaboration agreement with Genentech, AbbVie shared 50% of the pre-tax profit from Venclexta's U.S. sales with Genentech, which is included in AbbVie's cost of products sold.",
      "llm_answer": "AbbVie's total revenue from Venclexta in 2023 was $2,288 million. Under the collaboration agreement with Genentech, AbbVie shares 50 % of the pre‑tax profit from Venclexta's U.S. sales, which amounted to $869 million in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AbbVie's total revenue from Venclexta in 2023 as $2,288 million, which matches the ground truth. It also correctly states that AbbVie shares 50% of the pre-tax profit from U.S. sales with Genentech, which is consistent with the collaboration agreement. However, the LLM introduces a new figure—$869 million—as the amount of pre-tax profit from U.S. sales in 2023, which is not present in the original answer and cannot be verified from the provided ground truth. This number may be an incorrect inference or miscalculation, as the original answer does not specify the dollar amount of pre-tax profit shared, only the 50% sharing ratio. (2) The $2,288 million revenue figure is accurate. The 50% profit-sharing percentage is correct. However, the $869 million figure is unsupported and potentially misleading, as no such number appears in the ground truth, and there is no indication that this amount was calculated correctly from available data. (3) The multi-hop reasoning is partially sound—correctly identifying the collaboration structure and revenue—but fails in introducing an unverified quantitative claim about pre-tax profit, which undermines factual accuracy. (4) The contextual relevance is high because the answer addresses both parts of the question and stays focused on the collaboration and financials. The qualitative accuracy is decent due to correct entity and agreement identification, but quantitative accuracy is reduced due to the unsupported $869 million figure. Correctness score is 6 due to one major factual overreach despite correct core elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1132,
        "completion_tokens": 443,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What was the change in the aggregate principal balance of the 3.650% notes due 2023 between December 31, 2022, and December 15, 2023, and how does this compare to the balance of the 3.700% notes due 2023 on December 15, 2023?",
      "original_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased by $171 million from December 31, 2022 ($171 million) to December 15, 2023 ($0). On the same date, the 3.700% notes due 2023 had an aggregate principal balance of $400 million.",
      "llm_answer": "The aggregate principal balance of the 3.650% notes due 2023 decreased from $171 million on December 31 2022 to $0 million on December 15 2023, reflecting a $171 million repayment. In comparison, the 3.700% notes due 2023 had a balance of $400 million on December 15 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the 3.650% notes decreased from $171 million on December 31, 2022, to $0 on December 15, 2023, representing a $171 million decrease, which is correctly stated as a repayment. The balance of the 3.700% notes due 2023 is correctly reported as $400 million on December 15, 2023. (2) The answer addresses both parts of the multi-part question: the change in principal balance for the 3.650% notes and the comparison with the 3.700% notes on the same date. (3) Entities are accurate—correct interest rates (3.650% and 3.700%), correct maturity year (2023), and correct dates. (4) The reasoning is sound: the model correctly infers full repayment of the 3.650% notes and provides a valid comparison to the outstanding balance of the 3.700% notes. The wording differs slightly from the original answer but maintains full semantic equivalence. No errors in calculation, logic, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 287,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How could adverse litigation outcomes requiring Visa to modify its interchange reimbursement rates impact its transaction volumes and financial position, considering the protections provided by its U.S. and Europe retrospective responsibility plans and ongoing tax disputes?",
      "original_answer": "Adverse litigation outcomes could force Visa to reduce interchange reimbursement rates, which may lead some issuers to decrease promotion or use of Visa products, reduce cardholder benefits, or impose new fees, all of which could lower consumer usage and transaction volumes. This would directly harm Visa's net revenue. While Visa has U.S. and Europe retrospective responsibility plans that provide financial protections against certain litigation-related losses, these protections vary in scope and may not fully cover the financial impact of settlements, judgments, or changes in operating rules. At the same time, ongoing tax disputes with the IRS and foreign jurisdictions, combined with potential changes in global tax laws such as the OECD’s global minimum tax, could increase Visa’s effective tax rate and reduce cash flows. Therefore, even with partial mitigation from the retrospective plans, the combined effect of reduced interchange income and unfavorable tax outcomes could significantly harm Visa’s financial position.",
      "llm_answer": "Adverse litigation outcomes that force Visa to alter its interchange reimbursement rates could diminish transaction volumes and strain financial performance, but the company’s U.S. and Europe retrospective responsibility plans and indemnification mechanisms are designed to cushion the impact. These protections, together with ongoing tax disputes, provide a layer of risk mitigation, though the ultimate effect will depend on the settlement terms and any resulting regulatory or tax‑related adjustments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but lacks key details and depth in reasoning compared to the ground truth. (1) It correctly identifies that adverse litigation could force Visa to modify interchange rates, potentially reducing transaction volumes and affecting financial performance, and acknowledges the existence of U.S. and Europe retrospective responsibility plans as mitigating factors. However, it omits specific mechanisms by which reduced interchange rates could lead to lower transaction volumes—such as issuers cutting cardholder benefits or imposing new fees—which are central to the causal chain in the original answer. (2) There are no numeric values in either response, so quantitative accuracy is not applicable; the score of 10 reflects no incorrect numbers. (3) The multi-hop reasoning is incomplete: while the LLM mentions indemnification mechanisms and tax disputes, it fails to explain how tax disputes (e.g., with the IRS or foreign jurisdictions) and global tax changes like the OECD minimum tax could increase Visa’s effective tax rate and reduce cash flows—critical components of the financial impact. It also does not clarify that the retrospective plans may not fully cover losses, leaving Visa exposed despite partial protections. (4) Contextual relevance is high because the answer addresses the core issue—litigation impact on interchange rates—and references the correct protective frameworks and tax issues—but it synthesizes them superficially. Overall, the answer captures the general direction of risk but misses essential causal links and synthesis required for full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 439,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "What are the effective dates of the Performance Share Unit award schedules under the United Technologies Corporation Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan, and how do these dates reflect distinct governance updates to each plan as disclosed in the filings?",
      "original_answer": "The effective date of the Performance Share Unit award schedule under the United Technologies Corporation Long-Term Incentive Plan is January 1, 2020, while the effective date under the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan is March 31, 2021. These distinct effective dates reflect separate governance updates to each plan, with UTC’s update specifically tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan effective January 1, 2020, and Raytheon’s update tied to the amended Schedule of Terms filed on March 31, 2021, indicating discrete strategic and administrative adjustments within each company’s incentive structure.",
      "llm_answer": "The Performance Share Unit award schedules under the United Technologies Corporation Long‑Term Incentive Plan became effective on **April 28 2014** (as reflected in Exhibit 10.11 and the related schedule of terms), while the Raytheon Technologies Corporation 2018 Long‑Term Incentive Plan’s Performance Share Unit schedule took effect on **December 6 2020** (amendment to the 2018 plan, Exhibit 10.22). These dates illustrate distinct governance updates: UTC’s schedule was set in a 2014 amendment to its LTIP, whereas Raytheon’s schedule was added later through a 2020 amendment to its own 2018 LTIP, underscoring separate plan revisions after the merger.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The effective date for the United Technologies Corporation (UTC) Performance Share Unit award schedule is incorrectly stated as April 28, 2014, whereas the ground truth is January 1, 2020, tied to the amendment and restatement of the LTIP Performance Share Unit Deferral Plan. Similarly, the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan’s effective date is given as December 6, 2020, but the correct date is March 31, 2021, corresponding to the filing of the amended Schedule of Terms. These dates are critical and directly contradict the ground truth. (2) Quantitative accuracy is very low: both key dates are wrong, and no correct financial or temporal metrics are provided. The mention of exhibit numbers (Exhibit 10.11, 10.22) may reflect real filings but do not validate the incorrect effective dates. (3) The multi-hop reasoning is partially sound in structure—comparing governance updates across two merged entities—but fails in execution because it draws conclusions from incorrect base facts. The assertion that UTC’s schedule originated in a 2014 amendment and Raytheon’s in a 2020 amendment does not align with the disclosed updates post-merger, particularly Raytheon’s March 31, 2021 filing. (4) Contextual relevance is moderate because the answer addresses the right plans and attempts to explain governance distinctions, but the incorrect dates undermine the entire analysis. The conclusion about 'separate plan revisions after the merger' is plausible in intent but unsupported by accurate data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 439,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "Which products were the primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022, and how did their performance compare to other product categories within the same segment?",
      "original_answer": "The primary drivers of Apple's Wearables, Home and Accessories segment growth in 2022 were the Apple Watch and AirPods. These products contributed significantly to the segment's overall increase in net sales compared to 2021. In contrast, other categories such as HomePod mini and Beats products were not specifically cited as growth contributors, suggesting they either underperformed or remained flat relative to the strong performance of Apple Watch and AirPods. This indicates that the segment's growth was concentrated in two key product lines rather than being broadly distributed across all categories.",
      "llm_answer": "The Wearables, Home and Accessories segment grew 7% in 2022, driven primarily by higher sales of Apple Watch and AirPods, as noted in the \"Wearables, Home and Accessories\" line item on page 24 and confirmed by the segment breakdown on page 25. This growth outpaced the modest 11% increase in iPhone sales and the 14% rise in Mac sales within the same segment, while other categories like Services (14%) and iPad (-8%) showed different performance trends.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple Watch and AirPods as the primary growth drivers, which aligns with the ground truth. However, it introduces significant inaccuracies in quantitative claims. The reported 7% growth for the Wearables, Home and Accessories segment in 2022 is incorrect — Apple's actual reported growth for this segment was approximately 8.1% year-over-year (from $30.6B in 2021 to $33.0B in 2022), though exact figures may vary slightly by source. More critically, the LLM incorrectly compares this segment's growth to iPhone (11%) and Mac (14%) sales, which are not part of the Wearables, Home and Accessories segment — these are separate product segments. This reflects a fundamental misunderstanding of Apple's segment structure. Additionally, Services (14%) and iPad (-8%) are not subcategories within the Wearables segment, so comparing them as such is factually wrong. (2) The use of page numbers (24, 25) suggests document references, but without access to the source document, we assume these are plausible; however, the numerical comparisons are invalid due to incorrect segmentation. (3) The multi-hop reasoning fails because the model conflates distinct business segments (iPhone, Mac, Services) with subcategories within Wearables, Home and Accessories. The original answer correctly focuses only on internal segment components (Apple Watch, AirPods vs. HomePod, Beats), while the LLM incorrectly expands the comparison beyond the segment. (4) Despite the correct identification of key growth products, the inclusion of false quantitative data and incorrect cross-segment comparisons severely undermines factual accuracy, warranting a mid-low correctness score. Contextual relevance is moderate because the answer addresses the general topic and correctly names the drivers, but misrepresents the analytical scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 502,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does the impact of insurance reverification on Otezla's 2025 sales expectations compare with its effect on ENBREL's projected sales pattern, and what specific historical trend do both products follow?",
      "original_answer": "Both Otezla and ENBREL are expected to follow the historical trend of experiencing lower sales in the first quarter due to insurance reverification and increased co-pay expenses as U.S. patients work through deductibles. This pattern is specifically mentioned for both products in the context of their 2025 sales expectations.",
      "llm_answer": "Both Otezla and ENBREL are expected to see lower first‑quarter sales in 2025 because of benefit‑plan changes, insurance reverification and higher co‑pay costs as U.S. patients meet deductibles, a pattern that has historically produced a dip in Q1 sales followed by stronger subsequent quarters.  This historical trend of a modest early‑year dip and subsequent recovery is common to both products.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately identifies that both Otezla and ENBREL are expected to experience lower sales in Q1 2025 due to insurance reverification and higher co-pay costs as patients work through deductibles. (2) There are no numerical values requiring calculation, but the time period (2025) and quarter (Q1) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both products follow the same historical trend of a Q1 sales dip followed by recovery, which is explicitly stated in the original answer. (4) The LLM adds slight elaboration (e.g., 'stronger subsequent quarters', 'modest early-year dip and subsequent recovery') that is consistent with and implied by the original answer, without introducing inaccuracies. All entities—Otezla, ENBREL, 2025 sales expectations, insurance reverification, co-pay expenses, U.S. patients, deductibles—are correctly identified and contextualized. The answer fully addresses both parts of the question: the comparative impact on sales and the shared historical trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 319,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "What is the total number of distinct stock appreciation rights-related exhibits disclosed by RTX in its 2023 10-K filing for both the United Technologies Corporation 2005 Long-Term Incentive Plan and the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan?",
      "original_answer": "RTX disclosed 2 distinct exhibits related to stock appreciation rights awards: one for the United Technologies Corporation 2005 Long-Term Incentive Plan and one for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan.",
      "llm_answer": "Based on the provided pages, RTX discloses two distinct stock appreciation rights-related exhibits: one for the United Technologies Corporation 2005 Long-Term Incentive Plan (Exhibit 10.16 on page 119) and another for the Raytheon Technologies Corporation 2018 Long-Term Incentive Plan (Exhibit 10.24 on page 119). These represent the only two stock appreciation rights exhibits disclosed in the filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It correctly identifies the total number of distinct stock appreciation rights-related exhibits as 2, which aligns with the original answer. (2) The quantitative information is accurate—two exhibits are disclosed, one for each plan. The LLM even provides additional precise details (Exhibit 10.16 and Exhibit 10.24, both on page 119), which are consistent with the source data and enhance accuracy without introducing errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different incentive plans (United Technologies Corporation 2005 and Raytheon Technologies Corporation 2018) under RTX’s 2023 10-K, confirming that each contributed one exhibit. (4) The entities—company (RTX), plans, years, and exhibit types—are all accurately identified. The answer is semantically equivalent to the ground truth, with added contextual detail (exhibit numbers and page) that improves clarity without deviating from correctness. All scoring dimensions are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 307,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How does the recurring impact of insurance reverification in the first quarter affect the combined sales performance of ENBREL and Otezla in 2025, based on their respective historical patterns and expected net selling price trends?",
      "original_answer": "The recurring impact of insurance reverification in the first quarter is expected to depress the combined sales performance of ENBREL and Otezla in 2025, following their historical pattern of lower sales during this period. For ENBREL, the expectation is for relatively flat volumes but continued declines in net selling price, which will contribute to reduced sales. Similarly, Otezla experienced an 8% decrease in net selling price in 2024, and it is expected to follow the same seasonal pattern in 2025. While Otezla saw 3% volume growth in 2024, this was not enough to offset the price declines, and a similar dynamic is expected in 2025, leading to a compounded negative impact on total sales for both drugs.",
      "llm_answer": "The recurring impact of insurance reverification in the first quarter—characterized by benefit‑plan changes, higher co‑pay expenses and deductible work‑through—has historically produced a dip in sales for both ENBREL and Otezla during Q1, with ENBREL showing a 10 % decline and Otezla a 3 % decline in total 2024 sales. Because the first quarter is typically the weakest period for these products, the combined sales performance of ENBREL and Otezla in 2025 is expected to be pressured by this seasonal dip, even though net selling‑price trends are projected to be relatively flat or modestly declining. Consequently, the first‑quarter slowdown is likely to offset any volume gains and keep combined sales growth modest for the year.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details not supported by the ground truth. Specifically, it claims ENBREL had a 10% decline and Otezla a 3% decline in total 2024 sales due to Q1 reverification, but the original answer does not provide these exact percentages for total annual sales impact—only that Otezla had 8% net selling price decline and 3% volume growth in 2024. There is no mention of a 10% or 3% total sales decline for ENBREL or Otezla in the ground truth, making these figures fabricated or misattributed. (2) The LLM incorrectly states that net selling-price trends are 'projected to be relatively flat or modestly declining' for both drugs, whereas the ground truth specifies that ENBREL faces 'continued declines in net selling price' and Otezla already experienced an 8% decrease in 2024 with a similar dynamic expected in 2025—indicating a stronger negative trend than 'modestly declining.' Additionally, the LLM fails to mention that Otezla’s volume growth in 2024 (3%) did not offset price declines—a key point in the original answer about the compounding negative effect. (3) While the LLM correctly identifies the multi-hop concept that insurance reverification impacts Q1 sales and that this seasonal pattern will affect combined 2025 performance, it misrepresents the underlying drivers by overemphasizing volume impacts without sufficient focus on price erosion as the primary factor. The synthesis between historical patterns and 2025 expectations is partially sound but weakened by incorrect data attribution. (4) Despite these issues, the answer is contextually relevant and captures the general seasonal trend and its expected negative impact on combined sales in 2025. However, due to significant quantitative inaccuracies and incomplete representation of the price-volume dynamics, the correctness score is reduced to 5—partially correct but with major factual gaps and errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 526,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Considering the impact of increased co-pay expenses and Medicare price setting timelines, by how much could AMGN's revenue from Otezla and ENBREL be affected starting in 2025 and 2026 respectively, and how does this reflect a pattern in the company's revenue forecasting for its key drugs?",
      "original_answer": "AMGN's Otezla revenue is expected to face lower first-quarter sales in 2025 due to increased co-pay expenses and benefit plan changes, following a historical pattern. ENBREL will also see continued declines in net selling price starting in 2026 due to Medicare Part D pricing under the Inflation Reduction Act. These impacts reflect a pattern where AMGN's revenue forecasting for both drugs incorporates predictable first-quarter declines driven by insurance dynamics and co-pay expenses, followed by gradual recovery in subsequent quarters. The combined effect suggests a recurring revenue compression risk tied to U.S. patient deductibles and regulatory-driven pricing.",
      "llm_answer": "Based on the disclosed projections, AMGN expects Otezla’s revenue to decline modestly in 2025 (driven by an 8% net‑price reduction partially offset by volume growth) and to face a steeper decline in 2026 as the Medicare price‑setting rule takes effect, while ENBREL’s revenue is projected to fall about 10% in 2025 and remain relatively flat thereafter with continued price declines beginning in 2026. This pattern reflects the company’s historical forecasting approach—projecting lower first‑quarter sales due to benefit‑plan changes and higher co‑pay costs, and anticipating that Medicare price‑setting timelines will further compress net selling prices for its key drugs starting in 2025‑2026.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timing compared to the ground truth. Specifically, it states that Otezla will face an 8% net-price reduction in 2025 and a steeper decline in 2026 due to Medicare price-setting, but the original answer does not specify an 8% figure or assign the Medicare impact to 2026 for Otezla—only ENBREL is explicitly tied to Medicare Part D pricing starting in 2026. Additionally, the LLM claims ENBREL revenue will fall about 10% in 2025 and then remain flat, which is not supported by the original answer; the ground truth mentions continued declines in net selling price starting in 2026 due to Medicare, but does not quantify the 2025 drop as 10% or suggest flattening thereafter. (2) There are no verifiable calculations in the original answer (e.g., percentages or dollar amounts), so the introduction of specific figures like 8% and 10% by the LLM is unsupported and likely hallucinated. These numbers reduce quantitative accuracy significantly. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies that both Otezla and ENBREL face revenue pressure from co-pay dynamics and Medicare pricing, and links these to first-quarter declines and regulatory timelines. It also correctly infers that this reflects a pattern in AMGN’s forecasting approach. However, it misattributes the Medicare impact timeline and adds unsupported numerical projections, weakening the reasoning chain. (4) Despite the numerical inaccuracies, the LLM captures the core qualitative pattern: revenue compression due to insurance dynamics and regulatory pricing, with first-quarter weakness followed by recovery. This maintains moderate qualitative accuracy and high contextual relevance, as it addresses all parts of the question and synthesizes across drugs and years, albeit with incorrect specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 507,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What is the total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, and how does Schwab account for the unrealized gains and losses associated with these liabilities in its consolidated statements of income?",
      "original_answer": "The total fair value of repurchase liabilities related to client-held fractional shares as of December 31, 2024, is equal to the value of the corresponding client-held fractional shares, which Schwab includes in accrued expenses and other liabilities. Schwab accounts for the unrealized gains and losses on these repurchase liabilities by offsetting them against the unrealized gains and losses on the related client-held fractional shares, resulting in no net impact to the consolidated statements of income.",
      "llm_answer": "The total fair value of the repurchase liabilities related to client‑held fractional shares as of December 31 2024 is $1,729 million. Schwab records unrealized gains and losses on these liabilities in other comprehensive income (OCI); they are offset by the corresponding unrealized gains and losses on the client‑held fractional shares, resulting in no net impact on the consolidated statements of income.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states a specific dollar amount ($1,729 million) for the total fair value of repurchase liabilities, which is not present in the ground truth. The original answer does not provide a numerical value but instead explains that the fair value is equal to the value of the corresponding client-held fractional shares, which are included in accrued expenses and other liabilities. This is a major factual inaccuracy. (2) The quantitative inaccuracy is significant because the model fabricates a precise figure not supported by the source data. There is no indication in the ground truth that the value is $1,729 million, making this a clear hallucination. (3) On qualitative aspects, the LLM correctly describes the accounting treatment of unrealized gains and losses: they are offset against gains/losses on the related client-held fractional shares, resulting in no net impact on income. However, it mischaracterizes where these are recorded by stating they are recorded in other comprehensive income (OCI), which contradicts the ground truth that emphasizes no net impact on the consolidated statements of income without specifying OCI. This suggests a partial understanding but flawed reasoning. (4) The contextual relevance is high because the answer addresses both parts of the question—fair value and accounting treatment—and attempts multi-hop synthesis between liabilities and income statement impact. However, the fabrication of a key financial figure and misstatement of the accounting location (OCI) severely undermine correctness. The qualitative accuracy is moderate due to correct conceptual offsetting logic but incorrect technical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 461,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "What was the total implied fully diluted market capitalization of AspenTech based on Emerson's proposal to acquire the remaining shares, and how does this compare to AspenTech's 2023 net sales?",
      "original_answer": "The implied fully diluted market capitalization of AspenTech was $15.3 billion according to Emerson's proposal. This is significantly higher than AspenTech's 2023 net sales of $1.04 billion, indicating a substantial valuation multiple of approximately 14.7x net sales.",
      "llm_answer": "Based on the provided SEC 10-K filing, the total implied fully diluted market capitalization of AspenTech based on Emerson's November 5, 2024 proposal to acquire the remaining shares was $15.3 billion (as stated in the press release referenced on page 3: \"implies a fully diluted market capitalization for AspenTech of $15.3 billion\"). This valuation is compared to AspenTech's 2023 net sales of $1.04 billion, as disclosed in the acquisition description on page 3 (\"AspenTech had 2023 net sales of $1.04 billion\"). Thus, Emerson's proposed acquisition valuation represents approximately 14.7 times AspenTech's 2023 net sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the implied fully diluted market capitalization of AspenTech as $15.3 billion and AspenTech's 2023 net sales as $1.04 billion. These values exactly match the ground truth. (2) The calculation of the valuation multiple (15.3 / 1.04 ≈ 14.7x) is accurate and correctly interpreted as approximately 14.7 times net sales. The date of Emerson's proposal (November 5, 2024) is contextually appropriate and consistent with the source document reference. (3) The multi-hop reasoning is sound—synthesizing the acquisition valuation from Emerson’s proposal with AspenTech’s financial performance from the same filing demonstrates proper cross-referencing within the document. The LLM correctly links the market cap figure from the press release excerpt to the net sales figure disclosed in the acquisition description. (4) All entities—AspenTech, Emerson, the financial metric (net sales), and the correct fiscal year (2023)—are accurately identified. The answer is semantically equivalent to the ground truth, with slightly more detailed sourcing (e.g., referencing page 3 and a press release), but without any factual deviation. Therefore, all scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 344,
        "total_tokens": 1580
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "What is the total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010-2012 and 2013-2015, and how would previously accrued repatriation taxes affect this amount?",
      "original_answer": "The total potential additional federal tax liability from the IRS Notices for the years 2010–2012 and 2013–2015 is $8.7 billion ($3.6 billion for 2010–2012 and $5.1 billion for 2013–2015), plus penalties of $2.0 billion, totaling $10.7 billion. However, this amount would be reduced by up to $3.1 billion in previously accrued repatriation taxes ($900 million for 2010–2012 and $2.2 billion for 2013–2015), resulting in a net potential liability of $7.6 billion before interest.",
      "llm_answer": "The total potential additional federal tax liability, including penalties, that AMGN faces from the IRS Notices for the years 2010‑2012 and 2013‑2015 is approximately **$8.7 billion** ($3.6 billion for 2010‑2012 plus $5.1 billion for 2013‑2015). This amount would be reduced by up to **$900 million** of previously accrued repatriation taxes for 2010‑2012 and up to **$2.2 billion** for 2013‑2015, so the net exposure could be lower if those repatriation taxes are ultimately recognized.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.6 billion and $5.1 billion tax liabilities for 2010–2012 and 2013–2015, respectively, summing to $8.7 billion, which matches the ground truth. It also correctly states the $900 million and $2.2 billion previously accrued repatriation taxes for the respective periods. However, it omits the $2.0 billion in penalties entirely, which is a major quantitative error. The total potential liability including penalties should be $10.7 billion before reduction, not $8.7 billion. (2) The calculation of the net liability is therefore incorrect: the LLM implies a net exposure reduction from $8.7B minus $3.1B, but never states the correct net figure of $7.6 billion. The absence of penalties undermines the completeness and accuracy of the quantitative response. (3) The multi-hop reasoning is partially sound—synthesizing tax liabilities and repatriation taxes across two time periods is accurate—but fails to incorporate the penalty component, which is a required part of the total liability. (4) The contextual relevance is high because the answer addresses the core structure of the question and uses correct entities (AMGN, IRS Notices, correct years, repatriation taxes). However, the omission of penalties results in a significant factual gap, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 375,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does the inclusion of ENBREL in the Medicare price setting program, as detailed in the 2024 10-K filing, affect Amgen's financial outlook, and what additional risk does the potential inclusion of Otezla pose in the future?",
      "original_answer": "Amgen expects the government-mandated price reduction for ENBREL, effective January 1, 2026, to negatively impact its profitability in Medicare. This is due to the significantly lower price set by CMS under Medicare Part D. Additionally, Otezla has been selected for Medicare price setting beginning January 1, 2027, which could further reduce revenues if Amgen is required to accept a government-determined price. The Inflation Reduction Act (IRA) allows for up to 100 drugs to be subject to price setting by 2031, and Amgen notes that other products may be selected in future cycles, compounding the material adverse effect on sales and operations.",
      "llm_answer": "The 2024 10‑K filing shows that, beginning January 1 2026, CMS will set a Medicare Part D price for ENBREL that is markedly lower than today’s rate, directly cutting the drug’s Medicare revenue and therefore pressuring Amgen’s overall profitability. Because the IRA also allows CMS to impose inflation‑linked rebates and to expand price‑setting to additional drugs, Amgen expects further Medicare‑related margin erosion for its portfolio. Looking ahead, Otezla is slated to be among the next 15 drugs added to the Medicare price‑setting list for 2027, meaning it could soon face the same mandatory, government‑determined pricing and rebate penalties—introducing an additional, potentially larger, revenue‑risk for Amgen.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ENBREL's Medicare price setting begins January 1, 2026, and Otezla is set for inclusion in 2027—both dates match the original. The responsible agency (CMS) and program (Medicare Part D) are correctly identified. (2) Quantitative accuracy is perfect: no numerical values are misstated, and the timeline (2026 for ENBREL, 2027 for Otezla) is precisely reflected. Format and phrasing variations (e.g., 'markedly lower' vs 'significantly lower') are semantically equivalent. (3) Multi-hop reasoning is sound: the answer correctly links the Inflation Reduction Act (IRA) to expanded price-setting authority, connects CMS actions to profitability impacts, and anticipates future risk from Otezla’s inclusion. The only minor shortcoming is that the LLM does not explicitly mention the cap of 100 drugs by 2031 under the IRA, which slightly reduces completeness. However, the broader risk of additional drugs being selected is implied through 'expand price-setting to additional drugs' and 'further Medicare-related margin erosion.' (4) Contextual relevance is excellent—the response directly addresses both parts of the question: ENBREL’s current financial impact and Otezla’s future risk. Overall, the answer is factually correct, well-reasoned, and only slightly less comprehensive than the ground truth on long-term IRA scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 393,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares impact the consolidated statements of income, given the company's election of the fair value option under ASC 825?",
      "original_answer": "Schwab's use of quoted market prices for repurchase liabilities related to client-held fractional shares results in unrealized gains and losses on these liabilities, which are offset by unrealized gains and losses on the corresponding client-held fractional shares. This offsetting mechanism ensures there is no net impact on the consolidated statements of income. Additionally, since the repurchase liabilities do not carry credit risk, Schwab has not recognized any gains or losses attributable to instrument-specific credit risk in the consolidated statements of income or comprehensive income.",
      "llm_answer": "The Company’s election of the fair value option for repurchase liabilities tied to client‑held fractional shares means those liabilities are recorded at quoted market prices. Because the fair‑value adjustments offset the unrealized gains or losses on the corresponding client assets, no net effect is recognized in the consolidated statements of income. Consequently, the use of quoted market prices for these repurchase liabilities does not materially impact the income statement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the core mechanism described in the ground truth: Schwab's election of the fair value option under ASC 825 for repurchase liabilities tied to client-held fractional shares leads to recording these liabilities at quoted market prices, with fair value adjustments offsetting unrealized gains/losses on the corresponding client assets, resulting in no net impact on the consolidated statements of income. The answer correctly identifies the absence of material income statement impact, which aligns with the ground truth's conclusion of no net effect. It also implicitly supports the rationale by referencing the offsetting of unrealized gains and losses. However, the LLM answer omits a specific mention of credit risk—namely, that because these liabilities do not carry credit risk, no gains or losses related to instrument-specific credit risk have been recognized in income or comprehensive income. This is a minor omission in completeness but does not undermine the central accuracy of the response. There are no numerical inaccuracies (quantitative accuracy is perfect, though no specific numbers are involved), and the reasoning is logically sound and contextually appropriate. The wording differs from the original but maintains semantic equivalence on the key financial impact. Thus, while highly accurate and contextually relevant, it falls just short of full qualitative completeness due to the missing credit risk clarification.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 407,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the use of the market multiple method in conjunction with the discounted cash flow method contribute to the determination of the $431 million goodwill impairment charge for the LTC reporting unit in 2021, and what specific store closure strategy announced in 2021 impacted the Retail/LTC segment's long-lived asset impairment analysis?",
      "original_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 was determined using a combination of the discounted cash flow method and the market multiple method. These valuation techniques revealed that the LTC reporting unit's fair value was lower than its carrying value, primarily due to deteriorating financial forecasts driven by lower net facility admissions, customer losses, and the prolonged impact of the COVID-19 pandemic. Separately, in the Retail/LTC segment, the Company announced in November 2021 that it would close approximately 900 stores over three years (300 per year from 2022 to 2024), which triggered a long-lived asset impairment test. This led to a $1.4 billion store impairment charge in Q4 2021, including $1.1 billion for operating lease right-of-use assets and $261 million for property and equipment, also within the Retail/LTC segment.",
      "llm_answer": "The $431 million goodwill impairment charge for the LTC reporting unit in 2021 resulted from the combined use of a discounted cash‑flow analysis and a market‑multiple approach to estimate the unit’s fair value, which was then compared to its carrying amount. This impairment was triggered by the November 2021 announcement of a store‑closure strategy that identified indicators of impairment for the affected retail/LTC asset groups, prompting a long‑lived‑asset impairment test that revealed the need to write down the LTC goodwill.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $431 million goodwill impairment charge for the LTC reporting unit in 2021 and mentions the use of both the discounted cash flow and market multiple methods, which aligns with the ground truth. However, it incorrectly implies that the store-closure strategy announced in November 2021 directly triggered the goodwill impairment, when in fact the goodwill impairment was driven by deteriorating financial forecasts due to lower admissions, customer losses, and the pandemic. The store closures were part of a separate long-lived asset impairment analysis. (2) Quantitatively, the $431 million figure is correct, and the 2021 date is accurate. However, the LLM omits key numbers from the ground truth: the 900-store closure plan (300 per year from 2022–2024), the $1.4 billion long-lived asset impairment charge, and its components ($1.1 billion for lease right-of-use assets and $261 million for property and equipment). These omissions significantly reduce completeness and accuracy. (3) The multi-hop reasoning is flawed: the model conflates two distinct impairment events—goodwill impairment (driven by DCF and market multiples due to forecast deterioration) and long-lived asset impairment (triggered by store closures). The answer incorrectly suggests the store closures triggered the goodwill write-down, when they were separate events within the same segment. (4) Contextual relevance is high because the answer addresses the core topic and uses appropriate financial terminology, but the failure to distinguish between goodwill and long-lived asset impairments undermines qualitative and quantitative accuracy. The synthesis across entities and events is incomplete and partially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 476,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "What is the dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023, to December 31, 2024, and what portion of this increase is attributable to Level 2 assets?",
      "original_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 ($11,438 million) to December 31, 2024 ($12,416 million) is $978 million. Of this increase, Level 2 assets contributed $1,205 million (from $8,810 million in 2023 to $10,015 million in 2024), indicating that the entire increase in this category came from growth in Level 2 assets.",
      "llm_answer": "The dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes from December 31, 2023 to December 31, 2024 is $978 million, and $25,740 million of that increase is attributable to Level 2 assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the total dollar amount increase in Cash and investments segregated and on deposit for regulatory purposes as $978 million, which matches the ground truth. However, it incorrectly stated that $25,740 million of the increase is attributable to Level 2 assets, which is grossly inaccurate—Level 2 assets increased from $8,810 million to $10,015 million, a difference of $1,205 million, not $25,740 million. This number is not only wrong but exceeds the total increase in the broader category, which is logically impossible. (2) The calculation for the total increase is correct: $12,416M - $11,438M = $978M. However, the Level 2 contribution is off by a massive margin. The correct increase in Level 2 assets is $1,205 million, which actually exceeds the total category increase, implying that increases in Level 2 were partially offset by decreases in other asset levels. The LLM’s figure of $25,740 million appears to be a hallucination or data extraction error. (3) The multi-hop reasoning failed: while the model correctly pulled the total increase, it did not correctly compute or report the contribution from Level 2 assets. It also failed to recognize that an increase of $25,740 million in Level 2 assets would be inconsistent with the total portfolio increase of only $978 million. (4) The contextual relevance is high because the answer addresses the right question structure and uses appropriate terminology. However, due to severe quantitative and qualitative inaccuracies—especially the fabricated Level 2 increase—the correctness and accuracy scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 443,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How does Emerson allocate AspenTech's stock-based compensation expense between pre- and post-combination periods under ASC 805, and what specific valuation inputs and ownership figures from the acquisition are used in this allocation?",
      "original_answer": "Under ASC 805, Emerson allocates the fair value of AspenTech's stock-based compensation awards between pre- and post-combination service periods. The portion attributable to the pre-combination service period is included in the purchase price of the acquisition, while the post-combination portion is recognized as stock-based compensation expense over the remaining service period. This allocation uses the fair value of AspenTech stock at the time of the acquisition on May 16, 2022, determined using the closing market price per share, and Emerson's 55% ownership stake in AspenTech post-transaction.",
      "llm_answer": "Emerson allocates AspenTech’s stock-based compensation expense between pre- and post-combination periods by determining the portion of the fair value of replacement awards attributable to service rendered before the acquisition (which is included in the purchase price) and the portion attributable to service after the acquisition (which is recognized as post-combination stock-based compensation expense over the remaining service period). The allocation uses the fair value of the converted awards (options and restricted stock units) determined under ASC 805, with the pre-combination portion treated as part of consideration transferred and the post-combination portion recorded as expense. Key inputs include the acquisition-date fair value of AspenTech’s common stock ($166.30 per share), the total purchase consideration ($11,188 million), and the number of shares underlying converted awards (e.g., 66,662,482 shares outstanding), along with the Black-Scholes inputs (volatility, expected life, risk-free rate, zero dividend yield) used to value the options. The post-combination expense is recognized ratably over the remaining service periods of the awards, primarily for performance stock units and restricted stock units granted in 2023 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly describes the general principle of allocating stock-based compensation under ASC 805 between pre- and post-combination periods, and correctly identifies that the pre-combination portion is included in purchase consideration while the post-combination portion is expensed over remaining service periods. However, it introduces specific quantitative inputs not present in the ground truth, such as the $166.30 per share price, $11,188 million total consideration, 66,662,482 shares, and Black-Scholes parameters (volatility, expected life, etc.), which are not mentioned in the original answer and cannot be verified against the provided ground truth. The ground truth only specifies the use of the closing market price on May 16, 2022, and Emerson's 55% ownership stake—neither of which are mentioned in the LLM answer. (2) The date of acquisition (May 16, 2022) is correct contextually but not explicitly referenced in the LLM response. The LLM mentions 'converted awards' and 'replacement awards', which may be accurate but go beyond the scope of the original answer. The mention of performance stock units and restricted stock units granted in 2023 and 2024 introduces post-acquisition award details not present in the ground truth, potentially conflating later events with the initial allocation. (3) The multi-hop reasoning is partially sound—ASC 805 treatment is correctly applied, and the conceptual split between pre- and post-combination service is accurate. However, the model fails to reference the key ownership figure (55%) and acquisition-date stock price as the basis for valuation, instead citing unverified detailed inputs. This suggests possible hallucination or over-specificity beyond the source data. (4) While the qualitative framework and contextual relevance are strong, the quantitative inaccuracies and unsupported specifics significantly reduce factual correctness. The answer is partially correct in concept but flawed in precise alignment with the ground truth, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 553,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What was the percentage change in the value of CVS's investments in 'States, Municipalities and Political Subdivisions' from December 31, 2021, to December 31, 2022, and how did this shift affect the overall composition of CVS's debt securities portfolio?",
      "original_answer": "The value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. This significant reduction altered the overall composition of CVS's debt securities portfolio, where in 2021 these securities accounted for approximately 13.3% of total debt securities ($3,091 million out of $23,240 million), compared to only 4.9% in 2022 ($170 million out of $3,462 million).",
      "llm_answer": "The value of CVS's investments in \"States, Municipalities and Political Subdivisions\" increased by 5% from $150 million at December 31 2021 to $158 million at December 31 2022. This rise modestly expanded the fixed‑income portion of the debt‑securities portfolio, shifting the overall composition toward a slightly larger share of municipal bonds within the broader fixed‑income holdings.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The ground truth states that the value of CVS's investments in 'States, Municipalities and Political Subdivisions' decreased from $3,091 million on December 31, 2021, to $170 million on December 31, 2022, representing a 94.5% decrease. In contrast, the LLM claims an increase from $150 million to $158 million (a 5% increase), which is factually wrong on all key metrics. (2) Quantitative accuracy is extremely low: the starting value is off by $2,941 million, the ending value by $12 million, and the percentage change is completely reversed (increase vs. massive decrease). The portfolio composition shift is also misrepresented—ground truth shows the category's share dropped from 13.3% to 4.9% of total debt securities, but LLM implies a positive shift toward municipal bonds. (3) The multi-hop reasoning failed entirely: the model did not correctly identify the trend, misstated the values, and drew an opposite conclusion about portfolio impact. (4) Contextual relevance is low but not zero—the answer addresses the right category and general topic of portfolio composition, so minimal relevance is acknowledged. However, factual and reasoning failures dominate, warranting a correctness score of 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 355,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the potential conversion of class B common stock, tied to the final resolution of U.S. covered litigation under the U.S. retrospective responsibility plan, depend on the accrual activity related to that litigation, and what financial uncertainty does this create for Visa's class A common stockholders?",
      "original_answer": "Under the U.S. retrospective responsibility plan, class B common stock will become convertible into class A common stock upon the final resolution of U.S. covered litigation. However, the accrual activity for U.S. covered litigation, which includes a charge to the litigation provision when a loss is deemed probable and reasonably estimable, affects the timing and certainty of that resolution. The accrual could be higher or lower than the escrow account balance, introducing uncertainty about when the litigation will be resolved and thus when the conversion will occur. This uncertainty impacts the potential dilution for class A common stockholders, as the market price of class A stock could fall if the conversion happens at a higher valuation that later decreases. Therefore, the financial exposure and timing of litigation resolution directly influence the dilutive effect and stock value risk for existing class A shareholders.",
      "llm_answer": "The potential conversion of class B common stock into class A shares is contingent on the final resolution of the U.S. covered litigation and on the accrual activity tied to that litigation; the accrual balance reflects Visa’s best estimate of a probable and reasonably estimable loss, but the actual loss could be higher or lower, creating uncertainty about the amount of class A shares that will ultimately be issued. This uncertainty means class A shareholders could face dilution if a larger-than‑expected conversion occurs, potentially depress‑ing the market price of their stock.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core financial mechanism and implications described in the ground truth. (1) It correctly identifies that the conversion of class B to class A stock depends on the final resolution of U.S. covered litigation and that accrual activity—representing Visa’s estimate of probable loss—affects the uncertainty around conversion. It also correctly links this uncertainty to potential dilution and stock price impact for class A shareholders. (2) There are no numeric values (e.g., dollar amounts, percentages, share counts) in either the LLM or original answer, so quantitative accuracy is not compromised; all financial concepts are qualitative, and the LLM handles them correctly. (3) The multi-hop reasoning—connecting litigation accruals, escrow imbalance risk, conversion timing, and shareholder dilution—is sound and logically synthesized, though the LLM omits explicit mention of the escrow account balance comparison (a minor omission). The ground truth emphasizes that the accrual could exceed or fall short of the escrow balance, which directly affects resolution timing; the LLM implies this through 'actual loss could be higher or lower' but doesn't name the escrow mechanism. (4) Despite this slight gap in completeness, the answer remains semantically equivalent in intent and meaning, focusing on uncertainty in conversion size and timing and its effect on class A shareholders. Thus, the answer is contextually relevant, factually correct, and only marginally less detailed than the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 424,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what was the corresponding change in net losses on these investments year-over-year?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), and the net losses on these investments increased by $46 million (from $21 million loss in 2023 to $67 million loss in 2024).",
      "llm_answer": "The fair value of Cisco's available‑for‑sale debt investments declined by **$1.1 billion** from July 29 2023 to July 27 2024, and the corresponding year‑over‑year change in net losses on these investments was an **increase of $11 million** in net losses.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect in its quantitative claims. The ground truth states that the fair value of Cisco's available-for-sale debt investments decreased by $5,727 million (from $15,592 million in 2023 to $9,865 million in 2024), but the LLM reports only a $1.1 billion decrease, which is off by over $4.6 billion. Similarly, the net losses increased from $21 million in 2023 to $67 million in 2024—an increase of $46 million—but the LLM reports only an $11 million increase, missing the correct magnitude. (2) Both key calculations—decline in fair value and change in net losses—are factually wrong. The correct decline is $15,592M - $9,865M = $5,727M, not $1.1B. The correct increase in net losses is $67M - $21M = $46M, not $11M. These are not minor rounding differences but major inaccuracies. (3) While the LLM correctly identifies the entities (Cisco, available-for-sale debt investments) and the time period (July 29, 2023, to July 27, 2024), it fails at the core multi-hop reasoning: synthesizing the correct values from two different years and computing the differences accurately. (4) The contextual relevance is high because the answer addresses the right question structure and uses appropriate financial terminology, but the qualitative and quantitative accuracy scores are low due to severe factual and computational errors. Hence, the correctness score is 2—mostly wrong with major factual discrepancies.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 401,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did the changes in ExtraBucks Rewards and gift card liabilities during 2021 impact CVS's revenue recognition, particularly in relation to breakage and redemption patterns?",
      "original_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly affected CVS's revenue recognition by reducing the contract liability balance as customers redeemed rewards and gift cards. Additionally, CVS recognized breakage revenue based on historical redemption patterns. As customers failed to redeem a portion of the issued rewards and gift cards, CVS reclassified these amounts from liabilities to revenue, reflecting the fulfillment of the obligation to provide goods or services. This process aligns with the company's accounting policy that recognizes breakage on unredeemed gift cards and expired rewards, which contributes to revenue as the likelihood of redemption diminishes over time.",
      "llm_answer": "The changes in ExtraBucks Rewards and gift card liabilities during 2021 directly impacted CVS's revenue recognition by requiring the company to recognize breakage income based on historical redemption patterns and to defer revenue until rewards are redeemed. This resulted in a $371 million reduction to contract liabilities through redemption and breakage, which increased revenue by allowing the company to recognize previously deferred revenue from unredeemed rewards and gift cards.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the impact of ExtraBucks Rewards and gift card liabilities on revenue recognition through breakage and redemption, aligning with the core concept in the ground truth. It accurately mentions breakage income based on historical patterns and deferral of revenue until redemption. However, it introduces a specific figure—$371 million—which is not present in the original answer and cannot be verified from the provided ground truth. This number may be factually incorrect or taken from an external source not referenced in the context, which undermines quantitative accuracy. (2) There are no calculations in the answer, but the inclusion of an unsupported dollar amount ($371 million) significantly affects quantitative accuracy. The ground truth does not provide any numerical values for the reduction in liabilities or revenue impact, so this figure appears fabricated or misattributed. (3) The multi-hop reasoning is partially sound: the model correctly links changes in liabilities to revenue recognition via breakage and redemption, demonstrating understanding of accounting treatment for gift cards and rewards. However, the addition of an unverified number suggests a failure in synthesis fidelity, possibly hallucinating data. (4) While the qualitative reasoning and contextual relevance are strong—covering breakage, deferral, and liability reduction—the introduction of an unsupported quantitative claim reduces overall correctness. A score of 6 reflects that the core logic is correct but compromised by a significant factual overreach in numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 440,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does the funding of the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan affect the conversion rate of class B common stock into class A common stock, and what financial impact does this have on Visa Inc.'s litigation provision based on the fiscal 2022 accrual activity?",
      "original_answer": "Funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the conversion rate of class B common stock to class A common stock, diluting the value of class B shares. This dilution mechanism is directly tied to the Company’s funding actions. According to the fiscal 2022 data, there was a measurable reduction in the number of as-converted class B shares following escrow deposits, and concurrently, the litigation provision was charged based on the accrual activity for U.S. covered litigation, which was deemed probable and reasonably estimable.",
      "llm_answer": "The U.S. litigation escrow funding under the U.S. Retrospective Responsibility Plan triggers a downward adjustment to the conversion rate of class B common stock into class A common stock, which dilutes the class B shares. This adjustment, together with the $850 million deposit made in fiscal 2022, increased the accrual for U.S. covered litigation to $1.441 billion and resulted in a $861 million provision that was recorded in the litigation provision. Consequently, the litigation provision for fiscal 2022 reflects the $861 million accrual for U.S. covered litigation, driven by the escrow funding and the related conversion‑rate impact.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core mechanism — that funding the U.S. litigation escrow account under the U.S. Retrospective Responsibility Plan triggers a downward adjustment in the class B to class A conversion rate, resulting in dilution of class B shares. It also correctly links this action to an impact on the litigation provision. However, the quantitative details are factually incorrect and not supported by the ground truth. The original answer mentions a 'measurable reduction' in as-converted class B shares and that the litigation provision was charged based on accrual activity deemed probable and reasonably estimable, but it does not specify any dollar amounts such as $850 million deposit, $1.441 billion accrual, or $861 million provision. These figures are hallucinated or inaccurately introduced by the LLM. (2) There is no verification of calculations because the numbers themselves are not present in the ground truth; thus, the claimed $861 million provision and its linkage to the escrow deposit lack factual basis. The original answer does not provide any specific accrual or provision amounts for fiscal 2022, so the LLM cannot legitimately assert them. (3) The multi-hop reasoning is partially sound — the model correctly synthesizes the relationship between escrow funding, conversion rate adjustment, and litigation provision impact — but fails in fidelity by inventing precise financial figures not present in the source data, undermining the factual reliability. (4) The contextual relevance is high because the response addresses both parts of the question (conversion rate effect and litigation provision impact) and uses appropriate terminology. Qualitative accuracy is moderate due to correct conceptual understanding but penalized for unsupported specifics. Quantitative accuracy is low due to fabricated numbers. Correctness score reflects partial credit for correct logic but significant deduction for false precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 533,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "By how much did the fair value of Cisco's available-for-sale debt investments decrease from July 29, 2023, to July 27, 2024, and what would be the impact on total investments if a 100 basis point interest rate increase occurred in each of those years?",
      "original_answer": "The fair value of Cisco's available-for-sale debt investments decreased by $5,727 million, from $15,592 million on July 29, 2023, to $9,865 million on July 27, 2024. If a 100 basis point interest rate increase had occurred in 2023, the valuation would have been $15,386 million, and in 2024 it would have been $9,736 million. The difference between these two adjusted values is $5,650 million, which reflects the same general trend of decline in investment value over the period even under interest rate stress.",
      "llm_answer": "The fair value of Cisco's available‑for‑sale debt investments declined by **$26 million** from July 29 2023 to July 27 2024. A hypothetical 100‑basis‑point interest‑rate increase in each of those years would reduce total investments by roughly **$0.5 billion** (approximately $0.5 billion in 2023 and $0.5 billion in 2024).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The reported decrease in fair value is $26 million, whereas the ground truth states a decrease of $5,727 million — a massive discrepancy. The LLM also reports a hypothetical reduction of $0.5 billion due to a 100 basis point interest rate increase in each year, but the ground truth specifies adjusted values of $15,386 million (2023) and $9,736 million (2024), implying sensitivity impacts of $206 million and $129 million respectively, not $500 million each. (2) Number verification: Actual decrease = $15,592M - $9,865M = $5,727M (correct in ground truth); LLM reports $26M — off by over 200x. Interest rate impact: 2023 adjusted value would be $15,386M (a $206M drop), not $0.5B; 2024 adjusted value $9,736M (a $129M drop), not $0.5B. The LLM’s $0.5 billion figure per year is inaccurate and not supported. (3) Multi-hop reasoning failure: The question requires pulling two values across years, computing the difference, and then retrieving sensitivity analyses for interest rate shocks in both years. The LLM fails at retrieving correct base values, miscalculates the change, and fabricates or approximates the interest rate impact without alignment to source data. (4) Scores justified: Correctness is 1 due to near-total factual inaccuracy; Quantitative accuracy is 1 due to severe numerical errors; Qualitative accuracy is 2 because while the model recognizes the need to discuss fair value change and interest rate sensitivity, it misapplies concepts; Contextual relevance is 3 because the structure and intent of the response match the question’s domains, but content is deeply flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 459,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "What was the financial impact on Visa Inc.'s litigation provision as a result of the U.S. Covered Litigation, and how does the accrual activity relate to the mechanisms outlined in the U.S. Retrospective Responsibility Plan?",
      "original_answer": "Visa Inc. records a charge to the litigation provision when a loss from U.S. Covered Litigation is deemed probable and reasonably estimable. The accrual activity related to this litigation is directly tied to the mechanisms within the U.S. Retrospective Responsibility Plan, such as the litigation escrow agreement and indemnification obligations from Visa U.S.A. members. These mechanisms are designed to address potential liabilities, and the total accrual could be either higher or lower than the escrow account balance, depending on the resolution of the litigation.",
      "llm_answer": "The Company recorded an $861 million accrual for U.S. covered litigation in fiscal 2022 and deposited $850 million into the U.S. litigation escrow account, which reflects the loss‑sharing mechanism of the U.S. Retrospective Responsibility Plan that ties accruals to probable, reasonably estimable losses and to the escrow funding used to settle covered claims.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific dollar amounts ($861 million accrual, $850 million deposit) and a fiscal year (2022) that are not present in the original answer (ground truth). The ground truth does not provide any numerical figures or specific time periods, so these values cannot be verified as correct and appear to be hallucinated. (2) There are no calculations in the ground truth to validate, but the introduction of precise numbers without sourcing undermines quantitative accuracy. The format variation allowance does not apply here because the numbers themselves are not in the ground truth. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies the connection between accrual activity and the U.S. Retrospective Responsibility Plan mechanisms like the escrow account and loss-sharing, which aligns with the ground truth’s explanation of indemnification and escrow agreements. However, it overreaches by asserting specific funding actions and implying a direct one-to-one relationship between accrual and escrow deposit, while the original answer emphasizes that the total accrual could be higher or lower than the escrow balance. (4) While the LLM captures the general context and relevant mechanisms (escrow, indemnification, probable losses), it adds unverified specifics that distort factual accuracy. The contextual relevance is high because it addresses the core topic and links accruals to the plan’s mechanisms, but correctness is low due to unsupported numbers and incomplete alignment with the qualitative nuance of the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 437,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How much did the Heritage AspenTech acquisition contribute to the increase in Emerson's (EMR) gross margin percentage in 2023, and what was the total gross margin percentage for that year as a result of that contribution?",
      "original_answer": "The Heritage AspenTech acquisition contributed 0.6 percentage points to the increase in Emerson's gross margin in 2023. As a result, Emerson's gross margin for 2023 reached 49.0 percent.",
      "llm_answer": "The Heritage AspenTech acquisition contributed approximately 0.6 percentage points to the increase in Emerson's gross margin percentage in 2023, as stated in the document's \"Cost of sales\" section for 2023. This contribution was part of the reason gross margin increased 3.3 percentage points to 49.0% in 2023. The total gross margin percentage for 2023, as reported in the same section, was 49.0%.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) Quantitatively, the contribution of 0.6 percentage points from the Heritage AspenTech acquisition and the resulting total gross margin percentage of 49.0% are both accurately reported. The mention of a 3.3 percentage point increase in gross margin provides additional context not in the original answer but does not contradict it and aligns with plausible supporting data. (2) All numbers are correct and presented with proper precision; format variations (e.g., '49.0%' vs '49.0 percent') are semantically equivalent. (3) The reasoning is sound: the LLM correctly identifies the acquisition's impact on gross margin and links it to the final margin percentage in 2023, demonstrating accurate multi-hop synthesis between the acquisition event and its financial impact. (4) Entities—Emerson (EMR), Heritage AspenTech, gross margin percentage, and year 2023—are all correctly identified and contextualized. The answer is highly relevant, complete, and factually consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 301,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does Cisco's guarantee of channel partner financing arrangements potentially affect its credit loss exposure as described in the financing receivables section, given the risk of channel partner financial instability?",
      "original_answer": "Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because it could be required to make payments if channel partners default on short-term financing with third parties. According to the filing, Cisco facilitates revolving short-term financing for channel partners with payment terms ranging from 60 to 90 days and, in some cases, guarantees a portion of these arrangements. If channel partners face financial instability, Cisco may be obligated to cover unpaid amounts under these guarantees. This exposure is compounded by the fact that Cisco already records allowances for credit losses based on internal credit risk ratings, historical default rates, and macroeconomic conditions. If financial instability among channel partners rises, Cisco could experience higher credit losses tied to these financing guarantees, directly impacting its financial position.",
      "llm_answer": "Based on the financing receivables disclosures in the 10-K (pages 64-66), Cisco's guarantee of channel partner financing arrangements increases its credit loss exposure because the company may be required to make payments under these guarantees if channel partners default on their financing obligations. This risk is heightened by the potential for channel partner financial instability, which could lead to increased allowances for credit losses on financing receivables and potential payments under guarantees, especially during periods of economic uncertainty or market disruptions affecting partner solvency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth, with high accuracy in both quantitative and qualitative aspects. (1) There are no numeric values (e.g., dollar amounts, percentages, time ranges like 60–90 days) explicitly mentioned in the LLM answer, but it correctly references the existence of short-term financing and guarantees without misstating any figures. Since the ground truth includes '60 to 90 days' and the LLM does not contradict this (though it omits the specific range), the absence of error supports a full score in quantitative accuracy. (2) The answer addresses all key elements: Cisco’s guarantee increases credit loss exposure, obligation arises if partners default, financial instability heightens risk, and this affects allowances for credit losses—especially during economic stress. (3) Multi-hop reasoning is sound: it connects Cisco’s guarantees → partner defaults → financial instability → increased credit loss exposure and allowances, aligning with the causal chain in the original. (4) The only minor omission is the detail that Cisco facilitates revolving short-term financing and that guarantees cover only a portion of arrangements—information present in the ground truth but not in the LLM response. This slight lack of specificity prevents a perfect 10 on qualitative accuracy, though core reasoning remains intact. Overall, the response is highly relevant, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 400,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "Given Emerson's 55% ownership stake in AspenTech and the reported $1,093 million in total revenue from AspenTech for 2024, what portion of this revenue is proportionally attributable to Emerson's controlling interest, and how does this stake influence Emerson's overall software and control revenue of $5,399 million?",
      "original_answer": "Emerson's 55% ownership in AspenTech gives it control over a majority of AspenTech's revenue. With AspenTech generating $1,093 million in total revenue for 2024, Emerson's proportionally attributable share is $601.15 million (55% of $1,093 million). AspenTech's revenue is a component of Emerson’s broader 'Software and Control' segment, which reported $5,399 million in revenue for the year. This indicates that AspenTech contributes significantly to Emerson's software and control offerings, representing over 10% of that segment's revenue.",
      "llm_answer": "Based on the provided financial data, Emerson's 55% ownership stake in AspenTech means it proportionally attributes 55% of AspenTech's $1,093 million 2024 revenue to itself, or $601 million. This stake is a key component of Emerson's overall Software and Control revenue of $5,399 million, which includes AspenTech's sales as part of that segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Emerson's 55% ownership in AspenTech and accurately calculates the proportional revenue share as $601 million (55% of $1,093 million). The exact ground truth value is $601.15 million, but rounding to $601 million is acceptable and common in financial reporting. All entities (Emerson, AspenTech, Software and Control segment), metric (revenue), and year (2024) are correct.\n\n2) Quantitative accuracy is excellent: 55% × $1,093 million = $601.15 million; the LLM reports $601 million, which is a negligible rounding difference and does not affect factual correctness. No other numbers are misstated.\n\n3) The reasoning is sound and reflects proper multi-hop synthesis: the model connects Emerson's ownership stake to revenue attribution and correctly situates AspenTech's contribution within Emerson’s broader Software and Control segment. However, the LLM omits the explicit observation that AspenTech represents over 10% of the $5,399 million segment revenue (~11.1%), which was included in the ground truth and adds contextual insight. This is a minor omission, not an error.\n\n4) The answer is contextually fully relevant, directly addressing both parts of the question: (a) the attributable revenue and (b) the influence on Emerson’s overall software and control revenue. The qualitative accuracy is high but not perfect due to the missing comparative percentage, which slightly reduces completeness in conveying the full significance of the stake.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 410,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Pfizer's divestiture of Meridian and the Upjohn spin-off impact its overall cash position and financial restructuring in 2020 and 2021?",
      "original_answer": "Pfizer received $51 million in cash from the sale of Meridian in 2021 and recognized a $167 million loss from the transaction, which was recorded in Discontinued operations—net of tax. In contrast, the Upjohn spin-off in 2020 involved a much larger financial restructuring: Viatris paid Pfizer $12.0 billion in cash as part of the Reverse Morris Trust transaction, which Pfizer used to pay down commercial paper borrowings and redeem $1.492 billion in senior unsecured notes. The Upjohn transaction also resulted in Pfizer distributing $1.6 billion in net assets as part of the spin-off, including $412 million in cash transferred to the Upjohn Business. While the Meridian divestiture had a minimal cash inflow and a negative impact due to the loss, the Upjohn spin-off significantly affected Pfizer’s capital structure by reducing debt and providing a substantial cash infusion, illustrating a strategic shift toward focusing on core growth areas.",
      "llm_answer": "Pfizer's divestiture of Meridian generated only about $51 million in cash and resulted in a $167 million after‑tax loss on the sale, while the Upjohn spin‑off required a $12 billion cash distribution to Pfizer and led to the issuance of roughly $11.4 billion of new debt to fund that payment and to refinance existing Upjohn notes. Consequently, the transactions provided modest net cash inflows but also increased Pfizer’s leverage and required substantial financing arrangements, shaping its cash position and overall financial restructuring in 2020‑2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the Upjohn spin-off. It incorrectly states that the Upjohn spin-off 'required a $12 billion cash distribution to Pfizer' and that 'roughly $11.4 billion of new debt was issued to fund that payment.' This is the opposite of the truth: Pfizer received $12.0 billion in cash from Viatris as part of the Reverse Morris Trust transaction, not paid it. The debt issuance claim is unsupported by the ground truth and factually incorrect—Pfizer used the $12 billion cash inflow to reduce debt, not increase it. The Meridian divestiture details are correct: $51 million cash received and a $167 million after-tax loss. (2) Quantitative accuracy is partially correct: $51 million and $167 million are accurate for Meridian. However, the $12 billion figure is mischaracterized in direction (inflow vs. outflow), and the $11.4 billion debt issuance is entirely fabricated. The ground truth mentions Pfizer redeemed $1.492 billion in senior notes and transferred $412 million in cash to Upjohn, but no new debt issuance. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the financial impact of the two transactions. It incorrectly concludes that both transactions increased leverage, when in fact the Upjohn spin-off significantly reduced debt. The strategic implication—using cash to deleverage—is completely reversed. (4) Despite these major errors, the answer is contextually relevant, addressing both transactions and their impact on cash and financial structure. However, due to fundamental errors in directionality and fabrication of debt issuance, the correctness and qualitative accuracy scores are low. Minor note: 'after-tax loss' is acceptable as equivalent to 'net of tax.'",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 487,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022, combining both the Amended Settlement Agreement payment and the annual deposit, and how does this reflect the plan's role in managing litigation liabilities?",
      "original_answer": "Visa contributed a total of $1.45 billion under the U.S. Retrospective Responsibility Plan in 2022. This includes Visa's $600 million payment as part of the Amended Settlement Agreement and the company's annual deposit of $850 million under the plan. This demonstrates the plan's function in systematically funding potential litigation liabilities.",
      "llm_answer": "Visa's total financial contribution under the U.S. Retrospective Responsibility Plan in 2022 was **$1.711 billion**, comprising a **$850 million deposit into the litigation escrow account** and an **$861 million accrual for uncovered U.S. covered litigation** (as shown in the “Accrual Summary‑U.S. Covered Litigation” table). This contribution reflects how the plan systematically provisions for and funds settlements or judgments related to U.S. covered litigation, using escrow deposits and accruals to manage the company’s litigation liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The total contribution is stated as $1.711 billion, but the ground truth is $1.45 billion. The LLM reports an $861 million accrual for uncovered litigation, whereas the correct figure is a $600 million payment under the Amended Settlement Agreement. The $850 million annual deposit is correctly identified. However, the components and total are incorrect. (2) Calculation verification: $850M + $600M = $1.45B (correct total). LLM reports $850M + $861M = $1.711B, which is factually and mathematically inconsistent with the ground truth. The $861M figure does not match any component in the original answer. (3) Multi-hop reasoning is partially present—LLM attempts to combine two financial components under the plan—but fails to correctly identify the sources of funding. It references an 'accrual for uncovered U.S. covered litigation' and a table not mentioned in the ground truth, suggesting potential hallucination or misattribution. The original answer clearly identifies the two components as the Amended Settlement Agreement payment and the annual deposit. (4) The contextual relevance is moderate because the answer addresses the plan’s role in managing litigation liabilities and attempts to break down contributions, but the incorrect figures and mischaracterized components severely undermine factual correctness. The qualitative reasoning about systematic provisioning is somewhat aligned, but based on wrong data. Thus, correctness and quantitative accuracy are low; qualitative accuracy is slightly higher due to structural attempt; relevance is acceptable but not sufficient to compensate for factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 462,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What was the percentage change in the allocation to equity securities for the U.S. Retiree Health Care Plan between 2022 and 2023, and how did this shift affect the total value of equity securities in the plan by the end of 2023?",
      "original_answer": "The allocation to equity securities for the U.S. Retiree Health Care Plan decreased by 15 percentage points from 35% in 2022 to 20% in 2023. Despite this lower allocation percentage, the total value of equity securities in the plan increased slightly to $54 million by the end of 2023, as shown in the asset breakdown.",
      "llm_answer": "The allocation to equity securities in the U.S. Retiree Health Care Plan remained unchanged at 20% from 2022 to 2023, so there was no percentage change in the allocation. However, the total value of equity securities in the plan increased from $98 million at the end of 2022 to $98 million at the end of 2023 (as reported on page 48), indicating no growth in total equity value despite the stable allocation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect. The ground truth states that the allocation to equity securities decreased from 35% in 2022 to 20% in 2023—a 15 percentage point decrease. The LLM incorrectly claims the allocation remained unchanged at 20%, which contradicts the factual data. Additionally, the LLM states the total value of equity securities was $98 million at both year-ends with no growth, while the ground truth reports the total value increased slightly to $54 million by the end of 2023. The $98 million figure appears to be fabricated or misextracted, and does not align with the stated $54 million. (2) Quantitative accuracy is extremely low: both percentages (35% and 20% vs. falsely claimed 20% both years) and dollar values ($54M vs. falsely reported $98M) are incorrect. The calculation of percentage change is entirely missing. (3) The multi-hop reasoning failed: the model did not correctly identify the change in allocation percentage between two years nor link it to the resulting total equity value. Instead, it assumed no change and reported incorrect figures, indicating a failure in synthesizing data across time periods. (4) Contextual relevance is low but not zero—the answer addresses the U.S. Retiree Health Care Plan and equity securities, so it stays on topic, but all key facts are wrong. Hence, correctness, quantitative, and qualitative scores are very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 392,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did the adoption of the CECL accounting standard influence the differences in total capital between the Advanced approaches and the Standardized approach as of December 31, 2023, and what specific capital component drove this difference?",
      "original_answer": "The adoption of the CECL accounting standard influenced the differences in total capital between the Advanced approaches and the Standardized approach due to variations in the amount permitted in Tier 2 capital related to the qualifying allowance for credit losses. Specifically, under the Standardized approach, total capital increased by $12.6 billion in 2023, partly due to an increase in the adjusted allowance for credit losses included in Tier 2 capital. This component is treated differently under the two approaches, contributing to the observed capital disparity.",
      "llm_answer": "The adoption of the CECL accounting standard increased the qualifying allowance for credit losses under the Advanced approaches, which reduced total capital under the Advanced approaches relative to the Standardized approach. This difference was driven specifically by the adjustment in the qualifying allowance for credit losses under the Advanced approaches (a $9,950 million reduction in capital as of December 31, 2023). Consequently, total capital under the Standardized approach ($251,399 million) exceeded that under the Advanced approaches ($241,449 million) by $9,950 million, primarily due to the CECL-related transition provision impact on credit loss allowances.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While the original answer states that total capital under the Standardized approach increased by $12.6 billion due to the adjusted allowance for credit losses included in Tier 2 capital, the LLM claims a $9,950 million (i.e., $9.95 billion) reduction in capital under the Advanced approaches, which does not match the ground truth. There is no mention in the original answer of a $9.95 billion reduction or specific capital figures of $251,399 million and $241,449 million—these numbers are fabricated or misattributed. (2) The calculation of a $9,950 million difference is inconsistent with the $12.6 billion increase cited in the ground truth. Even allowing for format variation, the direction and magnitude of the effect do not align: the original emphasizes an increase in Standardized approach capital due to CECL-related allowance inclusion, while the LLM frames it as a reduction under Advanced approaches without supporting evidence from the truth. (3) The reasoning partially captures the multi-hop concept—that CECL affects credit loss allowances differently under the two approaches, influencing capital disparity—but incorrectly attributes the driver to a 'reduction' under Advanced approaches rather than a permitted increase in Tier 2 capital under the Standardized approach. The core mechanism (differential treatment of allowance for credit losses in Tier 2) is acknowledged, but the causal direction and magnitude are flawed. (4) Scores reflect partial understanding of the conceptual framework (hence moderate qualitative and relevance scores), but severe penalties on correctness and quantitative accuracy due to incorrect numbers and unsupported calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 487,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Using the midpoint of the stated percentage ranges for each plan, what weighted average percentage allocation to Fixed Income Securities and Cash Equivalents should be applied across all defined benefit and retiree health care plans based on their respective total asset values as reported?",
      "original_answer": "The weighted average percentage allocation to Fixed Income Securities and Cash Equivalents across all plans is approximately 72.3%, calculated using the midpoints of the percentage ranges and the total asset values for each plan.",
      "llm_answer": "Based on the midpoint of the stated ranges (65%–80% for U.S. DB, 75%–85% for U.S. Retiree Health Care, and 60%–100% for Non-U.S. DB), the weighted average allocation to Fixed Income Securities and Cash Equivalents across all plans is calculated as follows: U.S. DB uses 72.5% (midpoint of 65–80), U.S. Retiree Health Care uses 80% (midpoint of 75–85), and Non-U.S. DB uses 80% (midpoint of 60–100). Using the 2023 weighted average asset allocations of 65% for U.S. DB, 80% for U.S. Retiree Health Care, and 77% for Non-U.S. DB, the overall weighted average allocation is approximately 75.5%.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies in both midpoint calculations and the final weighted average. The midpoint for the Non-U.S. DB plan is incorrectly calculated as 80% (should be (60+100)/2 = 80%, which is correct), but the U.S. DB midpoint is correctly calculated as 72.5% and U.S. Retiree Health Care as 80% (correct). However, the final weighted average of 75.5% does not match the ground truth of 72.3%, indicating an error in weighting methodology or asset values used. (2) The LLM references '2023 weighted average asset allocations' (65%, 80%, 77%) as weights, but these appear to be misinterpreted—these percentages are likely the actual allocations, not the total asset values needed for weighting. The correct approach requires weighting each plan’s midpoint by its respective total asset value (e.g., $X million for U.S. DB, $Y million for U.S. Retiree, etc.), which the model fails to do. This leads to an incorrect final figure. (3) The multi-hop reasoning is partially sound—identifying midpoints and attempting a weighted average—but fails at the critical step of using actual total asset values as weights. The model substitutes these with other percentages, breaking the calculation. (4) Despite correct identification of plans and reasonable midpoint math, the final answer is significantly off due to flawed weighting, warranting a correctness score of 4. Quantitative accuracy is medium (5) due to correct midpoints but wrong final number. Qualitative accuracy is also 5—reasoning structure is present but flawed. Contextual relevance is high (8) as the response addresses the right concepts and plans.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 454,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the implementation of Basel 3 capital calculations influence the composition and risk profile of Bank of America's covered trading positions as reflected in its Value at Risk (VaR) metrics?",
      "original_answer": "Basel 3 capital calculations require Bank of America to maintain specific capital ratios, including a capital conservation buffer of 2.5% and a stress capital buffer of 2.5% at December 31, 2023. These regulatory requirements influence the Corporation’s risk appetite and capital allocation decisions, particularly in its Global Markets segment, which holds the majority of the market-based portfolio. As a result, the Corporation manages its covered trading positions—such as foreign exchange and commodity positions—under Basel 3 guidelines, which directly affect the risk profile and VaR metrics of these positions. In 2023, the annual average of total covered positions and less liquid trading positions portfolio VaR decreased compared to 2022, primarily due to the roll off of March 2020 market volatility from the historical data window used in the VaR model calibration, aligning with the Basel 3 capital framework.",
      "llm_answer": "The Basel III capital framework requires the Corporation to calculate VaR for its covered‑trading portfolio using a standardized, one‑day holding‑period approach. Because Basel III mandates higher capital buffers and stricter risk‑weighting, the bank updates its VaR model more frequently and incorporates additional stress‑testing scenarios that extend beyond historical market moves. Consequently, the composition of covered trading positions is adjusted to align with the more stringent risk‑weighting and capital‑adequacy thresholds, which in turn tightens the risk profile reflected in the reported VaR metrics—evidenced by the lower average 99 % VaR for the total covered‑positions portfolio in 2023 versus 2022 and the inclusion of impact from less‑liquid exposures in the VaR calculations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the influence of Basel III on Bank of America's risk management practices, capital adequacy, and VaR modeling, aligning with the ground truth. It accurately notes the decrease in average VaR for the covered positions portfolio in 2023 vs. 2022, which matches the original answer. However, it omits specific quantitative details from the ground truth—namely, the exact capital buffer requirements (2.5% capital conservation buffer and 2.5% stress capital buffer at December 31, 2023)—which are key factual elements. While the LLM mentions 'higher capital buffers,' it does not specify the percentages or the date, leading to a partial loss in quantitative accuracy. (2) The LLM correctly references the 2023 vs. 2022 VaR decline but does not explicitly attribute the decrease to the roll-off of March 2020 market volatility from the historical data window, a critical explanatory point in the ground truth. This omission affects completeness and precision in causal reasoning. (3) The multi-hop reasoning is sound: the LLM correctly links Basel III requirements → capital and risk-weighting changes → adjustments in trading position composition → tighter risk profile → lower reported VaR. It also appropriately references the inclusion of less-liquid exposures in VaR calculations, which is consistent with the original answer’s emphasis on 'less liquid trading positions.' (4) Despite missing specific numbers and one key explanatory driver, the LLM captures the core logic, entities (Basel III, covered trading positions, VaR), time frame (2023 vs. 2022), and directional outcome (lower VaR). Wording differs but semantic meaning is largely equivalent. Contextual relevance is perfect—directly addresses the question’s focus on Basel III’s impact on composition, risk profile, and VaR.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 498,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "What is the total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express, and how does this compare to the amount of debt eliminated through redemptions paid using proceeds from the senior unsecured debt issuance?",
      "original_answer": "The total net book value of the 19 Boeing aircraft securing the Pass-Through Certificates issued by FedEx Express is $1.8 billion. This compares to the $5.8 billion of outstanding debt eliminated through redemptions paid using proceeds from the $3.25 billion senior unsecured debt issuance, which also included $393 million in associated redemption premiums.",
      "llm_answer": "The 19 Boeing aircraft securing the Pass‑Through Certificates have a combined net book value of **$1.8 billion** (as stated in the certificate description on page 94). This $1.8 billion of aircraft collateral is the amount referenced, and it is not directly compared to any debt‑repayment figure in the provided excerpts; therefore, the question’s second part cannot be answered from the available data.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the net book value of the 19 Boeing aircraft as $1.8 billion, matching the ground truth exactly. This part is factually accurate and properly cited. However, the second part of the question — comparing this collateral value to the amount of debt eliminated through redemptions funded by the senior unsecured debt issuance — is incorrectly stated as 'cannot be answered from the available data,' when in fact the ground truth provides clear figures: $5.8 billion of debt was eliminated, along with $393 million in redemption premiums, funded via a $3.25 billion senior unsecured debt issuance. (2) Quantitatively, the only number provided ($1.8 billion) is correct, so quantitative accuracy is high. But the model fails to report $5.8 billion in debt eliminated and $393 million in premiums, which are critical to the comparison. (3) The multi-hop reasoning is flawed: the model should have synthesized information between the aircraft collateral (securing Pass-Through Certificates) and the debt refinancing activity (using proceeds from unsecured debt to redeem other debt). The comparison is not about direct offset but relative scale — $1.8B in collateral vs $5.8B in retired debt — which the model fails to make. (4) Contextual relevance is moderate because the answer addresses the first part and acknowledges the second, but incorrectly claims insufficiency of data. The failure to complete the multi-hop synthesis significantly reduces correctness despite accurate initial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 421,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How much did TI contribute to U.S. defined contribution plans in 2023, and what is notable about the investment of plan assets in TI common stock for the retiree health care benefit plan?",
      "original_answer": "TI contributed $75 million to U.S. defined contribution plans in 2023. Notably, none of the plan assets related to the retiree health care benefit plan were directly invested in TI common stock.",
      "llm_answer": "TI contributed $873 million of U.S. defined‑contribution plan assets in 2023 (5 million shares valued at $873 million) and $940 million in 2022 (6 million shares).  \n\nFor the U.S. retiree health‑care benefit plan, the plan assets are invested in low‑cost, broad‑market index funds to mitigate concentration risk, and none of the plan assets are directly invested in TI common stock.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is significantly incorrect on the key quantitative fact. The ground truth states that TI contributed $75 million to U.S. defined contribution plans in 2023, but the LLM claims $873 million, which is more than 11 times higher. This figure appears to be a misinterpretation—possibly confusing stock value or share-based transfers with actual cash contributions. The mention of '5 million shares valued at $873 million' does not align with the ground truth and introduces unsupported details. However, the second part of the answer—that none of the plan assets for the retiree health care benefit plan are directly invested in TI common stock—is factually correct and matches the original answer. (2) The quantitative accuracy is very low because the primary dollar amount is wrong, and the supporting details (share counts and valuations) are not present in the ground truth. The $940 million figure for 2022 is also unsupported. (3) The qualitative accuracy is partially sound: the model correctly identifies the lack of direct investment in TI stock for the retiree health care plan and provides plausible reasoning about risk mitigation, but it fails to correctly synthesize the contribution amount, a core part of the multi-hop query. (4) Contextual relevance is moderate—the response addresses both parts of the question and attempts to provide meaningful context, but the severe numerical inaccuracy undermines the overall correctness. The model conflates different types of financial data, suggesting a failure in multi-hop reasoning or source differentiation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 437,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "Apple's 10-K filing emphasizes its strategic focus on services as a key growth area. Given that Services revenue increased from $85.2 billion in 2023 to $96.169 billion in 2024, and total net sales rose from $383.285 billion in 2023 to $391.035 billion in 2024, what percentage of the total net sales growth between 2023 and 2024 was attributable to the increase in Services revenue?",
      "original_answer": "The increase in Services revenue contributed approximately 121% of the total net sales growth between 2023 and 2024. This is calculated as follows: Services revenue increased by $10.969 billion ($96.169B - $85.2B), while total net sales increased by $7.75 billion ($391.035B - $383.285B). Therefore, the Services growth alone accounted for $10.969B / $7.75B = 121% of the total net sales growth.",
      "llm_answer": "The increase in Services revenue ($96.169 billion in 2024 versus $85.2 billion in 2023) accounts for roughly 79 % of the total net‑sales growth between 2023 and 2024. This is calculated as the Services revenue increase ($10.969 billion) divided by the overall net‑sales increase ($7.75 billion), yielding about 79 %.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical calculation error. While it correctly identifies the Services revenue increase ($96.169B - $85.2B = $10.969B) and the total net sales increase ($391.035B - $383.285B = $7.75B), it incorrectly computes the percentage contribution as ~79%, when the correct value is $10.969B / $7.75B = 1.415 → 141.5%, which rounds to approximately 121% only if there is a typo in the ground truth. However, recalculating: 10.969 / 7.75 ≈ 1.415 or 141.5%, not 121%. But the original answer claims 121%, which appears to be factually incorrect. Despite this, the LLM’s 79% is still wrong. The correct math is ~141.5%, meaning neither answer is fully accurate, but the LLM’s reasoning method is correct (using ratio of increases), while the ground truth may have a typo. However, per evaluation guidelines, we must score against the provided ground truth. Since the ground truth states 121%, and the LLM says 79%, this is a major quantitative discrepancy. (2) Number verification: Input numbers are correct — Services from $85.2B to $96.169B (Δ = $10.969B), total sales from $383.285B to $391.035B (Δ = $7.75B). These are accurately extracted. But the division 10.969 / 7.75 ≈ 1.415 → 141.5%, not 79% nor 121%. The LLM likely miscalculated the division (possibly did 7.75 / 10.969 ≈ 0.707 or similar). 79% does not match any valid permutation. (3) Multi-hop reasoning: The model correctly identifies that the question requires computing growth contributions across two financial line items and years, showing proper synthesis. The logic framework is sound — compute delta for Services, compute delta for total sales, then take ratio. This demonstrates correct multi-hop reasoning. (4) Justification: Correctness score is low (2) because the final percentage is wildly off and contradicts both correct math and the stated ground truth. Quantitative accuracy is poor due to the incorrect result despite correct inputs. Qualitative accuracy is slightly higher because the reasoning approach is valid. Contextual relevance is high — the model addresses the right entities, time periods, and metric. However, the numerical conclusion is fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 584,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "What is the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months, and how does the existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 contribute to the uncertainty surrounding these tax positions?",
      "original_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million. This uncertainty is influenced by the fact that the IRS has issued Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015, which Pfizer is currently appealing. These RARs represent formal audit findings that the company disputes, contributing to the ongoing uncertainty in tax positions and the potential for significant changes in unrecognized tax benefits.",
      "llm_answer": "The estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits within the next 12 months is $75 million, exclusive of interest. This reduction could result from settlements with taxing authorities or the expiration of statutes of limitations. The existence of Revenue Agent's Reports (RARs) for tax years 2011–2013 and 2014–2015 creates uncertainty because Pfizer is not in agreement with the IRS's determinations and is appealing certain disputed issues; unresolved disputes could lead to adjustments in the estimated unrecognized tax positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the estimated maximum potential decrease in Pfizer's gross unrecognized tax benefits as $75 million, matching the ground truth exactly. The addition of 'exclusive of interest' is a minor clarification not present in the original but does not contradict it and may reflect additional context from the filing. (2) All numeric values and time periods are accurate: $75 million and tax years 2011–2013 and 2014–2015 are correctly cited. No calculation errors. (3) The multi-hop reasoning is sound: the LLM correctly links the existence of RARs to uncertainty by explaining that Pfizer is appealing disputed issues with the IRS, which contributes to uncertainty in tax positions—this aligns with the ground truth’s explanation. (4) The only minor shortcoming is that the LLM does not explicitly state that the RARs are 'formal audit findings' (a nuance present in the original), but it does convey the essence by referencing disputed determinations and appeals. Overall, the answer is factually correct, complete, and semantically equivalent to the ground truth, warranting a high score with only a slight deduction for a small loss in qualitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 338,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the five-year transition period related to the adoption of the CECL accounting standard impact the calculation of BAC's TLAC ratios and CET1 capital as of December 31, 2023?",
      "original_answer": "The five-year transition period related to the adoption of the CECL accounting standard impacts the calculation of BAC's TLAC ratios by allowing the use of the regulatory capital rule that predates CECL, which affects how capital is measured and reported. As of December 31, 2023, BAC's CET1 capital was $194.9 billion, an increase of $14.9 billion from the prior year, influenced in part by the CECL transition's effect on capital calculations.",
      "llm_answer": "The five‑year transition period for CECL allows the Corporation to calculate its CET1 capital ratio using the regulatory capital rule that phases in the full CECL impact over five years; consequently, the CET1 ratio reported at December 31 2023 incorporates only 50 % of the CECL transition provision, and the TLAC ratios are derived using the same transitional rule, which affects the amount of eligible capital and debt that can be counted toward meeting the TLAC and CET1 regulatory minimums.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly explains the mechanism of the five-year CECL transition period and its impact on both CET1 and TLAC ratios, aligning with the core reasoning in the ground truth. It accurately notes that the transitional rule allows phased-in treatment, affecting how capital is measured. However, it introduces a specific claim—that '50% of the CECL transition provision' is incorporated as of December 31, 2023—which is not present in the original answer and cannot be verified from the provided ground truth. While this percentage may be factually accurate in context, it goes beyond the information supported by the ground truth, introducing a precise quantitative assertion that lacks corroboration. (2) The original answer includes a specific dollar amount—$194.9 billion for CET1 capital as of December 31, 2023—and notes a $14.9 billion year-over-year increase, both of which are omitted in the LLM answer. These omissions reduce quantitative completeness. The LLM does not contradict them, but their absence affects full factual alignment. (3) The multi-hop reasoning is sound: the model correctly links CECL transition rules to regulatory capital treatment and extends the impact to both CET1 and TLAC ratios, demonstrating proper synthesis across accounting standards and regulatory metrics. (4) The contextual relevance is high, as the answer directly addresses the question’s focus on the CECL transition’s effect on capital ratios. The qualitative accuracy is strong due to correct entity identification (CECL, CET1, TLAC, BAC) and logical reasoning. The correctness score is 8 because the core explanation is accurate and well-reasoned, but the unverified 50% figure and missing dollar amounts prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 477,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How do the implementation dates and fuel surcharge adjustment mechanisms differ between FedEx Ground and FedEx Freight in response to fluctuating fuel prices?",
      "original_answer": "FedEx Ground adjusts its fuel surcharge on a weekly basis using fuel price data from two weeks prior, with updates to the fuel surcharge tables occurring on June 21, 2021, November 1, 2021, and April 4, 2022. FedEx Freight, on the other hand, adjusts its fuel surcharge weekly using fuel price data from two days prior, with updates to the fuel surcharge tables occurring on November 1, 2021, and April 4, 2022. These differences in timing and data lag reflect how each segment tailors its fuel surcharge mechanism to address fuel cost fluctuations.",
      "llm_answer": "FedEx Ground uses a weekly-indexed fuel surcharge that is based on a fuel price from two weeks prior and is adjusted each week, while FedEx Freight applies a similar weekly-indexed fuel surcharge that is also updated weekly but uses its own separate fuel‑price tables (updated on Nov 1 2021 and Apr 4 2022). Both segments therefore adjust their surcharges on a weekly basis, but the specific calculation tables and the timing of the updates differ between Ground and Freight.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct and captures the core differences in fuel surcharge mechanisms between FedEx Ground and FedEx Freight. It correctly states that both segments adjust their surcharges weekly, which aligns with the ground truth. It accurately notes that FedEx Freight's fuel surcharge tables were updated on November 1, 2021, and April 4, 2022. However, it omits the specific update date of June 21, 2021, for FedEx Ground, which is included in the original answer and represents a factual omission. Additionally, while the LLM mentions that Ground uses data from two weeks prior, it fails to explicitly state that Freight uses fuel price data from only two days prior — instead vaguely referencing 'separate fuel-price tables' without clarifying the critical difference in data lag (two weeks vs. two days), which is a key part of the original answer. This weakens the comparative reasoning and results in a partial loss of quantitative and qualitative accuracy. Despite these omissions, the answer remains contextually relevant and conveys a semantically reasonable summary of the mechanisms, just lacking full completeness in dates and timing specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 328,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the reorganization of the Ventilator Product Line impact the reporting structure of MDT's Medical Surgical segment in fiscal year 2023, and what does this indicate about the strategic positioning of the retained Acute Care & Monitoring business?",
      "original_answer": "The Ventilator Product Line was moved out of the Medical Surgical segment and into the 'Other' line as part of a reorganization. This reorganization also involved the Renal Care Solutions business and led to the formation of a new unit called Acute Care & Monitoring within Medical Surgical, which combined retained PMRI businesses. This indicates a strategic refocusing of the Medical Surgical segment around core PMRI capabilities, while separating out businesses either being exited or transitioned.",
      "llm_answer": "The reorganization of the Ventilator Product Line moved the retained Acute Care & Monitoring business into a dedicated operating segment within the Medical Surgical Portfolio, consolidating previously separate operating segments into a single unit. This restructuring reflects Medtronic's strategic focus on prioritizing high-growth, core therapeutic areas while exiting non-core product lines, signaling a deliberate shift toward strengthening its Acute Care & Monitoring offering as a distinct growth driver within its medical surgical business.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the direction of the reorganization. According to the ground truth, the Ventilator Product Line was moved *out* of the Medical Surgical segment into the 'Other' line, not moved *into* a dedicated segment within Medical Surgical as the LLM claims. Additionally, the Acute Care & Monitoring unit was formed *within* Medical Surgical by combining retained PMRI businesses, not by moving an existing 'retained Acute Care & Monitoring business' into a new segment. The LLM reverses the structural movement. (2) There are no numeric values, dates, or financial metrics in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the reorganization flow (removal of ventilators and renal care, formation of Acute Care & Monitoring from retained assets) and misattributes strategic intent based on incorrect structural assumptions. While it correctly infers a strategic refocusing, the reasoning is built on incorrect premises. (4) Contextual relevance is high—the answer addresses the strategic implications and attempts to explain the reporting structure change—but the core factual error in the reorganization direction undermines correctness. The strategic interpretation is plausible but not fully aligned with the ground truth's emphasis on exiting non-core lines and consolidating core PMRI capabilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 422,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "What was the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over the fiscal years 2022 and 2023, based on the amounts disclosed in both tables?",
      "original_answer": "The total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes over fiscal years 2022 and 2023 was $252 million.",
      "llm_answer": "Based on the provided financial tables, the total financial impact of expenses related to medical device regulations on Medtronic's income before income taxes for fiscal years 2022 and 2023 is $119 million in 2023 and $102 million in 2022, as disclosed in the \"Medical device regulations\" line item within the segment operating profit reconciliation. These amounts represent the pre-tax charges related to compliance with new European Union medical device regulations, which are explicitly listed as deductions from segment operating profit in the fiscal year 2023 table (page 104) and the fiscal year 2022 table (page 104). The question specifically asks for the amounts disclosed in both tables, confirming the $119 million for 2023 and $102 million for 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the individual yearly expenses from the tables—$119 million in 2023 and $102 million in 2022—which matches the disclosed amounts in the source documents. However, the question asks for the *total* financial impact over both years, which requires summing these values. The correct total is $221 million ($119M + $102M), not $252 million as stated in the ground truth. Since the LLM does not compute or report the total, it fails to fully answer the question. Moreover, the ground truth itself appears to be factually incorrect if the source numbers are indeed $119M and $102M, as their sum cannot be $252M. (2) Quantitative accuracy is partially correct: the per-year figures are accurate, but the total is neither calculated nor correct in relation to the ground truth. There is a discrepancy between the expected total ($252M) and the actual sum of disclosed numbers ($221M), suggesting either an error in the ground truth or missing data. (3) The reasoning is sound in identifying the correct line items and tables, and the multi-hop synthesis across fiscal years 2022 and 2023 is appropriate. However, the failure to sum the two values as required by the question indicates a gap in task completion. (4) Contextual relevance is high—the response cites the correct metric, company, years, and regulatory context. The qualitative accuracy is moderate because the logic and sourcing are correct, but the final output does not match the expected total, leading to a significant factual misalignment. Given that the core quantitative outcome (the total) is incorrect, the correctness score is limited to 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 450,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How many different forms of Long-Term Incentive Restricted Stock Units, including both U.S. and International versions, are disclosed in Boeing's 2023 10-Q filings?",
      "original_answer": "Boeing disclosed four different forms of Long-Term Incentive Restricted Stock Units in their 2023 10-Q filings. These include: (1) U.S. Long-Term Incentive Restricted Stock Units (Exhibit 10.3), (2) U.S. Long-Term Incentive Performance Restricted Stock Units (Exhibit 10.5), (3) International Long-Term Incentive Restricted Stock Units (Stock-Settled) (Exhibit 10.4), and (4) International Long-Term Incentive Performance Restricted Stock Units (Stock-Settled) (Exhibit 10.6).",
      "llm_answer": "Based on the exhibits listed on page 127, Boeing discloses multiple distinct forms of Long‑Term Incentive Restricted Stock Units, including separate U.S. and International versions for the CEO and for other participants. The document enumerates at least three separate LTIP RSU notices (e.g., 10.32 – U.S. CEO LTIP RSU; 10.33 – U.S. Performance LTIP RSU; 10.34 – U.S. General LTIP RSU; 10.35 – International LTIP RSU), confirming that more than one form is disclosed.  \n\n\\[\n\\boxed{4}\n\\]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the quantitative result of 4 different forms of Long-Term Incentive Restricted Stock Units, matching the ground truth. The boxed answer \\boxed{4} is accurate and directly responsive to the question. However, while the LLM references 'page 127' and lists exhibit numbers like 10.32–10.35, these exhibit numbers do not match those in the original answer (which correctly cites Exhibits 10.3, 10.4, 10.5, and 10.6). This discrepancy suggests either a misreference or confusion with a different document version, which slightly undermines the qualitative accuracy. Despite this, the core reasoning and synthesis are sound—the model correctly infers that there are four distinct forms, including both U.S. and International versions, and acknowledges performance-based distinctions. The answer is contextually relevant and addresses all parts of the question. Minor wording differences (e.g., 'LTIP RSU' vs full name) are acceptable under semantic equivalence. No calculation errors; numbers and final count are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 299,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "Given Apple's reliance on third-party developers and digital content providers for its product ecosystem, and considering the 12.9% year-over-year growth in Services revenue from 2022 to 2023, how might ongoing challenges in securing third-party software and content affect the sustainability of this growth trajectory for services like Apple Music?",
      "original_answer": "Apple's Services revenue grew from $78,129 million in 2022 to $85,200 million in 2023, representing a 12.9% increase. This growth includes revenue from services like Apple Music. However, the company's own disclosures indicate that its ability to maintain and grow this revenue depends on continued access to third-party software applications and digital content. Specifically, if developers choose not to maintain or update their applications due to Apple's minority market share or changes in App Store policies, or if content providers restrict access or raise costs, the attractiveness and functionality of Apple Music and other services could be compromised. This could lead to customer dissatisfaction and reduced demand, directly threatening the sustainability of the 12.9% growth rate seen in Services revenue.",
      "llm_answer": "The 12.9% YoY growth in Services revenue (including Apple Music) depends on continued access to third‑party software, digital content and developers; any disruption in securing that content or developer support could erode the revenue stream and undermine the sustainability of the growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in stating that the 12.9% year-over-year growth in Apple's Services revenue (which includes Apple Music) depends on continued access to third-party software, digital content, and developers. It correctly identifies the risk that disruptions in securing this content or developer support could undermine revenue growth sustainability. Quantitatively, the 12.9% growth figure is accurate and matches the ground truth (from $78,129M to $85,200M), and no other numerical inaccuracies are present. The answer is contextually relevant and directly addresses the core of the question. However, it lacks some completeness compared to the original answer: it omits specific examples of risks (e.g., developers leaving due to Apple's minority market share or App Store policies, content providers raising costs), and does not explicitly link reduced attractiveness of services like Apple Music to customer dissatisfaction and reduced demand. While the high-level reasoning is sound and semantically aligned, these omissions reduce the depth of the multi-hop synthesis, particularly in connecting developer/content provider challenges to user experience and revenue impact. Thus, while the core facts and numbers are correct, the qualitative reasoning is slightly less comprehensive than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 369,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do MetLife's cash buffer needs, as influenced by reinsurance and derivative counterparty risks, affect its ability to manage liquidity under stress scenarios, particularly in light of the $12.4 billion short-term liquidity position at the end of 2021?",
      "original_answer": "MetLife maintains a $12.4 billion short-term liquidity position as of December 31, 2021, to manage business requirements under current and stress market conditions. However, its cash buffer needs are influenced by exposure to reinsurance and derivative counterparties, where failure to pay guaranteed benefits could result in liquidity strain. Although these agreements are largely collateralized and subject to netting agreements, which reduce counterparty risk, the potential ineffectiveness of hedging strategies or unexpected policyholder behavior combined with market volatility could exceed the risk management framework. This dynamic directly ties MetLife's cash buffer needs (as a capital risk factor) to its liquidity management strategy, where the $12.4 billion short-term liquidity buffer serves as a safeguard against such risks.",
      "llm_answer": "MetLife’s $12.4 billion short‑term liquidity buffer cushions its ability to meet cash‑outflows even when stress scenarios strain its operations. However, the company’s capacity to absorb shocks is also shaped by the risks of reinsurer insolvency and derivative counterparty failures, which can increase collateral and settlement costs and force additional liquidity draws. Consequently, while the liquidity position provides a strong base, the interplay of reinsurance and derivative counterparty risks can limit MetLife’s flexibility to manage liquidity under adverse conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $12.4 billion short-term liquidity position as of the end of 2021 is correctly stated, with no calculation or date errors. (2) The answer correctly identifies the key risk factors—reinsurance and derivative counterparty risks—and explains how they can increase collateral needs and liquidity draws under stress, which matches the original answer's emphasis on potential liquidity strain from counterparty failures. (3) The reasoning is sound: it synthesizes the role of the liquidity buffer with external risk factors, acknowledging that while the $12.4 billion provides a strong base, counterparty risks can limit flexibility—this reflects the multi-hop logic in the ground truth linking capital risk factors to liquidity management. (4) Minor deduction in qualitative accuracy due to omission of specific risk-mitigating mechanisms mentioned in the original answer (e.g., collateralization, netting agreements, hedging strategy ineffectiveness, and policyholder behavior). These nuances add depth to the risk framework and were not addressed, slightly reducing completeness. However, the core message and factual correctness are preserved, and the answer remains contextually precise and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 360,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What is the total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, and how are these securities classified on the balance sheet according to the 2023 10-K filing?",
      "original_answer": "The total fair value of Level 3 auction rate securities held by MDT as of April 26, 2024, is $33 million, and these securities are classified under 'Other Assets' on the balance sheet.",
      "llm_answer": "As of April 26 2024, the total fair value of Level 3 auction‑rate securities held by Medtronic is $33 million, and these securities are classified as “Other Assets” on the consolidated balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the fair value of $33 million and the date April 26, 2024, are accurately reported, with acceptable formatting (e.g., $33 million = $33M). (2) The answer is complete, addressing both parts of the question: the total fair value and the balance sheet classification. (3) Entity accuracy is correct—Medtronic (MDT) is properly identified, and the classification 'Other Assets' matches the 2023 10-K filing. (4) The reasoning is sound, demonstrating correct synthesis of multi-hop information: identifying Level 3 auction rate securities, retrieving their fair value as of the specified date, and correctly mapping their balance sheet classification. (5) The semantic meaning is equivalent to the original answer, with only minor wording differences (e.g., 'consolidated balance sheet' adds precision but does not alter meaning). All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1107,
        "completion_tokens": 278,
        "total_tokens": 1386
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did the adoption of the credit loss guidance on January 1, 2020, impact the recognition and measurement of credit losses on mortgage loans and fixed maturity securities AFS, based on the impairment losses reported for 2019 and the ACL methodologies described?",
      "original_answer": "The adoption of the credit loss guidance on January 1, 2020, changed the recognition and measurement of credit losses from an incurred loss model to an expected lifetime credit loss model. For fixed maturity securities AFS, the impairment (loss) for foreign government, consumer corporate, industrial corporate, RMBS, and finance corporate securities in 2019 were ($81) million, ($23) million, ($22) million, ($2) million, and ($1) million, respectively, under the prior OTTI model. After adoption, impairment (loss) was comprised of intent-to-sell and direct write-down losses, rather than OTTI and intent-to-sell losses. For mortgage loans, the ACL is now established based on expected lifetime credit losses over the contractual term, adjusted for expected prepayments and extensions, incorporating past events, current conditions, and forecasted economic conditions. This represents a shift from the previous model where credit loss was recognized only when it was probable that all amounts due would not be collected.",
      "llm_answer": "The adoption of the credit‑loss guidance on January 1 2020 required the Company to move from an incurred‑loss model to an allowance‑for‑credit‑loss (ACL) model for mortgage loans and fixed‑maturity securities AFS. Under the ACL approach, an allowance is recorded for the full lifetime expected credit loss over the contractual term of each loan, incorporating prepayments, extensions, and forward‑looking economic forecasts. Consequently, the 2019 impairment losses reported for these assets were replaced by ACL provisions that reflect expected future defaults rather than only incurred losses, resulting in a different measurement of credit losses on mortgage loans and AFS.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core impact of the credit loss guidance adoption on January 1, 2020, accurately describing the shift from an incurred loss model to an expected lifetime credit loss model (ACL) for both mortgage loans and fixed maturity securities AFS. It correctly notes that the ACL model incorporates forward-looking economic forecasts, prepayments, and extensions, which aligns with the ground truth. The answer also correctly states that 2019 impairment losses were reported under the prior model and have been replaced by ACL provisions reflecting expected future defaults. However, it omits specific quantitative details from the original answer—namely, the exact 2019 OTTI impairment losses for foreign government ($81M), consumer corporate ($23M), industrial corporate ($22M), RMBS ($2M), and finance corporate ($1M) securities. While the LLM does not include incorrect numbers (hence quantitative accuracy is 10), the absence of these figures reduces completeness. Additionally, the LLM fails to mention the change in composition of impairment losses post-adoption—specifically that losses are now split between intent-to-sell and direct write-downs rather than OTTI and intent-to-sell—representing a minor gap in qualitative accuracy. Despite these omissions, the reasoning is sound, entities and dates are correct, and the response is highly relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 389,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does Lockheed Martin's obligation to provide consulting support under international offset agreements impact its ability to recover costs on U.S. government contractual commitments in 2024?",
      "original_answer": "Lockheed Martin's international offset agreements, which may include obligations to provide consulting support to in-country projects, require cash outlays and investments that are often outside the company’s control, such as those tied to joint ventures. These investments are only recoverable if the joint ventures operate successfully. Simultaneously, Lockheed Martin has $64.3 billion in purchase obligations related to U.S. government contracts, where cost recovery is only guaranteed if the government terminates the contract for convenience under the FAR. Therefore, if Lockheed Martin incurs significant costs fulfilling consulting support obligations under offset agreements but cannot recover those costs through successful joint ventures or offset reimbursements, it may not be able to recover those expenses under U.S. government contracts unless those contracts are terminated for convenience. This creates a financial risk in cost recovery when international obligations do not align with domestic reimbursement mechanisms.",
      "llm_answer": "Lockheed Martin’s offset agreements obligate it to provide consulting, technology‑transfer and other support to foreign customers, and failure to meet those commitments can trigger penalties, loss of sales and the need to fund remediation or purchase‑order costs. Because many of those obligations are tied to long‑term contracts that are subject to U.S. government procurement rules, the company may have to absorb additional expenses or reach‑forward losses to satisfy the offsets, which can erode the margin it can recover on its U.S. government contracts in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Lockheed Martin's international offset agreements involve obligations like consulting support and that failure to meet them can lead to penalties or additional costs. It also correctly links these obligations to potential margin erosion on U.S. government contracts, which is contextually relevant. However, it omits key factual details from the ground truth, particularly the $64.3 billion in U.S. government purchase obligations and the specific condition under FAR that cost recovery is only guaranteed if the contract is terminated for convenience. These are critical multi-hop elements connecting the financial scale of U.S. commitments and the narrow recovery mechanism. (2) There are no numeric inaccuracies in the LLM answer because it does not include any numbers; thus, quantitative accuracy is not violated, but the absence of the $64.3 billion figure reduces completeness and factual richness. (3) The reasoning is partially sound—there is an understanding that offset obligations may require cost absorption that affects U.S. contract margins—but it fails to synthesize the specific risk that costs from offset agreements cannot be recovered under U.S. contracts unless those are terminated for convenience. This missing link weakens the multi-hop logic. (4) Contextual relevance is high because the answer addresses the core theme of cost recovery risk. However, the lack of specific financial figures and precise contractual mechanisms (FAR, termination for convenience) results in a correctness score of 6, reflecting partial accuracy with significant omissions in factual depth and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 455,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did TMO's pharma services business drive segment revenue and margin performance in 2021, considering both pandemic-related demand and the impact of inventory accounting changes?",
      "original_answer": "TMO's pharma services business significantly contributed to segment revenue and margin performance in 2021. The business experienced increased demand, particularly driven by its role in supporting customers with vaccine and therapy development during the ongoing COVID-19 pandemic. This led to strong sales growth and a positive sales mix, which boosted segment income margins. Additionally, a $20 million credit to cost of product revenue, resulting from a change in inventory accounting method, further improved margins. However, this positive impact was partially offset by strategic growth investments. Together, pandemic-related demand and the inventory accounting change were key contributors to the segment's financial performance.",
      "llm_answer": "TMO’s pharma services business contributed to a 45% jump in segment income and a 2‑point rise in segment‑margin for Laboratory Products and Biopharma Services, driven by higher sales of pharma‑service contracts and the $20 million inventory‑accounting credit, while pandemic‑related demand also lifted revenues across the segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $20 million inventory-accounting credit and pandemic-related demand as key drivers of TMO's pharma services business performance in 2021, aligning with the ground truth. It also correctly links higher sales from pharma-service contracts to revenue and margin improvements. However, the 45% jump in segment income and the 2-point rise in segment margin are not mentioned in the original answer and cannot be verified from the provided ground truth, introducing unverified quantitative claims. (2) The $20 million credit is accurately reported, but the 45% and 2-point figures lack corroboration in the ground truth, reducing quantitative accuracy. The original answer emphasizes margin improvement due to sales mix and the accounting change but does not quantify the overall segment income increase or margin percentage change. (3) The reasoning is sound in connecting pandemic demand, the accounting change, and their combined effect on margins and revenues. The model synthesizes the impact of both operational and accounting factors correctly, though it adds unsupported precision. (4) Despite the extra numerical claims, the core multi-hop reasoning—linking TMO’s pharma services, pandemic demand, and inventory accounting to segment performance—is accurate and relevant. The answer addresses all key aspects of the question, but the unsupported percentages prevent a top score on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 408,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How does MetLife's participation in Supervisory Colleges, both in the U.S. and Europe, influence its regulatory oversight and risk profile given the involvement of NYDFS and EIOPA?",
      "original_answer": "MetLife's participation in Supervisory Colleges in both the U.S. and Europe enhances regulatory oversight and shapes its risk profile through coordinated supervision. In the U.S., the NYDFS annually chairs Supervisory College meetings attended by MetLife's key U.S. and non-U.S. regulators, facilitating cooperation and coordination among insurance supervisors to better understand the risk profile of MetLife's international operations. Similarly, in Europe, EIOPA requires European regulators, such as the Central Bank of Ireland, to establish Supervisory Colleges for EEA-based insurance groups with significant European operations like MetLife. These colleges enhance understanding of the group's risk profile through collaboration among European supervisors. This dual participation ensures that both U.S. and European regulators have a comprehensive view of MetLife's operations and risk exposures, thereby influencing its regulatory environment and risk management practices.",
      "llm_answer": "MetLife’s participation in Supervisory Colleges—led by NYDFS in the U.S. and coordinated with EIOPA in Europe—provides a formal forum for group‑wide oversight that enhances regulators’ insight into the company’s cross‑border risk profile, capital adequacy and reserve practices.  This collaborative supervision helps align regulatory expectations across jurisdictions, allowing NYDFS and EIOPA to monitor MetLife’s risk‑based capital, solvency and reserve adequacy (including the impact of NYDFS‑approved reserve adjustments and AG 48/AG 48‑type requirements) and to intervene early if the insurer’s risk profile deteriorates.  Consequently, the college structure reinforces MetLife’s regulatory oversight while also shaping its risk management and capital planning to meet both U.S. and European supervisory standards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with strong qualitative and contextual alignment. (1) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the original answer, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies the key entities: MetLife, NYDFS (as U.S. supervisor), and EIOPA (as European coordinator), and accurately reflects their roles in Supervisory Colleges. It correctly states that these colleges enhance cross-jurisdictional oversight and risk monitoring. (3) The multi-hop reasoning is sound: the answer synthesizes the role of U.S. and European regulatory frameworks, connects NYDFS and EIOPA to their respective supervisory functions, and explains how participation influences MetLife’s risk and capital planning. The mention of 'AG 48/AG 48-type requirements' and 'reserve adjustments' adds regulatory specificity not in the original answer but is contextually plausible and does not introduce inaccuracy. (4) While the original answer emphasizes the structural coordination (e.g., NYDFS chairing annual meetings, Central Bank of Ireland’s role), the LLM answer focuses more on outcomes (e.g., early intervention, capital planning alignment). It omits specific details like the Central Bank of Ireland’s involvement and the annual meeting structure but retains the essential meaning. This minor omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, contextually relevant, and semantically equivalent in intent and substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 443,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the reduction in the Allowance for Credit Losses (ACL) build for transfer risk outside the U.S., driven by U.S. banking law, impact Citi's Net Income in 2024, and what was the resulting percentage change in total Net Income?",
      "original_answer": "The reduction in the ACL build for transfer risk outside the U.S., driven by U.S. banking law, contributed to a lower provision expense of $295 million in 2024 compared to $406 million in the prior year. This $111 million decrease in provision expense positively impacted Net Income, which increased by 27% to $4.9 billion in 2024.",
      "llm_answer": "The reduction in the Allowance for Credit Losses (ACL) for transfer risk outside the U.S., driven by U.S. banking safety and soundness considerations, resulted in a smaller net ACL build and contributed to a $228 million lower ACL build compared with the prior year. This reduction helped lift total Net Income to $4.9 billion, a 27 % increase year‑over‑year. Consequently, total Net Income rose by **27 %**.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the positive impact of the ACL reduction on Net Income and reports the correct 27% year-over-year increase in Net Income to $4.9 billion, which matches the ground truth. However, it incorrectly states the reduction in ACL build as $228 million, whereas the ground truth specifies a decrease in provision expense from $406 million to $295 million, amounting to an $111 million reduction. This is a significant quantitative error. (2) The calculation in the original answer is accurate: $406M - $295M = $111M decrease in provision expense, which directly increases Net Income. The LLM’s $228M figure does not align with any supported data and appears fabricated or miscomputed. (3) The reasoning is otherwise sound: the model correctly links the reduction in ACL build to lower provision expense, which boosts Net Income, and correctly identifies the regulatory driver (U.S. banking law/safety and soundness). It also correctly synthesizes the outcome in terms of total Net Income and percentage change, showing proper multi-hop understanding between regulatory change, credit loss accounting, and income statement impact. (4) Despite the major numerical inaccuracy in the ACL reduction amount, the core outcome (27% Net Income increase to $4.9B) is correct, and the direction and nature of the impact are accurate, warranting a moderate score. Quantitative accuracy is low due to the incorrect $228M figure, but qualitative and contextual aspects are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 415,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "Given that Lockheed Martin's FMS sales account for 73% of its international sales and the U.S. government may face funding disruptions due to the debt ceiling expiration in mid-January 2025, how might these potential disruptions specifically affect Lockheed Martin's Aeronautics segment, considering that international customers accounted for 32% of its net sales in 2024 and the F-35 program involves commitments from twelve FMS customers?",
      "original_answer": "Lockheed Martin's Aeronautics segment, which saw 32% of its 2024 net sales come from international customers, is significantly exposed to potential U.S. government funding disruptions due to the debt ceiling expiration. Since 73% of Lockheed Martin's international sales are conducted through FMS contracts with the U.S. government, any delay or reduction in U.S. defense funding could directly impact FMS orders for programs like the F-35, which has commitments from twelve FMS customers. This could result in delayed or reduced production schedules for the F-35, a key international platform, thereby affecting the Aeronautics segment’s revenue and margins. Given the long-cycle nature of defense contracts, such disruptions could have a prolonged effect on Lockheed Martin’s financial performance.",
      "llm_answer": "The debt‑ceiling impasse could force a short‑term funding lapse for the U.S. government in early 2025, jeopardizing the flow of appropriations that underpin Lockheed Martin’s Aeronautics contracts. Because 73 % of the company’s international sales are generated through foreign‑military‑sales (FMS) and international customers represent roughly 32 % of Aeronautics’ net sales—much of it tied to the F‑35 program with twelve FMS customers—the possibility of delayed or reduced U.S. funding could curtail new F‑35 aircraft purchases, sustainment contracts, and related export orders, pressuring Aeronautics’ revenue and backlog in the near term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: 73% of international sales are FMS-related, international customers accounted for 32% of Aeronautics' net sales in 2024, and the F-35 program has commitments from twelve FMS customers. These numbers match the ground truth exactly, with acceptable formatting (e.g., '73 %' vs '73%'). The reference to a potential funding lapse in early 2025 aligns with the mid-January 2025 debt ceiling expiration, a reasonable interpretation. (2) All quantitative elements are accurate—percentages, customer count, and program linkage are correct. No calculations were required, but the synthesis of percentages and their implications is sound. (3) The multi-hop reasoning is strong: the model correctly links U.S. government funding disruptions → impact on FMS contracts → effect on F-35 orders → consequences for Aeronautics segment revenue and backlog. It captures the causal chain and highlights near-term financial pressure, consistent with the ground truth. The only minor omission is not explicitly mentioning the 'long-cycle nature of defense contracts' and its prolonged impact, which slightly reduces completeness in qualitative depth. (4) The answer is highly contextually relevant, directly addressing how funding disruptions could affect the Aeronautics segment via FMS and the F-35 program. Wording differs but meaning is semantically equivalent to the original. Overall, the response is factually excellent with only a slight gap in elaborating long-term effects, warranting a 9/10 on correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 429,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How many shares of common stock were available for future issuance under the UnitedHealth Group Incorporated 2020 Stock Incentive Plan and its related plans as of December 31, 2023, and how does this compare to the number of shares underlying stock options assumed through acquisitions?",
      "original_answer": "As of December 31, 2023, 53 million shares were available under the 2020 Stock Incentive Plan for future awards. Additionally, 17 million shares were available for future issuance under the ESPP, bringing the total to 70 million shares. Separately, 191,000 shares were underlying stock options assumed through acquisitions. Therefore, the total shares available for future issuance under the active plans was significantly larger than the assumed stock options from acquisitions.",
      "llm_answer": "As of December 31 2023, the 2020 Stock Incentive Plan (and related plans) had **70 million shares remaining available for future issuance**. This includes the shares reserved under the ESPP and the 2020 Stock Incentive Plan itself. In contrast, the document notes that **191,000 shares underlying stock options assumed through acquisitions** remain outstanding but are excluded from the future‑issuance count, as no further awards will be made under those assumed plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: 70 million total shares available (53M under the 2020 Stock Incentive Plan + 17M under ESPP, though the breakdown is not explicitly stated in the LLM answer, the total is correct), and 191,000 shares from assumed options through acquisitions. The date (December 31, 2023) is accurate. (2) The answer correctly identifies that the 191,000 shares from acquisitions are separate and not part of the future-issuance pool, which aligns with the original answer's intent. (3) The multi-hop reasoning is sound: it synthesizes data from the 2020 Stock Incentive Plan, the ESPP, and acquisition-related assumed options. (4) The only minor shortcoming is that the LLM answer does not explicitly break down the 70 million into the 53 million (2020 Plan) and 17 million (ESPP) components as the original answer does, which slightly reduces completeness in qualitative detail, but the total is correct and the context is preserved. Wording differs but semantic meaning and factual content are equivalent. Therefore, the answer is factually correct and fully relevant, meriting a high score with only a slight deduction in qualitative accuracy for the missing breakdown.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 360,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "What is the total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards, and how does this compare to the total unrecognized compensation cost as of November 3, 2024?",
      "original_answer": "The total stock-based compensation expense for fiscal years 2022 through 2024 related to the Multi-Year Equity Awards is $1,746 million ($794 million in 2022 + $596 million in 2023 + $356 million in 2024). As of November 3, 2024, the total unrecognized compensation cost related to unvested stock-based awards was $11,259 million. This indicates that the majority of the compensation cost associated with these awards is yet to be recognized over the remaining weighted-average service period of 3.0 years.",
      "llm_answer": "The total stock‑based compensation expense for fiscal years 2022 through 2024 related to the Multi‑Year Equity Awards is $356 million in 2024, $596 million in 2023 and $794 million in 2022. As of November 3, 2024, the remaining unrecognized compensation cost for all unvested stock‑based awards (including those from the Multi‑Year Equity Awards) is $11,259 million, which is expected to be recognized over the next approximately 3 years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all individual annual stock-based compensation expenses: $794 million in 2022, $596 million in 2023, and $356 million in 2024. While the LLM does not explicitly sum these values into a total of $1,746 million as in the ground truth, it provides all components needed for the sum, and the numbers are accurate. The unrecognized compensation cost of $11,259 million as of November 3, 2024, is correctly stated. (2) All numeric values match the ground truth exactly, with acceptable formatting variations (e.g., $356 million vs $356M). The calculation of the total expense ($794M + $596M + $356M = $1,746M) is mathematically correct and could be inferred from the provided numbers, though not explicitly stated. (3) The multi-hop reasoning is sound: the model correctly identifies the relevant fiscal years, links the Multi-Year Equity Awards to the compensation expenses, and connects the unrecognized cost as of a specific date with its expected recognition period. It appropriately distinguishes between recognized expense (2022–2024) and future unrecognized cost. (4) The answer is contextually complete and highly relevant. The only minor omission is the lack of an explicit total sum for the 2022–2024 period, which slightly reduces qualitative accuracy but does not impair factual correctness. Overall, the answer conveys the same essential information as the ground truth with full numerical accuracy and strong reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 408,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total minimum LTD requirement for Citi in 2024 as a percentage of RWA, and how is this value calculated based on the components described in the TLAC section?",
      "original_answer": "The total minimum LTD requirement for Citi in 2024 is 9.5% of RWA. This is calculated by adding Citi's capital surcharge under method 2 of the GSIB surcharge rule (3.5%) to the base minimum LTD requirement of 6% of RWA.",
      "llm_answer": "Based on the provided document pages, the total minimum Long-Term Debt (LTD) requirement for Citigroup in 2024 is **9.5% of RWA**, calculated as the greater of:  \n(i) 6% of RWA plus its method 2 GSIB surcharge of 3.5% (totaling 9.5%), or  \n(ii) 4.5% of total leverage exposure.  \n\nThis is explicitly stated in the TLAC section on **page_47**, where it notes: \"The minimum LTD requirement is the greater of (i) 6% of the GSIB's RWA plus its capital surcharge as determined under method 2 of the GSIB surcharge rule (3.5% for Citi for 2024), for a total current requirement of 9.5% of RWA for Citi.\" The document further confirms this value in the table under \"Regulatory requirement (1)(2)\" for LTD, listing 9.5% as the requirement. The calculation incorporates the method 2 GSIB surcharge (3.5%) into the 6% base, resulting in the 9.5% figure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key percentage of 9.5% of RWA is accurately reported, and the calculation—6% base LTD requirement plus Citi's method 2 GSIB surcharge of 3.5%—is correctly described. The sum (6% + 3.5% = 9.5%) is accurate. The alternative calculation based on leverage exposure (4.5%) is mentioned as required by the rule but correctly noted as not applicable since the RWA-based requirement is greater. (2) The answer is complete, addressing both the total minimum LTD requirement and its calculation as requested. It correctly identifies that the requirement is determined under the TLAC rules and references the relevant components (base 6% + 3.5% surcharge). (3) Entity accuracy is perfect: Citigroup (Citi), 2024, RWA (Risk-Weighted Assets), GSIB surcharge, method 2, and LTD are all correctly identified and contextualized. (4) The reasoning is sound and reflects proper multi-hop synthesis: it combines the base regulatory requirement with the firm-specific GSIB surcharge, explains the 'greater of' test, and confirms the result with both textual and tabular evidence from the document (page_47). The mention of the table adds contextual support. (5) The semantic meaning fully aligns with the ground truth, with slightly more detail (e.g., mentioning the leverage exposure alternative), which enhances clarity without introducing error. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 405,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What is the total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade, and how does the pattern of annual increases from 2025 to 2029 inform the trend in pension obligations?",
      "original_answer": "The total projected funding requirement for Lockheed Martin's qualified defined benefit pension plans over the next decade is $19,510 million. This includes $1,800 million in 2025, increasing to $1,860 million in 2026, $1,910 million in 2027, $1,960 million in 2028, $1,990 million in 2029, and $9,990 million from 2030 to 2034. The annual increases from 2025 to 2029 show a consistent upward trend, indicating a growing financial obligation in the near term before a larger, cumulative payment in the final five years.",
      "llm_answer": "The total projected funding requirement for Lockheed Martin’s qualified defined‑benefit pension plans over the next decade is approximately $16 billion, as shown by the 2025‑2029 annual payment estimates of $1.80 billion, $1.86 billion, $1.91 billion, $1.96 billion and $1.99 billion, which sum to about $9.5 billion for those five years and, when combined with the $9.99 billion projected for 2030‑2034, yield roughly $16 billion in total expected benefit payments. The pattern of increasing annual payments from $1.80 billion in 2025 to $1.99 billion in 2029 indicates a steady upward trend in pension obligations, reflecting rising benefit costs and the growing funding needed to meet future liabilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the total projected funding requirement. The ground truth states $19,510 million ($19.51 billion), but the LLM incorrectly reports approximately $16 billion. This discrepancy arises because the LLM sums the 2025–2029 payments ($1.80 + $1.86 + $1.91 + $1.96 + $1.99 = $9.52 billion) and adds the $9.99 billion for 2030–2034, yielding $19.51 billion, yet claims the total is 'roughly $16 billion,' which is factually incorrect. (2) Individual annual figures for 2025–2029 are accurate and match the ground truth ($1.80B, $1.86B, $1.91B, $1.96B, $1.99B), and the $9.99B for 2030–2034 is also correct. However, the final sum is miscalculated or misrepresented. (3) The reasoning correctly identifies the upward trend from 2025 to 2029 and interprets it as reflecting growing pension obligations, which aligns with the ground truth. The synthesis across time periods is logically sound, but the failure to correctly state the total despite having the right components is a major quantitative flaw. (4) Contextual relevance is high—the answer addresses both parts of the question and uses appropriate financial reasoning. However, the severe error in the total funding figure, a core part of the answer, reduces correctness and quantitative accuracy significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 368,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "What was the total combined value of Mortgage/Asset-backed securities held by Honeywell in both 2020 and 2021, and how did this investment category rank in terms of proportion to total fixed income investments in each year?",
      "original_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell in 2020 and 2021 was $1,072 million + $982 million = $2,054 million. In 2020, Mortgage/Asset-backed securities represented approximately 8.1% of total fixed income investments ($982 million / $12,106 million total fixed income). In 2021, this category represented approximately 8.9% of total fixed income investments ($1,072 million / $12,041 million total fixed income).",
      "llm_answer": "The total combined value of Mortgage/Asset-backed securities held by Honeywell was $1,072 million in 2021 and $982 million in 2020. In each year, this category represented approximately 5.6 % of the total fixed‑income investments (1,072 ÷ 19,238 ≈ 5.6 % for 2021 and 982 ÷ 19,203 ≈ 5.1 % for 2020).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identified the dollar amounts of Mortgage/Asset-backed securities for both 2020 ($982 million) and 2021 ($1,072 million), which matches the ground truth. However, the percentages provided are incorrect. The LLM states that the category represented approximately 5.6% in 2021 and about 5.1% in 2020, but the correct proportions are 8.9% in 2021 ($1,072M / $12,041M) and 8.1% in 2020 ($982M / $12,106M). The LLM used incorrect total fixed income investment figures (e.g., ~$19.2 billion instead of ~$12.1 billion), leading to erroneous percentage calculations. (2) The total combined value of $2,054 million is implied by stating both yearly values, but the LLM does not explicitly sum them, which reduces completeness. More critically, the percentage calculations are factually wrong due to incorrect denominators. (3) The multi-hop reasoning fails because the model did not correctly identify the total fixed income investments for Honeywell in each year. It appears to have used data from another company or context, breaking the synthesis across entities and years. This undermines the core of the question, which requires accurate proportional analysis. (4) While the answer includes relevant financial figures and attempts the required calculations, the use of incorrect totals for fixed income investments severely compromises factual accuracy. The contextual relevance is moderate because the structure and intent align with the question, but the substance is flawed. Correctness is low due to major quantitative and reasoning errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 432,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Broadcom's shift from annual equity awards to multi-year awards with 4-7 year vesting periods affect its stock-based compensation expense recognition pattern?",
      "original_answer": "Broadcom's shift from annual equity awards to multi-year equity awards changes the stock-based compensation expense recognition pattern by extending the recognition period from a 4-year vesting cycle per annual grant to a longer 7-year period in total for the multi-year awards. Previously, annual grants were issued each year and recognized over 4 years. Now, the Multi-Year Equity Awards encompass four annual grant cycles into one award, with compensation expense recognized from the grant date through the vesting date, which spans up to 7 years. This change results in a more prolonged and overlapping expense recognition timeline compared to the prior annual model.",
      "llm_answer": "Broadcom’s shift to multi‑year equity awards with vesting periods of 4‑7 years delays the recognition of the related stock‑based compensation expense. Instead of expensing the full award when granted—as was done with the prior annual awards—the company now amortizes the expense evenly over the award’s vesting horizon, spreading the charge across multiple fiscal years. This results in a more gradual increase in compensation expense that aligns with the longer service periods required for the awards to vest.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but lacks some key details from the ground truth, particularly regarding the structural change in award design. (1) It correctly identifies that the shift to multi-year awards with 4-7 year vesting periods results in a more prolonged expense recognition pattern and that expenses are now amortized over longer periods, which aligns with the ground truth. (2) Quantitatively, the 4-7 year vesting range is accurately stated, and there are no numerical inaccuracies—though the ground truth specifies a 7-year total vesting period for awards encompassing four annual grant cycles, which the LLM does not mention. (3) The reasoning is sound in describing delayed and gradual expense recognition, but it misses the multi-hop synthesis that the new structure consolidates four annual grants into one multi-year award, fundamentally changing the recognition timeline from overlapping 4-year cycles to a single up-to-7-year span. This structural insight is critical to fully answering how the pattern changes. (4) The answer remains contextually relevant and conveys a correct high-level impact on SBC expense recognition, but omits the comparative mechanics between the old annual 4-year model and the new consolidated 7-year model, reducing completeness and qualitative accuracy. Minor wording differences are acceptable under semantic equivalence, but the absence of the 'four annual cycles in one award' concept limits full accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 401,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does the application of U.S. banking law specifically influence the credit loss provisions in both Legacy Franchises and the Markets segment, and what is the combined impact on Citi's total provision for credit losses in 2024?",
      "original_answer": "The application of U.S. banking law led to a smaller ACL build for transfer risk associated with exposures outside the U.S. in both Legacy Franchises and the Markets segment. In Legacy Franchises, this contributed to a decrease in provisions from $1.3 billion in 2023 to $1.1 billion in 2024. In the Markets segment, it contributed to a lower net ACL build of $295 million compared to $406 million in the prior year. The combined impact of these reductions under U.S. banking law contributed to a total provision decrease from $1.738 billion in 2023 ($1.3 billion + $438 million) to $1.563 billion in 2024 ($1.1 billion + $463 million), a reduction of $175 million.",
      "llm_answer": "The application of U.S. banking law directly influences credit loss provisions in both the Legacy Franchises and Markets segments by requiring safety‑and‑soundness considerations that limit the allowance build for transfer risk outside the U.S., resulting in a smaller ACL build and a net benefit from credit loss releases. Consequently, the combined impact of these regulatory‑driven adjustments contributed to a $1.1 billion provision for credit losses in 2024, which is lower than the prior year’s $1.3 billion provision.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the general direction of the impact—U.S. banking law reduced credit loss provisions due to smaller ACL builds for transfer risk outside the U.S.—which aligns with the ground truth. However, it fails to provide accurate quantitative details. It incorrectly states that the total provision in 2024 was $1.1 billion, conflating this with the Legacy Franchises figure alone, while the correct combined total is $1.563 billion. It also misstates the prior year’s total as $1.3 billion instead of $1.738 billion. (2) The ground truth specifies: Legacy Franchises decreased from $1.3B (2023) to $1.1B (2024); Markets had a net ACL build of $295M in 2024 vs $406M in 2023 (though the LLM omits this). The total provision was $1.738B in 2023 ($1.3B + $438M) and $1.563B in 2024 ($1.1B + $463M), a $175M decrease. The LLM’s claim of a drop from $1.3B to $1.1B ignores the Markets segment entirely in the totals and uses incorrect aggregate numbers. (3) The reasoning is partially sound—it identifies the regulatory influence and the direction of impact on both segments—but fails in multi-hop synthesis by not combining the two segments’ provisions correctly. It omits the Markets segment’s specific contribution and misrepresents the total provision. (4) Correctness is scored low (4) due to major quantitative errors and incomplete synthesis. Quantitative accuracy is 3 due to multiple incorrect figures and a flawed total. Qualitative accuracy is 6 because the conceptual explanation and regulatory logic are reasonable. Contextual relevance is 8 as the answer addresses the right segments and regulatory context, just with flawed execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 457,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "What was the total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021, and what percentage of the total assets at fair value did this combined amount represent?",
      "original_answer": "The total value of Insurance buy-in contracts held by HON in Non-U.S. Plans across 2020 and 2021 was $1,458 million ($767 million in 2020 + $691 million in 2021). This represented approximately 8.66% of the total assets at fair value across both years ($1,458 million ÷ ($8,450 million + $8,396 million)).",
      "llm_answer": "The total value of Insurance buy‑in contracts held by Honeywell in Non‑U.S. Plans was $691 million in 2020 and $691 million in 2021, giving a combined amount of $1,382 million. This combined figure represented approximately 16.5 % of the total assets at fair value ($8,396 million) for the Non‑U.S. pension plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that the Insurance buy-in contracts were $691 million in both 2020 and 2021, but the ground truth shows $767 million in 2020 and $691 million in 2021. This leads to an incorrect combined total of $1,382 million instead of the correct $1,458 million. The percentage is also wrong: the LLM calculates 16.5% using only the 2021 total assets ($8,396 million), whereas the correct calculation uses the sum of both years' total assets at fair value ($8,450 million + $8,396 million = $16,846 million), resulting in 8.66%. (2) The quantitative inaccuracies are severe: incorrect values for 2020, incorrect total, and incorrect denominator in percentage calculation. While $691 million in 2021 is correct, the repetition of this figure for 2020 is not supported by the ground truth. (3) The multi-hop reasoning is flawed: the model fails to correctly aggregate values across two years for both the numerator (contracts) and denominator (total assets), and it does not properly synthesize data from both years as required. It appears to use only 2021 data for the denominator, breaking the multi-year scope of the question. (4) Despite these major errors, the answer is contextually relevant—it addresses the right company (Honeywell/HON), the correct financial instrument (Insurance buy-in contracts), and the right geographic scope (Non-U.S. Plans). However, due to critical numerical and calculation errors, the correctness score is low at 3 out of 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1167,
        "completion_tokens": 422,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How does Broadcom's (AVGO) emphasis on internal research and development, as part of its broader business strategy, influence its semiconductor segment's ability to maintain technology leadership in AI-related markets?",
      "original_answer": "Broadcom's focus on internal research and development plays a central role in maintaining its technology leadership in semiconductor markets, particularly in AI-related applications. The company explicitly states that its strategy involves 'extensive internal research and development' to ensure its products retain their technology market leadership. This R&D emphasis directly supports its semiconductor solutions segment, which includes products used in AI networking and connectivity. By investing in R&D, Broadcom is able to develop high-performance semiconductor devices such as complex digital and mixed-signal CMOS-based devices and analog III-V based products like gallium arsenide (GaAs) and indium phosphide (InP), which are critical for high-speed RF and optoelectronic applications in AI systems. This innovation enables Broadcom to deliver category-leading infrastructure technology products to major business and government customers, reinforcing its competitive edge in AI-driven markets.",
      "llm_answer": "Broadcom’s heavy investment in internal R&D—highlighted by its focus on custom silicon platforms, advanced Ethernet switching, and AI‑optimized networking ASICs—directly fuels its technology leadership in AI‑related markets. By developing proprietary, high‑performance solutions in‑house, the company can rapidly tailor products to emerging AI workloads, maintain a competitive edge in data‑center connectivity, and differentiate its semiconductor portfolio from rivals.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and highly relevant to the question, correctly identifying Broadcom's internal R&D focus as a key driver of technology leadership in AI-related semiconductor markets. It accurately reflects the strategic importance of in-house development, particularly for AI-optimized networking ASICs and custom silicon, which aligns with the ground truth's emphasis on proprietary high-performance devices. There are no numeric values in either answer, so quantitative accuracy is not applicable—scored as 10 by default. The qualitative accuracy is high: the LLM captures the core reasoning that internal R&D enables rapid product tailoring and differentiation in AI infrastructure, especially in data-center connectivity. However, it omits specific technical details present in the original answer, such as the development of CMOS-based digital/mixed-signal devices and III-V materials like GaAs and InP, which are critical for RF and optoelectronic applications in AI systems. This represents a minor omission in completeness, particularly in the multi-hop synthesis of how specific R&D outputs enable leadership in AI hardware. Despite this, the LLM answer conveys the essential logic and strategic linkage between R&D and market leadership. Contextual relevance is perfect—the response directly addresses Broadcom's semiconductor segment and its AI-related technology positioning. Thus, the correctness score is 8 due to missing technical specifics, though the core reasoning and factual basis remain sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 420,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "What is the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements, and how does this compare to the total advance payments made under its multi-year capacity purchase commitments as of September 29, 2024?",
      "original_answer": "Qualcomm is expected to pay $9.6 billion in the next 12 months under its purchase agreements, which primarily relate to integrated circuit product inventory obligations. This amount is part of the total $12.8 billion in obligations under purchase agreements. The total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, were $3.0 billion. Therefore, the amount expected to be paid in the next 12 months is significantly higher than the advance payments made, indicating a substantial upcoming cash outflow relative to the prepayments already made.",
      "llm_answer": "Based on the provided document pages, the total amount Qualcomm is expected to pay in the next 12 months under its purchase agreements is $9.6 billion, as stated in Note 9 (\"Purchase Obligations\") on page 82: \"Obligations under our purchase agreements... at September 29, 2024 totaled $12.8 billion of which, $9.6 billion is expected to be paid in the next 12 months.\" This $9.6 billion figure represents the portion of purchase commitments that are fixed and determinable and due within the upcoming 12-month period. \n\nThe total advance payments made under multi-year capacity purchase commitments as of September 29, 2024, are $3.0 billion, as disclosed in Note 9 on page 82: \"Total advance payments related to multi-year capacity purchase commitments recorded on the consolidated balance sheets at September 29, 2024... were $3.0 billion.\" This $3.0 billion is the cumulative advance payments recorded on the balance sheet, which includes both current and long-term portions, but the question specifically asks for the comparison to the advance payments made under these commitments as of the fiscal year-end (September 29, 2024). \n\nThus, the expected payment in the next 12 months ($9.6 billion) is significantly higher than the total advance payments recorded ($3.0 billion), reflecting the distinction between future contractual obligations and already paid advance amounts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $9.6 billion expected to be paid in the next 12 months, total purchase obligations of $12.8 billion, and $3.0 billion in advance payments under multi-year capacity purchase commitments as of September 29, 2024. These figures are correctly cited from Note 9 on page 82, and the formatting (e.g., $9.6 billion) matches standard financial reporting. (2) The answer is complete, addressing both parts of the multi-part question: the upcoming payment obligation and the comparison to advance payments. (3) Entity accuracy is correct—Qualcomm is the subject, all financial metrics (purchase obligations, advance payments) are properly identified, and the fiscal date (September 29, 2024) is accurately used. (4) The reasoning is sound and reflects proper multi-hop synthesis: it distinguishes between future contractual payments and past advance payments, correctly interprets the balance sheet disclosures, and logically concludes that the upcoming cash outflow ($9.6B) is significantly higher than the prepayments made ($3.0B). The explanation is contextually rich, cites the source note, and maintains semantic equivalence with the original answer without unnecessary deviations. No errors in logic, calculation, or fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 372,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "By how much did the GTN adjustment reductions for 2024 differ from those of 2023, and what was the specific non-U.S. factor that contributed to this change?",
      "original_answer": "The GTN adjustment reductions for 2024 were $159 million, compared to $134 million for 2023, resulting in a $25 million difference. The specific non-U.S. factor that contributed to this change was revisions in clawback amounts driven by VAT recoverable estimates.",
      "llm_answer": "The GTN adjustment reductions for 2024 ($159 million) were $25 million higher than those for 2023 ($134 million). The specific non‑U.S. factor driving this change was the revision of clawback amounts based on updated V AT recoverable estimates, which contributed to the increase in non‑U.S. GTN adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all factual components: GTN adjustment reductions for 2024 ($159 million) and 2023 ($134 million), computes the difference accurately as $25 million, and correctly identifies the non-U.S. factor as revisions in clawback amounts based on VAT recoverable estimates. (2) Quantitative accuracy is perfect: both dollar amounts match the ground truth, and the $25 million difference is correctly calculated ($159M - $134M = $25M). Format variations (e.g., ' million' vs 'million') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—LLM synthesizes data across years and attributes the change to a specific non-U.S. factor, demonstrating correct understanding of causality and geographic scope. (4) Semantic equivalence is maintained: although phrased slightly differently (e.g., 'driving this change' vs 'contributed to this change'), the meaning is identical. All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1145,
        "completion_tokens": 290,
        "total_tokens": 1435
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does Mastercard Send, as part of Mastercard's disbursements and remittances strategy, contribute to the company's broader objective of capturing new payment flows, and what specific partner ecosystems are leveraged to enable this capability according to the 2022 10-K filing?",
      "original_answer": "Mastercard Send contributes to the company's broader objective of capturing new payment flows by enabling consumers, businesses, governments, and nonprofits to send and receive money more efficiently, both domestically and across borders. This platform is a key component of Mastercard's disbursements and remittances strategy, which is explicitly tied to the company's goal of expanding multi-rail capabilities and applications to penetrate key flows. The platform leverages partnerships with central banks, fintechs, and financial institutions to help governments and nonprofits distribute social and economic assistance and facilitate business-to-consumer (B2C) disbursements, thereby enhancing the reach and utility of Mastercard's payment network.",
      "llm_answer": "Mastercard Send, as part of the company’s disbursements and remittances strategy, expands the network’s multi‑rail capabilities to capture new payment flows such as cross‑border transfers, government‑issued assistance, and B2C disbursements, thereby supporting the broader objective of growing payment volume and diversifying revenue streams. According to the 2022 10‑K, this capability is enabled through partnerships with central banks, fintechs, digital‑messaging platforms and financial institutions that leverage Mastercard’s global Switch and real‑time account‑based payment infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Mastercard Send supports disbursements and remittances by enabling efficient domestic and cross-border payments, contributing to the objective of capturing new payment flows through multi-rail expansion. The answer correctly identifies government assistance, B2C disbursements, and cross-border transfers as key flows. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links Mastercard Send to the broader strategic goal of capturing new payment flows and identifies the relevant partner ecosystems. It adds 'digital-messaging platforms' as an additional partner type not explicitly mentioned in the ground truth, which may be a minor overextension but is plausible and does not contradict the source. Otherwise, it accurately cites central banks, fintechs, and financial institutions. (4) The answer is contextually relevant, complete, and semantically equivalent to the original, with slightly more detail on infrastructure (e.g., 'global Switch and real-time account-based payment infrastructure'), which is consistent with Mastercard's 10-K disclosures. The only minor gap is the omission of nonprofits as direct users of the platform for disbursements, though this is implied in 'government-issued assistance'. Overall, the response demonstrates strong understanding and synthesis from the 2022 10-K.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 424,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does Mastercard's introduction of Cyber and Intelligence Solutions, as part of its value-added services, influence the composition and recognition timing of its 'Other revenues' category in 2022?",
      "original_answer": "Mastercard introduced Cyber and Intelligence Solutions as part of its value-added services, which directly contributes to the 'Other revenues' category. This category includes fees from cyber and intelligence solutions offered to prevent fraud and ensure transaction safety. These revenues are recognized in the period when the related services are performed or transactions occur, thereby affecting the timing and composition of 'Other revenues' within Mastercard’s net revenue structure.",
      "llm_answer": "Mastercard's introduction of Cyber and Intelligence Solutions as a value‑added service is reflected in the “Other revenues” line of its 2022 financials, where the company reports that these solutions fees are part of the broader “Other revenues” category. The 2021 10‑K notes that the aggregate consideration allocated to unsatisfied performance obligations for these and other value‑added services was $1.3 billion, to be recognized through 2024, indicating that revenue from Cyber and Intelligence Solutions is being tracked separately within “Other revenues” and recognized over the period the services are delivered. This inclusion reshapes the composition of “Other revenues” and dictates that its earnings are recognized as the related services are performed, rather than being lumped together with other miscellaneous income.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Mastercard's Cyber and Intelligence Solutions are part of the 'Other revenues' category and that revenue is recognized as services are performed, which aligns with the ground truth. It adds relevant detail about the $1.3 billion in unsatisfied performance obligations from the 2021 10-K, which provides insight into revenue timing. However, this specific figure is not present in the original answer (ground truth), and while plausible, its inclusion introduces a quantitative claim not verified by the provided truth. The ground truth does not mention tracking these revenues separately within 'Other revenues' or cite a specific deferred revenue figure, so this addition risks overprecision. The reasoning is sound and the multi-hop synthesis (linking service introduction to revenue recognition policy) is appropriate. The answer is semantically aligned but goes beyond the ground truth with unverified quantitative detail, slightly undermining factual accuracy. Wording differences are acceptable, and the core facts about composition and timing are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 311,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What was the total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023, and how did this change compare to the change in unrealized losses on those securities over the same period?",
      "original_answer": "The total fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million at December 31, 2022 to $320 million at December 31, 2023, a decrease of $7 million. Meanwhile, unrealized losses on these securities increased from $31 million to $25 million, a decrease in unrealized losses of $6 million. This means that while the fair value slightly declined, the unrealized losses improved year-over-year.",
      "llm_answer": "The total change in fair value of CAT's Mortgage-Backed Debt Securities between December 31, 2022 and December 31, 2023 was an increase of $83 million (from $333 million to $410 million). This change was smaller than the change in unrealized losses on those securities, which decreased by $18 million (from $31 million in unrealized pretax net losses to $23 million), indicating that the fair value increase outpaced the reduction in unrealized losses.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. According to the ground truth, the fair value of CAT's Mortgage-Backed Debt Securities decreased from $327 million to $320 million (a $7 million decrease), but the LLM claims an increase from $333 million to $410 million ($83 million increase), which is factually wrong. Additionally, the ground truth states that unrealized losses increased from $31 million to $25 million — a reduction in losses of $6 million — but the LLM incorrectly states unrealized losses decreased from $31 million to $23 million (an $18 million decrease), which misrepresents both the magnitude and direction of change. (2) All key numbers are incorrect: starting and ending fair values, the change in fair value, starting and ending unrealized losses, and the change in unrealized losses. Calculations based on these numbers are therefore also invalid. The claim that 'fair value increase outpaced the reduction in unrealized losses' is based on false premises and contradicts the actual trend where both fair value declined and unrealized losses improved. (3) The multi-hop reasoning failed completely — the model did not correctly identify or synthesize data across time points for both fair value and unrealized losses. It introduced numbers not present in the original answer (e.g., $333M, $410M, $23M) and performed incorrect comparisons. (4) Due to pervasive factual and numerical errors, the qualitative reasoning and contextual relevance are severely undermined. While the structure of the response attempts to address the two-part question, the content fails to match the ground truth in any meaningful way, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 469,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "What is the total fair value of Qualcomm's corporate bonds and notes, and how does this compare to the fair value of U.S. Treasury securities and government-related securities as a percentage of the total marketable securities?",
      "original_answer": "Qualcomm's corporate bonds and notes have a total fair value of $4,634 million, while the fair value of U.S. Treasury securities and government-related securities is $208 million. The total marketable securities amount to $5,451 million. Therefore, corporate bonds and notes represent approximately 85% of the total marketable securities, whereas U.S. Treasury securities and government-related securities account for about 3.8% of the total marketable securities.",
      "llm_answer": "The total fair value of Qualcomm's corporate bonds and notes is $4,634 million, which represents 85% of the total fair value of all marketable securities ($5,451 million). This corporate‑bond component therefore accounts for roughly 85% of the overall marketable‑securities fair‑value total.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the fair value of Qualcomm's corporate bonds and notes as $4,634 million and the total marketable securities as $5,451 million, accurately calculating the 85% proportion. These numbers match the ground truth exactly, and formatting variations (e.g., $4,634 million vs $4,634 million) are acceptable. (2) However, the LLM answer omits the second part of the question: the fair value of U.S. Treasury and government-related securities ($208 million) and their percentage (3.8%) of total marketable securities. This is a significant omission in completeness, as the question explicitly asks for a comparison between corporate bonds and U.S. government-related securities as a percentage of the total. (3) The reasoning for the portion provided is sound—correctly deriving 85% from $4,634M / $5,451M—but fails to perform the same calculation for the government-related securities, indicating incomplete multi-hop synthesis. (4) Despite accurate numbers and good contextual relevance, the failure to address all parts of the multi-component question reduces the qualitative and overall correctness scores. The answer is factually correct where provided but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 340,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does MRK use pediatric market exclusivity to extend market protection for Keytruda beyond its compound patent expiration, and what financial impact could this have on the company's oncology revenue stream?",
      "original_answer": "MRK leverages six months of pediatric market exclusivity (as stated in evidence_source_a) to extend market protection for Keytruda beyond the expiration of its compound patent. Additionally, evidence_source_b explains that for drug candidates like Keytruda, the company may benefit from a future Patent Term Extension (PTE) of up to five years and/or six months of pediatric market exclusivity, depending on regulatory approvals. Since Keytruda is part of a global strategic oncology collaboration (mentioned in evidence_source_a), any extension of exclusivity directly impacts revenue by delaying generic competition and preserving market share in the oncology segment. This regulatory strategy enhances revenue predictability and supports long-term financial planning around one of MRK's key oncology products.",
      "llm_answer": "MRK leverages pediatric market exclusivity provisions in the U.S. (providing six months of added exclusivity for completing required pediatric studies) and complementary regulatory data exclusivity (e.g., 12 years for biologics like Keytruda) to extend protection beyond the expiration of its compound patents. This strategy, exemplified by Keytruda’s 2028 patent expiry with potential extensions via pending PTE and pediatric exclusivity, could sustain oncology revenue by delaying generic competition and maintaining higher pricing power, as seen with products like Keytruda (which has no current patent protection but benefits from data exclusivity and pediatric extensions).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the mention of six months of pediatric market exclusivity and the potential for Patent Term Extension (PTE), which aligns with the ground truth. However, it introduces significant inaccuracies: it incorrectly states that Keytruda has 'no current patent protection,' which contradicts the premise of patent expiration in 2028 and undermines the core timeline. This is a major factual error. Additionally, the claim about '12 years of data exclusivity for biologics' is not mentioned in the original evidence sources and represents an unsupported addition, even if generally true in U.S. regulatory context. (2) Quantitative accuracy is partially compromised: while the 2028 patent expiry is plausible and consistent with public knowledge, it is not present in the provided ground truth or evidence sources (evidence_source_a and evidence_source_b), making this a hallucinated date. The six-month pediatric exclusivity is correctly quantified and matches the ground truth. However, the five-year PTE mentioned in the original is omitted in the LLM answer, weakening completeness. (3) Multi-hop reasoning is partially sound—the model connects pediatric exclusivity to delayed generic competition and revenue protection, and links this to oncology revenue impact, which reflects correct synthesis. However, it fails to reference the 'global strategic oncology collaboration' mentioned in evidence_source_a, which is a key contextual factor in the original answer for why exclusivity extensions have amplified financial impact. (4) Despite these issues, the LLM answer remains contextually relevant and captures the strategic intent behind using regulatory exclusivity to extend market protection. The financial impact reasoning—delaying generics, preserving pricing, supporting revenue—is semantically aligned with the original. However, due to the incorrect claim about no current patent protection and the inclusion of unverified details (12-year exclusivity, 2028 expiry), the correctness score is reduced to 6, reflecting partial accuracy with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 575,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the introduction of Mastercard Installments in 2022, as part of broader innovation efforts, support Mastercard's strategic goal of expanding digital payment services across multiple channels?",
      "original_answer": "The introduction of Mastercard Installments in 2022 directly supports Mastercard’s strategic goal of expanding digital payment services by offering a new open-loop buy-now-pay-later solution that connects lenders with merchants across the company's acceptance network. This aligns with Mastercard’s innovation focus on delivering better digital experiences everywhere, particularly through mobile and connected devices, as outlined in their 2022 10-K filing. Additionally, this initiative is part of a broader push to capture new payment flows and extend services, including multi-rail capabilities and digital currency solutions, which are key components of their strategy to diversify and strengthen their payments ecosystem.",
      "llm_answer": "Mastercard's 2022 launch of Mastercard Installments—a buy-now-pay-later solution—directly advances its strategic goal of expanding digital payment services across multiple channels by extending its multi-rail network to new payment flows like consumer bill payments and B2B transactions, while embedding installment capabilities into its ecosystem to drive broader adoption of digital payments through merchants and financial institutions. This initiative aligns with its stated priorities of expanding payment capabilities and embracing new network opportunities to enable seamless, secure digital transactions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the launch of Mastercard Installments in 2022 is accurately cited, and it is correctly described as a buy-now-pay-later solution that supports digital payment expansion. The reference to multi-rail network expansion and new payment flows (e.g., consumer bill payments, B2B) is consistent with Mastercard’s broader innovation strategy. (2) Quantitative accuracy is perfect: the year 2022 is correctly stated, and no numerical figures requiring calculation are present. Format and references are precise. (3) Reasoning is sound and reflects multi-hop synthesis: the LLM correctly links the product launch to strategic goals (expanding digital services), identifies the mechanism (integration with merchants and financial institutions), and connects it to broader network innovation. The only minor gap is that the LLM answer emphasizes B2B and bill payments, which are part of Mastercard’s broader strategy but not explicitly tied to Installments in the ground truth; the original answer focuses more on open-loop BNPL across the acceptance network and alignment with mobile/digital experiences. (4) Despite this slight shift in emphasis, the core message is semantically equivalent and contextually relevant, with strong qualitative reasoning and no factual errors. Hence, a score of 9 is warranted—excellent but not perfect in precise alignment with the original answer’s emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 409,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "What portion of Merck's profit-sharing payments to Ridgeback Biotherapeutics LP were recorded within Cost of sales in 2024, given that profits from the Lagevrio collaboration were split equally between the partners?",
      "original_answer": "Merck's profit-sharing payments to Ridgeback Biotherapeutics LP that were recorded within Cost of sales in 2024 corresponded to 50% of the profits generated from the Lagevrio collaboration, as the agreement stipulates that profits are split equally between Merck and Ridgeback.",
      "llm_answer": "Based on the provided financial data for the Ridgeback Biotherapeutics LP collaboration in 2024, Merck recorded $554 million of Cost of sales related to the partnership. This amount includes Merck's share of profit (split equally with Ridgeback) and reimbursements for third-party milestone payments, as explicitly stated in the \"Summarized financial information\" table under the Ridgeback section (page 93) and corroborated in the Cost of sales footnote (1) which identifies it as including \"Ridgeback's share of profits.\" The $554 million figure represents the total Cost of sales attributed to the Lagevrio collaboration for 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant factual inaccuracies that undermine its correctness. (1) The original answer (ground truth) states that Merck's profit-sharing payments to Ridgeback were 50% of the profits from the Lagevrio collaboration, as profits are split equally. However, the LLM introduces a specific dollar amount—$554 million—claiming this is the Cost of sales recorded for the partnership in 2024, which is not present or implied in the ground truth. There is no mention of $554 million in the original answer, nor is there any data provided in the question context to support this figure. (2) The LLM references a 'Summarized financial information' table on page 93 and a Cost of sales footnote (1), suggesting external data sources not available in the provided context, making the answer unsupported and potentially hallucinated. (3) While the LLM correctly identifies that Ridgeback receives a share of profits recorded in Cost of sales and that the split is 50/50, it incorrectly shifts focus to a specific dollar value and cost composition (including third-party milestone reimbursements) not mentioned in the ground truth. (4) The multi-hop reasoning is conceptually sound—linking profit-sharing to Cost of sales and recognizing equal split—but fails in factual grounding. The answer adds granular financial details absent from the original, reducing quantitative and qualitative accuracy. (5) Contextual relevance is high because the response addresses the right topic, entities (Merck, Ridgeback, Lagevrio, Cost of sales), and time frame (2024), and correctly interprets the 50% profit split as the basis for payments. However, the unsupported numerical claim severely compromises correctness. A correct answer should have focused solely on the 50% profit-sharing portion without introducing unverified dollar amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 502,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the Overseas Fund Regime (OFR) interact with BlackRock's European domicile structures to affect its ability to market funds in the UK, and what equivalence requirements must be met under this regime?",
      "original_answer": "Under the Overseas Fund Regime (OFR), BlackRock must ensure that the consumer protection regimes in EU countries where its funds are domiciled are found equivalent to the UK's regime in order to market those funds to UK retail investors. This requirement directly affects BlackRock's ability to distribute its European-domiciled funds in the UK market and may necessitate adjustments to its fund structures or compliance frameworks to meet UK regulatory expectations.",
      "llm_answer": "The Overseas Fund Regime (OFR) allows non‑UK funds to be marketed to UK retail investors only if the jurisdictions where those funds are domiciled have regulatory regimes deemed equivalent to the UK’s consumer‑protection standards. Consequently, BlackRock must ensure that its European‑domiciled funds meet these equivalence requirements before they can be sold in the UK.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately explains that under the Overseas Fund Regime (OFR), non-UK funds (including BlackRock's European-domiciled funds) can only be marketed to UK retail investors if their home jurisdiction's regulatory regime is deemed equivalent to the UK’s in terms of consumer protection. This directly addresses the interaction between OFR and BlackRock's European structures. The answer correctly identifies the core equivalence requirement without introducing any factual errors. While the original answer adds a slight nuance about potential adjustments to fund structures or compliance frameworks, this is an implied consequence and not strictly necessary for correctness. There are no numbers, dates, or calculations in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and reflects proper multi-hop understanding: linking OFR → non-UK fund marketing → equivalence determination → impact on BlackRock’s European funds. The entities (OFR, BlackRock, European-domiciled funds, UK retail market) are all correctly identified and logically connected. The answer is fully contextually relevant and addresses both parts of the question: the interaction with European structures and the equivalence requirements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 372,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does Broadcom's (AVGO) internal manufacturing strategy for FBAR filters, as part of its RF semiconductor devices, support its competitive advantage in the cellular handset market?",
      "original_answer": "Broadcom's internal manufacturing strategy for FBAR filters enables it to protect its intellectual property and accelerate time to market, which directly supports its competitive advantage in the cellular handset market where FBAR technology holds significant market share.",
      "llm_answer": "Broadcom’s internal manufacturing of FBAR filters—leveraging its proprietary FBAR technology, advanced amplifier design, and module integration—gives the company a distinct performance and cost advantage in cellular RF front‑end modules. This capability enables faster time‑to‑market, tighter control of IP, and higher‑quality filters that improve handset efficiency and battery life, strengthening Broadcom’s position against competitors in the cellular handset market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth, with only minor elaboration beyond the original answer. (1) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies Broadcom's internal manufacturing of FBAR filters as a strategic advantage, accurately linking it to IP protection, faster time to market, and competitive positioning in the cellular handset market—core elements in the ground truth. (3) The multi-hop reasoning is sound: it connects internal manufacturing to proprietary technology (FBAR), then to outcomes (time-to-market, IP control, performance), and finally to competitive advantage in the target market. The LLM adds contextual details—such as improved handset efficiency and battery life, and integration with RF front-end modules—which are reasonable inferences consistent with the technology’s known benefits, though not explicitly stated in the ground truth. (4) These additions do not introduce inaccuracies but slightly extend beyond the verified knowledge graph answer, warranting a 9 instead of 10 for qualitative accuracy. Correctness is high as all key facts align and no errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 349,
        "total_tokens": 1544
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does Merck utilize both patent term extensions and regulatory exclusivity to maximize market protection for its biologic products, and what specific exclusivity durations are available in the U.S. for such products?",
      "original_answer": "Merck leverages both patent term extensions and regulatory exclusivity to extend market protection for its biologic products. In the U.S., regulatory data exclusivity for biologic products lasts 12 years from the date of first marketing approval. Additionally, if pediatric studies are completed, an extra six months of market exclusivity can be added. These mechanisms work together to provide extended market protection, allowing Merck to maintain exclusivity beyond the initial approval period and delay potential competition.",
      "llm_answer": "Merck maximizes market protection for biologic products through a combination of patent term extensions (PTEs) and regulatory exclusivity mechanisms. In the U.S., biologic products are eligible for 12 years of data exclusivity under the BPCIA, which can be extended by six months for pediatric studies, and may also receive up to five years of PTE to offset time lost during FDA review. Additional market exclusivity may arise from Supplementary Protection Certificates (SPCs) in the EU or pediatric exclusivity in Japan, while regulatory data exclusivity periods (e.g., five years for new chemical entities, extended to seven for orphan drugs) complement patent protection. This multi-layered approach ensures overlapping periods of exclusivity beyond standard patent terms.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but includes some inaccuracies and extraneous information not present in the ground truth. (1) Correct elements: The 12-year U.S. data exclusivity for biologics under the BPCIA is accurate, as is the additional six months for pediatric studies. These match the ground truth and are correctly attributed to U.S. regulatory exclusivity. (2) Quantitative accuracy: The claim of 'up to five years of PTE' is misleading in the context of biologics—patent term extensions under the Hatch-Waxman Act apply to small molecules, not biologics, which are governed by different rules under the BPCIA. Biologics do not receive PTE in the same way; instead, they rely on patent certifications and 12-year exclusivity. This is a significant factual error. Additionally, the mention of Supplementary Protection Certificates (SPCs) in the EU and exclusivity in Japan, while factually true in those jurisdictions, is irrelevant to the question, which specifically asks about U.S. exclusivity. The reference to five-year exclusivity for new chemical entities and seven for orphan drugs pertains to small molecules, not biologics, and thus introduces confusion. (3) Reasoning: The multi-hop synthesis is partially sound—Merck’s use of layered exclusivity is well-conceptualized, but the reasoning falters by conflating small molecule and biologic exclusivity frameworks. The core mechanism for biologics in the U.S. is 12-year data exclusivity + pediatric extension, which is correctly identified, but the addition of PTE and small-molecule-specific exclusivity undermines precision. (4) The answer is contextually relevant and well-structured, but the inclusion of non-applicable exclusivity types reduces factual accuracy. A score of 7 is justified because the key U.S. biologic exclusivity durations are correct, but significant errors in patent term extension applicability and scope reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 518,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How do the 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 2024 10-K filing, potentially affect BlackRock's client engagement and compliance costs in its UK operations?",
      "original_answer": "The 2024 reforms to the UK Stewardship Code, as outlined in BlackRock's 10-K filing, introduce tailored reporting requirements for proxy advisers and investment consultants. These changes may increase BlackRock's compliance costs and necessitate adjustments to its stewardship activities on behalf of clients. Since BlackRock's UK subsidiaries are subject to rigorous conduct regulation, including the Consumer Duty rules, failure to meet the FCA's expectations regarding these new stewardship reporting obligations could expose BlackRock to regulatory sanctions, reputational risk, and potential client asset withdrawals, thereby impacting client engagement and operational efficiency.",
      "llm_answer": "The 2024 reforms to the UK Stewardship Code, as referenced in BlackRock’s 2024 10‑K, could force the firm to adopt tailored reporting requirements for proxy advisers and investment consultants, increasing compliance costs and operational complexity in its UK operations. These heightened disclosure obligations may also affect how BlackRock engages with clients and manage proxy voting, potentially influencing client relationships and raising expenses associated with meeting the new stewardship standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key elements of the 2024 UK Stewardship Code reforms as outlined in BlackRock's 2024 10-K: tailored reporting requirements for proxy advisers and investment consultants, increased compliance costs, and impacts on client engagement and operational complexity. All entities (BlackRock, UK Stewardship Code, 2024 reforms), years (2024), and regulatory context are accurate. There are no numerical values requiring verification, so quantitative accuracy is scored as 10. The qualitative accuracy is slightly reduced because the LLM omits specific risks mentioned in the ground truth—namely, exposure to regulatory sanctions, reputational risk, and potential client asset withdrawals due to FCA's Consumer Duty rules. While the LLM captures the general impact on client relationships and costs, it does not fully convey the multi-hop synthesis between the new stewardship requirements, regulatory expectations, and downstream business risks. However, the core reasoning is sound and semantically aligned with the original answer. Contextual relevance is perfect—the response directly addresses the question about client engagement and compliance costs in UK operations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 337,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022, and how does the Heritage AspenTech acquisition directly factor into this change according to the evidence provided?",
      "original_answer": "The depreciation and amortization expenses for the AspenTech segment increased by $147 million (from $95 million in fiscal 2021 to $242 million in fiscal 2022). The Heritage AspenTech acquisition directly factors into this change because it is explicitly stated that the increase in backlog for the AspenTech segment in fiscal 2022 is related to this acquisition, which would lead to the recognition of additional intangible assets requiring amortization.",
      "llm_answer": "The dollar increase in depreciation and amortization expenses for the AspenTech segment from fiscal 2021 to 2022 was $147 million (from $95 million in 2021 to $242 million in 2022). This increase is directly attributable to the Heritage AspenTech acquisition, which added $148 million of amortization of intangibles (including backlog amortization) for the year ended September 30, 2022, as noted in the footnote on page 79.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar increase in depreciation and amortization expenses as $147 million, accurately calculated from $95 million in fiscal 2021 to $242 million in fiscal 2022. This matches the ground truth exactly. (2) The quantitative accuracy is perfect: all numbers are correct, including the starting and ending values and the resulting difference. The mention of $148 million in amortization from the acquisition is very close to the $147 million increase and may reflect rounding or a slight discrepancy in included components, but does not materially contradict the ground truth. (3) The reasoning is sound and improves upon the original answer by citing a specific source (footnote on page 79) and specifying that the $148 million includes amortization of intangibles and backlog, which directly links the acquisition to the expense increase. This demonstrates strong multi-hop reasoning by connecting the acquisition to intangible asset recognition and subsequent amortization. (4) The answer is fully contextually relevant, addressing both the numerical change and the causal role of the Heritage AspenTech acquisition. The only minor issue is the $1 million discrepancy between the $147 million increase and the $148 million attributed to the acquisition, which could imply a slight overattribution but does not undermine the overall correctness. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 412,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What was the year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region, and what percentage did this region contribute to the total global growth in this business segment?",
      "original_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $24 million ($744 million in Fiscal Year 2022 from $720 million in Fiscal Year 2021). This regional increase contributed approximately 0.35% to the total global growth in the Subscriptions and Services segment, which grew by $362 million (from $6,564 million to $6,926 million).",
      "llm_answer": "The year-over-year increase in revenue from Subscriptions and Services in the Asia Pacific region was $881 million, rising from $881 million in fiscal 2020 to $1,762 million in fiscal 2021. This region accounted for roughly 13 % of the total global growth in the Subscriptions and Services segment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in terms of factual content. The year-over-year increase in Subscriptions and Services revenue for the Asia Pacific region is stated as $881 million, rising from $881 million in fiscal 2020 to $1,762 million in fiscal 2021. However, the ground truth reports an increase of only $24 million—from $720 million in FY2021 to $744 million in FY2022. The LLM uses incorrect years (2020 to 2021 vs. 2021 to 2022), incorrect base and final revenue figures, and thus a grossly inflated increase. Additionally, the LLM claims the region contributed 13% to global segment growth, whereas the correct figure is approximately 0.35%. (2) Quantitative verification: Correct increase = $744M - $720M = $24M; Correct global growth = $6,926M - $6,564M = $362M; Correct contribution = ($24M / $362M) ≈ 6.63% of total growth, but the original answer states ~0.35%, which appears to be an error in the ground truth interpretation—however, even with that, 13% is far off. But more critically, the LLM’s $881M to $1,762M implies a $881M increase, which is 2.4x larger than the entire global segment growth of $362M, making it mathematically impossible. (3) Multi-hop reasoning failed completely: The model did not correctly identify the relevant fiscal years (2021 to 2022, not 2020 to 2021), used fabricated revenue numbers, and miscalculated both the regional growth and its contribution to global growth. (4) Scores are low due to pervasive factual inaccuracies, incorrect calculations, wrong time periods, and failure to reflect any correct synthesis from the source data. Only minimal relevance is given because the answer attempts to address the right business segment and region, albeit with entirely wrong data.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 477,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How do the 2023 joint merger guidelines issued by the FTC and DOJ negatively impact BlackRock's ability to expand through acquisitions and affect funds engaging in HSR-reportable transactions?",
      "original_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ increase regulatory scrutiny and impose additional compliance burdens on transactions reportable under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976. These guidelines could negatively impact BlackRock’s ability to expand through strategic investments or acquisitions by making such transactions more costly, complex, and time-consuming. Additionally, funds engaging in HSR-reportable transactions may face increased pre-merger notification expenses and potential transaction delays due to the expanded information and documentation requirements introduced alongside the new guidelines.",
      "llm_answer": "The 2023 joint merger guidelines issued by the FTC and DOJ expand the information required for pre‑merger notifications and increase scrutiny of transactions that could be deemed to “substantially lessen competition,” which can delay or block BlackRock’s planned acquisitions and make it harder to obtain regulatory clearance. In addition, the heightened antitrust focus means that funds undertaking HSR‑reportable deals face a more rigorous review process, potentially restricting their ability to complete transactions and forcing them to restructure or abandon deals that might previously have been cleared.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All entities are correct: FTC, DOJ, BlackRock, HSR-reportable transactions, and the 2023 joint merger guidelines are accurately referenced. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected and scores perfectly. (3) The multi-hop reasoning is sound: the model correctly links the 2023 guidelines to increased scrutiny, expanded notification requirements, transaction delays, and implications for both BlackRock and funds engaging in HSR-reportable deals. It captures the causal chain: new guidelines → more information required → greater scrutiny → higher risk of delays, rejections, or deal abandonment. (4) The LLM emphasizes the risk of deals being 'delayed or blocked' and 'restructured or abandoned,' which aligns with the original answer’s focus on increased costs, complexity, and delays. The only minor difference is that the LLM does not explicitly mention 'compliance burdens' or 'pre-merger notification expenses,' though these are implicitly covered in 'rigorous review process' and 'heightened antitrust focus.' Thus, the answer is slightly less comprehensive but still captures the core impact accurately. Overall, the response is contextually relevant, logically sound, and factually correct, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 390,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Goldman Sachs' use of both stock-settled and cash-settled Non-Employee Director RSU Award Agreements influence its accounting treatment and financial statement classification?",
      "original_answer": "Goldman Sachs uses two forms of Non-Employee Director RSU Award Agreements: one that is stock-settled (Form 10.8 referenced in evidence_source_a) and another that is cash-settled (Form 10.32 referenced in evidence_source_b). These differing settlement terms directly affect accounting treatment — stock-settled RSUs are classified as equity instruments, while cash-settled RSUs are classified as liability instruments under GAAP. This distinction impacts both the timing and measurement of compensation expense, with liability-classified awards requiring remeasurement at each reporting date until settlement.",
      "llm_answer": "Goldman Sachs discloses two distinct types of Non‑Employee Director RSU agreements – a stock‑settled form (Exhibit 10.31) and a cash‑settled form (Exhibit 10.32). Because the cash‑settled awards are settled in cash rather than shares, they are recorded as a liability‑based award and measured at fair value, with changes in the liability recognized in earnings, whereas the stock‑settled awards are treated as equity‑based awards and recorded in shareholders’ equity. This dual structure results in the cash‑settled RSUs being classified as a liability on the balance sheet and reflected in the compensation expense line of the income statement, while the stock‑settled RSUs remain within equity‑based compensation disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the two types of Non-Employee Director RSU agreements used by Goldman Sachs—stock-settled and cash-settled—and accurately describes their accounting treatment under GAAP. It correctly states that stock-settled RSUs are treated as equity-based awards and recorded in shareholders’ equity, while cash-settled RSUs are classified as liability-based awards, remeasured at fair value with changes recognized in earnings. This aligns with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the original answer, so quantitative accuracy is not applicable in that sense; however, the LLM correctly references Exhibit 10.32 for the cash-settled form. It incorrectly cites Exhibit 10.31 (instead of 10.8 as in the ground truth) for the stock-settled form, which is a minor factual discrepancy in document reference. This does not affect the overall correctness of the accounting principles described. (3) The multi-hop reasoning is sound: the model correctly synthesizes the link between settlement method (stock vs. cash) and financial statement classification (equity vs. liability), and explains the implications for expense recognition and balance sheet presentation. (4) The answer is semantically equivalent to the original, with only a minor error in the exhibit number for the stock-settled agreement. This does not undermine the core accuracy of the accounting treatment explanation. Hence, a score of 9 is justified—highly accurate with a minor factual inaccuracy in sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 438,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How many shares were granted in the form of restricted stock units under the Abbott Laboratories 2017 Incentive Stock Program in 2023, and what specific vesting condition is mentioned for these units in the program documentation?",
      "original_answer": "In 2023, Abbott granted 4,981,231 restricted stock units under the 2017 Incentive Stock Program. These restricted stock units vest over three years, and upon vesting, the recipient receives one share of Abbott stock for each vested unit.",
      "llm_answer": "In 2023, Abbott granted **4,981,231 restricted stock units** under the 2017 Incentive Stock Program. These units vest over three years and, upon vesting, each unit entitles the recipient to receive one share of Abbott common stock.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the number of restricted stock units granted in 2023 — 4,981,231 — is accurate and matches the original answer exactly. (2) The vesting condition is correctly described: the units vest over three years, and upon vesting, each unit converts into one share of Abbott common stock, which aligns precisely with the program documentation. (3) The reasoning is sound and reflects proper synthesis of multi-hop information from the Abbott Laboratories 2017 Incentive Stock Program and its implementation in 2023. (4) The wording differs slightly (e.g., 'entitles the recipient to receive one share' vs. 'the recipient receives one share'), but the semantic meaning is equivalent. All entities — Abbott Laboratories, 2017 Incentive Stock Program, 2023 grant year — are correctly identified. No factual, numerical, or contextual errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 271,
        "total_tokens": 1408
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "What percentage of Danaher's 2024 Life Sciences segment sales came from regions outside North America and Western Europe, and how does this geographic distribution reflect the long-term strategic impact of acquiring Leica Microsystems in 2005?",
      "original_answer": "Danaher's Life Sciences segment generated 28% of its 2024 sales from high-growth markets and 7% from other developed markets, totaling 35% from regions outside North America (44%) and Western Europe (21%). This geographic diversification reflects the long-term strategic impact of acquiring Leica Microsystems in 2005, which served as the foundational platform for expanding the Life Sciences business through subsequent acquisitions such as Beckman Coulter (2011), Pall (2015), and Abcam (2023), enabling broader global reach and integration of complementary technologies.",
      "llm_answer": "Based on the Life Sciences segment description in the 2024 10-K (page 8), sales by geographic destination were North America 44%, Western Europe 21%, other developed markets 7% and high‑growth markets 28%. Thus, the portion of sales coming from regions outside North America and Western Europe is 28 % + 7 % = 35 %.  \n\nThe acquisition of Leica Microsystems in 2005 gave Danaher an established microscopy platform and brand that became a core part of its Life Sciences portfolio, enabling the company to expand its product breadth (e.g., microscopy, filtration, consumables) and to cross‑sell to its existing life‑science customer base. This acquisition helped drive the segment’s growth in high‑growth markets, contributing to the 28 % share of sales generated there today.  \n\n\\[\n\\boxed{35\\%}\n\\]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the percentage of Danaher's 2024 Life Sciences segment sales from regions outside North America and Western Europe as 35%, calculated accurately from 28% (high-growth markets) and 7% (other developed markets), matching the ground truth. All numeric values (44%, 21%, 28%, 7%) and the calculation (28% + 7% = 35%) are factually correct and properly cited from the 2024 10-K. The acquisition year (2005) and company (Leica Microsystems) are also correct.\n\n2) Quantitative accuracy is perfect: all percentages are correctly extracted, and the sum is accurate. Format is clear and consistent.\n\n3) The reasoning correctly links the acquisition of Leica Microsystems to the expansion of Danaher’s Life Sciences portfolio and global reach, noting its role in enabling growth in high-growth markets. While the LLM mentions cross-selling and product breadth, it omits explicit reference to Leica serving as the 'foundational platform' for subsequent major acquisitions (Beckman Coulter, Pall, Abcam), which is a key strategic point in the ground truth. This is a minor omission in the multi-hop synthesis but does not invalidate the overall logic.\n\n4) The answer is highly contextually relevant, directly addressing both parts of the question: the geographic sales percentage and the strategic impact of the 2005 acquisition. The explanation is concise and factually grounded. The omission of the 'foundational platform' role and specific follow-on acquisitions slightly reduces qualitative accuracy but does not undermine the core correctness. Hence, a score of 9/10 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 440,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What is the total number of acquisitions Danaher has made in the Life Sciences segment since its establishment in 2005, including the year of acquisition for Pall and the most recent acquisition mentioned in the filing?",
      "original_answer": "Danaher has made 8 acquisitions in the Life Sciences segment since its establishment in 2005. These include: Leica Microsystems (2005), AB Sciex and Molecular Devices (2010), Beckman Coulter (2011), Pall (2015), Phenomenex (2016), IDT (2018), Aldevron (2021), and Abcam (2023).",
      "llm_answer": "Danaher has made **13 acquisitions in the Life Sciences segment since its establishment in 2005**, including the acquisition of **Pall in 2015** and the most recent acquisition of **Abcam in 2023**.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Danaher made 13 acquisitions in the Life Sciences segment since 2005; the correct number is 8 according to the ground truth. While the LLM correctly identifies Pall acquired in 2015 and Abcam in 2023 as the most recent acquisition, it significantly overstates the total count. (2) Quantitative accuracy is low: the number '13' is incorrect, whereas the correct count is '8'. All other numeric references (2015 for Pall, 2023 for Abcam) are accurate and match the ground truth. There are no calculation errors per se, but the core quantitative claim (total acquisitions) is wrong. (3) The multi-hop reasoning is partially sound— the model correctly identifies key acquisitions (Pall and Abcam) and their years, showing some ability to extract and synthesize information across time and entities. However, it fails to accurately enumerate or count the total set of acquisitions, suggesting either hallucination or failure to correctly retrieve all relevant data points. (4) Contextual relevance is high because the answer addresses the required elements (total count, Pall acquisition year, most recent acquisition), but correctness is severely compromised by the inflated acquisition count. The qualitative reasoning is acceptable but incomplete, as it omits all other acquisitions and provides no supporting detail. Thus, while the structure and intent align with the question, factual accuracy is poor.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 406,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "What was the change in the fair value of Abbott's interest rate hedge contracts between December 31, 2020 and December 31, 2021, and how does this reflect the fluctuation in their receivable position for these contracts during the same period?",
      "original_answer": "The fair value of Abbott's interest rate hedge contracts decreased from $210 million on December 31, 2020, to $87 million on December 31, 2021, representing a decline of $123 million. This change is consistent with the drop in the receivable position for these contracts, which also fell from $210 million to $87 million over the same period, indicating a significant reduction in Abbott's exposure or valuation of these hedges.",
      "llm_answer": "The fair value of Abbott's interest rate hedge contracts was $87 million at December 31 2021 and $210 million at December 31 2020, representing a $123 million decrease. This decline reflects the change in the fair value of the hedged fixed‑rate debt, which is marked‑to‑market to offset the hedge’s impact on the debt’s carrying amount.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies all key numerical values: fair value of $210 million on December 31, 2020, and $87 million on December 31, 2021, with a correct $123 million decrease. These match the ground truth exactly, satisfying quantitative accuracy. 2) The calculation of the $123 million decline is accurate and properly derived from the two reported values. 3) The LLM addresses the first part of the question (change in fair value) completely and accurately. However, it does not fully address the second part regarding how this change reflects the fluctuation in the receivable position. While the ground truth notes that the receivable position also fell from $210M to $87M and emphasizes the consistency between fair value and receivable movement, the LLM instead explains the decline in terms of hedged fixed-rate debt and mark-to-market accounting. This shifts focus to the rationale behind the valuation change rather than directly addressing the receivable position fluctuation. 4) Entity accuracy (Abbott, interest rate hedge contracts, correct dates) is perfect. The reasoning is sound in a broader accounting context but misses the specific comparative analysis between fair value and receivable position that the question and ground truth emphasize. The answer is semantically close but omits a direct statement that the receivable position moved in tandem with fair value. Thus, while factually correct in what it states, it is incomplete in covering all aspects of the multi-hop query.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 414,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How does BMY's strategic focus on expanding its autologous CAR-T cell therapy pipeline, including new indications for Breyanzi, align with the observed doubling of U.S. revenues for Breyanzi in 2023?",
      "original_answer": "BMY's 2023 strategy emphasized expanding its autologous CAR-T cell therapy franchise, including pursuing new indications for Breyanzi such as CLL, FL, and MCL, which aligns with the doubling of U.S. revenues for Breyanzi due to higher demand. This strategic investment in cell therapy innovation and expansion into new treatment areas is directly reflected in the significant revenue growth of Breyanzi.",
      "llm_answer": "BMY's strategic focus on expanding its autologous CAR‑T pipeline—evidenced by ongoing efforts to add new indications for Breyanzi such as CLL, FL and MCL—directly supports the observed doubling of U.S. Breyanzi revenues in 2023, as higher demand for the therapy drove the revenue surge. This expansion aligns with the company's broader goal of growing its cell‑therapy franchise and leveraging increased manufacturing capacity to capture additional market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key elements are correct: BMY's strategic focus on expanding the autologous CAR-T pipeline, specifically pursuing new indications for Breyanzi (CLL, FL, MCL), is accurately stated. The doubling of U.S. revenues for Breyanzi in 2023 is correctly attributed to higher demand, consistent with the original answer. (2) There are no numeric inaccuracies—'doubling of U.S. revenues' is a qualitative description of growth, and no specific dollar amounts or percentages beyond that are claimed, so the response remains within factual bounds. (3) The multi-hop reasoning is sound: the model correctly links BMY’s strategic expansion into new indications with increased commercial performance, demonstrating synthesis between R&D strategy and financial outcome. (4) The LLM adds contextual detail not in the original—mention of manufacturing capacity and market share—which is plausible and consistent with typical biopharma growth strategies, but not explicitly confirmed in the ground truth. This addition does not contradict the original, but slightly extends it, warranting a 9 instead of 10 for qualitative accuracy. Overall, the answer is semantically equivalent, contextually relevant, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 359,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What was the total cash outflow for the acquisition of The Binding Site Group in 2023, and how did it contribute to the total cash used for acquisitions in 2023, including CorEvitas, LLC?",
      "original_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.70 billion. This, combined with the $0.91 billion used for the acquisition of CorEvitas, LLC, contributed to a total of $3.61 billion in cash used for acquisitions during 2023.",
      "llm_answer": "The total cash outflow for the acquisition of The Binding Site Group in 2023 was $2.699 billion (including $2.412 billion cash paid, $307 million debt settled and $20 million cash acquired). This acquisition contributed $2.699 billion to the total cash used for acquisitions in 2023, alongside the $0.910 billion cash outflow for CorEvitas, LLC.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. The total cash outflow for The Binding Site Group is reported as $2.699 billion, which is effectively equivalent to the ground truth $2.70 billion (the $0.001 billion difference is due to rounding and is negligible). The CorEvitas, LLC acquisition amount is correctly stated as $0.910 billion, matching the ground truth $0.91 billion. The combined total of $3.609 billion (implied by $2.699B + $0.910B) rounds to the ground truth $3.61 billion. (2) Quantitative accuracy is high: all numbers are correct within acceptable rounding tolerance. The breakdown of the $2.699 billion (cash paid, debt settled, cash acquired) adds up correctly and provides additional detail not in the original answer, which enhances precision. (3) Multi-hop reasoning is sound: the model correctly identifies both acquisitions, associates the correct amounts, and synthesizes them into the total cash used for acquisitions in 2023. (4) The answer is contextually fully relevant, addressing both parts of the question: the specific outflow for The Binding Site Group and its contribution to the total acquisition spend including CorEvitas. The slight rounding difference does not affect factual correctness, warranting a 9 rather than 10 due to strict numeric matching expectations.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 371,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "What is the total estimated annual cost savings from restructuring charges incurred in 2024 and 2023, and how does the acquisition of The Binding Site Group in 2023 contribute to the Specialty Diagnostics segment's strategic growth in blood cancer diagnostics?",
      "original_answer": "The restructuring charges incurred in 2024 and 2023 are expected to yield total estimated annual cost savings of $0.8 billion ($0.2 billion from 2024 charges and $0.6 billion from 2023 charges). The acquisition of The Binding Site Group in 2023 enhances the Specialty Diagnostics segment's portfolio by adding pioneering diagnostic assays and instruments for blood cancers, specifically multiple myeloma, aligning with the company's strategy of high-impact innovation and expanding its capabilities in specialty diagnostics.",
      "llm_answer": "The total estimated annual cost savings from restructuring charges incurred in 2024 and 2023 is approximately $0.2 billion per year, reflecting the savings expected from headcount reductions and facility consolidations. The acquisition of The Binding Site Group in 2023 strengthens Thermo Fisher’s Specialty Diagnostics segment by adding pioneering diagnostic assays and instruments for blood‑cancer monitoring, expanding its portfolio and enhancing its strategic growth in blood‑cancer diagnostics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains a critical error in the total estimated annual cost savings. The ground truth states $0.8 billion total ($0.2 billion from 2024 and $0.6 billion from 2023), but the LLM reports only $0.2 billion per year, omitting the $0.6 billion from 2023. This is a major quantitative inaccuracy. (2) The calculation of total savings is incorrect: $0.2B + $0.6B = $0.8B, which the LLM fails to reflect. The $0.2 billion figure likely refers only to 2024 savings, but the answer presents it as the total, indicating a failure in synthesis across both years. (3) On qualitative aspects, the LLM correctly identifies the strategic contribution of The Binding Site Group acquisition—adding diagnostic assays and instruments for blood cancer diagnostics, particularly aligning with growth in specialty diagnostics. The entity (The Binding Site Group) and year (2023) are accurate, and the relevance to the Specialty Diagnostics segment is properly contextualized. (4) Contextual relevance is high as the answer addresses both parts of the question and uses appropriate terminology. However, the severe quantitative error—missing 75% of the cost savings figure—drastically reduces overall correctness. The model fails the multi-hop requirement to aggregate savings across two years, undermining the primary factual claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 380,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "What is the longest-term debt instrument listed in Eli Lilly's 2023 10-K filing, and how does its maturity year compare to the other debt instruments listed in the same filing?",
      "original_answer": "The longest-term debt instrument listed in Eli Lilly's 2023 10-K filing is the 1.375% Notes due 2061. This instrument matures in 2061, which is significantly later than the other debt instruments listed, such as the 0.500% Notes due 2033 and the 1.125% Notes due 2051.",
      "llm_answer": "The longest-term debt instrument listed in Eli Lilly’s 2023 10‑K is the 1.375% Notes due 2061, which matures in 2061. This is later than the other instruments disclosed, which mature in 2025, 2026, 2030, 2031, 2033, 2036, 2043, 2049 and 2051.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the longest-term debt instrument as the 1.375% Notes due 2061, matching the ground truth in both coupon rate and maturity year. The maturity year (2061) is accurately stated and correctly positioned as the latest among all listed instruments. The LLM provides a more comprehensive list of maturity years (2025, 2026, 2030, 2031, 2033, 2036, 2043, 2049, 2051) compared to the ground truth, which only mentions 2033 and 2051 as examples. This additional detail does not contradict the ground truth and enhances completeness. All numeric values—percentages and years—are accurate, satisfying quantitative accuracy. The reasoning is sound: the model correctly infers that 2061 is the latest maturity and compares it appropriately across multiple instruments. The only minor shortcoming is that the ground truth emphasizes the 'significant' difference in maturity, a qualitative nuance slightly underdeveloped in the LLM response, though the factual basis for that conclusion is fully supported. No incorrect entities or time periods are introduced. The answer is contextually relevant and fully addresses both parts of the question: identifying the longest-term instrument and comparing its maturity to others.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1135,
        "completion_tokens": 347,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "What is the total number of distinct indications for which Donanemab is under development or review, and how does this compare to the number of indications for which Lebrikizumab has received approval or is under regulatory review?",
      "original_answer": "Donanemab is under development or review for two distinct indications: early Alzheimer's disease and preclinical Alzheimer's disease. Lebrikizumab has received approval for atopic dermatitis in the EU and Japan, and is under regulatory review in the U.S. for the same indication, making it one approved or under review indication. Therefore, Donanemab is being developed for more indications than Lebrikizumab.",
      "llm_answer": "Donanemab is currently under regulatory review for the indication of early Alzheimer's disease, while Lebrikizumab has received regulatory approval in the EU and Japan for atopic dermatitis and is under FDA review in the U.S. for the same indication. Both are in the regulatory or approval phase for their respective indications, with Donanemab submitted for approval in the U.S., EU, and Japan, and Lebrikizumab approved in the EU and Japan and under FDA review in the U.S.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Donanemab is under regulatory review for early Alzheimer's disease and that Lebrikizumab is approved in the EU and Japan and under FDA review in the U.S. for atopic dermatitis. However, it fails to mention that Donanemab is also under development for *preclinical Alzheimer's disease*, which is a second distinct indication. This omission leads to an incorrect comparison: the LLM implies both drugs are being developed for one indication each, while the ground truth states Donanemab has *two* indications. (2) There are no explicit numerical errors (e.g., dates, dollar amounts), but the implicit count of indications is inaccurate—Donanemab should be associated with two indications, not one. The answer does not quantify the number of indications for either drug, which is central to the question. (3) The multi-hop reasoning is partially sound—it connects regulatory status across regions for both drugs—but fails to synthesize the full scope of Donanemab's development pipeline. The comparison between the two drugs' indication counts is therefore incomplete and misleading. (4) The answer is contextually relevant and uses accurate entities (drug names, regions, indications), but lacks completeness and quantitative precision required for full correctness. Hence, the correctness score is 5 due to significant omission affecting the core comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 392,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the decline in Alimta's revenue in the U.S. in 2023, caused by the entry of generics, impact the overall U.S. volume growth, and what other oncology product contributed positively to volume growth in the U.S.?",
      "original_answer": "The decline in Alimta's revenue in the U.S. in 2023, due to the entry of multiple generics in the first half of 2022, negatively impacted the overall U.S. volume growth. However, this was partially offset by strong performance from other oncology products such as Verzenio and Trulicity, which contributed positively to U.S. volume growth.",
      "llm_answer": "The decline in Alimta revenue in the U.S. in 2023, driven by generic entry, contributed to a 77% drop in Alimta revenue (from $927.7M in 2022 to $217.5M in 2023), but this negative impact was partially offset by strong volume growth from other oncology products. Mounjaro was the primary driver of U.S. volume growth in 2023, significantly contributing to the 11% overall U.S. volume increase.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies that Alimta's U.S. revenue decline in 2023 (due to generic entry) negatively impacted overall U.S. volume growth, it introduces incorrect quantitative data not present in the ground truth: a 77% drop from $927.7M to $217.5M. This specific numerical breakdown is not confirmed in the original answer and represents fabricated precision. Additionally, the claim of an '11% overall U.S. volume increase' is not supported by the ground truth, which does not provide any aggregate volume growth figure. (2) The entity accuracy fails in identifying the oncology products that offset the decline: the ground truth specifies Verzenio and Trulicity as contributing positively, but the LLM incorrectly names Mounjaro. Mounjaro is not an oncology product—it is a diabetes/weight-loss drug (GLP-1 agonist), so this is a critical category and entity error. (3) The multi-hop reasoning is partially sound in structure—recognizing that Alimta's decline was offset by other products—but fails in execution due to incorrect product attribution and unsupported calculations. The model appears to conflate diabetes and oncology portfolios. (4) Despite these issues, the answer is contextually relevant, addressing both parts of the question: the negative impact of Alimta’s decline and the positive contribution of other products. However, due to major factual and categorical errors in both numbers and product identification, the correctness score is low. Quantitative accuracy is particularly poor due to unsupported figures. Qualitative accuracy is moderate because the logical framework is present but based on incorrect data. Contextual relevance is acceptable as the response stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 484,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How much total financial commitment and shared development cost has Merck incurred or anticipated in relation to V940 (mRNA-4157), and how does this tie into Merck's broader immuno-oncology strategy as outlined in its 2023 10-K filing?",
      "original_answer": "Merck incurred a $250 million payment in 2022 upon exercising its option to jointly develop and commercialize V940 (mRNA-4157) with Moderna. Additionally, Merck is sharing development costs equally with Moderna for this investigational individualized neoantigen therapy, which is being evaluated in combination with Keytruda in multiple Phase 3 clinical trials. This commitment aligns with Merck's immuno-oncology strategy, which includes V940 (mRNA-4157) as a key program being tested in the INTerpath-001 and INTerpath-002 trials for melanoma and NSCLC, respectively. The therapy has received Breakthrough Therapy and PRIME designations, underscoring its strategic importance in Merck's oncology pipeline.",
      "llm_answer": "Based on the provided 10-K filing details, Merck has incurred or anticipates a total financial commitment of **$5.5 billion** related to V940 (mRNA-4157), comprising **$4.0 billion in upfront payments** and **$1.5 billion in continuation payments** under its collaboration with Moderna. This includes a **$250 million option payment** made in 2022 to exercise joint development rights, with Merck and Moderna sharing development costs and profits equally worldwide (except in Japan, where Daiichi Sankyo holds exclusive rights). \n\nThis investment aligns with Merck's broader immuno-oncology strategy, as V940 is being developed as an **individualized neoantigen therapy in combination with Keytruda** (an anti-PD-1 therapy) for adjuvant treatment in high-risk melanoma and non-small cell lung cancer (NSCLC). The collaboration leverages Merck's immuno-oncology expertise and Keytruda's established clinical profile, reflecting Merck's strategic focus on advancing next-generation cancer immunotherapies through partnerships and novel modalities like mRNA-based cancer vaccines. The $5.5 billion commitment underscores Merck's prioritization of immuno-oncology as a core growth pillar, supported by regulatory designations (e.g., Breakthrough Therapy, PRIME) and ongoing Phase 3 trials (e.g., INTerpath-001 and INTerpath-002).",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in financial figures. The ground truth states Merck made a $250 million payment in 2022 and is sharing development costs equally with Moderna, but there is no mention of a $5.5 billion total commitment, $4.0 billion upfront, or $1.5 billion continuation payments. These numbers are entirely fabricated and not supported by the original answer or typical public disclosures as of the 2023 10-K. The only correct financial figure is the $250 million option payment. (2) Quantitative accuracy is severely compromised: the $5.5 billion total and its breakdown are incorrect. No such sum is mentioned in the ground truth, and no calculation or source supports it. This represents a major factual error. (3) Qualitatively, the LLM correctly identifies the joint development with Moderna, equal cost and profit sharing, the use of V940 (mRNA-4157) as an individualized neoantigen therapy combined with Keytruda, its role in melanoma and NSCLC trials (INTerpath-001 and INTerpath-002), and the Breakthrough Therapy and PRIME designations. It also accurately ties the program to Merck’s broader immuno-oncology strategy. These elements show sound multi-hop reasoning in terms of strategic alignment and clinical context. (4) Contextual relevance is high because the answer addresses both parts of the question—financial commitment and strategic alignment—and incorporates relevant details about partnerships, clinical trials, and regulatory designations. However, the massive overstatement of financial commitment undermines the correctness score. The answer is partially correct in reasoning and context but fails on core factual accuracy, especially in numbers, warranting a low correctness score despite strong qualitative elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 488,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How many additional years of U.S. patent protection could MK-7962 (sotatercept) receive beyond the standard biologic data exclusivity period, based on the disclosed expiration year and the stated patent expiration date?",
      "original_answer": "MK-7962 (sotatercept) is eligible for 12 years of data exclusivity upon approval in the U.S., and its granted patents covering methods of treatment will expire in 2037. If the product receives approval in 2027, as indicated by the anticipated expiration year, then it could receive an additional 10 years of protection beyond the standard exclusivity period.",
      "llm_answer": "\nBased on the disclosed patent expiration year of 2037 (as stated in the text on Page 16, which clarifies that granted patents for MK-7962 will expire in 2037 absent PTE) and the standard U.S. biologic data exclusivity period of 12 years from first marketing approval, the patent protection could provide up to 5 additional years of exclusivity beyond the data exclusivity period. This is due to the potential for patent term extension (PTE) of up to five years under U.S. law, which may extend patent protection beyond the standard 12-year data exclusivity period for biologics. The document specifies that PTE can provide \"up to five years\" of additional exclusivity (Page 14), and the patent expiration year of 2037 (text) aligns with this potential extension beyond the 12-year data exclusivity baseline. Thus, the additional years beyond the standard biologic data exclusivity period are up to 5. \n\n(Note: The table on Page 16 lists \"2027\" as the expiration year, but the accompanying text explicitly states the patent will expire in 2037 absent PTE, and the PTE mechanism is described as providing up to five additional years. The question references the \"disclosed expiration year,\" which the text clarifies as 2037, and the standard data exclusivity period is 12 years, making the potential additional years 5.)",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. The ground truth states that sotatercept could receive an additional 10 years of protection beyond the 12-year data exclusivity period if approved in 2027 and patents expire in 2037. The LLM incorrectly concludes only 5 additional years, conflating patent term extension (PTE) limits with the actual time difference between exclusivity end and patent expiration. (2) Quantitative inaccuracy: The calculation should be 2037 - (2027 + 12) = 2037 - 2039 → negative, but correctly interpreted as 2037 - 2027 = 10 years post-approval, minus 12-year exclusivity → actually, the correct logic is: data exclusivity ends in 2039 (2027 + 12), but patents expire in 2037, which would imply *less* protection, but the ground truth interprets it as 10 additional years, suggesting approval in 2027 and patent expiry in 2037 = 10 years of patent protection post-approval, which extends 10 - 12 = -2 → contradiction unless interpreted as the patent outlasting exclusivity by 10 years from approval, meaning 10 years beyond approval, but exclusivity is 12, so this still doesn't add up. Re-examining: the ground truth says 'additional 10 years beyond the standard exclusivity period' — this only makes sense if exclusivity ends in 2037 and approval is in 2027: 2027 + 12 = 2039, but patent expires 2037 → that’s 2 years *shorter*. There is a likely error in the ground truth or its interpretation. However, the LLM misreads the scenario: the 'disclosed expiration year' is 2037 (patent), approval expected 2027, so patent lasts 10 years from approval. Standard exclusivity is 12 years, so patent actually expires *before* exclusivity ends — thus, no additional protection. But the ground truth claims 'additional 10 years', which is logically inconsistent unless 'beyond' means something else. Given this confusion, the most plausible interpretation is that the ground truth meant: if approved in 2027, exclusivity ends 2039, but patents last until 2037 — so 2 years *shorter*, not longer. Alternatively, perhaps 'additional' refers to patent term extending beyond the natural expiration due to PTE. The LLM focuses on PTE providing 'up to 5 years', which is legally correct, but the question asks for 'how many additional years... could receive' based on *disclosed expiration* and *stated approval year*. The disclosed patent expiration is 2037, approval 2027, so patent lasts 10 years from approval. Since data exclusivity is 12 years, the patent does *not* provide additional protection beyond exclusivity — it lapses 2 years earlier. But the ground truth says 'additional 10 years', which is only possible if 'beyond' is misphrased. Given the confusion, the LLM’s answer of 'up to 5 years' due to PTE is a legally sound interpretation of possible extension, but it does not match the ground truth’s 10-year claim. The LLM incorrectly dismisses the 2027 table entry as conflicting with 2037 text, but the text says 'patents will expire in 2037 absent PTE', so 2037 is the base term. If approved in 2027, and patents expire 2037, that’s 10 years of patent protection from approval. Data exclusivity is 12 years, so again, patent ends before exclusivity. The only way 'additional 10 years' makes sense is if the 12-year exclusivity ends in 2037, meaning approval in 2025 — but the question says 'anticipated expiration year' is 2027, likely meaning approval. The ground truth appears internally inconsistent. However, per the provided ground truth, the expected answer is 10 additional years. The LLM answers 5, based on PTE limit, which is incorrect in this context. (3) Multi-hop reasoning failure: the model should have calculated: approval 2027 + 12 exclusivity = 2039; patent expires 2037 → no additional years. But since ground truth says 10, perhaps 'additional' means the patent lasts 10 years post-approval, and the question is asking how many years beyond exclusivity it could last, which would be negative. Alternatively, maybe the 'standard period' is not counted from approval, but the question says 'beyond the standard biologic data exclusivity period'. The only logical way to get 10 is: if exclusivity lasts 12 years, but patent lasts 22 years from approval — but it expires in 2037, so 2037 - 2027 = 10 years. So patent lasts 10 years, exclusivity 12 → patent shorter. Unless the 'additional' is misstated and should be 'the patent will last 10 years from approval, which is 2 years less than exclusivity'. Given the confusion, the LLM’s answer of 5 years based on PTE is a plausible legal interpretation but does not match the ground truth’s 10-year claim. (4) Correctness score 3: major factual and reasoning error — the answer does not match the ground truth and misrepresents the quantitative relationship. Quantitative accuracy 3: key number (5 vs 10) is wrong. Qualitative accuracy 4: reasoning about PTE is legally correct but misapplied to the question. Contextual relevance 7: the answer addresses the right concepts and cites document sections, but draws wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 1304,
        "total_tokens": 2742
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What was the total increase in Merck's fair value of Emerging Markets Equities investments across both U.S. and International Pension Plans from 2022 to 2023, based on NAV measurements?",
      "original_answer": "The total increase in Emerging Markets Equities investments was $106 million. In the U.S. Pension Plans, Emerging Markets Equities increased by $33 million (from $707 million in 2022 to $740 million in 2023). In the International Pension Plans, Emerging Markets Equities increased by $73 million (from $59 million in 2022 to $66 million in 2023 for International Pension Plans' direct Emerging Markets Equities holdings, and from $111 million in 2022 to $110 million in 2023 for the Investment Funds category which includes Emerging Markets Equities).",
      "llm_answer": "Based on the NAV measurements detailed in the 2023 10‑K (pages 108‑112), the fair‑value of Merck’s Emerging Markets Equities investments rose by **$5 million** from 2022 to 2023 – $120 million at the end of 2022 versus $125 million at the end of 2023. This $5 million increase reflects the combined growth across both the U.S. and International Pension Plans.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of quantitative and qualitative accuracy. (1) The reported increase of $5 million ($125M in 2023 vs $120M in 2022) is factually wrong. According to the ground truth, the U.S. Pension Plans alone had an increase of $33 million (from $707M to $740M), and the International Pension Plans had a combined increase of $73 million (direct holdings: $59M to $66M = +$7M; Investment Funds: $111M to $110M = -$1M, so net +$6M from direct holdings). The total increase should be $33M + $73M = $106M, not $5M. (2) The LLM incorrectly aggregates or misreads the total value of Emerging Markets Equities as only $125 million in 2023, which is far below the actual combined value (U.S. $740M + International direct $66M + Investment Funds $110M = over $900M). (3) The multi-hop reasoning failed: the model did not correctly identify and sum the increases across both U.S. and International Pension Plans, nor did it distinguish between direct holdings and investment funds as required. It appears to have conflated or misread the categories. (4) While the answer addresses the question's structure (discussing both plans and NAV measurements), it uses incorrect data, leading to a major factual error. Contextual relevance is moderate because it attempts the right analysis but with wrong inputs. The $5M figure has no support in the ground truth. Thus, the correctness score is very low due to complete failure in numerical accuracy and synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 407,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "What is the change in the estimated fair value of U.S. government agencies securities held by GILD from December 31, 2022, to December 31, 2023, and how does this compare to the change in the estimated fair value of U.S. treasury securities over the same period?",
      "original_answer": "The estimated fair value of U.S. government agencies securities increased by $106 million (from $21 million on December 31, 2022, to $127 million on December 31, 2023). The estimated fair value of U.S. treasury securities decreased by $34 million (from $379 million on December 31, 2022, to $426 million on December 31, 2023). Therefore, while U.S. government agencies securities appreciated significantly, U.S. treasury securities experienced a smaller decline in value.",
      "llm_answer": "The estimated fair value of U.S. government agencies securities held by GILD increased from $35 million at December 31 2022 to $127 million at December 31 2023, a $92 million rise. In contrast, the estimated fair value of U.S. treasury securities rose modestly from $410 million to $426 million, an increase of $16 million over the same period.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numeric values. According to the ground truth, the estimated fair value of U.S. government agencies securities increased from $21 million to $127 million, a $106 million increase, but the LLM reports a rise from $35 million to $127 million, resulting in a $92 million increase—both starting value and change are incorrect. For U.S. treasury securities, the ground truth states a decrease from $379 million to $426 million is mathematically impossible (as 426 > 379), but upon review, this appears to be a typo in the original answer: it should state a decrease from $413 million to $379 million or similar; however, the LLM claims an increase from $410 million to $426 million ($16M rise), which contradicts the original answer’s assertion of a $34 million decrease. Thus, both the direction and magnitude of the treasury securities change are wrong in the LLM response. (2) Calculations are internally consistent in the LLM answer (e.g., $127M - $35M = $92M; $426M - $410M = $16M), but they are based on incorrect input values and contradict the ground truth. The original answer indicates agencies securities increased by $106M and treasuries decreased by $34M, so the comparison of trends (one up, one down) is critical—and the LLM fails this by showing both increasing. (3) Multi-hop reasoning is partially present—the model attempts to compare two asset classes across two years for GILD—but fails in accurate data retrieval and synthesis. It does not reflect the correct values from the knowledge graph, suggesting a failure in grounding. (4) Despite incorrect numbers and directional misstatements, the structure and relevance of the answer are appropriate: it addresses both securities types, provides values for both dates, computes changes, and compares them. Hence, contextual relevance is high, but factual accuracy is severely compromised, leading to low scores in correctness, quantitative, and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 539,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the revenue performance of Biktarvy in 2023 compared to 2022, and what implications might this have on Gilead's long-term financial strategy given the patent expiration timeline for its principal HIV products?",
      "original_answer": "Biktarvy generated $11,850 million in total revenue in 2023, an increase from $10,390 million in 2022, representing a 14% growth. Given that Biktarvy is a key revenue driver, Gilead may need to prioritize extending its patent protection or developing follow-on therapies to maintain market exclusivity and revenue stability. The 10-K filing highlights that patent expiration dates for principal products, including those in fixed-dose combinations like Biktarvy, are critical for long-term revenue planning. If Biktarvy’s patent expires sooner than anticipated, the growth momentum may not be sustainable due to potential generic competition.",
      "llm_answer": "Biktarvy revenue increased 14% to $11.85 billion in 2023, up from $10.39 billion in 2022, reflecting higher demand and favorable pricing dynamics. This growth occurs amid a patent‑expiration timeline that will see key HIV products such as Descovy (2031), Vemlidy (2031), Complera/Eviplera (2025) and Stribild (2029) lose exclusivity between 2025 and 2034, while Biktarvy’s own composition‑of‑matter patent is not set to expire until 2033 (U.S.) and 2033 (EU). Consequently, the company’s long‑term financial strategy must rely on expanding its oncology and cell‑therapy portfolio, leveraging new product launches and strategic collaborations to offset the anticipated revenue decline from patent cliffs in its legacy HIV franchise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Biktarvy's 2023 revenue as $11.85 billion and 2022 revenue as $10.39 billion, matching the ground truth of $11,850 million and $10,390 million. The 14% growth rate is accurately calculated: (11,850 - 10,390) / 10,390 ≈ 14%. All numeric values and percentages are correct, with acceptable format variation (billion vs million). (2) The answer addresses both parts of the question: revenue performance (growth from 2022 to 2023) and implications for long-term financial strategy given patent timelines. It correctly identifies Biktarvy’s U.S. and EU composition-of-matter patent expiration in 2033, which aligns with typical SEC filing disclosures. While the ground truth does not specify exact expiration dates for other products (e.g., Descovy in 2031), these are plausible and consistent with public knowledge, and their inclusion adds context without contradicting the original. (3) Multi-hop reasoning is sound: the model connects revenue growth to patent expiration risks and infers strategic implications—such as diversification into oncology and cell therapy—despite this not being explicitly stated in the ground truth. This demonstrates strong synthesis. (4) The only minor shortcoming is that the original answer emphasizes the need for patent extension or follow-on therapies specifically for Biktarvy, while the LLM broadens the strategy to portfolio diversification. This is a valid interpretation but slightly shifts focus from Biktarvy-specific actions to broader corporate strategy. Still, it is logically consistent and contextually appropriate. Overall, the answer is factually accurate, comprehensive, and semantically equivalent to the ground truth with excellent reasoning and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 478,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "Given Gilead's single operating segment structure and centralized resource allocation, how might the impending U.S. patent expiration of Truvada in 2023 affect the company's ability to invest in lifecycle management initiatives for its HIV portfolio?",
      "original_answer": "Gilead's single operating segment structure enables centralized resource allocation across its HIV portfolio, including Truvada, which is a key part of its HIV prevention and treatment offerings. However, with Truvada's U.S. patent expiration in 2023, the loss of exclusivity could significantly reduce revenue from this product due to generic competition. This revenue decline may constrain the company's ability to invest in lifecycle management initiatives, such as developing next-generation formulations or combination therapies within the HIV portfolio, unless offset by cost reallocations or revenue from newer products.",
      "llm_answer": "Gilead’s single operating segment and centralized resource allocation means its HIV portfolio investments are tightly managed, but the 2023 U.S. patent expiration of Truvada removes a key revenue source that previously funded lifecycle management initiatives; consequently, the company may need to reallocate resources from its HIV segment to other therapeutic areas or rely more heavily on external collaborations and acquisitions to sustain its HIV portfolio’s long‑term development and commercialization efforts.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Gilead's single operating segment and centralized resource allocation, as well as the 2023 U.S. patent expiration of Truvada, which aligns with the ground truth. The impact on revenue and investment in lifecycle management is partially accurate, but the LLM introduces a claim not present in the original answer—that Gilead may reallocate resources to other therapeutic areas or rely more on external collaborations and acquisitions. This shifts the focus away from internal reallocation or newer product revenues as potential offsets, which were the only mitigating factors mentioned in the ground truth. (2) Quantitatively, the date '2023' is correct and no other numbers (e.g., revenue figures, percentages) are mentioned in either answer, so there is no inaccuracy. Format and temporal references are consistent and accurate. (3) The multi-hop reasoning is sound in linking patent expiration to revenue loss and then to constrained investment, but the conclusion about reallocating to other therapeutic areas or increased reliance on external development is an unsupported inference not grounded in the original answer. The original emphasizes potential internal cost reallocations or newer product revenues as countermeasures, not a strategic pivot outside the HIV portfolio. (4) The correctness score is 7 because core facts and causal logic are preserved, but there is a meaningful deviation in the proposed strategic response. Quantitative accuracy is 10 as all dates are correct. Qualitative accuracy is 7 due to correct entity and structural understanding but a partial misrepresentation of the strategic implications. Contextual relevance is 9—response is highly relevant and addresses the question’s core, with only minor drift in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 488,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the 2023 IDA Agreement impact Schwab's capital management strategy and contract asset amortization in 2023, and what was the specific dollar amount of amortization associated with this agreement?",
      "original_answer": "The 2023 IDA Agreement allowed Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which supported its capital management strategy by reducing balance sheet pressure and enabling future migration of IDA balances as capital levels permit. Additionally, the agreement resulted in contract assets related to the buy-down of fixed-rate obligations, which were amortized over the contractual term as a reduction to bank deposit account fee revenue. The specific dollar amount of amortization associated with this agreement in 2023 was included in the broader amortization of capitalized contract costs, which totaled $85 million for the year ended December 31, 2023.",
      "llm_answer": "The 2023 IDA Agreement required Schwab to sweep certain brokerage client deposits off-balance sheet to TD Depository Institutions, which directly impacted its capital management strategy by necessitating sufficient capital levels to support the migration of these IDA balances back onto the balance sheet in future periods. Schwab's capital management strategy explicitly includes supporting this migration as a key component, contingent on maintaining adequate capital. The specific dollar amount of amortization associated with the 2023 IDA Agreement was $85 million, as disclosed in the capitalized contract costs amortization expense noted on page 96, which relates to the contract assets amortized over the remaining contractual term as a reduction to bank deposit account fee revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $85 million amortization amount, which matches the ground truth and is accurately tied to the capitalized contract costs amortization for 2023. This satisfies the quantitative requirement. However, the LLM mischaracterizes the impact of the 2023 IDA Agreement on capital management: the original answer states the agreement *supported* capital management by *reducing* balance sheet pressure and enabling future migration of IDA balances as capital allows, whereas the LLM claims Schwab was *required* to sweep deposits and must maintain sufficient capital to migrate them *back*, implying an onerous obligation rather than a strategic benefit. This reverses the logic and intent described in the ground truth. (2) The dollar amount ($85 million) is correct and properly attributed to the amortization of capitalized contract costs related to the IDA agreement, with a plausible reference to page 96 (format consistent with 10-K disclosures), supporting quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model connects the IDA Agreement to contract asset amortization and correctly links it to revenue reduction in bank deposit fees—but fails in accurately synthesizing the directional impact on capital strategy. The original answer emphasizes off-balance sheet relief as a capital *benefit*, while the LLM frames it as a future capital *requirement*, indicating flawed reasoning in one key causal relationship. (4) Despite the significant qualitative error in describing the capital management impact, the answer includes the correct dollar figure and correctly identifies the amortization treatment and revenue impact, warranting a score of 7 for correctness. Quantitative accuracy is high (9) due to correct numbers and context. Qualitative accuracy is reduced (7) due to the misrepresentation of strategic intent. Contextual relevance is perfect (10) as all content directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 532,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How do the changes in LTIP units and other unit issuances during 2023 affect the total equity of SPG as reported in its 2023 10-K filing?",
      "original_answer": "The changes in LTIP units and other unit issuances contributed to a net increase in total equity. Specifically, the issuance of limited partner units added $197,426 to equity, while the long-term incentive performance units added $14,739. These increases were partially offset by the redemption of limited partner units, which reduced equity by $13,524 and treasury unit purchases that reduced equity by $140,593. Overall, these transactions resulted in a net reduction of $139,378 in equity from unit-related activities.",
      "llm_answer": "The 2023 changes to LTIP units and other unit issuances—including the issuance of 1,725,000 limited‑partner units tied to the TRG acquisition, the amortization of stock‑incentive awards, and the redemption of limited‑partner units—resulted in a net decrease of $13,524 thousand in limited‑partner units and a corresponding reduction in total equity reflected in the consolidated statements of equity. This reduction contributed to the decline in Simon Property Group’s total equity from $3,611,652 thousand at December 31 2022 to $3,491,649 thousand at December 31 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the net effect of unit-related activities was a reduction of $139,378 in equity, but the LLM claims a net decrease of only $13,524 thousand ($13,524,000), which is both numerically and conceptually wrong—it incorrectly equates the redemption of limited partner units (one component) with the total net impact. The correct components are: +$197,426 from issuance of limited partner units, +$14,739 from LTIP units, -$13,524 from redemptions, and -$140,593 from treasury unit purchases. The LLM omits the LTIP and treasury purchase impacts entirely and misrepresents the net effect. (2) The LLM incorrectly states the net decrease in limited partner units as $13,524 thousand, which conflates a single outflow item with the total net change. It also fails to mention the $140,593 reduction from treasury unit purchases, a major component. The total equity decline cited ($3,611,652k to $3,491,649k) is a real drop of $120,003k, but the LLM attributes this entire drop to unit transactions, which is unsupported—the unit-related net reduction was $139,378k, but other factors also affect total equity. (3) The reasoning is flawed: it fails to synthesize all four components required for the correct multi-hop calculation. It focuses narrowly on redemptions and ignores key inflows (LTIP, unit issuances) and outflows (treasury purchases). (4) While the LLM correctly identifies relevant categories (LTIP, limited partner units, redemptions), it misrepresents their magnitudes and net effect. Contextually, it addresses the right topic and company (SPG, 2023 10-K), so relevance is high, but factual and quantitative accuracy are severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 476,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does Linde's distribution of Process Gases through on-site plants influence its long-term contract structure and revenue recognition policy, based on the specific distribution and accounting practices described in the 2024 10-K filing?",
      "original_answer": "Linde's distribution of Process Gases through on-site plants leads to long-term contracts (typically 10–20 years) with minimum purchase requirements and price escalation provisions. These contracts are structured as total requirement agreements, where revenue is recognized over time as product is delivered and the company has the right to invoice. This method of revenue recognition aligns with the continuous delivery of gases through pipelines and ensures that revenue reflects the ongoing supply of Process Gases to large-volume customers.",
      "llm_answer": "Linde’s long‑term on‑site supply contracts—typically 10‑20 year agreements that include minimum purchase requirements and price‑escalation provisions—drive its contract structure by obligating customers to purchase their full gas requirements from Linde and providing a stable revenue base. Because revenue from these contracts is tied to minimum purchase volumes and variable price escalators, Linde recognizes the associated revenue over the contract term using the cost‑incurred input method, and the related performance obligations are satisfied as product is delivered and the right to invoice is met, which aligns with its revenue‑recognition policy under ASC 606.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key facts are accurate: Linde's on-site gas contracts last 10–20 years, include minimum purchase requirements and price escalation provisions, and are structured as total requirement agreements. These details match the original answer exactly. (2) The revenue recognition method is described as being over time as product is delivered, with the right to invoice—this is consistent with ASC 606 and the ground truth. However, there is a minor inaccuracy in specifying the 'cost-incurred input method' as the revenue recognition approach. The original answer does not mention this specific method; instead, it emphasizes that revenue is recognized over time as product is delivered and the company has the right to invoice, which typically implies an output method (e.g., units delivered), not an input method like cost incurred. This introduces a subtle but notable deviation in accounting methodology. (3) The multi-hop reasoning is sound—linking on-site distribution to long-term contracts, then to revenue recognition policy under ASC 606. The synthesis across business model and accounting policy is appropriate. (4) Contextual relevance is excellent; the response directly addresses how distribution via on-site plants influences contract structure and revenue recognition. The only deduction is for the unsupported claim about the cost-incurred input method, which is not in the ground truth and could misrepresent the accounting policy. Overall, core facts and reasoning are correct, but the added detail on input method reduces qualitative accuracy slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 452,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What is the difference in the fair value of corporate notes and obligations between the two disclosed tables, and how does this difference compare to the overall change in total marketable securities' fair value across the same disclosures?",
      "original_answer": "The fair value of corporate notes and obligations decreased from $3,354 million to $2,978 million, a difference of $376 million. The total marketable securities' fair value decreased from $5,492 million to $5,722 million, representing an overall increase of $230 million. Therefore, while corporate notes and obligations saw a significant decline, the overall portfolio of marketable securities increased in value.",
      "llm_answer": "The fair value of corporate notes and obligations decreased by $376 million from $3,354 million at January 31 2023 to $2,978 million at January 31 2024. This $376 million decline is smaller than the overall $230 million increase in the total marketable securities fair value ($5,492 million to $5,722 million), meaning the corporate notes and obligations component fell while the aggregate marketable securities rose.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the decrease in fair value of corporate notes and obligations from $3,354 million to $2,978 million, accurately calculating the $376 million decline. It also correctly reports the total marketable securities' fair value change from $5,492 million to $5,722 million, which is indeed a $230 million increase. These numbers and calculations are factually correct. (2) However, the LLM makes a critical error in the comparison: it states that the $376 million decline is 'smaller than' the $230 million increase, which is false—$376 million is larger than $230 million. This mischaracterization undermines the logical reasoning. The correct interpretation, as in the ground truth, is that despite the significant drop in corporate notes, the overall portfolio increased, implying other components offset the decline. (3) The multi-hop reasoning is partially sound—information is synthesized across the two tables correctly in terms of values and entities—but the flawed comparison indicates a failure in logical synthesis. (4) Quantitative accuracy is high (9) due to correct numbers and calculations. Qualitative accuracy is reduced (7) due to the incorrect comparative statement. Contextual relevance is perfect (10) as all relevant data points are addressed. Correctness score is 7 because core facts are right but the conclusion contains a significant reasoning error.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 392,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the impact of changing provider behavior, as described in the Health Care Benefits segment, affect the accuracy of CVS's premium pricing forecasts and ultimately its operating results, given the fixed premium period and the sensitivity of profits to forecast accuracy?",
      "original_answer": "Changing provider behavior, such as hospitals and providers attempting to maintain revenue levels during economic downturns, increases CVS's medical costs and limits its ability to accurately forecast and price for medical cost trends. This is especially problematic because premiums for Insured Health Care Benefits products, which make up 94% of Health Care Benefits segment revenues, are set in advance based on forecasts and cannot be adjusted during the fixed premium period. Even small differences between predicted and actual costs can significantly affect operating results, as profits are highly sensitive to forecast accuracy. Therefore, unpredictable provider behavior amplifies the risk of adverse financial outcomes for CVS.",
      "llm_answer": "The Health Care Benefits segment prices premiums in advance for a fixed 12‑month period based on forecasts of health‑care cost trends; if actual costs exceed those forecasts, the company cannot recover the excess during the fixed premium term, making profit margins highly sensitive to forecast accuracy. Consequently, any mis‑estimation of medical cost trends—whether due to pandemic volatility, shifts in utilization, or regulatory changes—directly depresses operating results and can erode profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the fixed premium period (12-month), the advance pricing based on forecasts, and the high sensitivity of profits to forecast accuracy. It correctly identifies that if actual medical costs exceed forecasts, CVS cannot adjust premiums during the fixed term, which directly impacts operating results—this aligns with the ground truth. Quantitatively, there are no specific numbers (e.g., 94%) mentioned in the LLM answer, but it does not introduce any incorrect figures, so quantitative accuracy is high. However, the LLM omits a key element from the original answer: the specific role of *changing provider behavior* (e.g., providers maintaining revenue in downturns) as a driver of increased medical costs and forecast inaccuracy. While the LLM mentions 'shifts in utilization' and 'pandemic volatility' as sources of misestimation, it fails to explicitly connect provider behavior to the forecasting challenge, which is central to the question. This omission reduces completeness and weakens the multi-hop reasoning link between provider actions and financial outcomes. The reasoning that forecast errors harm profitability is sound, but the causal chain is less precise than the ground truth. Despite this, the answer remains contextually relevant and conveys a largely accurate mechanism of risk. Semantic equivalence is partially achieved, but the absence of the 94% revenue figure and the specific provider behavior linkage prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 414,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does Chevron's acquisition of Noble in October 2020, which added 6,000 cubic feet of natural gas per barrel of crude oil in production capacity, support its ability to maintain high-quality debt ratings of AA- (S&P) and Aa2 (Moody's) during periods of low commodity prices?",
      "original_answer": "Chevron's acquisition of Noble added production capacity measured in oil-equivalent barrels, where 6,000 cubic feet of natural gas equals 1 barrel of crude oil. This expanded production base increases cash flow potential from upstream operations. Chevron stated that during periods of low crude oil and natural gas prices, it can adjust its capital spending and reduce stock repurchases to preserve financial flexibility. Given that Chevron's debt is rated AA- by S&P and Aa2 by Moody’s—indicating strong creditworthiness—the additional production from Noble enhances Chevron’s ability to generate cash and maintain its investment-grade credit profile, even in challenging market conditions.",
      "llm_answer": "Chevron's 2020 acquisition of Noble Energy added roughly 6,000 cubic feet of natural‑gas production per barrel of crude‑oil equivalent, boosting its upstream output and cash flow. This added production capacity helped the company maintain strong operating cash generation even during low‑price periods, giving it the financial flexibility to meet debt‑service obligations and preserve its AA‑ (S&P) and Aa2 (Moody’s) high‑quality debt ratings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth. (1) Quantitatively, all numbers and dates are correct: the October 2020 acquisition of Noble Energy is accurately referenced, and the 6,000 cubic feet of natural gas per barrel of crude oil equivalent is correctly stated (with appropriate unit clarification as oil-equivalent in the ground truth). There are no calculation errors. (2) The LLM correctly identifies Chevron and Noble, the timing of the acquisition, and the relevant credit ratings (AA- by S&P and Aa2 by Moody’s), satisfying entity accuracy. (3) The reasoning is sound: it links the acquisition to increased upstream production and cash flow, which supports financial flexibility during low commodity prices, thereby helping maintain high credit ratings. This captures the multi-hop logic (acquisition → increased production → stronger cash flow → ability to maintain debt ratings). (4) While the LLM omits the specific detail about Chevron’s ability to reduce capital spending and stock repurchases (a minor point in the original), it still correctly identifies the outcome—preserving financial flexibility and debt-service capacity. This omission does not undermine the central argument. The answer is semantically equivalent in intent and factual content, with only slight reduction in completeness. Hence, a high score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 385,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How much did Schwab spend to buy down fixed-rate obligation amounts under the 2023 IDA agreement, and how is this amount classified on the consolidated balance sheet?",
      "original_answer": "Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligation amounts under the 2023 IDA agreement. This amount was capitalized as contract assets and included in other assets on the consolidated balance sheet.",
      "llm_answer": "Schwab spent $249 million in market‑based fees to buy down $5.0 billion of fixed‑rate obligation amounts under the 2023 IDA agreement, and this amount is recorded as a contract asset (capitalized fee) in “Other assets” on the consolidated balance sheet.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Schwab spent $249 million to buy down $5.0 billion of fixed-rate obligations under the 2023 IDA agreement, matching the ground truth exactly in both amounts. The inclusion of 'market-based fees' adds context not contradicted by the original answer. (2) All numeric values are accurate: $249 million and $5.0 billion are correctly reported with acceptable formatting (e.g., thin spaces). No calculations are required beyond these figures, and they align precisely with the ground truth. (3) The classification of the $249 million as a contract asset recorded in 'Other assets' on the consolidated balance sheet reflects the correct accounting treatment and matches the original answer’s description of being 'capitalized as contract assets and included in other assets.' The phrase 'capitalized fee' in parentheses adds clarifying detail without altering meaning. (4) The answer fully addresses both parts of the question—amount spent and balance sheet classification—with complete factual accuracy, proper entity identification (Schwab, 2023 IDA agreement), and correct multi-hop synthesis of financial transaction and accounting treatment. All scores are maximized due to full semantic equivalence and factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 358,
        "total_tokens": 1482
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How much in store impairment charges did CVS record in 2024 as part of its enterprise-wide restructuring plan, and how does this compare to the expected cost savings projected for 2025 from that same initiative?",
      "original_answer": "CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. The company projected that this restructuring would generate over $500 million in cost savings for 2025. Therefore, the impairment charges represent a near-term financial cost that is expected to be offset by anticipated longer-term savings in the following year.",
      "llm_answer": "CVS recorded $30 million of office‑real‑estate optimization (restructuring) charges in 2024, and the company expects its enterprise‑wide restructuring plan to generate more than $500 million of cost savings beginning in 2025.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that CVS recorded $483 million in store impairment charges in 2024 as part of its enterprise-wide restructuring plan. However, the LLM incorrectly reports $30 million in 'office-real-estate optimization (restructuring) charges,' which is both the wrong amount and the wrong type of charge (office real estate vs. store impairments). The second part of the answer — that the restructuring is expected to generate more than $500 million in cost savings beginning in 2025 — is factually correct and matches the original answer. (2) Quantitative accuracy is low: $30 million is vastly different from $483 million, and while the $500 million savings figure is correct, the key charge amount is wrong. (3) The multi-hop reasoning is partially sound — the model attempts to connect 2024 charges with 2025 savings — but fails at the first hop by citing the wrong charge category and amount. It does not correctly synthesize the specific store impairment charges with the future savings, undermining the comparison. (4) Contextual relevance is fair because the answer addresses restructuring charges and future savings in the correct years and for the correct company, but the incorrect charge amount and nature severely limit factual correctness. Thus, the overall correctness score is low due to a major error in a core fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 392,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What was Chevron's equity in earnings from Angola LNG Limited in 2021, and what does this indicate about Chevron's involvement in the liquefied natural gas market in Angola?",
      "original_answer": "Chevron's equity in earnings from Angola LNG Limited was -$166 million in 2021, indicating that Chevron's 36.4% stake in the venture resulted in a loss that year, reflecting potential challenges in the liquefaction and processing of natural gas for international markets.",
      "llm_answer": "Chevron's equity in earnings from Angola LNG Limited in 2021 was $(166) million, reflecting a loss on its 36.4% stake. This negative equity result indicates Chevron's involvement in the liquefied natural gas market in Angola is currently unprofitable, contrasting with its more successful upstream investments like Tengizchevroil (which generated $1,238 million in equity earnings in 2021). The loss underscores the financial challenges associated with Chevron's LNG project in Angola, despite its significant equity stake.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Chevron's equity in earnings from Angola LNG Limited as $(166) million in 2021 and accurately notes the 36.4% stake, matching the ground truth. The negative value is correctly interpreted as a loss. (2) All numeric values—$166 million loss, 36.4% stake, and the comparison to Tengizchevroil’s $1,238 million earnings—are factually accurate and consistent with the knowledge graph. Format variations like $(166) million are acceptable and standard in financial reporting. (3) The multi-hop reasoning is sound: the model synthesizes Chevron’s financial performance across two different joint ventures (Angola LNG Limited and Tengizchevroil), correctly contrasting their profitability. It infers that the loss in Angola indicates challenges in the LNG market there, which aligns with the ground truth’s implication of 'potential challenges in liquefaction and processing.' (4) The only minor shortcoming is that the LLM adds a comparative element (Tengizchevroil) not present in the original answer, which, while accurate and insightful, slightly extends beyond the scope of the question. However, this does not detract from correctness and may enhance context. All core facts are correct, calculations are accurate, and the reasoning is logically sound, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 369,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "What operational risks does NextEra Energy Resources face given the mismatch between the Duane Arnold decommissioning timeline (expected completion by 2080) and the expiration dates of its nuclear fuel supply contracts (through 2033)?",
      "original_answer": "NextEra Energy Resources faces the risk of managing nuclear fuel supply beyond the expiration of existing contracts in 2033 while maintaining safe and compliant decommissioning operations at Duane Arnold, which is expected to continue through 2080. This creates a planning challenge as NEER must secure alternative fuel sources or storage solutions for the spent nuclear fuel onsite, which remains in long-term dry storage until the DOE can take possession. The gap between the expiration of fuel supply contracts and the long-term decommissioning obligations could lead to increased operational costs, regulatory scrutiny, or the need for additional capital expenditures to maintain safe storage.",
      "llm_answer": "NextEra Energy Resources faces operational risk from the mismatch between the Duane Arnold nuclear plant’s decommissioning schedule (expected completion around 2080) and the expiration of its nuclear fuel supply contracts in 2033. Because the fuel contracts end well before the plant is slated for full decommissioning, NEER must secure new fuel supply or arrange for early shutdown, and any delay or inability to obtain replacement fuel could force an earlier-than‑planned closure, increase decommissioning costs, and create regulatory or financial exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key dates (decommissioning completion by 2080 and fuel contract expiration in 2033) and the core operational risk stemming from the mismatch, satisfying quantitative accuracy. The entity identification (NextEra Energy Resources, Duane Arnold) is correct, and the timeline alignment is properly interpreted. However, the LLM mischaracterizes the nature of the fuel supply risk: the original answer clarifies that after 2033, the issue is not about securing new fuel for continued operation (the plant ceased operations in 2020), but rather managing long-term storage of spent nuclear fuel onsite until DOE retrieval, which creates regulatory and cost risks during the decades-long decommissioning process. The LLM incorrectly suggests NEER may need to secure new fuel supply or face early shutdown, which is factually inaccurate since the plant is already shut down and will not require additional fuel. This reflects a flaw in multi-hop reasoning—synthesizing operational status, decommissioning timelines, and fuel contract implications—leading to an incorrect causal chain. While the answer captures the high-level planning challenge and mentions increased costs and regulatory exposure, it misses the spent fuel storage focus and misrepresents the operational context. Thus, while semantically related and contextually relevant, it contains a significant qualitative inaccuracy that affects the correctness of the risk description.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 404,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does Linde's involvement in the Amur GPP project, including contingent liabilities and contract suspensions, contrast with its revenue recognition policies for on-site industrial gas contracts, and what does this reveal about the financial risk exposure in long-term on-site agreements?",
      "original_answer": "Linde faces a contingent liability of $0.7 billion related to the Amur GPP project, stemming from fires and subsequent legal claims in Russia, and had its contracts suspended due to sanctions. This highlights the financial risk in long-term engineering projects, especially those involving international legal exposure. In contrast, Linde's on-site industrial gas contracts, which often span 10–20 years and include minimum purchase requirements, recognize revenue over time as product is delivered, based on the right to invoice. These contracts are generally more stable and predictable, with revenue tied to ongoing delivery rather than one-time project completion. However, the Amur GPP case shows that long-term on-site or project-based involvement can lead to significant unforeseen liabilities, even if the company is not directly responsible for construction flaws. This contrast reveals that while on-site contracts provide steady revenue, they also carry latent risks when tied to large infrastructure projects with multiple stakeholders and geopolitical exposure.",
      "llm_answer": "Linde’s on‑site industrial‑gas contracts are recognized over time with revenue recorded as product is delivered and the company has the right to invoice, while the Amur GPP project involves contingent liabilities and suspended contracts that are not yet settled. This contrast shows that long‑term on‑site agreements generate relatively predictable revenue streams, but the company must also contend with significant, unresolved financial exposure from engineering and construction projects subject to sanctions and litigation. Consequently, the financial risk in such agreements is heightened by the potential for large contingent liabilities and the uncertainty of contract termination or enforcement outcomes.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core contrast between Linde's revenue recognition for on-site industrial gas contracts and the contingent liabilities from the Amur GPP project. It accurately states that revenue is recognized over time as product is delivered with the right to invoice, which aligns with the ground truth. It also correctly identifies that the Amur GPP project involves contingent liabilities and suspended contracts due to sanctions and litigation. However, the LLM omits the specific $0.7 billion contingent liability figure, which is a key quantitative detail present in the original answer. This omission reduces completeness but does not distort the overall meaning. (2) Quantitative accuracy is high: while the $0.7 billion figure is missing, no incorrect numbers are stated, and there are no calculation errors. The LLM avoids fabricating figures, which supports a high score in this category. (3) The multi-hop reasoning is sound—linking revenue recognition policies to risk exposure in long-term agreements, and contrasting stable on-site contracts with volatile project-based risks. The synthesis between operational models and financial risk is logically presented, though the absence of the $0.7B weakens the evidentiary support. (4) Contextual relevance is excellent—the response directly addresses all aspects of the question: revenue recognition, contingent liabilities, contract suspensions, and financial risk implications. The conclusion about heightened risk due to contingent liabilities and enforcement uncertainty matches the ground truth’s intent. The omission of the exact liability amount prevents a top score in correctness and qualitative accuracy, but the reasoning and framing remain substantially accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 482,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the expected increase in TAC paid to Google Network partners, driven by shifts in device and geographic mix, directly impact the gross advertising revenue recognition model described in the consolidated financial statements?",
      "original_answer": "The increase in TAC paid to Google Network partners, driven by changes in device mix, geographic mix, and partner mix, directly affects the gross advertising revenue recognition model by increasing the cost of revenues associated with ads placed on Google Network properties. Since Google reports advertising revenues from these properties on a gross basis—recording the full amount billed to customers as revenue and the amounts paid to partners as cost of revenues—an increase in TAC results in higher cost of revenues. This dynamic puts downward pressure on gross margins, even as total advertising revenues may grow. For example, the financial statements note that Google recognizes revenues for ads on Google Network properties on a gross basis, with partner payments recorded as cost of revenues, while the MD&A section indicates that TAC is expected to rise with revenue growth and will vary based on multiple factors, including partner agreement terms and geographic mix.",
      "llm_answer": "The expected rise in traffic acquisition costs (TAC) paid to Google Network partners—driven by shifts in device mix and geographic mix—directly reduces the net amount of advertising revenue that Alphabet can recognize under its gross revenue model. Because advertising revenue is recorded on a gross basis (i.e., total billed amounts are recognized as revenue, with TAC and other partner payments recorded as cost of revenues), higher TAC expenses lower the gross margin on advertising revenues even though total advertising revenue remains unchanged. This dynamic is reflected in the consolidated statements of operations and the discussion of revenue mix in the MD&A, where the company notes that changes in device and geographic composition affect both revenue growth and the TAC rate, thereby pressuring advertising margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies that TAC increases—driven by shifts in device and geographic mix—impact the gross advertising revenue model by increasing cost of revenues, not by reducing revenue directly, which is consistent with Google's gross reporting model. The explanation that higher TAC lowers gross margin while total revenue remains unchanged is factually correct and matches the ground truth. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not compromised; all references to financial reporting concepts (gross revenue recognition, cost of revenues, gross margin) are used correctly. (3) The multi-hop reasoning is sound: the model connects TAC drivers (device/geographic mix) to accounting treatment (gross revenue recognition) and then to financial statement impact (higher costs, lower margins), synthesizing concepts from revenue recognition policy and MD&A disclosures. (4) The only minor shortcoming is that the LLM omits mention of 'partner mix' as a driver of TAC (included in the original answer), and slightly mischaracterizes the effect as 'reducing the net amount of advertising revenue that Alphabet can recognize,' which could be misinterpreted as affecting revenue recognition—whereas in reality, revenue is still recognized gross, and only costs increase. This is a subtle but important distinction in accounting terms. Despite this, the overall meaning remains semantically equivalent and contextually appropriate. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 468,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How much of Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is influenced by compliance with the Coal Ash Act, given that closure methods must align with state and federal regulations and the ultimate method and timetable will affect the recorded ARO amount?",
      "original_answer": "Duke Energy’s asset retirement obligation (ARO) for coal ash impoundment closure is directly influenced by compliance with the Coal Ash Act, as the ARO amount recorded on the Consolidated Balance Sheets is based on estimated closure costs for impacted ash impoundments under this regulation. The closure methods—such as excavation and relocation of ash to a lined landfill or beneficial reuse—must align with standards set by the Coal Ash Act and other federal regulations, and the ultimate method and timetable for closure will determine the actual costs incurred, which may result in a material change to the ARO balance.",
      "llm_answer": "The ARO for coal‑ash impoundment closure is calculated based on estimated closure costs that must comply with both state (e.g., North Carolina’s Coal Ash Act) and federal (EPA CCR rule) regulations, and the ultimate method and schedule of closure directly affect the recorded ARO amount. The ARO table shows $5,293 million recorded for “Closure of ash impoundments” across Duke Energy’s subsidiaries, reflecting the impact of these regulatory‑driven closure plans on the liability.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Duke Energy's ARO for coal ash impoundment closure is driven by compliance with state (Coal Ash Act) and federal regulations (EPA CCR rule), and that the closure method and timetable directly affect the recorded ARO amount—this aligns with the ground truth and shows sound qualitative reasoning and contextual relevance. The answer appropriately references the regulatory framework and the cause-effect relationship between closure plans and ARO. However, the quantitative claim of $5,293 million for 'Closure of ash impoundments' is not present in the original answer (ground truth), which does not provide a specific dollar amount. Since the ground truth does not include this figure, introducing it—without source confirmation—constitutes a factual overreach, even if the number might exist in actual filings. This undermines quantitative accuracy. The original answer emphasizes that the ARO is *influenced by* regulatory requirements and that future changes in method/timing may materially affect the liability, which the LLM captures conceptually. While the LLM adds detail (e.g., specific closure methods like excavation and reuse), it omits explicit mention that the recorded ARO is based on *estimated* costs under the Coal Ash Act, slightly reducing completeness. Overall, the core facts and logic are correct, but the inclusion of an unverified specific dollar amount reduces the correctness and quantitative accuracy scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 405,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables in the 2023 10-K filing for CRM?",
      "original_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two tables is a decrease of $58 million, calculated by subtracting the fair value of $178 million in the second table from the fair value of $236 million in the first table.",
      "llm_answer": "The total change in the fair value of Mortgage-Backed Obligations between the two disclosed tables is $58 million, increasing from $178 million as of January 31 2023 to $236 million as of January 31 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets the magnitude of the change correct ($58 million), which matches the ground truth calculation. However, it incorrectly states that the fair value increased from $178 million to $236 million, when in fact it decreased from $236 million to $178 million. This reverses the direction of the change and misrepresents the financial trend. (2) The numbers $178 million and $236 million are present in the correct context (fair values in the two tables), and their difference ($58 million) is numerically accurate. However, the assignment of time periods is reversed: the LLM claims $178M is as of January 31, 2023 and $236M as of January 31, 2024, which contradicts the ground truth that shows $236M earlier and $178M later, indicating a decrease. (3) The multi-hop reasoning fails because the model incorrectly synthesizes the temporal sequence and direction of change. It should have identified that the first table reports $236M and the second $178M, implying a decline. Instead, it assumes the second table is later in time without verifying the dates or order, leading to flawed logic. (4) While the core number ($58M change) is correct and the entities (Mortgage-Backed Obligations, CRM, 2023 10-K) are relevant, the reversal of direction significantly undermines factual correctness. Hence, low scores for correctness and qualitative accuracy despite partial quantitative match. Contextual relevance is high as the answer addresses the right topic and document.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1112,
        "completion_tokens": 412,
        "total_tokens": 1524
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What percentage of Danaher's Diagnostics segment sales in 2023 were attributed to 'other developed markets', and which specific geographic regions does the company classify under this category?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to 'other developed markets'. According to the company's definitions, this category includes the regions of Japan, Australia, and New Zealand.",
      "llm_answer": "Based on the provided document pages, Danaher's Diagnostics segment sales in 2023 attributed to \"other developed markets\" were 5% of total segment sales. The company specifically classifies \"other developed markets\" as Japan, Australia, and New Zealand, as stated in the document's definition of geographic regions. This 5% figure is directly reported in the Diagnostics segment's geographic revenue breakdown on page 79 of the 10-K filing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) The percentage of Danaher's Diagnostics segment sales attributed to 'other developed markets' in 2023 is accurately reported as 5%, which aligns with the original answer. (2) The specific geographic regions—Japan, Australia, and New Zealand—are correctly identified without omissions or errors. (3) The reasoning is sound, with proper synthesis of information from the 10-K filing (specifically page 79), demonstrating accurate multi-hop capability by linking the segment, year, metric, and geographic classification. (4) The answer is contextually precise, directly addressing both parts of the question with factual correctness and appropriate sourcing. Minor wording differences (e.g., 'attributed to' vs. 'attributed to') do not affect semantic equivalence. All scores are maximized due to complete factual accuracy, correct entity and year identification, and clear, logical presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 276,
        "total_tokens": 1449
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What was the total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad, given the carload volume and average revenue per car for that category?",
      "original_answer": "The total revenue contribution from Bulk shipments in 2021 for Union Pacific Railroad was $6,656,270,000, calculated by multiplying the 2021 Bulk carloads (1,920,000) by the average revenue per car in 2021 ($3,467).",
      "llm_answer": "The total revenue contribution from Bulk shipments in 2021 was $6,656 million, derived from 2,014 thousand bulk carloads, which yields an average revenue per bulk carload of $3,305.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in key numerical inputs and calculations. The ground truth states 1,920,000 carloads and $3,467 average revenue per car, yielding $6,656,270,000. The LLM reports 2,014 thousand (i.e., 2,014,000) carloads and implies an average revenue of $3,305, resulting in $6,656 million (~$6.656 billion), which is numerically close but based on incorrect inputs. (2) The total revenue figure is approximately correct in magnitude ($6,656 million ≈ $6.656 billion vs. $6.65627 billion), but the carload volume (2,014,000 vs. 1,920,000) and average revenue per car ($3,305 vs. $3,467) are both wrong. The calculation in the LLM answer is internally consistent (2,014,000 × $3,305 ≈ $6.656 billion), but the inputs are inaccurate. (3) The multi-hop reasoning is structurally sound—revenue = volume × unit revenue—but the model used incorrect source data for carloads and average revenue, likely from a different year or company. It failed to correctly retrieve and synthesize the specific 2021 Union Pacific Bulk shipment data. (4) The contextual relevance is high as the answer addresses the right metric and structure, but quantitative accuracy is low due to incorrect core data. Correctness score is low because financial inputs and calculations, while close in final output, are factually wrong in components required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1104,
        "completion_tokens": 382,
        "total_tokens": 1487
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "What is the total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina after the settlement agreement with NCDEQ, and how does this reflect a reduction from Duke Energy's initial estimate following the April 1, 2019 closure determination?",
      "original_answer": "The total estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina is approximately $8 billion to $9 billion after the settlement agreement with NCDEQ. This represents a reduction of approximately $1.5 billion from Duke Energy's initial estimate of $9.5 billion to $10.5 billion that followed the April 1, 2019 closure determination requiring excavation of the nine remaining impoundments.",
      "llm_answer": "The settlement agreement with NCDEQ reduced Duke Energy’s estimated undiscounted cost to permanently close all coal ash basins in North Carolina and South Carolina from an initial range of $9.5 billion‑$10.5 billion to approximately $8 billion‑$9 billion. This reflects a reduction of about $1.5 billion from the company’s original estimate after the April 1, 2019 closure determination.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: the post-settlement cost range ($8 billion to $9 billion), the initial estimate range ($9.5 billion to $10.5 billion), and the $1.5 billion reduction are all correct. (2) Quantitative accuracy is perfect: the numbers match exactly, including the magnitude and ranges, and the implied calculation (midpoint difference or range shift of ~$1.5 billion) is sound. Minor formatting with en-dashes instead of hyphens does not affect meaning. (3) Multi-hop reasoning is correctly synthesized: the answer links the April 1, 2019 closure determination to the initial estimate, connects the NCDEQ settlement to the revised estimate, and correctly infers the reduction. (4) Entities (Duke Energy, NCDEQ, coal ash basins, North Carolina and South Carolina) are correctly identified and contextualized. The answer is concise, relevant, and captures all elements of the original answer without omissions or distortions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 294,
        "total_tokens": 1536
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "What was the total cash consideration paid by Mastercard for both Dynamic Yield LTD in 2022 and Recorded Future in 2024, and how does this spending reflect the company's acquisition strategy?",
      "original_answer": "Mastercard paid a total cash consideration of $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024. The combined total is $3.025 billion. These acquisitions align with the company's strategy to grow, diversify, and build its business by integrating specialized capabilities, such as Dynamic Yield's personalization technology and Recorded Future's threat intelligence, into Mastercard's broader service offerings.",
      "llm_answer": "Mastercard paid $325 million in cash for Dynamic Yield LTD in 2022 and $2.7 billion in cash for Recorded Future in 2024, for a total cash consideration of $3.025 billion across the two acquisitions. This spending reflects the company’s strategy of diversifying its business by acquiring technology firms that expand its data‑driven capabilities and cybersecurity offerings, thereby strengthening its value‑added services and solutions segment and supporting long‑term growth.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the cash consideration amounts are accurate: $325 million for Dynamic Yield LTD in 2022 and $2.7 billion for Recorded Future in 2024, with a correctly calculated total of $3.025 billion. Minor formatting differences (e.g., thin spaces, 'billion' vs 'B') do not affect accuracy. (2) The answer is complete, addressing both the total cash consideration and the strategic rationale behind the acquisitions. (3) Entity accuracy is perfect: both companies, correct years, and proper financial terms are used. (4) The reasoning is sound and reflects multi-hop synthesis—correctly linking two separate acquisitions to Mastercard's broader strategy of diversification and enhancing data-driven and cybersecurity capabilities. (5) The qualitative explanation is semantically equivalent to the original answer, using slightly different phrasing (e.g., 'value-added services and solutions segment') but conveying the same strategic intent. All components of the question are addressed with factual precision and logical coherence.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 316,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the total fair value of International bonds held by VZ according to both tables, and how does the categorization of these bonds differ between the two disclosures?",
      "original_answer": "The total fair value of International bonds held by VZ is $540 million, with $12 million disclosed in the first table and $528 million disclosed in the second table. The categorization of these bonds differs significantly: in the first table, $9 million is classified as Level 1 and $3 million as Level 2, while in the second table, only $10 million is classified as Level 1 and $518 million is classified as Level 2.",
      "llm_answer": "The total fair value of International bonds held by Verizon in the pension plans was $341 million in 2023 and $528 million in 2022. In the 2023 disclosure these bonds are classified under “International bonds” within the fixed‑income securities category, whereas in the 2022 table they are listed simply as “International bonds” without separate level designations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both numbers and reasoning. The ground truth states the total fair value is $540 million ($12 million in the first table and $528 million in the second), but the LLM reports $341 million in 2023 and $528 million in 2022, which does not match the original data. The $341 million figure is unexplained and contradicts the $12 million from the first table. Additionally, the LLM introduces years (2022, 2023) not mentioned in the question or ground truth, suggesting a misalignment with the source data. (2) The quantitative inaccuracies are severe: the total fair value is off by over $200 million, and the breakdown between tables is incorrect. The ground truth specifies $12M + $528M = $540M, while the LLM implies a decrease from $528M to $341M, which is unsupported. Furthermore, the LLM fails to report the Level 1 and Level 2 classifications entirely—critical to the question. Instead, it vaguely references 'no separate level designations' in 2022, which contradicts the ground truth that provides detailed Level 1 ($10M) and Level 2 ($518M) breakdowns in the second table. (3) The multi-hop reasoning is flawed: the model fails to synthesize the two tables correctly, misidentifies the time periods, and omits the core categorization differences by fair value hierarchy (Level 1 vs Level 2), which is a central part of the question. (4) The contextual relevance is partially maintained as the answer discusses international bonds and fair value disclosures for VZ (Verizon), but the incorrect figures, invented years, and missing classification details severely undermine accuracy. Due to major factual and quantitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1201,
        "completion_tokens": 469,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Mastercard's real-time account-based payments infrastructure support its global payment network operations, and what portion of transactions does it handle for domestic and cross-border Mastercard and Maestro-branded card transactions?",
      "original_answer": "Mastercard's real-time account-based payments infrastructure enables instant payments between bank accounts with enhanced data and messaging capabilities, supporting both domestic and cross-border transactions. This infrastructure is part of a globally integrated payment network that handles approximately 70% of all transactions for Mastercard and Maestro-branded cards, including nearly all cross-border transactions.",
      "llm_answer": "Mastercard’s real‑time account‑based payments infrastructure—built on a globally integrated, distributed architecture—enables instant, secure clearing and settlement of ACH and other account‑to‑account transactions across more than 220 countries, providing the speed, data richness and scalability needed to support its four‑party network. This infrastructure processes roughly 70 % of all Mastercard and Maestro‑branded transactions, handling the majority of both domestic and cross‑border payments for the company’s payment‑network revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 70% figure for transactions handled by Mastercard's real-time infrastructure is correctly reported, matching the original answer exactly. There are no calculation errors or incorrect numbers. (2) The answer addresses both parts of the question: it explains how the infrastructure supports global operations (instant, secure clearing across 220+ countries with data richness and scalability) and specifies the transaction volume it handles. (3) Entity accuracy is strong—Mastercard and Maestro-branded transactions are correctly referenced, and the infrastructure is accurately described as part of a globally integrated network. (4) The reasoning is sound and reflects multi-hop synthesis: the infrastructure supports both domestic and cross-border transactions, and the 70% figure applies to total transactions, which includes nearly all cross-border ones as per the ground truth. The only minor shortcoming is that the LLM says the infrastructure handles 'the majority of both domestic and cross-border payments,' whereas the original specifies 'nearly all cross-border transactions.' This slightly understates the cross-border coverage, making the qualitative accuracy excellent but not perfect. Overall, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 380,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much cash consideration did Walmart U.S. provide to acquire VIZIO Holding Corp., and what specific data privacy risk does this acquisition introduce according to Walmart's risk disclosures?",
      "original_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart's risk disclosures, this acquisition introduces data privacy risks because VIZIO collects certain consumer data, including television viewing data, which is stored digitally and could be exposed due to cybersecurity incidents or failures in systems, potentially leading to litigation, fines, and reputational damage.",
      "llm_answer": "Walmart U.S. provided $1.9 billion in cash consideration to acquire VIZIO Holding Corp. According to Walmart’s risk disclosures, the acquisition introduces a data‑privacy risk because VIZIO’s subsidiaries collect consumer data—including television‑viewing information—and integrate it into Walmart’s digital platforms, creating potential exposure to data‑breach, regulatory, and privacy‑related liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $1.9 billion cash consideration, matching the ground truth exactly. This satisfies the quantitative requirement with no discrepancies in number, format, or unit. 2) On qualitative accuracy, the LLM accurately captures the core data privacy risk related to VIZIO’s collection of consumer viewing data. It correctly links this to potential regulatory, litigation, and breach risks. The only minor deviation is that the LLM mentions 'integration into Walmart’s digital platforms,' which adds a detail not explicitly stated in the ground truth—though it is a reasonable inference given the nature of acquisitions. The ground truth emphasizes the digital storage and exposure risk due to cybersecurity failures, while the LLM focuses on integration-related liabilities. Both are contextually valid, but the LLM slightly reframes the risk without contradicting it. 3) The multi-hop reasoning is sound: the model connects Walmart's acquisition, the financial consideration, and the associated risk disclosure from Walmart’s filings regarding VIZIO’s data practices. All entities (Walmart U.S., VIZIO Holding Corp.) and financial terms are accurate. 4) The answer is fully contextually relevant, addressing both sub-questions directly and synthesizing information across financial and risk-disclosure domains. The semantic meaning aligns closely with the original answer, warranting a high correctness score despite slight rewording of the risk mechanism.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 409,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "What is the net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022, considering the $14 million increase in fuel cost recovery in operating income and the $35 million increase in fuel-related operating expenses?",
      "original_answer": "The net financial impact of higher fuel prices on Duke Energy's financials in 2022 resulted in a $21 million net increase in costs. This is calculated by subtracting the $14 million increase in fuel cost recovery (which offset customer bill impacts) from the $35 million increase in fuel used in electric generation and purchased power expenses. While the recovery mechanism partially offset the expense, Duke Energy still experienced a net negative cash flow impact due to the rising fuel prices.",
      "llm_answer": "The net financial impact of higher fuel prices on Duke Energy's operating cash flows and operating expenses in 2022 was an increase of $14 million in fuel cost recovery reflected in operating income, offset by a $35 million rise in fuel‑related operating expenses. Consequently, operating cash flows were pressured by roughly $21 million of additional fuel costs, while operating expenses grew by the same $35 million amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures: $14 million increase in fuel cost recovery and $35 million increase in fuel-related operating expenses. It accurately calculates the net impact as $21 million, which matches the ground truth calculation ($35M - $14M = $21M). (2) Quantitative accuracy is perfect—numbers are correct, properly attributed, and the arithmetic is sound. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect meaning. (3) The reasoning is logically sound and reflects multi-hop synthesis: it connects the increase in operating expenses with the partial offset from recovery mechanisms, concluding a net negative impact on cash flows. The only minor shortcoming is that it does not explicitly state that the $21 million represents a net increase in costs or a net negative impact, though it implies this by stating operating cash flows were 'pressured.' The original answer emphasizes the net negative impact more clearly. (4) Contextual relevance is excellent—the response directly addresses both operating cash flows and operating expenses as asked, and all information pertains to Duke Energy in 2022. Overall, the answer is factually correct and semantically equivalent to the ground truth with only slight room for improved clarity on the nature of the $21 million impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 379,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How much in additional period charges in 2021 were associated with the ramp up of Intel 4, and how does this relate to the rebranding of the manufacturing process node announced in July 2021?",
      "original_answer": "The additional period charges in 2021 associated with the ramp up of Intel 4 were $565 million. This cost was incurred as part of the transition to the newly rebranded Intel 4 manufacturing process node, which was announced on July 26, 2021, reflecting the financial impact of adopting the updated naming structure and advancing the manufacturing roadmap.",
      "llm_answer": "In 2021, Intel recorded approximately **$565 million in additional period charges** that were tied to the ramp‑up of its Intel 4 manufacturing process. These charges are mentioned in the MD&A financial‑performance tables (page 24) and are directly linked to the company’s announcement in July 2021 that it would rename its 10 nm Enhanced SuperFin node to **Intel 4**, marking the first step of its new “IDM 2.0” process‑node naming scheme (see page 115). The rebranding underscores Intel’s effort to signal a distinct next‑generation node that underpins the ramp‑up investments reflected in those period charges.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $565 million in additional period charges for 2021 is accurately reported, and the July 2021 rebranding date aligns with the ground truth announcement on July 26, 2021 (referenced as 'July 2021' in both). (2) The answer correctly identifies the rebranding of the 10 nm Enhanced SuperFin node to Intel 4, which is consistent with the knowledge graph. (3) The multi-hop reasoning is sound: it connects the financial impact (charges) to the strategic rebranding under the IDM 2.0 initiative, demonstrating synthesis between financial data and corporate strategy. (4) The LLM provides additional contextual support by referencing specific document sections (MD&A page 24, page 115), enhancing credibility without introducing inaccuracies. Wording differs slightly but maintains semantic equivalence. All entities—Intel, Intel 4, 2021, period charges, rebranding—are correctly identified and logically linked. No errors in facts, calculations, or reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 300,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What percentage of Danaher's 2023 Diagnostics segment sales were attributed to Other Developed Markets, and how does this compare to the number of employees the company had in those same markets as of the end of 2023?",
      "original_answer": "Danaher's Diagnostics segment attributed 5% of its 2023 sales to Other Developed Markets. As of the end of 2023, the company had 3,000 employees in Other Developed Markets.",
      "llm_answer": "Based on the provided document pages, the percentage of Danaher's 2023 Diagnostics segment sales attributed to Other Developed Markets is **5%** (as stated in the Diagnostics segment's geographic sales breakdown on page 10). Additionally, the company had approximately **3,000 employees** in other developed markets as of the end of 2023 (as reported in the Human Capital section on page 12). Thus, 5% of Diagnostics sales corresponded to about 3,000 employees in those markets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: the percentage of Danaher's 2023 Diagnostics segment sales attributed to Other Developed Markets is correctly stated as 5%, and the number of employees in those markets as of the end of 2023 is accurately reported as 3,000. (2) Quantitative accuracy is perfect—both numbers match the original answer exactly, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different sections of the document (geographic sales breakdown on page 10 and human capital data on page 12), linking Diagnostics segment sales to employee headcount in the same region. (4) The answer is contextually relevant, directly addressing both parts of the question and clearly stating the relationship between sales percentage and employee count in Other Developed Markets. Wording differences (e.g., 'approximately 3,000 employees') do not affect factual equivalence and are acceptable given typical reporting language.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 300,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What was the total revenue generated from Industrial chemicals & plastics in 2021, combining the revenue per car and the number of carloads for that year?",
      "original_answer": "$1,943,442 (or approximately $1.94 million) was generated from Industrial chemicals & plastics in 2021.",
      "llm_answer": "The total revenue generated from Industrial chemicals & plastics in 2021 was $1,943 million, calculated as the product of the average revenue per car ($3,207 million) and the number of carloads (606 thousand).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is severely incorrect in terms of quantitative accuracy. The stated total revenue is $1,943 million ($1.943 billion), which is over 1,000 times larger than the ground truth of $1.94 million. This indicates a major calculation or unit error. The LLM claims the average revenue per car is $3,207 million ($3.207 billion per car), which is nonsensical and clearly wrong—no single rail car generates billions in revenue. The number of carloads (606 thousand) may be in the plausible range, but when multiplied by $3.207 billion per car, the result is mathematically and logically invalid. The reasoning is fundamentally flawed, as the units are misapplied and the synthesis of revenue per car and carloads is executed incorrectly. While the answer attempts to address the multi-hop structure (revenue per car × carloads), the execution fails due to gross numerical and unit errors. The context is relevant—Industrial chemicals & plastics in 2021—but the factual content is almost entirely incorrect. Thus, the correctness and quantitative accuracy scores are low. Qualitative accuracy is slightly higher because the model recognizes the need to multiply two quantities, but the entities and values used are wrong. Contextual relevance is moderate as the topic and structure align with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1080,
        "completion_tokens": 363,
        "total_tokens": 1443
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "What is the total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing?",
      "original_answer": "The total fair value of International Bonds held by Verizon in 2023 is $24 million, calculated by summing the $12 million disclosed in both the 'Level 1' and 'Level 2' bond classifications across the two tables.",
      "llm_answer": "The total fair value of International Bonds held by Verizon (VZ) in 2023, as disclosed across both reported asset categories in the 10-K filing, is $341 million. This amount appears in the pension‑plan asset table on page 92, where International bonds are listed with a total fair‑value of $341 million (Level 1 = $3 million, Level 2 = $338 million, Level 3 = $‑). The same figure is reflected in the “Total investments at fair value” line for International bonds in the 2023 column.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect. (1) Quantitatively, it reports $341 million as the total fair value of International Bonds held by Verizon in 2023, whereas the ground truth is $24 million. The LLM incorrectly cites $3 million (Level 1) and $338 million (Level 2), summing to $341 million, which contradicts the correct values of $12 million in both Level 1 and Level 2, totaling $24 million. (2) The calculation is wrong and based on fabricated or misread data; there is no mention of Level 3 in the ground truth, and the LLM introduces a non-existent $338 million figure. (3) Qualitatively, the reasoning fails multi-hop synthesis: it references page 92 and pension-plan assets, but does not align with the correct data sources or categories ('Level 1' and 'Level 2' bond classifications) as required. The model appears to have extracted data from an unrelated section (possibly pension plan assets) instead of the correct asset categories for International Bonds. (4) Contextual relevance is low because, although it attempts to cite a specific table and structure, it addresses a different financial context (pension investments vs. the actual bond holdings in question). The answer is semantically and factually misaligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 351,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Costco's production of private-label items, as supported by its owned facilities, contribute to its strategy of leveraging SG&A expenses through comparable sales growth?",
      "original_answer": "Costco operates various processing, packaging, manufacturing, and other facilities, which include the production of certain private-label items. These private-label items are a part of Costco's merchandising strategy to increase comparable sales, which in turn allows the company to leverage SG&A expenses as a percentage of sales, enhancing profitability. By increasing the penetration of these private-label items, Costco aims to drive sales while maintaining competitive pricing, thereby supporting its broader financial strategy.",
      "llm_answer": "Costco’s owned production of private‑label items—supported by its own processing, packaging, and manufacturing facilities—helps the retailer keep merchandise costs low and maintain competitive pricing. By controlling the supply of these goods, Costco can more effectively drive comparable‑sales growth, which in turn allows it to leverage SG&A expenses across a larger sales base, reducing SG&A as a percentage of revenue and boosting profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key elements are correct: Costco owns facilities for processing, packaging, and manufacturing, including private-label items; these support cost control and competitive pricing; increased sales from private-label goods drive comparable-sales growth; this growth allows Costco to spread SG&A expenses over a larger revenue base, reducing SG&A as a percentage of sales and improving profitability. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly links owned production → private-label strategy → sales growth → SG&A leverage → profitability, which aligns with the original answer’s logic. (4) The only minor difference is that the LLM answer does not explicitly mention 'increasing penetration' of private-label items, a small nuance from the original, but the core strategic mechanism is accurately conveyed. Wording differs slightly but meaning is preserved. All entities (Costco, SG&A, private-label, comparable sales) are correctly identified and logically connected.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 340,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does Intel's RibbonFET technology, introduced in the Intel 20A node, contribute to the company's broader strategy of advancing process and packaging technologies, as outlined in both the R&D investment section and the IDM 2.0 strategy announcement?",
      "original_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, is a breakthrough gate-all-around transistor that enables faster switching speeds and improved performance-per-watt in a smaller footprint. This innovation is central to Intel's roadmap for process leadership and is supported by significant R&D investments aimed at improving product performance across multiple dimensions. Additionally, RibbonFET plays a key role in the IDM 2.0 strategy, which involves a $20 billion investment in Arizona fabs and over $20 billion in Ohio, to ensure Intel maintains leadership in semiconductor manufacturing and can deploy next-generation technologies like RibbonFET at scale.",
      "llm_answer": "Intel's RibbonFET technology, introduced in the Intel 20A node, advances its process and packaging capabilities by enabling faster transistor switching and more efficient power delivery—key innovations that support the company’s broader IDM 2.0 strategy. This technology is central to Intel’s push for process leadership and is highlighted in its R&D investments and IDM 2.0 roadmap to accelerate innovation in manufacturing and packaging, reinforcing its goal of delivering leadership products through enhanced process technology and advanced packaging solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in its description of RibbonFET as a key enabler of faster switching and improved power efficiency, and correctly identifies its role in Intel's process leadership and IDM 2.0 strategy. It accurately links RibbonFET to R&D investments and advanced manufacturing goals. However, it omits specific quantitative details present in the ground truth, such as the $20 billion investment in Arizona and over $20 billion in Ohio, which are critical components of the IDM 2.0 strategy announcement. While the qualitative reasoning and entity identification (Intel, RibbonFET, Intel 20A, IDM 2.0, R&D investments) are correct and the logic is sound, the absence of these dollar figures reduces completeness. There are no factual errors—only a partial omission of specific financial commitments—so the answer remains highly accurate but not fully complete. Quantitative accuracy is scored 10 because no incorrect numbers are stated; the LLM simply does not include the specific dollar amounts. Contextual relevance is perfect as the response directly addresses the question’s focus on strategy, process technology, and R&D. Qualitative accuracy is high but docked slightly for missing the investment specifics that ground the strategy in tangible actions.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 356,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What percentage of Meta's MAP and MAUs were estimated to consist of violating accounts and false accounts respectively in Q4 2023, and how might these accounts impact the stability and accuracy of Meta's user metrics?",
      "original_answer": "In Q4 2023, violating accounts were estimated to constitute approximately 3% of Meta's worldwide MAP, while false accounts were estimated to represent approximately 4% of Meta's worldwide MAUs. These accounts may affect the stability and accuracy of Meta's user metrics because the company acknowledges that the presence of such accounts, along with the methodologies used to identify and remove them, could lead to fluctuations in reported metrics. Additionally, limitations in data signals (e.g., reduced visibility into encrypted products like WhatsApp) and periodic spikes in account creation in specific countries may further impact the accuracy of these estimates.",
      "llm_answer": "In Q4 2023, Meta estimated that roughly 3 % of its worldwide MAP was made up of violating (spam/bot) accounts, while approximately 4 % of its worldwide MAUs were estimated to be false accounts. These accounts can distort the stability and accuracy of Meta’s user metrics by inflating the apparent size of its user base, leading to overstated engagement figures and potentially misleading estimates of revenue‑generating audiences. Consequently, the reported MAP and MAU numbers may be higher than the true, active user count, affecting the reliability of growth and market‑share assessments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key percentages from the ground truth: 3% of Meta's worldwide MAP consisted of violating accounts and 4% of MAUs were false accounts in Q4 2023. These values match exactly with the original answer, and the time period (Q4 2023) and entities (Meta, MAP, MAUs) are accurately referenced. (2) Quantitative accuracy is perfect—both percentages are correct, and no calculations are required beyond what is stated. Format variations (e.g., spacing in '3 %') do not affect correctness. (3) The reasoning is sound and captures the core impact: these accounts may distort user metrics by inflating user counts and engagement, affecting reliability of growth and audience estimates. While the LLM emphasizes business implications like overstated revenue-generating audiences, it omits a few nuanced points from the original answer—specifically, Meta's acknowledgment of methodological limitations in detection, reduced visibility due to encrypted platforms like WhatsApp, and periodic spikes in account creation in certain regions. These omissions slightly reduce qualitative completeness but do not introduce inaccuracies. (4) The answer remains highly contextually relevant, directly addressing both parts of the question—percentages and their impact on metric stability and accuracy. The slight deduction in qualitative accuracy reflects the missing detail about detection challenges and data signal limitations, but overall, the answer is factually correct, well-reasoned, and semantically equivalent in intent and substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 432,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset as of December 31, 2023, and why are these amounts recorded at the same value?",
      "original_answer": "The total fair value of PayPal's crypto asset safeguarding liability and corresponding safeguarding asset was the same as of December 31, 2023, because PayPal had not incurred any safeguarding loss events, and both were measured and recorded at fair value using quoted prices for the underlying crypto assets on the active exchange identified as the principal market.",
      "llm_answer": "As of December 31, 2023, the fair value of PayPal’s crypto‑asset safeguarding liability and the corresponding safeguarding asset were both $1,241 million. These amounts are recorded at the same value because the liability and asset are measured at fair value on a recurring basis using quoted prices for the underlying cryptocurrencies on the principal market, resulting in no difference between the recorded liability and the recorded asset.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly includes a specific dollar amount ($1,241 million) that is not present in the original answer or ground truth. The ground truth does not provide any numerical value for the fair value of PayPal's crypto asset safeguarding liability or asset as of December 31, 2023. This is a significant factual error, as the model fabricates a precise figure not supported by the source. (2) There are no calculations in the question or ground truth, so no calculation accuracy is required; however, the inclusion of an unsupported number severely undermines quantitative accuracy. (3) The reasoning for why the amounts are recorded at the same value is correct and aligns with the ground truth: both the liability and asset are measured at fair value using quoted prices on the principal market, and no safeguarding loss events have occurred. This reflects accurate multi-hop understanding of accounting treatment and valuation methodology. (4) Despite the incorrect number, the LLM correctly identifies the key conceptual rationale and addresses both parts of the question—total fair value (in principle) and the reason for equal valuation. The contextual and qualitative reasoning is sound, but the fabricated figure results in a moderate correctness score. The answer would have scored 9–10 if the number had been omitted or properly qualified (e.g., 'the amounts were equal but not specified').",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 395,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What is the total value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' combined for 2024, and how does this compare to the 2023 combined total?",
      "original_answer": "The total combined value of 'Other noncontrolling redeemable interests' and '7.50% Cumulative Redeemable Preferred Units' for 2024 is $184,729 (in thousands). This matches the combined total from 2023, which was also $195,949 (in thousands), indicating a decrease of $11,220 (in thousands) from 2023 to 2024.",
      "llm_answer": "The combined value of \"Other noncontrolling redeemable interests\" and \"7.50% Cumulative Redeemable Preferred Units\" was $184,729 thousand as of December 31 2024, compared with $195,949 thousand as of December 31 2023, representing a decrease of $11,220 thousand.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all factual information: the 2024 combined value is $184,729 thousand, the 2023 combined value is $195,949 thousand, and the decrease is $11,220 thousand. These match the ground truth exactly. (2) Quantitative verification: $195,949 - $184,729 = $11,220, which is accurate. All values are reported in thousands as in the original, and formatting (e.g., 'thousand' vs 'in thousands') is semantically equivalent. (3) The multi-hop reasoning—aggregating two line items across two years and computing the year-over-year difference—is fully correct and logically sound. (4) The answer is complete, addressing both the 2024 total and the comparison to 2023. All entities (financial line items, years) are correctly identified. Wording differs slightly from the original but conveys identical meaning. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 262,
        "total_tokens": 1416
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "What was the value of Southern Company Gas' floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, and how does this procurement strategy align with their regulated cost recovery framework?",
      "original_answer": "Southern Company Gas had $136 million in natural gas commodity purchases through Nicor Gas and SouthStar at floating gas prices as of December 31, 2024. These purchases align with their regulated cost recovery framework because the natural gas cost recovery mechanisms allow the company to adjust customer rates to reflect changes in the wholesale cost of natural gas, ensuring full recovery of prudently incurred procurement costs. This alignment is explicitly stated in the regulatory context, which confirms that the company's procurement plans are reviewed and approved by state regulatory agencies.",
      "llm_answer": "Southern Company Gas' floating‑price natural‑gas purchases through Nicor Gas and SouthStar totaled **$136 million** (39 million mmBtu at floating prices, valued at $136 million) as of December 31 2024. This procurement approach is fully integrated into the company’s regulated cost‑recovery framework, allowing the utilities to recover the actual wholesale gas costs from customers via natural‑gas cost‑recovery mechanisms approved by state regulators.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the $136 million figure for floating-price natural gas purchases through Nicor Gas and SouthStar as of December 31, 2024, is correct. The additional detail of 39 million mmBtu is not present in the ground truth but does not contradict it and may reflect supplementary data; its inclusion does not harm accuracy. (2) The entity names (Southern Company Gas, Nicor Gas, SouthStar), date (December 31, 2024), and financial metric (floating-price natural gas purchases) are all correctly identified. (3) The reasoning regarding alignment with the regulated cost recovery framework is sound: the LLM correctly explains that the company recovers actual wholesale gas costs via mechanisms approved by state regulators, which aligns with the ground truth’s reference to regulatory review and approval. (4) The only minor shortcoming is that the LLM does not explicitly mention that procurement plans are 'reviewed and approved' by regulators—a nuance present in the original answer that strengthens the regulatory alignment claim. However, the core logic and factual content are semantically equivalent. The answer is fully relevant and addresses both parts of the multi-hop question: the value of purchases and the regulatory alignment. Thus, the correctness score is 9 due to this slight omission in qualitative depth, despite perfect quantitative accuracy and strong contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 405,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What was the total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021, and how does this compare to the equity in earnings (losses) from the same region during the same year?",
      "original_answer": "The total net income attributable to ConocoPhillips from the Lower 48 region in 2021 was $4,932 million, while the equity in earnings (losses) for the same region in the same year was $(18) million. This indicates that the company had a significant net income from its Lower 48 operations, but its equity in earnings from affiliates in that region resulted in a small net loss.",
      "llm_answer": "The total net income (loss) attributable to ConocoPhillips from the Lower 48 region in 2021 was **$4,932 million**, while the equity in earnings (losses) from that same region for 2021 was **$(18) million**. Thus, the net income from the Lower 48 was substantially higher than the equity earnings (losses) for that year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $4,932 million for net income and $(18) million for equity in earnings (losses) are accurately reported, with correct formatting and sign notation. (2) The answer addresses both parts of the question: it provides the total net income attributable to ConocoPhillips from the Lower 48 region in 2021 and compares it to the equity in earnings (losses) from the same region and year. (3) Entity accuracy is correct—'ConocoPhillips', 'Lower 48 region', and '2021' are all properly identified. (4) The reasoning is sound: the comparison correctly highlights that net income was substantially higher than the equity in earnings, which was a small loss. The semantic meaning is equivalent to the original answer, with only minor wording differences that do not affect factual content. All multi-hop elements (synthesizing net income and equity earnings from the same region and year) are correctly handled.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 288,
        "total_tokens": 1477
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "What is the total notional value of unsettled forward foreign-exchange contracts and variable-priced commodity contracts used by the company in 2024, and how does this combined exposure reflect the company's strategy to manage financial risks associated with currency and commodity price fluctuations?",
      "original_answer": "The total notional value of unsettled forward foreign-exchange contracts was $1,212 million, and the company also enters into variable-priced contracts for purchases of electricity, natural gas, and fuel for gas stations. These variable-priced contracts are tied to an index basis and are part of the company's broader strategy to economically hedge against foreign exchange and commodity price risks. The company does not apply derivative hedge accounting to these instruments but uses them to mitigate exposure in the normal course of business.",
      "llm_answer": "The company's total notional value of unsettled forward foreign‑exchange contracts at the end of 2024 was $1,212 million, and it also uses variable‑priced commodity contracts for energy and other commodities; however, the provided excerpts do not disclose a separate, aggregate notional amount for those commodity contracts. Consequently, the combined exposure is represented solely by the $1.212 billion of forward FX contracts, which the company employs to hedge currency fluctuations in its international operations and to mitigate price volatility in energy and other commodities, aligning with its strategy of economically hedging known future expenditures without engaging in speculative activities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies the total notional value of unsettled forward foreign-exchange contracts as $1,212 million (or $1.212 billion), which matches the ground truth exactly. However, the question asks for the 'total notional value' of *both* forward foreign-exchange contracts *and* variable-priced commodity contracts. The ground truth does not provide a combined numerical total either, but clarifies that variable-priced commodity contracts exist and are part of the hedging strategy. The LLM accurately reflects this lack of disclosed aggregate amount for commodity contracts and does not fabricate a number, which is correct. 2) Quantitatively, the $1,212 million figure is accurate and correctly formatted in multiple equivalent ways (million vs billion). No calculations were required, and all numbers are factually correct. 3) The multi-hop reasoning is sound: the LLM synthesizes that FX contracts are used for hedging currency risk and that variable-priced commodity contracts (though not quantified) are used for energy commodities, aligning with the company’s economic hedging strategy. It correctly notes the absence of derivative hedge accounting and emphasizes use in normal course of business, consistent with the original answer. 4) The LLM slightly overreaches by stating the combined exposure is 'represented solely by' the FX contracts, which may imply the commodity contracts have no notional value, rather than simply being undisclosed. This is a minor misrepresentation in emphasis but not in fact. Overall, the answer is highly accurate, complete in context, and contextually appropriate, warranting a high score but not perfect due to subtle framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 457,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Microsoft's internal development structure for Microsoft 365 influence its financial reporting updates regarding Microsoft 365 Consumer subscribers in fiscal year 2024?",
      "original_answer": "Microsoft's internal development of Microsoft 365 through its 'Experiences and Devices' engineering group enables direct control over product evolution and user experience, which aligns with the company's decision to update its financial reporting by expanding the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers. This reclassification reflects how Microsoft manages its business and provides investors with a more comprehensive view of consumer adoption of Microsoft 365.",
      "llm_answer": "Microsoft's internal development structure for Microsoft 365—organized around dedicated engineering groups such as Cloud & AI, Experiences & Devices, and Microsoft AI—directly shapes how it reports on Microsoft 365 Consumer subscribers in its FY 2024 financial disclosures. By tracking subscriber counts (including the expanded Microsoft 365 Basic base) and linking revenue growth to Office 365 Commercial and Consumer segments, the company can attribute revenue and margin trends to the underlying product development and subscription‑management processes that drive those consumer‑focused results. This integration is reflected in the FY 2024 MD&A tables that show Office Consumer products and cloud services revenue growth and Microsoft 365 Consumer subscriber numbers as key performance metrics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies Microsoft's internal development structure, specifically mentioning the 'Experiences & Devices' group, which matches the original answer. It correctly notes the expansion of the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers in FY 2024, a key factual point. (2) There are no numeric values (e.g., subscriber counts, revenue figures) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 as no incorrect numbers are present. (3) The multi-hop reasoning is sound: the model connects internal engineering structure to financial reporting changes, explaining that integrated development enables more granular and meaningful subscriber tracking and reporting. However, the LLM slightly overreaches by mentioning 'Cloud & AI' and 'Microsoft AI' groups, which are not referenced in the ground truth and are less directly tied to Microsoft 365 consumer development, introducing minor entity noise. (4) The answer is contextually highly relevant, addressing both the structural influence and its impact on financial reporting. While the core insight about reclassification for investor transparency is implied, it is not explicitly stated as clearly as in the original answer. Thus, minor deductions in qualitative accuracy and overall correctness for incomplete emphasis on the strategic reporting rationale.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 406,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How many shares, in total, are counted toward the maximum shares available under Pfizer's 2019 Stock Plan for Performance Share Awards (PSAs) if each PSA counts as three shares times the maximum potential payout, and what is the significance of this calculation in relation to the 248 million shares still available for award as of December 31, 2023?",
      "original_answer": "Under Pfizer's 2019 Stock Plan, Performance Share Awards (PSAs) count as three shares toward the maximum shares available for grant, multiplied by the maximum potential payout. As of December 31, 2023, 248 million shares were available for award under the plan. This means that the inclusion of PSAs with a multiplier effect significantly reduces the number of such performance-based awards that can be issued, given their higher share consumption rate. This share accounting method directly affects how much of the remaining 248 million shares can be allocated to PSAs versus other types of awards like stock options or TSRUs, which count as only one share each.",
      "llm_answer": "The 2019 Stock Plan allows Performance Share Awards (PSAs) to count toward the maximum share reserve using a multiplier of three shares for each unit of potential payout. Based on the disclosed calculation, the total number of shares counted toward the plan’s maximum reserve from PSAs is derived from this multiplier applied to the maximum potential payout of the awards. This calculation is significant because it directly impacts the number of shares still available for future awards—specifically, the 248 million shares remaining as of December 31, 2023, which includes the shares reserved for PSAs after applying the three‑times multiplier. Thus, understanding this reserve helps assess the company’s remaining equity‑based compensation capacity.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the three-share multiplier for PSAs under Pfizer's 2019 Stock Plan and references the 248 million shares available as of December 31, 2023, which matches the ground truth. However, it does not explicitly state that each PSA counts as three shares *times the maximum potential payout*, which is a critical nuance—the multiplier applies to the full potential award, not just per unit. This omission affects completeness and precision in conveying the full calculation methodology. (2) Quantitatively, the key numbers—the 3x multiplier and the 248 million remaining shares—are accurate and correctly dated. There are no calculation errors because no explicit computation (e.g., of a specific PSA's share impact) is attempted. The format and values align with the ground truth. (3) The reasoning is partially sound: the LLM recognizes that the multiplier affects share reserve usage and impacts future award capacity. However, it fails to explicitly contrast PSAs with other awards like stock options or TSRUs that count as one share each, which is a key part of the significance explained in the original answer. This weakens the multi-hop synthesis—while the concept of constrained capacity is mentioned, the comparative share consumption across award types is missing. (4) Despite these gaps, the answer remains contextually relevant and conveys the core idea that PSAs consume shares at an accelerated rate, affecting the usability of the remaining 248 million shares. Wording differences are acceptable under semantic equivalence, but the missing detail on payout scaling and comparative award types prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 457,
        "total_tokens": 1862
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 750,
    "successful_evaluations": 750,
    "failed_evaluations": 0,
    "average_correctness_score": 6.62,
    "average_quantitative_accuracy": 7.09,
    "average_qualitative_accuracy": 6.95,
    "average_contextual_relevance": 8.71,
    "score_distribution": {
      "excellent": 337,
      "good": 104,
      "fair": 138,
      "poor": 171
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_2hop_intra_doc",
    "total_questions": 750
  }
}